data_2jvi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jvi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.792 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 13.8 tt0 . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.545 0.688 . . . . 2.2999999999999998 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.894 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.7 tppt? -134.74 145.15 48.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.108 0.48 . . . . 1.3999999999999999 111.533 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.909 ' HB ' HG21 ' A' ' 30' ' ' THR . 1.7 mt -136.7 156.41 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.305 -0.861 . . . . 1.04 111.454 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.847 ' HB3' HG12 ' A' ' 51' ' ' VAL . 3.1 tt -133.48 120.16 20.5 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.656 -1.239 . . . . 0.98999999999999999 107.656 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.769 HD13 ' HB ' ' A' ' 30' ' ' THR . 1.8 mp -107.48 103.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.474 -0.89 . . . . 1.1200000000000001 110.385 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 28.9 t -88.7 82.62 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 110.051 -0.351 . . . . 1.0900000000000001 110.051 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.841 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 51.8 t0 -133.5 138.92 46.36 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.115 -0.328 . . . . 1.8200000000000001 110.115 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 1.044 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 37.0 t70 -85.82 -27.83 24.87 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.022 -0.732 . . . . 0.51000000000000001 109.022 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -78.86 73.47 5.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.51 -1.293 . . . . 2.5600000000000001 107.51 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 41.8 p90 -48.47 -19.67 0.34 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.511 -1.222 . . . . 1.8300000000000001 113.271 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.03 -69.71 1.19 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.36 -1.096 . . . . 0.41999999999999998 110.36 167.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 2.9 mp -51.03 -26.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 122.916 0.486 . . . . 1.5600000000000001 111.863 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.907 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 9.0 ttm180 -76.96 -46.53 23.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.312 -0.404 . . . . 0.47999999999999998 110.73 -172.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.514 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 36.3 pt -77.03 -25.45 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.283 -0.636 . . . . 1.1899999999999999 109.283 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 108' ' ' ILE . 4.5 tp -53.9 -66.19 0.44 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.135 -0.939 . . . . 1.22 109.157 169.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 64.5 mt -57.25 -39.95 76.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 1.8400000000000001 110.57 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.703 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.5 t30 -51.53 -67.87 0.22 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.042 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -39.59 77.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.313 0.486 . . . . 2.46 112.313 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' LEU . 39.5 t -55.18 -58.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.787 0.292 . . . . 1.2 111.787 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HB2' HG22 ' A' ' 30' ' ' THR . 8.2 m-85 -73.74 -35.13 65.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.287 -0.635 . . . . 0.51000000000000001 109.287 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.91 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.3 t-20 -50.48 -47.93 56.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.06 -0.973 . . . . 0.32000000000000001 108.668 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.517 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -57.68 -42.2 83.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.315 -1.766 . . . . 3.6699999999999999 111.938 -178.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 23' ' ' PHE . 3.2 mt-10 -58.62 -26.82 64.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.809 0.814 . . . . 1.51 109.719 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.6 ' HA3' HD22 ' A' ' 121' ' ' LEU . . . 139.09 -10.61 3.32 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 114.193 -1.367 . . . . 0.56999999999999995 110.295 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.91 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 1.8 m-85 -71.62 124.03 23.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 120.119 -0.632 . . . . 1.49 110.838 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.894 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -79.12 82.99 5.23 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.26 -1.015 . . . . 1.1399999999999999 108.26 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.909 HG21 ' HB ' ' A' ' 6' ' ' ILE . 20.6 p -91.04 134.02 34.84 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.973 -0.558 . . . . 0.95999999999999996 110.493 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 12.9 m-85 -125.48 120.76 31.83 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.57 1.176 . . . . 0.42999999999999999 109.419 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.907 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 5.2 pt20 -81.18 121.72 26.48 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 112.736 -2.029 . . . . 0.23999999999999999 111.693 -173.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.902 ' HB2' ' HB3' ' A' ' 38' ' ' GLN . . . -122.14 131.3 53.89 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.696 0.799 . . . . 1.0 109.145 176.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB1' ' NH2' ' A' ' 16' ' ' ARG . . . -91.16 -7.17 52.25 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.983 -0.687 . . . . 0.78000000000000003 110.897 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.533 HD21 ' HB2' ' A' ' 37' ' ' LEU . 2.4 p-10 -147.73 165.5 30.33 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.42 -0.512 . . . . 0.28999999999999998 111.699 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -23.16 73.13 Favored Glycine 0 CA--C 1.507 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.17999999999999999 113.118 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' HB2' HD21 ' A' ' 35' ' ' ASN . 2.9 mm? -76.54 -39.87 51.6 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.725 -0.843 . . . . 1.1200000000000001 108.725 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -60.51 -44.88 95.55 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.091 -2.189 . . . . 1.78 105.091 177.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -61.14 -44.43 97.34 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.98999999999999999 111.252 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.609 HD21 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -55.83 -44.82 78.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.461 0.648 . . . . 1.5700000000000001 109.473 175.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -61.59 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.666 -1.152 . . . . 1.3200000000000001 110.32 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.838 HG12 ' O ' ' A' ' 38' ' ' GLN . 8.5 mm -63.69 -47.35 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 120.551 0.215 . . . . 1.04 111.418 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' A' ' 69' ' ' MET . 41.2 t -59.88 -42.43 89.16 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.678 0 CA-C-O 121.486 0.66 . . . . 1.0600000000000001 109.506 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -72.31 -22.15 61.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.562 -0.745 . . . . 0.95999999999999996 111.197 -177.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.78 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 2.1 ptmt -89.82 -44.89 9.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 2.9900000000000002 111.225 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 60.6 mm-40 -111.14 -35.71 5.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 111.897 0.332 . . . . 0.63 111.897 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 43' ' ' VAL . 37.6 mmt180 69.01 59.83 0.62 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 123.936 0.772 . . . . 4.2800000000000002 109.123 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.646 ' O ' HG13 ' A' ' 76' ' ' ILE . 52.4 Cg_exo -61.23 153.74 63.01 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 121.457 1.438 . . . . 0.20999999999999999 111.222 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.3 m-20 -92.69 -34.1 14.09 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.713 -0.795 . . . . 0.97999999999999998 109.415 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD23 HD12 ' A' ' 79' ' ' ILE . 7.8 mp -118.57 113.33 21.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.013 -0.54 . . . . 1.1599999999999999 110.214 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.847 HG12 ' HB3' ' A' ' 7' ' ' LEU . 46.9 t -113.26 112.19 39.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.017 0.437 . . . . 1.05 111.665 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.412 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 2.9 mp -82.06 94.28 7.17 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.277 0.56 . . . . 1.0700000000000001 110.389 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.671 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -83.04 98.8 9.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.18 -0.918 . . . . 2.2000000000000002 111.635 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.612 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 35.6 t70 -70.98 103.91 2.82 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.426 -0.91 . . . . 1.47 109.156 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.593 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 19.9 mtm -80.29 -1.07 39.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.015 -0.539 . . . . 1.6499999999999999 110.772 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 12.6 mmmm -56.9 -67.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.724 1.009 . . . . 2.73 113.724 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.78 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 4.6 pt -152.91 -22.87 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.638 1.347 . . . . 2.6099999999999999 114.638 -167.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 1.044 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -33.62 -48.12 0.46 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.356 2.704 . . . . 0.55000000000000004 115.564 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 -48.36 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.551 -1.309 . . . . 0.55000000000000004 113.077 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.405 ' HG2' ' N ' ' A' ' 61' ' ' ASP . 58.1 ttm -143.35 163.35 33.28 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.113 -0.699 . . . . 2.6699999999999999 109.113 -175.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' N ' ' HG2' ' A' ' 60' ' ' MET . 35.3 m-20 -61.15 136.57 58.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.094 0.473 . . . . 0.67000000000000004 109.961 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.671 ' HA3' ' HB3' ' A' ' 53' ' ' LEU . . . -63.65 -9.93 34.83 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.309 -0.948 . . . . 0.32000000000000001 112.157 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.917 HD11 ' HB3' ' A' ' 89' ' ' MET . 4.7 mt -73.33 -52.64 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.123 0.487 . . . . 1.9199999999999999 110.067 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.81 -33.21 75.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.749 0.785 . . . . 0.46999999999999997 109.231 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.743 HG23 ' HE2' ' A' ' 69' ' ' MET . 49.7 mt -74.82 -37.7 42.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.177 -0.92 . . . . 1.3600000000000001 110.912 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 3.1 pp -66.96 -36.2 81.67 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.379 -0.528 . . . . 2.1600000000000001 110.414 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.683 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.9 ptpt -75.84 -34.63 60.09 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.453 -0.499 . . . . 1.3400000000000001 111.175 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.72 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.1 ptm180 -66.78 -33.49 75.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.559 -0.857 . . . . 2.8599999999999999 111.054 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.78 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.8 ptp -82.8 -13.69 55.76 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.561 -0.856 . . . . 1.95 109.889 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.683 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.3 mptp? -79.12 -29.83 43.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.572 0.701 . . . . 1.9299999999999999 109.877 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.4 p -78.47 -34.98 18.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.028 -0.73 . . . . 1.8300000000000001 109.028 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.78 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -81.14 -28.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 1.02 109.98 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -157.94 88.93 0.98 Allowed 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 112.928 0.714 . . . . 1.0800000000000001 112.928 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.0 1.73 10.28 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.047 -1.033 . . . . 1.78 109.831 175.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -27.29 63.86 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.796 1.284 . . . . 0.34999999999999998 107.722 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.669 HG22 ' HG3' ' A' ' 69' ' ' MET . 3.2 tt -74.25 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 112.492 -2.14 . . . . 1.05 110.938 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 3.4 ptp180 -139.21 174.32 10.64 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.981 -1.118 . . . . 1.45 107.981 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.675 HG21 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -138.97 148.32 24.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.618 0.723 . . . . 1.55 111.47 -173.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.824 HG22 ' HG1' ' A' ' 100' ' ' THR . 63.3 mt -119.72 72.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.961 -1.126 . . . . 1.3500000000000001 107.961 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -68.65 141.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.318 -0.856 . . . . 1.02 111.768 -172.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.55 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 4.0 mtm -102.05 135.22 44.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.012 -0.995 . . . . 2.5499999999999998 110.595 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 t -133.4 161.59 34.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.493 0.663 . . . . 1.78 112.672 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . . . -74.1 52.74 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.99 -1.005 . . . . 1.1000000000000001 110.593 169.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.443 ' HA ' ' HB3' ' A' ' 103' ' ' ALA . 22.4 t80 72.84 30.86 1.67 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.974 -1.012 . . . . 4.4400000000000004 112.085 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.87 76.53 1.23 Allowed Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.885 -0.674 . . . . 0.65000000000000002 112.892 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.44 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.5 mt-10 -81.06 12.04 3.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.444 -0.878 . . . . 1.3300000000000001 111.799 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 21.2 mt 54.38 -169.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.391 0.886 . . . . 2.2799999999999998 113.391 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 87' ' ' LEU . 13.4 t70 58.08 -97.62 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.337 -0.847 . . . . 1.3799999999999999 110.852 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.917 ' HB3' HD11 ' A' ' 63' ' ' ILE . 57.6 mtm -51.52 -37.01 47.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.834 0.854 . . . . 3.3700000000000001 110.731 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 93' ' ' SER . 33.0 mm -58.78 -47.67 88.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 1.3700000000000001 111.109 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -60.69 -55.05 37.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.451 -0.795 . . . . 3.1800000000000002 109.51 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' HG2' HG23 ' A' ' 63' ' ' ILE . 7.0 tt0 -58.42 -33.57 69.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.853 -1.067 . . . . 1.27 112.085 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.459 ' OG ' HG12 ' A' ' 63' ' ' ILE . 4.9 m -54.08 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.63 0.729 . . . . 1.5600000000000001 111.8 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.843 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 12.8 ptpt -52.33 -37.35 55.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.837 -1.074 . . . . 2.3100000000000001 111.004 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 17.7 tp10 -55.98 -37.99 69.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.965 -1.016 . . . . 1.8400000000000001 112.1 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.9 mt -85.77 -15.09 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.795 0.665 . . . . 1.8999999999999999 112.795 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 147.54 4.18 0.39 Allowed Glycine 0 C--N 1.317 -0.519 0 C-N-CA 119.778 -1.201 . . . . 0.34999999999999998 113.023 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.843 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -79.21 131.69 36.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.263 0.532 . . . . 1.02 109.936 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 77' ' ' ARG . 11.2 mt -74.39 -49.32 23.06 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.856 0.836 . . . . 1.05 109.734 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.824 ' HG1' HG22 ' A' ' 79' ' ' ILE . 41.3 p -140.14 153.45 46.67 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.0 -1.455 . . . . 1.05 111.756 -170.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -116.96 85.7 2.37 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.871 -1.059 . . . . 1.1799999999999999 109.215 172.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -76.43 145.66 39.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 4.75 110.579 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 84' ' ' TYR . . . -121.68 -168.43 1.69 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.109 -0.496 . . . . 1.24 112.001 -173.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 45.5 mtpt -52.92 -50.4 81.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.168 -0.924 . . . . 3.7200000000000002 111.654 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 68.9 Cg_endo -75.46 97.43 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.127 1.218 . . . . 1.6699999999999999 111.393 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB2' HD12 ' A' ' 111' ' ' ILE . 46.9 p90 -129.24 133.45 47.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.822 -0.626 . . . . 1.29 110.208 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.67 ' O ' HG21 ' A' ' 108' ' ' ILE . 7.3 t70 -72.73 -4.27 30.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.916 -0.584 . . . . 1.77 111.413 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.67 HG21 ' O ' ' A' ' 107' ' ' ASP . 3.6 tt 63.06 -54.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.559 1.144 . . . . 1.9199999999999999 109.882 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.2 -34.98 79.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.576 -0.284 . . . . 1.1599999999999999 110.516 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.499 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 11.5 pt-20 -65.15 -27.41 68.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.579 -0.449 . . . . 0.83999999999999997 110.772 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 106' ' ' PHE . 19.3 mt -80.51 -44.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.108 -0.33 . . . . 1.5600000000000001 110.108 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 113' ' ' ASP . 2.4 ppt_? -69.73 -35.47 75.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.776 0.798 . . . . 0.80000000000000004 109.423 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.61 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.0 t70 -63.77 -42.63 97.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.695 -0.854 . . . . 0.78000000000000003 108.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.946 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -60.29 -48.79 80.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.857 -1.065 . . . . 1.3100000000000001 111.462 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 112' ' ' ARG . 35.5 m -61.3 -43.06 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.912 -0.715 . . . . 1.1200000000000001 111.004 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 8.3 ttpt -58.06 -55.96 28.18 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 120.909 0.385 . . . . 1.99 111.151 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.946 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 46.1 pttt -65.68 -13.15 58.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.516 0.562 . . . . 2.0899999999999999 112.516 -176.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -92.01 -41.2 10.67 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.583 -0.447 . . . . 2.3900000000000001 111.443 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -146.6 95.96 4.51 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.331 -0.988 . . . . 2.7599999999999998 108.331 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -96.4 123.74 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.815 2.344 . . . . 0.92000000000000004 114.182 -171.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.693 ' HB3' ' CD ' ' A' ' 4' ' ' GLU . 12.7 tp . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.356 0.598 . . . . 1.9399999999999999 110.076 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.834 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 120.701 0.286 . . . . 2.2999999999999998 110.848 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 4.0 tppt? -134.6 140.44 46.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.016 0.436 . . . . 1.3999999999999999 112.06 -173.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.869 ' HB ' HG21 ' A' ' 30' ' ' THR . 1.9 mt -137.0 155.84 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.276 -0.874 . . . . 1.04 112.061 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.866 HD12 ' HB ' ' A' ' 42' ' ' ILE . 3.4 tt -133.86 118.35 17.87 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 107.934 -1.136 . . . . 0.98999999999999999 107.934 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.657 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -105.72 102.98 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.886 -0.725 . . . . 1.1200000000000001 110.211 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 44.3 t -89.38 79.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 122.967 0.167 . . . . 1.0900000000000001 110.68 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.818 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.3 t70 -129.97 140.84 50.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 1.8200000000000001 110.817 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.776 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 26.9 t70 -94.81 -32.91 13.07 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.501 -0.318 . . . . 0.51000000000000001 111.048 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 70.07 8.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.497 -1.297 . . . . 2.5600000000000001 107.497 173.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' O ' HG12 ' A' ' 17' ' ' ILE . 41.1 p90 -47.94 -16.08 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 111.862 -2.426 . . . . 1.8300000000000001 115.342 -166.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.49 -61.62 6.18 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.751 -1.339 . . . . 0.41999999999999998 109.751 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.587 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 3.1 mt -54.92 -29.34 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.224 0.535 . . . . 1.5600000000000001 111.136 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.837 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -77.58 -48.67 16.36 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.772 -0.649 . . . . 0.47999999999999998 111.055 -168.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 41.5 pt -75.71 -25.06 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.247 -0.649 . . . . 1.1899999999999999 109.247 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.48 ' O ' HG21 ' A' ' 22' ' ' VAL . 4.2 tp -58.64 -66.28 0.52 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.251 -0.886 . . . . 1.22 109.699 170.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 80.3 mt -53.83 -43.71 69.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.075 -0.343 . . . . 1.8400000000000001 110.075 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.607 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.1 t30 -50.31 -66.1 0.45 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.079 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.81 -39.84 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.888 0.742 . . . . 2.46 110.75 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -54.86 -60.1 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.52 -0.309 . . . . 1.2 111.423 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.655 ' HB2' HG22 ' A' ' 30' ' ' THR . 2.0 m-85 -70.95 -39.99 72.26 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.016 -0.735 . . . . 0.51000000000000001 109.016 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.2 t-20 -52.26 -52.69 51.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.895 -1.048 . . . . 0.32000000000000001 109.333 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 2.8 tmmm? -60.87 -43.13 98.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.722 -1.581 . . . . 3.6699999999999999 111.93 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 10.9 pt-20 -81.92 13.15 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 1.51 111.193 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.02 3.03 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.369 -0.92 . . . . 0.56999999999999995 113.427 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.834 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 7.8 m-85 -77.76 150.25 34.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.926 0.869 . . . . 1.49 112.511 -165.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.609 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -98.01 82.15 2.94 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.91 -1.041 . . . . 1.1399999999999999 108.336 166.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.869 HG21 ' HB ' ' A' ' 6' ' ' ILE . 19.3 p -92.52 138.59 31.37 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.659 -0.7 . . . . 0.95999999999999996 109.883 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.413 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 10.5 m-85 -128.55 107.55 9.8 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.869 1.319 . . . . 0.42999999999999999 110.299 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.837 ' HB2' HH11 ' A' ' 16' ' ' ARG . 5.3 pt20 -59.53 121.11 10.72 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 112.035 -2.348 . . . . 0.23999999999999999 112.516 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.687 ' HB3' HG13 ' A' ' 42' ' ' ILE . . . -124.94 129.7 50.88 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 174.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.686 ' HB3' HH21 ' A' ' 16' ' ' ARG . . . -90.4 -9.65 46.78 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.07 -0.652 . . . . 0.78000000000000003 110.831 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 3.4 p-10 -148.39 164.48 33.98 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.038 -0.528 . . . . 0.28999999999999998 111.736 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA3' HD13 ' A' ' 65' ' ' ILE . . . -69.42 -22.14 76.3 Favored Glycine 0 CA--C 1.504 -0.597 0 CA-C-N 115.254 -0.885 . . . . 0.17999999999999999 113.745 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.36 -41.57 21.79 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 122.216 1.008 . . . . 1.1200000000000001 108.946 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.814 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.1 tp60 -60.53 -39.67 88.7 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.584 -2.006 . . . . 1.78 105.584 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.57 88.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.132 -1.395 . . . . 0.98999999999999999 111.281 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.546 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -56.41 -47.87 78.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.38 -0.827 . . . . 1.5700000000000001 109.728 176.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -63.83 -36.0 82.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.326 -1.306 . . . . 1.3200000000000001 111.317 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.866 ' HB ' HD12 ' A' ' 7' ' ' LEU . 26.7 mm -65.47 -49.47 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.277 -0.268 . . . . 1.04 110.277 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.7 t -58.68 -43.14 86.97 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.265 1.031 . . . . 1.0600000000000001 108.835 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -58.13 -30.9 66.69 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.361 -1.291 . . . . 0.95999999999999996 111.702 177.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.532 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 5.7 tptt -90.57 -50.48 5.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.064 -0.517 . . . . 2.9900000000000002 111.511 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.587 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 58.1 mm-40 -106.1 -35.95 7.07 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.583 0.586 . . . . 0.63 112.583 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 43.6 mtt180 62.93 65.02 1.44 Allowed Pre-proline 0 C--N 1.322 -0.589 0 O-C-N 123.673 0.608 . . . . 4.2800000000000002 110.323 -170.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.762 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 66.4 Cg_exo -60.32 163.48 14.77 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.116 1.877 . . . . 0.20999999999999999 111.635 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.771 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.8 m-20 -92.6 -44.48 8.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.973 -0.751 . . . . 0.97999999999999998 108.973 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.733 HD22 HD13 ' A' ' 79' ' ' ILE . 7.6 mp -107.29 110.4 22.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 1.1599999999999999 110.014 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.794 HG12 ' HB3' ' A' ' 7' ' ' LEU . 62.6 t -110.16 107.35 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.453 . . . . 1.05 111.197 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.445 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 3.1 mp -78.51 95.93 5.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.432 0.634 . . . . 1.0700000000000001 110.032 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.613 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -85.65 92.83 8.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.951 -1.022 . . . . 2.2000000000000002 110.2 -176.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.649 ' OD1' ' HG2' ' A' ' 56' ' ' LYS . 34.6 t70 -68.59 108.82 3.49 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.75 0.786 . . . . 1.47 109.739 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.613 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 20.8 mtm -93.48 16.89 12.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.226 -0.897 . . . . 1.6499999999999999 110.244 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.649 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 2.9 mmpp? -54.09 -53.43 53.27 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 120.075 -0.65 . . . . 2.73 110.445 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.839 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.5 tt -179.83 -19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.563 -1.208 . . . . 2.6099999999999999 114.209 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.839 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -26.81 -54.43 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.465 2.777 . . . . 0.55000000000000004 116.014 -175.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.48 -55.65 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.742 -1.218 . . . . 0.55000000000000004 112.904 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 46.0 tpp -142.25 165.15 28.21 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.35 -0.611 . . . . 2.6699999999999999 109.35 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.2 m-20 -60.39 140.22 57.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.67000000000000004 110.785 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -64.65 -12.48 52.91 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.825 -1.079 . . . . 0.32000000000000001 112.184 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.619 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 11.9 mt -76.51 -46.72 31.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 1.9199999999999999 110.149 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -60.07 -43.0 95.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.658 -0.868 . . . . 0.46999999999999997 108.658 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.805 HG21 ' HE2' ' A' ' 69' ' ' MET . 16.5 mm -68.6 -43.18 83.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.475 -0.784 . . . . 1.3600000000000001 111.452 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 96' ' ' LEU . 3.0 pp -62.5 -37.66 86.91 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.718 -0.393 . . . . 2.1600000000000001 110.236 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 71' ' ' VAL . 18.0 ptpt -76.03 -36.37 59.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.125 -0.63 . . . . 1.3400000000000001 111.827 -176.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.546 ' HG3' HD23 ' A' ' 40' ' ' LEU . 3.0 ptm180 -67.38 -34.39 77.18 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.819 -1.152 . . . . 2.8599999999999999 111.004 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.805 ' HE2' HG21 ' A' ' 65' ' ' ILE . 11.8 ptp -78.85 -18.58 53.75 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.018 -0.673 . . . . 1.95 109.725 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.4 mptt -70.95 -40.59 71.91 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.554 -0.906 . . . . 1.9299999999999999 108.554 169.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 67' ' ' LYS . 92.8 t -61.41 -38.21 79.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.423 -0.808 . . . . 1.8300000000000001 110.531 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.694 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -83.86 -30.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.377 -0.529 . . . . 1.02 110.325 175.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -156.04 83.48 1.01 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.728 0.64 . . . . 1.0800000000000001 112.728 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 32.4 mt-10 -69.99 2.56 3.41 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.293 -0.879 . . . . 1.78 111.272 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -28.44 65.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.737 1.256 . . . . 0.34999999999999998 107.729 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.673 HG23 ' HG3' ' A' ' 69' ' ' MET . 3.8 tt -75.52 158.12 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 112.587 -2.097 . . . . 1.05 111.208 -172.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.771 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -134.19 -178.28 4.97 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.11 -0.95 . . . . 1.45 108.496 175.151 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.625 HG23 ' CB ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -143.09 148.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 120.133 -0.627 . . . . 1.55 111.019 -175.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.757 HG21 ' HG1' ' A' ' 100' ' ' THR . 64.5 mt -117.87 71.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.725 -1.213 . . . . 1.3500000000000001 107.725 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.613 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.81 141.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 119.045 -1.062 . . . . 1.02 111.181 -172.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.509 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 22.4 mtp -109.25 111.91 23.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.676 -1.147 . . . . 2.5499999999999998 110.412 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 1.2 t -120.55 166.65 13.33 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 122.162 -0.336 . . . . 1.78 111.316 -175.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 85' ' ' GLY . . . -58.37 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.782 -0.644 . . . . 1.1000000000000001 111.375 168.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.5 t80 59.67 3.66 0.46 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.828 1.251 . . . . 4.4400000000000004 112.39 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.96 93.18 1.87 Allowed Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.923 -0.656 . . . . 0.65000000000000002 112.354 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.572 ' N ' HG13 ' A' ' 90' ' ' ILE . 30.9 mt-10 -74.8 11.85 0.97 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 1.3300000000000001 111.002 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 85' ' ' GLY . 26.4 mt 64.81 -177.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.593 0.96 . . . . 2.2799999999999998 113.593 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 62.17 -92.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.606 -1.179 . . . . 1.3799999999999999 111.327 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.494 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 71.0 mtm -64.23 -22.91 67.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 120.925 0.393 . . . . 3.3700000000000001 110.428 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.572 HG13 ' N ' ' A' ' 86' ' ' GLU . 42.8 mm -67.03 -39.95 84.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.181 0.515 . . . . 1.3700000000000001 110.012 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.637 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 12.7 mm100 -67.24 -42.29 84.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.264 -0.88 . . . . 3.1800000000000002 108.996 176.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 9.4 tt0 -63.16 -39.92 96.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.371 -1.286 . . . . 1.27 112.047 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.414 ' CB ' HG12 ' A' ' 63' ' ' ILE . 8.5 t -55.37 -62.96 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 1.5600000000000001 110.414 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.943 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 50.3 pttt -56.93 -36.79 70.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.998 -0.546 . . . . 2.3100000000000001 111.892 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -65.99 -22.97 66.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.081 -0.248 . . . . 1.8400000000000001 111.545 -178.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.689 ' HB3' HD11 ' A' ' 66' ' ' LEU . 4.4 mp -88.63 -4.98 58.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 1.8999999999999999 111.495 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.42 16.72 1.84 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.864 -1.16 . . . . 0.34999999999999998 113.135 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.943 ' HB1' ' HA ' ' A' ' 94' ' ' LYS . . . -89.39 132.01 35.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.121 -0.696 . . . . 1.02 109.121 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.663 HD21 ' HD3' ' A' ' 77' ' ' ARG . 13.9 mt -73.63 -49.07 27.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.807 0.813 . . . . 1.05 109.506 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.757 ' HG1' HG21 ' A' ' 79' ' ' ILE . 70.0 p -141.51 142.8 33.57 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.081 -1.418 . . . . 1.05 111.519 -173.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.31 85.73 2.41 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.811 -1.086 . . . . 1.1799999999999999 109.457 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 81' ' ' MET . 13.3 m-85 -75.1 157.46 34.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 4.75 109.893 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -98.71 -170.71 1.98 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.338 0.496 . . . . 1.24 112.338 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 44.6 tttp -73.19 -45.47 8.03 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.087 -0.708 . . . . 3.7200000000000002 109.087 172.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 36.1 Cg_endo -68.29 97.89 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.438 1.425 . . . . 1.6699999999999999 111.026 166.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -112.67 139.32 48.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.488 -0.778 . . . . 1.29 109.65 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -87.56 20.21 3.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 119.238 -0.41 . . . . 1.77 111.306 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.452 HG21 ' H ' ' A' ' 109' ' ' ASP . 2.4 tt 49.18 -66.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 1.9199999999999999 112.781 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 107' ' ' ASP . 5.6 t70 -64.27 -25.78 68.2 Favored 'General case' 0 C--O 1.212 -0.884 0 O-C-N 122.397 -0.189 . . . . 1.1599999999999999 110.807 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.59 -27.86 65.46 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 120.425 -0.51 . . . . 0.83999999999999997 109.765 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -76.65 -47.5 28.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.224 -0.658 . . . . 1.5600000000000001 109.224 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.497 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.38 -39.32 85.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.122 0.487 . . . . 0.80000000000000004 109.922 179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 24.4 t70 -65.72 -43.34 89.35 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.304 -0.628 . . . . 0.78000000000000003 109.304 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.932 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.96 -51.05 69.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.666 -0.697 . . . . 1.3100000000000001 111.124 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.532 ' HB ' ' HH ' ' A' ' 28' ' ' TYR . 27.0 m -59.02 -50.77 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.844 -0.742 . . . . 1.1200000000000001 111.475 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -65.36 -29.34 70.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.345 0.498 . . . . 1.99 112.345 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.932 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 56.9 pttt -81.52 -11.74 59.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.49 -0.884 . . . . 2.0899999999999999 111.507 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.6 -58.65 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.175 0.512 . . . . 2.3900000000000001 110.176 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.502 ' HG ' ' OE1' ' A' ' 4' ' ' GLU . 57.1 tp -122.67 109.77 32.28 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.384 -0.969 . . . . 2.7599999999999998 108.384 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 47.4 Cg_endo -101.44 148.13 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.773 2.315 . . . . 0.92000000000000004 114.331 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.766 -0.828 . . . . 1.9399999999999999 108.766 174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.722 ' CD ' ' HB3' ' A' ' 121' ' ' LEU . 17.5 pt-20 . . . . . 0 N--CA 1.448 -0.575 0 CA-C-O 120.98 0.419 . . . . 2.2999999999999998 109.991 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.807 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -117.23 144.88 44.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.207 0.527 . . . . 1.3999999999999999 111.812 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.872 ' HB ' HG21 ' A' ' 30' ' ' THR . 3.4 mt -135.02 153.47 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 114.933 -1.031 . . . . 1.04 111.655 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.857 ' HG ' HG21 ' A' ' 42' ' ' ILE . 2.4 tt -129.51 124.95 35.22 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.562 -1.273 . . . . 0.98999999999999999 107.562 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' A' ' 30' ' ' THR . 1.5 mp -112.26 107.57 23.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.124 -0.63 . . . . 1.1200000000000001 109.963 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 57.6 t -96.15 89.55 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.103 -0.332 . . . . 1.0900000000000001 110.103 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.708 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 0.8 OUTLIER -135.42 136.04 41.07 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 110.215 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.695 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 20.9 t70 -88.91 -41.65 12.3 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.486 0.184 . . . . 0.51000000000000001 110.768 -177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.491 ' HG3' ' CD1' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -78.69 70.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.819 -1.178 . . . . 2.5600000000000001 107.819 172.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.8 p90 -48.09 -13.72 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 111.856 -2.429 . . . . 1.8300000000000001 115.588 -163.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.08 -57.38 6.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.249 -0.977 . . . . 0.41999999999999998 110.937 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 2.4 mt -59.94 -25.85 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.477 0.656 . . . . 1.5600000000000001 110.664 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.968 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.5 ttm180 -78.9 -49.24 13.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.47999999999999998 110.529 -168.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 37.9 pt -75.07 -24.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.219 -0.66 . . . . 1.1899999999999999 109.219 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.755 HD12 HD13 ' A' ' 108' ' ' ILE . 7.5 tp -58.09 -67.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.947 -1.024 . . . . 1.22 109.827 171.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.559 HD13 HD22 ' A' ' 52' ' ' LEU . 69.8 mt -54.18 -41.15 68.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.179 -0.464 . . . . 1.8400000000000001 110.08 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.7 t30 -49.94 -70.09 0.1 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.473 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -57.24 -36.9 71.5 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.308 0.38 . . . . 2.46 111.683 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.1 t -55.92 -55.66 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.592 0.219 . . . . 1.2 111.592 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.699 ' HB2' HG22 ' A' ' 30' ' ' THR . 7.7 m-85 -78.18 -36.73 47.07 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 120.659 -0.416 . . . . 0.51000000000000001 109.922 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.804 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.8 t-20 -50.27 -45.53 54.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.176 0.989 . . . . 0.32000000000000001 108.753 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -60.35 -38.44 83.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.09 -1.868 . . . . 3.6699999999999999 111.9 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE2' ' HD3' ' A' ' 112' ' ' ARG . 4.2 mm-40 -55.9 -33.14 64.36 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.297 1.046 . . . . 1.51 109.586 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.79 1.45 3.01 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 113.071 -1.877 . . . . 0.56999999999999995 109.417 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.804 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 45.4 m-85 -75.37 132.3 40.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.364 0.602 . . . . 1.49 110.666 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.807 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 12.0 mt-30 -86.52 81.38 8.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.79 -1.189 . . . . 1.1399999999999999 107.79 171.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.872 HG21 ' HB ' ' A' ' 6' ' ' ILE . 18.9 p -90.25 132.75 35.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.799 -0.637 . . . . 0.95999999999999996 110.214 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.601 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 20.1 m-85 -124.42 123.75 40.85 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 122.826 1.298 . . . . 0.42999999999999999 110.13 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.968 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.2 pt20 -82.74 121.91 27.49 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.053 -2.339 . . . . 0.23999999999999999 112.073 -171.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.83 137.42 54.66 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.166 0.987 . . . . 1.0 108.678 174.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.649 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . . . -98.98 -3.81 34.1 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.137 -0.625 . . . . 0.78000000000000003 110.402 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 5.3 p-10 -148.51 163.7 36.42 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.792 -0.64 . . . . 0.28999999999999998 111.315 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.17 79.41 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.534 -0.757 . . . . 0.17999999999999999 113.306 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 35' ' ' ASN . 2.9 mm? -80.42 -40.83 25.64 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 122.395 1.093 . . . . 1.1200000000000001 108.2 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.83 ' O ' HG12 ' A' ' 42' ' ' ILE . 2.6 tp-100 -58.96 -40.42 84.67 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.521 -2.127 . . . . 1.78 105.404 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -65.2 -45.56 84.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.794 -1.548 . . . . 0.98999999999999999 111.544 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.494 HD13 ' HD3' ' A' ' 68' ' ' ARG . 11.7 mt -55.53 -39.31 70.4 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.703 0.763 . . . . 1.5700000000000001 109.556 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 21.3 t70 -72.3 -38.01 68.83 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.54 -1.209 . . . . 1.3200000000000001 110.374 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.857 HG21 ' HG ' ' A' ' 7' ' ' LEU . 18.0 mm -58.86 -48.59 85.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 120.685 0.279 . . . . 1.04 110.674 176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 39' ' ' ALA . 24.0 t -61.43 -41.47 90.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.968 0.89 . . . . 1.0600000000000001 109.723 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -63.23 -28.51 70.09 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.604 -1.18 . . . . 0.95999999999999996 111.204 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -94.99 -48.53 5.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 2.9900000000000002 111.766 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.601 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 66.7 mm-40 -104.63 -37.05 7.26 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.69 0.256 . . . . 0.63 111.69 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 62.88 67.83 1.05 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.787 -0.642 . . . . 4.2800000000000002 110.02 -169.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.768 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 45.9 Cg_exo -65.03 154.89 71.18 Favored 'Trans proline' 0 CA--C 1.503 -1.035 0 C-N-CA 121.858 1.705 . . . . 0.20999999999999999 111.424 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.803 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 8.3 m-20 -89.65 -41.69 11.8 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.723 -0.791 . . . . 0.97999999999999998 109.013 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.511 HD21 HD11 ' A' ' 79' ' ' ILE . 6.7 mp -108.02 110.05 21.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.211 -0.45 . . . . 1.1599999999999999 110.166 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.8 ' HB ' HG11 ' A' ' 78' ' ' VAL . 57.9 t -109.95 109.32 27.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.081 0.467 . . . . 1.05 111.584 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -80.5 91.15 5.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.393 0.616 . . . . 1.0700000000000001 109.772 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.833 HD11 HG12 ' A' ' 78' ' ' VAL . 18.5 mt -89.13 103.13 15.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.298 -0.864 . . . . 2.2000000000000002 111.079 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.636 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 12.4 t70 -67.06 116.83 8.31 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.128 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.606 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 13.0 mtm -98.14 12.19 35.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.793 -0.64 . . . . 1.6499999999999999 110.696 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.636 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 13.0 mmmm -64.25 -49.32 72.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.662 -0.245 . . . . 2.73 111.368 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.849 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 17.3 tt 174.81 -28.6 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.718 1.377 . . . . 2.6099999999999999 114.718 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.849 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -18.31 -59.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 124.546 3.497 . . . . 0.55000000000000004 116.625 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.95 -63.86 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.072 -1.061 . . . . 0.55000000000000004 112.225 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.5 tpt -148.72 167.02 26.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.577 -0.897 . . . . 2.6699999999999999 108.577 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.46 135.67 57.74 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.67 0.748 . . . . 0.67000000000000004 110.563 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.556 ' O ' HD13 ' A' ' 53' ' ' LEU . . . -58.44 -18.79 38.14 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 114.239 -1.346 . . . . 0.32000000000000001 111.751 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.646 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 4.0 mt -66.97 -49.6 72.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.01 0.433 . . . . 1.9199999999999999 110.571 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.58 -34.65 77.46 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.635 0.731 . . . . 0.46999999999999997 109.072 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.791 HG23 ' HE3' ' A' ' 69' ' ' MET . 17.0 mt -73.37 -38.57 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.189 -0.914 . . . . 1.3600000000000001 111.025 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 4.3 pp -67.02 -35.09 79.13 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 121.074 -0.25 . . . . 2.1600000000000001 110.412 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.633 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.2 ptpt -76.23 -33.41 59.2 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.406 -0.517 . . . . 1.3400000000000001 111.12 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.738 ' O ' HG11 ' A' ' 71' ' ' VAL . 11.2 ptp180 -70.49 -29.84 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 118.752 -1.179 . . . . 2.8599999999999999 111.579 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.855 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.5 ptp -83.98 -13.36 53.52 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.455 -0.898 . . . . 1.95 109.579 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -78.68 -32.87 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.598 -0.728 . . . . 1.9299999999999999 109.855 172.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.738 HG11 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -74.34 -36.27 42.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.781 -0.822 . . . . 1.8300000000000001 108.781 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.855 HG12 ' HA ' ' A' ' 69' ' ' MET . 20.6 pt -80.62 -21.84 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.092 -0.958 . . . . 1.02 110.325 172.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.719 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 29.7 t0 -164.89 95.32 0.7 Allowed 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 112.887 0.699 . . . . 1.0800000000000001 112.887 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.622 ' OE1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -77.81 6.09 8.22 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.979 -1.076 . . . . 1.78 110.126 174.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.719 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -78.53 -34.0 47.52 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.339 -1.356 . . . . 0.34999999999999998 107.339 171.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.679 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.0 tt -60.18 159.38 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.185 -1.825 . . . . 1.05 111.685 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.803 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 2.8 ptp180 -142.76 173.83 11.19 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.989 -1.115 . . . . 1.45 107.989 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.833 HG12 HD11 ' A' ' 53' ' ' LEU . 2.3 m -141.79 147.98 21.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.477 -0.889 . . . . 1.55 112.066 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.817 HG23 ' HG1' ' A' ' 100' ' ' THR . 67.1 mt -116.4 72.85 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.57 -1.27 . . . . 1.3500000000000001 107.57 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.606 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.66 142.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.615 -0.834 . . . . 1.02 112.069 -171.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.533 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 10.2 mtt -99.33 124.69 44.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.489 -0.778 . . . . 2.5499999999999998 110.04 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.57 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t -133.15 160.3 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.998 0.74 . . . . 1.78 112.998 -173.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 63.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.649 -1.16 . . . . 1.1000000000000001 110.664 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 67.41 5.12 4.09 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.571 0.748 . . . . 4.4400000000000004 112.418 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.0 88.18 0.75 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.861 -0.685 . . . . 0.65000000000000002 111.801 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 90' ' ' ILE . 39.7 mt-10 -65.61 -89.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.483 -0.358 . . . . 1.3300000000000001 111.244 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.708 ' HG ' ' H ' ' A' ' 88' ' ' ASP . 9.5 tp -177.53 -167.76 0.16 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.69 0.281 . . . . 2.2799999999999998 111.716 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.708 ' H ' ' HG ' ' A' ' 87' ' ' LEU . 9.3 m-20 43.99 -89.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.857 1.263 . . . . 1.3799999999999999 113.009 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.626 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 62.7 mtt -56.94 -35.51 69.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.106 -0.497 . . . . 3.3700000000000001 110.461 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.531 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.6 mm -59.89 -44.76 95.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.81 -0.632 . . . . 1.3700000000000001 110.278 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.63 -53.53 57.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.559 -0.746 . . . . 3.1800000000000002 109.385 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 15.8 tt0 -58.9 -34.84 72.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.945 -1.025 . . . . 1.27 112.314 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.4 t -55.34 -69.51 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 1.5600000000000001 110.89 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.944 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 16.6 pttp -55.9 -36.54 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.383 0.611 . . . . 2.3100000000000001 111.069 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 10.9 tp10 -56.59 -45.37 81.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.864 -1.062 . . . . 1.8400000000000001 111.99 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.8 mt -70.47 -39.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.38 -0.373 . . . . 1.8999999999999999 111.16 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.543 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 170.19 15.15 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.818 -1.182 . . . . 0.34999999999999998 113.52 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 94' ' ' LYS . . . -83.9 128.75 34.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.538 -0.541 . . . . 1.02 109.538 173.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.515 HD13 ' HG3' ' A' ' 77' ' ' ARG . 9.6 mt -73.07 -49.44 28.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.891 0.853 . . . . 1.05 109.777 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.817 ' HG1' HG23 ' A' ' 79' ' ' ILE . 49.8 p -141.92 158.8 43.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.079 -1.419 . . . . 1.05 111.642 -170.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -110.17 93.47 4.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.816 -1.084 . . . . 1.1799999999999999 110.28 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.561 ' HD2' HD12 ' A' ' 111' ' ' ILE . 29.6 t80 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.653 -0.703 . . . . 4.75 109.373 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.26 -178.66 4.05 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.22 -0.592 . . . . 1.24 111.492 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 65.1 tttp -47.97 -53.85 29.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.345 -0.843 . . . . 3.7200000000000002 112.769 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 70.3 Cg_endo -77.09 98.28 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.279 1.319 . . . . 1.6699999999999999 111.706 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.506 ' HB2' HD13 ' A' ' 111' ' ' ILE . 33.2 p90 -127.9 129.15 46.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 1.29 110.665 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.582 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 7.0 t70 -67.9 -11.7 59.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.909 -0.587 . . . . 1.77 111.582 -177.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.755 HD13 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER 71.34 -54.67 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-N 115.718 -0.674 . . . . 1.9199999999999999 109.259 -164.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 15.9 t70 -66.9 -38.63 86.62 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 109.649 -0.5 . . . . 1.1599999999999999 109.649 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.582 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 13.2 pt-20 -66.13 -18.94 65.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.83999999999999997 110.807 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.609 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.4 mm -83.1 -45.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.466 -0.568 . . . . 1.5600000000000001 109.466 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HA ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.72 -31.06 67.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.876 0.846 . . . . 0.80000000000000004 109.161 174.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.535 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.8 t70 -67.88 -41.18 83.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.998 -1.001 . . . . 0.78000000000000003 109.324 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.616 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.28 -48.26 71.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.309 -0.859 . . . . 1.3100000000000001 111.222 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.516 HG21 ' HA ' ' A' ' 112' ' ' ARG . 29.4 m -58.95 -47.77 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.791 -0.764 . . . . 1.1200000000000001 110.422 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.463 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 10.5 ttpt -60.94 -51.99 66.91 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.902 -0.59 . . . . 1.99 111.697 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -55.32 -26.86 43.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.721 -0.392 . . . . 2.0899999999999999 111.866 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.519 ' HB3' HD23 ' A' ' 119' ' ' LEU . 35.1 m-85 -81.63 -71.72 0.46 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.75 -0.38 . . . . 2.3900000000000001 111.193 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.519 HD23 ' HB3' ' A' ' 118' ' ' TYR . 3.3 mm? -119.65 92.28 46.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.0 -0.37 . . . . 2.7599999999999998 110.0 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 91.1 Cg_endo -93.42 121.76 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.801 2.334 . . . . 0.92000000000000004 113.895 -172.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.722 ' HB3' ' CD ' ' A' ' 4' ' ' GLU . 11.7 tp . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.458 0.647 . . . . 1.9399999999999999 109.364 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 104.449 -2.426 . . . . 2.2999999999999998 104.449 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.972 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -163.56 141.46 7.6 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.542 -1.263 . . . . 1.3999999999999999 110.499 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.878 ' HB ' HG22 ' A' ' 30' ' ' THR . 5.1 mt -136.62 153.08 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.313 -0.858 . . . . 1.04 111.659 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.801 HD11 ' HB ' ' A' ' 42' ' ' ILE . 3.3 tt -137.24 117.38 13.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.236 -1.394 . . . . 0.98999999999999999 107.236 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.63 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.3 mp -106.32 107.99 24.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 119.716 -0.794 . . . . 1.1200000000000001 110.235 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 47.6 t -93.95 76.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.036 0.21 . . . . 1.0900000000000001 110.483 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.647 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.2 m-20 -123.45 133.03 54.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.421 . . . . 1.8200000000000001 110.754 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.953 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 22.9 t70 -78.42 -39.04 39.98 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.146 -1.057 . . . . 0.51000000000000001 108.146 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.822 ' HB2' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -64.23 78.38 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.658 -1.156 . . . . 2.5600000000000001 108.283 164.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 19.9 p90 -55.84 -16.11 4.13 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.21 -0.905 . . . . 1.8300000000000001 111.682 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.23 -60.21 9.17 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.875 -0.89 . . . . 0.41999999999999998 110.875 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.822 HG12 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -58.35 -25.44 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 121.403 0.621 . . . . 1.5600000000000001 109.972 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.907 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -79.4 -46.69 17.08 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.092 -0.958 . . . . 0.47999999999999998 111.148 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 13' ' ' TYR . 38.7 pt -77.4 -27.12 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.441 -0.577 . . . . 1.1899999999999999 109.441 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 22' ' ' VAL . 8.1 tp -56.71 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 1.22 109.261 170.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.638 ' HG ' ' CZ ' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -53.52 -43.27 68.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.186 -0.915 . . . . 1.8400000000000001 111.086 175.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.3 t30 -50.97 -70.02 0.1 Allowed 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.671 0.607 . . . . 1.0 109.425 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -55.08 -39.32 69.15 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.416 0.447 . . . . 2.46 112.175 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 112' ' ' ARG . 41.6 t -57.87 -53.64 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.114 0.413 . . . . 1.2 112.114 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.758 ' HB2' HG23 ' A' ' 30' ' ' THR . 4.9 m-85 -77.39 -40.26 44.35 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.264 -0.643 . . . . 0.51000000000000001 109.264 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.765 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.4 t-20 -51.11 -44.45 61.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.371 -0.831 . . . . 0.32000000000000001 108.793 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.22 -1.809 . . . . 3.6699999999999999 111.613 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.459 ' H ' ' HG2' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -56.19 -34.48 66.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.679 1.228 . . . . 1.51 109.273 177.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . 148.27 -17.53 1.33 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 112.828 -1.987 . . . . 0.56999999999999995 110.012 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.765 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 59.7 m-85 -63.89 134.87 55.95 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 112.755 0.65 . . . . 1.49 112.755 -163.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.916 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 27.9 mt-30 -84.16 77.47 9.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.897 -0.779 . . . . 1.1399999999999999 108.897 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.878 HG22 ' HB ' ' A' ' 6' ' ' ILE . 11.9 p -90.59 136.19 33.22 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.389 -0.823 . . . . 0.95999999999999996 110.392 -176.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.4 m-85 -128.78 130.32 46.86 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 122.68 1.229 . . . . 0.42999999999999999 109.888 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.907 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 3.8 pt20 -86.41 121.23 28.67 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 112.697 -2.047 . . . . 0.23999999999999999 112.077 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -121.88 137.9 54.6 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.575 -0.738 . . . . 1.0 109.248 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.572 ' HB1' ' NH2' ' A' ' 16' ' ' ARG . . . -95.03 -12.44 26.6 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.118 -0.633 . . . . 0.78000000000000003 110.133 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.43 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 2.0 p-10 -148.72 166.32 28.76 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.828 -0.624 . . . . 0.28999999999999998 111.6 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.02 -20.78 75.03 Favored Glycine 0 CA--C 1.505 -0.534 0 O-C-N 123.899 0.75 . . . . 0.17999999999999999 113.435 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.93 -43.67 19.41 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.218 1.008 . . . . 1.1200000000000001 108.666 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.783 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.1 tt0 -63.21 -36.01 82.24 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 112.798 -2.001 . . . . 1.78 105.94 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.77 -46.55 81.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.393 -1.276 . . . . 0.98999999999999999 111.14 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.77 -48.39 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.67 0.748 . . . . 1.5700000000000001 109.139 175.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 44' ' ' THR . 7.2 t70 -57.47 -42.93 83.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.155 -1.384 . . . . 1.3200000000000001 111.09 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.87 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 16.2 mm -63.29 -45.05 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 120.796 -0.361 . . . . 1.04 110.41 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.505 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -60.95 -41.67 89.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.707 0.765 . . . . 1.0600000000000001 109.631 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.34 -24.0 62.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 0.95999999999999996 111.166 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.87 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 1.6 ptmt -89.75 -46.91 8.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.159 -0.473 . . . . 2.9900000000000002 111.195 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 53.0 mm-40 -108.43 -37.93 5.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.706 0.289 . . . . 0.63 111.319 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 78.0 mtp180 66.27 65.62 0.79 Allowed Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.597 -0.728 . . . . 4.2800000000000002 109.714 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.972 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.4 Cg_exo -64.4 158.55 48.61 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 122.185 1.924 . . . . 0.20999999999999999 112.029 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.767 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 4.7 m-20 -93.53 -38.47 11.37 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.138 -1.06 . . . . 0.97999999999999998 108.138 174.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 1.035 HD13 ' HB3' ' A' ' 119' ' ' LEU . 5.7 mp -114.51 111.64 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.54 -0.755 . . . . 1.1599999999999999 110.272 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.04 HG13 ' HE2' ' A' ' 69' ' ' MET . 61.2 t -112.44 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.281 -0.418 . . . . 1.05 111.22 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.509 HD22 ' CD2' ' A' ' 19' ' ' LEU . 2.7 mp -78.52 93.73 4.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.789 0.804 . . . . 1.0700000000000001 109.616 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.672 HD13 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -86.59 96.98 10.28 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.468 -1.242 . . . . 2.2000000000000002 110.691 -174.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.608 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 9.4 t70 -63.88 116.03 5.42 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.978 -0.689 . . . . 1.47 109.844 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.843 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.7 mtp -94.03 7.53 44.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.666 -0.697 . . . . 1.6499999999999999 110.992 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.608 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 24.9 mmmt -63.82 -66.38 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.173 0.435 . . . . 2.73 112.173 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.943 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 14.6 tt -169.88 -17.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.289 1.588 . . . . 2.6099999999999999 115.289 -171.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.953 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -27.15 -51.95 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.52 2.813 . . . . 0.55000000000000004 116.112 175.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.38 -54.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.431 -1.366 . . . . 0.55000000000000004 113.648 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.489 ' HB3' HD13 ' A' ' 65' ' ' ILE . 19.4 ttt -148.69 166.76 27.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.552 -0.536 . . . . 2.6699999999999999 109.552 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.16 135.07 57.61 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.188 0.518 . . . . 0.67000000000000004 109.959 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -62.61 -10.46 30.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.055 -0.975 . . . . 0.32000000000000001 112.797 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.746 HD11 ' HE2' ' A' ' 89' ' ' MET . 22.0 mt -82.84 -47.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.03 0.443 . . . . 1.9199999999999999 110.593 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.4 mm-40 -64.62 -35.85 82.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.146 -0.687 . . . . 0.46999999999999997 109.146 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.812 ' O ' ' HG2' ' A' ' 69' ' ' MET . 55.2 mt -72.27 -38.59 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 1.3600000000000001 110.122 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.696 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -53.0 -49.53 66.01 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.215 -0.448 . . . . 2.1600000000000001 110.44 173.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.685 ' O ' HG21 ' A' ' 71' ' ' VAL . 15.0 ptpt -72.81 -35.61 67.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.474 -0.49 . . . . 1.3400000000000001 111.865 -174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 65' ' ' ILE . 4.3 ptp180 -64.35 -33.91 76.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 118.689 -1.204 . . . . 2.8599999999999999 111.605 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 1.04 ' HE2' HG13 ' A' ' 51' ' ' VAL . 10.0 ptp -83.25 -16.51 46.09 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 119.697 -0.801 . . . . 1.95 109.289 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.663 ' HZ3' ' HG ' ' A' ' 66' ' ' LEU . 13.1 mptt -72.32 -38.81 68.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.798 -0.816 . . . . 1.9299999999999999 108.798 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 67' ' ' LYS . 74.9 t -63.59 -38.52 82.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 1.8300000000000001 110.616 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.709 HG12 ' HA ' ' A' ' 69' ' ' MET . 11.4 pt -83.73 -30.01 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.535 -0.466 . . . . 1.02 110.608 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 88.03 1.0 Allowed 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 112.277 0.473 . . . . 1.0800000000000001 112.277 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 37.0 mt-10 -66.39 -2.26 4.34 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.421 -0.799 . . . . 1.78 111.288 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.49 -25.8 60.62 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.696 -1.224 . . . . 0.34999999999999998 107.696 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 48' ' ' PRO . 2.7 tt -71.34 154.46 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.14 -1.845 . . . . 1.05 110.513 -174.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.767 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 5.5 ptp180 -138.72 175.66 9.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.263 -1.014 . . . . 1.45 108.263 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.696 ' CG2' HD13 ' A' ' 66' ' ' LEU . 4.1 m -141.58 145.64 24.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 119.86 -0.736 . . . . 1.55 111.02 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.823 HG21 ' HG1' ' A' ' 100' ' ' THR . 64.0 mt -110.74 75.75 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.668 -1.234 . . . . 1.3500000000000001 107.668 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.843 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -66.89 139.68 20.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.722 -0.791 . . . . 1.02 112.367 -171.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.532 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 3.0 mtp -101.28 120.18 39.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.155 -0.93 . . . . 2.5499999999999998 110.586 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 4.2 t -133.22 164.57 26.77 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.454 0.538 . . . . 1.78 112.454 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.2 56.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.202 -0.908 . . . . 1.1000000000000001 111.435 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.499 ' HA ' ' HB1' ' A' ' 103' ' ' ALA . 74.6 t80 69.24 6.88 5.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.788 0.835 . . . . 4.4400000000000004 111.016 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.77 93.49 1.85 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.705 -0.759 . . . . 0.65000000000000002 111.9 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.628 ' N ' HG13 ' A' ' 90' ' ' ILE . 33.6 mt-10 -71.69 9.6 0.84 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.239 0.542 . . . . 1.3300000000000001 110.93 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 85' ' ' GLY . 40.9 mt 58.91 -169.5 0.13 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 2.2799999999999998 113.006 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 54.87 -93.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.011 -0.995 . . . . 1.3799999999999999 111.349 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.746 ' HE2' HD11 ' A' ' 63' ' ' ILE . 91.3 mtp -65.15 -23.96 67.27 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.666 0.27 . . . . 3.3700000000000001 110.344 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.628 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.5 mm -66.61 -41.08 87.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 1.3700000000000001 110.386 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.534 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 14.2 mt-30 -67.26 -35.53 79.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.014 0.911 . . . . 3.1800000000000002 108.83 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.616 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 33.2 tt0 -72.85 -31.98 65.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.0 -1.455 . . . . 1.27 111.448 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.413 ' CB ' HG12 ' A' ' 63' ' ' ILE . 14.6 t -59.04 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 1.5600000000000001 109.713 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.829 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 46.8 pttt -54.91 -38.84 68.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 2.3100000000000001 111.698 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.9 pt-20 -64.63 -25.93 68.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.859 0.3 . . . . 1.8400000000000001 111.203 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.459 HD11 ' CG2' ' A' ' 63' ' ' ILE . 17.9 mt -86.18 -19.24 30.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.968 0.413 . . . . 1.8999999999999999 111.528 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.93 19.7 0.23 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.087 -1.054 . . . . 0.34999999999999998 113.041 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.829 ' HB1' ' HA ' ' A' ' 94' ' ' LYS . . . -91.47 140.85 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.994 -0.743 . . . . 1.02 108.994 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.508 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.7 mt -82.92 -49.18 9.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.846 0.831 . . . . 1.05 109.842 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.823 ' HG1' HG21 ' A' ' 79' ' ' ILE . 51.3 p -143.39 150.61 39.33 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.022 -1.445 . . . . 1.05 111.685 -171.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -112.19 97.32 6.56 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.978 -1.01 . . . . 1.1799999999999999 109.322 173.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -90.49 150.32 21.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.257 -0.428 . . . . 4.75 110.767 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 84' ' ' TYR . . . -121.89 -171.53 2.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.089 -0.505 . . . . 1.24 111.321 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -56.81 -47.21 99.43 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 3.7200000000000002 111.804 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -73.29 96.65 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 120.644 0.896 . . . . 1.6699999999999999 111.03 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -137.22 138.36 40.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 1.29 110.281 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 22.7 t70 -76.6 -1.69 28.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.649 . . . . 1.77 110.984 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.43 -49.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.933 1.293 . . . . 1.9199999999999999 112.526 -170.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -70.19 -26.51 63.93 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.634 -0.506 . . . . 1.1599999999999999 109.634 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 12.5 pt-20 -67.87 -24.85 65.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.74 -0.467 . . . . 0.83999999999999997 109.74 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 26.3 mt -81.04 -40.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.962 -0.563 . . . . 1.5600000000000001 110.537 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.613 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.727 -0.789 . . . . 0.80000000000000004 109.182 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.504 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 26.7 t70 -68.38 -32.36 72.38 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.581 -0.896 . . . . 0.78000000000000003 108.581 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.77 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -64.08 -44.15 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.28 -0.873 . . . . 1.3100000000000001 111.007 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 112' ' ' ARG . 21.9 m -64.76 -39.54 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 119.003 -1.079 . . . . 1.1200000000000001 110.805 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -78.37 -21.45 49.39 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.332 0.493 . . . . 1.99 112.332 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.77 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -79.44 -24.32 42.52 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.461 -0.775 . . . . 2.0899999999999999 110.983 175.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 48.5 m-85 -92.15 -70.58 0.69 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.831 -0.348 . . . . 2.3900000000000001 111.84 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 1.035 ' HB3' HD13 ' A' ' 50' ' ' LEU . 2.4 tm? -127.03 89.72 51.28 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.504 -0.924 . . . . 2.7599999999999998 108.504 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.657 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 65.0 Cg_endo -88.09 155.0 7.02 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.899 2.399 . . . . 0.92000000000000004 113.971 -172.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 4' ' ' GLU . 11.3 tp . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 106.804 -1.554 . . . . 1.9399999999999999 106.804 167.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.985 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 11.2 tt0 . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 121.231 0.538 . . . . 2.2999999999999998 111.03 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.762 ' HD3' ' HB3' ' A' ' 29' ' ' GLN . 3.8 tppt? -137.39 142.51 41.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.298 0.639 . . . . 1.3999999999999999 110.871 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.913 ' HB ' HG23 ' A' ' 30' ' ' THR . 2.1 mt -138.28 157.61 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.788 -0.642 . . . . 1.04 111.46 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.826 HD13 ' HB ' ' A' ' 42' ' ' ILE . 2.8 tt -133.66 117.76 17.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.138 -1.06 . . . . 0.98999999999999999 108.138 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.827 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.3 mp -107.25 113.28 43.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 120.245 -0.582 . . . . 1.1200000000000001 110.255 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.71 HG23 HD23 ' A' ' 53' ' ' LEU . 49.5 t -103.58 82.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.629 0.252 . . . . 1.0900000000000001 111.335 -176.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.75 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 3.8 m-20 -121.05 130.97 54.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 1.8200000000000001 109.903 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.86 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 27.6 t70 -81.57 -31.98 32.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.545 -1.28 . . . . 0.51000000000000001 107.545 166.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.474 ' CG ' HD12 ' A' ' 15' ' ' ILE . 16.1 pt20 -74.32 74.69 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.455 -1.248 . . . . 2.5600000000000001 108.198 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.481 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 15.1 p90 -61.47 -15.45 37.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.838 -1.528 . . . . 1.8300000000000001 113.431 -167.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.65 -65.35 3.49 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.876 -1.289 . . . . 0.41999999999999998 109.876 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 15' ' ' ILE . 4.9 mp -47.25 -30.07 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 123.276 0.63 . . . . 1.5600000000000001 112.31 172.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.75 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 8.8 ttm180 -76.37 -50.19 14.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.291 -0.413 . . . . 0.47999999999999998 111.142 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 46.9 pt -75.34 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.375 -0.602 . . . . 1.1899999999999999 109.375 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 22' ' ' VAL . 5.5 tp -59.94 -65.52 0.67 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.96 -1.018 . . . . 1.22 109.627 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 52' ' ' LEU . 71.8 mt -54.29 -40.38 67.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.472 -0.331 . . . . 1.8400000000000001 110.69 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t30 -51.09 -67.52 0.24 Allowed 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.755 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.25 -40.09 76.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.81 0.694 . . . . 2.46 111.997 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 18' ' ' LEU . 36.3 t -54.3 -54.52 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 111.492 0.182 . . . . 1.2 111.492 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.7 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -81.01 -35.91 31.31 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.49 -0.484 . . . . 0.51000000000000001 110.223 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.612 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 10.0 t-20 -50.38 -47.28 56.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.857 0.837 . . . . 0.32000000000000001 108.758 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 25' ' ' LYS . 1.7 tmmt? -61.3 -36.22 79.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.462 -1.699 . . . . 3.6699999999999999 112.774 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 8.3 mm-40 -55.11 -31.81 61.54 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.204 1.002 . . . . 1.51 109.455 175.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 138.71 -10.65 3.42 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 113.161 -1.836 . . . . 0.56999999999999995 109.132 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.985 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 2.1 m-85 -68.45 156.74 37.32 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 122.605 1.193 . . . . 1.49 111.089 -169.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.762 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 4.4 mt-30 -109.69 69.8 0.71 Allowed 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 113.293 -1.776 . . . . 1.1399999999999999 108.042 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.913 HG23 ' HB ' ' A' ' 6' ' ' ILE . 16.0 p -90.01 132.01 35.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.687 -1.142 . . . . 0.95999999999999996 110.486 -168.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 14.4 m-85 -125.37 124.5 41.66 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.563 1.173 . . . . 0.42999999999999999 109.664 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.711 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.4 pt20 -80.8 122.05 26.7 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 112.764 -2.016 . . . . 0.23999999999999999 112.118 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -120.86 142.08 49.99 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.999 -1.001 . . . . 1.0 108.561 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -98.64 -12.53 20.99 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.928 -0.709 . . . . 0.78000000000000003 109.941 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 3.3 p-10 -148.09 165.25 31.38 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.729 -0.669 . . . . 0.28999999999999998 111.703 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.16 73.39 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.552 -0.749 . . . . 0.17999999999999999 113.45 -174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.414 ' HB2' HD21 ' A' ' 35' ' ' ASN . 3.2 mm? -81.94 -43.15 18.47 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.034 0.921 . . . . 1.1200000000000001 109.14 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.768 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.2 tt0 -63.34 -34.83 78.56 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.103 -1.814 . . . . 1.78 106.103 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -66.52 -46.67 75.43 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.485 -1.234 . . . . 0.98999999999999999 111.0 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.645 HD21 ' HG3' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -52.58 -46.92 67.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.641 0.734 . . . . 1.5700000000000001 109.292 173.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.09 -41.3 92.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.293 -1.322 . . . . 1.3200000000000001 111.203 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.826 ' HB ' HD13 ' A' ' 7' ' ' LEU . 17.2 mm -63.26 -48.32 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 110.121 -0.326 . . . . 1.04 110.121 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.488 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 38.7 t -60.19 -43.59 93.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-O 121.817 0.818 . . . . 1.0600000000000001 109.283 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.54 -29.28 69.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.261 -0.881 . . . . 0.95999999999999996 111.614 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.19 -45.08 8.03 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.949 0.352 . . . . 2.9900000000000002 111.949 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 57.2 mm-40 -107.78 -36.17 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 0.63 111.654 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 69.3 mtp180 62.74 62.01 2.0 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.368 -0.833 . . . . 4.2800000000000002 109.547 -170.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.657 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 77.1 Cg_exo -58.66 156.94 29.68 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.046 1.83 . . . . 0.20999999999999999 111.095 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.809 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -93.27 -34.7 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.901 -0.72 . . . . 0.97999999999999998 109.585 175.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.657 HD22 HD12 ' A' ' 79' ' ' ILE . 7.1 mp -115.47 114.02 24.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.007 -0.542 . . . . 1.1599999999999999 109.992 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.736 HG11 ' HE2' ' A' ' 69' ' ' MET . 92.7 t -112.63 121.61 65.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 110.527 -0.175 . . . . 1.05 110.527 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 19' ' ' LEU . 2.4 mp -92.0 97.6 11.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.579 -0.526 . . . . 1.0700000000000001 109.579 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.71 HD23 HG23 ' A' ' 9' ' ' VAL . 44.0 mt -93.52 106.24 18.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.762 -0.654 . . . . 2.2000000000000002 110.424 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.696 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 52.5 t0 -66.86 107.93 2.37 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.204 -0.598 . . . . 1.47 110.232 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.786 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 11.5 mtm -83.05 0.74 43.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.661 . . . . 1.6499999999999999 110.797 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.714 ' HZ2' ' HB2' ' A' ' 83' ' ' ALA . 25.5 mmmt -57.75 -58.5 8.08 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.408 0.522 . . . . 2.73 112.408 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.842 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 15.2 tt -175.57 -34.21 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.264 1.209 . . . . 2.6099999999999999 114.264 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.86 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -20.23 -63.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.261 3.307 . . . . 0.55000000000000004 116.482 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.93 -58.23 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.652 -1.261 . . . . 0.55000000000000004 113.204 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.487 ' HB3' HD12 ' A' ' 65' ' ' ILE . 47.2 ttm -148.96 165.85 30.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.415 -0.587 . . . . 2.6699999999999999 109.415 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' ILE . 38.3 m-20 -60.46 133.9 56.54 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.745 -0.465 . . . . 0.67000000000000004 109.745 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 66' ' ' LEU . . . -67.55 1.65 6.99 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 120.892 -0.67 . . . . 0.32000000000000001 112.364 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.573 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.3 mt -92.45 -45.7 14.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.842 0.353 . . . . 1.9199999999999999 110.116 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.74 -36.08 81.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.46999999999999997 109.701 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.652 HG21 ' HE3' ' A' ' 69' ' ' MET . 15.6 mt -73.5 -34.19 41.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.929 -0.578 . . . . 1.3600000000000001 109.483 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.655 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -54.77 -53.99 47.89 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.488 -0.778 . . . . 2.1600000000000001 109.978 174.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.6 ptpt -71.47 -33.42 69.29 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.118 0.414 . . . . 1.3400000000000001 112.118 -173.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.707 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.9 ptm180 -66.54 -34.6 78.27 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.465 -0.894 . . . . 2.8599999999999999 110.95 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.736 ' HE2' HG11 ' A' ' 51' ' ' VAL . 10.1 ptp -82.75 -16.74 46.81 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 119.834 -0.746 . . . . 1.95 109.722 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.655 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 11.3 mptt -78.88 -30.25 44.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.723 0.773 . . . . 1.9299999999999999 109.854 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 68' ' ' ARG . 2.7 p -78.59 -31.86 15.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.505 0.669 . . . . 1.8300000000000001 109.261 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.664 HG12 ' HA ' ' A' ' 69' ' ' MET . 21.8 pt -86.52 -21.89 7.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.102 -0.954 . . . . 1.02 110.724 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.489 ' O ' HG21 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -162.78 88.51 0.62 Allowed 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 112.559 0.577 . . . . 1.0800000000000001 112.559 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 11.6 mt-10 -76.67 5.93 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 120.68 -1.263 . . . . 1.78 109.688 173.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -73.7 -29.67 62.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.489 -1.232 . . . . 0.34999999999999998 107.894 171.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.649 HG22 ' HG3' ' A' ' 69' ' ' MET . 5.2 tt -76.66 159.4 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 112.767 -2.015 . . . . 1.05 111.296 -170.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.809 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 4.2 ptp180 -134.84 177.21 7.97 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.335 -0.848 . . . . 1.45 109.392 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.632 HG11 HD11 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -132.58 159.65 43.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.505 0.669 . . . . 1.55 110.507 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.725 HG22 ' HD2' ' A' ' 102' ' ' PHE . 54.9 mt -131.01 66.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.071 -1.455 . . . . 1.3500000000000001 107.071 170.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.786 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -63.5 140.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.745 0.783 . . . . 1.02 111.804 -170.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.763 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 mtp -95.84 124.1 39.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.764 -1.107 . . . . 2.5499999999999998 110.371 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 101' ' ' ALA . 12.1 p -130.84 159.13 38.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.1 -0.5 . . . . 1.78 112.173 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB2' ' HZ2' ' A' ' 56' ' ' LYS . . . -66.8 73.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.595 . . . . 1.1000000000000001 109.863 165.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 26.5 p90 50.88 21.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.225 1.41 . . . . 4.4400000000000004 113.714 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.65 92.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.828 -0.701 . . . . 0.65000000000000002 112.688 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.67 ' N ' HG13 ' A' ' 90' ' ' ILE . 19.3 mt-10 -89.01 14.67 10.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.067 0.461 . . . . 1.3300000000000001 110.855 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 65.65 -177.74 0.19 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.34 0.867 . . . . 2.2799999999999998 113.34 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.0 t70 60.83 -100.24 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.738 -1.119 . . . . 1.3799999999999999 112.042 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -58.97 -23.37 61.62 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.021 0.439 . . . . 3.3700000000000001 110.613 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.67 HG13 ' N ' ' A' ' 86' ' ' GLU . 34.9 mm -65.83 -40.2 86.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.272 0.558 . . . . 1.3700000000000001 110.088 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 22.8 mm-40 -72.76 -39.03 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.536 -0.756 . . . . 3.1800000000000002 109.591 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.601 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 23.5 tt0 -67.95 -40.92 83.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.785 -1.098 . . . . 1.27 111.729 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.428 ' OG ' HG21 ' A' ' 80' ' ' ILE . 6.6 t -54.46 -61.01 2.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.144 0.497 . . . . 1.5600000000000001 110.055 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.897 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -58.75 -39.45 80.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 2.3100000000000001 111.422 176.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.0 pt-20 -62.17 -27.23 68.82 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.637 0.236 . . . . 1.8400000000000001 111.637 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.462 ' HB3' HD21 ' A' ' 66' ' ' LEU . 11.8 mt -85.54 -8.23 58.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.256 0.465 . . . . 1.8999999999999999 112.256 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.97 19.22 0.72 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.034 -1.079 . . . . 0.34999999999999998 113.511 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.897 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -98.84 138.83 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.988 -0.745 . . . . 1.02 108.988 171.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.795 HD22 ' HD3' ' A' ' 77' ' ' ARG . 9.3 mt -77.41 -50.05 13.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.398 0.618 . . . . 1.05 110.397 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.581 ' OG1' HG21 ' A' ' 79' ' ' ILE . 62.6 p -139.65 148.72 42.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.224 -0.898 . . . . 1.05 111.664 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.588 ' HB3' HG23 ' A' ' 82' ' ' THR . . . -104.95 84.35 2.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.962 -1.017 . . . . 1.1799999999999999 108.973 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.763 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 1.1 p90 -86.73 144.4 27.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 4.75 110.568 -170.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . . . -95.98 166.31 11.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 1.24 110.743 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 18.0 pttp -70.36 -29.38 1.57 Allowed Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.724 0.639 . . . . 3.7200000000000002 112.724 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 103' ' ' ALA . 55.6 Cg_endo -76.14 95.45 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 120.501 1.215 . . . . 1.6699999999999999 110.166 163.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.499 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 30.1 p90 -132.3 152.77 51.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.451 0.643 . . . . 1.29 111.318 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 109' ' ' ASP . 19.0 t70 -75.56 -3.9 36.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.117 -0.947 . . . . 1.77 111.653 -173.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.499 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 13.7 mt 65.35 -62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 1.9199999999999999 110.114 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.475 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 29.8 t70 -63.06 -26.96 69.08 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.89 -0.596 . . . . 1.1599999999999999 110.817 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.8 -34.31 76.52 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.039 0.447 . . . . 0.83999999999999997 110.193 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 115' ' ' VAL . 28.3 mt -83.03 -40.22 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.987 -0.551 . . . . 1.5600000000000001 110.108 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.562 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -66.59 -35.97 81.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.638 -0.875 . . . . 0.80000000000000004 108.638 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.783 ' HA ' ' HE2' ' A' ' 116' ' ' LYS . 32.5 t70 -61.96 -53.03 61.31 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.999 -0.741 . . . . 0.78000000000000003 108.999 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.925 ' HA ' ' HE3' ' A' ' 117' ' ' LYS . . . -52.09 -46.38 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.459 -0.792 . . . . 1.3100000000000001 111.833 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 111' ' ' ILE . 32.3 m -68.24 -47.68 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.673 0.62 . . . . 1.1200000000000001 112.673 -173.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 1.2 pptt? -85.24 -8.68 58.43 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.099 0.409 . . . . 1.99 111.665 -177.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 114' ' ' ALA . 21.6 pttp -86.5 -21.52 26.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.715 -0.794 . . . . 2.0899999999999999 109.749 167.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.838 ' HD1' ' HG ' ' A' ' 119' ' ' LEU . 14.8 t80 -80.56 -66.67 0.85 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.282 -0.417 . . . . 2.3900000000000001 110.421 176.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.838 ' HG ' ' HD1' ' A' ' 118' ' ' TYR . 91.9 mt -122.36 86.23 48.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.414 -0.587 . . . . 2.7599999999999998 109.414 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.665 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 93.1 Cg_endo -80.68 133.66 9.41 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.564 2.176 . . . . 0.92000000000000004 113.434 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 4' ' ' GLU . 13.3 tp . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 121.6 0.714 . . . . 1.9399999999999999 110.211 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.697 ' HB3' HD11 ' A' ' 121' ' ' LEU . 7.2 tp10 . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.198 0.523 . . . . 2.2999999999999998 111.456 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.849 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -136.09 146.52 47.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.294 0.569 . . . . 1.3999999999999999 111.368 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.899 ' HB ' HG21 ' A' ' 30' ' ' THR . 2.9 mt -137.81 154.75 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.389 -0.823 . . . . 1.04 111.575 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.851 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -135.56 111.64 9.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.459 -1.246 . . . . 0.98999999999999999 107.724 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.614 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.2 mp -99.42 104.62 16.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.175 -1.01 . . . . 1.1200000000000001 110.219 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 47.9 t -85.67 93.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.777 -0.823 . . . . 1.0900000000000001 108.777 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.593 ' OD2' ' HG3' ' A' ' 12' ' ' GLN . 25.8 t70 -152.6 104.81 2.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.643 -0.423 . . . . 1.8200000000000001 111.138 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.693 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 19.7 t70 -54.14 -41.24 68.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.55 0.34 . . . . 0.51000000000000001 111.46 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.593 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 3.6 pt20 -70.94 76.29 0.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 122.23 1.014 . . . . 2.5600000000000001 109.217 173.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.438 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 31.0 p90 -53.67 -13.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.602 -1.635 . . . . 1.8300000000000001 114.648 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.73 -67.49 1.27 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.366 -0.921 . . . . 0.41999999999999998 111.547 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -70.48 -11.78 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 O-C-N 121.958 -0.731 . . . . 1.5600000000000001 111.241 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.884 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.4 ttm180 -79.89 -42.12 24.81 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.612 -0.435 . . . . 0.47999999999999998 110.229 -173.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 ' NE2' ' A' ' 32' ' ' GLN . 2.7 pp -83.64 -27.14 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 1.1899999999999999 109.967 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.483 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 3.5 tp -61.78 -61.59 2.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.637 -0.711 . . . . 1.22 109.485 170.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 1.1 tp -52.51 -41.96 63.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.653 -0.703 . . . . 1.8400000000000001 110.187 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.721 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.4 t30 -51.18 -70.9 0.07 Allowed 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.78 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.28 -39.12 69.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.355 0.41 . . . . 2.46 111.64 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' LEU . 35.6 t -55.76 -60.83 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.626 -0.261 . . . . 1.2 111.295 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.776 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 8.3 m-85 -72.37 -34.6 68.08 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.457 -0.571 . . . . 0.51000000000000001 109.457 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.91 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 3.5 t-20 -52.06 -48.56 64.56 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.269 -0.878 . . . . 0.32000000000000001 109.388 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.41 -31.72 73.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.626 -1.624 . . . . 3.6699999999999999 112.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.674 ' HB2' ' CD1' ' A' ' 28' ' ' TYR . 6.1 mm-40 -63.67 -25.27 68.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.639 0.733 . . . . 1.51 110.313 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . 143.21 -16.47 2.32 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.491 -1.231 . . . . 0.56999999999999995 110.648 -171.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.91 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 8.2 m-85 -81.64 124.06 29.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.308 0.575 . . . . 1.49 111.387 -162.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.849 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 20.7 mt-30 -79.39 82.61 5.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.46 -0.941 . . . . 1.1399999999999999 108.46 172.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.899 HG21 ' HB ' ' A' ' 6' ' ' ILE . 20.8 p -90.19 135.85 33.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.645 -0.707 . . . . 0.95999999999999996 109.921 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.518 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 15.4 m-85 -125.95 126.35 44.22 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.408 1.099 . . . . 0.42999999999999999 109.265 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.884 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.5 pt20 -86.43 120.74 28.08 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.004 -1.907 . . . . 0.23999999999999999 111.355 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.44 124.6 43.25 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.495 -0.558 . . . . 1.0 109.495 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.71 -19.03 60.41 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.738 -0.385 . . . . 0.78000000000000003 111.028 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.476 HD21 ' HB2' ' A' ' 37' ' ' LEU . 1.7 p-10 -148.23 168.57 22.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 0.28999999999999998 111.567 -174.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -75.03 -14.32 81.91 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 113.33 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.476 ' HB2' HD21 ' A' ' 35' ' ' ASN . 3.2 mm? -79.9 -44.71 19.91 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 122.617 1.198 . . . . 1.1200000000000001 108.279 175.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.802 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.3 tp-100 -60.94 -40.69 94.23 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 112.26 -2.245 . . . . 1.78 105.597 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB1' HG22 ' A' ' 9' ' ' VAL . . . -63.3 -44.36 95.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.722 -1.581 . . . . 0.98999999999999999 111.258 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.7 -43.64 76.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.037 -0.727 . . . . 1.5700000000000001 109.037 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 44' ' ' THR . 18.9 t70 -64.22 -41.95 96.79 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.492 -1.231 . . . . 1.3200000000000001 110.616 177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.851 ' HB ' HD11 ' A' ' 7' ' ' LEU . 10.3 mm -60.69 -48.78 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 120.922 -0.311 . . . . 1.04 111.033 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 39' ' ' ALA . 46.8 t -57.97 -41.75 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.741 0.781 . . . . 1.0600000000000001 109.947 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.38 -23.95 62.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.226 -0.897 . . . . 0.95999999999999996 111.134 -178.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.697 ' HE3' ' HA ' ' A' ' 42' ' ' ILE . 9.7 ptpt -91.23 -42.34 10.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.695 0.283 . . . . 2.9900000000000002 111.268 -177.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.625 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 62.5 mm-40 -111.61 -38.16 4.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 112.066 0.395 . . . . 0.63 112.066 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.2 mpt_? 64.78 64.28 1.11 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 123.857 0.723 . . . . 4.2800000000000002 109.769 -169.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.733 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 51.7 Cg_exo -62.77 157.71 46.28 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 121.57 1.513 . . . . 0.20999999999999999 111.473 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.901 ' HB2' HD11 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -85.03 -51.09 6.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.293 -1.373 . . . . 0.97999999999999998 107.293 171.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.901 HD11 ' HB2' ' A' ' 49' ' ' ASP . 7.1 mp -105.11 111.59 24.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.716 -1.129 . . . . 1.1599999999999999 110.75 -171.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.011 HG12 ' HE2' ' A' ' 69' ' ' MET . 60.0 t -112.18 108.51 25.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.213 -0.449 . . . . 1.05 111.419 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.624 HD23 HD21 ' A' ' 19' ' ' LEU . 2.1 mp -75.68 89.12 2.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.795 0.807 . . . . 1.0700000000000001 109.473 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -82.49 110.68 17.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.059 -1.428 . . . . 2.2000000000000002 111.294 -172.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.12 127.19 18.5 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.697 0.76 . . . . 1.47 110.714 174.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.906 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 18.8 mtp -114.94 9.52 16.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.172 -0.922 . . . . 1.6499999999999999 109.457 163.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -71.74 -67.55 0.52 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.63 . . . . 2.73 111.9 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.771 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -175.05 -36.03 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.036 0 CA-C-O 118.024 -0.989 . . . . 2.6099999999999999 112.708 -172.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.771 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 4.7 Cg_exo -19.48 -62.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.726 3.617 . . . . 0.55000000000000004 116.419 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.06 -73.23 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 119.764 -1.208 . . . . 0.55000000000000004 113.394 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.3 tpt -148.9 168.55 22.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.574 -0.899 . . . . 2.6699999999999999 108.574 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.17 129.18 40.79 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.172 0.51 . . . . 0.67000000000000004 109.654 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.58 ' CA ' ' HG ' ' A' ' 53' ' ' LEU . . . -62.92 -7.19 15.07 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.08 -0.964 . . . . 0.32000000000000001 112.718 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.688 HG13 ' HB3' ' A' ' 89' ' ' MET . 4.1 mm -78.22 -48.66 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.681 -0.488 . . . . 1.9199999999999999 109.681 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.9 -33.46 75.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.876 -0.787 . . . . 0.46999999999999997 108.876 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.717 ' O ' ' HG2' ' A' ' 69' ' ' MET . 59.9 mt -77.31 -38.79 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.292 -0.867 . . . . 1.3600000000000001 111.371 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.623 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 3.7 pp -65.66 -36.85 84.86 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 120.291 -0.564 . . . . 2.1600000000000001 110.285 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.664 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.8 ptpt -73.49 -35.41 65.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.332 -0.547 . . . . 1.3400000000000001 111.182 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.705 ' O ' HG13 ' A' ' 71' ' ' VAL . 11.6 ptm180 -65.28 -33.46 76.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 118.868 -1.133 . . . . 2.8599999999999999 111.668 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 1.011 ' HE2' HG12 ' A' ' 51' ' ' VAL . 12.2 ptp -84.86 -11.99 54.47 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.046 -1.033 . . . . 1.95 109.405 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.664 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 12.5 mptt -76.84 -36.98 56.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.016 -0.735 . . . . 1.9299999999999999 109.016 172.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 68' ' ' ARG . 4.0 p -72.07 -33.81 48.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.354 0.597 . . . . 1.8300000000000001 109.648 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.782 HG12 ' HA ' ' A' ' 69' ' ' MET . 26.1 pt -84.27 -24.46 7.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.291 -0.868 . . . . 1.02 110.973 172.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -161.74 88.18 0.69 Allowed 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.043 0.386 . . . . 1.0800000000000001 112.043 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.569 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 8.5 mt-10 -75.77 6.25 5.22 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.272 -0.892 . . . . 1.78 110.636 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -28.69 42.39 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.856 -1.535 . . . . 0.34999999999999998 106.856 170.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.3 tt -67.61 153.8 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 113.556 -1.657 . . . . 1.05 110.686 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 6.3 ptp180 -135.45 177.9 7.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.792 -1.188 . . . . 1.45 107.792 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.672 HG23 ' CB ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -144.17 144.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.52 0.676 . . . . 1.55 111.216 -174.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.89 HG21 ' HG1' ' A' ' 100' ' ' THR . 64.9 mt -114.79 74.75 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.304 -1.369 . . . . 1.3500000000000001 107.304 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.906 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -62.55 140.11 19.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 119.544 -0.862 . . . . 1.02 112.735 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 7.4 mtp -100.81 102.68 13.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.734 -1.121 . . . . 2.5499999999999998 110.159 -174.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 t -117.05 165.13 13.73 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.343 0.592 . . . . 1.78 112.284 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 56.09 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.954 -1.021 . . . . 1.1000000000000001 110.26 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 t80 72.3 5.59 5.32 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.983 -1.008 . . . . 4.4400000000000004 111.686 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.32 88.28 1.99 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.115 -0.564 . . . . 0.65000000000000002 112.619 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.423 ' N ' HG13 ' A' ' 90' ' ' ILE . 24.2 mt-10 -81.38 9.36 7.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.924 0.393 . . . . 1.3300000000000001 111.18 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.506 HD23 HE21 ' A' ' 91' ' ' GLN . 38.1 mt 65.8 -166.22 0.22 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.606 -0.725 . . . . 2.2799999999999998 112.621 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 87' ' ' LEU . 1.0 OUTLIER 59.53 -99.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.297 -0.865 . . . . 1.3799999999999999 111.531 -177.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.688 ' HB3' HG13 ' A' ' 63' ' ' ILE . 2.0 mpt? -64.25 -18.0 64.14 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.421 -0.354 . . . . 3.3700000000000001 110.291 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 87' ' ' LEU . 32.7 mm -69.49 -40.2 79.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.999 0.428 . . . . 1.3700000000000001 110.265 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.506 HE21 HD23 ' A' ' 87' ' ' LEU . 73.1 mt-30 -67.02 -53.36 31.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.842 -0.799 . . . . 3.1800000000000002 108.842 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 42.8 tt0 -56.72 -30.6 63.69 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 114.46 -1.245 . . . . 1.27 111.404 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.474 ' HA ' HD13 ' A' ' 63' ' ' ILE . 27.6 t -54.59 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.754 0.788 . . . . 1.5600000000000001 111.177 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 33.4 pttt -54.03 -38.02 64.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.629 -1.169 . . . . 2.3100000000000001 110.714 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 8.2 tp10 -55.37 -43.42 75.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.739 -1.118 . . . . 1.8400000000000001 111.874 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.75 -22.96 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.843 0.354 . . . . 1.8999999999999999 111.165 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.88 21.97 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.004 -1.093 . . . . 0.34999999999999998 113.935 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.672 ' CB ' HG23 ' A' ' 78' ' ' VAL . . . -88.54 140.54 29.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.9 0.85 . . . . 1.02 109.277 169.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.464 HD23 ' HD3' ' A' ' 77' ' ' ARG . 18.3 mt -82.19 -48.95 10.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.718 0.771 . . . . 1.05 109.865 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.89 ' HG1' HG21 ' A' ' 79' ' ' ILE . 52.6 p -144.57 150.2 37.08 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.486 -1.234 . . . . 1.05 111.64 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 82' ' ' THR . . . -108.55 86.89 2.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.363 -0.835 . . . . 1.1799999999999999 109.967 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 81' ' ' MET . 16.6 m-85 -84.33 143.02 29.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.985 0.421 . . . . 4.75 110.716 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . . . -95.48 178.14 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 1.24 109.431 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' HD1' ' A' ' 106' ' ' PHE . 20.5 mmtp -78.33 -29.75 0.66 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.639 0.607 . . . . 3.7200000000000002 112.639 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 103' ' ' ALA . 24.2 Cg_exo -65.62 96.99 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 120.368 1.167 . . . . 1.6699999999999999 109.922 162.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 1.6 p90 -130.19 146.16 51.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.875 -0.602 . . . . 1.29 111.516 -172.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -86.15 18.4 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.598 . . . . 1.77 111.726 178.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.533 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.4 tt 48.3 -67.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 125.035 1.334 . . . . 1.9199999999999999 113.003 -174.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.533 ' H ' HG23 ' A' ' 108' ' ' ILE . 18.5 t70 -58.22 -30.55 66.58 Favored 'General case' 0 C--O 1.212 -0.897 0 C-N-CA 122.55 0.34 . . . . 1.1599999999999999 111.364 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.11 -28.15 67.92 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 119.997 -0.681 . . . . 0.83999999999999997 110.143 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.48 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 17.0 mt -80.76 -41.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 1.5600000000000001 110.508 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.522 ' HD2' ' C ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -68.68 -32.99 73.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.744 0.783 . . . . 0.80000000000000004 109.215 175.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 19.1 t70 -70.91 -36.49 72.73 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.323 -0.853 . . . . 0.78000000000000003 108.828 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.717 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.6 -45.29 79.66 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.079 -0.964 . . . . 1.3100000000000001 111.459 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.418 HG22 ' HA ' ' A' ' 112' ' ' ARG . 34.5 m -61.77 -42.59 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.598 -0.841 . . . . 1.1200000000000001 110.184 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.547 ' HA ' ' OH ' ' A' ' 28' ' ' TYR . 7.1 ttpt -63.67 -49.65 72.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.795 -0.639 . . . . 1.99 111.418 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.717 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.5 OUTLIER -59.78 -30.67 69.04 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.664 -0.243 . . . . 2.0899999999999999 111.399 -176.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.535 ' HB3' HD13 ' A' ' 119' ' ' LEU . 44.5 m-85 -81.91 -68.91 0.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.417 -0.513 . . . . 2.3900000000000001 110.696 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.535 HD13 ' HB3' ' A' ' 118' ' ' TYR . 6.7 mp -121.48 103.63 41.06 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.175 -0.676 . . . . 2.7599999999999998 109.175 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -97.78 153.11 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.752 2.301 . . . . 0.92000000000000004 114.493 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 1.9399999999999999 108.396 172.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.812 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 8.3 tt0 . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 121.583 0.706 . . . . 2.2999999999999998 110.916 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.68 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 3.6 tppt? -140.57 147.33 39.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.009 -0.541 . . . . 1.3999999999999999 111.202 -172.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.879 ' HB ' HG21 ' A' ' 30' ' ' THR . 2.6 mt -141.23 153.99 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.439 -0.8 . . . . 1.04 111.696 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.814 HD12 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -131.82 123.47 27.64 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.61 -1.256 . . . . 0.98999999999999999 107.61 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.719 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.4 mp -109.66 103.21 15.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.556 -0.858 . . . . 1.1200000000000001 110.164 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.2 t -88.49 82.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 1.0900000000000001 110.003 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.868 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.0 t70 -133.1 144.28 49.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.548 -0.296 . . . . 1.8200000000000001 110.686 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.902 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 13.0 t70 -101.54 -35.94 8.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.896 -0.409 . . . . 0.51000000000000001 109.896 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.641 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 4.4 pt20 -81.06 70.61 7.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.098 -1.445 . . . . 2.5600000000000001 107.098 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -48.74 -13.92 0.06 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 112.334 -2.212 . . . . 1.8300000000000001 115.181 -161.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' GLN . . . -46.68 -59.48 5.4 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.198 -1.001 . . . . 0.41999999999999998 110.777 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 1.1 mm -54.51 -32.5 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.525 0.679 . . . . 1.5600000000000001 110.245 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.868 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.6 ttm180 -77.12 -48.78 16.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.118 -0.946 . . . . 0.47999999999999998 110.891 -165.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 42.4 pt -76.04 -25.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.312 -0.625 . . . . 1.1899999999999999 109.312 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' O ' HG21 ' A' ' 22' ' ' VAL . 7.4 tp -58.69 -68.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 1.22 109.416 171.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.814 HD13 HD21 ' A' ' 52' ' ' LEU . 39.0 mt -54.65 -40.91 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 1.8400000000000001 110.563 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 7.6 t30 -50.48 -68.81 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.97 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.65 -40.04 82.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.265 0.353 . . . . 2.46 111.639 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -55.15 -55.43 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.052 0.22 . . . . 1.2 111.576 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.632 ' HB2' HG22 ' A' ' 30' ' ' THR . 11.8 m-85 -78.87 -36.66 41.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.61 -0.436 . . . . 0.51000000000000001 110.038 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.84 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 9.3 t-20 -50.15 -50.54 48.55 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.176 0.988 . . . . 0.32000000000000001 108.934 -176.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -54.77 -42.49 71.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 112.637 -2.074 . . . . 3.6699999999999999 111.676 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -52.22 -34.6 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 122.191 0.996 . . . . 1.51 109.733 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.549 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 138.08 -6.66 3.43 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 113.303 -1.771 . . . . 0.56999999999999995 109.39 -171.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.84 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 5.5 m-85 -70.4 126.86 30.83 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.807 -0.757 . . . . 1.49 110.549 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.619 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 28.6 mt-30 -82.7 81.13 8.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.475 -0.935 . . . . 1.1399999999999999 108.475 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.879 HG21 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -90.07 133.09 35.05 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.064 -0.971 . . . . 0.95999999999999996 110.128 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.94 124.83 42.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.592 1.187 . . . . 0.42999999999999999 109.732 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.682 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 1.5 pt20 -82.17 120.71 25.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 112.748 -2.024 . . . . 0.23999999999999999 111.602 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 42' ' ' ILE . . . -123.93 124.02 41.69 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -84.83 -8.19 58.89 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.223 -0.591 . . . . 0.78000000000000003 111.293 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.442 HD21 ' HB2' ' A' ' 37' ' ' LEU . 1.7 p-10 -149.42 165.55 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.41 -0.359 . . . . 0.28999999999999998 111.56 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.91 -19.92 77.32 Favored Glycine 0 CA--C 1.506 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.17999999999999999 113.291 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.442 ' HB2' HD21 ' A' ' 35' ' ' ASN . 2.7 mm? -78.31 -42.97 29.16 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.458 1.123 . . . . 1.1200000000000001 108.075 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.843 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -60.96 -41.66 96.75 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 112.6 -2.091 . . . . 1.78 105.805 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -60.9 -43.87 97.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.003 -1.453 . . . . 0.98999999999999999 111.038 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.2 OUTLIER -57.44 -43.37 83.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.224 -0.658 . . . . 1.5700000000000001 109.224 177.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 44' ' ' THR . 2.1 t70 -64.57 -44.58 90.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 114.951 -1.022 . . . . 1.3200000000000001 110.213 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.843 HG12 ' O ' ' A' ' 38' ' ' GLN . 15.9 mm -60.19 -46.42 94.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.266 -0.879 . . . . 1.04 110.165 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 69' ' ' MET . 47.6 t -62.12 -41.25 90.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 121.727 0.775 . . . . 1.0600000000000001 109.604 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -73.23 -20.71 60.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.606 -0.725 . . . . 0.95999999999999996 111.155 -177.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.616 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -90.49 -45.99 8.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.604 -0.271 . . . . 2.9900000000000002 111.246 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 8.3 mm-40 -110.63 -36.89 5.61 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.392 0.515 . . . . 0.63 112.392 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 14.1 mtm-85 65.36 65.43 0.92 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 O-C-N 123.639 0.587 . . . . 4.2800000000000002 109.536 -170.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.759 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 71.3 Cg_exo -60.57 156.67 40.74 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 C-N-CA 121.689 1.592 . . . . 0.20999999999999999 111.033 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.814 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 12.3 m-20 -89.51 -42.27 11.55 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.293 -0.963 . . . . 0.97999999999999998 108.849 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.634 HD22 HD13 ' A' ' 79' ' ' ILE . 6.8 mp -110.42 111.97 23.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.737 -0.665 . . . . 1.1599999999999999 109.864 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.757 HG12 ' HB3' ' A' ' 7' ' ' LEU . 86.3 t -112.58 112.81 42.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.796 0.332 . . . . 1.05 110.669 -177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.814 HD21 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -83.64 93.01 7.8 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.411 0.624 . . . . 1.0700000000000001 109.986 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.693 HD12 HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -84.63 104.7 14.84 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.826 -1.079 . . . . 2.2000000000000002 111.155 -175.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.825 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 54.2 t0 -70.11 109.14 4.43 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.57 -0.852 . . . . 1.47 110.181 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.849 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.9 mtp -86.28 11.03 13.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.614 -0.721 . . . . 1.6499999999999999 111.083 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.638 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -71.32 -60.16 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.029 0.752 . . . . 2.73 113.029 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.878 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.1 tp -173.08 -21.73 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.671 1.36 . . . . 2.6099999999999999 114.671 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.902 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -27.62 -52.87 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 123.443 2.762 . . . . 0.55000000000000004 116.105 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.02 -60.07 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.756 -1.211 . . . . 0.55000000000000004 112.88 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.543 ' HE2' ' HG3' ' A' ' 64' ' ' GLU . 20.6 ttt -149.53 170.18 19.21 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.403 -0.592 . . . . 2.6699999999999999 109.403 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -57.66 135.38 56.72 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.977 0.417 . . . . 0.67000000000000004 110.283 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.589 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -66.49 -2.07 13.71 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.408 -0.815 . . . . 0.32000000000000001 112.885 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.53 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.2 mt -92.05 -42.03 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.157 0.503 . . . . 1.9199999999999999 110.286 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HG3' ' HE2' ' A' ' 60' ' ' MET . 6.3 mm-40 -68.85 -38.9 80.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.571 0.701 . . . . 0.46999999999999997 109.413 177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.693 HD13 HD12 ' A' ' 53' ' ' LEU . 54.0 mt -71.57 -35.85 57.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.149 -0.932 . . . . 1.3600000000000001 109.794 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.744 ' HA ' ' HE2' ' A' ' 69' ' ' MET . 3.2 tt -53.34 -53.43 51.19 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.677 -0.692 . . . . 2.1600000000000001 110.607 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.0 ptpp? -73.13 -30.16 63.41 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.233 -0.587 . . . . 1.3400000000000001 112.083 -172.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.693 ' O ' HG12 ' A' ' 71' ' ' VAL . 15.0 ptp180 -68.97 -33.59 73.95 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 118.92 -1.112 . . . . 2.8599999999999999 111.066 174.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.744 ' HE2' ' HA ' ' A' ' 66' ' ' LEU . 2.8 ptt? -80.63 -17.82 50.08 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 118.918 -1.113 . . . . 1.95 109.796 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.706 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -76.93 -30.24 55.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.636 . . . . 1.9299999999999999 110.572 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.7 p -78.12 -34.95 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 109.531 -0.544 . . . . 1.8300000000000001 109.531 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.596 HG12 ' HA ' ' A' ' 69' ' ' MET . 15.7 pt -81.42 -31.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 1.02 110.037 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 75' ' ' ASN . 3.4 m-20 -157.76 90.82 1.1 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.341 0.497 . . . . 1.0800000000000001 112.341 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.587 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.32 2.9 6.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.876 0.846 . . . . 1.78 109.796 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -69.53 -26.11 64.35 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.55 -1.278 . . . . 0.34999999999999998 107.55 171.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.0 tt -76.23 156.93 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 112.743 -2.026 . . . . 1.05 110.754 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.814 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -137.77 172.48 12.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.055 -0.975 . . . . 1.45 108.614 177.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.703 HG21 HD11 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -131.29 154.25 40.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 120.217 -0.593 . . . . 1.55 110.689 -171.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.704 HG23 ' HG1' ' A' ' 100' ' ' THR . 61.5 mt -128.64 68.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.402 -1.333 . . . . 1.3500000000000001 107.402 171.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.849 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -64.86 140.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.538 -0.756 . . . . 1.02 111.735 -172.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.633 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 11.0 mtt -93.15 131.1 38.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.071 -0.968 . . . . 2.5499999999999998 110.019 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.603 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 4.6 t -132.85 156.85 46.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.329 0.585 . . . . 1.78 112.578 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . -72.36 63.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.761 -1.109 . . . . 1.1000000000000001 109.804 170.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.451 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 40.3 t80 70.24 11.26 7.5 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.564 -1.198 . . . . 4.4400000000000004 112.021 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.72 81.88 1.6 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.051 -0.595 . . . . 0.65000000000000002 112.011 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.484 ' N ' HG13 ' A' ' 90' ' ' ILE . 5.6 mt-10 -72.6 8.12 1.59 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.678 0.791 . . . . 1.3300000000000001 112.052 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt 61.11 -177.55 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.569 1.322 . . . . 2.2799999999999998 114.569 171.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 t70 57.7 -93.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.328 -1.306 . . . . 1.3799999999999999 111.692 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.453 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 66.3 mtt -60.88 -26.77 67.65 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 120.838 0.351 . . . . 3.3700000000000001 110.363 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 86' ' ' GLU . 15.7 mm -62.52 -43.25 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.057 0.456 . . . . 1.3700000000000001 110.439 173.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 88.2 mt-30 -63.76 -48.31 77.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.473 -0.785 . . . . 3.1800000000000002 109.493 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.75 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 22.7 tt0 -70.11 -20.52 63.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.539 -1.21 . . . . 1.27 112.102 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.432 ' OG ' HG21 ' A' ' 80' ' ' ILE . 6.8 t -66.68 -63.84 0.98 Allowed 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.876 -0.515 . . . . 1.5600000000000001 110.062 174.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.908 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 17.0 ptpt -58.87 -31.14 68.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.694 0.759 . . . . 2.3100000000000001 109.964 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.75 ' CB ' ' HA ' ' A' ' 92' ' ' GLU . 6.1 tt0 -47.38 -58.87 3.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.366 -1.288 . . . . 1.8400000000000001 111.867 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.77 -28.57 65.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.764 -0.653 . . . . 1.8999999999999999 112.36 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.608 ' HA3' ' HZ3' ' A' ' 70' ' ' LYS . . . 163.72 11.22 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.835 -1.174 . . . . 0.34999999999999998 113.739 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.908 ' HB2' ' HA ' ' A' ' 94' ' ' LYS . . . -86.72 136.38 33.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.827 0.813 . . . . 1.02 109.66 173.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mt -74.98 -49.24 20.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.708 0.766 . . . . 1.05 109.867 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.704 ' HG1' HG23 ' A' ' 79' ' ' ILE . 60.2 p -139.17 147.83 42.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.383 -1.281 . . . . 1.05 111.603 -172.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -107.59 88.7 2.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.862 -1.063 . . . . 1.1799999999999999 108.431 170.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.608 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 0.3 OUTLIER -84.34 142.22 30.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.264 -0.425 . . . . 4.75 109.944 -172.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -108.42 177.07 4.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 1.24 111.424 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.703 ' HZ2' ' HB3' ' A' ' 104' ' ' LYS . 10.2 mtpm? -59.37 -43.3 96.16 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.959 -0.564 . . . . 3.7200000000000002 111.873 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 54.0 Cg_endo -74.37 96.2 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 120.633 0.889 . . . . 1.6699999999999999 110.995 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.436 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 51.1 p90 -130.81 148.2 52.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.585 -0.734 . . . . 1.29 110.252 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 33.6 t70 -81.99 6.95 14.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.483 -0.78 . . . . 1.77 110.962 -174.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 107' ' ' ASP . 6.0 tt 52.75 -60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.551 1.54 . . . . 1.9199999999999999 112.162 -171.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 108' ' ' ILE . 29.0 t70 -62.05 -30.71 71.17 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 110.298 -0.26 . . . . 1.1599999999999999 110.298 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 pt-20 -64.13 -29.71 70.82 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.536 -0.466 . . . . 0.83999999999999997 110.185 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.491 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 34.2 mt -81.71 -42.47 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.245 -0.434 . . . . 1.5600000000000001 110.459 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.443 ' HD2' ' C ' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -67.86 -34.96 77.71 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.818 0.818 . . . . 0.80000000000000004 109.222 175.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.2 t70 -64.2 -49.44 72.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.986 -1.006 . . . . 0.78000000000000003 108.664 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.854 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.94 -48.84 75.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.712 -1.131 . . . . 1.3100000000000001 111.729 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.466 ' HB ' ' HH ' ' A' ' 28' ' ' TYR . 35.7 m -60.8 -51.95 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.313 -0.555 . . . . 1.1200000000000001 111.663 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.4 OUTLIER -71.21 -29.83 65.63 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.627 0.232 . . . . 1.99 111.627 -176.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 65.0 pttt -72.54 -26.09 61.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.64 -0.824 . . . . 2.0899999999999999 111.184 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -77.89 -66.55 0.83 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.928 0.394 . . . . 2.3900000000000001 110.283 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -121.23 97.71 47.4 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.538 -0.912 . . . . 2.7599999999999998 108.538 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.568 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 77.1 Cg_endo -93.97 132.61 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.93 2.42 . . . . 0.92000000000000004 113.952 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.73 HD22 ' HB3' ' A' ' 4' ' ' GLU . 13.8 tp . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.299 0.571 . . . . 1.9399999999999999 110.209 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.741 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 12.5 tt0 . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 121.952 0.882 . . . . 2.2999999999999998 109.933 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.783 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -132.52 145.99 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.238 -0.892 . . . . 1.3999999999999999 110.661 -173.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.878 ' HB ' HG21 ' A' ' 30' ' ' THR . 1.8 mt -136.98 156.56 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.544 0.688 . . . . 1.04 111.774 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.892 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.9 tt -134.17 109.51 8.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.673 -1.149 . . . . 0.98999999999999999 108.146 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.651 HG21 HD23 ' A' ' 19' ' ' LEU . 1.4 mp -97.37 108.07 21.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.324 -0.55 . . . . 1.1200000000000001 109.763 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.726 HG21 HD22 ' A' ' 53' ' ' LEU . 59.9 t -97.04 88.53 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 110.005 -0.368 . . . . 1.0900000000000001 110.005 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.79 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.1 t70 -134.77 140.79 46.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.517 -0.549 . . . . 1.8200000000000001 109.517 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.806 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 35.8 t70 -88.81 -49.4 6.85 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.141 -0.349 . . . . 0.51000000000000001 111.016 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.641 ' HG3' HD12 ' A' ' 15' ' ' ILE . 9.2 pt20 -76.57 73.1 3.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.628 -0.879 . . . . 2.5600000000000001 108.628 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.534 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 52.0 p90 -44.94 -12.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 112.206 -2.27 . . . . 1.8300000000000001 115.986 -167.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.28 -58.87 4.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.978 -1.106 . . . . 0.41999999999999998 110.789 170.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 12' ' ' GLN . 2.3 mt -59.42 -27.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.608 0.718 . . . . 1.5600000000000001 110.409 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.87 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.3 ttm180 -78.79 -43.83 24.58 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.879 -1.055 . . . . 0.47999999999999998 110.513 -167.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.733 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 39.2 pt -80.46 -26.11 11.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.459 0.475 . . . . 1.1899999999999999 109.901 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.411 ' O ' HG21 ' A' ' 22' ' ' VAL . 1.8 tp -59.05 -63.54 1.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.08 -0.711 . . . . 1.22 109.08 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 1.031 HD22 HD23 ' A' ' 52' ' ' LEU . 8.1 tp -57.93 -41.15 82.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.759 -1.109 . . . . 1.8400000000000001 110.531 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.733 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.9 t-20 -51.14 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.406 -0.815 . . . . 1.0 110.566 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.55 -41.88 42.57 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.224 0.952 . . . . 2.46 112.244 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 18' ' ' LEU . 24.8 t -55.1 -63.19 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.457 0.169 . . . . 1.2 111.457 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.786 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 16.1 m-85 -70.3 -37.31 74.76 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.379 -0.6 . . . . 0.51000000000000001 109.379 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.82 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 12.0 t-20 -50.25 -49.01 54.4 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.93 -1.032 . . . . 0.32000000000000001 109.024 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -60.52 -46.77 88.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.524 -1.671 . . . . 3.6699999999999999 111.714 -176.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' OE2' ' HB2' ' A' ' 112' ' ' ARG . 9.6 pt-20 -80.71 11.87 3.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.451 -0.499 . . . . 1.51 112.235 -174.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.54 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 132.93 -16.53 4.72 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.523 -0.762 . . . . 0.56999999999999995 112.963 171.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.82 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 12.3 m-85 -82.15 137.0 35.07 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.3 -0.96 . . . . 1.49 111.875 -166.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.783 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.9 mt-30 -89.05 83.62 6.57 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.413 -0.958 . . . . 1.1399999999999999 108.413 168.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.878 HG21 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -91.33 132.54 36.1 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.898 -0.592 . . . . 0.95999999999999996 110.193 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 9.9 m-85 -121.68 124.39 44.17 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 122.486 1.136 . . . . 0.42999999999999999 109.254 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.87 ' HB2' HH11 ' A' ' 16' ' ' ARG . 4.5 pt20 -84.18 119.8 25.44 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 112.839 -1.982 . . . . 0.23999999999999999 111.693 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.885 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . . . -119.22 138.35 53.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.441 -0.948 . . . . 1.0 108.441 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . . . -97.15 -7.54 32.29 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.596 -0.841 . . . . 0.78000000000000003 110.3 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 5.5 p-10 -146.42 166.0 27.68 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 120.152 -0.619 . . . . 0.28999999999999998 111.68 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.64 -22.68 78.03 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.605 -0.725 . . . . 0.17999999999999999 112.543 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.5 ' HB2' HD21 ' A' ' 35' ' ' ASN . 3.3 mm? -78.84 -38.24 38.49 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.052 -0.722 . . . . 1.1200000000000001 109.052 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.885 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -59.0 -46.19 88.79 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 104.618 -2.364 . . . . 1.78 104.618 175.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -59.19 -49.14 79.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.501 -1.681 . . . . 0.98999999999999999 111.594 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.37 -42.13 66.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.674 0.749 . . . . 1.5700000000000001 109.405 176.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.27 -30.22 60.37 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.708 -1.133 . . . . 1.3200000000000001 111.47 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.892 ' HB ' HD12 ' A' ' 7' ' ' LEU . 8.8 mm -68.24 -46.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 O-C-N 121.714 -0.616 . . . . 1.04 110.003 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 69' ' ' MET . 48.2 t -58.07 -42.91 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.065 0.936 . . . . 1.0600000000000001 108.771 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -34.66 70.15 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.037 -1.438 . . . . 0.95999999999999996 111.388 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.737 ' HB3' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.92 -47.29 7.68 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.421 0.526 . . . . 2.9900000000000002 112.421 -174.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.624 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 46.0 mm-40 -107.44 -32.7 7.62 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.19 0.441 . . . . 0.63 112.19 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 27.4 mtp85 63.69 61.17 1.74 Allowed Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 123.694 0.621 . . . . 4.2800000000000002 110.247 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.754 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.2 Cg_exo -60.73 153.82 59.63 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 121.435 1.423 . . . . 0.20999999999999999 111.635 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.749 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 5.2 m-20 -85.91 -42.01 14.45 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.303 -0.999 . . . . 0.97999999999999998 108.303 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 49' ' ' ASP . 7.7 mp -111.56 111.61 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.422 -0.808 . . . . 1.1599999999999999 110.585 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.69 HG13 ' HG ' ' A' ' 53' ' ' LEU . 91.7 t -109.99 113.54 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.075 0.464 . . . . 1.05 111.414 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 1.031 HD23 HD22 ' A' ' 19' ' ' LEU . 2.0 mp -87.47 87.34 7.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.53 0.681 . . . . 1.0700000000000001 109.773 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.726 HD22 HG21 ' A' ' 9' ' ' VAL . 37.8 mt -84.88 110.31 18.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.786 -1.097 . . . . 2.2000000000000002 111.124 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.663 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 49.1 t0 -68.82 115.88 8.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.616 0.722 . . . . 1.47 111.1 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.493 ' SD ' HG12 ' A' ' 63' ' ' ILE . 9.2 mmm -84.33 -3.51 58.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.65 -1.159 . . . . 1.6499999999999999 111.343 176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 1.013 ' HZ2' ' HB2' ' A' ' 83' ' ' ALA . 22.2 mmmt -61.75 -65.57 0.67 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.893 0.701 . . . . 2.73 112.893 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.895 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 10.1 tp -169.81 -30.69 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.594 1.331 . . . . 2.6099999999999999 114.594 -171.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.895 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -23.72 -55.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 124.08 3.186 . . . . 0.55000000000000004 116.204 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -144.6 -62.75 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.824 -1.179 . . . . 0.55000000000000004 112.702 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.7 ttm -148.76 167.29 25.98 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.277 -0.638 . . . . 2.6699999999999999 109.277 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 65' ' ' ILE . 7.3 m-20 -58.48 127.7 33.46 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.297 0.57 . . . . 0.67000000000000004 109.485 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.36 -15.9 33.12 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.703 -1.135 . . . . 0.32000000000000001 112.528 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.791 HG13 ' HB3' ' A' ' 89' ' ' MET . 3.0 mm -77.75 -41.4 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 117.456 0.628 . . . . 1.9199999999999999 110.379 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -68.48 -37.31 80.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.723 -0.671 . . . . 0.46999999999999997 109.335 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.683 HG23 ' HE1' ' A' ' 69' ' ' MET . 14.5 mt -72.72 -36.37 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 1.3600000000000001 110.714 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.638 HD21 HG22 ' A' ' 78' ' ' VAL . 2.8 pp -67.32 -36.13 80.84 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.259 -0.576 . . . . 2.1600000000000001 109.814 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.645 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.9 ptpp? -75.77 -32.62 60.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.619 -0.832 . . . . 1.3400000000000001 111.354 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.489 ' CG ' ' HA ' ' A' ' 65' ' ' ILE . 10.9 ptp180 -67.71 -35.17 78.3 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 118.968 -1.093 . . . . 2.8599999999999999 111.493 174.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.766 ' HA ' HG12 ' A' ' 72' ' ' ILE . 9.5 ptp -80.29 -17.31 52.48 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 120.164 -0.615 . . . . 1.95 109.641 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.4 mptp? -70.3 -40.83 74.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.363 -0.977 . . . . 1.9299999999999999 108.363 167.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 67' ' ' LYS . 95.8 t -61.75 -39.16 82.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 1.8300000000000001 110.605 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.766 HG12 ' HA ' ' A' ' 69' ' ' MET . 32.0 pt -85.19 -20.25 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.676 -0.41 . . . . 1.02 110.655 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -162.69 85.22 0.55 Allowed 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 112.555 0.576 . . . . 1.0800000000000001 112.555 -178.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.9 mt-10 -73.96 5.56 4.11 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.412 -0.805 . . . . 1.78 109.845 173.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -73.15 -28.52 62.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.562 1.172 . . . . 0.34999999999999998 108.033 170.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.598 HG23 ' HG3' ' A' ' 69' ' ' MET . 3.3 tt -76.06 161.63 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-N 112.843 -1.98 . . . . 1.05 111.403 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.749 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -138.47 176.76 8.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.737 -1.12 . . . . 1.45 108.179 173.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.693 HG12 HD11 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -142.65 153.01 17.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 119.941 -0.704 . . . . 1.55 111.806 -173.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.903 HG22 ' HG1' ' A' ' 100' ' ' THR . 71.3 mt -124.71 73.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.328 -1.36 . . . . 1.3500000000000001 107.328 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -65.41 138.23 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.216 -0.902 . . . . 1.02 111.829 -171.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.762 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 6.1 mtm -94.18 117.93 30.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.089 -0.96 . . . . 2.5499999999999998 110.317 -174.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 11.0 p -125.82 157.4 37.65 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.667 -0.697 . . . . 1.78 112.163 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 1.013 ' HB2' ' HZ2' ' A' ' 56' ' ' LYS . . . -73.97 60.66 0.77 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.716 -0.675 . . . . 1.1000000000000001 110.436 167.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 58.4 t80 60.43 54.61 3.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.334 0.587 . . . . 4.4400000000000004 111.554 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.2 87.34 0.03 OUTLIER Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.891 -0.595 . . . . 0.65000000000000002 113.475 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.654 ' N ' HG13 ' A' ' 90' ' ' ILE . 22.5 mt-10 -87.12 16.12 5.43 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.948 0.499 . . . . 1.3300000000000001 111.582 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.407 ' CA ' ' HB ' ' A' ' 90' ' ' ILE . 3.7 mm? 63.65 179.35 0.16 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.8 1.407 . . . . 2.2799999999999998 114.8 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB3' ' H ' ' A' ' 89' ' ' MET . 1.7 t70 61.82 -93.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.268 -1.333 . . . . 1.3799999999999999 111.658 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.791 ' HB3' HG13 ' A' ' 63' ' ' ILE . 1.1 mpt? -64.25 -14.34 55.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.066 0.46 . . . . 3.3700000000000001 110.577 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.654 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.5 mm -77.34 -22.1 14.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.366 0.603 . . . . 1.3700000000000001 110.605 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 13.4 mt-30 -81.15 -47.2 13.78 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.793 -1.188 . . . . 3.1800000000000002 107.793 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.601 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 19.7 tt0 -65.33 -33.56 76.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.929 -1.487 . . . . 1.27 112.671 -177.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.77 ' HB3' HD13 ' A' ' 63' ' ' ILE . 7.9 p -52.45 -74.78 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.06 0.933 . . . . 1.5600000000000001 111.611 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.6 pttt -53.78 -35.91 61.84 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.779 -1.555 . . . . 2.3100000000000001 111.992 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -62.11 -34.3 76.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.886 -0.326 . . . . 1.8400000000000001 111.161 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.3 mt -81.31 -24.66 37.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.896 0.379 . . . . 1.8999999999999999 111.019 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.642 ' HA3' ' HZ2' ' A' ' 70' ' ' LYS . . . 153.31 -1.79 0.25 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 119.877 -1.154 . . . . 0.34999999999999998 113.706 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.633 ' CA ' HG23 ' A' ' 78' ' ' VAL . . . -70.74 132.15 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.954 0.877 . . . . 1.02 109.605 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.417 HD13 ' HG ' ' A' ' 50' ' ' LEU . 12.5 mt -75.29 -48.25 24.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.043 0.925 . . . . 1.05 109.392 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.903 ' HG1' HG22 ' A' ' 79' ' ' ILE . 71.1 p -141.72 156.74 45.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.889 -1.505 . . . . 1.05 111.914 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.62 98.62 8.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.354 -1.294 . . . . 1.1799999999999999 109.47 171.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.762 ' HB3' ' HA ' ' A' ' 81' ' ' MET . 26.0 t80 -56.41 143.23 35.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.445 -0.798 . . . . 4.75 109.441 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.524 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . . . -130.32 167.45 18.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.759 -0.46 . . . . 1.24 109.759 172.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 54.5 mtpt -68.15 -40.88 23.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.203 -0.453 . . . . 3.7200000000000002 111.387 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 103' ' ' ALA . 58.0 Cg_endo -76.6 96.36 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.767 0.952 . . . . 1.6699999999999999 110.62 166.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.608 ' HB2' HD11 ' A' ' 111' ' ' ILE . 53.0 p90 -129.03 143.62 50.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.059 -0.519 . . . . 1.29 111.607 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.515 ' O ' HG21 ' A' ' 108' ' ' ILE . 1.8 t70 -75.25 -3.68 34.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.888 -0.596 . . . . 1.77 110.712 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.515 HG21 ' O ' ' A' ' 107' ' ' ASP . 9.4 tp 52.2 -53.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.613 1.565 . . . . 1.9199999999999999 112.206 -165.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 35.0 t70 -65.9 -26.99 67.87 Favored 'General case' 0 C--O 1.211 -0.924 0 O-C-N 122.384 -0.197 . . . . 1.1599999999999999 110.94 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 11.3 pt-20 -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.203 -0.599 . . . . 0.83999999999999997 109.864 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 106' ' ' PHE . 47.7 mt -83.23 -43.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 1.5600000000000001 109.559 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.68 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -65.42 -39.58 92.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.809 -0.811 . . . . 0.80000000000000004 108.809 175.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.8 t70 -67.95 -40.53 83.24 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.187 -0.671 . . . . 0.78000000000000003 109.187 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.63 -48.71 74.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.324 -0.853 . . . . 1.3100000000000001 110.927 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.651 ' HB ' ' HH ' ' A' ' 28' ' ' TYR . 34.3 m -61.93 -48.23 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 120.082 -0.647 . . . . 1.1200000000000001 111.173 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -70.91 -19.91 62.54 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.598 0.592 . . . . 1.99 112.598 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 7.4 pttm -86.61 -23.14 25.83 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.415 -0.914 . . . . 2.0899999999999999 111.154 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.525 ' HD2' ' O ' ' A' ' 114' ' ' ALA . 28.4 m-85 -82.17 -67.19 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.024 -0.362 . . . . 2.3900000000000001 110.024 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.0 95.05 49.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.26 -0.645 . . . . 2.7599999999999998 109.26 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.634 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 84.1 Cg_endo -91.1 141.65 2.96 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.857 2.372 . . . . 0.92000000000000004 113.942 -173.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.72 HD21 ' HB3' ' A' ' 4' ' ' GLU . 29.7 tp . . . . . 0 CA--C 1.51 -0.564 0 CA-C-O 121.725 0.774 . . . . 1.9399999999999999 109.84 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.804 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 3.0 tp10 . . . . . 0 C--O 1.22 -0.49 0 N-CA-C 107.325 -1.361 . . . . 2.2999999999999998 107.325 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.701 ' HD3' ' HB3' ' A' ' 46' ' ' GLU . 2.7 ttmt -150.31 139.73 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.188 1.181 . . . . 1.3999999999999999 114.188 -167.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.906 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -139.39 154.82 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.233 -1.349 . . . . 1.04 111.49 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 1.004 ' HB3' HG12 ' A' ' 51' ' ' VAL . 3.4 tt -135.55 117.95 15.73 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.52 -1.289 . . . . 0.98999999999999999 107.52 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -103.7 100.92 11.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.987 -0.685 . . . . 1.1200000000000001 110.132 -177.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.752 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 48.8 t -83.61 91.25 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.559 -0.534 . . . . 1.0900000000000001 109.559 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.817 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.7 t70 -143.35 142.98 31.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.543 0.211 . . . . 1.8200000000000001 110.607 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.81 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 15.2 t70 -102.46 -31.62 10.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.891 0.377 . . . . 0.51000000000000001 110.27 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.604 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -79.12 70.91 5.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.507 -1.294 . . . . 2.5600000000000001 107.507 172.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' O ' HG12 ' A' ' 17' ' ' ILE . 46.7 p90 -52.29 -15.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 112.88 -1.964 . . . . 1.8300000000000001 115.099 -159.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.64 -60.9 5.54 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.906 -1.14 . . . . 0.41999999999999998 110.334 169.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 2.9 mt -55.17 -30.49 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.333 0.587 . . . . 1.5600000000000001 111.056 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.817 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.1 ttm180 -76.29 -49.79 16.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.749 . . . . 0.47999999999999998 110.596 -168.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.613 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.5 pt -76.19 -25.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.598 -0.519 . . . . 1.1899999999999999 109.598 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tp -57.24 -65.26 0.65 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.348 -0.842 . . . . 1.22 109.457 171.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.789 HD12 HD21 ' A' ' 52' ' ' LEU . 57.8 mt -58.26 -44.15 88.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.8400000000000001 109.939 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.613 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.5 t30 -50.5 -66.17 0.43 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.128 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.47 -39.21 82.95 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.662 0.601 . . . . 2.46 111.396 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.9 t -55.08 -58.17 5.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 111.787 0.291 . . . . 1.2 111.787 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.676 ' HB2' HG23 ' A' ' 30' ' ' THR . 7.9 m-85 -73.56 -40.09 64.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.256 -0.646 . . . . 0.51000000000000001 109.256 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.8 t-20 -50.78 -50.23 56.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.066 -0.97 . . . . 0.32000000000000001 108.557 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -51.11 -46.75 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.275 -1.784 . . . . 3.6699999999999999 112.58 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.61 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 6.5 pt-20 -88.21 16.16 6.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.116 -0.634 . . . . 1.51 111.544 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.763 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 126.98 -15.45 6.53 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.495 -0.859 . . . . 0.56999999999999995 113.581 169.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.804 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 10.2 m-85 -73.83 160.22 31.77 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 118.899 -1.12 . . . . 1.49 112.407 -168.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.694 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 2.1 mp0 -106.83 76.32 1.1 Allowed 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.101 -1.409 . . . . 1.1399999999999999 107.337 173.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.906 HG22 ' HB ' ' A' ' 6' ' ' ILE . 27.2 p -90.68 130.55 36.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.876 -1.056 . . . . 0.95999999999999996 109.457 -173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.446 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.3 m-85 -126.9 108.96 11.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.632 1.206 . . . . 0.42999999999999999 109.876 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.719 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.1 pt20 -61.29 120.72 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 112.483 -2.144 . . . . 0.23999999999999999 112.577 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 42' ' ' ILE . . . -124.33 125.94 45.17 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.957 0.903 . . . . 1.0 109.094 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -82.84 -11.03 58.55 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.042 -0.663 . . . . 0.78000000000000003 111.058 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.077 0.399 . . . . 0.28999999999999998 112.077 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.5 -19.34 78.94 Favored Glycine 0 CA--C 1.506 -0.492 0 CA-C-N 115.794 -0.639 . . . . 0.17999999999999999 113.051 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.62 -40.91 24.83 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.154 0.978 . . . . 1.1200000000000001 108.949 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.823 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -61.17 -41.87 97.54 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.391 -2.077 . . . . 1.78 105.391 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HB1' HG23 ' A' ' 9' ' ' VAL . . . -59.27 -46.74 87.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.157 -1.383 . . . . 0.98999999999999999 111.17 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -53.76 -48.27 69.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.623 -0.717 . . . . 1.5700000000000001 109.816 175.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.55 -39.1 92.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.42 -1.264 . . . . 1.3200000000000001 111.064 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.885 ' HB ' HD12 ' A' ' 7' ' ' LEU . 20.0 mm -65.94 -48.68 81.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.234 -0.439 . . . . 1.04 110.083 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 59.4 t -58.46 -42.73 85.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-O 121.828 0.823 . . . . 1.0600000000000001 109.231 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.36 -29.74 70.09 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.117 -0.947 . . . . 0.95999999999999996 111.425 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.754 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -88.94 -46.6 8.77 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.299 0.481 . . . . 2.9900000000000002 112.299 -177.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.701 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 46.3 mm-40 -108.45 -35.05 6.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 111.975 0.361 . . . . 0.63 111.975 -176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 45.4 mtp180 63.69 60.39 1.8 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.294 -0.867 . . . . 4.2800000000000002 109.889 -171.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.832 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 32.1 Cg_exo -62.65 146.62 95.31 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 121.376 1.384 . . . . 0.20999999999999999 110.95 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 m-20 -85.96 -35.24 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.409 -0.916 . . . . 0.97999999999999998 109.389 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.13 111.11 21.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 1.1599999999999999 109.638 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.004 HG12 ' HB3' ' A' ' 7' ' ' LEU . 19.0 t -117.34 112.59 39.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.383 -0.372 . . . . 1.05 110.821 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.789 HD21 HD12 ' A' ' 19' ' ' LEU . 3.2 mp -83.59 104.67 13.9 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.957 -0.464 . . . . 1.0700000000000001 110.496 -176.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.752 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 8.1 mp -99.04 102.52 14.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.516 -0.311 . . . . 2.2000000000000002 111.824 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.682 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t70 -63.83 111.1 2.31 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.527 -0.469 . . . . 1.47 110.059 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.688 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 17.1 mtm -91.37 12.38 20.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.234 -0.439 . . . . 1.6499999999999999 111.013 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.682 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 14.2 mmmm -70.61 -65.91 0.67 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.782 0.289 . . . . 2.73 111.782 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.893 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 2.3 pt -160.72 -39.5 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.908 1.077 . . . . 2.6099999999999999 113.908 -169.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.893 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -21.2 -60.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 124.905 3.737 . . . . 0.55000000000000004 116.928 -175.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.68 -66.64 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.651 -1.262 . . . . 0.55000000000000004 113.0 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 49.5 ttm -139.69 164.14 30.73 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 2.6699999999999999 109.414 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 65' ' ' ILE . 2.7 m-20 -61.06 134.67 57.31 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.75 -0.463 . . . . 0.67000000000000004 109.75 174.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.448 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -62.01 -15.23 49.08 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 115.451 -0.795 . . . . 0.32000000000000001 112.378 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.597 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 9.6 mt -78.3 -44.25 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.061 -0.67 . . . . 1.9199999999999999 109.836 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.58 -33.56 74.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.351 0.596 . . . . 0.46999999999999997 110.048 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.803 HG23 ' HE3' ' A' ' 69' ' ' MET . 31.9 mt -74.16 -39.38 49.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.981 -0.554 . . . . 1.3600000000000001 110.453 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 2.9 pp -65.92 -36.8 84.37 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 120.187 -0.605 . . . . 2.1600000000000001 109.951 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.68 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.1 ptpt -75.42 -36.08 60.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 120.491 -0.483 . . . . 1.3400000000000001 111.391 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 11.2 ptm180 -64.87 -36.86 85.7 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 119.497 -0.881 . . . . 2.8599999999999999 111.144 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.803 ' HE3' HG23 ' A' ' 65' ' ' ILE . 11.4 ptp -82.46 -14.12 55.6 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.102 -0.639 . . . . 1.95 109.618 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.68 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -70.45 -40.02 73.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.089 -1.078 . . . . 1.9299999999999999 108.089 167.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 67' ' ' LYS . 94.0 t -62.54 -38.58 81.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.453 -0.794 . . . . 1.8300000000000001 110.125 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.794 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.1 pt -86.47 -19.03 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.525 -0.47 . . . . 1.02 111.074 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.96 86.12 0.42 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.484 0.55 . . . . 1.0800000000000001 112.484 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.574 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.1 mt-10 -70.53 1.34 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.046 -1.034 . . . . 1.78 110.646 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -30.43 64.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.596 1.189 . . . . 0.34999999999999998 108.05 171.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.727 HG22 ' HG3' ' A' ' 69' ' ' MET . 3.9 tt -69.24 161.54 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.636 -2.075 . . . . 1.05 111.482 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -141.56 174.72 10.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.849 -1.069 . . . . 1.45 108.649 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 10.1 m -141.54 143.4 27.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.55 0.69 . . . . 1.55 111.273 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.863 HG23 ' HG1' ' A' ' 100' ' ' THR . 4.2 mp -108.79 75.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.581 -1.266 . . . . 1.3500000000000001 107.581 174.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.688 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -69.51 141.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 119.363 -0.935 . . . . 1.02 112.016 -172.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 27.8 mtt -95.23 136.78 35.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.22 -0.9 . . . . 2.5499999999999998 110.335 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 t -132.83 158.12 43.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.117 0.784 . . . . 1.78 113.117 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HB1' ' HE3' ' A' ' 56' ' ' LYS . . . -72.71 64.16 0.64 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.544 -1.207 . . . . 1.1000000000000001 109.654 169.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 70.15 15.06 7.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.235 -0.893 . . . . 4.4400000000000004 112.32 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.28 92.03 1.07 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.58 -0.819 . . . . 0.65000000000000002 111.412 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.555 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.4 mt-10 -88.03 7.25 32.15 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 122.927 0.491 . . . . 1.3300000000000001 111.644 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 59.9 -175.11 0.11 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.47 -0.786 . . . . 2.2799999999999998 112.813 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.86 -93.34 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.083 -0.962 . . . . 1.3799999999999999 112.324 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB2' HD13 ' A' ' 63' ' ' ILE . 26.8 ptt? -61.2 -24.11 66.09 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.137 0.494 . . . . 3.3700000000000001 110.332 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.555 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.1 mm -66.01 -47.38 85.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 1.3700000000000001 109.952 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.617 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 14.1 mm100 -61.64 -50.23 73.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.39 -0.823 . . . . 3.1800000000000002 109.647 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 13.3 tt0 -63.59 -33.44 75.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.041 -0.981 . . . . 1.27 112.431 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -59.13 -63.7 1.21 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.662 0.268 . . . . 1.5600000000000001 110.631 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.923 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 pttt -55.83 -40.18 72.45 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.433 0.635 . . . . 2.3100000000000001 110.871 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 6.8 tp10 -54.52 -35.59 63.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 1.8400000000000001 111.51 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.1 tp -90.19 -10.86 42.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.723 0.268 . . . . 1.8999999999999999 111.723 -173.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.541 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 154.86 -12.13 0.45 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.76 -1.21 . . . . 0.34999999999999998 113.644 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.923 ' HB1' ' HA ' ' A' ' 94' ' ' LYS . . . -73.99 145.59 44.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.292 0.546 . . . . 1.02 110.784 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.513 HD13 ' HG3' ' A' ' 77' ' ' ARG . 16.7 mt -87.86 -50.37 6.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.501 0.667 . . . . 1.05 109.797 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.863 ' HG1' HG23 ' A' ' 79' ' ' ILE . 52.3 p -143.26 160.44 40.48 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.263 -1.335 . . . . 1.05 111.433 -170.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -109.98 98.22 7.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.846 -1.07 . . . . 1.1799999999999999 110.081 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.563 ' HD2' HD12 ' A' ' 111' ' ' ILE . 43.7 t80 -68.29 124.86 24.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.611 -0.722 . . . . 4.75 109.954 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . . . -123.07 178.0 5.28 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.769 -0.372 . . . . 1.24 110.463 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.37 -47.16 97.15 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.501 0.556 . . . . 3.7200000000000002 112.501 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 103' ' ' ALA . 57.5 Cg_endo -73.27 97.49 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 120.86 1.04 . . . . 1.6699999999999999 111.593 173.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CZ ' HD22 ' A' ' 18' ' ' LEU . 40.5 p90 -133.37 138.22 46.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.968 -0.56 . . . . 1.29 110.727 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 108' ' ' ILE . 8.0 t70 -72.82 -4.99 35.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.895 -0.593 . . . . 1.77 111.078 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 107' ' ' ASP . 6.3 tt 59.41 -56.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.856 1.262 . . . . 1.9199999999999999 110.598 -165.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.96 -38.86 92.77 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 110.26 -0.274 . . . . 1.1599999999999999 110.26 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.563 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 pt-20 -61.19 -27.92 68.77 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.695 -0.402 . . . . 0.83999999999999997 110.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.563 HD12 ' HD2' ' A' ' 102' ' ' PHE . 4.7 mm -77.43 -50.91 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.354 -0.61 . . . . 1.5600000000000001 109.354 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.61 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -66.87 -36.43 82.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.563 0.697 . . . . 0.80000000000000004 109.697 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.533 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 35.0 t70 -69.56 -42.45 74.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.635 -0.711 . . . . 0.78000000000000003 109.088 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.615 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.88 -40.74 98.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.525 -0.761 . . . . 1.3100000000000001 110.978 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 112' ' ' ARG . 33.0 m -63.83 -53.38 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 119.15 -1.02 . . . . 1.1200000000000001 110.952 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -69.68 -16.85 63.43 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.343 0.497 . . . . 1.99 112.343 -178.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.615 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 18.6 ptpt -83.64 -26.89 29.54 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.29 -0.881 . . . . 2.0899999999999999 111.041 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -81.42 -59.39 2.64 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.996 0.427 . . . . 2.3900000000000001 109.955 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 44.2 tp -120.55 107.83 38.24 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.368 -0.975 . . . . 2.7599999999999998 108.368 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.553 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 91.2 Cg_endo -100.86 146.97 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.893 2.395 . . . . 0.92000000000000004 114.683 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.763 HD21 ' HA3' ' A' ' 27' ' ' GLY . 16.4 tp . . . . . 0 N--CA 1.449 -0.518 0 CA-C-N 115.474 -0.785 . . . . 1.9399999999999999 110.536 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.799 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 7.3 tt0 . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 122.096 0.95 . . . . 2.2999999999999998 111.612 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.829 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -131.28 152.41 50.57 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.012 -0.994 . . . . 1.3999999999999999 110.622 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.829 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.3 mt -142.36 154.25 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.614 0.721 . . . . 1.04 111.645 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.871 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.2 tt -132.11 122.04 24.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.418 -1.326 . . . . 0.98999999999999999 107.418 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.764 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.6 mp -108.71 106.33 20.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.125 -0.63 . . . . 1.1200000000000001 109.59 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 23.5 t -95.11 71.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 O-C-N 122.97 0.169 . . . . 1.0900000000000001 110.683 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.833 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.1 m-20 -118.33 135.63 54.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.651 0.262 . . . . 1.8200000000000001 111.208 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 1.084 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 29.7 t70 -86.69 -27.46 23.71 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.184 -1.043 . . . . 0.51000000000000001 108.184 171.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.768 ' HB2' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -78.88 73.37 5.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.475 -1.306 . . . . 2.5600000000000001 107.475 167.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.557 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 40.3 p90 -54.13 -17.49 2.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.829 -1.532 . . . . 1.8300000000000001 113.178 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.5 -63.89 4.87 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.925 -1.27 . . . . 0.41999999999999998 109.925 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.768 HD12 ' HB2' ' A' ' 12' ' ' GLN . 3.0 mt -53.62 -25.28 11.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.869 0.366 . . . . 1.5600000000000001 111.574 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.833 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 10.2 ttm180 -76.94 -50.24 13.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.308 -0.406 . . . . 0.47999999999999998 111.081 -171.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.1 pt -74.74 -24.67 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.193 -0.669 . . . . 1.1899999999999999 109.193 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.7 tp -57.27 -67.76 0.29 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.928 -1.033 . . . . 1.22 109.493 170.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.687 HD12 HD22 ' A' ' 52' ' ' LEU . 60.5 mt -54.64 -40.88 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 1.8400000000000001 110.451 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.8 t30 -50.68 -69.25 0.12 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.139 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.3 -39.41 75.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 2.46 111.568 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 18' ' ' LEU . 49.4 t -57.1 -55.69 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 111.999 0.37 . . . . 1.2 111.999 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HB2' HG23 ' A' ' 30' ' ' THR . 6.7 m-85 -77.03 -37.73 54.27 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.782 -0.451 . . . . 0.51000000000000001 109.782 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.81 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 17.1 t-20 -49.95 -50.3 47.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.033 0.921 . . . . 0.32000000000000001 109.189 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -59.09 -33.68 71.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.343 -1.753 . . . . 3.6699999999999999 113.06 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.656 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 4.2 mt-10 -68.08 -23.49 64.94 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.307 -0.627 . . . . 1.51 109.307 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.05 -13.32 2.6 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.66 -1.155 . . . . 0.56999999999999995 110.569 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 6.7 m-85 -72.65 134.25 45.02 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.612 0.72 . . . . 1.49 111.557 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.829 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 19.2 mt-30 -88.61 80.95 7.19 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.212 -1.033 . . . . 1.1399999999999999 108.212 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.829 HG22 ' HB ' ' A' ' 6' ' ' ILE . 17.2 p -90.25 137.32 32.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.808 -0.633 . . . . 0.95999999999999996 110.026 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 38.1 m-85 -129.78 126.09 37.32 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.677 1.227 . . . . 0.42999999999999999 110.272 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.822 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 4.6 pt20 -85.28 121.13 27.57 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.639 -2.073 . . . . 0.23999999999999999 111.93 -171.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -121.47 137.12 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.89 . . . . 1.0 108.894 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . . . -93.06 -10.72 35.09 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.778 -0.369 . . . . 0.78000000000000003 110.42 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 37' ' ' LEU . 3.1 p-10 -149.0 165.8 30.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.28999999999999998 111.444 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.3 76.47 Favored Glycine 0 CA--C 1.504 -0.611 0 CA-C-N 115.747 -0.66 . . . . 0.17999999999999999 113.467 -174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 35' ' ' ASN . 2.8 mm? -81.31 -43.73 18.68 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.679 1.228 . . . . 1.1200000000000001 108.038 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.8 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 tp-100 -60.33 -41.11 92.87 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.114 -2.312 . . . . 1.78 105.49 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.418 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -64.78 -44.23 90.66 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.699 -1.591 . . . . 0.98999999999999999 111.079 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.584 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.3 OUTLIER -55.5 -42.63 74.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.401 -0.592 . . . . 1.5700000000000001 109.401 175.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 14.7 m-20 -64.65 -41.79 95.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.108 -0.951 . . . . 1.3200000000000001 110.906 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.871 ' HB ' HD11 ' A' ' 7' ' ' LEU . 9.9 mm -61.04 -50.11 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 121.015 -0.274 . . . . 1.04 110.748 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -59.04 -45.33 92.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-O 121.817 0.817 . . . . 1.0600000000000001 109.45 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -59.87 -28.91 67.94 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.868 -1.06 . . . . 0.95999999999999996 111.783 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -96.04 -46.66 6.41 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.966 -0.561 . . . . 2.9900000000000002 111.848 -173.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 60.8 mm-40 -105.07 -36.52 7.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.733 0.271 . . . . 0.63 111.733 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 64.58 65.96 1.0 Allowed Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.776 0.672 . . . . 4.2800000000000002 109.929 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.792 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 76.9 Cg_exo -58.97 161.42 15.75 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.803 1.669 . . . . 0.20999999999999999 112.118 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.755 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.7 m-20 -94.63 -40.04 10.03 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.195 -1.039 . . . . 0.97999999999999998 108.195 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.755 HD12 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mp -116.91 118.6 32.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.255 -0.884 . . . . 1.1599999999999999 109.876 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' ' 7' ' ' LEU . 96.7 t -118.06 112.02 36.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.122 0.487 . . . . 1.05 110.871 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.687 HD22 HD12 ' A' ' 19' ' ' LEU . 2.6 mp -82.9 98.5 9.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.46 0.647 . . . . 1.0700000000000001 109.544 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.585 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -88.18 99.71 12.41 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.972 -1.013 . . . . 2.2000000000000002 111.007 -175.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.571 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 23.2 t0 -68.23 100.8 1.08 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.351 -0.611 . . . . 1.47 109.351 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.765 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 44.9 mtp -77.03 -5.9 50.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.041 -0.527 . . . . 1.6499999999999999 110.95 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.2 mmmm -50.63 -54.64 21.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.267 0.84 . . . . 2.73 113.267 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.78 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 10.4 tp -177.48 -11.09 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 114.974 1.472 . . . . 2.6099999999999999 114.974 -171.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 1.084 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -32.09 -51.04 0.33 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.991 2.461 . . . . 0.55000000000000004 115.723 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.36 -43.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.913 -1.137 . . . . 0.55000000000000004 112.739 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.431 ' HE3' ' HG3' ' A' ' 64' ' ' GLU . 14.8 tpt -147.81 167.23 25.27 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.816 -0.809 . . . . 2.6699999999999999 108.816 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.23 139.1 57.29 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.247 0.546 . . . . 0.67000000000000004 110.308 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.585 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -60.53 -15.06 38.04 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.984 -1.007 . . . . 0.32000000000000001 112.49 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.789 HG13 ' HB3' ' A' ' 89' ' ' MET . 3.7 mm -79.85 -47.64 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.736 0.303 . . . . 1.9199999999999999 110.311 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' HG3' ' HE3' ' A' ' 60' ' ' MET . 35.1 mm-40 -61.43 -36.72 81.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.657 0.741 . . . . 0.46999999999999997 109.216 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.543 ' CD1' HD12 ' A' ' 53' ' ' LEU . 68.1 mt -72.73 -36.93 54.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.137 -0.938 . . . . 1.3600000000000001 111.225 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.632 HD13 HD21 ' A' ' 96' ' ' LEU . 2.2 pp -70.65 -37.44 73.73 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.289 -0.564 . . . . 2.1600000000000001 110.715 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.1 ptpt -73.06 -34.57 66.36 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.526 -0.469 . . . . 1.3400000000000001 110.964 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.696 ' O ' HG11 ' A' ' 71' ' ' VAL . 12.0 ptm180 -65.5 -34.68 78.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.436 -0.905 . . . . 2.8599999999999999 111.29 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.709 ' HA ' HG12 ' A' ' 72' ' ' ILE . 4.7 ptt? -83.66 -12.33 56.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.894 -1.122 . . . . 1.95 109.864 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.6 mptp? -78.81 -35.05 44.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.635 -0.711 . . . . 1.9299999999999999 110.058 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.696 HG11 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -73.79 -34.33 40.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.742 -0.663 . . . . 1.8300000000000001 109.419 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.709 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.0 pt -80.85 -34.77 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.373 -0.83 . . . . 1.02 110.204 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -155.79 90.39 1.22 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.565 0.58 . . . . 1.0800000000000001 112.565 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.04 4.72 3.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.525 0.679 . . . . 1.78 110.34 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -26.1 63.84 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.488 -1.301 . . . . 0.34999999999999998 107.488 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.9 tt -77.32 160.43 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 112.706 -2.043 . . . . 1.05 110.919 -172.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.671 ' HE ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -137.63 -179.68 5.89 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.356 -0.838 . . . . 1.45 109.046 173.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.601 HG22 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -134.48 153.53 35.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.299 -0.561 . . . . 1.55 110.218 -172.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.787 HG23 ' HG1' ' A' ' 100' ' ' THR . 63.4 mt -130.73 71.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.411 -1.329 . . . . 1.3500000000000001 107.411 170.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.765 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -68.31 139.61 20.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.257 -0.883 . . . . 1.02 111.849 -172.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 4.8 mtp -99.1 131.62 45.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.044 -0.98 . . . . 2.5499999999999998 110.445 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 t -133.3 158.52 42.75 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.048 0.758 . . . . 1.78 113.048 -175.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.48 65.66 0.66 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.028 -0.987 . . . . 1.1000000000000001 109.719 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.493 ' HE1' ' HE2' ' A' ' 104' ' ' LYS . 49.8 m-85 71.44 15.27 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 4.4400000000000004 112.677 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.425 ' CA ' HG23 ' A' ' 90' ' ' ILE . . . 85.51 79.87 1.14 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.332 -0.937 . . . . 0.65000000000000002 111.522 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.559 ' N ' HG13 ' A' ' 90' ' ' ILE . 6.9 mt-10 -75.86 14.96 0.58 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.817 0.847 . . . . 1.3300000000000001 111.693 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.48 ' CA ' ' HB ' ' A' ' 90' ' ' ILE . 27.6 mt 59.36 -170.48 0.13 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.62 0.97 . . . . 2.2799999999999998 113.62 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 89' ' ' MET . 8.5 t70 58.74 -94.6 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.801 -1.09 . . . . 1.3799999999999999 110.885 -176.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.789 ' HB3' HG13 ' A' ' 63' ' ' ILE . 3.1 mpp? -64.36 -19.66 65.62 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.943 0.402 . . . . 3.3700000000000001 110.368 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 86' ' ' GLU . 41.6 mm -75.88 -23.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.601 0.715 . . . . 1.3700000000000001 110.592 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -82.37 -48.58 10.98 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.029 -1.1 . . . . 3.1800000000000002 108.029 172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 89' ' ' MET . 38.8 tt0 -63.48 -30.54 71.65 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 113.708 -1.587 . . . . 1.27 112.149 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.611 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 16.8 p -53.66 -77.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.094 0.95 . . . . 1.5600000000000001 112.245 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 13.1 ptpt -51.0 -41.0 59.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.506 -1.679 . . . . 2.3100000000000001 110.79 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -54.58 -44.82 73.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.387 -0.824 . . . . 1.8400000000000001 111.612 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 66' ' ' LEU . 12.4 tp -82.68 -15.94 50.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 1.8999999999999999 111.778 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.522 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 149.41 1.67 0.37 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.672 -1.251 . . . . 0.34999999999999998 113.954 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.663 ' O ' ' HA ' ' A' ' 94' ' ' LYS . . . -80.64 137.54 36.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.992 0.896 . . . . 1.02 109.769 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.551 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.5 mt -76.3 -48.59 19.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.87 0.843 . . . . 1.05 109.411 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.787 ' HG1' HG23 ' A' ' 79' ' ' ILE . 41.1 p -139.29 150.77 45.82 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.368 -1.287 . . . . 1.05 111.955 -171.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -114.54 67.74 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.04 -0.982 . . . . 1.1799999999999999 109.735 173.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' MET . 39.1 m-85 -62.18 130.31 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 4.75 110.543 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.16 -167.1 1.36 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.058 -0.519 . . . . 1.24 110.823 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HE2' ' HE1' ' A' ' 84' ' ' TYR . 46.1 mtmt -55.59 -43.08 98.98 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.226 -0.443 . . . . 3.7200000000000002 112.064 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 44.1 Cg_endo -70.5 97.26 0.69 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 120.816 1.011 . . . . 1.6699999999999999 111.218 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -131.7 136.71 47.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.732 -0.667 . . . . 1.29 110.049 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.7 t70 -84.73 14.38 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 1.77 111.04 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 109' ' ' ASP . 4.2 tt 50.45 -64.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 125.095 1.497 . . . . 1.9199999999999999 112.315 -171.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.8 OUTLIER -65.36 -23.87 67.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.815 -0.175 . . . . 1.1599999999999999 110.66 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.429 ' OE2' ' HB2' ' A' ' 107' ' ' ASP . 8.9 pt-20 -68.5 -28.2 66.81 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.4 -0.52 . . . . 0.83999999999999997 110.421 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.3 mt -81.21 -40.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 1.5600000000000001 110.256 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.656 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.04 -37.1 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.843 0.83 . . . . 0.80000000000000004 109.577 174.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.531 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 4.7 t70 -68.44 -37.02 79.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.379 -0.828 . . . . 0.78000000000000003 109.359 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.495 ' O ' ' HD1' ' A' ' 118' ' ' TYR . . . -62.98 -47.66 82.21 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.323 -0.853 . . . . 1.3100000000000001 111.224 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.602 HG13 HD21 ' A' ' 50' ' ' LEU . 17.8 m -62.82 -48.77 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 119.209 -0.996 . . . . 1.1200000000000001 110.377 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 3.6 ttpp -53.98 -50.33 66.79 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.145 0.578 . . . . 1.99 112.237 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 19.1 ptpt -60.21 -35.54 75.66 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.778 -0.576 . . . . 2.0899999999999999 111.462 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 24.6 m-85 -76.07 -56.4 4.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.993 0.425 . . . . 2.3900000000000001 110.836 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.9 tp -127.47 97.53 30.8 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.925 -0.58 . . . . 2.7599999999999998 109.686 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 65.8 Cg_endo -98.58 117.29 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.83 2.354 . . . . 0.92000000000000004 113.215 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HB2' ' CD ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 122.138 0.97 . . . . 1.9399999999999999 109.409 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 110.169 -0.308 . . . . 6.79 110.169 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 55.4 mtt -64.48 144.2 57.36 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.765 -0.457 . . . . 4.4100000000000001 109.765 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -77.41 -5.58 50.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.085 -0.507 . . . . 2.3500000000000001 111.398 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.792 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 13.8 tt0 69.57 101.92 0.06 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.545 0.688 . . . . 2.2999999999999998 110.976 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.894 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.7 tppt? -134.74 145.15 48.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.108 0.48 . . . . 1.3999999999999999 111.533 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.909 ' HB ' HG21 ' A' ' 30' ' ' THR . 1.7 mt -136.7 156.41 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.305 -0.861 . . . . 1.04 111.454 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.847 ' HB3' HG12 ' A' ' 51' ' ' VAL . 3.1 tt -133.48 120.16 20.5 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.656 -1.239 . . . . 0.98999999999999999 107.656 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.769 HD13 ' HB ' ' A' ' 30' ' ' THR . 1.8 mp -107.48 103.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.474 -0.89 . . . . 1.1200000000000001 110.385 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 28.9 t -88.7 82.62 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 110.051 -0.351 . . . . 1.0900000000000001 110.051 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.841 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 51.8 t0 -133.5 138.92 46.36 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.115 -0.328 . . . . 1.8200000000000001 110.115 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 1.044 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 37.0 t70 -85.82 -27.83 24.87 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.022 -0.732 . . . . 0.51000000000000001 109.022 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -78.86 73.47 5.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.51 -1.293 . . . . 2.5600000000000001 107.51 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 41.8 p90 -48.47 -19.67 0.34 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.511 -1.222 . . . . 1.8300000000000001 113.271 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.03 -69.71 1.19 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.36 -1.096 . . . . 0.41999999999999998 110.36 167.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 2.9 mp -51.03 -26.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 122.916 0.486 . . . . 1.5600000000000001 111.863 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.907 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 9.0 ttm180 -76.96 -46.53 23.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.312 -0.404 . . . . 0.47999999999999998 110.73 -172.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.514 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 36.3 pt -77.03 -25.45 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.283 -0.636 . . . . 1.1899999999999999 109.283 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 108' ' ' ILE . 4.5 tp -53.9 -66.19 0.44 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.135 -0.939 . . . . 1.22 109.157 169.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 64.5 mt -57.25 -39.95 76.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 1.8400000000000001 110.57 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.703 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.5 t30 -51.53 -67.87 0.22 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.042 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -39.59 77.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.313 0.486 . . . . 2.46 112.313 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' LEU . 39.5 t -55.18 -58.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.787 0.292 . . . . 1.2 111.787 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HB2' HG22 ' A' ' 30' ' ' THR . 8.2 m-85 -73.74 -35.13 65.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.287 -0.635 . . . . 0.51000000000000001 109.287 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.91 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.3 t-20 -50.48 -47.93 56.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.06 -0.973 . . . . 0.32000000000000001 108.668 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.517 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -57.68 -42.2 83.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.315 -1.766 . . . . 3.6699999999999999 111.938 -178.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 1.049 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 3.2 mt-10 -58.62 -26.82 64.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.809 0.814 . . . . 1.51 109.719 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.6 ' HA3' HD22 ' A' ' 121' ' ' LEU . . . 139.09 -10.61 3.32 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 114.193 -1.367 . . . . 0.56999999999999995 110.295 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.91 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 1.8 m-85 -71.62 124.03 23.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 120.119 -0.632 . . . . 1.49 110.838 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.894 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -79.12 82.99 5.23 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.26 -1.015 . . . . 1.1399999999999999 108.26 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.909 HG21 ' HB ' ' A' ' 6' ' ' ILE . 20.6 p -91.04 134.02 34.84 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.973 -0.558 . . . . 0.95999999999999996 110.493 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 12.9 m-85 -125.48 120.76 31.83 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.57 1.176 . . . . 0.42999999999999999 109.419 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.907 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 5.2 pt20 -81.18 121.72 26.48 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 112.736 -2.029 . . . . 0.23999999999999999 111.693 -173.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.902 ' HB2' ' HB3' ' A' ' 38' ' ' GLN . . . -122.14 131.3 53.89 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.696 0.799 . . . . 1.0 109.145 176.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB1' ' NH2' ' A' ' 16' ' ' ARG . . . -91.16 -7.17 52.25 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.983 -0.687 . . . . 0.78000000000000003 110.897 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.533 HD21 ' HB2' ' A' ' 37' ' ' LEU . 2.4 p-10 -147.73 165.5 30.33 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.42 -0.512 . . . . 0.28999999999999998 111.699 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -23.16 73.13 Favored Glycine 0 CA--C 1.507 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.17999999999999999 113.118 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' HB2' HD21 ' A' ' 35' ' ' ASN . 2.9 mm? -76.54 -39.87 51.6 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.725 -0.843 . . . . 1.1200000000000001 108.725 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -60.51 -44.88 95.55 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.091 -2.189 . . . . 1.78 105.091 177.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -61.14 -44.43 97.34 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.98999999999999999 111.252 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.609 HD21 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -55.83 -44.82 78.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.461 0.648 . . . . 1.5700000000000001 109.473 175.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -61.59 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.666 -1.152 . . . . 1.3200000000000001 110.32 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.838 HG12 ' O ' ' A' ' 38' ' ' GLN . 8.5 mm -63.69 -47.35 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 120.551 0.215 . . . . 1.04 111.418 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' A' ' 69' ' ' MET . 41.2 t -59.88 -42.43 89.16 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.678 0 CA-C-O 121.486 0.66 . . . . 1.0600000000000001 109.506 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -72.31 -22.15 61.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.562 -0.745 . . . . 0.95999999999999996 111.197 -177.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.78 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 2.1 ptmt -89.82 -44.89 9.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 2.9900000000000002 111.225 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 60.6 mm-40 -111.14 -35.71 5.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 111.897 0.332 . . . . 0.63 111.897 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 43' ' ' VAL . 37.6 mmt180 69.01 59.83 0.62 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 123.936 0.772 . . . . 4.2800000000000002 109.123 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.646 ' O ' HG13 ' A' ' 76' ' ' ILE . 52.4 Cg_exo -61.23 153.74 63.01 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 121.457 1.438 . . . . 0.20999999999999999 111.222 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.3 m-20 -92.69 -34.1 14.09 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.713 -0.795 . . . . 0.97999999999999998 109.415 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD23 HD12 ' A' ' 79' ' ' ILE . 7.8 mp -118.57 113.33 21.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.013 -0.54 . . . . 1.1599999999999999 110.214 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.847 HG12 ' HB3' ' A' ' 7' ' ' LEU . 46.9 t -113.26 112.19 39.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.017 0.437 . . . . 1.05 111.665 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.412 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 2.9 mp -82.06 94.28 7.17 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.277 0.56 . . . . 1.0700000000000001 110.389 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.671 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -83.04 98.8 9.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.18 -0.918 . . . . 2.2000000000000002 111.635 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.612 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 35.6 t70 -70.98 103.91 2.82 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.426 -0.91 . . . . 1.47 109.156 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.593 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 19.9 mtm -80.29 -1.07 39.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.015 -0.539 . . . . 1.6499999999999999 110.772 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 12.6 mmmm -56.9 -67.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.724 1.009 . . . . 2.73 113.724 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.78 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 4.6 pt -152.91 -22.87 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.638 1.347 . . . . 2.6099999999999999 114.638 -167.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 1.044 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -33.62 -48.12 0.46 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.356 2.704 . . . . 0.55000000000000004 115.564 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 -48.36 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.551 -1.309 . . . . 0.55000000000000004 113.077 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.405 ' HG2' ' N ' ' A' ' 61' ' ' ASP . 58.1 ttm -143.35 163.35 33.28 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.113 -0.699 . . . . 2.6699999999999999 109.113 -175.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' N ' ' HG2' ' A' ' 60' ' ' MET . 35.3 m-20 -61.15 136.57 58.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.094 0.473 . . . . 0.67000000000000004 109.961 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.671 ' HA3' ' HB3' ' A' ' 53' ' ' LEU . . . -63.65 -9.93 34.83 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.309 -0.948 . . . . 0.32000000000000001 112.157 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.917 HD11 ' HB3' ' A' ' 89' ' ' MET . 4.7 mt -73.33 -52.64 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.123 0.487 . . . . 1.9199999999999999 110.067 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.81 -33.21 75.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.749 0.785 . . . . 0.46999999999999997 109.231 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.743 HG23 ' HE2' ' A' ' 69' ' ' MET . 49.7 mt -74.82 -37.7 42.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.177 -0.92 . . . . 1.3600000000000001 110.912 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 3.1 pp -66.96 -36.2 81.67 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.379 -0.528 . . . . 2.1600000000000001 110.414 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.683 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.9 ptpt -75.84 -34.63 60.09 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.453 -0.499 . . . . 1.3400000000000001 111.175 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.72 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.1 ptm180 -66.78 -33.49 75.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.559 -0.857 . . . . 2.8599999999999999 111.054 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.78 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.8 ptp -82.8 -13.69 55.76 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.561 -0.856 . . . . 1.95 109.889 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.683 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.3 mptp? -79.12 -29.83 43.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.572 0.701 . . . . 1.9299999999999999 109.877 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.4 p -78.47 -34.98 18.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.028 -0.73 . . . . 1.8300000000000001 109.028 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.78 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -81.14 -28.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 1.02 109.98 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -157.94 88.93 0.98 Allowed 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 112.928 0.714 . . . . 1.0800000000000001 112.928 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.0 1.73 10.28 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.047 -1.033 . . . . 1.78 109.831 175.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -27.29 63.86 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.796 1.284 . . . . 0.34999999999999998 107.722 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.669 HG22 ' HG3' ' A' ' 69' ' ' MET . 3.2 tt -74.25 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 112.492 -2.14 . . . . 1.05 110.938 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 3.4 ptp180 -139.21 174.32 10.64 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.981 -1.118 . . . . 1.45 107.981 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.675 HG21 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -138.97 148.32 24.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.618 0.723 . . . . 1.55 111.47 -173.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.824 HG22 ' HG1' ' A' ' 100' ' ' THR . 63.3 mt -119.72 72.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.961 -1.126 . . . . 1.3500000000000001 107.961 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -68.65 141.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.318 -0.856 . . . . 1.02 111.768 -172.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.55 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 4.0 mtm -102.05 135.22 44.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.012 -0.995 . . . . 2.5499999999999998 110.595 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 t -133.4 161.59 34.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.493 0.663 . . . . 1.78 112.672 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . . . -74.1 52.74 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.99 -1.005 . . . . 1.1000000000000001 110.593 169.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.443 ' HA ' ' HB3' ' A' ' 103' ' ' ALA . 22.4 t80 72.84 30.86 1.67 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.974 -1.012 . . . . 4.4400000000000004 112.085 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.87 76.53 1.23 Allowed Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.885 -0.674 . . . . 0.65000000000000002 112.892 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.44 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.5 mt-10 -81.06 12.04 3.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.444 -0.878 . . . . 1.3300000000000001 111.799 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 21.2 mt 54.38 -169.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.391 0.886 . . . . 2.2799999999999998 113.391 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 87' ' ' LEU . 13.4 t70 58.08 -97.62 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.337 -0.847 . . . . 1.3799999999999999 110.852 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.917 ' HB3' HD11 ' A' ' 63' ' ' ILE . 57.6 mtm -51.52 -37.01 47.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.834 0.854 . . . . 3.3700000000000001 110.731 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 93' ' ' SER . 33.0 mm -58.78 -47.67 88.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 1.3700000000000001 111.109 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -60.69 -55.05 37.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.451 -0.795 . . . . 3.1800000000000002 109.51 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' HG2' HG23 ' A' ' 63' ' ' ILE . 7.0 tt0 -58.42 -33.57 69.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.853 -1.067 . . . . 1.27 112.085 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.459 ' OG ' HG12 ' A' ' 63' ' ' ILE . 4.9 m -54.08 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.63 0.729 . . . . 1.5600000000000001 111.8 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.843 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 12.8 ptpt -52.33 -37.35 55.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.837 -1.074 . . . . 2.3100000000000001 111.004 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 17.7 tp10 -55.98 -37.99 69.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.965 -1.016 . . . . 1.8400000000000001 112.1 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.9 mt -85.77 -15.09 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.795 0.665 . . . . 1.8999999999999999 112.795 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 147.54 4.18 0.39 Allowed Glycine 0 C--N 1.317 -0.519 0 C-N-CA 119.778 -1.201 . . . . 0.34999999999999998 113.023 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.843 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -79.21 131.69 36.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.263 0.532 . . . . 1.02 109.936 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 77' ' ' ARG . 11.2 mt -74.39 -49.32 23.06 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.856 0.836 . . . . 1.05 109.734 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.824 ' HG1' HG22 ' A' ' 79' ' ' ILE . 41.3 p -140.14 153.45 46.67 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.0 -1.455 . . . . 1.05 111.756 -170.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -116.96 85.7 2.37 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.871 -1.059 . . . . 1.1799999999999999 109.215 172.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -76.43 145.66 39.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 4.75 110.579 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 84' ' ' TYR . . . -121.68 -168.43 1.69 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.109 -0.496 . . . . 1.24 112.001 -173.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 45.5 mtpt -52.92 -50.4 81.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.168 -0.924 . . . . 3.7200000000000002 111.654 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 68.9 Cg_endo -75.46 97.43 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.127 1.218 . . . . 1.6699999999999999 111.393 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB2' HD12 ' A' ' 111' ' ' ILE . 46.9 p90 -129.24 133.45 47.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.822 -0.626 . . . . 1.29 110.208 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.67 ' O ' HG21 ' A' ' 108' ' ' ILE . 7.3 t70 -72.73 -4.27 30.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.916 -0.584 . . . . 1.77 111.413 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.67 HG21 ' O ' ' A' ' 107' ' ' ASP . 3.6 tt 63.06 -54.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.559 1.144 . . . . 1.9199999999999999 109.882 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.2 -34.98 79.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.576 -0.284 . . . . 1.1599999999999999 110.516 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.499 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 11.5 pt-20 -65.15 -27.41 68.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.579 -0.449 . . . . 0.83999999999999997 110.772 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 106' ' ' PHE . 19.3 mt -80.51 -44.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.108 -0.33 . . . . 1.5600000000000001 110.108 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.515 ' NH1' ' HA ' ' A' ' 124' ' ' ASN . 2.4 ppt_? -69.73 -35.47 75.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.776 0.798 . . . . 0.80000000000000004 109.423 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.61 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.0 t70 -63.77 -42.63 97.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.695 -0.854 . . . . 0.78000000000000003 108.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.946 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -60.29 -48.79 80.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.857 -1.065 . . . . 1.3100000000000001 111.462 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 112' ' ' ARG . 35.5 m -61.3 -43.06 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.912 -0.715 . . . . 1.1200000000000001 111.004 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 8.3 ttpt -58.06 -55.96 28.18 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 120.909 0.385 . . . . 1.99 111.151 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.946 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 46.1 pttt -65.68 -13.15 58.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.516 0.562 . . . . 2.0899999999999999 112.516 -176.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -92.01 -41.2 10.67 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.583 -0.447 . . . . 2.3900000000000001 111.443 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -146.6 95.96 4.51 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.331 -0.988 . . . . 2.7599999999999998 108.331 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -96.4 123.74 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.815 2.344 . . . . 0.92000000000000004 114.182 -171.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.721 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 12.7 tp -105.44 -65.48 1.05 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.356 0.598 . . . . 1.9399999999999999 110.076 176.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.721 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 48.5 mtmt -136.39 -57.97 0.74 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.171 -0.922 . . . . 3.3599999999999999 109.21 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 1.049 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 89.8 p 60.26 171.12 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.021 1.119 . . . . 2.1699999999999999 114.021 171.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.515 ' HA ' ' NH1' ' A' ' 112' ' ' ARG . 57.1 m-80 70.73 -108.42 0.06 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.452 -1.249 . . . . 6.0 111.509 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -179.78 -43.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.358 -0.979 . . . . 6.2699999999999996 108.358 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.48 90.72 2.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.126 -0.943 . . . . 8.6500000000000004 110.986 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.0 m80 60.15 -169.69 0.15 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.283 0.563 . . . . 10.210000000000001 111.125 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -109.32 95.88 5.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.786 -0.82 . . . . 13.26 108.786 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -121.19 -179.82 4.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.568 -0.287 . . . . 12.92 110.95 -174.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -67.02 -47.97 69.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 17.120000000000001 110.944 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -68.72 145.38 53.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.245 -0.434 . . . . 17.550000000000001 110.425 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.0 m170 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.82 -0.609 . . . . 19.600000000000001 110.255 176.619 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.027 -0.36 . . . . 6.79 110.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 53.2 mtm 66.16 164.8 0.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.944 0.778 . . . . 4.4100000000000001 111.27 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -149.4 19.56 0.94 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.58 -0.526 . . . . 2.3500000000000001 109.58 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.834 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER 69.83 102.37 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.411 -0.813 . . . . 2.2999999999999998 110.848 177.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 4.0 tppt? -134.6 140.44 46.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.016 0.436 . . . . 1.3999999999999999 112.06 -173.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.869 ' HB ' HG21 ' A' ' 30' ' ' THR . 1.9 mt -137.0 155.84 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.276 -0.874 . . . . 1.04 112.061 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.866 HD12 ' HB ' ' A' ' 42' ' ' ILE . 3.4 tt -133.86 118.35 17.87 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 107.934 -1.136 . . . . 0.98999999999999999 107.934 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.657 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -105.72 102.98 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.886 -0.725 . . . . 1.1200000000000001 110.211 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 44.3 t -89.38 79.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 122.967 0.167 . . . . 1.0900000000000001 110.68 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.818 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.3 t70 -129.97 140.84 50.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 1.8200000000000001 110.817 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.776 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 26.9 t70 -94.81 -32.91 13.07 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.501 -0.318 . . . . 0.51000000000000001 111.048 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 70.07 8.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.497 -1.297 . . . . 2.5600000000000001 107.497 173.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' O ' HG12 ' A' ' 17' ' ' ILE . 41.1 p90 -47.94 -16.08 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 111.862 -2.426 . . . . 1.8300000000000001 115.342 -166.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.49 -61.62 6.18 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.751 -1.339 . . . . 0.41999999999999998 109.751 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.587 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 3.1 mt -54.92 -29.34 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.224 0.535 . . . . 1.5600000000000001 111.136 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.837 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -77.58 -48.67 16.36 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.772 -0.649 . . . . 0.47999999999999998 111.055 -168.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 41.5 pt -75.71 -25.06 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.247 -0.649 . . . . 1.1899999999999999 109.247 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.48 ' O ' HG21 ' A' ' 22' ' ' VAL . 4.2 tp -58.64 -66.28 0.52 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.251 -0.886 . . . . 1.22 109.699 170.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 80.3 mt -53.83 -43.71 69.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.075 -0.343 . . . . 1.8400000000000001 110.075 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.607 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.1 t30 -50.31 -66.1 0.45 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.079 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.81 -39.84 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.888 0.742 . . . . 2.46 110.75 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -54.86 -60.1 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.52 -0.309 . . . . 1.2 111.423 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.655 ' HB2' HG22 ' A' ' 30' ' ' THR . 2.0 m-85 -70.95 -39.99 72.26 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.016 -0.735 . . . . 0.51000000000000001 109.016 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.2 t-20 -52.26 -52.69 51.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.895 -1.048 . . . . 0.32000000000000001 109.333 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 2.8 tmmm? -60.87 -43.13 98.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.722 -1.581 . . . . 3.6699999999999999 111.93 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.86 ' HB2' ' HA ' ' A' ' 123' ' ' SER . 10.9 pt-20 -81.92 13.15 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 1.51 111.193 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.02 3.03 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.369 -0.92 . . . . 0.56999999999999995 113.427 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.834 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 7.8 m-85 -77.76 150.25 34.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.926 0.869 . . . . 1.49 112.511 -165.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.609 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -98.01 82.15 2.94 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.91 -1.041 . . . . 1.1399999999999999 108.336 166.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.869 HG21 ' HB ' ' A' ' 6' ' ' ILE . 19.3 p -92.52 138.59 31.37 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.659 -0.7 . . . . 0.95999999999999996 109.883 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.413 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 10.5 m-85 -128.55 107.55 9.8 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.869 1.319 . . . . 0.42999999999999999 110.299 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.837 ' HB2' HH11 ' A' ' 16' ' ' ARG . 5.3 pt20 -59.53 121.11 10.72 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 112.035 -2.348 . . . . 0.23999999999999999 112.516 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.687 ' HB3' HG13 ' A' ' 42' ' ' ILE . . . -124.94 129.7 50.88 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 174.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.686 ' HB3' HH21 ' A' ' 16' ' ' ARG . . . -90.4 -9.65 46.78 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.07 -0.652 . . . . 0.78000000000000003 110.831 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 3.4 p-10 -148.39 164.48 33.98 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.038 -0.528 . . . . 0.28999999999999998 111.736 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA3' HD13 ' A' ' 65' ' ' ILE . . . -69.42 -22.14 76.3 Favored Glycine 0 CA--C 1.504 -0.597 0 CA-C-N 115.254 -0.885 . . . . 0.17999999999999999 113.745 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.36 -41.57 21.79 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 122.216 1.008 . . . . 1.1200000000000001 108.946 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.814 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.1 tp60 -60.53 -39.67 88.7 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.584 -2.006 . . . . 1.78 105.584 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.57 88.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.132 -1.395 . . . . 0.98999999999999999 111.281 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.546 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -56.41 -47.87 78.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.38 -0.827 . . . . 1.5700000000000001 109.728 176.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -63.83 -36.0 82.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.326 -1.306 . . . . 1.3200000000000001 111.317 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.866 ' HB ' HD12 ' A' ' 7' ' ' LEU . 26.7 mm -65.47 -49.47 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.277 -0.268 . . . . 1.04 110.277 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.7 t -58.68 -43.14 86.97 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.265 1.031 . . . . 1.0600000000000001 108.835 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -58.13 -30.9 66.69 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.361 -1.291 . . . . 0.95999999999999996 111.702 177.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 5.7 tptt -90.57 -50.48 5.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.064 -0.517 . . . . 2.9900000000000002 111.511 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.587 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 58.1 mm-40 -106.1 -35.95 7.07 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.583 0.586 . . . . 0.63 112.583 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 43.6 mtt180 62.93 65.02 1.44 Allowed Pre-proline 0 C--N 1.322 -0.589 0 O-C-N 123.673 0.608 . . . . 4.2800000000000002 110.323 -170.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.762 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 66.4 Cg_exo -60.32 163.48 14.77 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.116 1.877 . . . . 0.20999999999999999 111.635 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.771 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.8 m-20 -92.6 -44.48 8.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.973 -0.751 . . . . 0.97999999999999998 108.973 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.733 HD22 HD13 ' A' ' 79' ' ' ILE . 7.6 mp -107.29 110.4 22.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 1.1599999999999999 110.014 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.794 HG12 ' HB3' ' A' ' 7' ' ' LEU . 62.6 t -110.16 107.35 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.453 . . . . 1.05 111.197 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.445 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 3.1 mp -78.51 95.93 5.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.432 0.634 . . . . 1.0700000000000001 110.032 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.613 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -85.65 92.83 8.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.951 -1.022 . . . . 2.2000000000000002 110.2 -176.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.649 ' OD1' ' HG2' ' A' ' 56' ' ' LYS . 34.6 t70 -68.59 108.82 3.49 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.75 0.786 . . . . 1.47 109.739 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.613 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 20.8 mtm -93.48 16.89 12.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.226 -0.897 . . . . 1.6499999999999999 110.244 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.649 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 2.9 mmpp? -54.09 -53.43 53.27 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 120.075 -0.65 . . . . 2.73 110.445 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.839 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.5 tt -179.83 -19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.563 -1.208 . . . . 2.6099999999999999 114.209 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.839 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -26.81 -54.43 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.465 2.777 . . . . 0.55000000000000004 116.014 -175.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.48 -55.65 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.742 -1.218 . . . . 0.55000000000000004 112.904 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 46.0 tpp -142.25 165.15 28.21 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.35 -0.611 . . . . 2.6699999999999999 109.35 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.2 m-20 -60.39 140.22 57.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.67000000000000004 110.785 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -64.65 -12.48 52.91 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.825 -1.079 . . . . 0.32000000000000001 112.184 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.619 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 11.9 mt -76.51 -46.72 31.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 1.9199999999999999 110.149 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -60.07 -43.0 95.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.658 -0.868 . . . . 0.46999999999999997 108.658 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.805 HG21 ' HE2' ' A' ' 69' ' ' MET . 16.5 mm -68.6 -43.18 83.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.475 -0.784 . . . . 1.3600000000000001 111.452 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 96' ' ' LEU . 3.0 pp -62.5 -37.66 86.91 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.718 -0.393 . . . . 2.1600000000000001 110.236 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 71' ' ' VAL . 18.0 ptpt -76.03 -36.37 59.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.125 -0.63 . . . . 1.3400000000000001 111.827 -176.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.546 ' HG3' HD23 ' A' ' 40' ' ' LEU . 3.0 ptm180 -67.38 -34.39 77.18 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.819 -1.152 . . . . 2.8599999999999999 111.004 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.805 ' HE2' HG21 ' A' ' 65' ' ' ILE . 11.8 ptp -78.85 -18.58 53.75 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.018 -0.673 . . . . 1.95 109.725 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.4 mptt -70.95 -40.59 71.91 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.554 -0.906 . . . . 1.9299999999999999 108.554 169.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 67' ' ' LYS . 92.8 t -61.41 -38.21 79.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.423 -0.808 . . . . 1.8300000000000001 110.531 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.694 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -83.86 -30.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.377 -0.529 . . . . 1.02 110.325 175.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -156.04 83.48 1.01 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.728 0.64 . . . . 1.0800000000000001 112.728 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 32.4 mt-10 -69.99 2.56 3.41 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.293 -0.879 . . . . 1.78 111.272 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -28.44 65.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.737 1.256 . . . . 0.34999999999999998 107.729 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.673 HG23 ' HG3' ' A' ' 69' ' ' MET . 3.8 tt -75.52 158.12 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 112.587 -2.097 . . . . 1.05 111.208 -172.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.771 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -134.19 -178.28 4.97 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.11 -0.95 . . . . 1.45 108.496 175.151 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.625 HG23 ' CB ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -143.09 148.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 120.133 -0.627 . . . . 1.55 111.019 -175.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.757 HG21 ' HG1' ' A' ' 100' ' ' THR . 64.5 mt -117.87 71.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.725 -1.213 . . . . 1.3500000000000001 107.725 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.613 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.81 141.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 119.045 -1.062 . . . . 1.02 111.181 -172.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.509 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 22.4 mtp -109.25 111.91 23.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.676 -1.147 . . . . 2.5499999999999998 110.412 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 1.2 t -120.55 166.65 13.33 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 122.162 -0.336 . . . . 1.78 111.316 -175.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 85' ' ' GLY . . . -58.37 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.782 -0.644 . . . . 1.1000000000000001 111.375 168.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.5 t80 59.67 3.66 0.46 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.828 1.251 . . . . 4.4400000000000004 112.39 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.96 93.18 1.87 Allowed Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.923 -0.656 . . . . 0.65000000000000002 112.354 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.572 ' N ' HG13 ' A' ' 90' ' ' ILE . 30.9 mt-10 -74.8 11.85 0.97 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 1.3300000000000001 111.002 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 85' ' ' GLY . 26.4 mt 64.81 -177.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.593 0.96 . . . . 2.2799999999999998 113.593 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 62.17 -92.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.606 -1.179 . . . . 1.3799999999999999 111.327 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.494 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 71.0 mtm -64.23 -22.91 67.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 120.925 0.393 . . . . 3.3700000000000001 110.428 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.572 HG13 ' N ' ' A' ' 86' ' ' GLU . 42.8 mm -67.03 -39.95 84.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.181 0.515 . . . . 1.3700000000000001 110.012 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.637 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 12.7 mm100 -67.24 -42.29 84.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.264 -0.88 . . . . 3.1800000000000002 108.996 176.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 9.4 tt0 -63.16 -39.92 96.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.371 -1.286 . . . . 1.27 112.047 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.414 ' CB ' HG12 ' A' ' 63' ' ' ILE . 8.5 t -55.37 -62.96 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 1.5600000000000001 110.414 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.943 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 50.3 pttt -56.93 -36.79 70.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.998 -0.546 . . . . 2.3100000000000001 111.892 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -65.99 -22.97 66.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.081 -0.248 . . . . 1.8400000000000001 111.545 -178.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.689 ' HB3' HD11 ' A' ' 66' ' ' LEU . 4.4 mp -88.63 -4.98 58.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 1.8999999999999999 111.495 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.42 16.72 1.84 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.864 -1.16 . . . . 0.34999999999999998 113.135 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.943 ' HB1' ' HA ' ' A' ' 94' ' ' LYS . . . -89.39 132.01 35.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.121 -0.696 . . . . 1.02 109.121 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.663 HD21 ' HD3' ' A' ' 77' ' ' ARG . 13.9 mt -73.63 -49.07 27.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.807 0.813 . . . . 1.05 109.506 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.757 ' HG1' HG21 ' A' ' 79' ' ' ILE . 70.0 p -141.51 142.8 33.57 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.081 -1.418 . . . . 1.05 111.519 -173.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.31 85.73 2.41 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.811 -1.086 . . . . 1.1799999999999999 109.457 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 81' ' ' MET . 13.3 m-85 -75.1 157.46 34.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 4.75 109.893 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -98.71 -170.71 1.98 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.338 0.496 . . . . 1.24 112.338 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 44.6 tttp -73.19 -45.47 8.03 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.087 -0.708 . . . . 3.7200000000000002 109.087 172.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 36.1 Cg_endo -68.29 97.89 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.438 1.425 . . . . 1.6699999999999999 111.026 166.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -112.67 139.32 48.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.488 -0.778 . . . . 1.29 109.65 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -87.56 20.21 3.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 119.238 -0.41 . . . . 1.77 111.306 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.452 HG21 ' H ' ' A' ' 109' ' ' ASP . 2.4 tt 49.18 -66.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 1.9199999999999999 112.781 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 107' ' ' ASP . 5.6 t70 -64.27 -25.78 68.2 Favored 'General case' 0 C--O 1.212 -0.884 0 O-C-N 122.397 -0.189 . . . . 1.1599999999999999 110.807 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.59 -27.86 65.46 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 120.425 -0.51 . . . . 0.83999999999999997 109.765 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -76.65 -47.5 28.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.224 -0.658 . . . . 1.5600000000000001 109.224 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.497 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.38 -39.32 85.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.122 0.487 . . . . 0.80000000000000004 109.922 179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 24.4 t70 -65.72 -43.34 89.35 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.304 -0.628 . . . . 0.78000000000000003 109.304 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.932 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.96 -51.05 69.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.666 -0.697 . . . . 1.3100000000000001 111.124 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.532 ' HB ' ' HH ' ' A' ' 28' ' ' TYR . 27.0 m -59.02 -50.77 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.844 -0.742 . . . . 1.1200000000000001 111.475 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -65.36 -29.34 70.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.345 0.498 . . . . 1.99 112.345 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.932 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 56.9 pttt -81.52 -11.74 59.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.49 -0.884 . . . . 2.0899999999999999 111.507 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.6 -58.65 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.175 0.512 . . . . 2.3900000000000001 110.176 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.502 ' HG ' ' OE1' ' A' ' 4' ' ' GLU . 57.1 tp -122.67 109.77 32.28 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.384 -0.969 . . . . 2.7599999999999998 108.384 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 47.4 Cg_endo -101.44 148.13 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.773 2.315 . . . . 0.92000000000000004 114.331 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -125.67 -70.1 0.75 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.766 -0.828 . . . . 1.9399999999999999 108.766 174.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.558 ' HE2' HD23 ' A' ' 121' ' ' LEU . 75.0 mmtt -133.79 -63.04 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.553 -1.203 . . . . 3.3599999999999999 108.19 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.86 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 12.4 p 37.52 -89.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 125.04 1.462 . . . . 2.1699999999999999 114.088 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -155.95 120.57 4.64 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.356 -0.609 . . . . 6.0 109.356 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.693 ' HB3' ' HB3' ' A' ' 129' ' ' HIS . 89.7 mt -82.39 44.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.131 0.491 . . . . 6.2699999999999996 110.059 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.1 -56.98 10.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.725 -1.125 . . . . 8.6500000000000004 113.308 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -127.85 -67.45 0.82 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.031 0.443 . . . . 10.210000000000001 110.017 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -87.98 75.48 8.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.62 0.724 . . . . 13.26 111.112 -175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 125' ' ' LEU . 2.6 p-80 -95.81 103.65 15.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.51 -0.768 . . . . 12.92 109.874 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -104.58 133.13 49.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 17.120000000000001 110.549 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -86.57 107.49 18.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.2 -0.667 . . . . 17.550000000000001 109.2 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-N 115.135 -0.939 . . . . 19.600000000000001 110.197 -175.072 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.948 0.404 . . . . 6.79 110.727 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.571 ' O ' HD13 ' A' ' 121' ' ' LEU . 15.9 ptt? -109.82 174.93 5.64 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.361 -0.607 . . . . 4.4100000000000001 109.361 173.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.512 ' HB3' ' NE2' ' A' ' 29' ' ' GLN . 83.5 m-20 -94.85 106.69 18.69 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.494 -1.299 . . . . 2.3500000000000001 107.494 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.722 ' CD ' ' HB3' ' A' ' 121' ' ' LEU . 17.5 pt-20 -66.89 127.89 34.24 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.822 -0.626 . . . . 2.2999999999999998 109.991 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.807 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -117.23 144.88 44.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.207 0.527 . . . . 1.3999999999999999 111.812 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.872 ' HB ' HG21 ' A' ' 30' ' ' THR . 3.4 mt -135.02 153.47 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 114.933 -1.031 . . . . 1.04 111.655 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.857 ' HG ' HG21 ' A' ' 42' ' ' ILE . 2.4 tt -129.51 124.95 35.22 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.562 -1.273 . . . . 0.98999999999999999 107.562 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' A' ' 30' ' ' THR . 1.5 mp -112.26 107.57 23.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.124 -0.63 . . . . 1.1200000000000001 109.963 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 57.6 t -96.15 89.55 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.103 -0.332 . . . . 1.0900000000000001 110.103 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.708 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 0.8 OUTLIER -135.42 136.04 41.07 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 110.215 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.695 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 20.9 t70 -88.91 -41.65 12.3 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.486 0.184 . . . . 0.51000000000000001 110.768 -177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.491 ' HG3' ' CD1' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -78.69 70.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.819 -1.178 . . . . 2.5600000000000001 107.819 172.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.8 p90 -48.09 -13.72 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 111.856 -2.429 . . . . 1.8300000000000001 115.588 -163.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.08 -57.38 6.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.249 -0.977 . . . . 0.41999999999999998 110.937 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 2.4 mt -59.94 -25.85 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.477 0.656 . . . . 1.5600000000000001 110.664 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.968 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.5 ttm180 -78.9 -49.24 13.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.47999999999999998 110.529 -168.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 37.9 pt -75.07 -24.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.219 -0.66 . . . . 1.1899999999999999 109.219 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.755 HD12 HD13 ' A' ' 108' ' ' ILE . 7.5 tp -58.09 -67.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.947 -1.024 . . . . 1.22 109.827 171.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.559 HD13 HD22 ' A' ' 52' ' ' LEU . 69.8 mt -54.18 -41.15 68.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.179 -0.464 . . . . 1.8400000000000001 110.08 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.7 t30 -49.94 -70.09 0.1 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.473 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -57.24 -36.9 71.5 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.308 0.38 . . . . 2.46 111.683 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.1 t -55.92 -55.66 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.592 0.219 . . . . 1.2 111.592 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.699 ' HB2' HG22 ' A' ' 30' ' ' THR . 7.7 m-85 -78.18 -36.73 47.07 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 120.659 -0.416 . . . . 0.51000000000000001 109.922 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.804 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.8 t-20 -50.27 -45.53 54.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.176 0.989 . . . . 0.32000000000000001 108.753 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -60.35 -38.44 83.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.09 -1.868 . . . . 3.6699999999999999 111.9 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.697 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 4.2 mm-40 -55.9 -33.14 64.36 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.297 1.046 . . . . 1.51 109.586 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.79 1.45 3.01 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 113.071 -1.877 . . . . 0.56999999999999995 109.417 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.804 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 45.4 m-85 -75.37 132.3 40.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.364 0.602 . . . . 1.49 110.666 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.807 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 12.0 mt-30 -86.52 81.38 8.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.79 -1.189 . . . . 1.1399999999999999 107.79 171.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.872 HG21 ' HB ' ' A' ' 6' ' ' ILE . 18.9 p -90.25 132.75 35.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.799 -0.637 . . . . 0.95999999999999996 110.214 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.601 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 20.1 m-85 -124.42 123.75 40.85 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 122.826 1.298 . . . . 0.42999999999999999 110.13 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.968 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.2 pt20 -82.74 121.91 27.49 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.053 -2.339 . . . . 0.23999999999999999 112.073 -171.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.83 137.42 54.66 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.166 0.987 . . . . 1.0 108.678 174.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.649 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . . . -98.98 -3.81 34.1 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.137 -0.625 . . . . 0.78000000000000003 110.402 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 5.3 p-10 -148.51 163.7 36.42 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.792 -0.64 . . . . 0.28999999999999998 111.315 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.17 79.41 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.534 -0.757 . . . . 0.17999999999999999 113.306 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 35' ' ' ASN . 2.9 mm? -80.42 -40.83 25.64 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 122.395 1.093 . . . . 1.1200000000000001 108.2 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.83 ' O ' HG12 ' A' ' 42' ' ' ILE . 2.6 tp-100 -58.96 -40.42 84.67 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.521 -2.127 . . . . 1.78 105.404 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -65.2 -45.56 84.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.794 -1.548 . . . . 0.98999999999999999 111.544 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.494 HD13 ' HD3' ' A' ' 68' ' ' ARG . 11.7 mt -55.53 -39.31 70.4 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.703 0.763 . . . . 1.5700000000000001 109.556 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 21.3 t70 -72.3 -38.01 68.83 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.54 -1.209 . . . . 1.3200000000000001 110.374 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.857 HG21 ' HG ' ' A' ' 7' ' ' LEU . 18.0 mm -58.86 -48.59 85.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 120.685 0.279 . . . . 1.04 110.674 176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 39' ' ' ALA . 24.0 t -61.43 -41.47 90.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.968 0.89 . . . . 1.0600000000000001 109.723 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -63.23 -28.51 70.09 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.604 -1.18 . . . . 0.95999999999999996 111.204 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -94.99 -48.53 5.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 2.9900000000000002 111.766 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.601 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 66.7 mm-40 -104.63 -37.05 7.26 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.69 0.256 . . . . 0.63 111.69 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 62.88 67.83 1.05 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.787 -0.642 . . . . 4.2800000000000002 110.02 -169.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.768 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 45.9 Cg_exo -65.03 154.89 71.18 Favored 'Trans proline' 0 CA--C 1.503 -1.035 0 C-N-CA 121.858 1.705 . . . . 0.20999999999999999 111.424 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.803 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 8.3 m-20 -89.65 -41.69 11.8 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.723 -0.791 . . . . 0.97999999999999998 109.013 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.511 HD21 HD11 ' A' ' 79' ' ' ILE . 6.7 mp -108.02 110.05 21.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.211 -0.45 . . . . 1.1599999999999999 110.166 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.8 ' HB ' HG11 ' A' ' 78' ' ' VAL . 57.9 t -109.95 109.32 27.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.081 0.467 . . . . 1.05 111.584 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -80.5 91.15 5.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.393 0.616 . . . . 1.0700000000000001 109.772 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.833 HD11 HG12 ' A' ' 78' ' ' VAL . 18.5 mt -89.13 103.13 15.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.298 -0.864 . . . . 2.2000000000000002 111.079 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.636 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 12.4 t70 -67.06 116.83 8.31 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.128 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.606 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 13.0 mtm -98.14 12.19 35.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.793 -0.64 . . . . 1.6499999999999999 110.696 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.636 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 13.0 mmmm -64.25 -49.32 72.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.662 -0.245 . . . . 2.73 111.368 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.849 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 17.3 tt 174.81 -28.6 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.718 1.377 . . . . 2.6099999999999999 114.718 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.849 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -18.31 -59.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 124.546 3.497 . . . . 0.55000000000000004 116.625 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.95 -63.86 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.072 -1.061 . . . . 0.55000000000000004 112.225 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.5 tpt -148.72 167.02 26.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.577 -0.897 . . . . 2.6699999999999999 108.577 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.46 135.67 57.74 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.67 0.748 . . . . 0.67000000000000004 110.563 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.556 ' O ' HD13 ' A' ' 53' ' ' LEU . . . -58.44 -18.79 38.14 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 114.239 -1.346 . . . . 0.32000000000000001 111.751 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.646 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 4.0 mt -66.97 -49.6 72.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.01 0.433 . . . . 1.9199999999999999 110.571 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.58 -34.65 77.46 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.635 0.731 . . . . 0.46999999999999997 109.072 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.791 HG23 ' HE3' ' A' ' 69' ' ' MET . 17.0 mt -73.37 -38.57 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.189 -0.914 . . . . 1.3600000000000001 111.025 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 4.3 pp -67.02 -35.09 79.13 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 121.074 -0.25 . . . . 2.1600000000000001 110.412 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.633 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.2 ptpt -76.23 -33.41 59.2 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.406 -0.517 . . . . 1.3400000000000001 111.12 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.738 ' O ' HG11 ' A' ' 71' ' ' VAL . 11.2 ptp180 -70.49 -29.84 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 118.752 -1.179 . . . . 2.8599999999999999 111.579 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.855 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.5 ptp -83.98 -13.36 53.52 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.455 -0.898 . . . . 1.95 109.579 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -78.68 -32.87 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.598 -0.728 . . . . 1.9299999999999999 109.855 172.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.738 HG11 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -74.34 -36.27 42.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.781 -0.822 . . . . 1.8300000000000001 108.781 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.855 HG12 ' HA ' ' A' ' 69' ' ' MET . 20.6 pt -80.62 -21.84 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.092 -0.958 . . . . 1.02 110.325 172.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.719 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 29.7 t0 -164.89 95.32 0.7 Allowed 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 112.887 0.699 . . . . 1.0800000000000001 112.887 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.622 ' OE1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -77.81 6.09 8.22 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.979 -1.076 . . . . 1.78 110.126 174.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.719 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -78.53 -34.0 47.52 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.339 -1.356 . . . . 0.34999999999999998 107.339 171.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.679 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.0 tt -60.18 159.38 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.185 -1.825 . . . . 1.05 111.685 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.803 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 2.8 ptp180 -142.76 173.83 11.19 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.989 -1.115 . . . . 1.45 107.989 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.833 HG12 HD11 ' A' ' 53' ' ' LEU . 2.3 m -141.79 147.98 21.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.477 -0.889 . . . . 1.55 112.066 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.817 HG23 ' HG1' ' A' ' 100' ' ' THR . 67.1 mt -116.4 72.85 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.57 -1.27 . . . . 1.3500000000000001 107.57 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.606 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.66 142.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.615 -0.834 . . . . 1.02 112.069 -171.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.533 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 10.2 mtt -99.33 124.69 44.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.489 -0.778 . . . . 2.5499999999999998 110.04 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.57 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t -133.15 160.3 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.998 0.74 . . . . 1.78 112.998 -173.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 63.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.649 -1.16 . . . . 1.1000000000000001 110.664 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 67.41 5.12 4.09 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.571 0.748 . . . . 4.4400000000000004 112.418 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.0 88.18 0.75 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.861 -0.685 . . . . 0.65000000000000002 111.801 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 90' ' ' ILE . 39.7 mt-10 -65.61 -89.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.483 -0.358 . . . . 1.3300000000000001 111.244 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.708 ' HG ' ' H ' ' A' ' 88' ' ' ASP . 9.5 tp -177.53 -167.76 0.16 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.69 0.281 . . . . 2.2799999999999998 111.716 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.708 ' H ' ' HG ' ' A' ' 87' ' ' LEU . 9.3 m-20 43.99 -89.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.857 1.263 . . . . 1.3799999999999999 113.009 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.626 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 62.7 mtt -56.94 -35.51 69.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.106 -0.497 . . . . 3.3700000000000001 110.461 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.531 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.6 mm -59.89 -44.76 95.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.81 -0.632 . . . . 1.3700000000000001 110.278 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.63 -53.53 57.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.559 -0.746 . . . . 3.1800000000000002 109.385 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 15.8 tt0 -58.9 -34.84 72.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.945 -1.025 . . . . 1.27 112.314 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.4 t -55.34 -69.51 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 1.5600000000000001 110.89 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.944 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 16.6 pttp -55.9 -36.54 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.383 0.611 . . . . 2.3100000000000001 111.069 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 10.9 tp10 -56.59 -45.37 81.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.864 -1.062 . . . . 1.8400000000000001 111.99 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.8 mt -70.47 -39.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.38 -0.373 . . . . 1.8999999999999999 111.16 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.543 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 170.19 15.15 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.818 -1.182 . . . . 0.34999999999999998 113.52 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 94' ' ' LYS . . . -83.9 128.75 34.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.538 -0.541 . . . . 1.02 109.538 173.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.515 HD13 ' HG3' ' A' ' 77' ' ' ARG . 9.6 mt -73.07 -49.44 28.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.891 0.853 . . . . 1.05 109.777 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.817 ' HG1' HG23 ' A' ' 79' ' ' ILE . 49.8 p -141.92 158.8 43.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.079 -1.419 . . . . 1.05 111.642 -170.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -110.17 93.47 4.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.816 -1.084 . . . . 1.1799999999999999 110.28 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.561 ' HD2' HD12 ' A' ' 111' ' ' ILE . 29.6 t80 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.653 -0.703 . . . . 4.75 109.373 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.26 -178.66 4.05 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.22 -0.592 . . . . 1.24 111.492 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 65.1 tttp -47.97 -53.85 29.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.345 -0.843 . . . . 3.7200000000000002 112.769 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 70.3 Cg_endo -77.09 98.28 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.279 1.319 . . . . 1.6699999999999999 111.706 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.506 ' HB2' HD13 ' A' ' 111' ' ' ILE . 33.2 p90 -127.9 129.15 46.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 1.29 110.665 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.582 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 7.0 t70 -67.9 -11.7 59.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.909 -0.587 . . . . 1.77 111.582 -177.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.755 HD13 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER 71.34 -54.67 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-N 115.718 -0.674 . . . . 1.9199999999999999 109.259 -164.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 15.9 t70 -66.9 -38.63 86.62 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 109.649 -0.5 . . . . 1.1599999999999999 109.649 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.582 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 13.2 pt-20 -66.13 -18.94 65.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.83999999999999997 110.807 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.609 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 7.4 mm -83.1 -45.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.466 -0.568 . . . . 1.5600000000000001 109.466 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HA ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.72 -31.06 67.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.876 0.846 . . . . 0.80000000000000004 109.161 174.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.535 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.8 t70 -67.88 -41.18 83.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.998 -1.001 . . . . 0.78000000000000003 109.324 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.616 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.28 -48.26 71.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.309 -0.859 . . . . 1.3100000000000001 111.222 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.516 HG21 ' HA ' ' A' ' 112' ' ' ARG . 29.4 m -58.95 -47.77 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.791 -0.764 . . . . 1.1200000000000001 110.422 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.463 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 10.5 ttpt -60.94 -51.99 66.91 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.902 -0.59 . . . . 1.99 111.697 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -55.32 -26.86 43.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.721 -0.392 . . . . 2.0899999999999999 111.866 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.519 ' HB3' HD23 ' A' ' 119' ' ' LEU . 35.1 m-85 -81.63 -71.72 0.46 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.75 -0.38 . . . . 2.3900000000000001 111.193 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.519 HD23 ' HB3' ' A' ' 118' ' ' TYR . 3.3 mm? -119.65 92.28 46.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.0 -0.37 . . . . 2.7599999999999998 110.0 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 91.1 Cg_endo -93.42 121.76 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.801 2.334 . . . . 0.92000000000000004 113.895 -172.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.836 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 11.7 tp -97.35 -60.04 1.66 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.458 0.647 . . . . 1.9399999999999999 109.364 172.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.836 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 88.3 mttt -142.63 -60.0 0.44 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.089 -0.959 . . . . 3.3599999999999999 110.12 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.697 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 16.2 t 61.79 14.61 6.35 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.527 -0.761 . . . . 2.1699999999999999 110.452 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 26' ' ' GLU . 52.1 m-80 61.75 30.3 18.33 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.455 -0.793 . . . . 6.0 111.268 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.82 21.88 0.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.769 -0.651 . . . . 6.2699999999999996 110.431 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 1.3 pm0 -71.12 168.67 16.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.307 -0.86 . . . . 8.6500000000000004 111.815 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -57.24 -71.84 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.393 -0.821 . . . . 10.210000000000001 111.346 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -160.52 144.6 13.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.081 -0.711 . . . . 13.26 109.081 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -83.75 105.36 14.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.618 0.247 . . . . 12.92 110.594 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -83.42 134.68 34.87 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.989 -0.745 . . . . 17.120000000000001 108.989 173.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -97.52 143.95 27.71 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.943 0.402 . . . . 17.550000000000001 110.766 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.274 -0.869 . . . . 19.600000000000001 109.237 178.054 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.589 0.233 . . . . 6.79 111.102 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.408 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 24.3 mmt -78.52 -172.02 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.057 -0.349 . . . . 4.4100000000000001 110.057 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -58.92 -59.58 5.22 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.032 -1.099 . . . . 2.3500000000000001 108.032 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 0.6 OUTLIER 178.76 140.45 0.1 Allowed 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 104.449 -2.426 . . . . 2.2999999999999998 104.449 167.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.972 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -163.56 141.46 7.6 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.542 -1.263 . . . . 1.3999999999999999 110.499 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.878 ' HB ' HG22 ' A' ' 30' ' ' THR . 5.1 mt -136.62 153.08 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.313 -0.858 . . . . 1.04 111.659 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.801 HD11 ' HB ' ' A' ' 42' ' ' ILE . 3.3 tt -137.24 117.38 13.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.236 -1.394 . . . . 0.98999999999999999 107.236 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.63 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.3 mp -106.32 107.99 24.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 119.716 -0.794 . . . . 1.1200000000000001 110.235 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 47.6 t -93.95 76.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.036 0.21 . . . . 1.0900000000000001 110.483 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.647 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.2 m-20 -123.45 133.03 54.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.421 . . . . 1.8200000000000001 110.754 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.953 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 22.9 t70 -78.42 -39.04 39.98 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.146 -1.057 . . . . 0.51000000000000001 108.146 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.822 ' HB2' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -64.23 78.38 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.658 -1.156 . . . . 2.5600000000000001 108.283 164.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 19.9 p90 -55.84 -16.11 4.13 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.21 -0.905 . . . . 1.8300000000000001 111.682 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.23 -60.21 9.17 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.875 -0.89 . . . . 0.41999999999999998 110.875 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.822 HG12 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -58.35 -25.44 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 121.403 0.621 . . . . 1.5600000000000001 109.972 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.907 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -79.4 -46.69 17.08 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.092 -0.958 . . . . 0.47999999999999998 111.148 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 13' ' ' TYR . 38.7 pt -77.4 -27.12 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.441 -0.577 . . . . 1.1899999999999999 109.441 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 22' ' ' VAL . 8.1 tp -56.71 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 1.22 109.261 170.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.638 ' HG ' ' CZ ' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -53.52 -43.27 68.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.186 -0.915 . . . . 1.8400000000000001 111.086 175.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.3 t30 -50.97 -70.02 0.1 Allowed 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.671 0.607 . . . . 1.0 109.425 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -55.08 -39.32 69.15 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.416 0.447 . . . . 2.46 112.175 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 112' ' ' ARG . 41.6 t -57.87 -53.64 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.114 0.413 . . . . 1.2 112.114 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.758 ' HB2' HG23 ' A' ' 30' ' ' THR . 4.9 m-85 -77.39 -40.26 44.35 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.264 -0.643 . . . . 0.51000000000000001 109.264 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.765 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.4 t-20 -51.11 -44.45 61.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.371 -0.831 . . . . 0.32000000000000001 108.793 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.22 -1.809 . . . . 3.6699999999999999 111.613 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' H ' ' HG2' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -56.19 -34.48 66.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.679 1.228 . . . . 1.51 109.273 177.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . 148.27 -17.53 1.33 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 112.828 -1.987 . . . . 0.56999999999999995 110.012 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.765 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 59.7 m-85 -63.89 134.87 55.95 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 112.755 0.65 . . . . 1.49 112.755 -163.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.916 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 27.9 mt-30 -84.16 77.47 9.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.897 -0.779 . . . . 1.1399999999999999 108.897 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.878 HG22 ' HB ' ' A' ' 6' ' ' ILE . 11.9 p -90.59 136.19 33.22 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.389 -0.823 . . . . 0.95999999999999996 110.392 -176.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.4 m-85 -128.78 130.32 46.86 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 122.68 1.229 . . . . 0.42999999999999999 109.888 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.907 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 3.8 pt20 -86.41 121.23 28.67 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 112.697 -2.047 . . . . 0.23999999999999999 112.077 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -121.88 137.9 54.6 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.575 -0.738 . . . . 1.0 109.248 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.572 ' HB1' ' NH2' ' A' ' 16' ' ' ARG . . . -95.03 -12.44 26.6 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.118 -0.633 . . . . 0.78000000000000003 110.133 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.43 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 2.0 p-10 -148.72 166.32 28.76 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.828 -0.624 . . . . 0.28999999999999998 111.6 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.02 -20.78 75.03 Favored Glycine 0 CA--C 1.505 -0.534 0 O-C-N 123.899 0.75 . . . . 0.17999999999999999 113.435 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.93 -43.67 19.41 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.218 1.008 . . . . 1.1200000000000001 108.666 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.783 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.1 tt0 -63.21 -36.01 82.24 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 112.798 -2.001 . . . . 1.78 105.94 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.77 -46.55 81.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.393 -1.276 . . . . 0.98999999999999999 111.14 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.77 -48.39 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.67 0.748 . . . . 1.5700000000000001 109.139 175.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 44' ' ' THR . 7.2 t70 -57.47 -42.93 83.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.155 -1.384 . . . . 1.3200000000000001 111.09 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.87 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 16.2 mm -63.29 -45.05 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 120.796 -0.361 . . . . 1.04 110.41 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.505 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -60.95 -41.67 89.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.707 0.765 . . . . 1.0600000000000001 109.631 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.34 -24.0 62.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 0.95999999999999996 111.166 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.87 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 1.6 ptmt -89.75 -46.91 8.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.159 -0.473 . . . . 2.9900000000000002 111.195 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 53.0 mm-40 -108.43 -37.93 5.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.706 0.289 . . . . 0.63 111.319 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 78.0 mtp180 66.27 65.62 0.79 Allowed Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.597 -0.728 . . . . 4.2800000000000002 109.714 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.972 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.4 Cg_exo -64.4 158.55 48.61 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 122.185 1.924 . . . . 0.20999999999999999 112.029 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.767 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 4.7 m-20 -93.53 -38.47 11.37 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.138 -1.06 . . . . 0.97999999999999998 108.138 174.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 1.035 HD13 ' HB3' ' A' ' 119' ' ' LEU . 5.7 mp -114.51 111.64 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.54 -0.755 . . . . 1.1599999999999999 110.272 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.04 HG13 ' HE2' ' A' ' 69' ' ' MET . 61.2 t -112.44 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.281 -0.418 . . . . 1.05 111.22 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.509 HD22 ' CD2' ' A' ' 19' ' ' LEU . 2.7 mp -78.52 93.73 4.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.789 0.804 . . . . 1.0700000000000001 109.616 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.672 HD13 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -86.59 96.98 10.28 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.468 -1.242 . . . . 2.2000000000000002 110.691 -174.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.608 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 9.4 t70 -63.88 116.03 5.42 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.978 -0.689 . . . . 1.47 109.844 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.843 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.7 mtp -94.03 7.53 44.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.666 -0.697 . . . . 1.6499999999999999 110.992 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.608 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 24.9 mmmt -63.82 -66.38 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.173 0.435 . . . . 2.73 112.173 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.943 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 14.6 tt -169.88 -17.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.289 1.588 . . . . 2.6099999999999999 115.289 -171.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.953 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -27.15 -51.95 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.52 2.813 . . . . 0.55000000000000004 116.112 175.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.38 -54.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.431 -1.366 . . . . 0.55000000000000004 113.648 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.489 ' HB3' HD13 ' A' ' 65' ' ' ILE . 19.4 ttt -148.69 166.76 27.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.552 -0.536 . . . . 2.6699999999999999 109.552 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.16 135.07 57.61 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.188 0.518 . . . . 0.67000000000000004 109.959 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -62.61 -10.46 30.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.055 -0.975 . . . . 0.32000000000000001 112.797 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.746 HD11 ' HE2' ' A' ' 89' ' ' MET . 22.0 mt -82.84 -47.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.03 0.443 . . . . 1.9199999999999999 110.593 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.4 mm-40 -64.62 -35.85 82.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.146 -0.687 . . . . 0.46999999999999997 109.146 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.812 ' O ' ' HG2' ' A' ' 69' ' ' MET . 55.2 mt -72.27 -38.59 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 1.3600000000000001 110.122 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.696 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -53.0 -49.53 66.01 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.215 -0.448 . . . . 2.1600000000000001 110.44 173.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.685 ' O ' HG21 ' A' ' 71' ' ' VAL . 15.0 ptpt -72.81 -35.61 67.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.474 -0.49 . . . . 1.3400000000000001 111.865 -174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 65' ' ' ILE . 4.3 ptp180 -64.35 -33.91 76.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 118.689 -1.204 . . . . 2.8599999999999999 111.605 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 1.04 ' HE2' HG13 ' A' ' 51' ' ' VAL . 10.0 ptp -83.25 -16.51 46.09 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 119.697 -0.801 . . . . 1.95 109.289 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.663 ' HZ3' ' HG ' ' A' ' 66' ' ' LEU . 13.1 mptt -72.32 -38.81 68.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.798 -0.816 . . . . 1.9299999999999999 108.798 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 67' ' ' LYS . 74.9 t -63.59 -38.52 82.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 1.8300000000000001 110.616 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.709 HG12 ' HA ' ' A' ' 69' ' ' MET . 11.4 pt -83.73 -30.01 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.535 -0.466 . . . . 1.02 110.608 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 88.03 1.0 Allowed 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 112.277 0.473 . . . . 1.0800000000000001 112.277 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 37.0 mt-10 -66.39 -2.26 4.34 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.421 -0.799 . . . . 1.78 111.288 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.49 -25.8 60.62 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.696 -1.224 . . . . 0.34999999999999998 107.696 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 48' ' ' PRO . 2.7 tt -71.34 154.46 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.14 -1.845 . . . . 1.05 110.513 -174.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.767 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 5.5 ptp180 -138.72 175.66 9.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.263 -1.014 . . . . 1.45 108.263 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.696 ' CG2' HD13 ' A' ' 66' ' ' LEU . 4.1 m -141.58 145.64 24.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 119.86 -0.736 . . . . 1.55 111.02 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.823 HG21 ' HG1' ' A' ' 100' ' ' THR . 64.0 mt -110.74 75.75 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.668 -1.234 . . . . 1.3500000000000001 107.668 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.843 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -66.89 139.68 20.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.722 -0.791 . . . . 1.02 112.367 -171.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.532 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 3.0 mtp -101.28 120.18 39.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.155 -0.93 . . . . 2.5499999999999998 110.586 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 4.2 t -133.22 164.57 26.77 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.454 0.538 . . . . 1.78 112.454 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.2 56.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.202 -0.908 . . . . 1.1000000000000001 111.435 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.499 ' HA ' ' HB1' ' A' ' 103' ' ' ALA . 74.6 t80 69.24 6.88 5.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.788 0.835 . . . . 4.4400000000000004 111.016 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.77 93.49 1.85 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.705 -0.759 . . . . 0.65000000000000002 111.9 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.628 ' N ' HG13 ' A' ' 90' ' ' ILE . 33.6 mt-10 -71.69 9.6 0.84 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.239 0.542 . . . . 1.3300000000000001 110.93 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 85' ' ' GLY . 40.9 mt 58.91 -169.5 0.13 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 2.2799999999999998 113.006 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 54.87 -93.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.011 -0.995 . . . . 1.3799999999999999 111.349 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.746 ' HE2' HD11 ' A' ' 63' ' ' ILE . 91.3 mtp -65.15 -23.96 67.27 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.666 0.27 . . . . 3.3700000000000001 110.344 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.628 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.5 mm -66.61 -41.08 87.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 1.3700000000000001 110.386 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.534 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 14.2 mt-30 -67.26 -35.53 79.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.014 0.911 . . . . 3.1800000000000002 108.83 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.616 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 33.2 tt0 -72.85 -31.98 65.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.0 -1.455 . . . . 1.27 111.448 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.413 ' CB ' HG12 ' A' ' 63' ' ' ILE . 14.6 t -59.04 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 1.5600000000000001 109.713 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.829 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 46.8 pttt -54.91 -38.84 68.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 2.3100000000000001 111.698 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.9 pt-20 -64.63 -25.93 68.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.859 0.3 . . . . 1.8400000000000001 111.203 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.459 HD11 ' CG2' ' A' ' 63' ' ' ILE . 17.9 mt -86.18 -19.24 30.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.968 0.413 . . . . 1.8999999999999999 111.528 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.93 19.7 0.23 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.087 -1.054 . . . . 0.34999999999999998 113.041 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.829 ' HB1' ' HA ' ' A' ' 94' ' ' LYS . . . -91.47 140.85 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.994 -0.743 . . . . 1.02 108.994 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.508 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.7 mt -82.92 -49.18 9.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.846 0.831 . . . . 1.05 109.842 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.823 ' HG1' HG21 ' A' ' 79' ' ' ILE . 51.3 p -143.39 150.61 39.33 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.022 -1.445 . . . . 1.05 111.685 -171.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -112.19 97.32 6.56 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.978 -1.01 . . . . 1.1799999999999999 109.322 173.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -90.49 150.32 21.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.257 -0.428 . . . . 4.75 110.767 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 84' ' ' TYR . . . -121.89 -171.53 2.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.089 -0.505 . . . . 1.24 111.321 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -56.81 -47.21 99.43 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 3.7200000000000002 111.804 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -73.29 96.65 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 120.644 0.896 . . . . 1.6699999999999999 111.03 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -137.22 138.36 40.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 1.29 110.281 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 22.7 t70 -76.6 -1.69 28.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.649 . . . . 1.77 110.984 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.43 -49.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.933 1.293 . . . . 1.9199999999999999 112.526 -170.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -70.19 -26.51 63.93 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.634 -0.506 . . . . 1.1599999999999999 109.634 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 12.5 pt-20 -67.87 -24.85 65.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.74 -0.467 . . . . 0.83999999999999997 109.74 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 26.3 mt -81.04 -40.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.962 -0.563 . . . . 1.5600000000000001 110.537 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.613 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.727 -0.789 . . . . 0.80000000000000004 109.182 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.504 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 26.7 t70 -68.38 -32.36 72.38 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.581 -0.896 . . . . 0.78000000000000003 108.581 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.77 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -64.08 -44.15 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.28 -0.873 . . . . 1.3100000000000001 111.007 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 112' ' ' ARG . 21.9 m -64.76 -39.54 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 119.003 -1.079 . . . . 1.1200000000000001 110.805 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -78.37 -21.45 49.39 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.332 0.493 . . . . 1.99 112.332 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.77 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -79.44 -24.32 42.52 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.461 -0.775 . . . . 2.0899999999999999 110.983 175.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 48.5 m-85 -92.15 -70.58 0.69 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.831 -0.348 . . . . 2.3900000000000001 111.84 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 1.035 ' HB3' HD13 ' A' ' 50' ' ' LEU . 2.4 tm? -127.03 89.72 51.28 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.504 -0.924 . . . . 2.7599999999999998 108.504 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.657 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 65.0 Cg_endo -88.09 155.0 7.02 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.899 2.399 . . . . 0.92000000000000004 113.971 -172.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.653 ' HG ' ' HG2' ' A' ' 122' ' ' LYS . 11.3 tp -88.7 -67.66 0.82 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.804 -1.554 . . . . 1.9399999999999999 106.804 167.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.653 ' HG2' ' HG ' ' A' ' 121' ' ' LEU . 69.1 mmtt -148.99 -65.22 0.23 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.0 -1.454 . . . . 3.3599999999999999 108.144 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t 66.52 -62.15 0.29 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.883 -1.053 . . . . 2.1699999999999999 110.689 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 52.32 83.76 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.421 0.689 . . . . 6.0 112.247 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.1 mt -104.13 -55.07 2.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.128 -0.487 . . . . 6.2699999999999996 109.895 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.3 153.75 49.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.845 -0.616 . . . . 8.6500000000000004 110.517 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -89.18 157.3 18.32 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.536 -0.913 . . . . 10.210000000000001 108.536 173.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -130.29 67.44 1.48 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.682 -0.807 . . . . 13.26 112.861 -165.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -108.87 -57.95 2.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.819 -1.178 . . . . 12.92 107.819 164.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 58.68 -160.98 0.26 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.07 -0.968 . . . . 17.120000000000001 111.402 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -117.9 115.57 25.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.166 -0.47 . . . . 17.550000000000001 110.199 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.5 p80 . . . . . 0 C--O 1.246 0.908 0 N-CA-C 109.302 -0.629 . . . . 19.600000000000001 109.302 176.507 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.17 -0.307 . . . . 6.79 110.17 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.3 mpp? 62.41 -173.24 0.15 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.948 -0.569 . . . . 4.4100000000000001 110.734 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.657 ' HB3' HE22 ' A' ' 29' ' ' GLN . 1.9 t-20 -116.75 11.82 14.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.048 -0.524 . . . . 2.3500000000000001 109.639 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.985 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 11.2 tt0 71.68 101.61 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 124.0 0.813 . . . . 2.2999999999999998 111.03 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.762 ' HD3' ' HB3' ' A' ' 29' ' ' GLN . 3.8 tppt? -137.39 142.51 41.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.298 0.639 . . . . 1.3999999999999999 110.871 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.913 ' HB ' HG23 ' A' ' 30' ' ' THR . 2.1 mt -138.28 157.61 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.788 -0.642 . . . . 1.04 111.46 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.826 HD13 ' HB ' ' A' ' 42' ' ' ILE . 2.8 tt -133.66 117.76 17.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.138 -1.06 . . . . 0.98999999999999999 108.138 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.827 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.3 mp -107.25 113.28 43.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 120.245 -0.582 . . . . 1.1200000000000001 110.255 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.71 HG23 HD23 ' A' ' 53' ' ' LEU . 49.5 t -103.58 82.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.629 0.252 . . . . 1.0900000000000001 111.335 -176.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.75 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 3.8 m-20 -121.05 130.97 54.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 1.8200000000000001 109.903 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.86 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 27.6 t70 -81.57 -31.98 32.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.545 -1.28 . . . . 0.51000000000000001 107.545 166.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.474 ' CG ' HD12 ' A' ' 15' ' ' ILE . 16.1 pt20 -74.32 74.69 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.455 -1.248 . . . . 2.5600000000000001 108.198 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.481 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 15.1 p90 -61.47 -15.45 37.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.838 -1.528 . . . . 1.8300000000000001 113.431 -167.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.65 -65.35 3.49 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.876 -1.289 . . . . 0.41999999999999998 109.876 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 15' ' ' ILE . 4.9 mp -47.25 -30.07 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 123.276 0.63 . . . . 1.5600000000000001 112.31 172.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.75 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 8.8 ttm180 -76.37 -50.19 14.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.291 -0.413 . . . . 0.47999999999999998 111.142 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 46.9 pt -75.34 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.375 -0.602 . . . . 1.1899999999999999 109.375 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 22' ' ' VAL . 5.5 tp -59.94 -65.52 0.67 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.96 -1.018 . . . . 1.22 109.627 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 52' ' ' LEU . 71.8 mt -54.29 -40.38 67.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.472 -0.331 . . . . 1.8400000000000001 110.69 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t30 -51.09 -67.52 0.24 Allowed 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.755 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.25 -40.09 76.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.81 0.694 . . . . 2.46 111.997 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 18' ' ' LEU . 36.3 t -54.3 -54.52 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 111.492 0.182 . . . . 1.2 111.492 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.7 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -81.01 -35.91 31.31 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.49 -0.484 . . . . 0.51000000000000001 110.223 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.612 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 10.0 t-20 -50.38 -47.28 56.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.857 0.837 . . . . 0.32000000000000001 108.758 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 25' ' ' LYS . 1.7 tmmt? -61.3 -36.22 79.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.462 -1.699 . . . . 3.6699999999999999 112.774 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 8.3 mm-40 -55.11 -31.81 61.54 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.204 1.002 . . . . 1.51 109.455 175.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 138.71 -10.65 3.42 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 113.161 -1.836 . . . . 0.56999999999999995 109.132 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.985 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 2.1 m-85 -68.45 156.74 37.32 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 122.605 1.193 . . . . 1.49 111.089 -169.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.762 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 4.4 mt-30 -109.69 69.8 0.71 Allowed 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 113.293 -1.776 . . . . 1.1399999999999999 108.042 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.913 HG23 ' HB ' ' A' ' 6' ' ' ILE . 16.0 p -90.01 132.01 35.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.687 -1.142 . . . . 0.95999999999999996 110.486 -168.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 14.4 m-85 -125.37 124.5 41.66 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.563 1.173 . . . . 0.42999999999999999 109.664 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.711 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.4 pt20 -80.8 122.05 26.7 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 112.764 -2.016 . . . . 0.23999999999999999 112.118 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -120.86 142.08 49.99 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.999 -1.001 . . . . 1.0 108.561 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -98.64 -12.53 20.99 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.928 -0.709 . . . . 0.78000000000000003 109.941 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 3.3 p-10 -148.09 165.25 31.38 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.729 -0.669 . . . . 0.28999999999999998 111.703 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.16 73.39 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.552 -0.749 . . . . 0.17999999999999999 113.45 -174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.414 ' HB2' HD21 ' A' ' 35' ' ' ASN . 3.2 mm? -81.94 -43.15 18.47 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.034 0.921 . . . . 1.1200000000000001 109.14 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.768 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.2 tt0 -63.34 -34.83 78.56 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.103 -1.814 . . . . 1.78 106.103 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -66.52 -46.67 75.43 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.485 -1.234 . . . . 0.98999999999999999 111.0 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.645 HD21 ' HG3' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -52.58 -46.92 67.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.641 0.734 . . . . 1.5700000000000001 109.292 173.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.09 -41.3 92.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.293 -1.322 . . . . 1.3200000000000001 111.203 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.826 ' HB ' HD13 ' A' ' 7' ' ' LEU . 17.2 mm -63.26 -48.32 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 110.121 -0.326 . . . . 1.04 110.121 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.488 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 38.7 t -60.19 -43.59 93.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-O 121.817 0.818 . . . . 1.0600000000000001 109.283 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.54 -29.28 69.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.261 -0.881 . . . . 0.95999999999999996 111.614 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.19 -45.08 8.03 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.949 0.352 . . . . 2.9900000000000002 111.949 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 57.2 mm-40 -107.78 -36.17 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 0.63 111.654 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 69.3 mtp180 62.74 62.01 2.0 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.368 -0.833 . . . . 4.2800000000000002 109.547 -170.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.657 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 77.1 Cg_exo -58.66 156.94 29.68 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.046 1.83 . . . . 0.20999999999999999 111.095 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.809 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -93.27 -34.7 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.901 -0.72 . . . . 0.97999999999999998 109.585 175.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.657 HD22 HD12 ' A' ' 79' ' ' ILE . 7.1 mp -115.47 114.02 24.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.007 -0.542 . . . . 1.1599999999999999 109.992 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.736 HG11 ' HE2' ' A' ' 69' ' ' MET . 92.7 t -112.63 121.61 65.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 110.527 -0.175 . . . . 1.05 110.527 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 19' ' ' LEU . 2.4 mp -92.0 97.6 11.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.579 -0.526 . . . . 1.0700000000000001 109.579 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.71 HD23 HG23 ' A' ' 9' ' ' VAL . 44.0 mt -93.52 106.24 18.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.762 -0.654 . . . . 2.2000000000000002 110.424 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.696 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 52.5 t0 -66.86 107.93 2.37 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.204 -0.598 . . . . 1.47 110.232 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.786 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 11.5 mtm -83.05 0.74 43.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.661 . . . . 1.6499999999999999 110.797 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.714 ' HZ2' ' HB2' ' A' ' 83' ' ' ALA . 25.5 mmmt -57.75 -58.5 8.08 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.408 0.522 . . . . 2.73 112.408 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.842 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 15.2 tt -175.57 -34.21 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.264 1.209 . . . . 2.6099999999999999 114.264 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.86 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -20.23 -63.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.261 3.307 . . . . 0.55000000000000004 116.482 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.93 -58.23 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.652 -1.261 . . . . 0.55000000000000004 113.204 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.487 ' HB3' HD12 ' A' ' 65' ' ' ILE . 47.2 ttm -148.96 165.85 30.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.415 -0.587 . . . . 2.6699999999999999 109.415 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' ILE . 38.3 m-20 -60.46 133.9 56.54 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.745 -0.465 . . . . 0.67000000000000004 109.745 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 66' ' ' LEU . . . -67.55 1.65 6.99 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 120.892 -0.67 . . . . 0.32000000000000001 112.364 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.573 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.3 mt -92.45 -45.7 14.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.842 0.353 . . . . 1.9199999999999999 110.116 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.74 -36.08 81.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.46999999999999997 109.701 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.652 HG21 ' HE3' ' A' ' 69' ' ' MET . 15.6 mt -73.5 -34.19 41.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.929 -0.578 . . . . 1.3600000000000001 109.483 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.655 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -54.77 -53.99 47.89 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.488 -0.778 . . . . 2.1600000000000001 109.978 174.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.6 ptpt -71.47 -33.42 69.29 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.118 0.414 . . . . 1.3400000000000001 112.118 -173.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.707 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.9 ptm180 -66.54 -34.6 78.27 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.465 -0.894 . . . . 2.8599999999999999 110.95 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.736 ' HE2' HG11 ' A' ' 51' ' ' VAL . 10.1 ptp -82.75 -16.74 46.81 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 119.834 -0.746 . . . . 1.95 109.722 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.3 mptt -78.88 -30.25 44.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.723 0.773 . . . . 1.9299999999999999 109.854 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 68' ' ' ARG . 2.7 p -78.59 -31.86 15.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.505 0.669 . . . . 1.8300000000000001 109.261 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.664 HG12 ' HA ' ' A' ' 69' ' ' MET . 21.8 pt -86.52 -21.89 7.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.102 -0.954 . . . . 1.02 110.724 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.489 ' O ' HG21 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -162.78 88.51 0.62 Allowed 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 112.559 0.577 . . . . 1.0800000000000001 112.559 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 11.6 mt-10 -76.67 5.93 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 120.68 -1.263 . . . . 1.78 109.688 173.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -73.7 -29.67 62.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.489 -1.232 . . . . 0.34999999999999998 107.894 171.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.649 HG22 ' HG3' ' A' ' 69' ' ' MET . 5.2 tt -76.66 159.4 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 112.767 -2.015 . . . . 1.05 111.296 -170.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.809 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 4.2 ptp180 -134.84 177.21 7.97 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.335 -0.848 . . . . 1.45 109.392 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.632 HG11 HD11 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -132.58 159.65 43.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.505 0.669 . . . . 1.55 110.507 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.725 HG22 ' HD2' ' A' ' 102' ' ' PHE . 54.9 mt -131.01 66.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.071 -1.455 . . . . 1.3500000000000001 107.071 170.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.786 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -63.5 140.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.745 0.783 . . . . 1.02 111.804 -170.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.763 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 mtp -95.84 124.1 39.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.764 -1.107 . . . . 2.5499999999999998 110.371 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 101' ' ' ALA . 12.1 p -130.84 159.13 38.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.1 -0.5 . . . . 1.78 112.173 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB2' ' HZ2' ' A' ' 56' ' ' LYS . . . -66.8 73.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.595 . . . . 1.1000000000000001 109.863 165.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 26.5 p90 50.88 21.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.225 1.41 . . . . 4.4400000000000004 113.714 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.65 92.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.828 -0.701 . . . . 0.65000000000000002 112.688 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.67 ' N ' HG13 ' A' ' 90' ' ' ILE . 19.3 mt-10 -89.01 14.67 10.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.067 0.461 . . . . 1.3300000000000001 110.855 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 65.65 -177.74 0.19 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.34 0.867 . . . . 2.2799999999999998 113.34 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.0 t70 60.83 -100.24 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.738 -1.119 . . . . 1.3799999999999999 112.042 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -58.97 -23.37 61.62 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.021 0.439 . . . . 3.3700000000000001 110.613 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.67 HG13 ' N ' ' A' ' 86' ' ' GLU . 34.9 mm -65.83 -40.2 86.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.272 0.558 . . . . 1.3700000000000001 110.088 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 22.8 mm-40 -72.76 -39.03 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.536 -0.756 . . . . 3.1800000000000002 109.591 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.601 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 23.5 tt0 -67.95 -40.92 83.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.785 -1.098 . . . . 1.27 111.729 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.428 ' OG ' HG21 ' A' ' 80' ' ' ILE . 6.6 t -54.46 -61.01 2.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.144 0.497 . . . . 1.5600000000000001 110.055 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.897 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -58.75 -39.45 80.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 2.3100000000000001 111.422 176.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.0 pt-20 -62.17 -27.23 68.82 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.637 0.236 . . . . 1.8400000000000001 111.637 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.462 ' HB3' HD21 ' A' ' 66' ' ' LEU . 11.8 mt -85.54 -8.23 58.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.256 0.465 . . . . 1.8999999999999999 112.256 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.97 19.22 0.72 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.034 -1.079 . . . . 0.34999999999999998 113.511 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.897 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -98.84 138.83 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.988 -0.745 . . . . 1.02 108.988 171.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.795 HD22 ' HD3' ' A' ' 77' ' ' ARG . 9.3 mt -77.41 -50.05 13.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.398 0.618 . . . . 1.05 110.397 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.581 ' OG1' HG21 ' A' ' 79' ' ' ILE . 62.6 p -139.65 148.72 42.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.224 -0.898 . . . . 1.05 111.664 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.588 ' HB3' HG23 ' A' ' 82' ' ' THR . . . -104.95 84.35 2.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.962 -1.017 . . . . 1.1799999999999999 108.973 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.763 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 1.1 p90 -86.73 144.4 27.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 4.75 110.568 -170.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . . . -95.98 166.31 11.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 1.24 110.743 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 18.0 pttp -70.36 -29.38 1.57 Allowed Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.724 0.639 . . . . 3.7200000000000002 112.724 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 103' ' ' ALA . 55.6 Cg_endo -76.14 95.45 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 120.501 1.215 . . . . 1.6699999999999999 110.166 163.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.499 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 30.1 p90 -132.3 152.77 51.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.451 0.643 . . . . 1.29 111.318 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 109' ' ' ASP . 19.0 t70 -75.56 -3.9 36.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.117 -0.947 . . . . 1.77 111.653 -173.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.499 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 13.7 mt 65.35 -62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 1.9199999999999999 110.114 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.475 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 29.8 t70 -63.06 -26.96 69.08 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.89 -0.596 . . . . 1.1599999999999999 110.817 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.8 -34.31 76.52 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.039 0.447 . . . . 0.83999999999999997 110.193 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 115' ' ' VAL . 28.3 mt -83.03 -40.22 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.987 -0.551 . . . . 1.5600000000000001 110.108 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.562 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -66.59 -35.97 81.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.638 -0.875 . . . . 0.80000000000000004 108.638 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.783 ' HA ' ' HE2' ' A' ' 116' ' ' LYS . 32.5 t70 -61.96 -53.03 61.31 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.999 -0.741 . . . . 0.78000000000000003 108.999 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.925 ' HA ' ' HE3' ' A' ' 117' ' ' LYS . . . -52.09 -46.38 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.459 -0.792 . . . . 1.3100000000000001 111.833 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 111' ' ' ILE . 32.3 m -68.24 -47.68 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.673 0.62 . . . . 1.1200000000000001 112.673 -173.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 1.2 pptt? -85.24 -8.68 58.43 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.099 0.409 . . . . 1.99 111.665 -177.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 114' ' ' ALA . 21.6 pttp -86.5 -21.52 26.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.715 -0.794 . . . . 2.0899999999999999 109.749 167.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.838 ' HD1' ' HG ' ' A' ' 119' ' ' LEU . 14.8 t80 -80.56 -66.67 0.85 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.282 -0.417 . . . . 2.3900000000000001 110.421 176.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.838 ' HG ' ' HD1' ' A' ' 118' ' ' TYR . 91.9 mt -122.36 86.23 48.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.414 -0.587 . . . . 2.7599999999999998 109.414 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.665 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 93.1 Cg_endo -80.68 133.66 9.41 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.564 2.176 . . . . 0.92000000000000004 113.434 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 1.071 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 13.3 tp -113.07 -66.57 1.07 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.6 0.714 . . . . 1.9399999999999999 110.211 176.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 1.071 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 63.6 mttm -127.65 -49.75 1.38 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.985 -1.007 . . . . 3.3599999999999999 109.985 -175.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 79.7 p 54.34 39.1 30.63 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.157 -0.929 . . . . 2.1699999999999999 109.908 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -71.78 94.69 1.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.992 -1.003 . . . . 6.0 111.13 -176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.41 HD23 HH22 ' A' ' 112' ' ' ARG . 32.9 tp -91.46 -19.08 23.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.524 -0.762 . . . . 6.2699999999999996 110.029 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.76 67.23 2.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.878 -0.601 . . . . 8.6500000000000004 110.621 -172.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 55.81 -93.88 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.418 -0.81 . . . . 10.210000000000001 112.269 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -170.7 118.73 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.43 -0.582 . . . . 13.26 109.43 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -88.15 160.84 17.58 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.865 0.364 . . . . 12.92 110.959 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -124.04 128.58 49.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.764 -0.653 . . . . 17.120000000000001 109.49 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -71.61 131.05 42.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.761 0.315 . . . . 17.550000000000001 110.988 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.1 m80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.123 -0.941 . . . . 19.600000000000001 109.776 176.868 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' H1 ' ' HB3' ' A' ' 119' ' ' LEU . 78.4 mtp . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.276 -0.268 . . . . 6.79 110.276 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 1' ' ' MET . 86.4 mtp 70.45 -85.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.432 -0.581 . . . . 4.4100000000000001 109.432 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.566 ' HB3' HE22 ' A' ' 29' ' ' GLN . 18.8 t-20 -121.86 4.16 9.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.639 -1.245 . . . . 2.3500000000000001 107.639 171.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.697 ' HB3' HD11 ' A' ' 121' ' ' LEU . 7.2 tp10 66.4 110.84 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.018 -1.446 . . . . 2.2999999999999998 111.456 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.849 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -136.09 146.52 47.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.294 0.569 . . . . 1.3999999999999999 111.368 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.899 ' HB ' HG21 ' A' ' 30' ' ' THR . 2.9 mt -137.81 154.75 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.389 -0.823 . . . . 1.04 111.575 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.851 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -135.56 111.64 9.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.459 -1.246 . . . . 0.98999999999999999 107.724 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.614 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.2 mp -99.42 104.62 16.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.175 -1.01 . . . . 1.1200000000000001 110.219 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 47.9 t -85.67 93.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.777 -0.823 . . . . 1.0900000000000001 108.777 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.593 ' OD2' ' HG3' ' A' ' 12' ' ' GLN . 25.8 t70 -152.6 104.81 2.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.643 -0.423 . . . . 1.8200000000000001 111.138 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.693 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 19.7 t70 -54.14 -41.24 68.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.55 0.34 . . . . 0.51000000000000001 111.46 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.593 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 3.6 pt20 -70.94 76.29 0.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 122.23 1.014 . . . . 2.5600000000000001 109.217 173.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.438 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 31.0 p90 -53.67 -13.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.602 -1.635 . . . . 1.8300000000000001 114.648 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.73 -67.49 1.27 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.366 -0.921 . . . . 0.41999999999999998 111.547 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -70.48 -11.78 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 O-C-N 121.958 -0.731 . . . . 1.5600000000000001 111.241 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.884 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.4 ttm180 -79.89 -42.12 24.81 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.612 -0.435 . . . . 0.47999999999999998 110.229 -173.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 ' NE2' ' A' ' 32' ' ' GLN . 2.7 pp -83.64 -27.14 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 1.1899999999999999 109.967 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.483 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 3.5 tp -61.78 -61.59 2.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.637 -0.711 . . . . 1.22 109.485 170.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 1.1 tp -52.51 -41.96 63.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.653 -0.703 . . . . 1.8400000000000001 110.187 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.721 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.4 t30 -51.18 -70.9 0.07 Allowed 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.78 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.28 -39.12 69.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.355 0.41 . . . . 2.46 111.64 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' LEU . 35.6 t -55.76 -60.83 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.626 -0.261 . . . . 1.2 111.295 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.776 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 8.3 m-85 -72.37 -34.6 68.08 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.457 -0.571 . . . . 0.51000000000000001 109.457 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.91 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 3.5 t-20 -52.06 -48.56 64.56 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.269 -0.878 . . . . 0.32000000000000001 109.388 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.41 -31.72 73.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.626 -1.624 . . . . 3.6699999999999999 112.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.674 ' HB2' ' CD1' ' A' ' 28' ' ' TYR . 6.1 mm-40 -63.67 -25.27 68.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.639 0.733 . . . . 1.51 110.313 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . 143.21 -16.47 2.32 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.491 -1.231 . . . . 0.56999999999999995 110.648 -171.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.91 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 8.2 m-85 -81.64 124.06 29.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.308 0.575 . . . . 1.49 111.387 -162.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.849 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 20.7 mt-30 -79.39 82.61 5.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.46 -0.941 . . . . 1.1399999999999999 108.46 172.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.899 HG21 ' HB ' ' A' ' 6' ' ' ILE . 20.8 p -90.19 135.85 33.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.645 -0.707 . . . . 0.95999999999999996 109.921 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.518 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 15.4 m-85 -125.95 126.35 44.22 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.408 1.099 . . . . 0.42999999999999999 109.265 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.884 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.5 pt20 -86.43 120.74 28.08 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.004 -1.907 . . . . 0.23999999999999999 111.355 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.44 124.6 43.25 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.495 -0.558 . . . . 1.0 109.495 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.71 -19.03 60.41 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.738 -0.385 . . . . 0.78000000000000003 111.028 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.476 HD21 ' HB2' ' A' ' 37' ' ' LEU . 1.7 p-10 -148.23 168.57 22.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 0.28999999999999998 111.567 -174.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -75.03 -14.32 81.91 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 113.33 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' HB2' HD21 ' A' ' 35' ' ' ASN . 3.2 mm? -79.9 -44.71 19.91 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 122.617 1.198 . . . . 1.1200000000000001 108.279 175.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.802 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.3 tp-100 -60.94 -40.69 94.23 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 112.26 -2.245 . . . . 1.78 105.597 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB1' HG22 ' A' ' 9' ' ' VAL . . . -63.3 -44.36 95.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.722 -1.581 . . . . 0.98999999999999999 111.258 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.7 -43.64 76.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.037 -0.727 . . . . 1.5700000000000001 109.037 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 44' ' ' THR . 18.9 t70 -64.22 -41.95 96.79 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.492 -1.231 . . . . 1.3200000000000001 110.616 177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.851 ' HB ' HD11 ' A' ' 7' ' ' LEU . 10.3 mm -60.69 -48.78 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 120.922 -0.311 . . . . 1.04 111.033 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 39' ' ' ALA . 46.8 t -57.97 -41.75 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.741 0.781 . . . . 1.0600000000000001 109.947 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.38 -23.95 62.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.226 -0.897 . . . . 0.95999999999999996 111.134 -178.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.697 ' HE3' ' HA ' ' A' ' 42' ' ' ILE . 9.7 ptpt -91.23 -42.34 10.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.695 0.283 . . . . 2.9900000000000002 111.268 -177.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.625 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 62.5 mm-40 -111.61 -38.16 4.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 112.066 0.395 . . . . 0.63 112.066 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.2 mpt_? 64.78 64.28 1.11 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 123.857 0.723 . . . . 4.2800000000000002 109.769 -169.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.733 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 51.7 Cg_exo -62.77 157.71 46.28 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 121.57 1.513 . . . . 0.20999999999999999 111.473 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.901 ' HB2' HD11 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -85.03 -51.09 6.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.293 -1.373 . . . . 0.97999999999999998 107.293 171.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.901 HD11 ' HB2' ' A' ' 49' ' ' ASP . 7.1 mp -105.11 111.59 24.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.716 -1.129 . . . . 1.1599999999999999 110.75 -171.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.011 HG12 ' HE2' ' A' ' 69' ' ' MET . 60.0 t -112.18 108.51 25.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.213 -0.449 . . . . 1.05 111.419 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.624 HD23 HD21 ' A' ' 19' ' ' LEU . 2.1 mp -75.68 89.12 2.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.795 0.807 . . . . 1.0700000000000001 109.473 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -82.49 110.68 17.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.059 -1.428 . . . . 2.2000000000000002 111.294 -172.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.12 127.19 18.5 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.697 0.76 . . . . 1.47 110.714 174.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.906 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 18.8 mtp -114.94 9.52 16.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.172 -0.922 . . . . 1.6499999999999999 109.457 163.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -71.74 -67.55 0.52 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.63 . . . . 2.73 111.9 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.771 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -175.05 -36.03 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.036 0 CA-C-O 118.024 -0.989 . . . . 2.6099999999999999 112.708 -172.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.771 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 4.7 Cg_exo -19.48 -62.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.726 3.617 . . . . 0.55000000000000004 116.419 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.06 -73.23 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 119.764 -1.208 . . . . 0.55000000000000004 113.394 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.3 tpt -148.9 168.55 22.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.574 -0.899 . . . . 2.6699999999999999 108.574 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.17 129.18 40.79 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.172 0.51 . . . . 0.67000000000000004 109.654 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.58 ' CA ' ' HG ' ' A' ' 53' ' ' LEU . . . -62.92 -7.19 15.07 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.08 -0.964 . . . . 0.32000000000000001 112.718 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.688 HG13 ' HB3' ' A' ' 89' ' ' MET . 4.1 mm -78.22 -48.66 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.681 -0.488 . . . . 1.9199999999999999 109.681 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.9 -33.46 75.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.876 -0.787 . . . . 0.46999999999999997 108.876 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.717 ' O ' ' HG2' ' A' ' 69' ' ' MET . 59.9 mt -77.31 -38.79 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.292 -0.867 . . . . 1.3600000000000001 111.371 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.623 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 3.7 pp -65.66 -36.85 84.86 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 120.291 -0.564 . . . . 2.1600000000000001 110.285 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.664 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.8 ptpt -73.49 -35.41 65.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.332 -0.547 . . . . 1.3400000000000001 111.182 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.705 ' O ' HG13 ' A' ' 71' ' ' VAL . 11.6 ptm180 -65.28 -33.46 76.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 118.868 -1.133 . . . . 2.8599999999999999 111.668 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 1.011 ' HE2' HG12 ' A' ' 51' ' ' VAL . 12.2 ptp -84.86 -11.99 54.47 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.046 -1.033 . . . . 1.95 109.405 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.664 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 12.5 mptt -76.84 -36.98 56.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.016 -0.735 . . . . 1.9299999999999999 109.016 172.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 68' ' ' ARG . 4.0 p -72.07 -33.81 48.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.354 0.597 . . . . 1.8300000000000001 109.648 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.782 HG12 ' HA ' ' A' ' 69' ' ' MET . 26.1 pt -84.27 -24.46 7.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.291 -0.868 . . . . 1.02 110.973 172.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -161.74 88.18 0.69 Allowed 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.043 0.386 . . . . 1.0800000000000001 112.043 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.569 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 8.5 mt-10 -75.77 6.25 5.22 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.272 -0.892 . . . . 1.78 110.636 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -28.69 42.39 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.856 -1.535 . . . . 0.34999999999999998 106.856 170.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.3 tt -67.61 153.8 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 113.556 -1.657 . . . . 1.05 110.686 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 6.3 ptp180 -135.45 177.9 7.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.792 -1.188 . . . . 1.45 107.792 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.672 HG23 ' CB ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -144.17 144.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.52 0.676 . . . . 1.55 111.216 -174.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.89 HG21 ' HG1' ' A' ' 100' ' ' THR . 64.9 mt -114.79 74.75 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.304 -1.369 . . . . 1.3500000000000001 107.304 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.906 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -62.55 140.11 19.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 119.544 -0.862 . . . . 1.02 112.735 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 7.4 mtp -100.81 102.68 13.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.734 -1.121 . . . . 2.5499999999999998 110.159 -174.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 t -117.05 165.13 13.73 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.343 0.592 . . . . 1.78 112.284 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 56.09 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.954 -1.021 . . . . 1.1000000000000001 110.26 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 t80 72.3 5.59 5.32 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.983 -1.008 . . . . 4.4400000000000004 111.686 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.32 88.28 1.99 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.115 -0.564 . . . . 0.65000000000000002 112.619 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.423 ' N ' HG13 ' A' ' 90' ' ' ILE . 24.2 mt-10 -81.38 9.36 7.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.924 0.393 . . . . 1.3300000000000001 111.18 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.506 HD23 HE21 ' A' ' 91' ' ' GLN . 38.1 mt 65.8 -166.22 0.22 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.606 -0.725 . . . . 2.2799999999999998 112.621 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 87' ' ' LEU . 1.0 OUTLIER 59.53 -99.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.297 -0.865 . . . . 1.3799999999999999 111.531 -177.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.688 ' HB3' HG13 ' A' ' 63' ' ' ILE . 2.0 mpt? -64.25 -18.0 64.14 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.421 -0.354 . . . . 3.3700000000000001 110.291 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 87' ' ' LEU . 32.7 mm -69.49 -40.2 79.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.999 0.428 . . . . 1.3700000000000001 110.265 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.506 HE21 HD23 ' A' ' 87' ' ' LEU . 73.1 mt-30 -67.02 -53.36 31.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.842 -0.799 . . . . 3.1800000000000002 108.842 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 42.8 tt0 -56.72 -30.6 63.69 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 114.46 -1.245 . . . . 1.27 111.404 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.474 ' HA ' HD13 ' A' ' 63' ' ' ILE . 27.6 t -54.59 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.754 0.788 . . . . 1.5600000000000001 111.177 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 33.4 pttt -54.03 -38.02 64.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.629 -1.169 . . . . 2.3100000000000001 110.714 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 8.2 tp10 -55.37 -43.42 75.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.739 -1.118 . . . . 1.8400000000000001 111.874 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.75 -22.96 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.843 0.354 . . . . 1.8999999999999999 111.165 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.88 21.97 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.004 -1.093 . . . . 0.34999999999999998 113.935 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.672 ' CB ' HG23 ' A' ' 78' ' ' VAL . . . -88.54 140.54 29.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.9 0.85 . . . . 1.02 109.277 169.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.464 HD23 ' HD3' ' A' ' 77' ' ' ARG . 18.3 mt -82.19 -48.95 10.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.718 0.771 . . . . 1.05 109.865 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.89 ' HG1' HG21 ' A' ' 79' ' ' ILE . 52.6 p -144.57 150.2 37.08 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.486 -1.234 . . . . 1.05 111.64 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 82' ' ' THR . . . -108.55 86.89 2.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.363 -0.835 . . . . 1.1799999999999999 109.967 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 81' ' ' MET . 16.6 m-85 -84.33 143.02 29.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.985 0.421 . . . . 4.75 110.716 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . . . -95.48 178.14 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 1.24 109.431 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' HD1' ' A' ' 106' ' ' PHE . 20.5 mmtp -78.33 -29.75 0.66 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.639 0.607 . . . . 3.7200000000000002 112.639 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 103' ' ' ALA . 24.2 Cg_exo -65.62 96.99 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 120.368 1.167 . . . . 1.6699999999999999 109.922 162.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 1.6 p90 -130.19 146.16 51.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.875 -0.602 . . . . 1.29 111.516 -172.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -86.15 18.4 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.598 . . . . 1.77 111.726 178.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.533 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.4 tt 48.3 -67.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 125.035 1.334 . . . . 1.9199999999999999 113.003 -174.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.533 ' H ' HG23 ' A' ' 108' ' ' ILE . 18.5 t70 -58.22 -30.55 66.58 Favored 'General case' 0 C--O 1.212 -0.897 0 C-N-CA 122.55 0.34 . . . . 1.1599999999999999 111.364 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.11 -28.15 67.92 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 119.997 -0.681 . . . . 0.83999999999999997 110.143 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.48 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 17.0 mt -80.76 -41.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 1.5600000000000001 110.508 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.522 ' HD2' ' C ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -68.68 -32.99 73.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.744 0.783 . . . . 0.80000000000000004 109.215 175.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 19.1 t70 -70.91 -36.49 72.73 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.323 -0.853 . . . . 0.78000000000000003 108.828 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.717 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.6 -45.29 79.66 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.079 -0.964 . . . . 1.3100000000000001 111.459 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.418 HG22 ' HA ' ' A' ' 112' ' ' ARG . 34.5 m -61.77 -42.59 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.598 -0.841 . . . . 1.1200000000000001 110.184 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.547 ' HA ' ' OH ' ' A' ' 28' ' ' TYR . 7.1 ttpt -63.67 -49.65 72.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.795 -0.639 . . . . 1.99 111.418 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.717 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.5 OUTLIER -59.78 -30.67 69.04 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.664 -0.243 . . . . 2.0899999999999999 111.399 -176.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.535 ' HB3' HD13 ' A' ' 119' ' ' LEU . 44.5 m-85 -81.91 -68.91 0.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.417 -0.513 . . . . 2.3900000000000001 110.696 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.535 HD13 ' HB3' ' A' ' 118' ' ' TYR . 6.7 mp -121.48 103.63 41.06 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.175 -0.676 . . . . 2.7599999999999998 109.175 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -97.78 153.11 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.752 2.301 . . . . 0.92000000000000004 114.493 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -127.35 -64.97 0.96 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 1.9399999999999999 108.396 172.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.617 ' HG3' HD23 ' A' ' 121' ' ' LEU . 82.8 mttt -135.18 -50.3 0.75 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.169 -0.923 . . . . 3.3599999999999999 110.234 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 56.0 p 54.99 87.97 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.408 1.068 . . . . 2.1699999999999999 109.594 -171.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -115.48 147.41 40.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.024 -0.989 . . . . 6.0 111.701 -164.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.89 45.88 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.475 -0.33 . . . . 6.2699999999999996 110.581 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -59.41 -36.43 75.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.173 -0.467 . . . . 8.6500000000000004 111.73 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -72.77 160.26 32.47 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.358 0.599 . . . . 10.210000000000001 111.108 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -101.08 113.33 26.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.347 -0.842 . . . . 13.26 110.162 -171.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -65.78 -50.88 63.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.962 0.41 . . . . 12.92 110.547 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -97.55 129.67 44.67 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.041 -0.527 . . . . 17.120000000000001 110.058 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -102.04 143.62 31.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.142 -0.481 . . . . 17.550000000000001 109.791 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.4 p80 . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.227 -0.892 . . . . 19.600000000000001 110.332 179.416 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 109.897 -0.409 . . . . 6.79 109.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.4 ' HE1' ' OD1' ' A' ' 49' ' ' ASP . 56.0 mtp 61.07 -166.54 0.2 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.802 -0.635 . . . . 4.4100000000000001 111.889 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.557 ' HB3' HE22 ' A' ' 29' ' ' GLN . 15.7 m120 -106.71 -18.86 13.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.216 -0.902 . . . . 2.3500000000000001 110.391 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.812 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 8.3 tt0 68.02 105.69 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.583 0.706 . . . . 2.2999999999999998 110.916 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.68 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 3.6 tppt? -140.57 147.33 39.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.009 -0.541 . . . . 1.3999999999999999 111.202 -172.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.879 ' HB ' HG21 ' A' ' 30' ' ' THR . 2.6 mt -141.23 153.99 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.439 -0.8 . . . . 1.04 111.696 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.814 HD12 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -131.82 123.47 27.64 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.61 -1.256 . . . . 0.98999999999999999 107.61 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.719 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.4 mp -109.66 103.21 15.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.556 -0.858 . . . . 1.1200000000000001 110.164 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.2 t -88.49 82.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 1.0900000000000001 110.003 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.868 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.0 t70 -133.1 144.28 49.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.548 -0.296 . . . . 1.8200000000000001 110.686 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.902 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 13.0 t70 -101.54 -35.94 8.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.896 -0.409 . . . . 0.51000000000000001 109.896 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.641 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 4.4 pt20 -81.06 70.61 7.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.098 -1.445 . . . . 2.5600000000000001 107.098 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -48.74 -13.92 0.06 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 112.334 -2.212 . . . . 1.8300000000000001 115.181 -161.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' GLN . . . -46.68 -59.48 5.4 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.198 -1.001 . . . . 0.41999999999999998 110.777 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 1.1 mm -54.51 -32.5 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.525 0.679 . . . . 1.5600000000000001 110.245 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.868 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.6 ttm180 -77.12 -48.78 16.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.118 -0.946 . . . . 0.47999999999999998 110.891 -165.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 42.4 pt -76.04 -25.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.312 -0.625 . . . . 1.1899999999999999 109.312 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' O ' HG21 ' A' ' 22' ' ' VAL . 7.4 tp -58.69 -68.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 1.22 109.416 171.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.814 HD13 HD21 ' A' ' 52' ' ' LEU . 39.0 mt -54.65 -40.91 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 1.8400000000000001 110.563 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 7.6 t30 -50.48 -68.81 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.97 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.65 -40.04 82.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.265 0.353 . . . . 2.46 111.639 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -55.15 -55.43 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.052 0.22 . . . . 1.2 111.576 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' HB2' HG22 ' A' ' 30' ' ' THR . 11.8 m-85 -78.87 -36.66 41.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.61 -0.436 . . . . 0.51000000000000001 110.038 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.84 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 9.3 t-20 -50.15 -50.54 48.55 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.176 0.988 . . . . 0.32000000000000001 108.934 -176.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.557 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -54.77 -42.49 71.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 112.637 -2.074 . . . . 3.6699999999999999 111.676 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 4.5 mm-40 -52.22 -34.6 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 122.191 0.996 . . . . 1.51 109.733 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.549 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 138.08 -6.66 3.43 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 113.303 -1.771 . . . . 0.56999999999999995 109.39 -171.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.84 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 5.5 m-85 -70.4 126.86 30.83 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.807 -0.757 . . . . 1.49 110.549 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.619 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 28.6 mt-30 -82.7 81.13 8.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.475 -0.935 . . . . 1.1399999999999999 108.475 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.879 HG21 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -90.07 133.09 35.05 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.064 -0.971 . . . . 0.95999999999999996 110.128 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.94 124.83 42.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.592 1.187 . . . . 0.42999999999999999 109.732 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.682 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 1.5 pt20 -82.17 120.71 25.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 112.748 -2.024 . . . . 0.23999999999999999 111.602 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 42' ' ' ILE . . . -123.93 124.02 41.69 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -84.83 -8.19 58.89 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.223 -0.591 . . . . 0.78000000000000003 111.293 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.442 HD21 ' HB2' ' A' ' 37' ' ' LEU . 1.7 p-10 -149.42 165.55 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.41 -0.359 . . . . 0.28999999999999998 111.56 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.91 -19.92 77.32 Favored Glycine 0 CA--C 1.506 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.17999999999999999 113.291 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.442 ' HB2' HD21 ' A' ' 35' ' ' ASN . 2.7 mm? -78.31 -42.97 29.16 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.458 1.123 . . . . 1.1200000000000001 108.075 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.843 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -60.96 -41.66 96.75 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 112.6 -2.091 . . . . 1.78 105.805 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -60.9 -43.87 97.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.003 -1.453 . . . . 0.98999999999999999 111.038 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.2 OUTLIER -57.44 -43.37 83.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.224 -0.658 . . . . 1.5700000000000001 109.224 177.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 44' ' ' THR . 2.1 t70 -64.57 -44.58 90.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 114.951 -1.022 . . . . 1.3200000000000001 110.213 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.843 HG12 ' O ' ' A' ' 38' ' ' GLN . 15.9 mm -60.19 -46.42 94.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.266 -0.879 . . . . 1.04 110.165 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 69' ' ' MET . 47.6 t -62.12 -41.25 90.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 121.727 0.775 . . . . 1.0600000000000001 109.604 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -73.23 -20.71 60.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.606 -0.725 . . . . 0.95999999999999996 111.155 -177.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.616 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -90.49 -45.99 8.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.604 -0.271 . . . . 2.9900000000000002 111.246 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 8.3 mm-40 -110.63 -36.89 5.61 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.392 0.515 . . . . 0.63 112.392 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 14.1 mtm-85 65.36 65.43 0.92 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 O-C-N 123.639 0.587 . . . . 4.2800000000000002 109.536 -170.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.759 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 71.3 Cg_exo -60.57 156.67 40.74 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 C-N-CA 121.689 1.592 . . . . 0.20999999999999999 111.033 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.814 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 12.3 m-20 -89.51 -42.27 11.55 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.293 -0.963 . . . . 0.97999999999999998 108.849 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.634 HD22 HD13 ' A' ' 79' ' ' ILE . 6.8 mp -110.42 111.97 23.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.737 -0.665 . . . . 1.1599999999999999 109.864 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.757 HG12 ' HB3' ' A' ' 7' ' ' LEU . 86.3 t -112.58 112.81 42.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.796 0.332 . . . . 1.05 110.669 -177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.814 HD21 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -83.64 93.01 7.8 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.411 0.624 . . . . 1.0700000000000001 109.986 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.693 HD12 HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -84.63 104.7 14.84 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.826 -1.079 . . . . 2.2000000000000002 111.155 -175.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.825 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 54.2 t0 -70.11 109.14 4.43 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.57 -0.852 . . . . 1.47 110.181 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.849 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.9 mtp -86.28 11.03 13.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.614 -0.721 . . . . 1.6499999999999999 111.083 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.638 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -71.32 -60.16 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.029 0.752 . . . . 2.73 113.029 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.878 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.1 tp -173.08 -21.73 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.671 1.36 . . . . 2.6099999999999999 114.671 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.902 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -27.62 -52.87 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 123.443 2.762 . . . . 0.55000000000000004 116.105 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.02 -60.07 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.756 -1.211 . . . . 0.55000000000000004 112.88 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.543 ' HE2' ' HG3' ' A' ' 64' ' ' GLU . 20.6 ttt -149.53 170.18 19.21 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.403 -0.592 . . . . 2.6699999999999999 109.403 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -57.66 135.38 56.72 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.977 0.417 . . . . 0.67000000000000004 110.283 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.589 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -66.49 -2.07 13.71 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.408 -0.815 . . . . 0.32000000000000001 112.885 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.53 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.2 mt -92.05 -42.03 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.157 0.503 . . . . 1.9199999999999999 110.286 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HG3' ' HE2' ' A' ' 60' ' ' MET . 6.3 mm-40 -68.85 -38.9 80.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.571 0.701 . . . . 0.46999999999999997 109.413 177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.693 HD13 HD12 ' A' ' 53' ' ' LEU . 54.0 mt -71.57 -35.85 57.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.149 -0.932 . . . . 1.3600000000000001 109.794 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.744 ' HA ' ' HE2' ' A' ' 69' ' ' MET . 3.2 tt -53.34 -53.43 51.19 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.677 -0.692 . . . . 2.1600000000000001 110.607 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.0 ptpp? -73.13 -30.16 63.41 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.233 -0.587 . . . . 1.3400000000000001 112.083 -172.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.693 ' O ' HG12 ' A' ' 71' ' ' VAL . 15.0 ptp180 -68.97 -33.59 73.95 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 118.92 -1.112 . . . . 2.8599999999999999 111.066 174.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.744 ' HE2' ' HA ' ' A' ' 66' ' ' LEU . 2.8 ptt? -80.63 -17.82 50.08 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 118.918 -1.113 . . . . 1.95 109.796 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.706 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -76.93 -30.24 55.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.636 . . . . 1.9299999999999999 110.572 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.7 p -78.12 -34.95 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 109.531 -0.544 . . . . 1.8300000000000001 109.531 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.596 HG12 ' HA ' ' A' ' 69' ' ' MET . 15.7 pt -81.42 -31.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 1.02 110.037 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 75' ' ' ASN . 3.4 m-20 -157.76 90.82 1.1 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.341 0.497 . . . . 1.0800000000000001 112.341 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.587 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.32 2.9 6.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.876 0.846 . . . . 1.78 109.796 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -69.53 -26.11 64.35 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.55 -1.278 . . . . 0.34999999999999998 107.55 171.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.0 tt -76.23 156.93 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 112.743 -2.026 . . . . 1.05 110.754 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.814 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -137.77 172.48 12.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.055 -0.975 . . . . 1.45 108.614 177.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.703 HG21 HD11 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -131.29 154.25 40.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 120.217 -0.593 . . . . 1.55 110.689 -171.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.704 HG23 ' HG1' ' A' ' 100' ' ' THR . 61.5 mt -128.64 68.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.402 -1.333 . . . . 1.3500000000000001 107.402 171.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.849 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -64.86 140.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.538 -0.756 . . . . 1.02 111.735 -172.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.633 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 11.0 mtt -93.15 131.1 38.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.071 -0.968 . . . . 2.5499999999999998 110.019 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.603 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 4.6 t -132.85 156.85 46.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.329 0.585 . . . . 1.78 112.578 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . -72.36 63.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.761 -1.109 . . . . 1.1000000000000001 109.804 170.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.451 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 40.3 t80 70.24 11.26 7.5 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.564 -1.198 . . . . 4.4400000000000004 112.021 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.72 81.88 1.6 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.051 -0.595 . . . . 0.65000000000000002 112.011 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' N ' HG13 ' A' ' 90' ' ' ILE . 5.6 mt-10 -72.6 8.12 1.59 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.678 0.791 . . . . 1.3300000000000001 112.052 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt 61.11 -177.55 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.569 1.322 . . . . 2.2799999999999998 114.569 171.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 t70 57.7 -93.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.328 -1.306 . . . . 1.3799999999999999 111.692 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.453 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 66.3 mtt -60.88 -26.77 67.65 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 120.838 0.351 . . . . 3.3700000000000001 110.363 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 86' ' ' GLU . 15.7 mm -62.52 -43.25 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.057 0.456 . . . . 1.3700000000000001 110.439 173.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 88.2 mt-30 -63.76 -48.31 77.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.473 -0.785 . . . . 3.1800000000000002 109.493 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.75 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 22.7 tt0 -70.11 -20.52 63.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.539 -1.21 . . . . 1.27 112.102 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.432 ' OG ' HG21 ' A' ' 80' ' ' ILE . 6.8 t -66.68 -63.84 0.98 Allowed 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.876 -0.515 . . . . 1.5600000000000001 110.062 174.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.908 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 17.0 ptpt -58.87 -31.14 68.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.694 0.759 . . . . 2.3100000000000001 109.964 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.75 ' CB ' ' HA ' ' A' ' 92' ' ' GLU . 6.1 tt0 -47.38 -58.87 3.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.366 -1.288 . . . . 1.8400000000000001 111.867 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.77 -28.57 65.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.764 -0.653 . . . . 1.8999999999999999 112.36 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.608 ' HA3' ' HZ3' ' A' ' 70' ' ' LYS . . . 163.72 11.22 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.835 -1.174 . . . . 0.34999999999999998 113.739 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.908 ' HB2' ' HA ' ' A' ' 94' ' ' LYS . . . -86.72 136.38 33.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.827 0.813 . . . . 1.02 109.66 173.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mt -74.98 -49.24 20.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.708 0.766 . . . . 1.05 109.867 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.704 ' HG1' HG23 ' A' ' 79' ' ' ILE . 60.2 p -139.17 147.83 42.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.383 -1.281 . . . . 1.05 111.603 -172.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -107.59 88.7 2.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.862 -1.063 . . . . 1.1799999999999999 108.431 170.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.608 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 0.3 OUTLIER -84.34 142.22 30.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.264 -0.425 . . . . 4.75 109.944 -172.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -108.42 177.07 4.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 1.24 111.424 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.703 ' HZ2' ' HB3' ' A' ' 104' ' ' LYS . 10.2 mtpm? -59.37 -43.3 96.16 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.959 -0.564 . . . . 3.7200000000000002 111.873 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 54.0 Cg_endo -74.37 96.2 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 120.633 0.889 . . . . 1.6699999999999999 110.995 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.436 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 51.1 p90 -130.81 148.2 52.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.585 -0.734 . . . . 1.29 110.252 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 33.6 t70 -81.99 6.95 14.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.483 -0.78 . . . . 1.77 110.962 -174.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 107' ' ' ASP . 6.0 tt 52.75 -60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.551 1.54 . . . . 1.9199999999999999 112.162 -171.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 108' ' ' ILE . 29.0 t70 -62.05 -30.71 71.17 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 110.298 -0.26 . . . . 1.1599999999999999 110.298 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 pt-20 -64.13 -29.71 70.82 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.536 -0.466 . . . . 0.83999999999999997 110.185 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.491 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 34.2 mt -81.71 -42.47 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.245 -0.434 . . . . 1.5600000000000001 110.459 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.443 ' C ' ' HD2' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -67.86 -34.96 77.71 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.818 0.818 . . . . 0.80000000000000004 109.222 175.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.2 t70 -64.2 -49.44 72.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.986 -1.006 . . . . 0.78000000000000003 108.664 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.854 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.94 -48.84 75.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.712 -1.131 . . . . 1.3100000000000001 111.729 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.466 ' HB ' ' HH ' ' A' ' 28' ' ' TYR . 35.7 m -60.8 -51.95 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.313 -0.555 . . . . 1.1200000000000001 111.663 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.4 OUTLIER -71.21 -29.83 65.63 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.627 0.232 . . . . 1.99 111.627 -176.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 65.0 pttt -72.54 -26.09 61.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.64 -0.824 . . . . 2.0899999999999999 111.184 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -77.89 -66.55 0.83 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.928 0.394 . . . . 2.3900000000000001 110.283 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -121.23 97.71 47.4 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.538 -0.912 . . . . 2.7599999999999998 108.538 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.568 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 77.1 Cg_endo -93.97 132.61 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.93 2.42 . . . . 0.92000000000000004 113.952 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 1.018 ' HG ' ' HG2' ' A' ' 122' ' ' LYS . 13.8 tp -114.34 -66.16 1.11 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.299 0.571 . . . . 1.9399999999999999 110.209 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 1.018 ' HG2' ' HG ' ' A' ' 121' ' ' LEU . 32.9 mmtp -133.73 -63.07 0.75 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.232 -0.895 . . . . 3.3599999999999999 109.256 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 36.6 p 51.44 -96.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.288 -0.869 . . . . 2.1699999999999999 112.533 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -90.01 -9.4 48.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.19 0.519 . . . . 6.0 110.737 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.7 tp -92.99 83.63 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.785 -0.643 . . . . 6.2699999999999996 109.685 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -141.01 128.26 20.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.698 -0.683 . . . . 8.6500000000000004 110.638 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -120.48 -53.16 2.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.974 -0.75 . . . . 10.210000000000001 108.974 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -103.29 102.3 12.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.56 0.695 . . . . 13.26 109.809 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -109.51 133.33 53.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.457 -0.792 . . . . 12.92 108.888 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -85.74 112.38 21.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.083 0.468 . . . . 17.120000000000001 112.058 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -86.17 104.6 15.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.835 -0.802 . . . . 17.550000000000001 108.835 171.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 p80 . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.949 -1.024 . . . . 19.600000000000001 110.269 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HE2' ' HB2' ' A' ' 1' ' ' MET . 2.3 mpp? . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.149 -0.686 . . . . 6.79 109.149 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.499 ' HE3' HH21 ' A' ' 47' ' ' ARG . 5.8 mmt -71.99 -19.13 61.92 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.01 -0.737 . . . . 4.4100000000000001 109.01 175.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' MET . 89.4 m-20 74.42 35.94 0.67 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.016 -0.993 . . . . 2.3500000000000001 111.023 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.741 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 12.5 tt0 68.41 94.54 0.07 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.952 0.882 . . . . 2.2999999999999998 109.933 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.783 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -132.52 145.99 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.238 -0.892 . . . . 1.3999999999999999 110.661 -173.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.878 ' HB ' HG21 ' A' ' 30' ' ' THR . 1.8 mt -136.98 156.56 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.544 0.688 . . . . 1.04 111.774 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.892 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.9 tt -134.17 109.51 8.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.673 -1.149 . . . . 0.98999999999999999 108.146 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.651 HG21 HD23 ' A' ' 19' ' ' LEU . 1.4 mp -97.37 108.07 21.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.324 -0.55 . . . . 1.1200000000000001 109.763 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.726 HG21 HD22 ' A' ' 53' ' ' LEU . 59.9 t -97.04 88.53 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 110.005 -0.368 . . . . 1.0900000000000001 110.005 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.79 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.1 t70 -134.77 140.79 46.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.517 -0.549 . . . . 1.8200000000000001 109.517 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.806 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 35.8 t70 -88.81 -49.4 6.85 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.141 -0.349 . . . . 0.51000000000000001 111.016 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.641 ' HG3' HD12 ' A' ' 15' ' ' ILE . 9.2 pt20 -76.57 73.1 3.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.628 -0.879 . . . . 2.5600000000000001 108.628 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.534 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 52.0 p90 -44.94 -12.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 112.206 -2.27 . . . . 1.8300000000000001 115.986 -167.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.28 -58.87 4.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.978 -1.106 . . . . 0.41999999999999998 110.789 170.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 12' ' ' GLN . 2.3 mt -59.42 -27.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.608 0.718 . . . . 1.5600000000000001 110.409 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.87 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.3 ttm180 -78.79 -43.83 24.58 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.879 -1.055 . . . . 0.47999999999999998 110.513 -167.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.733 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 39.2 pt -80.46 -26.11 11.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.459 0.475 . . . . 1.1899999999999999 109.901 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.411 ' O ' HG21 ' A' ' 22' ' ' VAL . 1.8 tp -59.05 -63.54 1.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.08 -0.711 . . . . 1.22 109.08 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 1.031 HD22 HD23 ' A' ' 52' ' ' LEU . 8.1 tp -57.93 -41.15 82.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.759 -1.109 . . . . 1.8400000000000001 110.531 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.733 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.9 t-20 -51.14 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.406 -0.815 . . . . 1.0 110.566 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.55 -41.88 42.57 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.224 0.952 . . . . 2.46 112.244 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 18' ' ' LEU . 24.8 t -55.1 -63.19 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.457 0.169 . . . . 1.2 111.457 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.786 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 16.1 m-85 -70.3 -37.31 74.76 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.379 -0.6 . . . . 0.51000000000000001 109.379 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.82 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 12.0 t-20 -50.25 -49.01 54.4 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.93 -1.032 . . . . 0.32000000000000001 109.024 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -60.52 -46.77 88.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.524 -1.671 . . . . 3.6699999999999999 111.714 -176.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.692 ' HB2' ' HA ' ' A' ' 123' ' ' SER . 9.6 pt-20 -80.71 11.87 3.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.451 -0.499 . . . . 1.51 112.235 -174.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.54 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 132.93 -16.53 4.72 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.523 -0.762 . . . . 0.56999999999999995 112.963 171.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.82 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 12.3 m-85 -82.15 137.0 35.07 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.3 -0.96 . . . . 1.49 111.875 -166.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.783 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.9 mt-30 -89.05 83.62 6.57 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.413 -0.958 . . . . 1.1399999999999999 108.413 168.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.878 HG21 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -91.33 132.54 36.1 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.898 -0.592 . . . . 0.95999999999999996 110.193 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 9.9 m-85 -121.68 124.39 44.17 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 122.486 1.136 . . . . 0.42999999999999999 109.254 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.87 ' HB2' HH11 ' A' ' 16' ' ' ARG . 4.5 pt20 -84.18 119.8 25.44 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 112.839 -1.982 . . . . 0.23999999999999999 111.693 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.885 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . . . -119.22 138.35 53.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.441 -0.948 . . . . 1.0 108.441 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . . . -97.15 -7.54 32.29 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.596 -0.841 . . . . 0.78000000000000003 110.3 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 5.5 p-10 -146.42 166.0 27.68 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 120.152 -0.619 . . . . 0.28999999999999998 111.68 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.64 -22.68 78.03 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.605 -0.725 . . . . 0.17999999999999999 112.543 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.5 ' HB2' HD21 ' A' ' 35' ' ' ASN . 3.3 mm? -78.84 -38.24 38.49 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.052 -0.722 . . . . 1.1200000000000001 109.052 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.885 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -59.0 -46.19 88.79 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 104.618 -2.364 . . . . 1.78 104.618 175.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -59.19 -49.14 79.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.501 -1.681 . . . . 0.98999999999999999 111.594 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.37 -42.13 66.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.674 0.749 . . . . 1.5700000000000001 109.405 176.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.27 -30.22 60.37 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.708 -1.133 . . . . 1.3200000000000001 111.47 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.892 ' HB ' HD12 ' A' ' 7' ' ' LEU . 8.8 mm -68.24 -46.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 O-C-N 121.714 -0.616 . . . . 1.04 110.003 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 69' ' ' MET . 48.2 t -58.07 -42.91 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.065 0.936 . . . . 1.0600000000000001 108.771 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -34.66 70.15 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.037 -1.438 . . . . 0.95999999999999996 111.388 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.737 ' HB3' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.92 -47.29 7.68 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.421 0.526 . . . . 2.9900000000000002 112.421 -174.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.624 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 46.0 mm-40 -107.44 -32.7 7.62 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.19 0.441 . . . . 0.63 112.19 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.499 HH21 ' HE3' ' A' ' 2' ' ' MET . 27.4 mtp85 63.69 61.17 1.74 Allowed Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 123.694 0.621 . . . . 4.2800000000000002 110.247 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.754 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.2 Cg_exo -60.73 153.82 59.63 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 121.435 1.423 . . . . 0.20999999999999999 111.635 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.749 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 5.2 m-20 -85.91 -42.01 14.45 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.303 -0.999 . . . . 0.97999999999999998 108.303 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 49' ' ' ASP . 7.7 mp -111.56 111.61 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.422 -0.808 . . . . 1.1599999999999999 110.585 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.69 HG13 ' HG ' ' A' ' 53' ' ' LEU . 91.7 t -109.99 113.54 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.075 0.464 . . . . 1.05 111.414 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 1.031 HD23 HD22 ' A' ' 19' ' ' LEU . 2.0 mp -87.47 87.34 7.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.53 0.681 . . . . 1.0700000000000001 109.773 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.726 HD22 HG21 ' A' ' 9' ' ' VAL . 37.8 mt -84.88 110.31 18.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.786 -1.097 . . . . 2.2000000000000002 111.124 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.663 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 49.1 t0 -68.82 115.88 8.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.616 0.722 . . . . 1.47 111.1 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.493 ' SD ' HG12 ' A' ' 63' ' ' ILE . 9.2 mmm -84.33 -3.51 58.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.65 -1.159 . . . . 1.6499999999999999 111.343 176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 1.013 ' HZ2' ' HB2' ' A' ' 83' ' ' ALA . 22.2 mmmt -61.75 -65.57 0.67 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.893 0.701 . . . . 2.73 112.893 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.895 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 10.1 tp -169.81 -30.69 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.594 1.331 . . . . 2.6099999999999999 114.594 -171.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.895 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -23.72 -55.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 124.08 3.186 . . . . 0.55000000000000004 116.204 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -144.6 -62.75 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.824 -1.179 . . . . 0.55000000000000004 112.702 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.7 ttm -148.76 167.29 25.98 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.277 -0.638 . . . . 2.6699999999999999 109.277 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 65' ' ' ILE . 7.3 m-20 -58.48 127.7 33.46 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.297 0.57 . . . . 0.67000000000000004 109.485 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.36 -15.9 33.12 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.703 -1.135 . . . . 0.32000000000000001 112.528 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.791 HG13 ' HB3' ' A' ' 89' ' ' MET . 3.0 mm -77.75 -41.4 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 117.456 0.628 . . . . 1.9199999999999999 110.379 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -68.48 -37.31 80.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.723 -0.671 . . . . 0.46999999999999997 109.335 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.683 HG23 ' HE1' ' A' ' 69' ' ' MET . 14.5 mt -72.72 -36.37 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 1.3600000000000001 110.714 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.638 HD21 HG22 ' A' ' 78' ' ' VAL . 2.8 pp -67.32 -36.13 80.84 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.259 -0.576 . . . . 2.1600000000000001 109.814 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.645 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.9 ptpp? -75.77 -32.62 60.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.619 -0.832 . . . . 1.3400000000000001 111.354 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.489 ' CG ' ' HA ' ' A' ' 65' ' ' ILE . 10.9 ptp180 -67.71 -35.17 78.3 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 118.968 -1.093 . . . . 2.8599999999999999 111.493 174.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.766 ' HA ' HG12 ' A' ' 72' ' ' ILE . 9.5 ptp -80.29 -17.31 52.48 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 120.164 -0.615 . . . . 1.95 109.641 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.4 mptp? -70.3 -40.83 74.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.363 -0.977 . . . . 1.9299999999999999 108.363 167.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 67' ' ' LYS . 95.8 t -61.75 -39.16 82.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 1.8300000000000001 110.605 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.766 HG12 ' HA ' ' A' ' 69' ' ' MET . 32.0 pt -85.19 -20.25 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.676 -0.41 . . . . 1.02 110.655 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -162.69 85.22 0.55 Allowed 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 112.555 0.576 . . . . 1.0800000000000001 112.555 -178.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.9 mt-10 -73.96 5.56 4.11 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.412 -0.805 . . . . 1.78 109.845 173.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -73.15 -28.52 62.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.562 1.172 . . . . 0.34999999999999998 108.033 170.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.598 HG23 ' HG3' ' A' ' 69' ' ' MET . 3.3 tt -76.06 161.63 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-N 112.843 -1.98 . . . . 1.05 111.403 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.749 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -138.47 176.76 8.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.737 -1.12 . . . . 1.45 108.179 173.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.693 HG12 HD11 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -142.65 153.01 17.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 119.941 -0.704 . . . . 1.55 111.806 -173.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.903 HG22 ' HG1' ' A' ' 100' ' ' THR . 71.3 mt -124.71 73.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.328 -1.36 . . . . 1.3500000000000001 107.328 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -65.41 138.23 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.216 -0.902 . . . . 1.02 111.829 -171.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.762 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 6.1 mtm -94.18 117.93 30.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.089 -0.96 . . . . 2.5499999999999998 110.317 -174.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 11.0 p -125.82 157.4 37.65 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.667 -0.697 . . . . 1.78 112.163 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 1.013 ' HB2' ' HZ2' ' A' ' 56' ' ' LYS . . . -73.97 60.66 0.77 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.716 -0.675 . . . . 1.1000000000000001 110.436 167.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 58.4 t80 60.43 54.61 3.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.334 0.587 . . . . 4.4400000000000004 111.554 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.2 87.34 0.03 OUTLIER Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.891 -0.595 . . . . 0.65000000000000002 113.475 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.654 ' N ' HG13 ' A' ' 90' ' ' ILE . 22.5 mt-10 -87.12 16.12 5.43 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.948 0.499 . . . . 1.3300000000000001 111.582 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.407 ' CA ' ' HB ' ' A' ' 90' ' ' ILE . 3.7 mm? 63.65 179.35 0.16 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.8 1.407 . . . . 2.2799999999999998 114.8 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB3' ' H ' ' A' ' 89' ' ' MET . 1.7 t70 61.82 -93.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.268 -1.333 . . . . 1.3799999999999999 111.658 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.791 ' HB3' HG13 ' A' ' 63' ' ' ILE . 1.1 mpt? -64.25 -14.34 55.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.066 0.46 . . . . 3.3700000000000001 110.577 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.654 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.5 mm -77.34 -22.1 14.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.366 0.603 . . . . 1.3700000000000001 110.605 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 13.4 mt-30 -81.15 -47.2 13.78 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.793 -1.188 . . . . 3.1800000000000002 107.793 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.601 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 19.7 tt0 -65.33 -33.56 76.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.929 -1.487 . . . . 1.27 112.671 -177.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.77 ' HB3' HD13 ' A' ' 63' ' ' ILE . 7.9 p -52.45 -74.78 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.06 0.933 . . . . 1.5600000000000001 111.611 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.6 pttt -53.78 -35.91 61.84 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.779 -1.555 . . . . 2.3100000000000001 111.992 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -62.11 -34.3 76.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.886 -0.326 . . . . 1.8400000000000001 111.161 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.3 mt -81.31 -24.66 37.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.896 0.379 . . . . 1.8999999999999999 111.019 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.642 ' HA3' ' HZ2' ' A' ' 70' ' ' LYS . . . 153.31 -1.79 0.25 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 119.877 -1.154 . . . . 0.34999999999999998 113.706 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.633 ' CA ' HG23 ' A' ' 78' ' ' VAL . . . -70.74 132.15 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.954 0.877 . . . . 1.02 109.605 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.417 HD13 ' HG ' ' A' ' 50' ' ' LEU . 12.5 mt -75.29 -48.25 24.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.043 0.925 . . . . 1.05 109.392 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.903 ' HG1' HG22 ' A' ' 79' ' ' ILE . 71.1 p -141.72 156.74 45.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.889 -1.505 . . . . 1.05 111.914 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.62 98.62 8.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.354 -1.294 . . . . 1.1799999999999999 109.47 171.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.762 ' HB3' ' HA ' ' A' ' 81' ' ' MET . 26.0 t80 -56.41 143.23 35.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.445 -0.798 . . . . 4.75 109.441 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.524 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . . . -130.32 167.45 18.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.759 -0.46 . . . . 1.24 109.759 172.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 54.5 mtpt -68.15 -40.88 23.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.203 -0.453 . . . . 3.7200000000000002 111.387 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 103' ' ' ALA . 58.0 Cg_endo -76.6 96.36 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.767 0.952 . . . . 1.6699999999999999 110.62 166.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.608 ' HB2' HD11 ' A' ' 111' ' ' ILE . 53.0 p90 -129.03 143.62 50.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.059 -0.519 . . . . 1.29 111.607 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.515 ' O ' HG21 ' A' ' 108' ' ' ILE . 1.8 t70 -75.25 -3.68 34.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.888 -0.596 . . . . 1.77 110.712 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.515 HG21 ' O ' ' A' ' 107' ' ' ASP . 9.4 tp 52.2 -53.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.613 1.565 . . . . 1.9199999999999999 112.206 -165.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 35.0 t70 -65.9 -26.99 67.87 Favored 'General case' 0 C--O 1.211 -0.924 0 O-C-N 122.384 -0.197 . . . . 1.1599999999999999 110.94 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 11.3 pt-20 -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.203 -0.599 . . . . 0.83999999999999997 109.864 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 106' ' ' PHE . 47.7 mt -83.23 -43.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 1.5600000000000001 109.559 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.68 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -65.42 -39.58 92.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.809 -0.811 . . . . 0.80000000000000004 108.809 175.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.8 t70 -67.95 -40.53 83.24 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.187 -0.671 . . . . 0.78000000000000003 109.187 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.63 -48.71 74.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.324 -0.853 . . . . 1.3100000000000001 110.927 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.651 ' HB ' ' HH ' ' A' ' 28' ' ' TYR . 34.3 m -61.93 -48.23 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 120.082 -0.647 . . . . 1.1200000000000001 111.173 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -70.91 -19.91 62.54 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.598 0.592 . . . . 1.99 112.598 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 7.4 pttm -86.61 -23.14 25.83 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.415 -0.914 . . . . 2.0899999999999999 111.154 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.525 ' HD2' ' O ' ' A' ' 114' ' ' ALA . 28.4 m-85 -82.17 -67.19 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.024 -0.362 . . . . 2.3900000000000001 110.024 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.0 95.05 49.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.26 -0.645 . . . . 2.7599999999999998 109.26 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.634 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 84.1 Cg_endo -91.1 141.65 2.96 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.857 2.372 . . . . 0.92000000000000004 113.942 -173.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 1.009 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 29.7 tp -114.66 -66.28 1.1 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.725 0.774 . . . . 1.9399999999999999 109.84 174.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 1.009 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 60.8 mttm -143.94 -51.51 0.32 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.645 -1.161 . . . . 3.3599999999999999 109.87 -172.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.692 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 90.3 p 55.18 -108.75 0.45 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.012 -0.995 . . . . 2.1699999999999999 111.252 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -174.94 -38.0 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 111.832 0.308 . . . . 6.0 111.832 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.8 tp -105.48 131.68 52.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.882 0.373 . . . . 6.2699999999999996 111.583 -172.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -82.88 170.39 15.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.557 -0.747 . . . . 8.6500000000000004 110.386 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 34.8 m80 62.85 -170.3 0.18 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.456 0.646 . . . . 10.210000000000001 111.628 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -146.15 91.34 2.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.587 -0.733 . . . . 13.26 109.332 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -79.43 -178.48 6.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.74 -0.664 . . . . 12.92 109.359 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 73.69 25.36 2.03 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.295 0.372 . . . . 17.120000000000001 110.198 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -73.58 96.43 2.44 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.362 -0.607 . . . . 17.550000000000001 109.362 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-N 114.846 -1.07 . . . . 19.600000000000001 111.094 -174.232 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.417 0.151 . . . . 6.79 110.929 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.8 tpt 176.99 -161.67 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.951 -1.129 . . . . 4.4100000000000001 107.951 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.534 ' HB2' HE22 ' A' ' 29' ' ' GLN . 0.0 OUTLIER -91.39 -72.36 0.59 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.333 -0.988 . . . . 2.3500000000000001 108.333 167.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.804 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 3.0 tp10 169.11 124.01 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.325 -1.361 . . . . 2.2999999999999998 107.325 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.701 ' HD3' ' HB3' ' A' ' 46' ' ' GLU . 2.7 ttmt -150.31 139.73 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.188 1.181 . . . . 1.3999999999999999 114.188 -167.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.906 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -139.39 154.82 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.233 -1.349 . . . . 1.04 111.49 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 1.004 ' HB3' HG12 ' A' ' 51' ' ' VAL . 3.4 tt -135.55 117.95 15.73 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.52 -1.289 . . . . 0.98999999999999999 107.52 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -103.7 100.92 11.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.987 -0.685 . . . . 1.1200000000000001 110.132 -177.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.752 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 48.8 t -83.61 91.25 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.559 -0.534 . . . . 1.0900000000000001 109.559 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.817 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.7 t70 -143.35 142.98 31.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.543 0.211 . . . . 1.8200000000000001 110.607 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.81 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 15.2 t70 -102.46 -31.62 10.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.891 0.377 . . . . 0.51000000000000001 110.27 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.604 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -79.12 70.91 5.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.507 -1.294 . . . . 2.5600000000000001 107.507 172.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' O ' HG12 ' A' ' 17' ' ' ILE . 46.7 p90 -52.29 -15.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 112.88 -1.964 . . . . 1.8300000000000001 115.099 -159.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.64 -60.9 5.54 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.906 -1.14 . . . . 0.41999999999999998 110.334 169.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 2.9 mt -55.17 -30.49 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.333 0.587 . . . . 1.5600000000000001 111.056 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.817 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.1 ttm180 -76.29 -49.79 16.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.749 . . . . 0.47999999999999998 110.596 -168.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.613 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.5 pt -76.19 -25.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.598 -0.519 . . . . 1.1899999999999999 109.598 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tp -57.24 -65.26 0.65 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.348 -0.842 . . . . 1.22 109.457 171.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.789 HD12 HD21 ' A' ' 52' ' ' LEU . 57.8 mt -58.26 -44.15 88.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.8400000000000001 109.939 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.613 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.5 t30 -50.5 -66.17 0.43 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.128 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.47 -39.21 82.95 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.662 0.601 . . . . 2.46 111.396 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.9 t -55.08 -58.17 5.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 111.787 0.291 . . . . 1.2 111.787 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.676 ' HB2' HG23 ' A' ' 30' ' ' THR . 7.9 m-85 -73.56 -40.09 64.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.256 -0.646 . . . . 0.51000000000000001 109.256 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.8 t-20 -50.78 -50.23 56.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.066 -0.97 . . . . 0.32000000000000001 108.557 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -51.11 -46.75 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.275 -1.784 . . . . 3.6699999999999999 112.58 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.61 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 6.5 pt-20 -88.21 16.16 6.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.116 -0.634 . . . . 1.51 111.544 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.763 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 126.98 -15.45 6.53 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.495 -0.859 . . . . 0.56999999999999995 113.581 169.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.804 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 10.2 m-85 -73.83 160.22 31.77 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 118.899 -1.12 . . . . 1.49 112.407 -168.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.694 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 2.1 mp0 -106.83 76.32 1.1 Allowed 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.101 -1.409 . . . . 1.1399999999999999 107.337 173.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.906 HG22 ' HB ' ' A' ' 6' ' ' ILE . 27.2 p -90.68 130.55 36.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.876 -1.056 . . . . 0.95999999999999996 109.457 -173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.446 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.3 m-85 -126.9 108.96 11.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.632 1.206 . . . . 0.42999999999999999 109.876 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.719 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.1 pt20 -61.29 120.72 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 112.483 -2.144 . . . . 0.23999999999999999 112.577 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 42' ' ' ILE . . . -124.33 125.94 45.17 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.957 0.903 . . . . 1.0 109.094 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -82.84 -11.03 58.55 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.042 -0.663 . . . . 0.78000000000000003 111.058 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.077 0.399 . . . . 0.28999999999999998 112.077 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.5 -19.34 78.94 Favored Glycine 0 CA--C 1.506 -0.492 0 CA-C-N 115.794 -0.639 . . . . 0.17999999999999999 113.051 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.62 -40.91 24.83 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.154 0.978 . . . . 1.1200000000000001 108.949 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.823 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -61.17 -41.87 97.54 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.391 -2.077 . . . . 1.78 105.391 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HB1' HG23 ' A' ' 9' ' ' VAL . . . -59.27 -46.74 87.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.157 -1.383 . . . . 0.98999999999999999 111.17 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -53.76 -48.27 69.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.623 -0.717 . . . . 1.5700000000000001 109.816 175.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.55 -39.1 92.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.42 -1.264 . . . . 1.3200000000000001 111.064 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.885 ' HB ' HD12 ' A' ' 7' ' ' LEU . 20.0 mm -65.94 -48.68 81.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.234 -0.439 . . . . 1.04 110.083 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 59.4 t -58.46 -42.73 85.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-O 121.828 0.823 . . . . 1.0600000000000001 109.231 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.36 -29.74 70.09 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.117 -0.947 . . . . 0.95999999999999996 111.425 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.754 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -88.94 -46.6 8.77 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.299 0.481 . . . . 2.9900000000000002 112.299 -177.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.701 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 46.3 mm-40 -108.45 -35.05 6.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 111.975 0.361 . . . . 0.63 111.975 -176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 45.4 mtp180 63.69 60.39 1.8 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.294 -0.867 . . . . 4.2800000000000002 109.889 -171.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.832 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 32.1 Cg_exo -62.65 146.62 95.31 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 121.376 1.384 . . . . 0.20999999999999999 110.95 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 m-20 -85.96 -35.24 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.409 -0.916 . . . . 0.97999999999999998 109.389 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.13 111.11 21.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 1.1599999999999999 109.638 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.004 HG12 ' HB3' ' A' ' 7' ' ' LEU . 19.0 t -117.34 112.59 39.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.383 -0.372 . . . . 1.05 110.821 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.789 HD21 HD12 ' A' ' 19' ' ' LEU . 3.2 mp -83.59 104.67 13.9 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.957 -0.464 . . . . 1.0700000000000001 110.496 -176.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.752 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 8.1 mp -99.04 102.52 14.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.516 -0.311 . . . . 2.2000000000000002 111.824 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.682 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t70 -63.83 111.1 2.31 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.527 -0.469 . . . . 1.47 110.059 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.688 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 17.1 mtm -91.37 12.38 20.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.234 -0.439 . . . . 1.6499999999999999 111.013 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.682 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 14.2 mmmm -70.61 -65.91 0.67 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.782 0.289 . . . . 2.73 111.782 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.893 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 2.3 pt -160.72 -39.5 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.908 1.077 . . . . 2.6099999999999999 113.908 -169.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.893 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -21.2 -60.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 124.905 3.737 . . . . 0.55000000000000004 116.928 -175.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.68 -66.64 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.651 -1.262 . . . . 0.55000000000000004 113.0 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 49.5 ttm -139.69 164.14 30.73 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 2.6699999999999999 109.414 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 65' ' ' ILE . 2.7 m-20 -61.06 134.67 57.31 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.75 -0.463 . . . . 0.67000000000000004 109.75 174.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.448 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -62.01 -15.23 49.08 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 115.451 -0.795 . . . . 0.32000000000000001 112.378 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.597 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 9.6 mt -78.3 -44.25 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.061 -0.67 . . . . 1.9199999999999999 109.836 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.58 -33.56 74.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.351 0.596 . . . . 0.46999999999999997 110.048 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.803 HG23 ' HE3' ' A' ' 69' ' ' MET . 31.9 mt -74.16 -39.38 49.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.981 -0.554 . . . . 1.3600000000000001 110.453 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 2.9 pp -65.92 -36.8 84.37 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 120.187 -0.605 . . . . 2.1600000000000001 109.951 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.68 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.1 ptpt -75.42 -36.08 60.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 120.491 -0.483 . . . . 1.3400000000000001 111.391 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 11.2 ptm180 -64.87 -36.86 85.7 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 119.497 -0.881 . . . . 2.8599999999999999 111.144 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.803 ' HE3' HG23 ' A' ' 65' ' ' ILE . 11.4 ptp -82.46 -14.12 55.6 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.102 -0.639 . . . . 1.95 109.618 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.68 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -70.45 -40.02 73.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.089 -1.078 . . . . 1.9299999999999999 108.089 167.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 67' ' ' LYS . 94.0 t -62.54 -38.58 81.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.453 -0.794 . . . . 1.8300000000000001 110.125 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.794 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.1 pt -86.47 -19.03 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.525 -0.47 . . . . 1.02 111.074 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.96 86.12 0.42 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.484 0.55 . . . . 1.0800000000000001 112.484 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.574 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.1 mt-10 -70.53 1.34 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.046 -1.034 . . . . 1.78 110.646 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -30.43 64.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.596 1.189 . . . . 0.34999999999999998 108.05 171.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.727 HG22 ' HG3' ' A' ' 69' ' ' MET . 3.9 tt -69.24 161.54 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.636 -2.075 . . . . 1.05 111.482 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -141.56 174.72 10.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.849 -1.069 . . . . 1.45 108.649 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 10.1 m -141.54 143.4 27.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.55 0.69 . . . . 1.55 111.273 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.863 HG23 ' HG1' ' A' ' 100' ' ' THR . 4.2 mp -108.79 75.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.581 -1.266 . . . . 1.3500000000000001 107.581 174.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.688 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -69.51 141.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 119.363 -0.935 . . . . 1.02 112.016 -172.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 27.8 mtt -95.23 136.78 35.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.22 -0.9 . . . . 2.5499999999999998 110.335 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 t -132.83 158.12 43.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.117 0.784 . . . . 1.78 113.117 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HB1' ' HE3' ' A' ' 56' ' ' LYS . . . -72.71 64.16 0.64 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.544 -1.207 . . . . 1.1000000000000001 109.654 169.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 70.15 15.06 7.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.235 -0.893 . . . . 4.4400000000000004 112.32 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.28 92.03 1.07 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.58 -0.819 . . . . 0.65000000000000002 111.412 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.555 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.4 mt-10 -88.03 7.25 32.15 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 122.927 0.491 . . . . 1.3300000000000001 111.644 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 59.9 -175.11 0.11 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.47 -0.786 . . . . 2.2799999999999998 112.813 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.86 -93.34 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.083 -0.962 . . . . 1.3799999999999999 112.324 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB2' HD13 ' A' ' 63' ' ' ILE . 26.8 ptt? -61.2 -24.11 66.09 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.137 0.494 . . . . 3.3700000000000001 110.332 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.555 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.1 mm -66.01 -47.38 85.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 1.3700000000000001 109.952 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.617 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 14.1 mm100 -61.64 -50.23 73.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.39 -0.823 . . . . 3.1800000000000002 109.647 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 13.3 tt0 -63.59 -33.44 75.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.041 -0.981 . . . . 1.27 112.431 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -59.13 -63.7 1.21 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.662 0.268 . . . . 1.5600000000000001 110.631 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.923 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 pttt -55.83 -40.18 72.45 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.433 0.635 . . . . 2.3100000000000001 110.871 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 6.8 tp10 -54.52 -35.59 63.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 1.8400000000000001 111.51 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.1 tp -90.19 -10.86 42.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.723 0.268 . . . . 1.8999999999999999 111.723 -173.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.541 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 154.86 -12.13 0.45 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.76 -1.21 . . . . 0.34999999999999998 113.644 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.923 ' HB1' ' HA ' ' A' ' 94' ' ' LYS . . . -73.99 145.59 44.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.292 0.546 . . . . 1.02 110.784 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.513 HD13 ' HG3' ' A' ' 77' ' ' ARG . 16.7 mt -87.86 -50.37 6.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.501 0.667 . . . . 1.05 109.797 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.863 ' HG1' HG23 ' A' ' 79' ' ' ILE . 52.3 p -143.26 160.44 40.48 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.263 -1.335 . . . . 1.05 111.433 -170.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -109.98 98.22 7.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.846 -1.07 . . . . 1.1799999999999999 110.081 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.563 ' HD2' HD12 ' A' ' 111' ' ' ILE . 43.7 t80 -68.29 124.86 24.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.611 -0.722 . . . . 4.75 109.954 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . . . -123.07 178.0 5.28 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.769 -0.372 . . . . 1.24 110.463 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.37 -47.16 97.15 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.501 0.556 . . . . 3.7200000000000002 112.501 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 103' ' ' ALA . 57.5 Cg_endo -73.27 97.49 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 120.86 1.04 . . . . 1.6699999999999999 111.593 173.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CZ ' HD22 ' A' ' 18' ' ' LEU . 40.5 p90 -133.37 138.22 46.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.968 -0.56 . . . . 1.29 110.727 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 108' ' ' ILE . 8.0 t70 -72.82 -4.99 35.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.895 -0.593 . . . . 1.77 111.078 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 107' ' ' ASP . 6.3 tt 59.41 -56.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.856 1.262 . . . . 1.9199999999999999 110.598 -165.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.96 -38.86 92.77 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 110.26 -0.274 . . . . 1.1599999999999999 110.26 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.563 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 pt-20 -61.19 -27.92 68.77 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.695 -0.402 . . . . 0.83999999999999997 110.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.563 HD12 ' HD2' ' A' ' 102' ' ' PHE . 4.7 mm -77.43 -50.91 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.354 -0.61 . . . . 1.5600000000000001 109.354 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.61 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -66.87 -36.43 82.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.563 0.697 . . . . 0.80000000000000004 109.697 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.533 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 35.0 t70 -69.56 -42.45 74.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.635 -0.711 . . . . 0.78000000000000003 109.088 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.615 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.88 -40.74 98.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.525 -0.761 . . . . 1.3100000000000001 110.978 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 112' ' ' ARG . 33.0 m -63.83 -53.38 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 119.15 -1.02 . . . . 1.1200000000000001 110.952 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -69.68 -16.85 63.43 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.343 0.497 . . . . 1.99 112.343 -178.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.615 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 18.6 ptpt -83.64 -26.89 29.54 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.29 -0.881 . . . . 2.0899999999999999 111.041 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -81.42 -59.39 2.64 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.996 0.427 . . . . 2.3900000000000001 109.955 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 44.2 tp -120.55 107.83 38.24 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.368 -0.975 . . . . 2.7599999999999998 108.368 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.553 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 91.2 Cg_endo -100.86 146.97 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.893 2.395 . . . . 0.92000000000000004 114.683 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 1.107 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 16.4 tp -116.08 -67.56 0.99 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.474 -0.785 . . . . 1.9399999999999999 110.536 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 1.107 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 67.9 mttm -134.12 -42.05 0.81 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.888 -1.051 . . . . 3.3599999999999999 111.211 -169.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 m -36.85 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.385 1.053 . . . . 2.1699999999999999 110.311 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -105.71 141.3 37.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.334 -0.848 . . . . 6.0 112.524 -161.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.42 10.77 4.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.353 -0.839 . . . . 6.2699999999999996 109.698 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -167.97 115.61 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.64 -0.709 . . . . 8.6500000000000004 109.737 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -90.7 -52.91 4.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.118 0.485 . . . . 10.210000000000001 109.998 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -115.14 -77.12 0.57 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.589 -0.732 . . . . 13.26 109.203 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -135.66 156.44 48.84 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.52 -0.919 . . . . 12.92 108.52 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -75.02 123.77 25.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.209 -0.663 . . . . 17.120000000000001 109.209 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -79.44 98.28 6.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.767 0.794 . . . . 17.550000000000001 110.484 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.103 -0.953 . . . . 19.600000000000001 109.051 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.24 -0.281 . . . . 6.79 110.24 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.71 ' HB2' HD12 ' A' ' 119' ' ' LEU . 2.0 mpt? 52.43 -167.01 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.426 0.631 . . . . 4.4100000000000001 112.06 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -112.36 -6.37 14.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.644 -0.707 . . . . 2.3500000000000001 109.316 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.799 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 7.3 tt0 68.14 92.36 0.08 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.096 0.95 . . . . 2.2999999999999998 111.612 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.829 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -131.28 152.41 50.57 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.012 -0.994 . . . . 1.3999999999999999 110.622 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.829 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.3 mt -142.36 154.25 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.614 0.721 . . . . 1.04 111.645 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.871 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.2 tt -132.11 122.04 24.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.418 -1.326 . . . . 0.98999999999999999 107.418 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.764 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.6 mp -108.71 106.33 20.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.125 -0.63 . . . . 1.1200000000000001 109.59 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 23.5 t -95.11 71.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 O-C-N 122.97 0.169 . . . . 1.0900000000000001 110.683 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.833 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.1 m-20 -118.33 135.63 54.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.651 0.262 . . . . 1.8200000000000001 111.208 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 1.084 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 29.7 t70 -86.69 -27.46 23.71 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.184 -1.043 . . . . 0.51000000000000001 108.184 171.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.768 ' HB2' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -78.88 73.37 5.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.475 -1.306 . . . . 2.5600000000000001 107.475 167.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.557 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 40.3 p90 -54.13 -17.49 2.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.829 -1.532 . . . . 1.8300000000000001 113.178 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.5 -63.89 4.87 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.925 -1.27 . . . . 0.41999999999999998 109.925 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.768 HD12 ' HB2' ' A' ' 12' ' ' GLN . 3.0 mt -53.62 -25.28 11.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.869 0.366 . . . . 1.5600000000000001 111.574 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.833 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 10.2 ttm180 -76.94 -50.24 13.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.308 -0.406 . . . . 0.47999999999999998 111.081 -171.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.1 pt -74.74 -24.67 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.193 -0.669 . . . . 1.1899999999999999 109.193 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.7 tp -57.27 -67.76 0.29 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.928 -1.033 . . . . 1.22 109.493 170.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.687 HD12 HD22 ' A' ' 52' ' ' LEU . 60.5 mt -54.64 -40.88 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 1.8400000000000001 110.451 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.8 t30 -50.68 -69.25 0.12 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.139 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.3 -39.41 75.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 2.46 111.568 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 18' ' ' LEU . 49.4 t -57.1 -55.69 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 111.999 0.37 . . . . 1.2 111.999 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HB2' HG23 ' A' ' 30' ' ' THR . 6.7 m-85 -77.03 -37.73 54.27 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.782 -0.451 . . . . 0.51000000000000001 109.782 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.81 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 17.1 t-20 -49.95 -50.3 47.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.033 0.921 . . . . 0.32000000000000001 109.189 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -59.09 -33.68 71.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.343 -1.753 . . . . 3.6699999999999999 113.06 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 4.2 mt-10 -68.08 -23.49 64.94 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.307 -0.627 . . . . 1.51 109.307 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.05 -13.32 2.6 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.66 -1.155 . . . . 0.56999999999999995 110.569 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 6.7 m-85 -72.65 134.25 45.02 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.612 0.72 . . . . 1.49 111.557 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.829 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 19.2 mt-30 -88.61 80.95 7.19 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.212 -1.033 . . . . 1.1399999999999999 108.212 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.829 HG22 ' HB ' ' A' ' 6' ' ' ILE . 17.2 p -90.25 137.32 32.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.808 -0.633 . . . . 0.95999999999999996 110.026 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 38.1 m-85 -129.78 126.09 37.32 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.677 1.227 . . . . 0.42999999999999999 110.272 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.822 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 4.6 pt20 -85.28 121.13 27.57 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.639 -2.073 . . . . 0.23999999999999999 111.93 -171.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -121.47 137.12 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.89 . . . . 1.0 108.894 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . . . -93.06 -10.72 35.09 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.778 -0.369 . . . . 0.78000000000000003 110.42 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 37' ' ' LEU . 3.1 p-10 -149.0 165.8 30.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.28999999999999998 111.444 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.3 76.47 Favored Glycine 0 CA--C 1.504 -0.611 0 CA-C-N 115.747 -0.66 . . . . 0.17999999999999999 113.467 -174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 35' ' ' ASN . 2.8 mm? -81.31 -43.73 18.68 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.679 1.228 . . . . 1.1200000000000001 108.038 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.8 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 tp-100 -60.33 -41.11 92.87 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.114 -2.312 . . . . 1.78 105.49 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.418 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -64.78 -44.23 90.66 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.699 -1.591 . . . . 0.98999999999999999 111.079 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.584 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.3 OUTLIER -55.5 -42.63 74.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.401 -0.592 . . . . 1.5700000000000001 109.401 175.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 14.7 m-20 -64.65 -41.79 95.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.108 -0.951 . . . . 1.3200000000000001 110.906 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.871 ' HB ' HD11 ' A' ' 7' ' ' LEU . 9.9 mm -61.04 -50.11 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 121.015 -0.274 . . . . 1.04 110.748 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -59.04 -45.33 92.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-O 121.817 0.817 . . . . 1.0600000000000001 109.45 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -59.87 -28.91 67.94 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.868 -1.06 . . . . 0.95999999999999996 111.783 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -96.04 -46.66 6.41 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.966 -0.561 . . . . 2.9900000000000002 111.848 -173.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 60.8 mm-40 -105.07 -36.52 7.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.733 0.271 . . . . 0.63 111.733 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 64.58 65.96 1.0 Allowed Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.776 0.672 . . . . 4.2800000000000002 109.929 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.792 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 76.9 Cg_exo -58.97 161.42 15.75 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.803 1.669 . . . . 0.20999999999999999 112.118 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.755 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.7 m-20 -94.63 -40.04 10.03 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.195 -1.039 . . . . 0.97999999999999998 108.195 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.755 HD12 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mp -116.91 118.6 32.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.255 -0.884 . . . . 1.1599999999999999 109.876 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' ' 7' ' ' LEU . 96.7 t -118.06 112.02 36.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.122 0.487 . . . . 1.05 110.871 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.687 HD22 HD12 ' A' ' 19' ' ' LEU . 2.6 mp -82.9 98.5 9.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.46 0.647 . . . . 1.0700000000000001 109.544 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.585 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -88.18 99.71 12.41 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.972 -1.013 . . . . 2.2000000000000002 111.007 -175.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.571 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 23.2 t0 -68.23 100.8 1.08 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.351 -0.611 . . . . 1.47 109.351 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.765 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 44.9 mtp -77.03 -5.9 50.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.041 -0.527 . . . . 1.6499999999999999 110.95 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.2 mmmm -50.63 -54.64 21.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.267 0.84 . . . . 2.73 113.267 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.78 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 10.4 tp -177.48 -11.09 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 114.974 1.472 . . . . 2.6099999999999999 114.974 -171.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 1.084 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -32.09 -51.04 0.33 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.991 2.461 . . . . 0.55000000000000004 115.723 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.36 -43.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.913 -1.137 . . . . 0.55000000000000004 112.739 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.431 ' HE3' ' HG3' ' A' ' 64' ' ' GLU . 14.8 tpt -147.81 167.23 25.27 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.816 -0.809 . . . . 2.6699999999999999 108.816 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.23 139.1 57.29 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.247 0.546 . . . . 0.67000000000000004 110.308 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.585 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -60.53 -15.06 38.04 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.984 -1.007 . . . . 0.32000000000000001 112.49 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.789 HG13 ' HB3' ' A' ' 89' ' ' MET . 3.7 mm -79.85 -47.64 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.736 0.303 . . . . 1.9199999999999999 110.311 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' HG3' ' HE3' ' A' ' 60' ' ' MET . 35.1 mm-40 -61.43 -36.72 81.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.657 0.741 . . . . 0.46999999999999997 109.216 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.543 ' CD1' HD12 ' A' ' 53' ' ' LEU . 68.1 mt -72.73 -36.93 54.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.137 -0.938 . . . . 1.3600000000000001 111.225 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.632 HD13 HD21 ' A' ' 96' ' ' LEU . 2.2 pp -70.65 -37.44 73.73 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.289 -0.564 . . . . 2.1600000000000001 110.715 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.1 ptpt -73.06 -34.57 66.36 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.526 -0.469 . . . . 1.3400000000000001 110.964 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.696 ' O ' HG11 ' A' ' 71' ' ' VAL . 12.0 ptm180 -65.5 -34.68 78.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.436 -0.905 . . . . 2.8599999999999999 111.29 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.709 ' HA ' HG12 ' A' ' 72' ' ' ILE . 4.7 ptt? -83.66 -12.33 56.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.894 -1.122 . . . . 1.95 109.864 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.6 mptp? -78.81 -35.05 44.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.635 -0.711 . . . . 1.9299999999999999 110.058 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.696 HG11 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -73.79 -34.33 40.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.742 -0.663 . . . . 1.8300000000000001 109.419 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.709 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.0 pt -80.85 -34.77 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.373 -0.83 . . . . 1.02 110.204 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -155.79 90.39 1.22 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.565 0.58 . . . . 1.0800000000000001 112.565 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.04 4.72 3.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.525 0.679 . . . . 1.78 110.34 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -26.1 63.84 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.488 -1.301 . . . . 0.34999999999999998 107.488 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.9 tt -77.32 160.43 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 112.706 -2.043 . . . . 1.05 110.919 -172.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.671 ' HE ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -137.63 -179.68 5.89 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.356 -0.838 . . . . 1.45 109.046 173.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.601 HG22 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -134.48 153.53 35.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.299 -0.561 . . . . 1.55 110.218 -172.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.787 HG23 ' HG1' ' A' ' 100' ' ' THR . 63.4 mt -130.73 71.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.411 -1.329 . . . . 1.3500000000000001 107.411 170.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.765 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -68.31 139.61 20.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.257 -0.883 . . . . 1.02 111.849 -172.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 4.8 mtp -99.1 131.62 45.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.044 -0.98 . . . . 2.5499999999999998 110.445 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 t -133.3 158.52 42.75 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.048 0.758 . . . . 1.78 113.048 -175.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.48 65.66 0.66 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.028 -0.987 . . . . 1.1000000000000001 109.719 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.493 ' HE1' ' HE2' ' A' ' 104' ' ' LYS . 49.8 m-85 71.44 15.27 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 4.4400000000000004 112.677 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.425 ' CA ' HG23 ' A' ' 90' ' ' ILE . . . 85.51 79.87 1.14 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.332 -0.937 . . . . 0.65000000000000002 111.522 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.559 ' N ' HG13 ' A' ' 90' ' ' ILE . 6.9 mt-10 -75.86 14.96 0.58 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.817 0.847 . . . . 1.3300000000000001 111.693 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.48 ' CA ' ' HB ' ' A' ' 90' ' ' ILE . 27.6 mt 59.36 -170.48 0.13 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.62 0.97 . . . . 2.2799999999999998 113.62 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 89' ' ' MET . 8.5 t70 58.74 -94.6 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.801 -1.09 . . . . 1.3799999999999999 110.885 -176.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.789 ' HB3' HG13 ' A' ' 63' ' ' ILE . 3.1 mpp? -64.36 -19.66 65.62 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.943 0.402 . . . . 3.3700000000000001 110.368 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 86' ' ' GLU . 41.6 mm -75.88 -23.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.601 0.715 . . . . 1.3700000000000001 110.592 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -82.37 -48.58 10.98 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.029 -1.1 . . . . 3.1800000000000002 108.029 172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 89' ' ' MET . 38.8 tt0 -63.48 -30.54 71.65 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 113.708 -1.587 . . . . 1.27 112.149 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.611 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 16.8 p -53.66 -77.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.094 0.95 . . . . 1.5600000000000001 112.245 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 13.1 ptpt -51.0 -41.0 59.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.506 -1.679 . . . . 2.3100000000000001 110.79 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -54.58 -44.82 73.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.387 -0.824 . . . . 1.8400000000000001 111.612 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 66' ' ' LEU . 12.4 tp -82.68 -15.94 50.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 1.8999999999999999 111.778 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.522 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 149.41 1.67 0.37 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.672 -1.251 . . . . 0.34999999999999998 113.954 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.663 ' O ' ' HA ' ' A' ' 94' ' ' LYS . . . -80.64 137.54 36.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.992 0.896 . . . . 1.02 109.769 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.551 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.5 mt -76.3 -48.59 19.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.87 0.843 . . . . 1.05 109.411 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.787 ' HG1' HG23 ' A' ' 79' ' ' ILE . 41.1 p -139.29 150.77 45.82 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.368 -1.287 . . . . 1.05 111.955 -171.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -114.54 67.74 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.04 -0.982 . . . . 1.1799999999999999 109.735 173.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' MET . 39.1 m-85 -62.18 130.31 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 4.75 110.543 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.16 -167.1 1.36 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.058 -0.519 . . . . 1.24 110.823 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HE2' ' HE1' ' A' ' 84' ' ' TYR . 46.1 mtmt -55.59 -43.08 98.98 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.226 -0.443 . . . . 3.7200000000000002 112.064 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 44.1 Cg_endo -70.5 97.26 0.69 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 120.816 1.011 . . . . 1.6699999999999999 111.218 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -131.7 136.71 47.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.732 -0.667 . . . . 1.29 110.049 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.7 t70 -84.73 14.38 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 1.77 111.04 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 109' ' ' ASP . 4.2 tt 50.45 -64.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 125.095 1.497 . . . . 1.9199999999999999 112.315 -171.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.8 OUTLIER -65.36 -23.87 67.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.815 -0.175 . . . . 1.1599999999999999 110.66 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.429 ' OE2' ' HB2' ' A' ' 107' ' ' ASP . 8.9 pt-20 -68.5 -28.2 66.81 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.4 -0.52 . . . . 0.83999999999999997 110.421 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.3 mt -81.21 -40.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 1.5600000000000001 110.256 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.656 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.04 -37.1 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.843 0.83 . . . . 0.80000000000000004 109.577 174.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.531 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 4.7 t70 -68.44 -37.02 79.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.379 -0.828 . . . . 0.78000000000000003 109.359 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.495 ' O ' ' HD1' ' A' ' 118' ' ' TYR . . . -62.98 -47.66 82.21 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.323 -0.853 . . . . 1.3100000000000001 111.224 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.602 HG13 HD21 ' A' ' 50' ' ' LEU . 17.8 m -62.82 -48.77 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 119.209 -0.996 . . . . 1.1200000000000001 110.377 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.592 ' HD2' ' CA ' ' A' ' 124' ' ' ASN . 3.6 ttpp -53.98 -50.33 66.79 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.145 0.578 . . . . 1.99 112.237 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 19.1 ptpt -60.21 -35.54 75.66 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.778 -0.576 . . . . 2.0899999999999999 111.462 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 24.6 m-85 -76.07 -56.4 4.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.993 0.425 . . . . 2.3900000000000001 110.836 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.71 HD12 ' HB2' ' A' ' 2' ' ' MET . 55.9 tp -127.47 97.53 30.8 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.925 -0.58 . . . . 2.7599999999999998 109.686 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 65.8 Cg_endo -98.58 117.29 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.83 2.354 . . . . 0.92000000000000004 113.215 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.892 HD23 ' HE3' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -90.36 -61.47 1.67 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.138 0.97 . . . . 1.9399999999999999 109.409 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.892 ' HE3' HD23 ' A' ' 121' ' ' LEU . 32.3 mmtp -127.62 -41.98 1.65 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.465 -1.698 . . . . 3.3599999999999999 109.923 -172.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.85 ' HB2' ' HB3' ' A' ' 26' ' ' GLU . 9.0 t -53.13 179.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.524 -1.216 . . . . 2.1699999999999999 112.715 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.592 ' CA ' ' HD2' ' A' ' 116' ' ' LYS . 7.1 t30 90.54 -29.85 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.105 1.362 . . . . 6.0 109.683 -172.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.84 95.16 9.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.094 -0.706 . . . . 6.2699999999999996 109.094 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -78.59 99.73 6.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.03 -0.532 . . . . 8.6500000000000004 110.339 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -86.29 166.52 15.59 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.888 -0.596 . . . . 10.210000000000001 110.189 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -130.91 -75.77 0.53 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.894 -0.322 . . . . 13.26 110.615 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.0 m170 61.25 -89.19 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.56 0.538 . . . . 12.92 111.448 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -169.15 91.03 0.23 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.394 -0.965 . . . . 17.120000000000001 108.394 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -146.59 122.4 10.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.027 0.441 . . . . 17.550000000000001 111.141 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.2 m80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.008 -0.996 . . . . 19.600000000000001 109.742 175.86 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.828 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 13.8 tt0 . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.545 0.688 . . . . 2.3 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.915 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.7 tppt? -134.74 145.15 48.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.108 0.48 . . . . 0.8 111.533 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.918 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.7 mt -136.7 156.41 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.305 -0.861 . . . . 0.2 111.454 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.862 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.1 tt -133.48 120.16 20.5 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.656 -1.239 . . . . 0.17 107.656 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.724 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.8 mp -107.48 103.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.474 -0.89 . . . . 0.22 110.385 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 28.9 t -88.7 82.62 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 110.051 -0.351 . . . . 0.28 110.051 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.859 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 51.8 t0 -133.5 138.92 46.36 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.115 -0.328 . . . . 1.82 110.115 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 1.013 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 37.0 t70 -85.82 -27.83 24.87 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.022 -0.732 . . . . 0.51 109.022 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' CB ' HD12 ' A' ' 15' ' ' ILE . 9.5 mm-40 -78.86 73.47 5.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.51 -1.293 . . . . 2.07 107.51 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 41.8 p90 -48.47 -19.67 0.34 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.511 -1.222 . . . . 1.44 113.271 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.03 -69.71 1.19 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.36 -1.096 . . . . 0.38 110.36 167.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.553 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 2.9 mp -51.03 -26.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 122.916 0.486 . . . . 0.8 111.863 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.94 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 9.0 ttm180 -76.96 -46.53 23.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.312 -0.404 . . . . 0.38 110.73 -172.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.49 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 36.3 pt -77.03 -25.45 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.283 -0.636 . . . . 0.56 109.283 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.5 tp -53.9 -66.19 0.44 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.135 -0.939 . . . . 0.58 109.157 169.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 64.5 mt -57.25 -39.95 76.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 1.23 110.57 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.72 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.5 t30 -51.53 -67.87 0.22 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.94 110.042 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -39.59 77.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.313 0.486 . . . . 2.46 112.313 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' LEU . 39.5 t -55.18 -58.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.787 0.292 . . . . 0.37 111.787 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.677 ' HB2' HG21 ' A' ' 30' ' ' THR . 8.2 m-85 -73.74 -35.13 65.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.287 -0.635 . . . . 0.43 109.287 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.932 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.3 t-20 -50.48 -47.93 56.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.06 -0.973 . . . . 0.28 108.668 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -57.68 -42.2 83.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.315 -1.766 . . . . 3.25 111.938 -178.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 23' ' ' PHE . 3.2 mt-10 -58.62 -26.82 64.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.809 0.814 . . . . 1.45 109.719 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.682 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 139.09 -10.61 3.32 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 114.193 -1.367 . . . . 0.44 110.295 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.932 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 1.8 m-85 -71.62 124.03 23.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 120.119 -0.632 . . . . 1.07 110.838 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.915 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -79.12 82.99 5.23 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.26 -1.015 . . . . 1.14 108.26 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.918 HG22 ' HB ' ' A' ' 6' ' ' ILE . 20.6 p -91.04 134.02 34.84 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.973 -0.558 . . . . 0.14 110.493 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 12.9 m-85 -125.48 120.76 31.83 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.57 1.176 . . . . 0.34 109.419 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.94 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 6.5 pt20 -81.18 121.72 26.48 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 112.736 -2.029 . . . . 0.22 111.693 -173.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.919 ' HB1' ' HB3' ' A' ' 38' ' ' GLN . . . -122.14 131.3 53.89 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.696 0.799 . . . . 0.23 109.145 176.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.569 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -91.16 -7.17 52.25 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.983 -0.687 . . . . 0.18 110.897 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -147.73 165.5 30.33 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.42 -0.512 . . . . 0.29 111.699 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -23.16 73.13 Favored Glycine 0 CA--C 1.507 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.14 113.118 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.54 -39.87 51.6 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.725 -0.843 . . . . 0.28 108.725 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.919 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -60.51 -44.88 95.55 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.091 -2.189 . . . . 1.29 105.091 177.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -61.14 -44.43 97.34 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.14 111.252 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.61 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -55.83 -44.82 78.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.461 0.648 . . . . 0.97 109.473 175.165 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -61.59 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.666 -1.152 . . . . 1.32 110.32 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.841 HG12 ' O ' ' A' ' 38' ' ' GLN . 8.5 mm -63.69 -47.35 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 120.551 0.215 . . . . 0.14 111.418 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 69' ' ' MET . 41.2 t -59.88 -42.43 89.16 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.678 0 CA-C-O 121.486 0.66 . . . . 0.15 109.506 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -72.31 -22.15 61.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.562 -0.745 . . . . 0.39 111.197 -177.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.83 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 2.1 ptmt -89.82 -44.89 9.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 2.42 111.225 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' HE3' ' A' ' 5' ' ' LYS . 60.6 mm-40 -111.14 -35.71 5.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 111.897 0.332 . . . . 0.63 111.897 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 43' ' ' VAL . 37.6 mmt180 69.01 59.83 0.62 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 123.936 0.772 . . . . 3.66 109.123 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' ILE . 52.4 Cg_exo -61.23 153.74 63.01 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 121.457 1.438 . . . . 0.21 111.222 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.3 m-20 -92.69 -34.1 14.09 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.713 -0.795 . . . . 0.98 109.415 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 79' ' ' ILE . 7.8 mp -118.57 113.33 21.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.013 -0.54 . . . . 0.26 110.214 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 7' ' ' LEU . 46.9 t -113.26 112.19 39.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.017 0.437 . . . . 0.21 111.665 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.44 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 2.9 mp -82.06 94.28 7.17 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.277 0.56 . . . . 0.15 110.389 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.682 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -83.04 98.8 9.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.18 -0.918 . . . . 1.53 111.635 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.63 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 35.6 t70 -70.98 103.91 2.82 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.426 -0.91 . . . . 1.47 109.156 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.624 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 19.9 mtm -80.29 -1.07 39.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.015 -0.539 . . . . 0.94 110.772 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.561 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 12.6 mmmm -56.9 -67.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.724 1.009 . . . . 2.24 113.724 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.859 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 4.6 pt -152.91 -22.87 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.638 1.347 . . . . 2.06 114.638 -167.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.013 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -33.62 -48.12 0.46 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.356 2.704 . . . . 0.45 115.564 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 -48.36 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.551 -1.309 . . . . 0.47 113.077 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.418 ' HG2' ' N ' ' A' ' 61' ' ' ASP . 58.1 ttm -143.35 163.35 33.28 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.113 -0.699 . . . . 2.23 109.113 -175.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 60' ' ' MET . 35.3 m-20 -61.15 136.57 58.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.094 0.473 . . . . 0.67 109.961 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 53' ' ' LEU . . . -63.65 -9.93 34.83 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.309 -0.948 . . . . 0.32 112.157 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.927 HD11 ' HB3' ' A' ' 89' ' ' MET . 4.7 mt -73.33 -52.64 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.123 0.487 . . . . 1.31 110.067 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.81 -33.21 75.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.749 0.785 . . . . 0.47 109.231 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 49.7 mt -74.82 -37.7 42.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.177 -0.92 . . . . 0.69 110.912 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 3.1 pp -66.96 -36.2 81.67 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.414 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.707 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.9 ptpt -75.84 -34.63 60.09 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.453 -0.499 . . . . 0.65 111.175 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.729 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.1 ptm180 -66.78 -33.49 75.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.559 -0.857 . . . . 2.18 111.054 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.761 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.8 ptp -82.8 -13.69 55.76 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.561 -0.856 . . . . 1.28 109.889 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.3 mptp? -79.12 -29.83 43.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.572 0.701 . . . . 1.3 109.877 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.4 p -78.47 -34.98 18.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.028 -0.73 . . . . 1.03 109.028 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.761 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -81.14 -28.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 0.26 109.98 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -157.94 88.93 0.98 Allowed 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 112.928 0.714 . . . . 1.08 112.928 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.0 1.73 10.28 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.047 -1.033 . . . . 1.78 109.831 175.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -27.29 63.86 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.796 1.284 . . . . 0.35 107.722 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.69 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.2 tt -74.25 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 112.492 -2.14 . . . . 0.21 110.938 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 3.4 ptp180 -139.21 174.32 10.64 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.981 -1.118 . . . . 1.08 107.981 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.696 HG23 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -138.97 148.32 24.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.618 0.723 . . . . 0.79 111.47 -173.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.694 HG23 ' OG1' ' A' ' 100' ' ' THR . 63.3 mt -119.72 72.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.961 -1.126 . . . . 0.6 107.961 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.642 HG22 ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -68.65 141.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.318 -0.856 . . . . 0.14 111.768 -172.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.555 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 4.0 mtm -102.05 135.22 44.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.012 -0.995 . . . . 1.88 110.595 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 t -133.4 161.59 34.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.493 0.663 . . . . 1.13 112.672 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . . . -74.1 52.74 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.99 -1.005 . . . . 0.54 110.593 169.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.406 ' HA ' ' CB ' ' A' ' 103' ' ' ALA . 22.4 t80 72.84 30.86 1.67 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.974 -1.012 . . . . 4.3 112.085 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.87 76.53 1.23 Allowed Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.885 -0.674 . . . . 0.62 112.892 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.446 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.5 mt-10 -81.06 12.04 3.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.444 -0.878 . . . . 1.33 111.799 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 87' ' ' LEU . 21.2 mt 54.38 -169.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.391 0.886 . . . . 1.73 113.391 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 58.08 -97.62 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.337 -0.847 . . . . 1.38 110.852 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.927 ' HB3' HD11 ' A' ' 63' ' ' ILE . 57.6 mtm -51.52 -37.01 47.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.834 0.854 . . . . 2.72 110.731 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 86' ' ' GLU . 33.0 mm -58.78 -47.67 88.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.67 111.109 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -60.69 -55.05 37.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.451 -0.795 . . . . 2.5 109.51 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HG2' HG21 ' A' ' 63' ' ' ILE . 7.0 tt0 -58.42 -33.57 69.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.853 -1.067 . . . . 1.27 112.085 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.47 ' OG ' HG12 ' A' ' 63' ' ' ILE . 4.9 m -54.08 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.63 0.729 . . . . 1.28 111.8 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.828 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 12.8 ptpt -52.33 -37.35 55.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.837 -1.074 . . . . 1.91 111.004 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 17.7 tp10 -55.98 -37.99 69.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.965 -1.016 . . . . 1.84 112.1 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.9 mt -85.77 -15.09 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.795 0.665 . . . . 1.25 112.795 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.48 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 147.54 4.18 0.39 Allowed Glycine 0 C--N 1.317 -0.519 0 C-N-CA 119.778 -1.201 . . . . 0.35 113.023 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.828 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -79.21 131.69 36.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.263 0.532 . . . . 0.21 109.936 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.513 HD11 ' HG3' ' A' ' 77' ' ' ARG . 11.2 mt -74.39 -49.32 23.06 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.856 0.836 . . . . 0.18 109.734 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.694 ' OG1' HG23 ' A' ' 79' ' ' ILE . 41.3 p -140.14 153.45 46.67 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.0 -1.455 . . . . 0.19 111.756 -170.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -116.96 85.7 2.37 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.871 -1.059 . . . . 0.52 109.215 172.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -76.43 145.66 39.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 3.86 110.579 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 84' ' ' TYR . . . -121.68 -168.43 1.69 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.109 -0.496 . . . . 0.76 112.001 -173.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 45.5 mtpt -52.92 -50.4 81.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.168 -0.924 . . . . 3.35 111.654 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 68.9 Cg_endo -75.46 97.43 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.127 1.218 . . . . 1.36 111.393 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 111' ' ' ILE . 46.9 p90 -129.24 133.45 47.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.822 -0.626 . . . . 1.1 110.208 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.672 ' O ' HG22 ' A' ' 108' ' ' ILE . 7.3 t70 -72.73 -4.27 30.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.916 -0.584 . . . . 1.77 111.413 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.672 HG22 ' O ' ' A' ' 107' ' ' ASP . 3.6 tt 63.06 -54.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.559 1.144 . . . . 1.39 109.882 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.2 -34.98 79.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.576 -0.284 . . . . 1.16 110.516 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.5 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 11.5 pt-20 -65.15 -27.41 68.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.579 -0.449 . . . . 0.84 110.772 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 106' ' ' PHE . 19.3 mt -80.51 -44.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.108 -0.33 . . . . 0.74 110.108 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.482 ' HD2' ' C ' ' A' ' 112' ' ' ARG . 2.4 ppt_? -69.73 -35.47 75.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.776 0.798 . . . . 0.72 109.423 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.0 t70 -63.77 -42.63 97.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.695 -0.854 . . . . 0.78 108.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.973 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -60.29 -48.79 80.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.857 -1.065 . . . . 0.59 111.462 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 112' ' ' ARG . 35.5 m -61.3 -43.06 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.912 -0.715 . . . . 0.47 111.004 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 8.3 ttpt -58.06 -55.96 28.18 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 120.909 0.385 . . . . 1.16 111.151 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.973 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 46.1 pttt -65.68 -13.15 58.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.516 0.562 . . . . 1.48 112.516 -176.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -92.01 -41.2 10.67 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.583 -0.447 . . . . 2.21 111.443 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -146.6 95.96 4.51 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.331 -0.988 . . . . 2.09 108.331 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -96.4 123.74 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.815 2.344 . . . . 0.92 114.182 -171.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 4' ' ' GLU . 12.7 tp . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.356 0.598 . . . . 1.25 110.076 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.854 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 120.701 0.286 . . . . 2.3 110.848 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.632 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 4.0 tppt? -134.6 140.44 46.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.016 0.436 . . . . 0.8 112.06 -173.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.891 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.9 mt -137.0 155.84 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.276 -0.874 . . . . 0.2 112.061 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.863 ' HG ' HG21 ' A' ' 42' ' ' ILE . 3.4 tt -133.86 118.35 17.87 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 107.934 -1.136 . . . . 0.17 107.934 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -105.72 102.98 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.886 -0.725 . . . . 0.22 110.211 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 44.3 t -89.38 79.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 122.967 0.167 . . . . 0.28 110.68 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.827 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.3 t70 -129.97 140.84 50.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 1.82 110.817 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.812 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 26.9 t70 -94.81 -32.91 13.07 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.501 -0.318 . . . . 0.51 111.048 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 70.07 8.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.497 -1.297 . . . . 2.07 107.497 173.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.441 ' O ' HG12 ' A' ' 17' ' ' ILE . 41.1 p90 -47.94 -16.08 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 111.862 -2.426 . . . . 1.44 115.342 -166.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.49 -61.62 6.18 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.751 -1.339 . . . . 0.38 109.751 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 3.1 mt -54.92 -29.34 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.224 0.535 . . . . 0.8 111.136 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.869 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -77.58 -48.67 16.36 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.772 -0.649 . . . . 0.38 111.055 -168.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 41.5 pt -75.71 -25.06 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.247 -0.649 . . . . 0.56 109.247 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.2 tp -58.64 -66.28 0.52 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.251 -0.886 . . . . 0.58 109.699 170.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 80.3 mt -53.83 -43.71 69.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.075 -0.343 . . . . 1.23 110.075 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.1 t30 -50.31 -66.1 0.45 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.261 -0.881 . . . . 0.94 110.079 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.81 -39.84 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.888 0.742 . . . . 2.46 110.75 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -54.86 -60.1 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.52 -0.309 . . . . 0.37 111.423 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.655 ' HB2' HG21 ' A' ' 30' ' ' THR . 2.0 m-85 -70.95 -39.99 72.26 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.016 -0.735 . . . . 0.43 109.016 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.627 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 1.2 t30 -52.26 -52.69 51.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.895 -1.048 . . . . 0.28 109.333 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 2.8 tmmm? -60.87 -43.13 98.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.722 -1.581 . . . . 3.25 111.93 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.516 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 10.9 pt-20 -81.92 13.15 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 1.45 111.193 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.02 3.03 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.369 -0.92 . . . . 0.44 113.427 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.854 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 7.8 m-85 -77.76 150.25 34.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.926 0.869 . . . . 1.07 112.511 -165.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.632 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -98.01 82.15 2.94 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.91 -1.041 . . . . 1.14 108.336 166.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.891 HG22 ' HB ' ' A' ' 6' ' ' ILE . 19.3 p -92.52 138.59 31.37 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.659 -0.7 . . . . 0.14 109.883 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 10.5 m-85 -128.55 107.55 9.8 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.869 1.319 . . . . 0.34 110.299 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.869 ' HB2' HH11 ' A' ' 16' ' ' ARG . 7.0 pt20 -59.53 121.11 10.72 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 112.035 -2.348 . . . . 0.22 112.516 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.721 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -124.94 129.7 50.88 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 108.89 -0.781 . . . . 0.23 108.89 174.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.731 ' HB2' HH21 ' A' ' 16' ' ' ARG . . . -90.4 -9.65 46.78 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.07 -0.652 . . . . 0.18 110.831 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.39 164.48 33.98 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.038 -0.528 . . . . 0.29 111.736 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 65' ' ' ILE . . . -69.42 -22.14 76.3 Favored Glycine 0 CA--C 1.504 -0.597 0 CA-C-N 115.254 -0.885 . . . . 0.14 113.745 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.36 -41.57 21.79 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 122.216 1.008 . . . . 0.28 108.946 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.808 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.1 tp60 -60.53 -39.67 88.7 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.584 -2.006 . . . . 1.29 105.584 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.57 88.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.132 -1.395 . . . . 0.14 111.281 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.547 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -56.41 -47.87 78.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.38 -0.827 . . . . 0.97 109.728 176.111 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -63.83 -36.0 82.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.326 -1.306 . . . . 1.32 111.317 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.863 HG21 ' HG ' ' A' ' 7' ' ' LEU . 26.7 mm -65.47 -49.47 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.277 -0.268 . . . . 0.14 110.277 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.7 t -58.68 -43.14 86.97 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.265 1.031 . . . . 0.15 108.835 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -58.13 -30.9 66.69 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.361 -1.291 . . . . 0.39 111.702 177.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.546 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 5.7 tptt -90.57 -50.48 5.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.064 -0.517 . . . . 2.42 111.511 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.578 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 58.1 mm-40 -106.1 -35.95 7.07 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.583 0.586 . . . . 0.63 112.583 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 43.6 mtt180 62.93 65.02 1.44 Allowed Pre-proline 0 C--N 1.322 -0.589 0 O-C-N 123.673 0.608 . . . . 3.66 110.323 -170.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.76 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 66.4 Cg_exo -60.32 163.48 14.77 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.116 1.877 . . . . 0.21 111.635 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.781 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.8 m-20 -92.6 -44.48 8.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.973 -0.751 . . . . 0.98 108.973 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.762 HD23 HD11 ' A' ' 79' ' ' ILE . 7.6 mp -107.29 110.4 22.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.26 110.014 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 7' ' ' LEU . 62.6 t -110.16 107.35 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.453 . . . . 0.21 111.197 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 3.1 mp -78.51 95.93 5.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.432 0.634 . . . . 0.15 110.032 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.63 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -85.65 92.83 8.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.951 -1.022 . . . . 1.53 110.2 -176.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.673 ' OD1' ' HG2' ' A' ' 56' ' ' LYS . 34.6 t70 -68.59 108.82 3.49 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.75 0.786 . . . . 1.47 109.739 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.632 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 20.8 mtm -93.48 16.89 12.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.226 -0.897 . . . . 0.94 110.244 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.673 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 2.9 mmpp? -54.09 -53.43 53.27 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 120.075 -0.65 . . . . 2.24 110.445 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.932 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.5 tt -179.83 -19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.563 -1.208 . . . . 2.06 114.209 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.932 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -26.81 -54.43 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.465 2.777 . . . . 0.45 116.014 -175.203 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.48 -55.65 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.742 -1.218 . . . . 0.47 112.904 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.427 ' HB3' HD11 ' A' ' 65' ' ' ILE . 46.0 tpp -142.25 165.15 28.21 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.35 -0.611 . . . . 2.23 109.35 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.2 m-20 -60.39 140.22 57.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.67 110.785 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.585 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -64.65 -12.48 52.91 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.825 -1.079 . . . . 0.32 112.184 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.635 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 11.9 mt -76.51 -46.72 31.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 1.31 110.149 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -60.07 -43.0 95.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.658 -0.868 . . . . 0.47 108.658 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.626 HD12 ' HA3' ' A' ' 36' ' ' GLY . 16.5 mm -68.6 -43.18 83.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.475 -0.784 . . . . 0.69 111.452 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 96' ' ' LEU . 3.0 pp -62.5 -37.66 86.91 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.718 -0.393 . . . . 1.47 110.236 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.0 ptpt -76.03 -36.37 59.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.125 -0.63 . . . . 0.65 111.827 -176.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HG3' HD23 ' A' ' 40' ' ' LEU . 3.0 ptm180 -67.38 -34.39 77.18 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.819 -1.152 . . . . 2.18 111.004 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.681 ' HG3' HG21 ' A' ' 76' ' ' ILE . 11.8 ptp -78.85 -18.58 53.75 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.018 -0.673 . . . . 1.28 109.725 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.4 mptt -70.95 -40.59 71.91 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.554 -0.906 . . . . 1.3 108.554 169.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 67' ' ' LYS . 92.8 t -61.41 -38.21 79.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.423 -0.808 . . . . 1.03 110.531 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.68 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -83.86 -30.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.377 -0.529 . . . . 0.26 110.325 175.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -156.04 83.48 1.01 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.728 0.64 . . . . 1.08 112.728 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 32.4 mt-10 -69.99 2.56 3.41 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.293 -0.879 . . . . 1.78 111.272 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -28.44 65.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.737 1.256 . . . . 0.35 107.729 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.681 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.8 tt -75.52 158.12 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 112.587 -2.097 . . . . 0.21 111.208 -172.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.781 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -134.19 -178.28 4.97 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.11 -0.95 . . . . 1.08 108.496 175.151 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.648 HG23 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -143.09 148.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 120.133 -0.627 . . . . 0.79 111.019 -175.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.762 HD11 HD23 ' A' ' 50' ' ' LEU . 64.5 mt -117.87 71.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.725 -1.213 . . . . 0.6 107.725 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.632 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.81 141.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 119.045 -1.062 . . . . 0.14 111.181 -172.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.515 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 22.4 mtp -109.25 111.91 23.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.676 -1.147 . . . . 1.88 110.412 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.708 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 1.2 t -120.55 166.65 13.33 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 122.162 -0.336 . . . . 1.13 111.316 -175.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.37 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.782 -0.644 . . . . 0.54 111.375 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 13.5 t80 59.67 3.66 0.46 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.828 1.251 . . . . 4.3 112.39 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.96 93.18 1.87 Allowed Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.923 -0.656 . . . . 0.62 112.354 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 90' ' ' ILE . 30.9 mt-10 -74.8 11.85 0.97 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 1.33 111.002 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 85' ' ' GLY . 26.4 mt 64.81 -177.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.593 0.96 . . . . 1.73 113.593 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 62.17 -92.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.606 -1.179 . . . . 1.38 111.327 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.503 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 71.0 mtm -64.23 -22.91 67.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 120.925 0.393 . . . . 2.72 110.428 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.582 HG13 ' N ' ' A' ' 86' ' ' GLU . 42.8 mm -67.03 -39.95 84.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.181 0.515 . . . . 0.67 110.012 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.67 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 12.7 mm100 -67.24 -42.29 84.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.264 -0.88 . . . . 2.5 108.996 176.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.628 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 9.4 tt0 -63.16 -39.92 96.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.371 -1.286 . . . . 1.27 112.047 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.425 ' CB ' HG12 ' A' ' 63' ' ' ILE . 8.5 t -55.37 -62.96 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 1.28 110.414 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.958 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 50.3 pttt -56.93 -36.79 70.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.998 -0.546 . . . . 1.91 111.892 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -65.99 -22.97 66.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.081 -0.248 . . . . 1.84 111.545 -178.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.722 ' HB3' HD11 ' A' ' 66' ' ' LEU . 4.4 mp -88.63 -4.98 58.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 1.25 111.495 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.42 16.72 1.84 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.864 -1.16 . . . . 0.35 113.135 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.958 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -89.39 132.01 35.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.121 -0.696 . . . . 0.21 109.121 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.679 HD21 ' HD3' ' A' ' 77' ' ' ARG . 13.9 mt -73.63 -49.07 27.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.807 0.813 . . . . 0.18 109.506 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.668 ' OG1' HG23 ' A' ' 79' ' ' ILE . 70.0 p -141.51 142.8 33.57 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.081 -1.418 . . . . 0.19 111.519 -173.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.31 85.73 2.41 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.811 -1.086 . . . . 0.52 109.457 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 13.3 m-85 -75.1 157.46 34.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 3.86 109.893 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -98.71 -170.71 1.98 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.338 0.496 . . . . 0.76 112.338 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 44.6 tttp -73.19 -45.47 8.03 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.087 -0.708 . . . . 3.35 109.087 172.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 36.1 Cg_endo -68.29 97.89 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.438 1.425 . . . . 1.36 111.026 166.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -112.67 139.32 48.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.488 -0.778 . . . . 1.1 109.65 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -87.56 20.21 3.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 119.238 -0.41 . . . . 1.77 111.306 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 109' ' ' ASP . 2.4 tt 49.18 -66.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 1.39 112.781 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.478 ' H ' HG23 ' A' ' 108' ' ' ILE . 5.6 t70 -64.27 -25.78 68.2 Favored 'General case' 0 C--O 1.212 -0.884 0 O-C-N 122.397 -0.189 . . . . 1.16 110.807 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.59 -27.86 65.46 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 120.425 -0.51 . . . . 0.84 109.765 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -76.65 -47.5 28.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.224 -0.658 . . . . 0.74 109.224 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.38 -39.32 85.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.122 0.487 . . . . 0.72 109.922 179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 24.4 t70 -65.72 -43.34 89.35 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.304 -0.628 . . . . 0.78 109.304 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.943 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.96 -51.05 69.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.666 -0.697 . . . . 0.59 111.124 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 112' ' ' ARG . 27.0 m -59.02 -50.77 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.844 -0.742 . . . . 0.47 111.475 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -65.36 -29.34 70.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.345 0.498 . . . . 1.16 112.345 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.943 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 56.9 pttt -81.52 -11.74 59.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.49 -0.884 . . . . 1.48 111.507 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.6 -58.65 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.175 0.512 . . . . 2.21 110.176 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.512 ' HG ' ' OE1' ' A' ' 4' ' ' GLU . 57.1 tp -122.67 109.77 32.28 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.384 -0.969 . . . . 2.09 108.384 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 47.4 Cg_endo -101.44 148.13 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.773 2.315 . . . . 0.92 114.331 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.766 -0.828 . . . . 1.25 108.766 174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.744 ' CD ' ' HB3' ' A' ' 121' ' ' LEU . 17.5 pt-20 . . . . . 0 N--CA 1.448 -0.575 0 CA-C-O 120.98 0.419 . . . . 2.3 109.991 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.827 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -117.23 144.88 44.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.8 111.812 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.869 ' HB ' HG22 ' A' ' 30' ' ' THR . 3.4 mt -135.02 153.47 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 114.933 -1.031 . . . . 0.2 111.655 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.861 ' HG ' HG21 ' A' ' 42' ' ' ILE . 2.4 tt -129.51 124.95 35.22 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.562 -1.273 . . . . 0.17 107.562 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.745 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.5 mp -112.26 107.57 23.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.124 -0.63 . . . . 0.22 109.963 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.669 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 57.6 t -96.15 89.55 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.103 -0.332 . . . . 0.28 110.103 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.717 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 0.8 OUTLIER -135.42 136.04 41.07 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.118 -0.492 . . . . 1.82 110.215 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.748 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 20.9 t70 -88.91 -41.65 12.3 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.486 0.184 . . . . 0.51 110.768 -177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HG3' ' CD1' ' A' ' 15' ' ' ILE . 3.1 pt20 -78.69 70.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.819 -1.178 . . . . 2.07 107.819 172.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.8 p90 -48.09 -13.72 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 111.856 -2.429 . . . . 1.44 115.588 -163.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.08 -57.38 6.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.249 -0.977 . . . . 0.38 110.937 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 2.4 mt -59.94 -25.85 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.477 0.656 . . . . 0.8 110.664 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 1.0 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.5 ttm180 -78.9 -49.24 13.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.38 110.529 -168.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 37.9 pt -75.07 -24.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.219 -0.66 . . . . 0.56 109.219 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.765 HD11 HD11 ' A' ' 108' ' ' ILE . 7.5 tp -58.09 -67.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.947 -1.024 . . . . 0.58 109.827 171.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.575 HD13 HD22 ' A' ' 52' ' ' LEU . 69.8 mt -54.18 -41.15 68.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.179 -0.464 . . . . 1.23 110.08 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.7 t30 -49.94 -70.09 0.1 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.263 -0.88 . . . . 0.94 110.473 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -57.24 -36.9 71.5 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.308 0.38 . . . . 2.46 111.683 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 18' ' ' LEU . 31.1 t -55.92 -55.66 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.592 0.219 . . . . 0.37 111.592 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.717 ' HB2' HG21 ' A' ' 30' ' ' THR . 7.7 m-85 -78.18 -36.73 47.07 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 120.659 -0.416 . . . . 0.43 109.922 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.818 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.8 t-20 -50.27 -45.53 54.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.176 0.989 . . . . 0.28 108.753 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -60.35 -38.44 83.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.09 -1.868 . . . . 3.25 111.9 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' OE2' ' HD3' ' A' ' 112' ' ' ARG . 4.2 mm-40 -55.9 -33.14 64.36 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.297 1.046 . . . . 1.45 109.586 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.79 1.45 3.01 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 113.071 -1.877 . . . . 0.44 109.417 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.818 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 45.4 m-85 -75.37 132.3 40.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.364 0.602 . . . . 1.07 110.666 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.827 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 12.0 mt-30 -86.52 81.38 8.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.79 -1.189 . . . . 1.14 107.79 171.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.869 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.9 p -90.25 132.75 35.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.799 -0.637 . . . . 0.14 110.214 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 20.1 m-85 -124.42 123.75 40.85 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 122.826 1.298 . . . . 0.34 110.13 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 1.0 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.6 pt20 -82.74 121.91 27.49 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.053 -2.339 . . . . 0.22 112.073 -171.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.83 137.42 54.66 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.166 0.987 . . . . 0.23 108.678 174.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.659 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -98.98 -3.81 34.1 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.137 -0.625 . . . . 0.18 110.402 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -148.51 163.7 36.42 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.792 -0.64 . . . . 0.29 111.315 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.17 79.41 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.534 -0.757 . . . . 0.14 113.306 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.42 -40.83 25.64 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 122.395 1.093 . . . . 0.28 108.2 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.829 ' O ' HG12 ' A' ' 42' ' ' ILE . 2.6 tp-100 -58.96 -40.42 84.67 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.521 -2.127 . . . . 1.29 105.404 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -65.2 -45.56 84.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.794 -1.548 . . . . 0.14 111.544 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 68' ' ' ARG . 11.7 mt -55.53 -39.31 70.4 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.703 0.763 . . . . 0.97 109.556 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 21.3 t70 -72.3 -38.01 68.83 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.54 -1.209 . . . . 1.32 110.374 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.861 HG21 ' HG ' ' A' ' 7' ' ' LEU . 18.0 mm -58.86 -48.59 85.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 120.685 0.279 . . . . 0.14 110.674 176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 39' ' ' ALA . 24.0 t -61.43 -41.47 90.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.968 0.89 . . . . 0.15 109.723 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -63.23 -28.51 70.09 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.604 -1.18 . . . . 0.39 111.204 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -94.99 -48.53 5.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 2.42 111.766 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 66.7 mm-40 -104.63 -37.05 7.26 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.69 0.256 . . . . 0.63 111.69 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 62.88 67.83 1.05 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.787 -0.642 . . . . 3.66 110.02 -169.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.776 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 45.9 Cg_exo -65.03 154.89 71.18 Favored 'Trans proline' 0 CA--C 1.503 -1.035 0 C-N-CA 121.858 1.705 . . . . 0.21 111.424 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.805 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 8.3 m-20 -89.65 -41.69 11.8 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.723 -0.791 . . . . 0.98 109.013 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.538 HD23 HD11 ' A' ' 79' ' ' ILE . 6.7 mp -108.02 110.05 21.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.211 -0.45 . . . . 0.26 110.166 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.816 ' HB ' HG12 ' A' ' 78' ' ' VAL . 57.9 t -109.95 109.32 27.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.081 0.467 . . . . 0.21 111.584 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -80.5 91.15 5.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.393 0.616 . . . . 0.15 109.772 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.818 HD12 HG11 ' A' ' 78' ' ' VAL . 18.5 mt -89.13 103.13 15.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.298 -0.864 . . . . 1.53 111.079 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.625 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 12.4 t70 -67.06 116.83 8.31 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.128 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.643 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 13.0 mtm -98.14 12.19 35.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.793 -0.64 . . . . 0.94 110.696 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 13.0 mmmm -64.25 -49.32 72.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.662 -0.245 . . . . 2.24 111.368 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.892 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 17.3 tt 174.81 -28.6 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.718 1.377 . . . . 2.06 114.718 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.892 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -18.31 -59.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 124.546 3.497 . . . . 0.45 116.625 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.95 -63.86 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.072 -1.061 . . . . 0.47 112.225 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.5 tpt -148.72 167.02 26.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.577 -0.897 . . . . 2.23 108.577 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.46 135.67 57.74 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.67 0.748 . . . . 0.67 110.563 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -58.44 -18.79 38.14 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 114.239 -1.346 . . . . 0.32 111.751 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.657 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 4.0 mt -66.97 -49.6 72.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.01 0.433 . . . . 1.31 110.571 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.58 -34.65 77.46 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.635 0.731 . . . . 0.47 109.072 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.548 HG22 ' HE3' ' A' ' 69' ' ' MET . 17.0 mt -73.37 -38.57 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.189 -0.914 . . . . 0.69 111.025 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 4.3 pp -67.02 -35.09 79.13 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 121.074 -0.25 . . . . 1.47 110.412 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.2 ptpt -76.23 -33.41 59.2 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.406 -0.517 . . . . 0.65 111.12 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.2 ptp180 -70.49 -29.84 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 118.752 -1.179 . . . . 2.18 111.579 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.837 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.5 ptp -83.98 -13.36 53.52 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.455 -0.898 . . . . 1.28 109.579 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -78.68 -32.87 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.598 -0.728 . . . . 1.3 109.855 172.301 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -74.34 -36.27 42.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.781 -0.822 . . . . 1.03 108.781 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.837 HG12 ' HA ' ' A' ' 69' ' ' MET . 20.6 pt -80.62 -21.84 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.092 -0.958 . . . . 0.26 110.325 172.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.734 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 29.7 t0 -164.89 95.32 0.7 Allowed 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 112.887 0.699 . . . . 1.08 112.887 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.631 ' OE1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -77.81 6.09 8.22 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.979 -1.076 . . . . 1.78 110.126 174.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.734 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -78.53 -34.0 47.52 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.339 -1.356 . . . . 0.35 107.339 171.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.71 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.0 tt -60.18 159.38 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.185 -1.825 . . . . 0.21 111.685 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.805 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 2.8 ptp180 -142.76 173.83 11.19 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.989 -1.115 . . . . 1.08 107.989 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.818 HG11 HD12 ' A' ' 53' ' ' LEU . 2.3 m -141.79 147.98 21.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.477 -0.889 . . . . 0.79 112.066 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.672 HG23 ' OG1' ' A' ' 100' ' ' THR . 67.1 mt -116.4 72.85 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.57 -1.27 . . . . 0.6 107.57 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.643 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.66 142.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.615 -0.834 . . . . 0.14 112.069 -171.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 10.2 mtt -99.33 124.69 44.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.489 -0.778 . . . . 1.88 110.04 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.58 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t -133.15 160.3 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.998 0.74 . . . . 1.13 112.998 -173.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 63.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.649 -1.16 . . . . 0.54 110.664 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 67.41 5.12 4.09 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.571 0.748 . . . . 4.3 112.418 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.0 88.18 0.75 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.861 -0.685 . . . . 0.62 111.801 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.528 ' N ' HG13 ' A' ' 90' ' ' ILE . 39.7 mt-10 -65.61 -89.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.483 -0.358 . . . . 1.33 111.244 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HG ' ' H ' ' A' ' 88' ' ' ASP . 9.5 tp -177.53 -167.76 0.16 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.69 0.281 . . . . 1.73 111.716 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.722 ' H ' ' HG ' ' A' ' 87' ' ' LEU . 9.3 m-20 43.99 -89.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.857 1.263 . . . . 1.38 113.009 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.641 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 62.7 mtt -56.94 -35.51 69.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.106 -0.497 . . . . 2.72 110.461 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.528 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.6 mm -59.89 -44.76 95.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.81 -0.632 . . . . 0.67 110.278 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.63 -53.53 57.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.559 -0.746 . . . . 2.5 109.385 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 15.8 tt0 -58.9 -34.84 72.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.945 -1.025 . . . . 1.27 112.314 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.4 t -55.34 -69.51 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 1.28 110.89 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 16.6 pttp -55.9 -36.54 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.383 0.611 . . . . 1.91 111.069 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 10.9 tp10 -56.59 -45.37 81.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.864 -1.062 . . . . 1.84 111.99 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.8 mt -70.47 -39.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.38 -0.373 . . . . 1.25 111.16 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.54 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 170.19 15.15 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.818 -1.182 . . . . 0.35 113.52 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.946 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -83.9 128.75 34.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.538 -0.541 . . . . 0.21 109.538 173.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.529 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.6 mt -73.07 -49.44 28.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.891 0.853 . . . . 0.18 109.777 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 79' ' ' ILE . 49.8 p -141.92 158.8 43.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.079 -1.419 . . . . 0.19 111.642 -170.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -110.17 93.47 4.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.816 -1.084 . . . . 0.52 110.28 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HD2' HD12 ' A' ' 111' ' ' ILE . 29.6 t80 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.653 -0.703 . . . . 3.86 109.373 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.26 -178.66 4.05 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.76 111.492 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 65.1 tttp -47.97 -53.85 29.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.345 -0.843 . . . . 3.35 112.769 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 70.3 Cg_endo -77.09 98.28 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.279 1.319 . . . . 1.36 111.706 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 111' ' ' ILE . 33.2 p90 -127.9 129.15 46.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 1.1 110.665 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.646 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 7.0 t70 -67.9 -11.7 59.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.909 -0.587 . . . . 1.77 111.582 -177.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.765 HD11 HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER 71.34 -54.67 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-N 115.718 -0.674 . . . . 1.39 109.259 -164.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 15.9 t70 -66.9 -38.63 86.62 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 109.649 -0.5 . . . . 1.16 109.649 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.646 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 13.2 pt-20 -66.13 -18.94 65.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.84 110.807 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.577 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 7.4 mm -83.1 -45.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.466 -0.568 . . . . 0.74 109.466 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.52 ' HA ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.72 -31.06 67.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.876 0.846 . . . . 0.72 109.161 174.303 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.8 t70 -67.88 -41.18 83.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.998 -1.001 . . . . 0.78 109.324 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.639 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.28 -48.26 71.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.309 -0.859 . . . . 0.59 111.222 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 112' ' ' ARG . 29.4 m -58.95 -47.77 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.791 -0.764 . . . . 0.47 110.422 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 10.5 ttpt -60.94 -51.99 66.91 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.902 -0.59 . . . . 1.16 111.697 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.639 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -55.32 -26.86 43.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.721 -0.392 . . . . 1.48 111.866 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.535 ' HB3' HD22 ' A' ' 119' ' ' LEU . 35.1 m-85 -81.63 -71.72 0.46 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.75 -0.38 . . . . 2.21 111.193 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 118' ' ' TYR . 3.3 mm? -119.65 92.28 46.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.0 -0.37 . . . . 2.09 110.0 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -93.42 121.76 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.801 2.334 . . . . 0.92 113.895 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.744 ' HB3' ' CD ' ' A' ' 4' ' ' GLU . 11.7 tp . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.458 0.647 . . . . 1.25 109.364 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.765 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 104.449 -2.426 . . . . 2.3 104.449 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.989 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -163.56 141.46 7.6 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.542 -1.263 . . . . 0.8 110.499 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.904 ' HB ' HG22 ' A' ' 30' ' ' THR . 5.1 mt -136.62 153.08 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.313 -0.858 . . . . 0.2 111.659 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.811 HD11 ' HB ' ' A' ' 42' ' ' ILE . 3.3 tt -137.24 117.38 13.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.236 -1.394 . . . . 0.17 107.236 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.639 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.3 mp -106.32 107.99 24.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 119.716 -0.794 . . . . 0.22 110.235 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 47.6 t -93.95 76.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.036 0.21 . . . . 0.28 110.483 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.647 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.2 m-20 -123.45 133.03 54.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.421 . . . . 1.82 110.754 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 1.025 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 22.9 t70 -78.42 -39.04 39.98 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.146 -1.057 . . . . 0.51 108.146 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.837 ' HB2' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -64.23 78.38 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.658 -1.156 . . . . 2.07 108.283 164.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 19.9 p90 -55.84 -16.11 4.13 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.21 -0.905 . . . . 1.44 111.682 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.23 -60.21 9.17 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.875 -0.89 . . . . 0.38 110.875 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.837 HG12 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -58.35 -25.44 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 121.403 0.621 . . . . 0.8 109.972 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.957 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -79.4 -46.69 17.08 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.092 -0.958 . . . . 0.38 111.148 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 13' ' ' TYR . 38.7 pt -77.4 -27.12 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.441 -0.577 . . . . 0.56 109.441 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.1 tp -56.71 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.58 109.261 170.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.662 ' HG ' ' CZ ' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -53.52 -43.27 68.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.186 -0.915 . . . . 1.23 111.086 175.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.3 t30 -50.97 -70.02 0.1 Allowed 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.671 0.607 . . . . 0.94 109.425 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -55.08 -39.32 69.15 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.416 0.447 . . . . 2.46 112.175 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 112' ' ' ARG . 41.6 t -57.87 -53.64 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.114 0.413 . . . . 0.37 112.114 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.78 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -77.39 -40.26 44.35 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.264 -0.643 . . . . 0.43 109.264 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.779 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 2.5 t30 -51.11 -44.45 61.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.371 -0.831 . . . . 0.28 108.793 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.22 -1.809 . . . . 3.25 111.613 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -56.19 -34.48 66.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.679 1.228 . . . . 1.45 109.273 177.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . 148.27 -17.53 1.33 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 112.828 -1.987 . . . . 0.44 110.012 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 59.7 m-85 -63.89 134.87 55.95 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 112.755 0.65 . . . . 1.07 112.755 -163.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.936 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 27.9 mt-30 -84.16 77.47 9.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.897 -0.779 . . . . 1.14 108.897 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.904 HG22 ' HB ' ' A' ' 6' ' ' ILE . 11.9 p -90.59 136.19 33.22 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.389 -0.823 . . . . 0.14 110.392 -176.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.4 m-85 -128.78 130.32 46.86 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 122.68 1.229 . . . . 0.34 109.888 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.957 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 4.6 pt20 -86.41 121.23 28.67 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 112.697 -2.047 . . . . 0.22 112.077 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.693 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -121.88 137.9 54.6 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.575 -0.738 . . . . 0.23 109.248 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -95.03 -12.44 26.6 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.118 -0.633 . . . . 0.18 110.133 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.72 166.32 28.76 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.828 -0.624 . . . . 0.29 111.6 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -69.02 -20.78 75.03 Favored Glycine 0 CA--C 1.505 -0.534 0 O-C-N 123.899 0.75 . . . . 0.14 113.435 -174.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.93 -43.67 19.41 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.218 1.008 . . . . 0.28 108.666 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.778 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.1 tt0 -63.21 -36.01 82.24 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 112.798 -2.001 . . . . 1.29 105.94 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.77 -46.55 81.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.393 -1.276 . . . . 0.14 111.14 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.77 -48.39 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.67 0.748 . . . . 0.97 109.139 175.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 44' ' ' THR . 7.2 t70 -57.47 -42.93 83.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.155 -1.384 . . . . 1.32 111.09 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.903 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 16.2 mm -63.29 -45.05 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 120.796 -0.361 . . . . 0.14 110.41 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -60.95 -41.67 89.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.707 0.765 . . . . 0.15 109.631 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.34 -24.0 62.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 0.39 111.166 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 1.6 ptmt -89.75 -46.91 8.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.159 -0.473 . . . . 2.42 111.195 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 53.0 mm-40 -108.43 -37.93 5.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.706 0.289 . . . . 0.63 111.319 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 78.0 mtp180 66.27 65.62 0.79 Allowed Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.597 -0.728 . . . . 3.66 109.714 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.989 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.4 Cg_exo -64.4 158.55 48.61 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 122.185 1.924 . . . . 0.21 112.029 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.763 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 4.7 m-20 -93.53 -38.47 11.37 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.138 -1.06 . . . . 0.98 108.138 174.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 119' ' ' LEU . 5.7 mp -114.51 111.64 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.26 110.272 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.789 HG13 ' HB3' ' A' ' 7' ' ' LEU . 61.2 t -112.44 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.281 -0.418 . . . . 0.21 111.22 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' A' ' 19' ' ' LEU . 2.7 mp -78.52 93.73 4.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.789 0.804 . . . . 0.15 109.616 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.658 HD12 ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -86.59 96.98 10.28 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.468 -1.242 . . . . 1.53 110.691 -174.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.595 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 9.4 t70 -63.88 116.03 5.42 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.978 -0.689 . . . . 1.47 109.844 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.883 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.7 mtp -94.03 7.53 44.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.666 -0.697 . . . . 0.94 110.992 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 24.9 mmmt -63.82 -66.38 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.173 0.435 . . . . 2.24 112.173 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.021 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 14.6 tt -169.88 -17.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.289 1.588 . . . . 2.06 115.289 -171.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.025 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -27.15 -51.95 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.52 2.813 . . . . 0.45 116.112 175.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.38 -54.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.431 -1.366 . . . . 0.47 113.648 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.517 ' HB3' HD11 ' A' ' 65' ' ' ILE . 19.4 ttt -148.69 166.76 27.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.552 -0.536 . . . . 2.23 109.552 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.16 135.07 57.61 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.188 0.518 . . . . 0.67 109.959 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -62.61 -10.46 30.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.055 -0.975 . . . . 0.32 112.797 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.0 mt -82.84 -47.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.03 0.443 . . . . 1.31 110.593 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.4 mm-40 -64.62 -35.85 82.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.146 -0.687 . . . . 0.47 109.146 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.843 ' O ' ' HG2' ' A' ' 69' ' ' MET . 55.2 mt -72.27 -38.59 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.69 110.122 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.714 HD12 ' CG2' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -53.0 -49.53 66.01 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.44 173.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 71' ' ' VAL . 15.0 ptpt -72.81 -35.61 67.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.65 111.865 -174.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' A' ' 65' ' ' ILE . 4.3 ptp180 -64.35 -33.91 76.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 118.689 -1.204 . . . . 2.18 111.605 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.843 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 10.0 ptp -83.25 -16.51 46.09 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 119.697 -0.801 . . . . 1.28 109.289 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 13.1 mptt -72.32 -38.81 68.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.798 -0.816 . . . . 1.3 108.798 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 67' ' ' LYS . 74.9 t -63.59 -38.52 82.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 1.03 110.616 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.701 HG12 ' HA ' ' A' ' 69' ' ' MET . 11.4 pt -83.73 -30.01 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.535 -0.466 . . . . 0.26 110.608 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 88.03 1.0 Allowed 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 112.277 0.473 . . . . 1.08 112.277 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 37.0 mt-10 -66.39 -2.26 4.34 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.421 -0.799 . . . . 1.78 111.288 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.49 -25.8 60.62 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.696 -1.224 . . . . 0.35 107.696 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 48' ' ' PRO . 2.7 tt -71.34 154.46 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.14 -1.845 . . . . 0.21 110.513 -174.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 5.5 ptp180 -138.72 175.66 9.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.263 -1.014 . . . . 1.08 108.263 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.714 ' CG2' HD12 ' A' ' 66' ' ' LEU . 4.1 m -141.58 145.64 24.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 119.86 -0.736 . . . . 0.79 111.02 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.671 HG23 ' OG1' ' A' ' 100' ' ' THR . 64.0 mt -110.74 75.75 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.668 -1.234 . . . . 0.6 107.668 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.883 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -66.89 139.68 20.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.722 -0.791 . . . . 0.14 112.367 -171.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.547 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 3.0 mtp -101.28 120.18 39.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.155 -0.93 . . . . 1.88 110.586 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.432 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.2 t -133.22 164.57 26.77 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.454 0.538 . . . . 1.13 112.454 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.2 56.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.202 -0.908 . . . . 0.54 111.435 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 74.6 t80 69.24 6.88 5.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.788 0.835 . . . . 4.3 111.016 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.77 93.49 1.85 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.705 -0.759 . . . . 0.62 111.9 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' N ' HG13 ' A' ' 90' ' ' ILE . 33.6 mt-10 -71.69 9.6 0.84 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.239 0.542 . . . . 1.33 110.93 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 85' ' ' GLY . 40.9 mt 58.91 -169.5 0.13 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 1.73 113.006 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 54.87 -93.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.011 -0.995 . . . . 1.38 111.349 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.533 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 91.3 mtp -65.15 -23.96 67.27 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.666 0.27 . . . . 2.72 110.344 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.641 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.5 mm -66.61 -41.08 87.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.67 110.386 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.566 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 14.2 mt-30 -67.26 -35.53 79.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.014 0.911 . . . . 2.5 108.83 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 33.2 tt0 -72.85 -31.98 65.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.0 -1.455 . . . . 1.27 111.448 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.422 ' CB ' HG12 ' A' ' 63' ' ' ILE . 14.6 t -59.04 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 1.28 109.713 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.834 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 46.8 pttt -54.91 -38.84 68.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.91 111.698 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.9 pt-20 -64.63 -25.93 68.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.859 0.3 . . . . 1.84 111.203 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.458 HD12 ' CG2' ' A' ' 63' ' ' ILE . 17.9 mt -86.18 -19.24 30.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.968 0.413 . . . . 1.25 111.528 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.93 19.7 0.23 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.087 -1.054 . . . . 0.35 113.041 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -91.47 140.85 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.994 -0.743 . . . . 0.21 108.994 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.533 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.7 mt -82.92 -49.18 9.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.846 0.831 . . . . 0.18 109.842 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.671 ' OG1' HG23 ' A' ' 79' ' ' ILE . 51.3 p -143.39 150.61 39.33 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.022 -1.445 . . . . 0.19 111.685 -171.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -112.19 97.32 6.56 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.52 109.322 173.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -90.49 150.32 21.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.257 -0.428 . . . . 3.86 110.767 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -121.89 -171.53 2.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.321 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 40.0 ttmt -56.81 -47.21 99.43 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 3.35 111.804 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 51.8 Cg_endo -73.29 96.65 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 120.644 0.896 . . . . 1.36 111.03 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -137.22 138.36 40.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 1.1 110.281 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 22.7 t70 -76.6 -1.69 28.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.649 . . . . 1.77 110.984 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.43 -49.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.933 1.293 . . . . 1.39 112.526 -170.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -70.19 -26.51 63.93 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.634 -0.506 . . . . 1.16 109.634 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 12.5 pt-20 -67.87 -24.85 65.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.74 -0.467 . . . . 0.84 109.74 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.477 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 26.3 mt -81.04 -40.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.962 -0.563 . . . . 0.74 110.537 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.616 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.727 -0.789 . . . . 0.72 109.182 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.49 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 26.7 t70 -68.38 -32.36 72.38 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.581 -0.896 . . . . 0.78 108.581 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.797 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -64.08 -44.15 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.59 111.007 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 112' ' ' ARG . 21.9 m -64.76 -39.54 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 119.003 -1.079 . . . . 0.47 110.805 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -78.37 -21.45 49.39 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.332 0.493 . . . . 1.16 112.332 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.797 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -79.44 -24.32 42.52 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.461 -0.775 . . . . 1.48 110.983 175.027 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 48.5 m-85 -92.15 -70.58 0.69 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.831 -0.348 . . . . 2.21 111.84 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 1.056 ' HB3' HD11 ' A' ' 50' ' ' LEU . 2.4 tm? -127.03 89.72 51.28 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.504 -0.924 . . . . 2.09 108.504 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.654 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 65.0 Cg_endo -88.09 155.0 7.02 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.899 2.399 . . . . 0.92 113.971 -172.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 4' ' ' GLU . 11.3 tp . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 106.804 -1.554 . . . . 1.25 106.804 167.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 1.067 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 11.2 tt0 . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 121.231 0.538 . . . . 2.3 111.03 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.77 ' HD3' ' HB3' ' A' ' 29' ' ' GLN . 3.8 tppt? -137.39 142.51 41.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.298 0.639 . . . . 0.8 110.871 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.925 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.1 mt -138.28 157.61 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.788 -0.642 . . . . 0.2 111.46 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.823 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.8 tt -133.66 117.76 17.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.138 -1.06 . . . . 0.17 108.138 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.8 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.3 mp -107.25 113.28 43.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 120.245 -0.582 . . . . 0.22 110.255 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 53' ' ' LEU . 49.5 t -103.58 82.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.629 0.252 . . . . 0.28 111.335 -176.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.757 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 3.8 m-20 -121.05 130.97 54.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 1.82 109.903 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.895 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 27.6 t70 -81.57 -31.98 32.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.545 -1.28 . . . . 0.51 107.545 166.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.481 ' CG ' HD13 ' A' ' 15' ' ' ILE . 16.1 pt20 -74.32 74.69 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.455 -1.248 . . . . 2.07 108.198 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 15.1 p90 -61.47 -15.45 37.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.838 -1.528 . . . . 1.44 113.431 -167.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.65 -65.35 3.49 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.876 -1.289 . . . . 0.38 109.876 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.814 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.9 mp -47.25 -30.07 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 123.276 0.63 . . . . 0.8 112.31 172.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 8.8 ttm180 -76.37 -50.19 14.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.291 -0.413 . . . . 0.38 111.142 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 46.9 pt -75.34 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.375 -0.602 . . . . 0.56 109.375 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.5 tp -59.94 -65.52 0.67 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.58 109.627 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 52' ' ' LEU . 71.8 mt -54.29 -40.38 67.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.472 -0.331 . . . . 1.23 110.69 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t30 -51.09 -67.52 0.24 Allowed 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.64 -0.709 . . . . 0.94 109.755 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.25 -40.09 76.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.81 0.694 . . . . 2.46 111.997 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 18' ' ' LEU . 36.3 t -54.3 -54.52 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 111.492 0.182 . . . . 0.37 111.492 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.711 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -81.01 -35.91 31.31 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.49 -0.484 . . . . 0.43 110.223 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.631 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 10.0 t-20 -50.38 -47.28 56.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.857 0.837 . . . . 0.28 108.758 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 25' ' ' LYS . 1.7 tmmt? -61.3 -36.22 79.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.462 -1.699 . . . . 3.25 112.774 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 8.3 mm-40 -55.11 -31.81 61.54 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.204 1.002 . . . . 1.45 109.455 175.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 138.71 -10.65 3.42 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 113.161 -1.836 . . . . 0.44 109.132 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 1.067 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 2.1 m-85 -68.45 156.74 37.32 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 122.605 1.193 . . . . 1.07 111.089 -169.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.77 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 4.4 mt-30 -109.69 69.8 0.71 Allowed 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 113.293 -1.776 . . . . 1.14 108.042 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.925 HG22 ' HB ' ' A' ' 6' ' ' ILE . 16.0 p -90.01 132.01 35.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.687 -1.142 . . . . 0.14 110.486 -168.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 14.4 m-85 -125.37 124.5 41.66 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.563 1.173 . . . . 0.34 109.664 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.739 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.9 pt20 -80.8 122.05 26.7 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 112.764 -2.016 . . . . 0.22 112.118 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -120.86 142.08 49.99 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.999 -1.001 . . . . 0.23 108.561 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -98.64 -12.53 20.99 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.928 -0.709 . . . . 0.18 109.941 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -148.09 165.25 31.38 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.729 -0.669 . . . . 0.29 111.703 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.16 73.39 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.552 -0.749 . . . . 0.14 113.45 -174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.94 -43.15 18.47 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.034 0.921 . . . . 0.28 109.14 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.764 ' O ' HG12 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -63.34 -34.83 78.56 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.103 -1.814 . . . . 1.29 106.103 176.263 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -66.52 -46.67 75.43 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.485 -1.234 . . . . 0.14 111.0 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.635 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -52.58 -46.92 67.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.641 0.734 . . . . 0.97 109.292 173.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.09 -41.3 92.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.293 -1.322 . . . . 1.32 111.203 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.823 ' HB ' HD11 ' A' ' 7' ' ' LEU . 17.2 mm -63.26 -48.32 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 110.121 -0.326 . . . . 0.14 110.121 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 38.7 t -60.19 -43.59 93.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-O 121.817 0.818 . . . . 0.15 109.283 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.54 -29.28 69.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.261 -0.881 . . . . 0.39 111.614 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -93.19 -45.08 8.03 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.949 0.352 . . . . 2.42 111.949 -176.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 57.2 mm-40 -107.78 -36.17 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 0.63 111.654 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 69.3 mtp180 62.74 62.01 2.0 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.368 -0.833 . . . . 3.66 109.547 -170.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.646 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 77.1 Cg_exo -58.66 156.94 29.68 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.046 1.83 . . . . 0.21 111.095 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.809 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -93.27 -34.7 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.901 -0.72 . . . . 0.98 109.585 175.174 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.684 HD23 HD11 ' A' ' 79' ' ' ILE . 7.1 mp -115.47 114.02 24.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.007 -0.542 . . . . 0.26 109.992 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG13 ' HB3' ' A' ' 7' ' ' LEU . 92.7 t -112.63 121.61 65.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 110.527 -0.175 . . . . 0.21 110.527 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 19' ' ' LEU . 2.4 mp -92.0 97.6 11.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.579 -0.526 . . . . 0.15 109.579 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 9' ' ' VAL . 44.0 mt -93.52 106.24 18.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.762 -0.654 . . . . 1.53 110.424 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 52.5 t0 -66.86 107.93 2.37 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.204 -0.598 . . . . 1.47 110.232 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.832 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 11.5 mtm -83.05 0.74 43.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.661 . . . . 0.94 110.797 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 25.5 mmmt -57.75 -58.5 8.08 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.408 0.522 . . . . 2.24 112.408 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.927 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 15.2 tt -175.57 -34.21 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.264 1.209 . . . . 2.06 114.264 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.927 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -20.23 -63.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.261 3.307 . . . . 0.45 116.482 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.93 -58.23 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.652 -1.261 . . . . 0.47 113.204 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.5 ' HB3' HD11 ' A' ' 65' ' ' ILE . 47.2 ttm -148.96 165.85 30.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.415 -0.587 . . . . 2.23 109.415 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 65' ' ' ILE . 38.3 m-20 -60.46 133.9 56.54 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.745 -0.465 . . . . 0.67 109.745 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 66' ' ' LEU . . . -67.55 1.65 6.99 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 120.892 -0.67 . . . . 0.32 112.364 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.3 mt -92.45 -45.7 14.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.842 0.353 . . . . 1.31 110.116 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.74 -36.08 81.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.47 109.701 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.674 ' HB ' HD13 ' A' ' 53' ' ' LEU . 15.6 mt -73.5 -34.19 41.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.929 -0.578 . . . . 0.69 109.483 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.665 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -54.77 -53.99 47.89 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.488 -0.778 . . . . 1.47 109.978 174.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.6 ptpt -71.47 -33.42 69.29 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.118 0.414 . . . . 0.65 112.118 -173.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.71 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.9 ptm180 -66.54 -34.6 78.27 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.465 -0.894 . . . . 2.18 110.95 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.661 ' HG3' HG21 ' A' ' 76' ' ' ILE . 10.1 ptp -82.75 -16.74 46.81 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 119.834 -0.746 . . . . 1.28 109.722 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.3 mptt -78.88 -30.25 44.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.723 0.773 . . . . 1.3 109.854 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 68' ' ' ARG . 2.7 p -78.59 -31.86 15.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.505 0.669 . . . . 1.03 109.261 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.644 HG12 ' HA ' ' A' ' 69' ' ' MET . 21.8 pt -86.52 -21.89 7.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.102 -0.954 . . . . 0.26 110.724 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -162.78 88.51 0.62 Allowed 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 112.559 0.577 . . . . 1.08 112.559 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 11.6 mt-10 -76.67 5.93 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 120.68 -1.263 . . . . 1.78 109.688 173.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -29.67 62.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.489 -1.232 . . . . 0.35 107.894 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.661 HG21 ' HG3' ' A' ' 69' ' ' MET . 5.2 tt -76.66 159.4 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 112.767 -2.015 . . . . 0.21 111.296 -170.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.817 ' HD3' HD21 ' A' ' 99' ' ' LEU . 4.2 ptp180 -134.84 177.21 7.97 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.335 -0.848 . . . . 1.08 109.392 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.65 HG11 HD12 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -132.58 159.65 43.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.505 0.669 . . . . 0.79 110.507 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.735 HG22 ' HD2' ' A' ' 102' ' ' PHE . 54.9 mt -131.01 66.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.071 -1.455 . . . . 0.6 107.071 170.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.832 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -63.5 140.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.745 0.783 . . . . 0.14 111.804 -170.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.773 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 mtp -95.84 124.1 39.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.764 -1.107 . . . . 1.88 110.371 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.465 HG21 ' HB1' ' A' ' 101' ' ' ALA . 12.1 p -130.84 159.13 38.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.1 -0.5 . . . . 1.13 112.173 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.494 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . . . -66.8 73.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.595 . . . . 0.54 109.863 165.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 26.5 p90 50.88 21.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.225 1.41 . . . . 4.3 113.714 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.65 92.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.828 -0.701 . . . . 0.62 112.688 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.674 ' N ' HG13 ' A' ' 90' ' ' ILE . 19.3 mt-10 -89.01 14.67 10.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.067 0.461 . . . . 1.33 110.855 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 65.65 -177.74 0.19 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.34 0.867 . . . . 1.73 113.34 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.0 t70 60.83 -100.24 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.738 -1.119 . . . . 1.38 112.042 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -58.97 -23.37 61.62 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.021 0.439 . . . . 2.72 110.613 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.674 HG13 ' N ' ' A' ' 86' ' ' GLU . 34.9 mm -65.83 -40.2 86.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.272 0.558 . . . . 0.67 110.088 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.502 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 22.8 mm-40 -72.76 -39.03 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.536 -0.756 . . . . 2.5 109.591 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.617 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 23.5 tt0 -67.95 -40.92 83.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.785 -1.098 . . . . 1.27 111.729 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.409 ' OG ' HG21 ' A' ' 80' ' ' ILE . 6.6 t -54.46 -61.01 2.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.144 0.497 . . . . 1.28 110.055 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.897 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -58.75 -39.45 80.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.91 111.422 176.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.0 pt-20 -62.17 -27.23 68.82 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.637 0.236 . . . . 1.84 111.637 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 11.8 mt -85.54 -8.23 58.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.256 0.465 . . . . 1.25 112.256 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.97 19.22 0.72 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.034 -1.079 . . . . 0.35 113.511 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.897 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -98.84 138.83 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.988 -0.745 . . . . 0.21 108.988 171.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.817 HD21 ' HD3' ' A' ' 77' ' ' ARG . 9.3 mt -77.41 -50.05 13.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.398 0.618 . . . . 0.18 110.397 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.59 ' OG1' HG23 ' A' ' 79' ' ' ILE . 62.6 p -139.65 148.72 42.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.224 -0.898 . . . . 0.19 111.664 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.95 84.35 2.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.962 -1.017 . . . . 0.52 108.973 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.773 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 1.1 p90 -86.73 144.4 27.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 3.86 110.568 -170.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 105' ' ' PRO . . . -95.98 166.31 11.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.76 110.743 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 18.0 pttp -70.36 -29.38 1.57 Allowed Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.724 0.639 . . . . 3.35 112.724 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 55.6 Cg_endo -76.14 95.45 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 120.501 1.215 . . . . 1.36 110.166 163.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.568 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 30.1 p90 -132.3 152.77 51.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.451 0.643 . . . . 1.1 111.318 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 109' ' ' ASP . 19.0 t70 -75.56 -3.9 36.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.117 -0.947 . . . . 1.77 111.653 -173.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.568 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 13.7 mt 65.35 -62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 1.39 110.114 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.507 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 29.8 t70 -63.06 -26.96 69.08 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.89 -0.596 . . . . 1.16 110.817 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.8 -34.31 76.52 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.039 0.447 . . . . 0.84 110.193 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 115' ' ' VAL . 28.3 mt -83.03 -40.22 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.987 -0.551 . . . . 0.74 110.108 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.58 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -66.59 -35.97 81.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.638 -0.875 . . . . 0.72 108.638 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.814 ' HA ' ' HE2' ' A' ' 116' ' ' LYS . 32.5 t70 -61.96 -53.03 61.31 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.999 -0.741 . . . . 0.78 108.999 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.923 ' HA ' ' HE3' ' A' ' 117' ' ' LYS . . . -52.09 -46.38 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.459 -0.792 . . . . 0.59 111.833 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 111' ' ' ILE . 32.3 m -68.24 -47.68 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.673 0.62 . . . . 0.47 112.673 -173.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.814 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 1.2 pptt? -85.24 -8.68 58.43 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.099 0.409 . . . . 1.16 111.665 -177.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.923 ' HE3' ' HA ' ' A' ' 114' ' ' ALA . 21.6 pttp -86.5 -21.52 26.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.715 -0.794 . . . . 1.48 109.749 167.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.843 ' HD1' ' HG ' ' A' ' 119' ' ' LEU . 14.8 t80 -80.56 -66.67 0.85 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.282 -0.417 . . . . 2.21 110.421 176.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.843 ' HG ' ' HD1' ' A' ' 118' ' ' TYR . 91.9 mt -122.36 86.23 48.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.414 -0.587 . . . . 2.09 109.414 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.653 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 93.1 Cg_endo -80.68 133.66 9.41 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.564 2.176 . . . . 0.92 113.434 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 4' ' ' GLU . 13.3 tp . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 121.6 0.714 . . . . 1.25 110.211 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.726 ' HB3' HD12 ' A' ' 121' ' ' LEU . 7.2 tp10 . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.198 0.523 . . . . 2.3 111.456 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.869 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -136.09 146.52 47.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.294 0.569 . . . . 0.8 111.368 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.901 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.9 mt -137.81 154.75 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.389 -0.823 . . . . 0.2 111.575 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.838 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -135.56 111.64 9.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.459 -1.246 . . . . 0.17 107.724 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.638 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.2 mp -99.42 104.62 16.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.175 -1.01 . . . . 0.22 110.219 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 47.9 t -85.67 93.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.777 -0.823 . . . . 0.28 108.777 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.608 ' OD2' ' HG3' ' A' ' 12' ' ' GLN . 25.8 t70 -152.6 104.81 2.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.643 -0.423 . . . . 1.82 111.138 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.79 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 19.7 t70 -54.14 -41.24 68.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.55 0.34 . . . . 0.51 111.46 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.608 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 3.6 pt20 -70.94 76.29 0.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 122.23 1.014 . . . . 2.07 109.217 173.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.451 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 31.0 p90 -53.67 -13.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.602 -1.635 . . . . 1.44 114.648 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.73 -67.49 1.27 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.366 -0.921 . . . . 0.38 111.547 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.782 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -70.48 -11.78 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 O-C-N 121.958 -0.731 . . . . 0.8 111.241 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.908 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.4 ttm180 -79.89 -42.12 24.81 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.612 -0.435 . . . . 0.38 110.229 -173.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.64 -27.14 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.56 109.967 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.496 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 3.5 tp -61.78 -61.59 2.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.637 -0.711 . . . . 0.58 109.485 170.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.782 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 1.1 tp -52.51 -41.96 63.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.653 -0.703 . . . . 1.23 110.187 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.4 t30 -51.18 -70.9 0.07 Allowed 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.209 -0.905 . . . . 0.94 109.78 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.28 -39.12 69.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.355 0.41 . . . . 2.46 111.64 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' LEU . 35.6 t -55.76 -60.83 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.626 -0.261 . . . . 0.37 111.295 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.782 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 8.3 m-85 -72.37 -34.6 68.08 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.457 -0.571 . . . . 0.43 109.457 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.932 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 2.5 t30 -52.06 -48.56 64.56 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.269 -0.878 . . . . 0.28 109.388 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.41 -31.72 73.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.626 -1.624 . . . . 3.25 112.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.686 ' HB2' ' CD1' ' A' ' 28' ' ' TYR . 6.1 mm-40 -63.67 -25.27 68.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.639 0.733 . . . . 1.45 110.313 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.653 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . 143.21 -16.47 2.32 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.491 -1.231 . . . . 0.44 110.648 -171.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.932 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 8.2 m-85 -81.64 124.06 29.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.308 0.575 . . . . 1.07 111.387 -162.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.869 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 20.7 mt-30 -79.39 82.61 5.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.46 -0.941 . . . . 1.14 108.46 172.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.901 HG22 ' HB ' ' A' ' 6' ' ' ILE . 20.8 p -90.19 135.85 33.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.645 -0.707 . . . . 0.14 109.921 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 15.4 m-85 -125.95 126.35 44.22 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.408 1.099 . . . . 0.34 109.265 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.908 ' HB2' HH11 ' A' ' 16' ' ' ARG . 4.2 pt20 -86.43 120.74 28.08 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.004 -1.907 . . . . 0.22 111.355 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.44 124.6 43.25 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.495 -0.558 . . . . 0.23 109.495 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 11' ' ' ASP . . . -74.71 -19.03 60.41 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.738 -0.385 . . . . 0.18 111.028 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.23 168.57 22.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 0.29 111.567 -174.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -75.03 -14.32 81.91 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.834 -0.621 . . . . 0.14 113.33 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.9 -44.71 19.91 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 122.617 1.198 . . . . 0.28 108.279 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.803 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.3 tp-100 -60.94 -40.69 94.23 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 112.26 -2.245 . . . . 1.29 105.597 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -63.3 -44.36 95.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.722 -1.581 . . . . 0.14 111.258 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.7 -43.64 76.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.037 -0.727 . . . . 0.97 109.037 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 44' ' ' THR . 18.9 t70 -64.22 -41.95 96.79 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.492 -1.231 . . . . 1.32 110.616 177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.838 ' HB ' HD11 ' A' ' 7' ' ' LEU . 10.3 mm -60.69 -48.78 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 120.922 -0.311 . . . . 0.14 111.033 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 76' ' ' ILE . 46.8 t -57.97 -41.75 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.741 0.781 . . . . 0.15 109.947 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.38 -23.95 62.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.226 -0.897 . . . . 0.39 111.134 -178.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.742 ' HE3' ' HA ' ' A' ' 42' ' ' ILE . 9.7 ptpt -91.23 -42.34 10.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.695 0.283 . . . . 2.42 111.268 -177.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 62.5 mm-40 -111.61 -38.16 4.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 112.066 0.395 . . . . 0.63 112.066 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.2 mpt_? 64.78 64.28 1.11 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 123.857 0.723 . . . . 3.66 109.769 -169.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.761 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 51.7 Cg_exo -62.77 157.71 46.28 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 121.57 1.513 . . . . 0.21 111.473 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.927 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -85.03 -51.09 6.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.293 -1.373 . . . . 0.98 107.293 171.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.927 HD12 ' HB2' ' A' ' 49' ' ' ASP . 7.1 mp -105.11 111.59 24.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.716 -1.129 . . . . 0.26 110.75 -171.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.769 HG13 ' HB3' ' A' ' 7' ' ' LEU . 60.0 t -112.18 108.51 25.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.213 -0.449 . . . . 0.21 111.419 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.576 HD22 HD21 ' A' ' 19' ' ' LEU . 2.1 mp -75.68 89.12 2.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.795 0.807 . . . . 0.15 109.473 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -82.49 110.68 17.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.059 -1.428 . . . . 1.53 111.294 -172.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.12 127.19 18.5 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.697 0.76 . . . . 1.47 110.714 174.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.922 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 18.8 mtp -114.94 9.52 16.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.172 -0.922 . . . . 0.94 109.457 163.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -71.74 -67.55 0.52 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.63 . . . . 2.24 111.9 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.839 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -175.05 -36.03 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.036 0 CA-C-O 118.024 -0.989 . . . . 2.06 112.708 -172.178 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.839 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 4.7 Cg_exo -19.48 -62.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.726 3.617 . . . . 0.45 116.419 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.06 -73.23 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 119.764 -1.208 . . . . 0.47 113.394 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.3 tpt -148.9 168.55 22.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.574 -0.899 . . . . 2.23 108.574 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.17 129.18 40.79 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.172 0.51 . . . . 0.67 109.654 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.589 ' CA ' ' HG ' ' A' ' 53' ' ' LEU . . . -62.92 -7.19 15.07 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.08 -0.964 . . . . 0.32 112.718 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.724 HG13 ' HB3' ' A' ' 89' ' ' MET . 4.1 mm -78.22 -48.66 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.681 -0.488 . . . . 1.31 109.681 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.9 -33.46 75.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.876 -0.787 . . . . 0.47 108.876 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.739 ' O ' ' HG2' ' A' ' 69' ' ' MET . 59.9 mt -77.31 -38.79 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.292 -0.867 . . . . 0.69 111.371 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.64 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 3.7 pp -65.66 -36.85 84.86 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 120.291 -0.564 . . . . 1.47 110.285 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.678 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.8 ptpt -73.49 -35.41 65.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.332 -0.547 . . . . 0.65 111.182 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.6 ptm180 -65.28 -33.46 76.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 118.868 -1.133 . . . . 2.18 111.668 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.775 ' HA ' HG12 ' A' ' 72' ' ' ILE . 12.2 ptp -84.86 -11.99 54.47 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.046 -1.033 . . . . 1.28 109.405 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 12.5 mptt -76.84 -36.98 56.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.016 -0.735 . . . . 1.3 109.016 172.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 68' ' ' ARG . 4.0 p -72.07 -33.81 48.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.354 0.597 . . . . 1.03 109.648 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.775 HG12 ' HA ' ' A' ' 69' ' ' MET . 26.1 pt -84.27 -24.46 7.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.291 -0.868 . . . . 0.26 110.973 172.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -161.74 88.18 0.69 Allowed 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.043 0.386 . . . . 1.08 112.043 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 8.5 mt-10 -75.77 6.25 5.22 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.272 -0.892 . . . . 1.78 110.636 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -28.69 42.39 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.856 -1.535 . . . . 0.35 106.856 170.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.3 tt -67.61 153.8 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 113.556 -1.657 . . . . 0.21 110.686 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 6.3 ptp180 -135.45 177.9 7.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.792 -1.188 . . . . 1.08 107.792 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -144.17 144.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.52 0.676 . . . . 0.79 111.216 -174.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.709 HG23 ' OG1' ' A' ' 100' ' ' THR . 64.9 mt -114.79 74.75 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.304 -1.369 . . . . 0.6 107.304 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.922 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -62.55 140.11 19.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 119.544 -0.862 . . . . 0.14 112.735 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 7.4 mtp -100.81 102.68 13.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.734 -1.121 . . . . 1.88 110.159 -174.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.43 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.7 t -117.05 165.13 13.73 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.343 0.592 . . . . 1.13 112.284 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 56.09 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.954 -1.021 . . . . 0.54 110.26 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 t80 72.3 5.59 5.32 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.983 -1.008 . . . . 4.3 111.686 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.32 88.28 1.99 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.115 -0.564 . . . . 0.62 112.619 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.431 ' N ' HG13 ' A' ' 90' ' ' ILE . 24.2 mt-10 -81.38 9.36 7.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.924 0.393 . . . . 1.33 111.18 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 38.1 mt 65.8 -166.22 0.22 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.606 -0.725 . . . . 1.73 112.621 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.53 -99.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.297 -0.865 . . . . 1.38 111.531 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.724 ' HB3' HG13 ' A' ' 63' ' ' ILE . 2.0 mpt? -64.25 -18.0 64.14 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.421 -0.354 . . . . 2.72 110.291 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 87' ' ' LEU . 32.7 mm -69.49 -40.2 79.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.999 0.428 . . . . 0.67 110.265 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -67.02 -53.36 31.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.842 -0.799 . . . . 2.5 108.842 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 42.8 tt0 -56.72 -30.6 63.69 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 114.46 -1.245 . . . . 1.27 111.404 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 63' ' ' ILE . 27.6 t -54.59 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.754 0.788 . . . . 1.28 111.177 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 33.4 pttt -54.03 -38.02 64.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.629 -1.169 . . . . 1.91 110.714 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 8.2 tp10 -55.37 -43.42 75.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.739 -1.118 . . . . 1.84 111.874 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.75 -22.96 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.843 0.354 . . . . 1.25 111.165 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.88 21.97 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.004 -1.093 . . . . 0.35 113.935 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 78' ' ' VAL . . . -88.54 140.54 29.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.9 0.85 . . . . 0.21 109.277 169.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.514 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.3 mt -82.19 -48.95 10.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.718 0.771 . . . . 0.18 109.865 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.709 ' OG1' HG23 ' A' ' 79' ' ' ILE . 52.6 p -144.57 150.2 37.08 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.486 -1.234 . . . . 0.19 111.64 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -108.55 86.89 2.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.363 -0.835 . . . . 0.52 109.967 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 16.6 m-85 -84.33 143.02 29.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.985 0.421 . . . . 3.86 110.716 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB1' ' HD2' ' A' ' 105' ' ' PRO . . . -95.48 178.14 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.76 109.431 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' O ' ' HD1' ' A' ' 106' ' ' PHE . 20.5 mmtp -78.33 -29.75 0.66 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.639 0.607 . . . . 3.35 112.639 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' HB1' ' A' ' 103' ' ' ALA . 24.2 Cg_exo -65.62 96.99 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 120.368 1.167 . . . . 1.36 109.922 162.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.496 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 1.6 p90 -130.19 146.16 51.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.875 -0.602 . . . . 1.1 111.516 -172.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -86.15 18.4 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.598 . . . . 1.77 111.726 178.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.549 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.4 tt 48.3 -67.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 125.035 1.334 . . . . 1.39 113.003 -174.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.549 ' H ' HG23 ' A' ' 108' ' ' ILE . 18.5 t70 -58.22 -30.55 66.58 Favored 'General case' 0 C--O 1.212 -0.897 0 C-N-CA 122.55 0.34 . . . . 1.16 111.364 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.11 -28.15 67.92 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 119.997 -0.681 . . . . 0.84 110.143 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.54 HG22 ' HZ ' ' A' ' 23' ' ' PHE . 17.0 mt -80.76 -41.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.74 110.508 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.516 ' C ' ' HD2' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -68.68 -32.99 73.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.744 0.783 . . . . 0.72 109.215 175.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 19.1 t70 -70.91 -36.49 72.73 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.323 -0.853 . . . . 0.78 108.828 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.6 -45.29 79.66 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.079 -0.964 . . . . 0.59 111.459 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 112' ' ' ARG . 34.5 m -61.77 -42.59 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.598 -0.841 . . . . 0.47 110.184 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.524 ' HA ' ' OH ' ' A' ' 28' ' ' TYR . 7.1 ttpt -63.67 -49.65 72.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.795 -0.639 . . . . 1.16 111.418 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.739 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.5 OUTLIER -59.78 -30.67 69.04 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.664 -0.243 . . . . 1.48 111.399 -176.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.576 ' HB3' HD12 ' A' ' 119' ' ' LEU . 44.5 m-85 -81.91 -68.91 0.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.417 -0.513 . . . . 2.21 110.696 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 118' ' ' TYR . 6.7 mp -121.48 103.63 41.06 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.175 -0.676 . . . . 2.09 109.175 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -97.78 153.11 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.752 2.301 . . . . 0.92 114.493 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 1.25 108.396 172.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.853 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 8.3 tt0 . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 121.583 0.706 . . . . 2.3 110.916 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.688 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 3.6 tppt? -140.57 147.33 39.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.009 -0.541 . . . . 0.8 111.202 -172.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.899 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -141.23 153.99 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.439 -0.8 . . . . 0.2 111.696 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.796 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -131.82 123.47 27.64 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.61 -1.256 . . . . 0.17 107.61 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.701 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.4 mp -109.66 103.21 15.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.556 -0.858 . . . . 0.22 110.164 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.2 t -88.49 82.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.28 110.003 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.876 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.0 t70 -133.1 144.28 49.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.548 -0.296 . . . . 1.82 110.686 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.89 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 13.0 t70 -101.54 -35.94 8.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.896 -0.409 . . . . 0.51 109.896 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.658 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 4.4 pt20 -81.06 70.61 7.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.098 -1.445 . . . . 2.07 107.098 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.9 p90 -48.74 -13.92 0.06 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 112.334 -2.212 . . . . 1.44 115.181 -161.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' GLN . . . -46.68 -59.48 5.4 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.198 -1.001 . . . . 0.38 110.777 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 1.1 mm -54.51 -32.5 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.525 0.679 . . . . 0.8 110.245 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.876 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.6 ttm180 -77.12 -48.78 16.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.118 -0.946 . . . . 0.38 110.891 -165.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 42.4 pt -76.04 -25.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.312 -0.625 . . . . 0.56 109.312 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.4 tp -58.69 -68.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.58 109.416 171.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.798 HD13 HD22 ' A' ' 52' ' ' LEU . 39.0 mt -54.65 -40.91 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 1.23 110.563 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.632 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 7.6 t30 -50.48 -68.81 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.94 109.97 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.65 -40.04 82.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.265 0.353 . . . . 2.46 111.639 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -55.15 -55.43 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.052 0.22 . . . . 0.37 111.576 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB2' HG21 ' A' ' 30' ' ' THR . 11.8 m-85 -78.87 -36.66 41.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.61 -0.436 . . . . 0.43 110.038 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 5.0 t30 -50.15 -50.54 48.55 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.176 0.988 . . . . 0.28 108.934 -176.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -54.77 -42.49 71.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 112.637 -2.074 . . . . 3.25 111.676 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 112' ' ' ARG . 4.5 mm-40 -52.22 -34.6 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 122.191 0.996 . . . . 1.45 109.733 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.612 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 138.08 -6.66 3.43 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 113.303 -1.771 . . . . 0.44 109.39 -171.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.856 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 5.5 m-85 -70.4 126.86 30.83 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.807 -0.757 . . . . 1.07 110.549 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.641 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 28.6 mt-30 -82.7 81.13 8.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.475 -0.935 . . . . 1.14 108.475 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.899 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -90.07 133.09 35.05 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.064 -0.971 . . . . 0.14 110.128 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.94 124.83 42.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.592 1.187 . . . . 0.34 109.732 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.71 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 1.8 pt20 -82.17 120.71 25.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 112.748 -2.024 . . . . 0.22 111.602 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.783 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -123.93 124.02 41.69 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.585 -0.734 . . . . 0.23 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -84.83 -8.19 58.89 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.223 -0.591 . . . . 0.18 111.293 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.42 165.55 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.41 -0.359 . . . . 0.29 111.56 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.91 -19.92 77.32 Favored Glycine 0 CA--C 1.506 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.14 113.291 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.31 -42.97 29.16 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.458 1.123 . . . . 0.28 108.075 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.843 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -60.96 -41.66 96.75 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 112.6 -2.091 . . . . 1.29 105.805 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -60.9 -43.87 97.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.003 -1.453 . . . . 0.14 111.038 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.2 OUTLIER -57.44 -43.37 83.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.224 -0.658 . . . . 0.97 109.224 177.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 44' ' ' THR . 2.1 t70 -64.57 -44.58 90.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 114.951 -1.022 . . . . 1.32 110.213 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.843 HG12 ' O ' ' A' ' 38' ' ' GLN . 15.9 mm -60.19 -46.42 94.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.266 -0.879 . . . . 0.14 110.165 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 69' ' ' MET . 47.6 t -62.12 -41.25 90.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 121.727 0.775 . . . . 0.15 109.604 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -73.23 -20.71 60.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.606 -0.725 . . . . 0.39 111.155 -177.543 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.631 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -90.49 -45.99 8.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.604 -0.271 . . . . 2.42 111.246 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.631 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 8.3 mm-40 -110.63 -36.89 5.61 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.392 0.515 . . . . 0.63 112.392 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 14.1 mtm-85 65.36 65.43 0.92 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 O-C-N 123.639 0.587 . . . . 3.66 109.536 -170.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.751 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 71.3 Cg_exo -60.57 156.67 40.74 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 C-N-CA 121.689 1.592 . . . . 0.21 111.033 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.814 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 12.3 m-20 -89.51 -42.27 11.55 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.293 -0.963 . . . . 0.98 108.849 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.654 HD23 HD11 ' A' ' 79' ' ' ILE . 6.8 mp -110.42 111.97 23.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.737 -0.665 . . . . 0.26 109.864 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 7' ' ' LEU . 86.3 t -112.58 112.81 42.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.796 0.332 . . . . 0.21 110.669 -177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.798 HD22 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -83.64 93.01 7.8 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.411 0.624 . . . . 0.15 109.986 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.656 HD11 HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -84.63 104.7 14.84 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.826 -1.079 . . . . 1.53 111.155 -175.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.835 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 54.2 t0 -70.11 109.14 4.43 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.57 -0.852 . . . . 1.47 110.181 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.87 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.9 mtp -86.28 11.03 13.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.614 -0.721 . . . . 0.94 111.083 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -71.32 -60.16 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.029 0.752 . . . . 2.24 113.029 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.962 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.1 tp -173.08 -21.73 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.671 1.36 . . . . 2.06 114.671 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.962 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -27.62 -52.87 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 123.443 2.762 . . . . 0.45 116.105 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.02 -60.07 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.756 -1.211 . . . . 0.47 112.88 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 65' ' ' ILE . 20.6 ttt -149.53 170.18 19.21 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.403 -0.592 . . . . 2.23 109.403 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -57.66 135.38 56.72 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.977 0.417 . . . . 0.67 110.283 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.615 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -66.49 -2.07 13.71 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.408 -0.815 . . . . 0.32 112.885 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.528 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.2 mt -92.05 -42.03 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.157 0.503 . . . . 1.31 110.286 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.85 -38.9 80.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.571 0.701 . . . . 0.47 109.413 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.656 HD12 HD11 ' A' ' 53' ' ' LEU . 54.0 mt -71.57 -35.85 57.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.149 -0.932 . . . . 0.69 109.794 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.733 HD12 HG21 ' A' ' 78' ' ' VAL . 3.2 tt -53.34 -53.43 51.19 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.677 -0.692 . . . . 1.47 110.607 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.0 ptpp? -73.13 -30.16 63.41 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.233 -0.587 . . . . 0.65 112.083 -172.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.693 ' O ' HG12 ' A' ' 71' ' ' VAL . 15.0 ptp180 -68.97 -33.59 73.95 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 118.92 -1.112 . . . . 2.18 111.066 174.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.703 ' HE1' HG13 ' A' ' 78' ' ' VAL . 2.8 ptt? -80.63 -17.82 50.08 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 118.918 -1.113 . . . . 1.28 109.796 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.742 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -76.93 -30.24 55.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.636 . . . . 1.3 110.572 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.7 p -78.12 -34.95 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 109.531 -0.544 . . . . 1.03 109.531 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.567 HG12 ' HA ' ' A' ' 69' ' ' MET . 15.7 pt -81.42 -31.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.26 110.037 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.76 90.82 1.1 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.32 2.9 6.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.876 0.846 . . . . 1.78 109.796 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -26.11 64.35 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.55 -1.278 . . . . 0.35 107.55 171.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.0 tt -76.23 156.93 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 112.743 -2.026 . . . . 0.21 110.754 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.814 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -137.77 172.48 12.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.055 -0.975 . . . . 1.08 108.614 177.017 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -131.29 154.25 40.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 120.217 -0.593 . . . . 0.79 110.689 -171.19 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.654 HD11 HD23 ' A' ' 50' ' ' LEU . 61.5 mt -128.64 68.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.402 -1.333 . . . . 0.6 107.402 171.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.87 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -64.86 140.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.538 -0.756 . . . . 0.14 111.735 -172.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.638 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 11.0 mtt -93.15 131.1 38.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.071 -0.968 . . . . 1.88 110.019 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.638 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 4.6 t -132.85 156.85 46.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.329 0.585 . . . . 1.13 112.578 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . -72.36 63.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.761 -1.109 . . . . 0.54 109.804 170.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 40.3 t80 70.24 11.26 7.5 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.564 -1.198 . . . . 4.3 112.021 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.72 81.88 1.6 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.051 -0.595 . . . . 0.62 112.011 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' N ' HG13 ' A' ' 90' ' ' ILE . 5.6 mt-10 -72.6 8.12 1.59 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.678 0.791 . . . . 1.33 112.052 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.405 ' N ' HG13 ' A' ' 90' ' ' ILE . 25.6 mt 61.11 -177.55 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.569 1.322 . . . . 1.73 114.569 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 t70 57.7 -93.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.328 -1.306 . . . . 1.38 111.692 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.461 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 66.3 mtt -60.88 -26.77 67.65 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 120.838 0.351 . . . . 2.72 110.363 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 86' ' ' GLU . 15.7 mm -62.52 -43.25 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.057 0.456 . . . . 0.67 110.439 173.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.563 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 88.2 mt-30 -63.76 -48.31 77.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.473 -0.785 . . . . 2.5 109.493 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.783 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 22.7 tt0 -70.11 -20.52 63.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.539 -1.21 . . . . 1.27 112.102 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.8 t -66.68 -63.84 0.98 Allowed 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.876 -0.515 . . . . 1.28 110.062 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.919 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 17.0 ptpt -58.87 -31.14 68.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.694 0.759 . . . . 1.91 109.964 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.783 ' CB ' ' HA ' ' A' ' 92' ' ' GLU . 6.1 tt0 -47.38 -58.87 3.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.366 -1.288 . . . . 1.84 111.867 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.77 -28.57 65.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.764 -0.653 . . . . 1.25 112.36 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' HZ1' ' A' ' 70' ' ' LYS . . . 163.72 11.22 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.835 -1.174 . . . . 0.35 113.739 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.919 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -86.72 136.38 33.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.827 0.813 . . . . 0.21 109.66 173.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.415 HD11 ' HG3' ' A' ' 77' ' ' ARG . 7.8 mt -74.98 -49.24 20.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.708 0.766 . . . . 0.18 109.867 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.635 ' OG1' HG23 ' A' ' 79' ' ' ILE . 60.2 p -139.17 147.83 42.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.383 -1.281 . . . . 0.19 111.603 -172.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -107.59 88.7 2.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.862 -1.063 . . . . 0.52 108.431 170.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.603 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 0.3 OUTLIER -84.34 142.22 30.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.264 -0.425 . . . . 3.86 109.944 -172.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -108.42 177.07 4.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.76 111.424 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 10.2 mtpm? -59.37 -43.3 96.16 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.959 -0.564 . . . . 3.35 111.873 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 54.0 Cg_endo -74.37 96.2 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 120.633 0.889 . . . . 1.36 110.995 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.519 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 51.1 p90 -130.81 148.2 52.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.585 -0.734 . . . . 1.1 110.252 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 33.6 t70 -81.99 6.95 14.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.483 -0.78 . . . . 1.77 110.962 -174.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.519 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 6.0 tt 52.75 -60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.551 1.54 . . . . 1.39 112.162 -171.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 107' ' ' ASP . 29.0 t70 -62.05 -30.71 71.17 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 110.298 -0.26 . . . . 1.16 110.298 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 pt-20 -64.13 -29.71 70.82 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.536 -0.466 . . . . 0.84 110.185 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.512 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 34.2 mt -81.71 -42.47 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.245 -0.434 . . . . 0.74 110.459 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.446 ' C ' ' HD2' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -67.86 -34.96 77.71 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.818 0.818 . . . . 0.72 109.222 175.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.2 t70 -64.2 -49.44 72.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.986 -1.006 . . . . 0.78 108.664 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.859 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.94 -48.84 75.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.712 -1.131 . . . . 0.59 111.729 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 112' ' ' ARG . 35.7 m -60.8 -51.95 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.313 -0.555 . . . . 0.47 111.663 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.4 OUTLIER -71.21 -29.83 65.63 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.627 0.232 . . . . 1.16 111.627 -176.077 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.859 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 65.0 pttt -72.54 -26.09 61.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.64 -0.824 . . . . 1.48 111.184 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -77.89 -66.55 0.83 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.928 0.394 . . . . 2.21 110.283 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -121.23 97.71 47.4 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.538 -0.912 . . . . 2.09 108.538 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.554 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 77.1 Cg_endo -93.97 132.61 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.93 2.42 . . . . 0.92 113.952 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 4' ' ' GLU . 13.8 tp . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.299 0.571 . . . . 1.25 110.209 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.786 ' HB3' HD22 ' A' ' 121' ' ' LEU . 12.5 tt0 . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 121.952 0.882 . . . . 2.3 109.933 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.802 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -132.52 145.99 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.238 -0.892 . . . . 0.8 110.661 -173.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.886 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.8 mt -136.98 156.56 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.544 0.688 . . . . 0.2 111.774 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.917 HD11 ' HB ' ' A' ' 42' ' ' ILE . 1.9 tt -134.17 109.51 8.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.673 -1.149 . . . . 0.17 108.146 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.4 mp -97.37 108.07 21.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.324 -0.55 . . . . 0.22 109.763 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.739 HG21 HD23 ' A' ' 53' ' ' LEU . 59.9 t -97.04 88.53 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 110.005 -0.368 . . . . 0.28 110.005 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.8 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.1 t70 -134.77 140.79 46.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.517 -0.549 . . . . 1.82 109.517 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.893 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 35.8 t70 -88.81 -49.4 6.85 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.141 -0.349 . . . . 0.51 111.016 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HG3' HD12 ' A' ' 15' ' ' ILE . 7.1 pt20 -76.57 73.1 3.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.628 -0.879 . . . . 2.07 108.628 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.565 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 52.0 p90 -44.94 -12.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 112.206 -2.27 . . . . 1.44 115.986 -167.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.28 -58.87 4.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.978 -1.106 . . . . 0.38 110.789 170.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.634 HD12 ' HG3' ' A' ' 12' ' ' GLN . 2.3 mt -59.42 -27.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.608 0.718 . . . . 0.8 110.409 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.897 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.3 ttm180 -78.79 -43.83 24.58 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.879 -1.055 . . . . 0.38 110.513 -167.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.728 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 39.2 pt -80.46 -26.11 11.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.459 0.475 . . . . 0.56 109.901 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 19' ' ' LEU . 1.8 tp -59.05 -63.54 1.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.08 -0.711 . . . . 0.58 109.08 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.02 HD21 HD22 ' A' ' 52' ' ' LEU . 8.1 tp -57.93 -41.15 82.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.759 -1.109 . . . . 1.23 110.531 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.728 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 2.1 t30 -51.14 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.406 -0.815 . . . . 0.94 110.566 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.55 -41.88 42.57 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.224 0.952 . . . . 2.46 112.244 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.8 t -55.1 -63.19 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.457 0.169 . . . . 0.37 111.457 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.797 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 16.1 m-85 -70.3 -37.31 74.76 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.379 -0.6 . . . . 0.43 109.379 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.832 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 2.6 t30 -50.25 -49.01 54.4 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.93 -1.032 . . . . 0.28 109.024 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -60.52 -46.77 88.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.524 -1.671 . . . . 3.25 111.714 -176.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' OE2' ' HB2' ' A' ' 112' ' ' ARG . 9.6 pt-20 -80.71 11.87 3.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.451 -0.499 . . . . 1.45 112.235 -174.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.582 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 132.93 -16.53 4.72 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.523 -0.762 . . . . 0.44 112.963 171.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.832 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 12.3 m-85 -82.15 137.0 35.07 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.3 -0.96 . . . . 1.07 111.875 -166.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.802 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.9 mt-30 -89.05 83.62 6.57 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.413 -0.958 . . . . 1.14 108.413 168.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.886 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -91.33 132.54 36.1 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.898 -0.592 . . . . 0.14 110.193 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 9.9 m-85 -121.68 124.39 44.17 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 122.486 1.136 . . . . 0.34 109.254 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.897 ' HB2' HH11 ' A' ' 16' ' ' ARG . 5.2 pt20 -84.18 119.8 25.44 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 112.839 -1.982 . . . . 0.22 111.693 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.953 ' HB1' ' HB3' ' A' ' 38' ' ' GLN . . . -119.22 138.35 53.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.441 -0.948 . . . . 0.23 108.441 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.495 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -97.15 -7.54 32.29 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.596 -0.841 . . . . 0.18 110.3 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' CG ' ' HB2' ' A' ' 38' ' ' GLN . 1.9 p30 -146.42 166.0 27.68 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 120.152 -0.619 . . . . 0.29 111.68 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.64 -22.68 78.03 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.605 -0.725 . . . . 0.14 112.543 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.84 -38.24 38.49 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.052 -0.722 . . . . 0.28 109.052 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.953 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -59.0 -46.19 88.79 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 104.618 -2.364 . . . . 1.29 104.618 175.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -59.19 -49.14 79.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.501 -1.681 . . . . 0.14 111.594 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.37 -42.13 66.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.674 0.749 . . . . 0.97 109.405 176.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.27 -30.22 60.37 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.708 -1.133 . . . . 1.32 111.47 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.917 ' HB ' HD11 ' A' ' 7' ' ' LEU . 8.8 mm -68.24 -46.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 O-C-N 121.714 -0.616 . . . . 0.14 110.003 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.2 t -58.07 -42.91 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.065 0.936 . . . . 0.15 108.771 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -34.66 70.15 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.037 -1.438 . . . . 0.39 111.388 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.741 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.92 -47.29 7.68 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.421 0.526 . . . . 2.42 112.421 -174.01 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 46.0 mm-40 -107.44 -32.7 7.62 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.19 0.441 . . . . 0.63 112.19 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 27.4 mtp85 63.69 61.17 1.74 Allowed Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 123.694 0.621 . . . . 3.66 110.247 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.788 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.2 Cg_exo -60.73 153.82 59.63 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 121.435 1.423 . . . . 0.21 111.635 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.745 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 5.2 m-20 -85.91 -42.01 14.45 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.303 -0.999 . . . . 0.98 108.303 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 49' ' ' ASP . 7.7 mp -111.56 111.61 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.422 -0.808 . . . . 0.26 110.585 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' HB3' ' A' ' 7' ' ' LEU . 91.7 t -109.99 113.54 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.075 0.464 . . . . 0.21 111.414 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.02 HD22 HD21 ' A' ' 19' ' ' LEU . 2.0 mp -87.47 87.34 7.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.53 0.681 . . . . 0.15 109.773 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 9' ' ' VAL . 37.8 mt -84.88 110.31 18.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.786 -1.097 . . . . 1.53 111.124 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.66 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 49.1 t0 -68.82 115.88 8.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.616 0.722 . . . . 1.47 111.1 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.489 ' SD ' HG12 ' A' ' 63' ' ' ILE . 9.2 mmm -84.33 -3.51 58.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.65 -1.159 . . . . 0.94 111.343 176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' NZ ' ' HB2' ' A' ' 83' ' ' ALA . 22.2 mmmt -61.75 -65.57 0.67 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.893 0.701 . . . . 2.24 112.893 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.969 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 10.1 tp -169.81 -30.69 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.594 1.331 . . . . 2.06 114.594 -171.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -23.72 -55.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 124.08 3.186 . . . . 0.45 116.204 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -144.6 -62.75 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.824 -1.179 . . . . 0.47 112.702 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.7 ttm -148.76 167.29 25.98 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.277 -0.638 . . . . 2.23 109.277 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 65' ' ' ILE . 7.3 m-20 -58.48 127.7 33.46 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.297 0.57 . . . . 0.67 109.485 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.36 -15.9 33.12 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.703 -1.135 . . . . 0.32 112.528 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 93' ' ' SER . 3.0 mm -77.75 -41.4 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 117.456 0.628 . . . . 1.31 110.379 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -68.48 -37.31 80.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.723 -0.671 . . . . 0.47 109.335 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.538 ' HB ' HD13 ' A' ' 53' ' ' LEU . 14.5 mt -72.72 -36.37 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.69 110.714 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.65 HD22 HG21 ' A' ' 78' ' ' VAL . 2.8 pp -67.32 -36.13 80.84 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.259 -0.576 . . . . 1.47 109.814 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.9 ptpp? -75.77 -32.62 60.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.619 -0.832 . . . . 0.65 111.354 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' CG ' ' HA ' ' A' ' 65' ' ' ILE . 10.9 ptp180 -67.71 -35.17 78.3 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 118.968 -1.093 . . . . 2.18 111.493 174.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.781 ' HA ' HG12 ' A' ' 72' ' ' ILE . 9.5 ptp -80.29 -17.31 52.48 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 120.164 -0.615 . . . . 1.28 109.641 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.4 mptp? -70.3 -40.83 74.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.363 -0.977 . . . . 1.3 108.363 167.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 67' ' ' LYS . 95.8 t -61.75 -39.16 82.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 1.03 110.605 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.781 HG12 ' HA ' ' A' ' 69' ' ' MET . 32.0 pt -85.19 -20.25 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.676 -0.41 . . . . 0.26 110.655 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.69 85.22 0.55 Allowed 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 112.555 0.576 . . . . 1.08 112.555 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.9 mt-10 -73.96 5.56 4.11 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.412 -0.805 . . . . 1.78 109.845 173.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.15 -28.52 62.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.562 1.172 . . . . 0.35 108.033 170.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.618 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.3 tt -76.06 161.63 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-N 112.843 -1.98 . . . . 0.21 111.403 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -138.47 176.76 8.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.737 -1.12 . . . . 1.08 108.179 173.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.68 HG11 HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -142.65 153.01 17.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 119.941 -0.704 . . . . 0.79 111.806 -173.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.712 HG23 ' OG1' ' A' ' 100' ' ' THR . 71.3 mt -124.71 73.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.328 -1.36 . . . . 0.6 107.328 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -65.41 138.23 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.216 -0.902 . . . . 0.14 111.829 -171.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.773 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 6.1 mtm -94.18 117.93 30.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.089 -0.96 . . . . 1.88 110.317 -174.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 11.0 p -125.82 157.4 37.65 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.667 -0.697 . . . . 1.13 112.163 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . . . -73.97 60.66 0.77 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.716 -0.675 . . . . 0.54 110.436 167.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 58.4 t80 60.43 54.61 3.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.334 0.587 . . . . 4.3 111.554 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.2 87.34 0.03 OUTLIER Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.891 -0.595 . . . . 0.62 113.475 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.657 ' N ' HG13 ' A' ' 90' ' ' ILE . 22.5 mt-10 -87.12 16.12 5.43 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.948 0.499 . . . . 1.33 111.582 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 87' ' ' LEU . 3.7 mm? 63.65 179.35 0.16 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.8 1.407 . . . . 1.73 114.8 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 89' ' ' MET . 1.7 t70 61.82 -93.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.268 -1.333 . . . . 1.38 111.658 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.824 ' HB3' HG13 ' A' ' 63' ' ' ILE . 1.1 mpt? -64.25 -14.34 55.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.066 0.46 . . . . 2.72 110.577 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.657 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.5 mm -77.34 -22.1 14.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.366 0.603 . . . . 0.67 110.605 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 13.4 mt-30 -81.15 -47.2 13.78 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.793 -1.188 . . . . 2.5 107.793 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.615 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 19.7 tt0 -65.33 -33.56 76.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.929 -1.487 . . . . 1.27 112.671 -177.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.833 ' HB3' HD12 ' A' ' 63' ' ' ILE . 7.9 p -52.45 -74.78 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.06 0.933 . . . . 1.28 111.611 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.6 pttt -53.78 -35.91 61.84 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.779 -1.555 . . . . 1.91 111.992 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -62.11 -34.3 76.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.886 -0.326 . . . . 1.84 111.161 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.3 mt -81.31 -24.66 37.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.896 0.379 . . . . 1.25 111.019 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.31 -1.79 0.25 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 119.877 -1.154 . . . . 0.35 113.706 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.649 ' HB2' HG23 ' A' ' 78' ' ' VAL . . . -70.74 132.15 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.954 0.877 . . . . 0.21 109.605 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.41 HD11 ' HG ' ' A' ' 50' ' ' LEU . 12.5 mt -75.29 -48.25 24.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.043 0.925 . . . . 0.18 109.392 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.712 ' OG1' HG23 ' A' ' 79' ' ' ILE . 71.1 p -141.72 156.74 45.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.889 -1.505 . . . . 0.19 111.914 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.62 98.62 8.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.354 -1.294 . . . . 0.52 109.47 171.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.773 ' HB3' ' HA ' ' A' ' 81' ' ' MET . 26.0 t80 -56.41 143.23 35.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.445 -0.798 . . . . 3.86 109.441 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -130.32 167.45 18.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.759 -0.46 . . . . 0.76 109.759 172.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 54.5 mtpt -68.15 -40.88 23.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.203 -0.453 . . . . 3.35 111.387 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 58.0 Cg_endo -76.6 96.36 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.767 0.952 . . . . 1.36 110.62 166.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.625 ' HB2' HD11 ' A' ' 111' ' ' ILE . 53.0 p90 -129.03 143.62 50.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.059 -0.519 . . . . 1.1 111.607 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.511 ' HB3' ' HG2' ' A' ' 110' ' ' GLU . 1.8 t70 -75.25 -3.68 34.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.888 -0.596 . . . . 1.77 110.712 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 107' ' ' ASP . 9.4 tp 52.2 -53.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.613 1.565 . . . . 1.39 112.206 -165.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.458 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 35.0 t70 -65.9 -26.99 67.87 Favored 'General case' 0 C--O 1.211 -0.924 0 O-C-N 122.384 -0.197 . . . . 1.16 110.94 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 11.3 pt-20 -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.203 -0.599 . . . . 0.84 109.864 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 106' ' ' PHE . 47.7 mt -83.23 -43.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.74 109.559 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.636 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -65.42 -39.58 92.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.809 -0.811 . . . . 0.72 108.809 175.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.8 t70 -67.95 -40.53 83.24 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.187 -0.671 . . . . 0.78 109.187 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.612 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.63 -48.71 74.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.324 -0.853 . . . . 0.59 110.927 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 112' ' ' ARG . 34.3 m -61.93 -48.23 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 120.082 -0.647 . . . . 0.47 111.173 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.631 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -70.91 -19.91 62.54 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.598 0.592 . . . . 1.16 112.598 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 7.4 pttm -86.61 -23.14 25.83 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.415 -0.914 . . . . 1.48 111.154 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.523 ' HD2' ' O ' ' A' ' 114' ' ' ALA . 28.4 m-85 -82.17 -67.19 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.024 -0.362 . . . . 2.21 110.024 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.0 95.05 49.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.26 -0.645 . . . . 2.09 109.26 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 84.1 Cg_endo -91.1 141.65 2.96 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.857 2.372 . . . . 0.92 113.942 -173.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.786 HD22 ' HB3' ' A' ' 4' ' ' GLU . 29.7 tp . . . . . 0 CA--C 1.51 -0.564 0 CA-C-O 121.725 0.774 . . . . 1.25 109.84 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.818 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 3.0 tp10 . . . . . 0 C--O 1.22 -0.49 0 N-CA-C 107.325 -1.361 . . . . 2.3 107.325 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.73 ' HD3' ' HB3' ' A' ' 46' ' ' GLU . 2.7 ttmt -150.31 139.73 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.188 1.181 . . . . 0.8 114.188 -167.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.938 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -139.39 154.82 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.233 -1.349 . . . . 0.2 111.49 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.01 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.4 tt -135.55 117.95 15.73 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.52 -1.289 . . . . 0.17 107.52 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.749 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -103.7 100.92 11.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.987 -0.685 . . . . 0.22 110.132 -177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.777 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 48.8 t -83.61 91.25 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.559 -0.534 . . . . 0.28 109.559 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.83 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.7 t70 -143.35 142.98 31.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.543 0.211 . . . . 1.82 110.607 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.883 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 15.2 t70 -102.46 -31.62 10.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.891 0.377 . . . . 0.51 110.27 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -79.12 70.91 5.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.507 -1.294 . . . . 2.07 107.507 172.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 17' ' ' ILE . 46.7 p90 -52.29 -15.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 112.88 -1.964 . . . . 1.44 115.099 -159.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.64 -60.9 5.54 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.906 -1.14 . . . . 0.38 110.334 169.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HA ' HD23 ' A' ' 18' ' ' LEU . 2.9 mt -55.17 -30.49 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.333 0.587 . . . . 0.8 111.056 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.83 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.1 ttm180 -76.29 -49.79 16.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.749 . . . . 0.38 110.596 -168.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.5 pt -76.19 -25.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.598 -0.519 . . . . 0.56 109.598 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 15' ' ' ILE . 2.8 tp -57.24 -65.26 0.65 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.348 -0.842 . . . . 0.58 109.457 171.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.827 HD13 HD22 ' A' ' 52' ' ' LEU . 57.8 mt -58.26 -44.15 88.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.23 109.939 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.609 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.5 t30 -50.5 -66.17 0.43 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.36 -0.837 . . . . 0.94 110.128 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.47 -39.21 82.95 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.662 0.601 . . . . 2.46 111.396 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.9 t -55.08 -58.17 5.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 111.787 0.291 . . . . 0.37 111.787 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.694 ' CD2' HD13 ' A' ' 6' ' ' ILE . 7.9 m-85 -73.56 -40.09 64.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.256 -0.646 . . . . 0.43 109.256 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.8 t-20 -50.78 -50.23 56.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.066 -0.97 . . . . 0.28 108.557 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -51.11 -46.75 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.275 -1.784 . . . . 3.25 112.58 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.625 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 6.5 pt-20 -88.21 16.16 6.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.116 -0.634 . . . . 1.45 111.544 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.79 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 126.98 -15.45 6.53 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.495 -0.859 . . . . 0.44 113.581 169.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.818 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 10.2 m-85 -73.83 160.22 31.77 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 118.899 -1.12 . . . . 1.07 112.407 -168.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.697 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 2.1 mp0 -106.83 76.32 1.1 Allowed 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.101 -1.409 . . . . 1.14 107.337 173.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.938 HG22 ' HB ' ' A' ' 6' ' ' ILE . 27.2 p -90.68 130.55 36.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.876 -1.056 . . . . 0.14 109.457 -173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.462 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.3 m-85 -126.9 108.96 11.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.632 1.206 . . . . 0.34 109.876 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.753 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.7 pt20 -61.29 120.72 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 112.483 -2.144 . . . . 0.22 112.577 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -124.33 125.94 45.17 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.957 0.903 . . . . 0.23 109.094 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -82.84 -11.03 58.55 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.042 -0.663 . . . . 0.18 111.058 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.077 0.399 . . . . 0.29 112.077 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.5 -19.34 78.94 Favored Glycine 0 CA--C 1.506 -0.492 0 CA-C-N 115.794 -0.639 . . . . 0.14 113.051 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.62 -40.91 24.83 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.154 0.978 . . . . 0.28 108.949 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.827 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -61.17 -41.87 97.54 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.391 -2.077 . . . . 1.29 105.391 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -59.27 -46.74 87.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.157 -1.383 . . . . 0.14 111.17 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -53.76 -48.27 69.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.623 -0.717 . . . . 0.97 109.816 175.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.55 -39.1 92.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.42 -1.264 . . . . 1.32 111.064 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.86 ' HB ' HD11 ' A' ' 7' ' ' LEU . 20.0 mm -65.94 -48.68 81.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.234 -0.439 . . . . 0.14 110.083 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.494 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 59.4 t -58.46 -42.73 85.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.15 109.231 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.36 -29.74 70.09 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.117 -0.947 . . . . 0.39 111.425 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -88.94 -46.6 8.77 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.299 0.481 . . . . 2.42 112.299 -177.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.73 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 46.3 mm-40 -108.45 -35.05 6.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 111.975 0.361 . . . . 0.63 111.975 -176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 45.4 mtp180 63.69 60.39 1.8 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.294 -0.867 . . . . 3.66 109.889 -171.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 32.1 Cg_exo -62.65 146.62 95.31 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 121.376 1.384 . . . . 0.21 110.95 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 m-20 -85.96 -35.24 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.409 -0.916 . . . . 0.98 109.389 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 7.0 mp -113.13 111.11 21.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.26 109.638 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 7' ' ' LEU . 19.0 t -117.34 112.59 39.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.383 -0.372 . . . . 0.21 110.821 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.827 HD22 HD13 ' A' ' 19' ' ' LEU . 3.2 mp -83.59 104.67 13.9 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.957 -0.464 . . . . 0.15 110.496 -176.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.777 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 8.1 mp -99.04 102.52 14.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.516 -0.311 . . . . 1.53 111.824 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.658 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t70 -63.83 111.1 2.31 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.527 -0.469 . . . . 1.47 110.059 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.741 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 17.1 mtm -91.37 12.38 20.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.234 -0.439 . . . . 0.94 111.013 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.658 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 14.2 mmmm -70.61 -65.91 0.67 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.782 0.289 . . . . 2.24 111.782 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.995 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 2.3 pt -160.72 -39.5 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.908 1.077 . . . . 2.06 113.908 -169.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -21.2 -60.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 124.905 3.737 . . . . 0.45 116.928 -175.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.68 -66.64 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.651 -1.262 . . . . 0.47 113.0 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 49.5 ttm -139.69 164.14 30.73 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 2.23 109.414 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.463 ' O ' HG13 ' A' ' 65' ' ' ILE . 2.7 m-20 -61.06 134.67 57.31 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.75 -0.463 . . . . 0.67 109.75 174.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -62.01 -15.23 49.08 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 115.451 -0.795 . . . . 0.32 112.378 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.611 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 9.6 mt -78.3 -44.25 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.061 -0.67 . . . . 1.31 109.836 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.58 -33.56 74.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.351 0.596 . . . . 0.47 110.048 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 53' ' ' LEU . 31.9 mt -74.16 -39.38 49.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.69 110.453 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 2.9 pp -65.92 -36.8 84.37 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 120.187 -0.605 . . . . 1.47 109.951 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.1 ptpt -75.42 -36.08 60.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 120.491 -0.483 . . . . 0.65 111.391 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 11.2 ptm180 -64.87 -36.86 85.7 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 119.497 -0.881 . . . . 2.18 111.144 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.79 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.4 ptp -82.46 -14.12 55.6 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.102 -0.639 . . . . 1.28 109.618 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -70.45 -40.02 73.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.089 -1.078 . . . . 1.3 108.089 167.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 67' ' ' LYS . 94.0 t -62.54 -38.58 81.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.453 -0.794 . . . . 1.03 110.125 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.79 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.1 pt -86.47 -19.03 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.525 -0.47 . . . . 0.26 111.074 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.96 86.12 0.42 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.484 0.55 . . . . 1.08 112.484 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.586 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.1 mt-10 -70.53 1.34 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.046 -1.034 . . . . 1.78 110.646 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -30.43 64.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.596 1.189 . . . . 0.35 108.05 171.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.783 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.9 tt -69.24 161.54 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.636 -2.075 . . . . 0.21 111.482 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -141.56 174.72 10.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.849 -1.069 . . . . 1.08 108.649 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 98' ' ' ALA . 10.1 m -141.54 143.4 27.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.55 0.69 . . . . 0.79 111.273 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.625 HG23 ' OG1' ' A' ' 100' ' ' THR . 4.2 mp -108.79 75.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.581 -1.266 . . . . 0.6 107.581 174.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.741 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -69.51 141.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 119.363 -0.935 . . . . 0.14 112.016 -172.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.596 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 27.8 mtt -95.23 136.78 35.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.22 -0.9 . . . . 1.88 110.335 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.533 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.7 t -132.83 158.12 43.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.117 0.784 . . . . 1.13 113.117 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . . . -72.71 64.16 0.64 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.544 -1.207 . . . . 0.54 109.654 169.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 70.15 15.06 7.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.235 -0.893 . . . . 4.3 112.32 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.28 92.03 1.07 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.58 -0.819 . . . . 0.62 111.412 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.566 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.4 mt-10 -88.03 7.25 32.15 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 122.927 0.491 . . . . 1.33 111.644 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 59.9 -175.11 0.11 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.47 -0.786 . . . . 1.73 112.813 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.86 -93.34 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.083 -0.962 . . . . 1.38 112.324 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.533 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.8 ptt? -61.2 -24.11 66.09 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.137 0.494 . . . . 2.72 110.332 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.1 mm -66.01 -47.38 85.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 0.67 109.952 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 14.1 mm100 -61.64 -50.23 73.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.39 -0.823 . . . . 2.5 109.647 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 13.3 tt0 -63.59 -33.44 75.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.041 -0.981 . . . . 1.27 112.431 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -59.13 -63.7 1.21 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.662 0.268 . . . . 1.28 110.631 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.9 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 20.6 pttt -55.83 -40.18 72.45 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.433 0.635 . . . . 1.91 110.871 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 6.8 tp10 -54.52 -35.59 63.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 1.84 111.51 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.416 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 18.1 tp -90.19 -10.86 42.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.723 0.268 . . . . 1.25 111.723 -173.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.554 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 154.86 -12.13 0.45 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.76 -1.21 . . . . 0.35 113.644 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.9 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -73.99 145.59 44.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.292 0.546 . . . . 0.21 110.784 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 77' ' ' ARG . 16.7 mt -87.86 -50.37 6.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.501 0.667 . . . . 0.18 109.797 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.625 ' OG1' HG23 ' A' ' 79' ' ' ILE . 52.3 p -143.26 160.44 40.48 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.263 -1.335 . . . . 0.19 111.433 -170.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -109.98 98.22 7.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.846 -1.07 . . . . 0.52 110.081 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HD2' HD12 ' A' ' 111' ' ' ILE . 43.7 t80 -68.29 124.86 24.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.611 -0.722 . . . . 3.86 109.954 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.07 178.0 5.28 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.769 -0.372 . . . . 0.76 110.463 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 94.2 mttt -53.37 -47.16 97.15 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.501 0.556 . . . . 3.35 112.501 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 57.5 Cg_endo -73.27 97.49 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 120.86 1.04 . . . . 1.36 111.593 173.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.411 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 40.5 p90 -133.37 138.22 46.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.968 -0.56 . . . . 1.1 110.727 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.645 ' O ' HG22 ' A' ' 108' ' ' ILE . 8.0 t70 -72.82 -4.99 35.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.895 -0.593 . . . . 1.77 111.078 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 107' ' ' ASP . 6.3 tt 59.41 -56.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.856 1.262 . . . . 1.39 110.598 -165.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.96 -38.86 92.77 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 110.26 -0.274 . . . . 1.16 110.26 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.583 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 pt-20 -61.19 -27.92 68.77 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.695 -0.402 . . . . 0.84 110.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.611 HD12 ' HD2' ' A' ' 102' ' ' PHE . 4.7 mm -77.43 -50.91 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.354 -0.61 . . . . 0.74 109.354 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.625 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -66.87 -36.43 82.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.563 0.697 . . . . 0.72 109.697 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.526 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 35.0 t70 -69.56 -42.45 74.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.635 -0.711 . . . . 0.78 109.088 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.88 -40.74 98.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.525 -0.761 . . . . 0.59 110.978 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 112' ' ' ARG . 33.0 m -63.83 -53.38 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 119.15 -1.02 . . . . 0.47 110.952 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -69.68 -16.85 63.43 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.343 0.497 . . . . 1.16 112.343 -178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 18.6 ptpt -83.64 -26.89 29.54 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.29 -0.881 . . . . 1.48 111.041 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -81.42 -59.39 2.64 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.996 0.427 . . . . 2.21 109.955 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 44.2 tp -120.55 107.83 38.24 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.368 -0.975 . . . . 2.09 108.368 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.54 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 91.2 Cg_endo -100.86 146.97 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.893 2.395 . . . . 0.92 114.683 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.79 HD23 ' HA3' ' A' ' 27' ' ' GLY . 16.4 tp . . . . . 0 N--CA 1.449 -0.518 0 CA-C-N 115.474 -0.785 . . . . 1.25 110.536 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.809 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 7.3 tt0 . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 122.096 0.95 . . . . 2.3 111.612 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.853 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -131.28 152.41 50.57 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.012 -0.994 . . . . 0.8 110.622 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.836 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.3 mt -142.36 154.25 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.614 0.721 . . . . 0.2 111.645 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.859 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.2 tt -132.11 122.04 24.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.418 -1.326 . . . . 0.17 107.418 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.6 mp -108.71 106.33 20.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.125 -0.63 . . . . 0.22 109.59 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 23.5 t -95.11 71.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 O-C-N 122.97 0.169 . . . . 0.28 110.683 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.836 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.1 m-20 -118.33 135.63 54.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.651 0.262 . . . . 1.82 111.208 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 1.05 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 29.7 t70 -86.69 -27.46 23.71 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.184 -1.043 . . . . 0.51 108.184 171.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.793 ' HB2' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -78.88 73.37 5.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.475 -1.306 . . . . 2.07 107.475 167.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 40.3 p90 -54.13 -17.49 2.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.829 -1.532 . . . . 1.44 113.178 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.5 -63.89 4.87 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.925 -1.27 . . . . 0.38 109.925 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 12' ' ' GLN . 3.0 mt -53.62 -25.28 11.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.869 0.366 . . . . 0.8 111.574 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.868 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 10.2 ttm180 -76.94 -50.24 13.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.308 -0.406 . . . . 0.38 111.081 -171.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.1 pt -74.74 -24.67 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.193 -0.669 . . . . 0.56 109.193 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.7 tp -57.27 -67.76 0.29 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.928 -1.033 . . . . 0.58 109.493 170.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 52' ' ' LEU . 60.5 mt -54.64 -40.88 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 1.23 110.451 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.8 t30 -50.68 -69.25 0.12 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.585 -0.734 . . . . 0.94 110.139 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.3 -39.41 75.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 2.46 111.568 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 18' ' ' LEU . 49.4 t -57.1 -55.69 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 111.999 0.37 . . . . 0.37 111.999 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.694 ' HB2' HG21 ' A' ' 30' ' ' THR . 6.7 m-85 -77.03 -37.73 54.27 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.782 -0.451 . . . . 0.43 109.782 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.823 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 3.6 t30 -49.95 -50.3 47.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.033 0.921 . . . . 0.28 109.189 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.09 -33.68 71.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.343 -1.753 . . . . 3.25 113.06 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.672 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 4.2 mt-10 -68.08 -23.49 64.94 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.307 -0.627 . . . . 1.45 109.307 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.05 -13.32 2.6 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.66 -1.155 . . . . 0.44 110.569 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.823 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 6.7 m-85 -72.65 134.25 45.02 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.612 0.72 . . . . 1.07 111.557 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.853 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 19.2 mt-30 -88.61 80.95 7.19 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.212 -1.033 . . . . 1.14 108.212 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.836 HG22 ' HB ' ' A' ' 6' ' ' ILE . 17.2 p -90.25 137.32 32.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.808 -0.633 . . . . 0.14 110.026 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.584 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 38.1 m-85 -129.78 126.09 37.32 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.677 1.227 . . . . 0.34 110.272 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.868 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 5.8 pt20 -85.28 121.13 27.57 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.639 -2.073 . . . . 0.22 111.93 -171.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -121.47 137.12 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.89 . . . . 0.23 108.894 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 58' ' ' PRO . . . -93.06 -10.72 35.09 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.778 -0.369 . . . . 0.18 110.42 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.0 165.8 30.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.29 111.444 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -71.94 -16.3 76.47 Favored Glycine 0 CA--C 1.504 -0.611 0 CA-C-N 115.747 -0.66 . . . . 0.14 113.467 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.31 -43.73 18.68 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.679 1.228 . . . . 0.28 108.038 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.8 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 tp-100 -60.33 -41.11 92.87 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.114 -2.312 . . . . 1.29 105.49 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.78 -44.23 90.66 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.699 -1.591 . . . . 0.14 111.079 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.581 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.3 OUTLIER -55.5 -42.63 74.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.401 -0.592 . . . . 0.97 109.401 175.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 14.7 m-20 -64.65 -41.79 95.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.108 -0.951 . . . . 1.32 110.906 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.859 ' HB ' HD11 ' A' ' 7' ' ' LEU . 9.9 mm -61.04 -50.11 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 121.015 -0.274 . . . . 0.14 110.748 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -59.04 -45.33 92.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-O 121.817 0.817 . . . . 0.15 109.45 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.581 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -59.87 -28.91 67.94 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.868 -1.06 . . . . 0.39 111.783 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -96.04 -46.66 6.41 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.966 -0.561 . . . . 2.42 111.848 -173.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 60.8 mm-40 -105.07 -36.52 7.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.733 0.271 . . . . 0.63 111.733 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 64.58 65.96 1.0 Allowed Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.776 0.672 . . . . 3.66 109.929 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.808 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 76.9 Cg_exo -58.97 161.42 15.75 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.803 1.669 . . . . 0.21 112.118 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.784 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.7 m-20 -94.63 -40.04 10.03 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.195 -1.039 . . . . 0.98 108.195 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mp -116.91 118.6 32.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.255 -0.884 . . . . 0.26 109.876 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 7' ' ' LEU . 96.7 t -118.06 112.02 36.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.122 0.487 . . . . 0.21 110.871 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -82.9 98.5 9.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.46 0.647 . . . . 0.15 109.544 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.677 HD12 ' HA2' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -88.18 99.71 12.41 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.972 -1.013 . . . . 1.53 111.007 -175.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 23.2 t0 -68.23 100.8 1.08 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.351 -0.611 . . . . 1.47 109.351 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.782 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 44.9 mtp -77.03 -5.9 50.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.041 -0.527 . . . . 0.94 110.95 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.2 mmmm -50.63 -54.64 21.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.267 0.84 . . . . 2.24 113.267 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.864 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 10.4 tp -177.48 -11.09 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 114.974 1.472 . . . . 2.06 114.974 -171.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.05 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -32.09 -51.04 0.33 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.991 2.461 . . . . 0.45 115.723 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.36 -43.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.913 -1.137 . . . . 0.47 112.739 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.8 tpt -147.81 167.23 25.27 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.816 -0.809 . . . . 2.23 108.816 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.23 139.1 57.29 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.247 0.546 . . . . 0.67 110.308 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.677 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -60.53 -15.06 38.04 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.984 -1.007 . . . . 0.32 112.49 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.829 HG13 ' HB3' ' A' ' 89' ' ' MET . 3.7 mm -79.85 -47.64 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.736 0.303 . . . . 1.31 110.311 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -61.43 -36.72 81.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.657 0.741 . . . . 0.47 109.216 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 68.1 mt -72.73 -36.93 54.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.137 -0.938 . . . . 0.69 111.225 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.624 ' CD2' ' HA ' ' A' ' 63' ' ' ILE . 2.2 pp -70.65 -37.44 73.73 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.289 -0.564 . . . . 1.47 110.715 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.663 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.1 ptpt -73.06 -34.57 66.36 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.526 -0.469 . . . . 0.65 110.964 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.702 ' O ' HG12 ' A' ' 71' ' ' VAL . 12.0 ptm180 -65.5 -34.68 78.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.436 -0.905 . . . . 2.18 111.29 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.685 ' HA ' HG12 ' A' ' 72' ' ' ILE . 4.7 ptt? -83.66 -12.33 56.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.894 -1.122 . . . . 1.28 109.864 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.6 mptp? -78.81 -35.05 44.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.635 -0.711 . . . . 1.3 110.058 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -73.79 -34.33 40.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.742 -0.663 . . . . 1.03 109.419 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.685 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.0 pt -80.85 -34.77 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.373 -0.83 . . . . 0.26 110.204 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -155.79 90.39 1.22 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.565 0.58 . . . . 1.08 112.565 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.04 4.72 3.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.525 0.679 . . . . 1.78 110.34 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -26.1 63.84 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.488 -1.301 . . . . 0.35 107.488 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.9 tt -77.32 160.43 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 112.706 -2.043 . . . . 0.21 110.919 -172.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.692 ' HE ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -137.63 -179.68 5.89 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.356 -0.838 . . . . 1.08 109.046 173.182 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.614 HG21 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -134.48 153.53 35.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.299 -0.561 . . . . 0.79 110.218 -172.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.635 HG23 ' OG1' ' A' ' 100' ' ' THR . 63.4 mt -130.73 71.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.411 -1.329 . . . . 0.6 107.411 170.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.782 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -68.31 139.61 20.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.257 -0.883 . . . . 0.14 111.849 -172.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 4.8 mtp -99.1 131.62 45.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.044 -0.98 . . . . 1.88 110.445 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 t -133.3 158.52 42.75 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.048 0.758 . . . . 1.13 113.048 -175.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.48 65.66 0.66 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.028 -0.987 . . . . 0.54 109.719 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.515 ' HE1' ' HE2' ' A' ' 104' ' ' LYS . 49.8 m-85 71.44 15.27 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 4.3 112.677 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 90' ' ' ILE . . . 85.51 79.87 1.14 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.332 -0.937 . . . . 0.62 111.522 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 90' ' ' ILE . 6.9 mt-10 -75.86 14.96 0.58 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.817 0.847 . . . . 1.33 111.693 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 27.6 mt 59.36 -170.48 0.13 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.62 0.97 . . . . 1.73 113.62 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 58.74 -94.6 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.801 -1.09 . . . . 1.38 110.885 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.829 ' HB3' HG13 ' A' ' 63' ' ' ILE . 3.1 mpp? -64.36 -19.66 65.62 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.943 0.402 . . . . 2.72 110.368 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 86' ' ' GLU . 41.6 mm -75.88 -23.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.601 0.715 . . . . 0.67 110.592 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 91' ' ' GLN . 10.6 mt-30 -82.37 -48.58 10.98 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.029 -1.1 . . . . 2.5 108.029 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 89' ' ' MET . 38.8 tt0 -63.48 -30.54 71.65 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 113.708 -1.587 . . . . 1.27 112.149 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.632 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 16.8 p -53.66 -77.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.094 0.95 . . . . 1.28 112.245 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 13.1 ptpt -51.0 -41.0 59.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.506 -1.679 . . . . 1.91 110.79 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 4.6 tp10 -54.58 -44.82 73.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.387 -0.824 . . . . 1.84 111.612 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.62 HD23 HD11 ' A' ' 66' ' ' LEU . 12.4 tp -82.68 -15.94 50.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 1.25 111.778 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.527 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 149.41 1.67 0.37 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.672 -1.251 . . . . 0.35 113.954 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 94' ' ' LYS . . . -80.64 137.54 36.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.992 0.896 . . . . 0.21 109.769 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.5 mt -76.3 -48.59 19.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.87 0.843 . . . . 0.18 109.411 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.635 ' OG1' HG23 ' A' ' 79' ' ' ILE . 41.1 p -139.29 150.77 45.82 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.368 -1.287 . . . . 0.19 111.955 -171.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -114.54 67.74 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.04 -0.982 . . . . 0.52 109.735 173.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 81' ' ' MET . 39.1 m-85 -62.18 130.31 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 3.86 110.543 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.16 -167.1 1.36 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.058 -0.519 . . . . 0.76 110.823 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HE2' ' HE1' ' A' ' 84' ' ' TYR . 46.1 mtmt -55.59 -43.08 98.98 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.226 -0.443 . . . . 3.35 112.064 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 44.1 Cg_endo -70.5 97.26 0.69 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 120.816 1.011 . . . . 1.36 111.218 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB2' HD11 ' A' ' 111' ' ' ILE . 45.1 p90 -131.7 136.71 47.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.732 -0.667 . . . . 1.1 110.049 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.7 t70 -84.73 14.38 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 1.77 111.04 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.2 tt 50.45 -64.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 125.095 1.497 . . . . 1.39 112.315 -171.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.8 OUTLIER -65.36 -23.87 67.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.815 -0.175 . . . . 1.16 110.66 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' OE2' ' HB2' ' A' ' 107' ' ' ASP . 8.9 pt-20 -68.5 -28.2 66.81 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.4 -0.52 . . . . 0.84 110.421 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' A' ' 106' ' ' PHE . 28.3 mt -81.21 -40.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.74 110.256 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.672 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.04 -37.1 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.843 0.83 . . . . 0.72 109.577 174.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.524 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 4.7 t70 -68.44 -37.02 79.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.379 -0.828 . . . . 0.78 109.359 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.506 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.98 -47.66 82.21 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.323 -0.853 . . . . 0.59 111.224 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.638 HG12 HD22 ' A' ' 50' ' ' LEU . 17.8 m -62.82 -48.77 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 119.209 -0.996 . . . . 0.47 110.377 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -53.98 -50.33 66.79 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.145 0.578 . . . . 1.16 112.237 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 19.1 ptpt -60.21 -35.54 75.66 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.778 -0.576 . . . . 1.48 111.462 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.497 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 24.6 m-85 -76.07 -56.4 4.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.993 0.425 . . . . 2.21 110.836 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.9 tp -127.47 97.53 30.8 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.925 -0.58 . . . . 2.09 109.686 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -98.58 117.29 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.83 2.354 . . . . 0.92 113.215 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.793 ' HB2' ' CD ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 122.138 0.97 . . . . 1.25 109.409 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 110.169 -0.308 . . . . 6.07 110.169 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 55.4 mtt -64.48 144.2 57.36 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.765 -0.457 . . . . 3.88 109.765 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -77.41 -5.58 50.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.085 -0.507 . . . . 2.35 111.398 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.828 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 13.8 tt0 69.57 101.92 0.06 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.545 0.688 . . . . 2.3 110.976 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.915 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.7 tppt? -134.74 145.15 48.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.108 0.48 . . . . 0.8 111.533 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.918 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.7 mt -136.7 156.41 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.305 -0.861 . . . . 0.2 111.454 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.862 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.1 tt -133.48 120.16 20.5 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.656 -1.239 . . . . 0.17 107.656 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.724 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.8 mp -107.48 103.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.474 -0.89 . . . . 0.22 110.385 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 28.9 t -88.7 82.62 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 110.051 -0.351 . . . . 0.28 110.051 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.859 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 51.8 t0 -133.5 138.92 46.36 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.115 -0.328 . . . . 1.82 110.115 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 1.013 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 37.0 t70 -85.82 -27.83 24.87 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.022 -0.732 . . . . 0.51 109.022 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' CB ' HD12 ' A' ' 15' ' ' ILE . 9.5 mm-40 -78.86 73.47 5.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.51 -1.293 . . . . 2.07 107.51 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 41.8 p90 -48.47 -19.67 0.34 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.511 -1.222 . . . . 1.44 113.271 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.03 -69.71 1.19 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.36 -1.096 . . . . 0.38 110.36 167.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.553 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 2.9 mp -51.03 -26.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 122.916 0.486 . . . . 0.8 111.863 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.94 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 9.0 ttm180 -76.96 -46.53 23.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.312 -0.404 . . . . 0.38 110.73 -172.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.49 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 36.3 pt -77.03 -25.45 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.283 -0.636 . . . . 0.56 109.283 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.5 tp -53.9 -66.19 0.44 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.135 -0.939 . . . . 0.58 109.157 169.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 64.5 mt -57.25 -39.95 76.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 1.23 110.57 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.72 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.5 t30 -51.53 -67.87 0.22 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.94 110.042 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -39.59 77.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.313 0.486 . . . . 2.46 112.313 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' LEU . 39.5 t -55.18 -58.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.787 0.292 . . . . 0.37 111.787 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.677 ' HB2' HG21 ' A' ' 30' ' ' THR . 8.2 m-85 -73.74 -35.13 65.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.287 -0.635 . . . . 0.43 109.287 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.932 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.3 t-20 -50.48 -47.93 56.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.06 -0.973 . . . . 0.28 108.668 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -57.68 -42.2 83.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.315 -1.766 . . . . 3.25 111.938 -178.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.079 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 3.2 mt-10 -58.62 -26.82 64.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.809 0.814 . . . . 1.45 109.719 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.682 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 139.09 -10.61 3.32 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 114.193 -1.367 . . . . 0.44 110.295 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.932 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 1.8 m-85 -71.62 124.03 23.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 120.119 -0.632 . . . . 1.07 110.838 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.915 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -79.12 82.99 5.23 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.26 -1.015 . . . . 1.14 108.26 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.918 HG22 ' HB ' ' A' ' 6' ' ' ILE . 20.6 p -91.04 134.02 34.84 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.973 -0.558 . . . . 0.14 110.493 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 12.9 m-85 -125.48 120.76 31.83 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.57 1.176 . . . . 0.34 109.419 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.94 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 6.5 pt20 -81.18 121.72 26.48 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 112.736 -2.029 . . . . 0.22 111.693 -173.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.919 ' HB1' ' HB3' ' A' ' 38' ' ' GLN . . . -122.14 131.3 53.89 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.696 0.799 . . . . 0.23 109.145 176.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.569 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -91.16 -7.17 52.25 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.983 -0.687 . . . . 0.18 110.897 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -147.73 165.5 30.33 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.42 -0.512 . . . . 0.29 111.699 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -23.16 73.13 Favored Glycine 0 CA--C 1.507 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.14 113.118 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.54 -39.87 51.6 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.725 -0.843 . . . . 0.28 108.725 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.919 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -60.51 -44.88 95.55 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.091 -2.189 . . . . 1.29 105.091 177.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -61.14 -44.43 97.34 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.14 111.252 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.61 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -55.83 -44.82 78.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.461 0.648 . . . . 0.97 109.473 175.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -61.59 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.666 -1.152 . . . . 1.32 110.32 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.841 HG12 ' O ' ' A' ' 38' ' ' GLN . 8.5 mm -63.69 -47.35 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 120.551 0.215 . . . . 0.14 111.418 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 69' ' ' MET . 41.2 t -59.88 -42.43 89.16 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.678 0 CA-C-O 121.486 0.66 . . . . 0.15 109.506 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -72.31 -22.15 61.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.562 -0.745 . . . . 0.39 111.197 -177.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.83 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 2.1 ptmt -89.82 -44.89 9.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 2.42 111.225 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' HE3' ' A' ' 5' ' ' LYS . 60.6 mm-40 -111.14 -35.71 5.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 111.897 0.332 . . . . 0.63 111.897 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 43' ' ' VAL . 37.6 mmt180 69.01 59.83 0.62 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 123.936 0.772 . . . . 3.66 109.123 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' ILE . 52.4 Cg_exo -61.23 153.74 63.01 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 121.457 1.438 . . . . 0.21 111.222 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.3 m-20 -92.69 -34.1 14.09 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.713 -0.795 . . . . 0.98 109.415 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 79' ' ' ILE . 7.8 mp -118.57 113.33 21.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.013 -0.54 . . . . 0.26 110.214 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 7' ' ' LEU . 46.9 t -113.26 112.19 39.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.017 0.437 . . . . 0.21 111.665 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 2.9 mp -82.06 94.28 7.17 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.277 0.56 . . . . 0.15 110.389 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.682 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -83.04 98.8 9.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.18 -0.918 . . . . 1.53 111.635 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.63 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 35.6 t70 -70.98 103.91 2.82 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.426 -0.91 . . . . 1.47 109.156 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.624 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 19.9 mtm -80.29 -1.07 39.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.015 -0.539 . . . . 0.94 110.772 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.561 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 12.6 mmmm -56.9 -67.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.724 1.009 . . . . 2.24 113.724 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.859 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 4.6 pt -152.91 -22.87 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.638 1.347 . . . . 2.06 114.638 -167.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.013 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -33.62 -48.12 0.46 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.356 2.704 . . . . 0.45 115.564 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 -48.36 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.551 -1.309 . . . . 0.47 113.077 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.418 ' HG2' ' N ' ' A' ' 61' ' ' ASP . 58.1 ttm -143.35 163.35 33.28 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.113 -0.699 . . . . 2.23 109.113 -175.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 60' ' ' MET . 35.3 m-20 -61.15 136.57 58.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.094 0.473 . . . . 0.67 109.961 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 53' ' ' LEU . . . -63.65 -9.93 34.83 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.309 -0.948 . . . . 0.32 112.157 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.927 HD11 ' HB3' ' A' ' 89' ' ' MET . 4.7 mt -73.33 -52.64 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.123 0.487 . . . . 1.31 110.067 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.81 -33.21 75.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.749 0.785 . . . . 0.47 109.231 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 49.7 mt -74.82 -37.7 42.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.177 -0.92 . . . . 0.69 110.912 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 3.1 pp -66.96 -36.2 81.67 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.414 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.707 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.9 ptpt -75.84 -34.63 60.09 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.453 -0.499 . . . . 0.65 111.175 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.729 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.1 ptm180 -66.78 -33.49 75.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.559 -0.857 . . . . 2.18 111.054 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.761 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.8 ptp -82.8 -13.69 55.76 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.561 -0.856 . . . . 1.28 109.889 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.3 mptp? -79.12 -29.83 43.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.572 0.701 . . . . 1.3 109.877 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.4 p -78.47 -34.98 18.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.028 -0.73 . . . . 1.03 109.028 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.761 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -81.14 -28.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 0.26 109.98 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -157.94 88.93 0.98 Allowed 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 112.928 0.714 . . . . 1.08 112.928 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.0 1.73 10.28 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.047 -1.033 . . . . 1.78 109.831 175.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -27.29 63.86 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.796 1.284 . . . . 0.35 107.722 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.69 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.2 tt -74.25 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 112.492 -2.14 . . . . 0.21 110.938 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 3.4 ptp180 -139.21 174.32 10.64 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.981 -1.118 . . . . 1.08 107.981 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.696 HG23 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -138.97 148.32 24.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.618 0.723 . . . . 0.79 111.47 -173.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.694 HG23 ' OG1' ' A' ' 100' ' ' THR . 63.3 mt -119.72 72.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.961 -1.126 . . . . 0.6 107.961 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.642 HG22 ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -68.65 141.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.318 -0.856 . . . . 0.14 111.768 -172.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.555 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 4.0 mtm -102.05 135.22 44.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.012 -0.995 . . . . 1.88 110.595 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 t -133.4 161.59 34.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.493 0.663 . . . . 1.13 112.672 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . . . -74.1 52.74 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.99 -1.005 . . . . 0.54 110.593 169.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.406 ' HA ' ' CB ' ' A' ' 103' ' ' ALA . 22.4 t80 72.84 30.86 1.67 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.974 -1.012 . . . . 4.3 112.085 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.87 76.53 1.23 Allowed Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.885 -0.674 . . . . 0.62 112.892 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.446 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.5 mt-10 -81.06 12.04 3.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.444 -0.878 . . . . 1.33 111.799 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 87' ' ' LEU . 21.2 mt 54.38 -169.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.391 0.886 . . . . 1.73 113.391 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 58.08 -97.62 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.337 -0.847 . . . . 1.38 110.852 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.927 ' HB3' HD11 ' A' ' 63' ' ' ILE . 57.6 mtm -51.52 -37.01 47.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.834 0.854 . . . . 2.72 110.731 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 86' ' ' GLU . 33.0 mm -58.78 -47.67 88.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.67 111.109 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -60.69 -55.05 37.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.451 -0.795 . . . . 2.5 109.51 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HG2' HG21 ' A' ' 63' ' ' ILE . 7.0 tt0 -58.42 -33.57 69.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.853 -1.067 . . . . 1.27 112.085 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.47 ' OG ' HG12 ' A' ' 63' ' ' ILE . 4.9 m -54.08 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.63 0.729 . . . . 1.28 111.8 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.828 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 12.8 ptpt -52.33 -37.35 55.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.837 -1.074 . . . . 1.91 111.004 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 17.7 tp10 -55.98 -37.99 69.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.965 -1.016 . . . . 1.84 112.1 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.9 mt -85.77 -15.09 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.795 0.665 . . . . 1.25 112.795 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.48 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 147.54 4.18 0.39 Allowed Glycine 0 C--N 1.317 -0.519 0 C-N-CA 119.778 -1.201 . . . . 0.35 113.023 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.828 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -79.21 131.69 36.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.263 0.532 . . . . 0.21 109.936 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.513 HD11 ' HG3' ' A' ' 77' ' ' ARG . 11.2 mt -74.39 -49.32 23.06 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.856 0.836 . . . . 0.18 109.734 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.694 ' OG1' HG23 ' A' ' 79' ' ' ILE . 41.3 p -140.14 153.45 46.67 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.0 -1.455 . . . . 0.19 111.756 -170.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -116.96 85.7 2.37 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.871 -1.059 . . . . 0.52 109.215 172.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -76.43 145.66 39.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 3.86 110.579 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 84' ' ' TYR . . . -121.68 -168.43 1.69 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.109 -0.496 . . . . 0.76 112.001 -173.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 45.5 mtpt -52.92 -50.4 81.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.168 -0.924 . . . . 3.35 111.654 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 68.9 Cg_endo -75.46 97.43 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.127 1.218 . . . . 1.36 111.393 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 111' ' ' ILE . 46.9 p90 -129.24 133.45 47.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.822 -0.626 . . . . 1.1 110.208 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.672 ' O ' HG22 ' A' ' 108' ' ' ILE . 7.3 t70 -72.73 -4.27 30.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.916 -0.584 . . . . 1.77 111.413 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.672 HG22 ' O ' ' A' ' 107' ' ' ASP . 3.6 tt 63.06 -54.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.559 1.144 . . . . 1.39 109.882 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.2 -34.98 79.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.576 -0.284 . . . . 1.16 110.516 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.5 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 11.5 pt-20 -65.15 -27.41 68.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.579 -0.449 . . . . 0.84 110.772 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 106' ' ' PHE . 19.3 mt -80.51 -44.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.108 -0.33 . . . . 0.74 110.108 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.522 ' NH1' ' HA ' ' A' ' 124' ' ' ASN . 2.4 ppt_? -69.73 -35.47 75.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.776 0.798 . . . . 0.72 109.423 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.0 t70 -63.77 -42.63 97.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.695 -0.854 . . . . 0.78 108.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.973 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -60.29 -48.79 80.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.857 -1.065 . . . . 0.59 111.462 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 112' ' ' ARG . 35.5 m -61.3 -43.06 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.912 -0.715 . . . . 0.47 111.004 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 8.3 ttpt -58.06 -55.96 28.18 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 120.909 0.385 . . . . 1.16 111.151 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.973 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 46.1 pttt -65.68 -13.15 58.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.516 0.562 . . . . 1.48 112.516 -176.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -92.01 -41.2 10.67 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.583 -0.447 . . . . 2.21 111.443 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -146.6 95.96 4.51 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.331 -0.988 . . . . 2.09 108.331 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -96.4 123.74 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.815 2.344 . . . . 0.92 114.182 -171.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 4' ' ' GLU . 12.7 tp -105.44 -65.48 1.05 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.356 0.598 . . . . 1.25 110.076 176.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.727 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 48.5 mtmt -136.39 -57.97 0.74 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.171 -0.922 . . . . 2.78 109.21 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.079 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 89.8 p 60.26 171.12 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.021 1.119 . . . . 2.17 114.021 171.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.522 ' HA ' ' NH1' ' A' ' 112' ' ' ARG . 57.1 m-80 70.73 -108.42 0.06 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.452 -1.249 . . . . 5.26 111.509 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -179.78 -43.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.358 -0.979 . . . . 5.75 108.358 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.48 90.72 2.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.126 -0.943 . . . . 8.65 110.986 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.0 m80 60.15 -169.69 0.15 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.283 0.563 . . . . 9.73 111.125 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -109.32 95.88 5.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.786 -0.82 . . . . 12.67 108.786 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -121.19 -179.82 4.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.568 -0.287 . . . . 12.92 110.95 -174.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -67.02 -47.97 69.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 16.51 110.944 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -68.72 145.38 53.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.245 -0.434 . . . . 17.15 110.425 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.413 ' HB3' HH21 ' A' ' 112' ' ' ARG . 20.0 m170 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.82 -0.609 . . . . 19.6 110.255 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.027 -0.36 . . . . 6.07 110.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 53.2 mtm 66.16 164.8 0.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.944 0.778 . . . . 3.88 111.27 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -149.4 19.56 0.94 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.58 -0.526 . . . . 2.35 109.58 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.854 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER 69.83 102.37 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.411 -0.813 . . . . 2.3 110.848 177.047 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.632 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 4.0 tppt? -134.6 140.44 46.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.016 0.436 . . . . 0.8 112.06 -173.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.891 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.9 mt -137.0 155.84 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.276 -0.874 . . . . 0.2 112.061 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.863 ' HG ' HG21 ' A' ' 42' ' ' ILE . 3.4 tt -133.86 118.35 17.87 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 107.934 -1.136 . . . . 0.17 107.934 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -105.72 102.98 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.886 -0.725 . . . . 0.22 110.211 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 44.3 t -89.38 79.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 122.967 0.167 . . . . 0.28 110.68 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.827 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.3 t70 -129.97 140.84 50.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 1.82 110.817 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.812 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 26.9 t70 -94.81 -32.91 13.07 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.501 -0.318 . . . . 0.51 111.048 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 70.07 8.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.497 -1.297 . . . . 2.07 107.497 173.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.441 ' O ' HG12 ' A' ' 17' ' ' ILE . 41.1 p90 -47.94 -16.08 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 111.862 -2.426 . . . . 1.44 115.342 -166.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.49 -61.62 6.18 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.751 -1.339 . . . . 0.38 109.751 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 3.1 mt -54.92 -29.34 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.224 0.535 . . . . 0.8 111.136 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.869 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -77.58 -48.67 16.36 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.772 -0.649 . . . . 0.38 111.055 -168.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 41.5 pt -75.71 -25.06 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.247 -0.649 . . . . 0.56 109.247 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.2 tp -58.64 -66.28 0.52 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.251 -0.886 . . . . 0.58 109.699 170.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 80.3 mt -53.83 -43.71 69.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.075 -0.343 . . . . 1.23 110.075 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.1 t30 -50.31 -66.1 0.45 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.261 -0.881 . . . . 0.94 110.079 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.81 -39.84 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.888 0.742 . . . . 2.46 110.75 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -54.86 -60.1 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.52 -0.309 . . . . 0.37 111.423 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.655 ' HB2' HG21 ' A' ' 30' ' ' THR . 2.0 m-85 -70.95 -39.99 72.26 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.016 -0.735 . . . . 0.43 109.016 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.627 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 1.2 t30 -52.26 -52.69 51.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.895 -1.048 . . . . 0.28 109.333 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 2.8 tmmm? -60.87 -43.13 98.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.722 -1.581 . . . . 3.25 111.93 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.879 ' HB2' ' HA ' ' A' ' 123' ' ' SER . 10.9 pt-20 -81.92 13.15 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 1.45 111.193 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.02 3.03 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.369 -0.92 . . . . 0.44 113.427 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.854 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 7.8 m-85 -77.76 150.25 34.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.926 0.869 . . . . 1.07 112.511 -165.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.632 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 10.3 mt-30 -98.01 82.15 2.94 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.91 -1.041 . . . . 1.14 108.336 166.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.891 HG22 ' HB ' ' A' ' 6' ' ' ILE . 19.3 p -92.52 138.59 31.37 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.659 -0.7 . . . . 0.14 109.883 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 10.5 m-85 -128.55 107.55 9.8 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.869 1.319 . . . . 0.34 110.299 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.869 ' HB2' HH11 ' A' ' 16' ' ' ARG . 7.0 pt20 -59.53 121.11 10.72 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 112.035 -2.348 . . . . 0.22 112.516 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.721 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -124.94 129.7 50.88 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 108.89 -0.781 . . . . 0.23 108.89 174.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.731 ' HB2' HH21 ' A' ' 16' ' ' ARG . . . -90.4 -9.65 46.78 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.07 -0.652 . . . . 0.18 110.831 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.39 164.48 33.98 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.038 -0.528 . . . . 0.29 111.736 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 65' ' ' ILE . . . -69.42 -22.14 76.3 Favored Glycine 0 CA--C 1.504 -0.597 0 CA-C-N 115.254 -0.885 . . . . 0.14 113.745 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.36 -41.57 21.79 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 122.216 1.008 . . . . 0.28 108.946 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.808 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.1 tp60 -60.53 -39.67 88.7 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.584 -2.006 . . . . 1.29 105.584 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.57 88.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.132 -1.395 . . . . 0.14 111.281 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.547 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -56.41 -47.87 78.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.38 -0.827 . . . . 0.97 109.728 176.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -63.83 -36.0 82.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.326 -1.306 . . . . 1.32 111.317 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.863 HG21 ' HG ' ' A' ' 7' ' ' LEU . 26.7 mm -65.47 -49.47 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.277 -0.268 . . . . 0.14 110.277 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.7 t -58.68 -43.14 86.97 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.265 1.031 . . . . 0.15 108.835 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -58.13 -30.9 66.69 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.361 -1.291 . . . . 0.39 111.702 177.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.546 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 5.7 tptt -90.57 -50.48 5.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.064 -0.517 . . . . 2.42 111.511 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 58.1 mm-40 -106.1 -35.95 7.07 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.583 0.586 . . . . 0.63 112.583 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 43.6 mtt180 62.93 65.02 1.44 Allowed Pre-proline 0 C--N 1.322 -0.589 0 O-C-N 123.673 0.608 . . . . 3.66 110.323 -170.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.76 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 66.4 Cg_exo -60.32 163.48 14.77 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.116 1.877 . . . . 0.21 111.635 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.781 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.8 m-20 -92.6 -44.48 8.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.973 -0.751 . . . . 0.98 108.973 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.762 HD23 HD11 ' A' ' 79' ' ' ILE . 7.6 mp -107.29 110.4 22.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.26 110.014 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 7' ' ' LEU . 62.6 t -110.16 107.35 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.453 . . . . 0.21 111.197 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 3.1 mp -78.51 95.93 5.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.432 0.634 . . . . 0.15 110.032 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.63 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -85.65 92.83 8.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.951 -1.022 . . . . 1.53 110.2 -176.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.673 ' OD1' ' HG2' ' A' ' 56' ' ' LYS . 34.6 t70 -68.59 108.82 3.49 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.75 0.786 . . . . 1.47 109.739 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.632 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 20.8 mtm -93.48 16.89 12.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.226 -0.897 . . . . 0.94 110.244 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.673 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 2.9 mmpp? -54.09 -53.43 53.27 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 120.075 -0.65 . . . . 2.24 110.445 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.932 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.5 tt -179.83 -19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.563 -1.208 . . . . 2.06 114.209 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.932 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -26.81 -54.43 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.465 2.777 . . . . 0.45 116.014 -175.203 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.48 -55.65 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.742 -1.218 . . . . 0.47 112.904 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.427 ' HB3' HD11 ' A' ' 65' ' ' ILE . 46.0 tpp -142.25 165.15 28.21 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.35 -0.611 . . . . 2.23 109.35 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.2 m-20 -60.39 140.22 57.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.67 110.785 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.585 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -64.65 -12.48 52.91 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.825 -1.079 . . . . 0.32 112.184 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.635 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 11.9 mt -76.51 -46.72 31.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 1.31 110.149 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -60.07 -43.0 95.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.658 -0.868 . . . . 0.47 108.658 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.626 HD12 ' HA3' ' A' ' 36' ' ' GLY . 16.5 mm -68.6 -43.18 83.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.475 -0.784 . . . . 0.69 111.452 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 96' ' ' LEU . 3.0 pp -62.5 -37.66 86.91 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.718 -0.393 . . . . 1.47 110.236 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.0 ptpt -76.03 -36.37 59.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.125 -0.63 . . . . 0.65 111.827 -176.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HG3' HD23 ' A' ' 40' ' ' LEU . 3.0 ptm180 -67.38 -34.39 77.18 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.819 -1.152 . . . . 2.18 111.004 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.681 ' HG3' HG21 ' A' ' 76' ' ' ILE . 11.8 ptp -78.85 -18.58 53.75 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.018 -0.673 . . . . 1.28 109.725 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.4 mptt -70.95 -40.59 71.91 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.554 -0.906 . . . . 1.3 108.554 169.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 67' ' ' LYS . 92.8 t -61.41 -38.21 79.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.423 -0.808 . . . . 1.03 110.531 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.68 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -83.86 -30.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.377 -0.529 . . . . 0.26 110.325 175.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -156.04 83.48 1.01 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.728 0.64 . . . . 1.08 112.728 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 32.4 mt-10 -69.99 2.56 3.41 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.293 -0.879 . . . . 1.78 111.272 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -28.44 65.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.737 1.256 . . . . 0.35 107.729 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.681 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.8 tt -75.52 158.12 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 112.587 -2.097 . . . . 0.21 111.208 -172.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.781 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -134.19 -178.28 4.97 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.11 -0.95 . . . . 1.08 108.496 175.151 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.648 HG23 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -143.09 148.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 120.133 -0.627 . . . . 0.79 111.019 -175.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.762 HD11 HD23 ' A' ' 50' ' ' LEU . 64.5 mt -117.87 71.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.725 -1.213 . . . . 0.6 107.725 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.632 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.81 141.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 119.045 -1.062 . . . . 0.14 111.181 -172.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.515 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 22.4 mtp -109.25 111.91 23.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.676 -1.147 . . . . 1.88 110.412 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.708 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 1.2 t -120.55 166.65 13.33 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 122.162 -0.336 . . . . 1.13 111.316 -175.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.37 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.782 -0.644 . . . . 0.54 111.375 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 13.5 t80 59.67 3.66 0.46 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.828 1.251 . . . . 4.3 112.39 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.96 93.18 1.87 Allowed Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.923 -0.656 . . . . 0.62 112.354 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 90' ' ' ILE . 30.9 mt-10 -74.8 11.85 0.97 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 1.33 111.002 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 85' ' ' GLY . 26.4 mt 64.81 -177.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.593 0.96 . . . . 1.73 113.593 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 62.17 -92.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.606 -1.179 . . . . 1.38 111.327 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.503 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 71.0 mtm -64.23 -22.91 67.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 120.925 0.393 . . . . 2.72 110.428 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.582 HG13 ' N ' ' A' ' 86' ' ' GLU . 42.8 mm -67.03 -39.95 84.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.181 0.515 . . . . 0.67 110.012 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.67 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 12.7 mm100 -67.24 -42.29 84.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.264 -0.88 . . . . 2.5 108.996 176.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.628 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 9.4 tt0 -63.16 -39.92 96.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.371 -1.286 . . . . 1.27 112.047 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.425 ' CB ' HG12 ' A' ' 63' ' ' ILE . 8.5 t -55.37 -62.96 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 1.28 110.414 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.958 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 50.3 pttt -56.93 -36.79 70.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.998 -0.546 . . . . 1.91 111.892 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -65.99 -22.97 66.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.081 -0.248 . . . . 1.84 111.545 -178.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.722 ' HB3' HD11 ' A' ' 66' ' ' LEU . 4.4 mp -88.63 -4.98 58.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 1.25 111.495 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.42 16.72 1.84 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.864 -1.16 . . . . 0.35 113.135 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.958 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -89.39 132.01 35.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.121 -0.696 . . . . 0.21 109.121 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.679 HD21 ' HD3' ' A' ' 77' ' ' ARG . 13.9 mt -73.63 -49.07 27.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.807 0.813 . . . . 0.18 109.506 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.668 ' OG1' HG23 ' A' ' 79' ' ' ILE . 70.0 p -141.51 142.8 33.57 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.081 -1.418 . . . . 0.19 111.519 -173.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.31 85.73 2.41 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.811 -1.086 . . . . 0.52 109.457 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 13.3 m-85 -75.1 157.46 34.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 3.86 109.893 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -98.71 -170.71 1.98 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.338 0.496 . . . . 0.76 112.338 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 44.6 tttp -73.19 -45.47 8.03 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.087 -0.708 . . . . 3.35 109.087 172.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 36.1 Cg_endo -68.29 97.89 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.438 1.425 . . . . 1.36 111.026 166.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -112.67 139.32 48.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.488 -0.778 . . . . 1.1 109.65 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -87.56 20.21 3.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 119.238 -0.41 . . . . 1.77 111.306 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 109' ' ' ASP . 2.4 tt 49.18 -66.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 1.39 112.781 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.478 ' H ' HG23 ' A' ' 108' ' ' ILE . 5.6 t70 -64.27 -25.78 68.2 Favored 'General case' 0 C--O 1.212 -0.884 0 O-C-N 122.397 -0.189 . . . . 1.16 110.807 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.59 -27.86 65.46 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 120.425 -0.51 . . . . 0.84 109.765 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -76.65 -47.5 28.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.224 -0.658 . . . . 0.74 109.224 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.38 -39.32 85.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.122 0.487 . . . . 0.72 109.922 179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 24.4 t70 -65.72 -43.34 89.35 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.304 -0.628 . . . . 0.78 109.304 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.943 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.96 -51.05 69.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.666 -0.697 . . . . 0.59 111.124 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 112' ' ' ARG . 27.0 m -59.02 -50.77 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.844 -0.742 . . . . 0.47 111.475 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -65.36 -29.34 70.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.345 0.498 . . . . 1.16 112.345 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.943 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 56.9 pttt -81.52 -11.74 59.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.49 -0.884 . . . . 1.48 111.507 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.6 -58.65 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.175 0.512 . . . . 2.21 110.176 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.512 ' HG ' ' OE1' ' A' ' 4' ' ' GLU . 57.1 tp -122.67 109.77 32.28 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.384 -0.969 . . . . 2.09 108.384 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 47.4 Cg_endo -101.44 148.13 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.773 2.315 . . . . 0.92 114.331 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -125.67 -70.1 0.75 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.766 -0.828 . . . . 1.25 108.766 174.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.57 ' HE2' HD22 ' A' ' 121' ' ' LEU . 75.0 mmtt -133.79 -63.04 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.553 -1.203 . . . . 2.78 108.19 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.879 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 12.4 p 37.52 -89.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 125.04 1.462 . . . . 2.17 114.088 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -155.95 120.57 4.64 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.356 -0.609 . . . . 5.26 109.356 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 129' ' ' HIS . 89.7 mt -82.39 44.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.131 0.491 . . . . 5.75 110.059 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.474 ' H ' ' HG3' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -52.1 -56.98 10.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.725 -1.125 . . . . 8.65 113.308 -172.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -127.85 -67.45 0.82 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.031 0.443 . . . . 9.73 110.017 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -87.98 75.48 8.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.62 0.724 . . . . 12.67 111.112 -175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 125' ' ' LEU . 2.6 p-80 -95.81 103.65 15.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.51 -0.768 . . . . 12.92 109.874 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -104.58 133.13 49.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 16.51 110.549 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -86.57 107.49 18.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.2 -0.667 . . . . 17.15 109.2 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-N 115.135 -0.939 . . . . 19.6 110.197 -175.072 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.948 0.404 . . . . 6.07 110.727 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.587 ' O ' HD13 ' A' ' 121' ' ' LEU . 15.9 ptt? -109.82 174.93 5.64 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.361 -0.607 . . . . 3.88 109.361 173.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.532 ' HB3' ' NE2' ' A' ' 29' ' ' GLN . 83.5 m-20 -94.85 106.69 18.69 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.494 -1.299 . . . . 2.35 107.494 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.744 ' CD ' ' HB3' ' A' ' 121' ' ' LEU . 17.5 pt-20 -66.89 127.89 34.24 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.822 -0.626 . . . . 2.3 109.991 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.827 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -117.23 144.88 44.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.8 111.812 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.869 ' HB ' HG22 ' A' ' 30' ' ' THR . 3.4 mt -135.02 153.47 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 114.933 -1.031 . . . . 0.2 111.655 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.861 ' HG ' HG21 ' A' ' 42' ' ' ILE . 2.4 tt -129.51 124.95 35.22 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.562 -1.273 . . . . 0.17 107.562 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.745 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.5 mp -112.26 107.57 23.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.124 -0.63 . . . . 0.22 109.963 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.669 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 57.6 t -96.15 89.55 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.103 -0.332 . . . . 0.28 110.103 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.717 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 0.8 OUTLIER -135.42 136.04 41.07 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.118 -0.492 . . . . 1.82 110.215 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.748 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 20.9 t70 -88.91 -41.65 12.3 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.486 0.184 . . . . 0.51 110.768 -177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HG3' ' CD1' ' A' ' 15' ' ' ILE . 3.1 pt20 -78.69 70.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.819 -1.178 . . . . 2.07 107.819 172.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.8 p90 -48.09 -13.72 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 111.856 -2.429 . . . . 1.44 115.588 -163.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.08 -57.38 6.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.249 -0.977 . . . . 0.38 110.937 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 2.4 mt -59.94 -25.85 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.477 0.656 . . . . 0.8 110.664 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 1.0 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.5 ttm180 -78.9 -49.24 13.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.38 110.529 -168.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 37.9 pt -75.07 -24.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.219 -0.66 . . . . 0.56 109.219 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.765 HD11 HD11 ' A' ' 108' ' ' ILE . 7.5 tp -58.09 -67.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.947 -1.024 . . . . 0.58 109.827 171.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.575 HD13 HD22 ' A' ' 52' ' ' LEU . 69.8 mt -54.18 -41.15 68.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.179 -0.464 . . . . 1.23 110.08 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.7 t30 -49.94 -70.09 0.1 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.263 -0.88 . . . . 0.94 110.473 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -57.24 -36.9 71.5 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.308 0.38 . . . . 2.46 111.683 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 18' ' ' LEU . 31.1 t -55.92 -55.66 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.592 0.219 . . . . 0.37 111.592 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.717 ' HB2' HG21 ' A' ' 30' ' ' THR . 7.7 m-85 -78.18 -36.73 47.07 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 120.659 -0.416 . . . . 0.43 109.922 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.818 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.8 t-20 -50.27 -45.53 54.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.176 0.989 . . . . 0.28 108.753 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -60.35 -38.44 83.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.09 -1.868 . . . . 3.25 111.9 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.68 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 4.2 mm-40 -55.9 -33.14 64.36 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.297 1.046 . . . . 1.45 109.586 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.79 1.45 3.01 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 113.071 -1.877 . . . . 0.44 109.417 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.818 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 45.4 m-85 -75.37 132.3 40.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.364 0.602 . . . . 1.07 110.666 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.827 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 12.0 mt-30 -86.52 81.38 8.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.79 -1.189 . . . . 1.14 107.79 171.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.869 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.9 p -90.25 132.75 35.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.799 -0.637 . . . . 0.14 110.214 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 20.1 m-85 -124.42 123.75 40.85 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 122.826 1.298 . . . . 0.34 110.13 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 1.0 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.6 pt20 -82.74 121.91 27.49 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.053 -2.339 . . . . 0.22 112.073 -171.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.83 137.42 54.66 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.166 0.987 . . . . 0.23 108.678 174.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.659 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -98.98 -3.81 34.1 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.137 -0.625 . . . . 0.18 110.402 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -148.51 163.7 36.42 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.792 -0.64 . . . . 0.29 111.315 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.17 79.41 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.534 -0.757 . . . . 0.14 113.306 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.42 -40.83 25.64 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 122.395 1.093 . . . . 0.28 108.2 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.829 ' O ' HG12 ' A' ' 42' ' ' ILE . 2.6 tp-100 -58.96 -40.42 84.67 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.521 -2.127 . . . . 1.29 105.404 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -65.2 -45.56 84.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.794 -1.548 . . . . 0.14 111.544 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 68' ' ' ARG . 11.7 mt -55.53 -39.31 70.4 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.703 0.763 . . . . 0.97 109.556 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 21.3 t70 -72.3 -38.01 68.83 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.54 -1.209 . . . . 1.32 110.374 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.861 HG21 ' HG ' ' A' ' 7' ' ' LEU . 18.0 mm -58.86 -48.59 85.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 120.685 0.279 . . . . 0.14 110.674 176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 39' ' ' ALA . 24.0 t -61.43 -41.47 90.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.968 0.89 . . . . 0.15 109.723 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -63.23 -28.51 70.09 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.604 -1.18 . . . . 0.39 111.204 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -94.99 -48.53 5.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 2.42 111.766 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 66.7 mm-40 -104.63 -37.05 7.26 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.69 0.256 . . . . 0.63 111.69 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 62.88 67.83 1.05 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.787 -0.642 . . . . 3.66 110.02 -169.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.776 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 45.9 Cg_exo -65.03 154.89 71.18 Favored 'Trans proline' 0 CA--C 1.503 -1.035 0 C-N-CA 121.858 1.705 . . . . 0.21 111.424 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.805 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 8.3 m-20 -89.65 -41.69 11.8 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.723 -0.791 . . . . 0.98 109.013 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.538 HD23 HD11 ' A' ' 79' ' ' ILE . 6.7 mp -108.02 110.05 21.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.211 -0.45 . . . . 0.26 110.166 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.816 ' HB ' HG12 ' A' ' 78' ' ' VAL . 57.9 t -109.95 109.32 27.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.081 0.467 . . . . 0.21 111.584 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -80.5 91.15 5.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.393 0.616 . . . . 0.15 109.772 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.818 HD12 HG11 ' A' ' 78' ' ' VAL . 18.5 mt -89.13 103.13 15.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.298 -0.864 . . . . 1.53 111.079 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.625 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 12.4 t70 -67.06 116.83 8.31 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.128 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.643 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 13.0 mtm -98.14 12.19 35.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.793 -0.64 . . . . 0.94 110.696 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 13.0 mmmm -64.25 -49.32 72.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.662 -0.245 . . . . 2.24 111.368 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.892 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 17.3 tt 174.81 -28.6 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.718 1.377 . . . . 2.06 114.718 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.892 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -18.31 -59.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 124.546 3.497 . . . . 0.45 116.625 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.95 -63.86 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.072 -1.061 . . . . 0.47 112.225 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.5 tpt -148.72 167.02 26.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.577 -0.897 . . . . 2.23 108.577 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.46 135.67 57.74 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.67 0.748 . . . . 0.67 110.563 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -58.44 -18.79 38.14 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 114.239 -1.346 . . . . 0.32 111.751 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.657 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 4.0 mt -66.97 -49.6 72.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.01 0.433 . . . . 1.31 110.571 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.58 -34.65 77.46 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.635 0.731 . . . . 0.47 109.072 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.548 HG22 ' HE3' ' A' ' 69' ' ' MET . 17.0 mt -73.37 -38.57 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.189 -0.914 . . . . 0.69 111.025 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 4.3 pp -67.02 -35.09 79.13 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 121.074 -0.25 . . . . 1.47 110.412 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.2 ptpt -76.23 -33.41 59.2 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.406 -0.517 . . . . 0.65 111.12 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.2 ptp180 -70.49 -29.84 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 118.752 -1.179 . . . . 2.18 111.579 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.837 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.5 ptp -83.98 -13.36 53.52 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.455 -0.898 . . . . 1.28 109.579 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -78.68 -32.87 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.598 -0.728 . . . . 1.3 109.855 172.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -74.34 -36.27 42.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.781 -0.822 . . . . 1.03 108.781 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.837 HG12 ' HA ' ' A' ' 69' ' ' MET . 20.6 pt -80.62 -21.84 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.092 -0.958 . . . . 0.26 110.325 172.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.734 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 29.7 t0 -164.89 95.32 0.7 Allowed 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 112.887 0.699 . . . . 1.08 112.887 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.631 ' OE1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -77.81 6.09 8.22 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.979 -1.076 . . . . 1.78 110.126 174.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.734 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -78.53 -34.0 47.52 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.339 -1.356 . . . . 0.35 107.339 171.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.71 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.0 tt -60.18 159.38 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.185 -1.825 . . . . 0.21 111.685 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.805 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 2.8 ptp180 -142.76 173.83 11.19 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.989 -1.115 . . . . 1.08 107.989 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.818 HG11 HD12 ' A' ' 53' ' ' LEU . 2.3 m -141.79 147.98 21.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.477 -0.889 . . . . 0.79 112.066 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.672 HG23 ' OG1' ' A' ' 100' ' ' THR . 67.1 mt -116.4 72.85 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.57 -1.27 . . . . 0.6 107.57 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.643 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.66 142.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.615 -0.834 . . . . 0.14 112.069 -171.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 10.2 mtt -99.33 124.69 44.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.489 -0.778 . . . . 1.88 110.04 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.58 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t -133.15 160.3 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.998 0.74 . . . . 1.13 112.998 -173.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 63.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.649 -1.16 . . . . 0.54 110.664 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 67.41 5.12 4.09 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.571 0.748 . . . . 4.3 112.418 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.0 88.18 0.75 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.861 -0.685 . . . . 0.62 111.801 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.528 ' N ' HG13 ' A' ' 90' ' ' ILE . 39.7 mt-10 -65.61 -89.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.483 -0.358 . . . . 1.33 111.244 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HG ' ' H ' ' A' ' 88' ' ' ASP . 9.5 tp -177.53 -167.76 0.16 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.69 0.281 . . . . 1.73 111.716 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.722 ' H ' ' HG ' ' A' ' 87' ' ' LEU . 9.3 m-20 43.99 -89.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.857 1.263 . . . . 1.38 113.009 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.641 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 62.7 mtt -56.94 -35.51 69.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.106 -0.497 . . . . 2.72 110.461 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.528 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.6 mm -59.89 -44.76 95.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.81 -0.632 . . . . 0.67 110.278 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.63 -53.53 57.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.559 -0.746 . . . . 2.5 109.385 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 15.8 tt0 -58.9 -34.84 72.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.945 -1.025 . . . . 1.27 112.314 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.4 t -55.34 -69.51 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 1.28 110.89 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 16.6 pttp -55.9 -36.54 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.383 0.611 . . . . 1.91 111.069 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 10.9 tp10 -56.59 -45.37 81.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.864 -1.062 . . . . 1.84 111.99 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.8 mt -70.47 -39.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.38 -0.373 . . . . 1.25 111.16 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.54 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 170.19 15.15 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.818 -1.182 . . . . 0.35 113.52 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.946 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -83.9 128.75 34.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.538 -0.541 . . . . 0.21 109.538 173.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.529 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.6 mt -73.07 -49.44 28.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.891 0.853 . . . . 0.18 109.777 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 79' ' ' ILE . 49.8 p -141.92 158.8 43.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.079 -1.419 . . . . 0.19 111.642 -170.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -110.17 93.47 4.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.816 -1.084 . . . . 0.52 110.28 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HD2' HD12 ' A' ' 111' ' ' ILE . 29.6 t80 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.653 -0.703 . . . . 3.86 109.373 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.26 -178.66 4.05 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.76 111.492 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 65.1 tttp -47.97 -53.85 29.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.345 -0.843 . . . . 3.35 112.769 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 70.3 Cg_endo -77.09 98.28 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.279 1.319 . . . . 1.36 111.706 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 111' ' ' ILE . 33.2 p90 -127.9 129.15 46.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 1.1 110.665 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.646 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 7.0 t70 -67.9 -11.7 59.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.909 -0.587 . . . . 1.77 111.582 -177.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.765 HD11 HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER 71.34 -54.67 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-N 115.718 -0.674 . . . . 1.39 109.259 -164.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 15.9 t70 -66.9 -38.63 86.62 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 109.649 -0.5 . . . . 1.16 109.649 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.646 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 13.2 pt-20 -66.13 -18.94 65.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.84 110.807 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.577 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 7.4 mm -83.1 -45.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.466 -0.568 . . . . 0.74 109.466 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.52 ' HA ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.72 -31.06 67.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.876 0.846 . . . . 0.72 109.161 174.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.8 t70 -67.88 -41.18 83.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.998 -1.001 . . . . 0.78 109.324 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.639 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.28 -48.26 71.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.309 -0.859 . . . . 0.59 111.222 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 112' ' ' ARG . 29.4 m -58.95 -47.77 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.791 -0.764 . . . . 0.47 110.422 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 10.5 ttpt -60.94 -51.99 66.91 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.902 -0.59 . . . . 1.16 111.697 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.639 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -55.32 -26.86 43.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.721 -0.392 . . . . 1.48 111.866 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.535 ' HB3' HD22 ' A' ' 119' ' ' LEU . 35.1 m-85 -81.63 -71.72 0.46 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.75 -0.38 . . . . 2.21 111.193 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 118' ' ' TYR . 3.3 mm? -119.65 92.28 46.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.0 -0.37 . . . . 2.09 110.0 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -93.42 121.76 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.801 2.334 . . . . 0.92 113.895 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.837 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 11.7 tp -97.35 -60.04 1.66 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.458 0.647 . . . . 1.25 109.364 172.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.837 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 88.3 mttt -142.63 -60.0 0.44 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.089 -0.959 . . . . 2.78 110.12 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 16.2 t 61.79 14.61 6.35 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.527 -0.761 . . . . 2.17 110.452 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 26' ' ' GLU . 52.1 m-80 61.75 30.3 18.33 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.455 -0.793 . . . . 5.26 111.268 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.82 21.88 0.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.769 -0.651 . . . . 5.75 110.431 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 126' ' ' GLU . 1.3 pm0 -71.12 168.67 16.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.307 -0.86 . . . . 8.65 111.815 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -57.24 -71.84 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.393 -0.821 . . . . 9.73 111.346 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -160.52 144.6 13.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.081 -0.711 . . . . 12.67 109.081 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -83.75 105.36 14.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.618 0.247 . . . . 12.92 110.594 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -83.42 134.68 34.87 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.989 -0.745 . . . . 16.51 108.989 173.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -97.52 143.95 27.71 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.943 0.402 . . . . 17.15 110.766 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.274 -0.869 . . . . 19.6 109.237 178.054 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.589 0.233 . . . . 6.07 111.102 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.403 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 24.3 mmt -78.52 -172.02 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.057 -0.349 . . . . 3.88 110.057 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -58.92 -59.58 5.22 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.032 -1.099 . . . . 2.35 108.032 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.765 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 0.6 OUTLIER 178.76 140.45 0.1 Allowed 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 104.449 -2.426 . . . . 2.3 104.449 167.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.989 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -163.56 141.46 7.6 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.542 -1.263 . . . . 0.8 110.499 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.904 ' HB ' HG22 ' A' ' 30' ' ' THR . 5.1 mt -136.62 153.08 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.313 -0.858 . . . . 0.2 111.659 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.811 HD11 ' HB ' ' A' ' 42' ' ' ILE . 3.3 tt -137.24 117.38 13.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.236 -1.394 . . . . 0.17 107.236 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.639 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.3 mp -106.32 107.99 24.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 119.716 -0.794 . . . . 0.22 110.235 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 47.6 t -93.95 76.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.036 0.21 . . . . 0.28 110.483 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.647 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.2 m-20 -123.45 133.03 54.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.421 . . . . 1.82 110.754 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 1.025 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 22.9 t70 -78.42 -39.04 39.98 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.146 -1.057 . . . . 0.51 108.146 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.837 ' HB2' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -64.23 78.38 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.658 -1.156 . . . . 2.07 108.283 164.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 19.9 p90 -55.84 -16.11 4.13 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.21 -0.905 . . . . 1.44 111.682 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.23 -60.21 9.17 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.875 -0.89 . . . . 0.38 110.875 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.837 HG12 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -58.35 -25.44 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 121.403 0.621 . . . . 0.8 109.972 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.957 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -79.4 -46.69 17.08 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.092 -0.958 . . . . 0.38 111.148 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 13' ' ' TYR . 38.7 pt -77.4 -27.12 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.441 -0.577 . . . . 0.56 109.441 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.1 tp -56.71 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.58 109.261 170.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.662 ' HG ' ' CZ ' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -53.52 -43.27 68.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.186 -0.915 . . . . 1.23 111.086 175.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.3 t30 -50.97 -70.02 0.1 Allowed 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.671 0.607 . . . . 0.94 109.425 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -55.08 -39.32 69.15 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.416 0.447 . . . . 2.46 112.175 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 112' ' ' ARG . 41.6 t -57.87 -53.64 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.114 0.413 . . . . 0.37 112.114 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.78 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -77.39 -40.26 44.35 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.264 -0.643 . . . . 0.43 109.264 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.779 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 2.5 t30 -51.11 -44.45 61.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.371 -0.831 . . . . 0.28 108.793 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.22 -1.809 . . . . 3.25 111.613 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -56.19 -34.48 66.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.679 1.228 . . . . 1.45 109.273 177.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . 148.27 -17.53 1.33 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 112.828 -1.987 . . . . 0.44 110.012 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 59.7 m-85 -63.89 134.87 55.95 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 112.755 0.65 . . . . 1.07 112.755 -163.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.936 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 23.1 mt-30 -84.16 77.47 9.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.897 -0.779 . . . . 1.14 108.897 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.904 HG22 ' HB ' ' A' ' 6' ' ' ILE . 11.9 p -90.59 136.19 33.22 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.389 -0.823 . . . . 0.14 110.392 -176.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.4 m-85 -128.78 130.32 46.86 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 122.68 1.229 . . . . 0.34 109.888 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.957 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 4.6 pt20 -86.41 121.23 28.67 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 112.697 -2.047 . . . . 0.22 112.077 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.693 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -121.88 137.9 54.6 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.575 -0.738 . . . . 0.23 109.248 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -95.03 -12.44 26.6 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.118 -0.633 . . . . 0.18 110.133 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.72 166.32 28.76 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.828 -0.624 . . . . 0.29 111.6 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -69.02 -20.78 75.03 Favored Glycine 0 CA--C 1.505 -0.534 0 O-C-N 123.899 0.75 . . . . 0.14 113.435 -174.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.93 -43.67 19.41 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.218 1.008 . . . . 0.28 108.666 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.778 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.1 tt0 -63.21 -36.01 82.24 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 112.798 -2.001 . . . . 1.29 105.94 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.77 -46.55 81.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.393 -1.276 . . . . 0.14 111.14 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.77 -48.39 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.67 0.748 . . . . 0.97 109.139 175.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 44' ' ' THR . 7.2 t70 -57.47 -42.93 83.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.155 -1.384 . . . . 1.32 111.09 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.903 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 16.2 mm -63.29 -45.05 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 120.796 -0.361 . . . . 0.14 110.41 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -60.95 -41.67 89.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.707 0.765 . . . . 0.15 109.631 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.34 -24.0 62.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 0.39 111.166 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 1.6 ptmt -89.75 -46.91 8.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.159 -0.473 . . . . 2.42 111.195 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 53.0 mm-40 -108.43 -37.93 5.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.706 0.289 . . . . 0.63 111.319 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 78.0 mtp180 66.27 65.62 0.79 Allowed Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.597 -0.728 . . . . 3.66 109.714 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.989 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.4 Cg_exo -64.4 158.55 48.61 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 122.185 1.924 . . . . 0.21 112.029 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.763 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 4.7 m-20 -93.53 -38.47 11.37 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.138 -1.06 . . . . 0.98 108.138 174.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 119' ' ' LEU . 5.7 mp -114.51 111.64 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.26 110.272 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.789 HG13 ' HB3' ' A' ' 7' ' ' LEU . 61.2 t -112.44 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.281 -0.418 . . . . 0.21 111.22 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' A' ' 19' ' ' LEU . 2.7 mp -78.52 93.73 4.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.789 0.804 . . . . 0.15 109.616 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.658 HD12 ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -86.59 96.98 10.28 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.468 -1.242 . . . . 1.53 110.691 -174.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.595 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 9.4 t70 -63.88 116.03 5.42 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.978 -0.689 . . . . 1.47 109.844 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.883 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.7 mtp -94.03 7.53 44.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.666 -0.697 . . . . 0.94 110.992 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 24.9 mmmt -63.82 -66.38 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.173 0.435 . . . . 2.24 112.173 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.021 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 14.6 tt -169.88 -17.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.289 1.588 . . . . 2.06 115.289 -171.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.025 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -27.15 -51.95 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.52 2.813 . . . . 0.45 116.112 175.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.38 -54.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.431 -1.366 . . . . 0.47 113.648 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.517 ' HB3' HD11 ' A' ' 65' ' ' ILE . 19.4 ttt -148.69 166.76 27.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.552 -0.536 . . . . 2.23 109.552 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.16 135.07 57.61 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.188 0.518 . . . . 0.67 109.959 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -62.61 -10.46 30.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.055 -0.975 . . . . 0.32 112.797 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.0 mt -82.84 -47.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.03 0.443 . . . . 1.31 110.593 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.4 mm-40 -64.62 -35.85 82.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.146 -0.687 . . . . 0.47 109.146 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.843 ' O ' ' HG2' ' A' ' 69' ' ' MET . 55.2 mt -72.27 -38.59 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.69 110.122 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.714 HD12 ' CG2' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -53.0 -49.53 66.01 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.44 173.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 71' ' ' VAL . 15.0 ptpt -72.81 -35.61 67.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.65 111.865 -174.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' A' ' 65' ' ' ILE . 4.3 ptp180 -64.35 -33.91 76.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 118.689 -1.204 . . . . 2.18 111.605 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.843 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 10.0 ptp -83.25 -16.51 46.09 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 119.697 -0.801 . . . . 1.28 109.289 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 13.1 mptt -72.32 -38.81 68.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.798 -0.816 . . . . 1.3 108.798 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 67' ' ' LYS . 74.9 t -63.59 -38.52 82.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 1.03 110.616 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.701 HG12 ' HA ' ' A' ' 69' ' ' MET . 11.4 pt -83.73 -30.01 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.535 -0.466 . . . . 0.26 110.608 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 88.03 1.0 Allowed 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 112.277 0.473 . . . . 1.08 112.277 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 37.0 mt-10 -66.39 -2.26 4.34 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.421 -0.799 . . . . 1.78 111.288 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.49 -25.8 60.62 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.696 -1.224 . . . . 0.35 107.696 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 48' ' ' PRO . 2.7 tt -71.34 154.46 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.14 -1.845 . . . . 0.21 110.513 -174.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 5.5 ptp180 -138.72 175.66 9.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.263 -1.014 . . . . 1.08 108.263 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.714 ' CG2' HD12 ' A' ' 66' ' ' LEU . 4.1 m -141.58 145.64 24.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 119.86 -0.736 . . . . 0.79 111.02 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.671 HG23 ' OG1' ' A' ' 100' ' ' THR . 64.0 mt -110.74 75.75 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.668 -1.234 . . . . 0.6 107.668 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.883 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -66.89 139.68 20.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.722 -0.791 . . . . 0.14 112.367 -171.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.547 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 3.0 mtp -101.28 120.18 39.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.155 -0.93 . . . . 1.88 110.586 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.432 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.2 t -133.22 164.57 26.77 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.454 0.538 . . . . 1.13 112.454 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.2 56.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.202 -0.908 . . . . 0.54 111.435 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 74.6 t80 69.24 6.88 5.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.788 0.835 . . . . 4.3 111.016 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.77 93.49 1.85 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.705 -0.759 . . . . 0.62 111.9 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' N ' HG13 ' A' ' 90' ' ' ILE . 33.6 mt-10 -71.69 9.6 0.84 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.239 0.542 . . . . 1.33 110.93 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 85' ' ' GLY . 40.9 mt 58.91 -169.5 0.13 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 1.73 113.006 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 54.87 -93.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.011 -0.995 . . . . 1.38 111.349 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.533 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 91.3 mtp -65.15 -23.96 67.27 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.666 0.27 . . . . 2.72 110.344 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.641 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.5 mm -66.61 -41.08 87.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.67 110.386 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.566 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 14.2 mt-30 -67.26 -35.53 79.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.014 0.911 . . . . 2.5 108.83 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 33.2 tt0 -72.85 -31.98 65.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.0 -1.455 . . . . 1.27 111.448 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.422 ' CB ' HG12 ' A' ' 63' ' ' ILE . 14.6 t -59.04 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 1.28 109.713 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.834 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 46.8 pttt -54.91 -38.84 68.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.91 111.698 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.9 pt-20 -64.63 -25.93 68.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.859 0.3 . . . . 1.84 111.203 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.458 HD12 ' CG2' ' A' ' 63' ' ' ILE . 17.9 mt -86.18 -19.24 30.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.968 0.413 . . . . 1.25 111.528 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.93 19.7 0.23 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.087 -1.054 . . . . 0.35 113.041 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -91.47 140.85 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.994 -0.743 . . . . 0.21 108.994 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.533 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.7 mt -82.92 -49.18 9.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.846 0.831 . . . . 0.18 109.842 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.671 ' OG1' HG23 ' A' ' 79' ' ' ILE . 51.3 p -143.39 150.61 39.33 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.022 -1.445 . . . . 0.19 111.685 -171.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -112.19 97.32 6.56 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.52 109.322 173.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -90.49 150.32 21.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.257 -0.428 . . . . 3.86 110.767 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -121.89 -171.53 2.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.321 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 40.0 ttmt -56.81 -47.21 99.43 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 3.35 111.804 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 51.8 Cg_endo -73.29 96.65 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 120.644 0.896 . . . . 1.36 111.03 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -137.22 138.36 40.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 1.1 110.281 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 22.7 t70 -76.6 -1.69 28.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.649 . . . . 1.77 110.984 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.43 -49.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.933 1.293 . . . . 1.39 112.526 -170.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -70.19 -26.51 63.93 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.634 -0.506 . . . . 1.16 109.634 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 12.5 pt-20 -67.87 -24.85 65.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.74 -0.467 . . . . 0.84 109.74 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.477 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 26.3 mt -81.04 -40.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.962 -0.563 . . . . 0.74 110.537 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.616 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.727 -0.789 . . . . 0.72 109.182 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.49 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 26.7 t70 -68.38 -32.36 72.38 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.581 -0.896 . . . . 0.78 108.581 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.797 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -64.08 -44.15 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.59 111.007 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 112' ' ' ARG . 21.9 m -64.76 -39.54 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 119.003 -1.079 . . . . 0.47 110.805 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -78.37 -21.45 49.39 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.332 0.493 . . . . 1.16 112.332 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.797 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -79.44 -24.32 42.52 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.461 -0.775 . . . . 1.48 110.983 175.027 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 48.5 m-85 -92.15 -70.58 0.69 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.831 -0.348 . . . . 2.21 111.84 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 1.056 ' HB3' HD11 ' A' ' 50' ' ' LEU . 2.4 tm? -127.03 89.72 51.28 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.504 -0.924 . . . . 2.09 108.504 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.654 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 65.0 Cg_endo -88.09 155.0 7.02 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.899 2.399 . . . . 0.92 113.971 -172.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.667 ' HG ' ' HG2' ' A' ' 122' ' ' LYS . 11.3 tp -88.7 -67.66 0.82 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.804 -1.554 . . . . 1.25 106.804 167.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.667 ' HG2' ' HG ' ' A' ' 121' ' ' LEU . 69.1 mmtt -148.99 -65.22 0.23 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.0 -1.454 . . . . 2.78 108.144 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t 66.52 -62.15 0.29 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.883 -1.053 . . . . 2.17 110.689 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 52.32 83.76 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.421 0.689 . . . . 5.26 112.247 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.1 mt -104.13 -55.07 2.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.128 -0.487 . . . . 5.75 109.895 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.3 153.75 49.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.845 -0.616 . . . . 8.65 110.517 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -89.18 157.3 18.32 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.536 -0.913 . . . . 9.73 108.536 173.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 130' ' ' HIS . 2.4 t60 -130.29 67.44 1.48 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.682 -0.807 . . . . 12.67 112.861 -165.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -108.87 -57.95 2.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.819 -1.178 . . . . 12.92 107.819 164.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 128' ' ' HIS . 59.5 m-70 58.68 -160.98 0.26 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.07 -0.968 . . . . 16.51 111.402 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -117.9 115.57 25.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.166 -0.47 . . . . 17.15 110.199 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.5 p80 . . . . . 0 C--O 1.246 0.908 0 N-CA-C 109.302 -0.629 . . . . 19.6 109.302 176.507 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.17 -0.307 . . . . 6.07 110.17 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.3 mpp? 62.41 -173.24 0.15 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.948 -0.569 . . . . 3.88 110.734 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.712 ' HB3' HE22 ' A' ' 29' ' ' GLN . 53.5 t30 -116.75 11.82 14.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.048 -0.524 . . . . 2.35 109.639 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 1.067 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 11.2 tt0 71.68 101.61 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 124.0 0.813 . . . . 2.3 111.03 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.77 ' HD3' ' HB3' ' A' ' 29' ' ' GLN . 3.8 tppt? -137.39 142.51 41.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.298 0.639 . . . . 0.8 110.871 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.925 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.1 mt -138.28 157.61 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.788 -0.642 . . . . 0.2 111.46 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.823 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.8 tt -133.66 117.76 17.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.138 -1.06 . . . . 0.17 108.138 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.8 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.3 mp -107.25 113.28 43.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 120.245 -0.582 . . . . 0.22 110.255 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 53' ' ' LEU . 49.5 t -103.58 82.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.629 0.252 . . . . 0.28 111.335 -176.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.757 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 3.8 m-20 -121.05 130.97 54.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 1.82 109.903 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.895 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 27.6 t70 -81.57 -31.98 32.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.545 -1.28 . . . . 0.51 107.545 166.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.481 ' CG ' HD13 ' A' ' 15' ' ' ILE . 16.1 pt20 -74.32 74.69 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.455 -1.248 . . . . 2.07 108.198 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 15.1 p90 -61.47 -15.45 37.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.838 -1.528 . . . . 1.44 113.431 -167.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.65 -65.35 3.49 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.876 -1.289 . . . . 0.38 109.876 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.814 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.9 mp -47.25 -30.07 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 123.276 0.63 . . . . 0.8 112.31 172.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 8.8 ttm180 -76.37 -50.19 14.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.291 -0.413 . . . . 0.38 111.142 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 46.9 pt -75.34 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.375 -0.602 . . . . 0.56 109.375 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.5 tp -59.94 -65.52 0.67 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.58 109.627 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 52' ' ' LEU . 71.8 mt -54.29 -40.38 67.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.472 -0.331 . . . . 1.23 110.69 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t30 -51.09 -67.52 0.24 Allowed 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.64 -0.709 . . . . 0.94 109.755 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.25 -40.09 76.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.81 0.694 . . . . 2.46 111.997 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 18' ' ' LEU . 36.3 t -54.3 -54.52 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 111.492 0.182 . . . . 0.37 111.492 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.711 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -81.01 -35.91 31.31 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.49 -0.484 . . . . 0.43 110.223 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.631 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 10.0 t-20 -50.38 -47.28 56.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.857 0.837 . . . . 0.28 108.758 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 25' ' ' LYS . 1.7 tmmt? -61.3 -36.22 79.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.462 -1.699 . . . . 3.25 112.774 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 8.3 mm-40 -55.11 -31.81 61.54 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.204 1.002 . . . . 1.45 109.455 175.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 138.71 -10.65 3.42 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 113.161 -1.836 . . . . 0.44 109.132 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 1.067 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 2.1 m-85 -68.45 156.74 37.32 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 122.605 1.193 . . . . 1.07 111.089 -169.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.77 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 4.4 mt-30 -109.69 69.8 0.71 Allowed 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 113.293 -1.776 . . . . 1.14 108.042 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.925 HG22 ' HB ' ' A' ' 6' ' ' ILE . 16.0 p -90.01 132.01 35.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.687 -1.142 . . . . 0.14 110.486 -168.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 14.4 m-85 -125.37 124.5 41.66 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.563 1.173 . . . . 0.34 109.664 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.739 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.9 pt20 -80.8 122.05 26.7 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 112.764 -2.016 . . . . 0.22 112.118 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -120.86 142.08 49.99 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.999 -1.001 . . . . 0.23 108.561 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -98.64 -12.53 20.99 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.928 -0.709 . . . . 0.18 109.941 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -148.09 165.25 31.38 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.729 -0.669 . . . . 0.29 111.703 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.16 73.39 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.552 -0.749 . . . . 0.14 113.45 -174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.94 -43.15 18.47 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.034 0.921 . . . . 0.28 109.14 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.764 ' O ' HG12 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -63.34 -34.83 78.56 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.103 -1.814 . . . . 1.29 106.103 176.263 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -66.52 -46.67 75.43 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.485 -1.234 . . . . 0.14 111.0 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.635 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -52.58 -46.92 67.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.641 0.734 . . . . 0.97 109.292 173.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.09 -41.3 92.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.293 -1.322 . . . . 1.32 111.203 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.823 ' HB ' HD11 ' A' ' 7' ' ' LEU . 17.2 mm -63.26 -48.32 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 110.121 -0.326 . . . . 0.14 110.121 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 38.7 t -60.19 -43.59 93.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-O 121.817 0.818 . . . . 0.15 109.283 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.54 -29.28 69.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.261 -0.881 . . . . 0.39 111.614 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -93.19 -45.08 8.03 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.949 0.352 . . . . 2.42 111.949 -176.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 57.2 mm-40 -107.78 -36.17 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 0.63 111.654 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 69.3 mtp180 62.74 62.01 2.0 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.368 -0.833 . . . . 3.66 109.547 -170.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.646 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 77.1 Cg_exo -58.66 156.94 29.68 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.046 1.83 . . . . 0.21 111.095 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.809 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -93.27 -34.7 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.901 -0.72 . . . . 0.98 109.585 175.174 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.684 HD23 HD11 ' A' ' 79' ' ' ILE . 7.1 mp -115.47 114.02 24.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.007 -0.542 . . . . 0.26 109.992 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG13 ' HB3' ' A' ' 7' ' ' LEU . 92.7 t -112.63 121.61 65.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 110.527 -0.175 . . . . 0.21 110.527 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 19' ' ' LEU . 2.4 mp -92.0 97.6 11.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.579 -0.526 . . . . 0.15 109.579 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 9' ' ' VAL . 44.0 mt -93.52 106.24 18.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.762 -0.654 . . . . 1.53 110.424 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 52.5 t0 -66.86 107.93 2.37 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.204 -0.598 . . . . 1.47 110.232 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.832 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 11.5 mtm -83.05 0.74 43.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.661 . . . . 0.94 110.797 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 25.5 mmmt -57.75 -58.5 8.08 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.408 0.522 . . . . 2.24 112.408 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.927 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 15.2 tt -175.57 -34.21 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.264 1.209 . . . . 2.06 114.264 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.927 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -20.23 -63.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.261 3.307 . . . . 0.45 116.482 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.93 -58.23 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.652 -1.261 . . . . 0.47 113.204 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.5 ' HB3' HD11 ' A' ' 65' ' ' ILE . 47.2 ttm -148.96 165.85 30.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.415 -0.587 . . . . 2.23 109.415 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 65' ' ' ILE . 38.3 m-20 -60.46 133.9 56.54 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.745 -0.465 . . . . 0.67 109.745 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 66' ' ' LEU . . . -67.55 1.65 6.99 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 120.892 -0.67 . . . . 0.32 112.364 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.3 mt -92.45 -45.7 14.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.842 0.353 . . . . 1.31 110.116 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.74 -36.08 81.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.47 109.701 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.674 ' HB ' HD13 ' A' ' 53' ' ' LEU . 15.6 mt -73.5 -34.19 41.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.929 -0.578 . . . . 0.69 109.483 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.665 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -54.77 -53.99 47.89 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.488 -0.778 . . . . 1.47 109.978 174.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.6 ptpt -71.47 -33.42 69.29 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.118 0.414 . . . . 0.65 112.118 -173.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.71 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.9 ptm180 -66.54 -34.6 78.27 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.465 -0.894 . . . . 2.18 110.95 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.661 ' HG3' HG21 ' A' ' 76' ' ' ILE . 10.1 ptp -82.75 -16.74 46.81 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 119.834 -0.746 . . . . 1.28 109.722 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.3 mptt -78.88 -30.25 44.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.723 0.773 . . . . 1.3 109.854 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 68' ' ' ARG . 2.7 p -78.59 -31.86 15.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.505 0.669 . . . . 1.03 109.261 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.644 HG12 ' HA ' ' A' ' 69' ' ' MET . 21.8 pt -86.52 -21.89 7.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.102 -0.954 . . . . 0.26 110.724 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -162.78 88.51 0.62 Allowed 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 112.559 0.577 . . . . 1.08 112.559 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 11.6 mt-10 -76.67 5.93 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 120.68 -1.263 . . . . 1.78 109.688 173.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -29.67 62.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.489 -1.232 . . . . 0.35 107.894 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.661 HG21 ' HG3' ' A' ' 69' ' ' MET . 5.2 tt -76.66 159.4 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 112.767 -2.015 . . . . 0.21 111.296 -170.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.817 ' HD3' HD21 ' A' ' 99' ' ' LEU . 4.2 ptp180 -134.84 177.21 7.97 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.335 -0.848 . . . . 1.08 109.392 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.65 HG11 HD12 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -132.58 159.65 43.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.505 0.669 . . . . 0.79 110.507 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.735 HG22 ' HD2' ' A' ' 102' ' ' PHE . 54.9 mt -131.01 66.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.071 -1.455 . . . . 0.6 107.071 170.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.832 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -63.5 140.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.745 0.783 . . . . 0.14 111.804 -170.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.773 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 mtp -95.84 124.1 39.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.764 -1.107 . . . . 1.88 110.371 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.465 HG21 ' HB1' ' A' ' 101' ' ' ALA . 12.1 p -130.84 159.13 38.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.1 -0.5 . . . . 1.13 112.173 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.494 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . . . -66.8 73.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.595 . . . . 0.54 109.863 165.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 26.5 p90 50.88 21.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.225 1.41 . . . . 4.3 113.714 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.65 92.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.828 -0.701 . . . . 0.62 112.688 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.674 ' N ' HG13 ' A' ' 90' ' ' ILE . 19.3 mt-10 -89.01 14.67 10.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.067 0.461 . . . . 1.33 110.855 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 65.65 -177.74 0.19 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.34 0.867 . . . . 1.73 113.34 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.0 t70 60.83 -100.24 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.738 -1.119 . . . . 1.38 112.042 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -58.97 -23.37 61.62 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.021 0.439 . . . . 2.72 110.613 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.674 HG13 ' N ' ' A' ' 86' ' ' GLU . 34.9 mm -65.83 -40.2 86.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.272 0.558 . . . . 0.67 110.088 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.502 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 22.8 mm-40 -72.76 -39.03 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.536 -0.756 . . . . 2.5 109.591 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.617 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 23.5 tt0 -67.95 -40.92 83.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.785 -1.098 . . . . 1.27 111.729 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.409 ' OG ' HG21 ' A' ' 80' ' ' ILE . 6.6 t -54.46 -61.01 2.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.144 0.497 . . . . 1.28 110.055 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.897 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -58.75 -39.45 80.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.91 111.422 176.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.0 pt-20 -62.17 -27.23 68.82 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.637 0.236 . . . . 1.84 111.637 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 11.8 mt -85.54 -8.23 58.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.256 0.465 . . . . 1.25 112.256 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.97 19.22 0.72 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.034 -1.079 . . . . 0.35 113.511 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.897 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -98.84 138.83 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.988 -0.745 . . . . 0.21 108.988 171.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.817 HD21 ' HD3' ' A' ' 77' ' ' ARG . 9.3 mt -77.41 -50.05 13.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.398 0.618 . . . . 0.18 110.397 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.59 ' OG1' HG23 ' A' ' 79' ' ' ILE . 62.6 p -139.65 148.72 42.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.224 -0.898 . . . . 0.19 111.664 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.95 84.35 2.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.962 -1.017 . . . . 0.52 108.973 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.773 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 1.1 p90 -86.73 144.4 27.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 3.86 110.568 -170.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 105' ' ' PRO . . . -95.98 166.31 11.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.76 110.743 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 18.0 pttp -70.36 -29.38 1.57 Allowed Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.724 0.639 . . . . 3.35 112.724 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 55.6 Cg_endo -76.14 95.45 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 120.501 1.215 . . . . 1.36 110.166 163.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.568 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 30.1 p90 -132.3 152.77 51.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.451 0.643 . . . . 1.1 111.318 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 109' ' ' ASP . 19.0 t70 -75.56 -3.9 36.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.117 -0.947 . . . . 1.77 111.653 -173.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.568 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 13.7 mt 65.35 -62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 1.39 110.114 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.507 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 29.8 t70 -63.06 -26.96 69.08 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.89 -0.596 . . . . 1.16 110.817 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.8 -34.31 76.52 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.039 0.447 . . . . 0.84 110.193 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 115' ' ' VAL . 28.3 mt -83.03 -40.22 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.987 -0.551 . . . . 0.74 110.108 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.58 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -66.59 -35.97 81.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.638 -0.875 . . . . 0.72 108.638 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.814 ' HA ' ' HE2' ' A' ' 116' ' ' LYS . 32.5 t70 -61.96 -53.03 61.31 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.999 -0.741 . . . . 0.78 108.999 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.923 ' HA ' ' HE3' ' A' ' 117' ' ' LYS . . . -52.09 -46.38 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.459 -0.792 . . . . 0.59 111.833 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 111' ' ' ILE . 32.3 m -68.24 -47.68 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.673 0.62 . . . . 0.47 112.673 -173.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.814 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 1.2 pptt? -85.24 -8.68 58.43 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.099 0.409 . . . . 1.16 111.665 -177.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.923 ' HE3' ' HA ' ' A' ' 114' ' ' ALA . 21.6 pttp -86.5 -21.52 26.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.715 -0.794 . . . . 1.48 109.749 167.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.843 ' HD1' ' HG ' ' A' ' 119' ' ' LEU . 14.8 t80 -80.56 -66.67 0.85 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.282 -0.417 . . . . 2.21 110.421 176.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.843 ' HG ' ' HD1' ' A' ' 118' ' ' TYR . 91.9 mt -122.36 86.23 48.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.414 -0.587 . . . . 2.09 109.414 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.653 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 93.1 Cg_endo -80.68 133.66 9.41 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.564 2.176 . . . . 0.92 113.434 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.075 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 13.3 tp -113.07 -66.57 1.07 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.6 0.714 . . . . 1.25 110.211 176.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 1.075 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 63.6 mttm -127.65 -49.75 1.38 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.985 -1.007 . . . . 2.78 109.985 -175.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 79.7 p 54.34 39.1 30.63 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.157 -0.929 . . . . 2.17 109.908 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -71.78 94.69 1.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.992 -1.003 . . . . 5.26 111.13 -176.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.417 HD22 HH22 ' A' ' 112' ' ' ARG . 32.9 tp -91.46 -19.08 23.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.524 -0.762 . . . . 5.75 110.029 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.76 67.23 2.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.878 -0.601 . . . . 8.65 110.621 -172.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 55.81 -93.88 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.418 -0.81 . . . . 9.73 112.269 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -170.7 118.73 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.43 -0.582 . . . . 12.67 109.43 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -88.15 160.84 17.58 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.865 0.364 . . . . 12.92 110.959 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -124.04 128.58 49.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.764 -0.653 . . . . 16.51 109.49 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -71.61 131.05 42.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.761 0.315 . . . . 17.15 110.988 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.1 m80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.123 -0.941 . . . . 19.6 109.776 176.868 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.557 ' H1 ' ' HB3' ' A' ' 119' ' ' LEU . 78.4 mtp . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.276 -0.268 . . . . 6.07 110.276 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 1' ' ' MET . 86.4 mtp 70.45 -85.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.432 -0.581 . . . . 3.88 109.432 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.611 ' HB3' HE22 ' A' ' 29' ' ' GLN . 0.2 OUTLIER -121.86 4.16 9.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.639 -1.245 . . . . 2.35 107.639 171.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.726 ' HB3' HD12 ' A' ' 121' ' ' LEU . 7.2 tp10 66.4 110.84 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.018 -1.446 . . . . 2.3 111.456 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.869 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -136.09 146.52 47.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.294 0.569 . . . . 0.8 111.368 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.901 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.9 mt -137.81 154.75 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.389 -0.823 . . . . 0.2 111.575 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.838 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -135.56 111.64 9.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.459 -1.246 . . . . 0.17 107.724 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.638 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.2 mp -99.42 104.62 16.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.175 -1.01 . . . . 0.22 110.219 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 47.9 t -85.67 93.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.777 -0.823 . . . . 0.28 108.777 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.608 ' OD2' ' HG3' ' A' ' 12' ' ' GLN . 25.8 t70 -152.6 104.81 2.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.643 -0.423 . . . . 1.82 111.138 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.79 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 19.7 t70 -54.14 -41.24 68.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.55 0.34 . . . . 0.51 111.46 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.608 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 3.6 pt20 -70.94 76.29 0.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 122.23 1.014 . . . . 2.07 109.217 173.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.451 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 31.0 p90 -53.67 -13.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.602 -1.635 . . . . 1.44 114.648 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.73 -67.49 1.27 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.366 -0.921 . . . . 0.38 111.547 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.782 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -70.48 -11.78 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 O-C-N 121.958 -0.731 . . . . 0.8 111.241 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.908 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.4 ttm180 -79.89 -42.12 24.81 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.612 -0.435 . . . . 0.38 110.229 -173.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.64 -27.14 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.56 109.967 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.496 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 3.5 tp -61.78 -61.59 2.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.637 -0.711 . . . . 0.58 109.485 170.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.782 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 1.1 tp -52.51 -41.96 63.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.653 -0.703 . . . . 1.23 110.187 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.4 t30 -51.18 -70.9 0.07 Allowed 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.209 -0.905 . . . . 0.94 109.78 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.28 -39.12 69.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.355 0.41 . . . . 2.46 111.64 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' LEU . 35.6 t -55.76 -60.83 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.626 -0.261 . . . . 0.37 111.295 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.782 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 8.3 m-85 -72.37 -34.6 68.08 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.457 -0.571 . . . . 0.43 109.457 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.932 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 2.5 t30 -52.06 -48.56 64.56 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.269 -0.878 . . . . 0.28 109.388 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.41 -31.72 73.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.626 -1.624 . . . . 3.25 112.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.686 ' HB2' ' CD1' ' A' ' 28' ' ' TYR . 6.1 mm-40 -63.67 -25.27 68.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.639 0.733 . . . . 1.45 110.313 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.653 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . 143.21 -16.47 2.32 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.491 -1.231 . . . . 0.44 110.648 -171.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.932 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 8.2 m-85 -81.64 124.06 29.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.308 0.575 . . . . 1.07 111.387 -162.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.869 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 20.7 mt-30 -79.39 82.61 5.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.46 -0.941 . . . . 1.14 108.46 172.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.901 HG22 ' HB ' ' A' ' 6' ' ' ILE . 20.8 p -90.19 135.85 33.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.645 -0.707 . . . . 0.14 109.921 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 15.4 m-85 -125.95 126.35 44.22 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.408 1.099 . . . . 0.34 109.265 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.908 ' HB2' HH11 ' A' ' 16' ' ' ARG . 4.2 pt20 -86.43 120.74 28.08 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.004 -1.907 . . . . 0.22 111.355 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.44 124.6 43.25 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.495 -0.558 . . . . 0.23 109.495 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 11' ' ' ASP . . . -74.71 -19.03 60.41 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.738 -0.385 . . . . 0.18 111.028 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.23 168.57 22.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 0.29 111.567 -174.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -75.03 -14.32 81.91 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.834 -0.621 . . . . 0.14 113.33 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.9 -44.71 19.91 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 122.617 1.198 . . . . 0.28 108.279 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.803 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.3 tp-100 -60.94 -40.69 94.23 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 112.26 -2.245 . . . . 1.29 105.597 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -63.3 -44.36 95.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.722 -1.581 . . . . 0.14 111.258 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.7 -43.64 76.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.037 -0.727 . . . . 0.97 109.037 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 44' ' ' THR . 18.9 t70 -64.22 -41.95 96.79 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.492 -1.231 . . . . 1.32 110.616 177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.838 ' HB ' HD11 ' A' ' 7' ' ' LEU . 10.3 mm -60.69 -48.78 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 120.922 -0.311 . . . . 0.14 111.033 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 76' ' ' ILE . 46.8 t -57.97 -41.75 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.741 0.781 . . . . 0.15 109.947 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.38 -23.95 62.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.226 -0.897 . . . . 0.39 111.134 -178.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.742 ' HE3' ' HA ' ' A' ' 42' ' ' ILE . 9.7 ptpt -91.23 -42.34 10.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.695 0.283 . . . . 2.42 111.268 -177.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 62.5 mm-40 -111.61 -38.16 4.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 112.066 0.395 . . . . 0.63 112.066 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.2 mpt_? 64.78 64.28 1.11 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 123.857 0.723 . . . . 3.66 109.769 -169.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.761 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 51.7 Cg_exo -62.77 157.71 46.28 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 121.57 1.513 . . . . 0.21 111.473 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.927 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -85.03 -51.09 6.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.293 -1.373 . . . . 0.98 107.293 171.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.927 HD12 ' HB2' ' A' ' 49' ' ' ASP . 7.1 mp -105.11 111.59 24.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.716 -1.129 . . . . 0.26 110.75 -171.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.769 HG13 ' HB3' ' A' ' 7' ' ' LEU . 60.0 t -112.18 108.51 25.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.213 -0.449 . . . . 0.21 111.419 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.576 HD22 HD21 ' A' ' 19' ' ' LEU . 2.1 mp -75.68 89.12 2.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.795 0.807 . . . . 0.15 109.473 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -82.49 110.68 17.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.059 -1.428 . . . . 1.53 111.294 -172.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.12 127.19 18.5 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.697 0.76 . . . . 1.47 110.714 174.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.922 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 18.8 mtp -114.94 9.52 16.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.172 -0.922 . . . . 0.94 109.457 163.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -71.74 -67.55 0.52 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.63 . . . . 2.24 111.9 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.839 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -175.05 -36.03 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.036 0 CA-C-O 118.024 -0.989 . . . . 2.06 112.708 -172.178 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.839 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 4.7 Cg_exo -19.48 -62.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.726 3.617 . . . . 0.45 116.419 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.06 -73.23 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 119.764 -1.208 . . . . 0.47 113.394 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.3 tpt -148.9 168.55 22.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.574 -0.899 . . . . 2.23 108.574 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.17 129.18 40.79 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.172 0.51 . . . . 0.67 109.654 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.589 ' CA ' ' HG ' ' A' ' 53' ' ' LEU . . . -62.92 -7.19 15.07 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.08 -0.964 . . . . 0.32 112.718 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.724 HG13 ' HB3' ' A' ' 89' ' ' MET . 4.1 mm -78.22 -48.66 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.681 -0.488 . . . . 1.31 109.681 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.9 -33.46 75.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.876 -0.787 . . . . 0.47 108.876 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.739 ' O ' ' HG2' ' A' ' 69' ' ' MET . 59.9 mt -77.31 -38.79 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.292 -0.867 . . . . 0.69 111.371 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.64 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 3.7 pp -65.66 -36.85 84.86 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 120.291 -0.564 . . . . 1.47 110.285 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.678 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.8 ptpt -73.49 -35.41 65.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.332 -0.547 . . . . 0.65 111.182 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.6 ptm180 -65.28 -33.46 76.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 118.868 -1.133 . . . . 2.18 111.668 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.775 ' HA ' HG12 ' A' ' 72' ' ' ILE . 12.2 ptp -84.86 -11.99 54.47 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.046 -1.033 . . . . 1.28 109.405 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 12.5 mptt -76.84 -36.98 56.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.016 -0.735 . . . . 1.3 109.016 172.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 68' ' ' ARG . 4.0 p -72.07 -33.81 48.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.354 0.597 . . . . 1.03 109.648 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.775 HG12 ' HA ' ' A' ' 69' ' ' MET . 26.1 pt -84.27 -24.46 7.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.291 -0.868 . . . . 0.26 110.973 172.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -161.74 88.18 0.69 Allowed 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.043 0.386 . . . . 1.08 112.043 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 8.5 mt-10 -75.77 6.25 5.22 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.272 -0.892 . . . . 1.78 110.636 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -28.69 42.39 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.856 -1.535 . . . . 0.35 106.856 170.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.3 tt -67.61 153.8 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 113.556 -1.657 . . . . 0.21 110.686 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 6.3 ptp180 -135.45 177.9 7.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.792 -1.188 . . . . 1.08 107.792 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -144.17 144.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.52 0.676 . . . . 0.79 111.216 -174.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.709 HG23 ' OG1' ' A' ' 100' ' ' THR . 64.9 mt -114.79 74.75 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.304 -1.369 . . . . 0.6 107.304 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.922 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -62.55 140.11 19.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 119.544 -0.862 . . . . 0.14 112.735 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 7.4 mtp -100.81 102.68 13.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.734 -1.121 . . . . 1.88 110.159 -174.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.43 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.7 t -117.05 165.13 13.73 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.343 0.592 . . . . 1.13 112.284 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 56.09 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.954 -1.021 . . . . 0.54 110.26 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 t80 72.3 5.59 5.32 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.983 -1.008 . . . . 4.3 111.686 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.32 88.28 1.99 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.115 -0.564 . . . . 0.62 112.619 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.431 ' N ' HG13 ' A' ' 90' ' ' ILE . 24.2 mt-10 -81.38 9.36 7.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.924 0.393 . . . . 1.33 111.18 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 38.1 mt 65.8 -166.22 0.22 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.606 -0.725 . . . . 1.73 112.621 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.53 -99.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.297 -0.865 . . . . 1.38 111.531 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.724 ' HB3' HG13 ' A' ' 63' ' ' ILE . 2.0 mpt? -64.25 -18.0 64.14 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.421 -0.354 . . . . 2.72 110.291 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 87' ' ' LEU . 32.7 mm -69.49 -40.2 79.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.999 0.428 . . . . 0.67 110.265 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -67.02 -53.36 31.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.842 -0.799 . . . . 2.5 108.842 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 42.8 tt0 -56.72 -30.6 63.69 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 114.46 -1.245 . . . . 1.27 111.404 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 63' ' ' ILE . 27.6 t -54.59 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.754 0.788 . . . . 1.28 111.177 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 33.4 pttt -54.03 -38.02 64.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.629 -1.169 . . . . 1.91 110.714 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 8.2 tp10 -55.37 -43.42 75.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.739 -1.118 . . . . 1.84 111.874 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.75 -22.96 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.843 0.354 . . . . 1.25 111.165 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.88 21.97 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.004 -1.093 . . . . 0.35 113.935 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 78' ' ' VAL . . . -88.54 140.54 29.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.9 0.85 . . . . 0.21 109.277 169.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.514 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.3 mt -82.19 -48.95 10.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.718 0.771 . . . . 0.18 109.865 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.709 ' OG1' HG23 ' A' ' 79' ' ' ILE . 52.6 p -144.57 150.2 37.08 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.486 -1.234 . . . . 0.19 111.64 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -108.55 86.89 2.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.363 -0.835 . . . . 0.52 109.967 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 16.6 m-85 -84.33 143.02 29.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.985 0.421 . . . . 3.86 110.716 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB1' ' HD2' ' A' ' 105' ' ' PRO . . . -95.48 178.14 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.76 109.431 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' O ' ' HD1' ' A' ' 106' ' ' PHE . 20.5 mmtp -78.33 -29.75 0.66 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.639 0.607 . . . . 3.35 112.639 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' HB1' ' A' ' 103' ' ' ALA . 24.2 Cg_exo -65.62 96.99 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 120.368 1.167 . . . . 1.36 109.922 162.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.496 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 1.6 p90 -130.19 146.16 51.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.875 -0.602 . . . . 1.1 111.516 -172.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -86.15 18.4 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.598 . . . . 1.77 111.726 178.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.549 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.4 tt 48.3 -67.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 125.035 1.334 . . . . 1.39 113.003 -174.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.549 ' H ' HG23 ' A' ' 108' ' ' ILE . 18.5 t70 -58.22 -30.55 66.58 Favored 'General case' 0 C--O 1.212 -0.897 0 C-N-CA 122.55 0.34 . . . . 1.16 111.364 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.11 -28.15 67.92 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 119.997 -0.681 . . . . 0.84 110.143 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.54 HG22 ' HZ ' ' A' ' 23' ' ' PHE . 17.0 mt -80.76 -41.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.74 110.508 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HD2' ' C ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -68.68 -32.99 73.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.744 0.783 . . . . 0.72 109.215 175.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 19.1 t70 -70.91 -36.49 72.73 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.323 -0.853 . . . . 0.78 108.828 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.6 -45.29 79.66 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.079 -0.964 . . . . 0.59 111.459 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 112' ' ' ARG . 34.5 m -61.77 -42.59 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.598 -0.841 . . . . 0.47 110.184 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.524 ' HA ' ' OH ' ' A' ' 28' ' ' TYR . 7.1 ttpt -63.67 -49.65 72.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.795 -0.639 . . . . 1.16 111.418 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.739 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.5 OUTLIER -59.78 -30.67 69.04 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.664 -0.243 . . . . 1.48 111.399 -176.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.576 ' HB3' HD12 ' A' ' 119' ' ' LEU . 44.5 m-85 -81.91 -68.91 0.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.417 -0.513 . . . . 2.21 110.696 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 118' ' ' TYR . 6.7 mp -121.48 103.63 41.06 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.175 -0.676 . . . . 2.09 109.175 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -97.78 153.11 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.752 2.301 . . . . 0.92 114.493 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -127.35 -64.97 0.96 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 1.25 108.396 172.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.65 ' HG3' HD22 ' A' ' 121' ' ' LEU . 82.8 mttt -135.18 -50.3 0.75 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.169 -0.923 . . . . 2.78 110.234 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.609 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 56.0 p 54.99 87.97 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.408 1.068 . . . . 2.17 109.594 -171.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -115.48 147.41 40.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.024 -0.989 . . . . 5.26 111.701 -164.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.89 45.88 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.475 -0.33 . . . . 5.75 110.581 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 127' ' ' HIS . 9.1 pt-20 -59.41 -36.43 75.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.173 -0.467 . . . . 8.65 111.73 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.403 ' N ' ' HG3' ' A' ' 126' ' ' GLU . 36.3 m170 -72.77 160.26 32.47 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.358 0.599 . . . . 9.73 111.108 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -101.08 113.33 26.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.347 -0.842 . . . . 12.67 110.162 -171.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -65.78 -50.88 63.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.962 0.41 . . . . 12.92 110.547 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -97.55 129.67 44.67 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.041 -0.527 . . . . 16.51 110.058 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -102.04 143.62 31.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.142 -0.481 . . . . 17.15 109.791 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.4 p80 . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.227 -0.892 . . . . 19.6 110.332 179.416 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 109.897 -0.409 . . . . 6.07 109.897 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 56.0 mtp 61.07 -166.54 0.2 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.802 -0.635 . . . . 3.88 111.889 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -106.71 -18.86 13.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.216 -0.902 . . . . 2.35 110.391 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.853 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 8.3 tt0 68.02 105.69 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.583 0.706 . . . . 2.3 110.916 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.688 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 3.6 tppt? -140.57 147.33 39.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.009 -0.541 . . . . 0.8 111.202 -172.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.899 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -141.23 153.99 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.439 -0.8 . . . . 0.2 111.696 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.796 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -131.82 123.47 27.64 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.61 -1.256 . . . . 0.17 107.61 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.701 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.4 mp -109.66 103.21 15.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.556 -0.858 . . . . 0.22 110.164 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.2 t -88.49 82.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.28 110.003 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.876 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.0 t70 -133.1 144.28 49.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.548 -0.296 . . . . 1.82 110.686 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.89 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 13.0 t70 -101.54 -35.94 8.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.896 -0.409 . . . . 0.51 109.896 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.658 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 4.4 pt20 -81.06 70.61 7.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.098 -1.445 . . . . 2.07 107.098 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.9 p90 -48.74 -13.92 0.06 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 112.334 -2.212 . . . . 1.44 115.181 -161.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' GLN . . . -46.68 -59.48 5.4 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.198 -1.001 . . . . 0.38 110.777 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 1.1 mm -54.51 -32.5 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.525 0.679 . . . . 0.8 110.245 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.876 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.6 ttm180 -77.12 -48.78 16.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.118 -0.946 . . . . 0.38 110.891 -165.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 42.4 pt -76.04 -25.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.312 -0.625 . . . . 0.56 109.312 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.4 tp -58.69 -68.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.58 109.416 171.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.798 HD13 HD22 ' A' ' 52' ' ' LEU . 39.0 mt -54.65 -40.91 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 1.23 110.563 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.632 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 7.6 t30 -50.48 -68.81 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.94 109.97 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.65 -40.04 82.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.265 0.353 . . . . 2.46 111.639 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -55.15 -55.43 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.052 0.22 . . . . 0.37 111.576 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB2' HG21 ' A' ' 30' ' ' THR . 11.8 m-85 -78.87 -36.66 41.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.61 -0.436 . . . . 0.43 110.038 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 5.0 t30 -50.15 -50.54 48.55 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.176 0.988 . . . . 0.28 108.934 -176.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -54.77 -42.49 71.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 112.637 -2.074 . . . . 3.25 111.676 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.659 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 4.5 mm-40 -52.22 -34.6 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 122.191 0.996 . . . . 1.45 109.733 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.612 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 138.08 -6.66 3.43 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 113.303 -1.771 . . . . 0.44 109.39 -171.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.856 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 5.5 m-85 -70.4 126.86 30.83 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.807 -0.757 . . . . 1.07 110.549 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.641 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 26.0 mt-30 -82.7 81.13 8.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.475 -0.935 . . . . 1.14 108.475 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.899 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -90.07 133.09 35.05 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.064 -0.971 . . . . 0.14 110.128 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.94 124.83 42.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.592 1.187 . . . . 0.34 109.732 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.71 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 1.8 pt20 -82.17 120.71 25.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 112.748 -2.024 . . . . 0.22 111.602 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.783 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -123.93 124.02 41.69 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.585 -0.734 . . . . 0.23 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -84.83 -8.19 58.89 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.223 -0.591 . . . . 0.18 111.293 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.42 165.55 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.41 -0.359 . . . . 0.29 111.56 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.91 -19.92 77.32 Favored Glycine 0 CA--C 1.506 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.14 113.291 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.31 -42.97 29.16 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.458 1.123 . . . . 0.28 108.075 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.843 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -60.96 -41.66 96.75 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 112.6 -2.091 . . . . 1.29 105.805 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -60.9 -43.87 97.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.003 -1.453 . . . . 0.14 111.038 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.2 OUTLIER -57.44 -43.37 83.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.224 -0.658 . . . . 0.97 109.224 177.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 44' ' ' THR . 2.1 t70 -64.57 -44.58 90.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 114.951 -1.022 . . . . 1.32 110.213 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.843 HG12 ' O ' ' A' ' 38' ' ' GLN . 15.9 mm -60.19 -46.42 94.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.266 -0.879 . . . . 0.14 110.165 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 69' ' ' MET . 47.6 t -62.12 -41.25 90.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 121.727 0.775 . . . . 0.15 109.604 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -73.23 -20.71 60.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.606 -0.725 . . . . 0.39 111.155 -177.543 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.631 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -90.49 -45.99 8.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.604 -0.271 . . . . 2.42 111.246 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.631 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 8.3 mm-40 -110.63 -36.89 5.61 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.392 0.515 . . . . 0.63 112.392 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 14.1 mtm-85 65.36 65.43 0.92 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 O-C-N 123.639 0.587 . . . . 3.66 109.536 -170.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.751 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 71.3 Cg_exo -60.57 156.67 40.74 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 C-N-CA 121.689 1.592 . . . . 0.21 111.033 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.814 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 12.3 m-20 -89.51 -42.27 11.55 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.293 -0.963 . . . . 0.98 108.849 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.654 HD23 HD11 ' A' ' 79' ' ' ILE . 6.8 mp -110.42 111.97 23.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.737 -0.665 . . . . 0.26 109.864 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 7' ' ' LEU . 86.3 t -112.58 112.81 42.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.796 0.332 . . . . 0.21 110.669 -177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.798 HD22 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -83.64 93.01 7.8 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.411 0.624 . . . . 0.15 109.986 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.656 HD11 HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -84.63 104.7 14.84 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.826 -1.079 . . . . 1.53 111.155 -175.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.835 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 54.2 t0 -70.11 109.14 4.43 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.57 -0.852 . . . . 1.47 110.181 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.87 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.9 mtp -86.28 11.03 13.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.614 -0.721 . . . . 0.94 111.083 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -71.32 -60.16 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.029 0.752 . . . . 2.24 113.029 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.962 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.1 tp -173.08 -21.73 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.671 1.36 . . . . 2.06 114.671 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.962 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -27.62 -52.87 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 123.443 2.762 . . . . 0.45 116.105 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.02 -60.07 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.756 -1.211 . . . . 0.47 112.88 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 65' ' ' ILE . 20.6 ttt -149.53 170.18 19.21 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.403 -0.592 . . . . 2.23 109.403 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -57.66 135.38 56.72 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.977 0.417 . . . . 0.67 110.283 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.615 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -66.49 -2.07 13.71 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.408 -0.815 . . . . 0.32 112.885 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.528 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.2 mt -92.05 -42.03 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.157 0.503 . . . . 1.31 110.286 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.85 -38.9 80.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.571 0.701 . . . . 0.47 109.413 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.656 HD12 HD11 ' A' ' 53' ' ' LEU . 54.0 mt -71.57 -35.85 57.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.149 -0.932 . . . . 0.69 109.794 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.733 HD12 HG21 ' A' ' 78' ' ' VAL . 3.2 tt -53.34 -53.43 51.19 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.677 -0.692 . . . . 1.47 110.607 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.0 ptpp? -73.13 -30.16 63.41 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.233 -0.587 . . . . 0.65 112.083 -172.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.693 ' O ' HG12 ' A' ' 71' ' ' VAL . 15.0 ptp180 -68.97 -33.59 73.95 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 118.92 -1.112 . . . . 2.18 111.066 174.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.703 ' HE1' HG13 ' A' ' 78' ' ' VAL . 2.8 ptt? -80.63 -17.82 50.08 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 118.918 -1.113 . . . . 1.28 109.796 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.742 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -76.93 -30.24 55.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.636 . . . . 1.3 110.572 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.7 p -78.12 -34.95 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 109.531 -0.544 . . . . 1.03 109.531 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.567 HG12 ' HA ' ' A' ' 69' ' ' MET . 15.7 pt -81.42 -31.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.26 110.037 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.76 90.82 1.1 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.32 2.9 6.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.876 0.846 . . . . 1.78 109.796 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -26.11 64.35 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.55 -1.278 . . . . 0.35 107.55 171.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.0 tt -76.23 156.93 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 112.743 -2.026 . . . . 0.21 110.754 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.814 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -137.77 172.48 12.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.055 -0.975 . . . . 1.08 108.614 177.017 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -131.29 154.25 40.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 120.217 -0.593 . . . . 0.79 110.689 -171.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.654 HD11 HD23 ' A' ' 50' ' ' LEU . 61.5 mt -128.64 68.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.402 -1.333 . . . . 0.6 107.402 171.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.87 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -64.86 140.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.538 -0.756 . . . . 0.14 111.735 -172.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.638 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 11.0 mtt -93.15 131.1 38.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.071 -0.968 . . . . 1.88 110.019 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.638 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 4.6 t -132.85 156.85 46.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.329 0.585 . . . . 1.13 112.578 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . -72.36 63.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.761 -1.109 . . . . 0.54 109.804 170.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 40.3 t80 70.24 11.26 7.5 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.564 -1.198 . . . . 4.3 112.021 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.72 81.88 1.6 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.051 -0.595 . . . . 0.62 112.011 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' N ' HG13 ' A' ' 90' ' ' ILE . 5.6 mt-10 -72.6 8.12 1.59 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.678 0.791 . . . . 1.33 112.052 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.405 ' N ' HG13 ' A' ' 90' ' ' ILE . 25.6 mt 61.11 -177.55 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.569 1.322 . . . . 1.73 114.569 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 t70 57.7 -93.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.328 -1.306 . . . . 1.38 111.692 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.461 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 66.3 mtt -60.88 -26.77 67.65 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 120.838 0.351 . . . . 2.72 110.363 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 86' ' ' GLU . 15.7 mm -62.52 -43.25 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.057 0.456 . . . . 0.67 110.439 173.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.563 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 88.2 mt-30 -63.76 -48.31 77.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.473 -0.785 . . . . 2.5 109.493 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.783 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 22.7 tt0 -70.11 -20.52 63.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.539 -1.21 . . . . 1.27 112.102 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.8 t -66.68 -63.84 0.98 Allowed 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.876 -0.515 . . . . 1.28 110.062 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.919 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 17.0 ptpt -58.87 -31.14 68.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.694 0.759 . . . . 1.91 109.964 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.783 ' CB ' ' HA ' ' A' ' 92' ' ' GLU . 6.1 tt0 -47.38 -58.87 3.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.366 -1.288 . . . . 1.84 111.867 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.77 -28.57 65.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.764 -0.653 . . . . 1.25 112.36 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' HZ1' ' A' ' 70' ' ' LYS . . . 163.72 11.22 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.835 -1.174 . . . . 0.35 113.739 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.919 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -86.72 136.38 33.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.827 0.813 . . . . 0.21 109.66 173.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.415 HD11 ' HG3' ' A' ' 77' ' ' ARG . 7.8 mt -74.98 -49.24 20.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.708 0.766 . . . . 0.18 109.867 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.635 ' OG1' HG23 ' A' ' 79' ' ' ILE . 60.2 p -139.17 147.83 42.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.383 -1.281 . . . . 0.19 111.603 -172.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -107.59 88.7 2.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.862 -1.063 . . . . 0.52 108.431 170.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.603 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 0.3 OUTLIER -84.34 142.22 30.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.264 -0.425 . . . . 3.86 109.944 -172.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -108.42 177.07 4.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.76 111.424 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 10.2 mtpm? -59.37 -43.3 96.16 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.959 -0.564 . . . . 3.35 111.873 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 54.0 Cg_endo -74.37 96.2 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 120.633 0.889 . . . . 1.36 110.995 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.519 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 51.1 p90 -130.81 148.2 52.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.585 -0.734 . . . . 1.1 110.252 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 33.6 t70 -81.99 6.95 14.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.483 -0.78 . . . . 1.77 110.962 -174.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.519 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 6.0 tt 52.75 -60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.551 1.54 . . . . 1.39 112.162 -171.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 107' ' ' ASP . 29.0 t70 -62.05 -30.71 71.17 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 110.298 -0.26 . . . . 1.16 110.298 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 pt-20 -64.13 -29.71 70.82 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.536 -0.466 . . . . 0.84 110.185 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.512 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 34.2 mt -81.71 -42.47 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.245 -0.434 . . . . 0.74 110.459 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.446 ' C ' ' HD2' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -67.86 -34.96 77.71 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.818 0.818 . . . . 0.72 109.222 175.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.2 t70 -64.2 -49.44 72.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.986 -1.006 . . . . 0.78 108.664 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.859 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.94 -48.84 75.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.712 -1.131 . . . . 0.59 111.729 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 112' ' ' ARG . 35.7 m -60.8 -51.95 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.313 -0.555 . . . . 0.47 111.663 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.4 OUTLIER -71.21 -29.83 65.63 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.627 0.232 . . . . 1.16 111.627 -176.077 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.859 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 65.0 pttt -72.54 -26.09 61.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.64 -0.824 . . . . 1.48 111.184 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -77.89 -66.55 0.83 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.928 0.394 . . . . 2.21 110.283 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -121.23 97.71 47.4 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.538 -0.912 . . . . 2.09 108.538 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.554 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 77.1 Cg_endo -93.97 132.61 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.93 2.42 . . . . 0.92 113.952 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.995 ' HG ' ' HG2' ' A' ' 122' ' ' LYS . 13.8 tp -114.34 -66.16 1.11 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.299 0.571 . . . . 1.25 110.209 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.995 ' HG2' ' HG ' ' A' ' 121' ' ' LEU . 32.9 mmtp -133.73 -63.07 0.75 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.232 -0.895 . . . . 2.78 109.256 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 36.6 p 51.44 -96.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.288 -0.869 . . . . 2.17 112.533 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -90.01 -9.4 48.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.19 0.519 . . . . 5.26 110.737 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.7 tp -92.99 83.63 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.785 -0.643 . . . . 5.75 109.685 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -141.01 128.26 20.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.698 -0.683 . . . . 8.65 110.638 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -120.48 -53.16 2.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.974 -0.75 . . . . 9.73 108.974 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -103.29 102.3 12.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.56 0.695 . . . . 12.67 109.809 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -109.51 133.33 53.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.457 -0.792 . . . . 12.92 108.888 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -85.74 112.38 21.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.083 0.468 . . . . 16.51 112.058 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -86.17 104.6 15.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.835 -0.802 . . . . 17.15 108.835 171.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 p80 . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.949 -1.024 . . . . 19.6 110.269 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.149 -0.686 . . . . 6.07 109.149 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.458 ' CE ' HH21 ' A' ' 47' ' ' ARG . 5.8 mmt -71.99 -19.13 61.92 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.01 -0.737 . . . . 3.88 109.01 175.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 89.4 m-20 74.42 35.94 0.67 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.016 -0.993 . . . . 2.35 111.023 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.786 ' HB3' HD22 ' A' ' 121' ' ' LEU . 12.5 tt0 68.41 94.54 0.07 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.952 0.882 . . . . 2.3 109.933 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.802 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -132.52 145.99 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.238 -0.892 . . . . 0.8 110.661 -173.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.886 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.8 mt -136.98 156.56 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.544 0.688 . . . . 0.2 111.774 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.917 HD11 ' HB ' ' A' ' 42' ' ' ILE . 1.9 tt -134.17 109.51 8.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.673 -1.149 . . . . 0.17 108.146 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.4 mp -97.37 108.07 21.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.324 -0.55 . . . . 0.22 109.763 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.739 HG21 HD23 ' A' ' 53' ' ' LEU . 59.9 t -97.04 88.53 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 110.005 -0.368 . . . . 0.28 110.005 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.8 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.1 t70 -134.77 140.79 46.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.517 -0.549 . . . . 1.82 109.517 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.893 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 35.8 t70 -88.81 -49.4 6.85 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.141 -0.349 . . . . 0.51 111.016 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HG3' HD12 ' A' ' 15' ' ' ILE . 7.1 pt20 -76.57 73.1 3.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.628 -0.879 . . . . 2.07 108.628 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.565 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 52.0 p90 -44.94 -12.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 112.206 -2.27 . . . . 1.44 115.986 -167.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.28 -58.87 4.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.978 -1.106 . . . . 0.38 110.789 170.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.634 HD12 ' HG3' ' A' ' 12' ' ' GLN . 2.3 mt -59.42 -27.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.608 0.718 . . . . 0.8 110.409 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.897 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.3 ttm180 -78.79 -43.83 24.58 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.879 -1.055 . . . . 0.38 110.513 -167.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.728 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 39.2 pt -80.46 -26.11 11.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.459 0.475 . . . . 0.56 109.901 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 19' ' ' LEU . 1.8 tp -59.05 -63.54 1.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.08 -0.711 . . . . 0.58 109.08 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.02 HD21 HD22 ' A' ' 52' ' ' LEU . 8.1 tp -57.93 -41.15 82.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.759 -1.109 . . . . 1.23 110.531 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.728 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 2.1 t30 -51.14 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.406 -0.815 . . . . 0.94 110.566 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.55 -41.88 42.57 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.224 0.952 . . . . 2.46 112.244 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.8 t -55.1 -63.19 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.457 0.169 . . . . 0.37 111.457 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.797 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 16.1 m-85 -70.3 -37.31 74.76 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.379 -0.6 . . . . 0.43 109.379 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.832 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 2.6 t30 -50.25 -49.01 54.4 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.93 -1.032 . . . . 0.28 109.024 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -60.52 -46.77 88.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.524 -1.671 . . . . 3.25 111.714 -176.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 123' ' ' SER . 9.6 pt-20 -80.71 11.87 3.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.451 -0.499 . . . . 1.45 112.235 -174.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.582 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 132.93 -16.53 4.72 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.523 -0.762 . . . . 0.44 112.963 171.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.832 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 12.3 m-85 -82.15 137.0 35.07 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.3 -0.96 . . . . 1.07 111.875 -166.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.802 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.9 mt-30 -89.05 83.62 6.57 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.413 -0.958 . . . . 1.14 108.413 168.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.886 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -91.33 132.54 36.1 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.898 -0.592 . . . . 0.14 110.193 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 9.9 m-85 -121.68 124.39 44.17 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 122.486 1.136 . . . . 0.34 109.254 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.897 ' HB2' HH11 ' A' ' 16' ' ' ARG . 5.2 pt20 -84.18 119.8 25.44 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 112.839 -1.982 . . . . 0.22 111.693 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.953 ' HB1' ' HB3' ' A' ' 38' ' ' GLN . . . -119.22 138.35 53.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.441 -0.948 . . . . 0.23 108.441 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.495 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -97.15 -7.54 32.29 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.596 -0.841 . . . . 0.18 110.3 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' CG ' ' HB2' ' A' ' 38' ' ' GLN . 1.9 p30 -146.42 166.0 27.68 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 120.152 -0.619 . . . . 0.29 111.68 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.64 -22.68 78.03 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.605 -0.725 . . . . 0.14 112.543 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.84 -38.24 38.49 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.052 -0.722 . . . . 0.28 109.052 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.953 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -59.0 -46.19 88.79 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 104.618 -2.364 . . . . 1.29 104.618 175.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -59.19 -49.14 79.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.501 -1.681 . . . . 0.14 111.594 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.37 -42.13 66.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.674 0.749 . . . . 0.97 109.405 176.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.27 -30.22 60.37 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.708 -1.133 . . . . 1.32 111.47 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.917 ' HB ' HD11 ' A' ' 7' ' ' LEU . 8.8 mm -68.24 -46.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 O-C-N 121.714 -0.616 . . . . 0.14 110.003 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.2 t -58.07 -42.91 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.065 0.936 . . . . 0.15 108.771 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -34.66 70.15 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.037 -1.438 . . . . 0.39 111.388 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.741 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.92 -47.29 7.68 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.421 0.526 . . . . 2.42 112.421 -174.01 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 46.0 mm-40 -107.44 -32.7 7.62 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.19 0.441 . . . . 0.63 112.19 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.458 HH21 ' CE ' ' A' ' 2' ' ' MET . 27.4 mtp85 63.69 61.17 1.74 Allowed Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 123.694 0.621 . . . . 3.66 110.247 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.788 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.2 Cg_exo -60.73 153.82 59.63 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 121.435 1.423 . . . . 0.21 111.635 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.745 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 5.2 m-20 -85.91 -42.01 14.45 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.303 -0.999 . . . . 0.98 108.303 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 49' ' ' ASP . 7.7 mp -111.56 111.61 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.422 -0.808 . . . . 0.26 110.585 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' HB3' ' A' ' 7' ' ' LEU . 91.7 t -109.99 113.54 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.075 0.464 . . . . 0.21 111.414 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.02 HD22 HD21 ' A' ' 19' ' ' LEU . 2.0 mp -87.47 87.34 7.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.53 0.681 . . . . 0.15 109.773 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 9' ' ' VAL . 37.8 mt -84.88 110.31 18.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.786 -1.097 . . . . 1.53 111.124 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.66 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 49.1 t0 -68.82 115.88 8.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.616 0.722 . . . . 1.47 111.1 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.489 ' SD ' HG12 ' A' ' 63' ' ' ILE . 9.2 mmm -84.33 -3.51 58.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.65 -1.159 . . . . 0.94 111.343 176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' NZ ' ' HB2' ' A' ' 83' ' ' ALA . 22.2 mmmt -61.75 -65.57 0.67 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.893 0.701 . . . . 2.24 112.893 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.969 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 10.1 tp -169.81 -30.69 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.594 1.331 . . . . 2.06 114.594 -171.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -23.72 -55.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 124.08 3.186 . . . . 0.45 116.204 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -144.6 -62.75 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.824 -1.179 . . . . 0.47 112.702 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.7 ttm -148.76 167.29 25.98 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.277 -0.638 . . . . 2.23 109.277 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 65' ' ' ILE . 7.3 m-20 -58.48 127.7 33.46 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.297 0.57 . . . . 0.67 109.485 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.36 -15.9 33.12 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.703 -1.135 . . . . 0.32 112.528 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 93' ' ' SER . 3.0 mm -77.75 -41.4 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 117.456 0.628 . . . . 1.31 110.379 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -68.48 -37.31 80.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.723 -0.671 . . . . 0.47 109.335 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.538 ' HB ' HD13 ' A' ' 53' ' ' LEU . 14.5 mt -72.72 -36.37 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.69 110.714 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.65 HD22 HG21 ' A' ' 78' ' ' VAL . 2.8 pp -67.32 -36.13 80.84 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.259 -0.576 . . . . 1.47 109.814 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.9 ptpp? -75.77 -32.62 60.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.619 -0.832 . . . . 0.65 111.354 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' CG ' ' HA ' ' A' ' 65' ' ' ILE . 10.9 ptp180 -67.71 -35.17 78.3 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 118.968 -1.093 . . . . 2.18 111.493 174.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.781 ' HA ' HG12 ' A' ' 72' ' ' ILE . 9.5 ptp -80.29 -17.31 52.48 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 120.164 -0.615 . . . . 1.28 109.641 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.4 mptp? -70.3 -40.83 74.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.363 -0.977 . . . . 1.3 108.363 167.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 67' ' ' LYS . 95.8 t -61.75 -39.16 82.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 1.03 110.605 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.781 HG12 ' HA ' ' A' ' 69' ' ' MET . 32.0 pt -85.19 -20.25 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.676 -0.41 . . . . 0.26 110.655 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.69 85.22 0.55 Allowed 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 112.555 0.576 . . . . 1.08 112.555 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.9 mt-10 -73.96 5.56 4.11 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.412 -0.805 . . . . 1.78 109.845 173.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.15 -28.52 62.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.562 1.172 . . . . 0.35 108.033 170.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.618 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.3 tt -76.06 161.63 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-N 112.843 -1.98 . . . . 0.21 111.403 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -138.47 176.76 8.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.737 -1.12 . . . . 1.08 108.179 173.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.68 HG11 HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -142.65 153.01 17.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 119.941 -0.704 . . . . 0.79 111.806 -173.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.712 HG23 ' OG1' ' A' ' 100' ' ' THR . 71.3 mt -124.71 73.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.328 -1.36 . . . . 0.6 107.328 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -65.41 138.23 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.216 -0.902 . . . . 0.14 111.829 -171.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.773 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 6.1 mtm -94.18 117.93 30.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.089 -0.96 . . . . 1.88 110.317 -174.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 11.0 p -125.82 157.4 37.65 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.667 -0.697 . . . . 1.13 112.163 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . . . -73.97 60.66 0.77 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.716 -0.675 . . . . 0.54 110.436 167.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 58.4 t80 60.43 54.61 3.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.334 0.587 . . . . 4.3 111.554 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.2 87.34 0.03 OUTLIER Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.891 -0.595 . . . . 0.62 113.475 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.657 ' N ' HG13 ' A' ' 90' ' ' ILE . 22.5 mt-10 -87.12 16.12 5.43 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.948 0.499 . . . . 1.33 111.582 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 87' ' ' LEU . 3.7 mm? 63.65 179.35 0.16 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.8 1.407 . . . . 1.73 114.8 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 89' ' ' MET . 1.7 t70 61.82 -93.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.268 -1.333 . . . . 1.38 111.658 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.824 ' HB3' HG13 ' A' ' 63' ' ' ILE . 1.1 mpt? -64.25 -14.34 55.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.066 0.46 . . . . 2.72 110.577 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.657 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.5 mm -77.34 -22.1 14.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.366 0.603 . . . . 0.67 110.605 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 13.4 mt-30 -81.15 -47.2 13.78 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.793 -1.188 . . . . 2.5 107.793 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.615 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 19.7 tt0 -65.33 -33.56 76.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.929 -1.487 . . . . 1.27 112.671 -177.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.833 ' HB3' HD12 ' A' ' 63' ' ' ILE . 7.9 p -52.45 -74.78 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.06 0.933 . . . . 1.28 111.611 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.6 pttt -53.78 -35.91 61.84 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.779 -1.555 . . . . 1.91 111.992 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -62.11 -34.3 76.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.886 -0.326 . . . . 1.84 111.161 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.3 mt -81.31 -24.66 37.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.896 0.379 . . . . 1.25 111.019 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.31 -1.79 0.25 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 119.877 -1.154 . . . . 0.35 113.706 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.649 ' CA ' HG23 ' A' ' 78' ' ' VAL . . . -70.74 132.15 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.954 0.877 . . . . 0.21 109.605 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.41 HD11 ' HG ' ' A' ' 50' ' ' LEU . 12.5 mt -75.29 -48.25 24.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.043 0.925 . . . . 0.18 109.392 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.712 ' OG1' HG23 ' A' ' 79' ' ' ILE . 71.1 p -141.72 156.74 45.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.889 -1.505 . . . . 0.19 111.914 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.62 98.62 8.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.354 -1.294 . . . . 0.52 109.47 171.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.773 ' HB3' ' HA ' ' A' ' 81' ' ' MET . 26.0 t80 -56.41 143.23 35.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.445 -0.798 . . . . 3.86 109.441 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -130.32 167.45 18.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.759 -0.46 . . . . 0.76 109.759 172.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 54.5 mtpt -68.15 -40.88 23.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.203 -0.453 . . . . 3.35 111.387 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 58.0 Cg_endo -76.6 96.36 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.767 0.952 . . . . 1.36 110.62 166.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.625 ' HB2' HD11 ' A' ' 111' ' ' ILE . 53.0 p90 -129.03 143.62 50.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.059 -0.519 . . . . 1.1 111.607 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.511 ' HB3' ' HG2' ' A' ' 110' ' ' GLU . 1.8 t70 -75.25 -3.68 34.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.888 -0.596 . . . . 1.77 110.712 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 107' ' ' ASP . 9.4 tp 52.2 -53.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.613 1.565 . . . . 1.39 112.206 -165.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.458 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 35.0 t70 -65.9 -26.99 67.87 Favored 'General case' 0 C--O 1.211 -0.924 0 O-C-N 122.384 -0.197 . . . . 1.16 110.94 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 11.3 pt-20 -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.203 -0.599 . . . . 0.84 109.864 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 106' ' ' PHE . 47.7 mt -83.23 -43.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.74 109.559 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.636 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -65.42 -39.58 92.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.809 -0.811 . . . . 0.72 108.809 175.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.8 t70 -67.95 -40.53 83.24 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.187 -0.671 . . . . 0.78 109.187 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.612 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.63 -48.71 74.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.324 -0.853 . . . . 0.59 110.927 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 112' ' ' ARG . 34.3 m -61.93 -48.23 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 120.082 -0.647 . . . . 0.47 111.173 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.631 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -70.91 -19.91 62.54 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.598 0.592 . . . . 1.16 112.598 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 7.4 pttm -86.61 -23.14 25.83 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.415 -0.914 . . . . 1.48 111.154 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.523 ' HD2' ' O ' ' A' ' 114' ' ' ALA . 28.4 m-85 -82.17 -67.19 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.024 -0.362 . . . . 2.21 110.024 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.0 95.05 49.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.26 -0.645 . . . . 2.09 109.26 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 84.1 Cg_endo -91.1 141.65 2.96 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.857 2.372 . . . . 0.92 113.942 -173.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.02 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 29.7 tp -114.66 -66.28 1.1 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.725 0.774 . . . . 1.25 109.84 174.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 1.02 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 60.8 mttm -143.94 -51.51 0.32 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.645 -1.161 . . . . 2.78 109.87 -172.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.701 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 90.3 p 55.18 -108.75 0.45 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.012 -0.995 . . . . 2.17 111.252 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -174.94 -38.0 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 111.832 0.308 . . . . 5.26 111.832 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.8 tp -105.48 131.68 52.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.882 0.373 . . . . 5.75 111.583 -172.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -82.88 170.39 15.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.557 -0.747 . . . . 8.65 110.386 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 34.8 m80 62.85 -170.3 0.18 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.456 0.646 . . . . 9.73 111.628 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -146.15 91.34 2.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.587 -0.733 . . . . 12.67 109.332 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -79.43 -178.48 6.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.74 -0.664 . . . . 12.92 109.359 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 73.69 25.36 2.03 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.295 0.372 . . . . 16.51 110.198 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -73.58 96.43 2.44 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.362 -0.607 . . . . 17.15 109.362 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-N 114.846 -1.07 . . . . 19.6 111.094 -174.232 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.417 0.151 . . . . 6.07 110.929 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.8 tpt 176.99 -161.67 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.951 -1.129 . . . . 3.88 107.951 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -91.39 -72.36 0.59 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.333 -0.988 . . . . 2.35 108.333 167.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.818 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 3.0 tp10 169.11 124.01 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.325 -1.361 . . . . 2.3 107.325 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.73 ' HD3' ' HB3' ' A' ' 46' ' ' GLU . 2.7 ttmt -150.31 139.73 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.188 1.181 . . . . 0.8 114.188 -167.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.938 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -139.39 154.82 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.233 -1.349 . . . . 0.2 111.49 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.01 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.4 tt -135.55 117.95 15.73 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.52 -1.289 . . . . 0.17 107.52 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.749 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -103.7 100.92 11.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.987 -0.685 . . . . 0.22 110.132 -177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.777 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 48.8 t -83.61 91.25 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.559 -0.534 . . . . 0.28 109.559 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.83 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.7 t70 -143.35 142.98 31.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.543 0.211 . . . . 1.82 110.607 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.883 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 15.2 t70 -102.46 -31.62 10.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.891 0.377 . . . . 0.51 110.27 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -79.12 70.91 5.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.507 -1.294 . . . . 2.07 107.507 172.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 17' ' ' ILE . 46.7 p90 -52.29 -15.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 112.88 -1.964 . . . . 1.44 115.099 -159.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.64 -60.9 5.54 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.906 -1.14 . . . . 0.38 110.334 169.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HA ' HD23 ' A' ' 18' ' ' LEU . 2.9 mt -55.17 -30.49 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.333 0.587 . . . . 0.8 111.056 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.83 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.1 ttm180 -76.29 -49.79 16.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.749 . . . . 0.38 110.596 -168.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.5 pt -76.19 -25.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.598 -0.519 . . . . 0.56 109.598 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 15' ' ' ILE . 2.8 tp -57.24 -65.26 0.65 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.348 -0.842 . . . . 0.58 109.457 171.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.827 HD13 HD22 ' A' ' 52' ' ' LEU . 57.8 mt -58.26 -44.15 88.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.23 109.939 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.609 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.5 t30 -50.5 -66.17 0.43 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.36 -0.837 . . . . 0.94 110.128 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.47 -39.21 82.95 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.662 0.601 . . . . 2.46 111.396 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.9 t -55.08 -58.17 5.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 111.787 0.291 . . . . 0.37 111.787 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.694 ' CD2' HD13 ' A' ' 6' ' ' ILE . 7.9 m-85 -73.56 -40.09 64.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.256 -0.646 . . . . 0.43 109.256 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.8 t-20 -50.78 -50.23 56.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.066 -0.97 . . . . 0.28 108.557 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -51.11 -46.75 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.275 -1.784 . . . . 3.25 112.58 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.625 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 6.5 pt-20 -88.21 16.16 6.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.116 -0.634 . . . . 1.45 111.544 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.79 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 126.98 -15.45 6.53 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.495 -0.859 . . . . 0.44 113.581 169.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.818 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 10.2 m-85 -73.83 160.22 31.77 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 118.899 -1.12 . . . . 1.07 112.407 -168.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.697 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 1.5 mp0 -106.83 76.32 1.1 Allowed 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.101 -1.409 . . . . 1.14 107.337 173.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.938 HG22 ' HB ' ' A' ' 6' ' ' ILE . 27.2 p -90.68 130.55 36.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.876 -1.056 . . . . 0.14 109.457 -173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.462 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.3 m-85 -126.9 108.96 11.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.632 1.206 . . . . 0.34 109.876 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.753 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.7 pt20 -61.29 120.72 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 112.483 -2.144 . . . . 0.22 112.577 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -124.33 125.94 45.17 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.957 0.903 . . . . 0.23 109.094 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -82.84 -11.03 58.55 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.042 -0.663 . . . . 0.18 111.058 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.077 0.399 . . . . 0.29 112.077 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.5 -19.34 78.94 Favored Glycine 0 CA--C 1.506 -0.492 0 CA-C-N 115.794 -0.639 . . . . 0.14 113.051 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.62 -40.91 24.83 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.154 0.978 . . . . 0.28 108.949 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.827 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -61.17 -41.87 97.54 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.391 -2.077 . . . . 1.29 105.391 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -59.27 -46.74 87.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.157 -1.383 . . . . 0.14 111.17 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -53.76 -48.27 69.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.623 -0.717 . . . . 0.97 109.816 175.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.55 -39.1 92.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.42 -1.264 . . . . 1.32 111.064 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.86 ' HB ' HD11 ' A' ' 7' ' ' LEU . 20.0 mm -65.94 -48.68 81.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.234 -0.439 . . . . 0.14 110.083 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.494 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 59.4 t -58.46 -42.73 85.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.15 109.231 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.36 -29.74 70.09 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.117 -0.947 . . . . 0.39 111.425 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -88.94 -46.6 8.77 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.299 0.481 . . . . 2.42 112.299 -177.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.73 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 46.3 mm-40 -108.45 -35.05 6.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 111.975 0.361 . . . . 0.63 111.975 -176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 45.4 mtp180 63.69 60.39 1.8 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.294 -0.867 . . . . 3.66 109.889 -171.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 32.1 Cg_exo -62.65 146.62 95.31 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 121.376 1.384 . . . . 0.21 110.95 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 m-20 -85.96 -35.24 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.409 -0.916 . . . . 0.98 109.389 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 7.0 mp -113.13 111.11 21.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.26 109.638 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 7' ' ' LEU . 19.0 t -117.34 112.59 39.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.383 -0.372 . . . . 0.21 110.821 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.827 HD22 HD13 ' A' ' 19' ' ' LEU . 3.2 mp -83.59 104.67 13.9 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.957 -0.464 . . . . 0.15 110.496 -176.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.777 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 8.1 mp -99.04 102.52 14.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.516 -0.311 . . . . 1.53 111.824 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.658 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t70 -63.83 111.1 2.31 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.527 -0.469 . . . . 1.47 110.059 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.741 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 17.1 mtm -91.37 12.38 20.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.234 -0.439 . . . . 0.94 111.013 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.658 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 14.2 mmmm -70.61 -65.91 0.67 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.782 0.289 . . . . 2.24 111.782 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.995 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 2.3 pt -160.72 -39.5 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.908 1.077 . . . . 2.06 113.908 -169.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -21.2 -60.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 124.905 3.737 . . . . 0.45 116.928 -175.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.68 -66.64 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.651 -1.262 . . . . 0.47 113.0 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 49.5 ttm -139.69 164.14 30.73 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 2.23 109.414 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.463 ' O ' HG13 ' A' ' 65' ' ' ILE . 2.7 m-20 -61.06 134.67 57.31 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.75 -0.463 . . . . 0.67 109.75 174.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -62.01 -15.23 49.08 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 115.451 -0.795 . . . . 0.32 112.378 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.611 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 9.6 mt -78.3 -44.25 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.061 -0.67 . . . . 1.31 109.836 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.58 -33.56 74.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.351 0.596 . . . . 0.47 110.048 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 53' ' ' LEU . 31.9 mt -74.16 -39.38 49.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.69 110.453 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 2.9 pp -65.92 -36.8 84.37 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 120.187 -0.605 . . . . 1.47 109.951 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.1 ptpt -75.42 -36.08 60.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 120.491 -0.483 . . . . 0.65 111.391 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 11.2 ptm180 -64.87 -36.86 85.7 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 119.497 -0.881 . . . . 2.18 111.144 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.79 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.4 ptp -82.46 -14.12 55.6 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.102 -0.639 . . . . 1.28 109.618 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -70.45 -40.02 73.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.089 -1.078 . . . . 1.3 108.089 167.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 67' ' ' LYS . 94.0 t -62.54 -38.58 81.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.453 -0.794 . . . . 1.03 110.125 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.79 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.1 pt -86.47 -19.03 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.525 -0.47 . . . . 0.26 111.074 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.96 86.12 0.42 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.484 0.55 . . . . 1.08 112.484 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.586 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.1 mt-10 -70.53 1.34 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.046 -1.034 . . . . 1.78 110.646 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -30.43 64.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.596 1.189 . . . . 0.35 108.05 171.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.783 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.9 tt -69.24 161.54 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.636 -2.075 . . . . 0.21 111.482 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -141.56 174.72 10.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.849 -1.069 . . . . 1.08 108.649 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 98' ' ' ALA . 10.1 m -141.54 143.4 27.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.55 0.69 . . . . 0.79 111.273 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.625 HG23 ' OG1' ' A' ' 100' ' ' THR . 4.2 mp -108.79 75.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.581 -1.266 . . . . 0.6 107.581 174.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.741 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -69.51 141.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 119.363 -0.935 . . . . 0.14 112.016 -172.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.596 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 27.8 mtt -95.23 136.78 35.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.22 -0.9 . . . . 1.88 110.335 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.533 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.7 t -132.83 158.12 43.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.117 0.784 . . . . 1.13 113.117 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . . . -72.71 64.16 0.64 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.544 -1.207 . . . . 0.54 109.654 169.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 70.15 15.06 7.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.235 -0.893 . . . . 4.3 112.32 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.28 92.03 1.07 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.58 -0.819 . . . . 0.62 111.412 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.566 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.4 mt-10 -88.03 7.25 32.15 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 122.927 0.491 . . . . 1.33 111.644 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 59.9 -175.11 0.11 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.47 -0.786 . . . . 1.73 112.813 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.86 -93.34 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.083 -0.962 . . . . 1.38 112.324 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.533 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.8 ptt? -61.2 -24.11 66.09 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.137 0.494 . . . . 2.72 110.332 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.1 mm -66.01 -47.38 85.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 0.67 109.952 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 14.1 mm100 -61.64 -50.23 73.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.39 -0.823 . . . . 2.5 109.647 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 13.3 tt0 -63.59 -33.44 75.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.041 -0.981 . . . . 1.27 112.431 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -59.13 -63.7 1.21 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.662 0.268 . . . . 1.28 110.631 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.9 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 20.6 pttt -55.83 -40.18 72.45 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.433 0.635 . . . . 1.91 110.871 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 6.8 tp10 -54.52 -35.59 63.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 1.84 111.51 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.416 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 18.1 tp -90.19 -10.86 42.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.723 0.268 . . . . 1.25 111.723 -173.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.554 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 154.86 -12.13 0.45 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.76 -1.21 . . . . 0.35 113.644 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.9 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -73.99 145.59 44.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.292 0.546 . . . . 0.21 110.784 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 77' ' ' ARG . 16.7 mt -87.86 -50.37 6.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.501 0.667 . . . . 0.18 109.797 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.625 ' OG1' HG23 ' A' ' 79' ' ' ILE . 52.3 p -143.26 160.44 40.48 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.263 -1.335 . . . . 0.19 111.433 -170.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -109.98 98.22 7.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.846 -1.07 . . . . 0.52 110.081 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HD2' HD12 ' A' ' 111' ' ' ILE . 43.7 t80 -68.29 124.86 24.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.611 -0.722 . . . . 3.86 109.954 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.07 178.0 5.28 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.769 -0.372 . . . . 0.76 110.463 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 94.2 mttt -53.37 -47.16 97.15 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.501 0.556 . . . . 3.35 112.501 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 57.5 Cg_endo -73.27 97.49 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 120.86 1.04 . . . . 1.36 111.593 173.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.411 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 40.5 p90 -133.37 138.22 46.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.968 -0.56 . . . . 1.1 110.727 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.645 ' O ' HG22 ' A' ' 108' ' ' ILE . 8.0 t70 -72.82 -4.99 35.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.895 -0.593 . . . . 1.77 111.078 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 107' ' ' ASP . 6.3 tt 59.41 -56.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.856 1.262 . . . . 1.39 110.598 -165.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.96 -38.86 92.77 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 110.26 -0.274 . . . . 1.16 110.26 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.583 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 pt-20 -61.19 -27.92 68.77 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.695 -0.402 . . . . 0.84 110.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.611 HD12 ' HD2' ' A' ' 102' ' ' PHE . 4.7 mm -77.43 -50.91 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.354 -0.61 . . . . 0.74 109.354 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.625 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -66.87 -36.43 82.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.563 0.697 . . . . 0.72 109.697 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.526 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 35.0 t70 -69.56 -42.45 74.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.635 -0.711 . . . . 0.78 109.088 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.88 -40.74 98.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.525 -0.761 . . . . 0.59 110.978 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 112' ' ' ARG . 33.0 m -63.83 -53.38 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 119.15 -1.02 . . . . 0.47 110.952 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -69.68 -16.85 63.43 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.343 0.497 . . . . 1.16 112.343 -178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 18.6 ptpt -83.64 -26.89 29.54 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.29 -0.881 . . . . 1.48 111.041 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -81.42 -59.39 2.64 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.996 0.427 . . . . 2.21 109.955 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 44.2 tp -120.55 107.83 38.24 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.368 -0.975 . . . . 2.09 108.368 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.54 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 91.2 Cg_endo -100.86 146.97 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.893 2.395 . . . . 0.92 114.683 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.099 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 16.4 tp -116.08 -67.56 0.99 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.474 -0.785 . . . . 1.25 110.536 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 1.099 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 67.9 mttm -134.12 -42.05 0.81 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.888 -1.051 . . . . 2.78 111.211 -169.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 m -36.85 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.385 1.053 . . . . 2.17 110.311 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -105.71 141.3 37.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.334 -0.848 . . . . 5.26 112.524 -161.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.42 10.77 4.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.353 -0.839 . . . . 5.75 109.698 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -167.97 115.61 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.64 -0.709 . . . . 8.65 109.737 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -90.7 -52.91 4.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.118 0.485 . . . . 9.73 109.998 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -115.14 -77.12 0.57 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.589 -0.732 . . . . 12.67 109.203 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -135.66 156.44 48.84 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.52 -0.919 . . . . 12.92 108.52 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -75.02 123.77 25.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.209 -0.663 . . . . 16.51 109.209 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -79.44 98.28 6.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.767 0.794 . . . . 17.15 110.484 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.103 -0.953 . . . . 19.6 109.051 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.24 -0.281 . . . . 6.07 110.24 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.717 ' HB2' HD11 ' A' ' 119' ' ' LEU . 2.0 mpt? 52.43 -167.01 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.426 0.631 . . . . 3.88 112.06 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -112.36 -6.37 14.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.644 -0.707 . . . . 2.35 109.316 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.809 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 7.3 tt0 68.14 92.36 0.08 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.096 0.95 . . . . 2.3 111.612 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.853 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -131.28 152.41 50.57 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.012 -0.994 . . . . 0.8 110.622 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.836 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.3 mt -142.36 154.25 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.614 0.721 . . . . 0.2 111.645 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.859 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.2 tt -132.11 122.04 24.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.418 -1.326 . . . . 0.17 107.418 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.6 mp -108.71 106.33 20.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.125 -0.63 . . . . 0.22 109.59 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 23.5 t -95.11 71.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 O-C-N 122.97 0.169 . . . . 0.28 110.683 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.836 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.1 m-20 -118.33 135.63 54.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.651 0.262 . . . . 1.82 111.208 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 1.05 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 29.7 t70 -86.69 -27.46 23.71 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.184 -1.043 . . . . 0.51 108.184 171.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.793 ' HB2' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -78.88 73.37 5.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.475 -1.306 . . . . 2.07 107.475 167.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 40.3 p90 -54.13 -17.49 2.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.829 -1.532 . . . . 1.44 113.178 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.5 -63.89 4.87 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.925 -1.27 . . . . 0.38 109.925 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 12' ' ' GLN . 3.0 mt -53.62 -25.28 11.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.869 0.366 . . . . 0.8 111.574 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.868 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 10.2 ttm180 -76.94 -50.24 13.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.308 -0.406 . . . . 0.38 111.081 -171.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.1 pt -74.74 -24.67 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.193 -0.669 . . . . 0.56 109.193 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.7 tp -57.27 -67.76 0.29 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.928 -1.033 . . . . 0.58 109.493 170.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 52' ' ' LEU . 60.5 mt -54.64 -40.88 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 1.23 110.451 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.8 t30 -50.68 -69.25 0.12 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.585 -0.734 . . . . 0.94 110.139 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.3 -39.41 75.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 2.46 111.568 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 18' ' ' LEU . 49.4 t -57.1 -55.69 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 111.999 0.37 . . . . 0.37 111.999 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.694 ' HB2' HG21 ' A' ' 30' ' ' THR . 6.7 m-85 -77.03 -37.73 54.27 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.782 -0.451 . . . . 0.43 109.782 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.823 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 3.6 t30 -49.95 -50.3 47.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.033 0.921 . . . . 0.28 109.189 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.09 -33.68 71.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.343 -1.753 . . . . 3.25 113.06 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.872 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 4.2 mt-10 -68.08 -23.49 64.94 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.307 -0.627 . . . . 1.45 109.307 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.05 -13.32 2.6 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.66 -1.155 . . . . 0.44 110.569 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.823 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 6.7 m-85 -72.65 134.25 45.02 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.612 0.72 . . . . 1.07 111.557 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.853 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 19.2 mt-30 -88.61 80.95 7.19 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.212 -1.033 . . . . 1.14 108.212 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.836 HG22 ' HB ' ' A' ' 6' ' ' ILE . 17.2 p -90.25 137.32 32.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.808 -0.633 . . . . 0.14 110.026 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.584 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 38.1 m-85 -129.78 126.09 37.32 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.677 1.227 . . . . 0.34 110.272 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.868 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 5.8 pt20 -85.28 121.13 27.57 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.639 -2.073 . . . . 0.22 111.93 -171.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -121.47 137.12 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.89 . . . . 0.23 108.894 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 58' ' ' PRO . . . -93.06 -10.72 35.09 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.778 -0.369 . . . . 0.18 110.42 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.0 165.8 30.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.29 111.444 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -71.94 -16.3 76.47 Favored Glycine 0 CA--C 1.504 -0.611 0 CA-C-N 115.747 -0.66 . . . . 0.14 113.467 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.31 -43.73 18.68 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.679 1.228 . . . . 0.28 108.038 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.8 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 tp-100 -60.33 -41.11 92.87 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.114 -2.312 . . . . 1.29 105.49 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.78 -44.23 90.66 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.699 -1.591 . . . . 0.14 111.079 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.581 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.3 OUTLIER -55.5 -42.63 74.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.401 -0.592 . . . . 0.97 109.401 175.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 14.7 m-20 -64.65 -41.79 95.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.108 -0.951 . . . . 1.32 110.906 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.859 ' HB ' HD11 ' A' ' 7' ' ' LEU . 9.9 mm -61.04 -50.11 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 121.015 -0.274 . . . . 0.14 110.748 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -59.04 -45.33 92.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-O 121.817 0.817 . . . . 0.15 109.45 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.581 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -59.87 -28.91 67.94 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.868 -1.06 . . . . 0.39 111.783 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -96.04 -46.66 6.41 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.966 -0.561 . . . . 2.42 111.848 -173.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 60.8 mm-40 -105.07 -36.52 7.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.733 0.271 . . . . 0.63 111.733 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 64.58 65.96 1.0 Allowed Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.776 0.672 . . . . 3.66 109.929 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.808 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 76.9 Cg_exo -58.97 161.42 15.75 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.803 1.669 . . . . 0.21 112.118 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.784 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.7 m-20 -94.63 -40.04 10.03 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.195 -1.039 . . . . 0.98 108.195 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mp -116.91 118.6 32.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.255 -0.884 . . . . 0.26 109.876 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 7' ' ' LEU . 96.7 t -118.06 112.02 36.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.122 0.487 . . . . 0.21 110.871 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -82.9 98.5 9.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.46 0.647 . . . . 0.15 109.544 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.677 HD12 ' HA2' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -88.18 99.71 12.41 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.972 -1.013 . . . . 1.53 111.007 -175.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 23.2 t0 -68.23 100.8 1.08 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.351 -0.611 . . . . 1.47 109.351 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.782 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 44.9 mtp -77.03 -5.9 50.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.041 -0.527 . . . . 0.94 110.95 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.2 mmmm -50.63 -54.64 21.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.267 0.84 . . . . 2.24 113.267 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.864 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 10.4 tp -177.48 -11.09 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 114.974 1.472 . . . . 2.06 114.974 -171.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.05 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -32.09 -51.04 0.33 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.991 2.461 . . . . 0.45 115.723 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.36 -43.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.913 -1.137 . . . . 0.47 112.739 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.8 tpt -147.81 167.23 25.27 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.816 -0.809 . . . . 2.23 108.816 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.23 139.1 57.29 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.247 0.546 . . . . 0.67 110.308 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.677 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -60.53 -15.06 38.04 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.984 -1.007 . . . . 0.32 112.49 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.829 HG13 ' HB3' ' A' ' 89' ' ' MET . 3.7 mm -79.85 -47.64 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.736 0.303 . . . . 1.31 110.311 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -61.43 -36.72 81.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.657 0.741 . . . . 0.47 109.216 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 68.1 mt -72.73 -36.93 54.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.137 -0.938 . . . . 0.69 111.225 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.624 ' CD2' ' HA ' ' A' ' 63' ' ' ILE . 2.2 pp -70.65 -37.44 73.73 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.289 -0.564 . . . . 1.47 110.715 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.663 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.1 ptpt -73.06 -34.57 66.36 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.526 -0.469 . . . . 0.65 110.964 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.702 ' O ' HG12 ' A' ' 71' ' ' VAL . 12.0 ptm180 -65.5 -34.68 78.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.436 -0.905 . . . . 2.18 111.29 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.685 ' HA ' HG12 ' A' ' 72' ' ' ILE . 4.7 ptt? -83.66 -12.33 56.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.894 -1.122 . . . . 1.28 109.864 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.6 mptp? -78.81 -35.05 44.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.635 -0.711 . . . . 1.3 110.058 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -73.79 -34.33 40.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.742 -0.663 . . . . 1.03 109.419 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.685 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.0 pt -80.85 -34.77 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.373 -0.83 . . . . 0.26 110.204 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -155.79 90.39 1.22 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.565 0.58 . . . . 1.08 112.565 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.04 4.72 3.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.525 0.679 . . . . 1.78 110.34 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -26.1 63.84 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.488 -1.301 . . . . 0.35 107.488 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.9 tt -77.32 160.43 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 112.706 -2.043 . . . . 0.21 110.919 -172.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.692 ' HE ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -137.63 -179.68 5.89 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.356 -0.838 . . . . 1.08 109.046 173.182 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.614 HG21 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -134.48 153.53 35.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.299 -0.561 . . . . 0.79 110.218 -172.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.635 HG23 ' OG1' ' A' ' 100' ' ' THR . 63.4 mt -130.73 71.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.411 -1.329 . . . . 0.6 107.411 170.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.782 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -68.31 139.61 20.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.257 -0.883 . . . . 0.14 111.849 -172.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 4.8 mtp -99.1 131.62 45.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.044 -0.98 . . . . 1.88 110.445 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 t -133.3 158.52 42.75 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.048 0.758 . . . . 1.13 113.048 -175.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.48 65.66 0.66 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.028 -0.987 . . . . 0.54 109.719 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.515 ' HE1' ' HE2' ' A' ' 104' ' ' LYS . 49.8 m-85 71.44 15.27 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 4.3 112.677 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 90' ' ' ILE . . . 85.51 79.87 1.14 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.332 -0.937 . . . . 0.62 111.522 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 90' ' ' ILE . 6.9 mt-10 -75.86 14.96 0.58 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.817 0.847 . . . . 1.33 111.693 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 27.6 mt 59.36 -170.48 0.13 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.62 0.97 . . . . 1.73 113.62 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 58.74 -94.6 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.801 -1.09 . . . . 1.38 110.885 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.829 ' HB3' HG13 ' A' ' 63' ' ' ILE . 3.1 mpp? -64.36 -19.66 65.62 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.943 0.402 . . . . 2.72 110.368 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 86' ' ' GLU . 41.6 mm -75.88 -23.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.601 0.715 . . . . 0.67 110.592 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 91' ' ' GLN . 10.6 mt-30 -82.37 -48.58 10.98 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.029 -1.1 . . . . 2.5 108.029 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 89' ' ' MET . 38.8 tt0 -63.48 -30.54 71.65 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 113.708 -1.587 . . . . 1.27 112.149 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.632 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 16.8 p -53.66 -77.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.094 0.95 . . . . 1.28 112.245 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 13.1 ptpt -51.0 -41.0 59.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.506 -1.679 . . . . 1.91 110.79 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 4.6 tp10 -54.58 -44.82 73.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.387 -0.824 . . . . 1.84 111.612 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.62 HD23 HD11 ' A' ' 66' ' ' LEU . 12.4 tp -82.68 -15.94 50.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 1.25 111.778 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.527 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 149.41 1.67 0.37 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.672 -1.251 . . . . 0.35 113.954 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 94' ' ' LYS . . . -80.64 137.54 36.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.992 0.896 . . . . 0.21 109.769 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.5 mt -76.3 -48.59 19.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.87 0.843 . . . . 0.18 109.411 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.635 ' OG1' HG23 ' A' ' 79' ' ' ILE . 41.1 p -139.29 150.77 45.82 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.368 -1.287 . . . . 0.19 111.955 -171.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -114.54 67.74 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.04 -0.982 . . . . 0.52 109.735 173.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 81' ' ' MET . 39.1 m-85 -62.18 130.31 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 3.86 110.543 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.16 -167.1 1.36 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.058 -0.519 . . . . 0.76 110.823 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HE2' ' HE1' ' A' ' 84' ' ' TYR . 46.1 mtmt -55.59 -43.08 98.98 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.226 -0.443 . . . . 3.35 112.064 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 44.1 Cg_endo -70.5 97.26 0.69 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 120.816 1.011 . . . . 1.36 111.218 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB2' HD11 ' A' ' 111' ' ' ILE . 45.1 p90 -131.7 136.71 47.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.732 -0.667 . . . . 1.1 110.049 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.7 t70 -84.73 14.38 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 1.77 111.04 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.2 tt 50.45 -64.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 125.095 1.497 . . . . 1.39 112.315 -171.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.8 OUTLIER -65.36 -23.87 67.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.815 -0.175 . . . . 1.16 110.66 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' OE2' ' HB2' ' A' ' 107' ' ' ASP . 8.9 pt-20 -68.5 -28.2 66.81 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.4 -0.52 . . . . 0.84 110.421 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' A' ' 106' ' ' PHE . 28.3 mt -81.21 -40.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.74 110.256 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.672 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.04 -37.1 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.843 0.83 . . . . 0.72 109.577 174.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.524 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 4.7 t70 -68.44 -37.02 79.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.379 -0.828 . . . . 0.78 109.359 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.506 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.98 -47.66 82.21 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.323 -0.853 . . . . 0.59 111.224 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.638 HG12 HD22 ' A' ' 50' ' ' LEU . 17.8 m -62.82 -48.77 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 119.209 -0.996 . . . . 0.47 110.377 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 3.6 ttpp -53.98 -50.33 66.79 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.145 0.578 . . . . 1.16 112.237 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 19.1 ptpt -60.21 -35.54 75.66 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.778 -0.576 . . . . 1.48 111.462 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.497 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 24.6 m-85 -76.07 -56.4 4.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.993 0.425 . . . . 2.21 110.836 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 2' ' ' MET . 55.9 tp -127.47 97.53 30.8 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.925 -0.58 . . . . 2.09 109.686 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -98.58 117.29 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.83 2.354 . . . . 0.92 113.215 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.895 HD22 ' HE3' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -90.36 -61.47 1.67 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.138 0.97 . . . . 1.25 109.409 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.895 ' HE3' HD22 ' A' ' 121' ' ' LEU . 32.3 mmtp -127.62 -41.98 1.65 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.465 -1.698 . . . . 2.78 109.923 -172.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.872 ' HB2' ' HB3' ' A' ' 26' ' ' GLU . 9.0 t -53.13 179.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.524 -1.216 . . . . 2.17 112.715 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.609 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 7.1 t30 90.54 -29.85 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.105 1.362 . . . . 5.26 109.683 -172.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.84 95.16 9.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.094 -0.706 . . . . 5.75 109.094 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -78.59 99.73 6.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.03 -0.532 . . . . 8.65 110.339 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -86.29 166.52 15.59 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.888 -0.596 . . . . 9.73 110.189 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -130.91 -75.77 0.53 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.894 -0.322 . . . . 12.67 110.615 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.0 m170 61.25 -89.19 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.56 0.538 . . . . 12.92 111.448 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -169.15 91.03 0.23 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.394 -0.965 . . . . 16.51 108.394 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -146.59 122.4 10.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.027 0.441 . . . . 17.15 111.141 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.2 m80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.008 -0.996 . . . . 19.6 109.742 175.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.828 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 13.8 tt0 . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.545 0.688 . . . . 2.3 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.915 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.7 tppt? -134.74 145.15 48.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.108 0.48 . . . . 0.8 111.533 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.918 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.7 mt -136.7 156.41 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.305 -0.861 . . . . 0.2 111.454 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.862 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.1 tt -133.48 120.16 20.5 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.656 -1.239 . . . . 0.17 107.656 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.724 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.8 mp -107.48 103.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.474 -0.89 . . . . 0.22 110.385 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 28.9 t -88.7 82.62 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 110.051 -0.351 . . . . 0.28 110.051 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.859 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 51.8 t0 -133.5 138.92 46.36 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.115 -0.328 . . . . 1.82 110.115 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 1.013 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 37.0 t70 -85.82 -27.83 24.87 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.022 -0.732 . . . . 0.51 109.022 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' CB ' HD12 ' A' ' 15' ' ' ILE . 9.5 mm-40 -78.86 73.47 5.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.51 -1.293 . . . . 2.07 107.51 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 41.8 p90 -48.47 -19.67 0.34 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.511 -1.222 . . . . 1.44 113.271 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.03 -69.71 1.19 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.36 -1.096 . . . . 0.38 110.36 167.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.553 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 2.9 mp -51.03 -26.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 122.916 0.486 . . . . 0.8 111.863 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.94 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 9.0 ttm180 -76.96 -46.53 23.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.312 -0.404 . . . . 0.38 110.73 -172.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.49 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 36.3 pt -77.03 -25.45 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.283 -0.636 . . . . 0.56 109.283 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.5 tp -53.9 -66.19 0.44 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.135 -0.939 . . . . 0.58 109.157 169.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 64.5 mt -57.25 -39.95 76.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 1.23 110.57 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.72 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.5 t30 -51.53 -67.87 0.22 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.94 110.042 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -39.59 77.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.313 0.486 . . . . 2.46 112.313 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' LEU . 39.5 t -55.18 -58.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.787 0.292 . . . . 0.37 111.787 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.677 ' HB2' HG21 ' A' ' 30' ' ' THR . 8.2 m-85 -73.74 -35.13 65.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.287 -0.635 . . . . 0.43 109.287 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.932 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.3 t-20 -50.48 -47.93 56.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.06 -0.973 . . . . 0.28 108.668 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -57.68 -42.2 83.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.315 -1.766 . . . . 3.25 111.938 -178.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 23' ' ' PHE . 3.2 mt-10 -58.62 -26.82 64.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.809 0.814 . . . . 1.45 109.719 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.682 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 139.09 -10.61 3.32 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 114.193 -1.367 . . . . 0.44 110.295 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.932 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 1.8 m-85 -71.62 124.03 23.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 120.119 -0.632 . . . . 1.07 110.838 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.915 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -79.12 82.99 5.23 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.26 -1.015 . . . . 1.14 108.26 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.918 HG22 ' HB ' ' A' ' 6' ' ' ILE . 20.6 p -91.04 134.02 34.84 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.973 -0.558 . . . . 0.14 110.493 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 12.9 m-85 -125.48 120.76 31.83 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.57 1.176 . . . . 0.34 109.419 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.94 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 5.2 pt20 -81.18 121.72 26.48 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 112.736 -2.029 . . . . 0.22 111.693 -173.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.919 ' HB1' ' HB3' ' A' ' 38' ' ' GLN . . . -122.14 131.3 53.89 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.696 0.799 . . . . 0.23 109.145 176.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.569 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -91.16 -7.17 52.25 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.983 -0.687 . . . . 0.18 110.897 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.557 HD22 ' HB2' ' A' ' 37' ' ' LEU . 2.4 p-10 -147.73 165.5 30.33 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.42 -0.512 . . . . 0.29 111.699 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -23.16 73.13 Favored Glycine 0 CA--C 1.507 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.14 113.118 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.557 ' HB2' HD22 ' A' ' 35' ' ' ASN . 2.9 mm? -76.54 -39.87 51.6 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.725 -0.843 . . . . 0.28 108.725 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.919 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -60.51 -44.88 95.55 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.091 -2.189 . . . . 1.29 105.091 177.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -61.14 -44.43 97.34 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.14 111.252 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.61 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -55.83 -44.82 78.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.461 0.648 . . . . 0.97 109.473 175.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -61.59 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.666 -1.152 . . . . 1.32 110.32 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.841 HG12 ' O ' ' A' ' 38' ' ' GLN . 8.5 mm -63.69 -47.35 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 120.551 0.215 . . . . 0.14 111.418 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 69' ' ' MET . 41.2 t -59.88 -42.43 89.16 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.678 0 CA-C-O 121.486 0.66 . . . . 0.15 109.506 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -72.31 -22.15 61.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.562 -0.745 . . . . 0.39 111.197 -177.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.83 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 2.1 ptmt -89.82 -44.89 9.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 2.42 111.225 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' HE3' ' A' ' 5' ' ' LYS . 60.6 mm-40 -111.14 -35.71 5.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 111.897 0.332 . . . . 0.63 111.897 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 43' ' ' VAL . 37.6 mmt180 69.01 59.83 0.62 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 123.936 0.772 . . . . 3.66 109.123 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' ILE . 52.4 Cg_exo -61.23 153.74 63.01 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 121.457 1.438 . . . . 0.21 111.222 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.3 m-20 -92.69 -34.1 14.09 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.713 -0.795 . . . . 0.98 109.415 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 79' ' ' ILE . 7.8 mp -118.57 113.33 21.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.013 -0.54 . . . . 0.26 110.214 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 7' ' ' LEU . 46.9 t -113.26 112.19 39.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.017 0.437 . . . . 0.21 111.665 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.44 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 2.9 mp -82.06 94.28 7.17 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.277 0.56 . . . . 0.15 110.389 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.682 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -83.04 98.8 9.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.18 -0.918 . . . . 1.53 111.635 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.63 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 35.6 t70 -70.98 103.91 2.82 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.426 -0.91 . . . . 1.47 109.156 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.624 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 19.9 mtm -80.29 -1.07 39.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.015 -0.539 . . . . 0.94 110.772 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.561 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 12.6 mmmm -56.9 -67.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.724 1.009 . . . . 2.24 113.724 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.859 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 4.6 pt -152.91 -22.87 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.638 1.347 . . . . 2.06 114.638 -167.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.013 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -33.62 -48.12 0.46 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.356 2.704 . . . . 0.45 115.564 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 -48.36 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.551 -1.309 . . . . 0.47 113.077 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.418 ' HG2' ' N ' ' A' ' 61' ' ' ASP . 58.1 ttm -143.35 163.35 33.28 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.113 -0.699 . . . . 2.23 109.113 -175.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 60' ' ' MET . 35.3 m-20 -61.15 136.57 58.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.094 0.473 . . . . 0.67 109.961 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 53' ' ' LEU . . . -63.65 -9.93 34.83 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.309 -0.948 . . . . 0.32 112.157 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.927 HD11 ' HB3' ' A' ' 89' ' ' MET . 4.7 mt -73.33 -52.64 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.123 0.487 . . . . 1.31 110.067 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.81 -33.21 75.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.749 0.785 . . . . 0.47 109.231 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 49.7 mt -74.82 -37.7 42.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.177 -0.92 . . . . 0.69 110.912 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 3.1 pp -66.96 -36.2 81.67 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.414 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.707 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.9 ptpt -75.84 -34.63 60.09 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.453 -0.499 . . . . 0.65 111.175 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.729 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.1 ptm180 -66.78 -33.49 75.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.559 -0.857 . . . . 2.18 111.054 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.761 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.8 ptp -82.8 -13.69 55.76 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.561 -0.856 . . . . 1.28 109.889 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.3 mptp? -79.12 -29.83 43.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.572 0.701 . . . . 1.3 109.877 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.4 p -78.47 -34.98 18.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.028 -0.73 . . . . 1.03 109.028 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.761 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -81.14 -28.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 0.26 109.98 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -157.94 88.93 0.98 Allowed 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 112.928 0.714 . . . . 1.08 112.928 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.0 1.73 10.28 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.047 -1.033 . . . . 1.78 109.831 175.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -27.29 63.86 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.796 1.284 . . . . 0.35 107.722 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.69 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.2 tt -74.25 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 112.492 -2.14 . . . . 0.21 110.938 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 3.4 ptp180 -139.21 174.32 10.64 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.981 -1.118 . . . . 1.08 107.981 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.696 HG23 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -138.97 148.32 24.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.618 0.723 . . . . 0.79 111.47 -173.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.694 HG23 ' OG1' ' A' ' 100' ' ' THR . 63.3 mt -119.72 72.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.961 -1.126 . . . . 0.6 107.961 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.642 HG22 ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -68.65 141.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.318 -0.856 . . . . 0.14 111.768 -172.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.555 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 4.0 mtm -102.05 135.22 44.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.012 -0.995 . . . . 1.88 110.595 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 t -133.4 161.59 34.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.493 0.663 . . . . 1.13 112.672 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . . . -74.1 52.74 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.99 -1.005 . . . . 0.54 110.593 169.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.406 ' HA ' ' CB ' ' A' ' 103' ' ' ALA . 22.4 t80 72.84 30.86 1.67 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.974 -1.012 . . . . 4.3 112.085 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.87 76.53 1.23 Allowed Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.885 -0.674 . . . . 0.62 112.892 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.446 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.5 mt-10 -81.06 12.04 3.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.444 -0.878 . . . . 1.33 111.799 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 87' ' ' LEU . 21.2 mt 54.38 -169.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.391 0.886 . . . . 1.73 113.391 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 58.08 -97.62 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.337 -0.847 . . . . 1.38 110.852 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.927 ' HB3' HD11 ' A' ' 63' ' ' ILE . 57.6 mtm -51.52 -37.01 47.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.834 0.854 . . . . 2.72 110.731 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 86' ' ' GLU . 33.0 mm -58.78 -47.67 88.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.67 111.109 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -60.69 -55.05 37.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.451 -0.795 . . . . 2.5 109.51 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HG2' HG21 ' A' ' 63' ' ' ILE . 7.0 tt0 -58.42 -33.57 69.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.853 -1.067 . . . . 1.27 112.085 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.47 ' OG ' HG12 ' A' ' 63' ' ' ILE . 4.9 m -54.08 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.63 0.729 . . . . 1.28 111.8 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.828 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 12.8 ptpt -52.33 -37.35 55.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.837 -1.074 . . . . 1.91 111.004 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 17.7 tp10 -55.98 -37.99 69.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.965 -1.016 . . . . 1.84 112.1 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.9 mt -85.77 -15.09 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.795 0.665 . . . . 1.25 112.795 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.48 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 147.54 4.18 0.39 Allowed Glycine 0 C--N 1.317 -0.519 0 C-N-CA 119.778 -1.201 . . . . 0.35 113.023 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.828 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -79.21 131.69 36.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.263 0.532 . . . . 0.21 109.936 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.513 HD11 ' HG3' ' A' ' 77' ' ' ARG . 11.2 mt -74.39 -49.32 23.06 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.856 0.836 . . . . 0.18 109.734 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.694 ' OG1' HG23 ' A' ' 79' ' ' ILE . 41.3 p -140.14 153.45 46.67 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.0 -1.455 . . . . 0.19 111.756 -170.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -116.96 85.7 2.37 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.871 -1.059 . . . . 0.52 109.215 172.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -76.43 145.66 39.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 3.86 110.579 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 84' ' ' TYR . . . -121.68 -168.43 1.69 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.109 -0.496 . . . . 0.76 112.001 -173.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 45.5 mtpt -52.92 -50.4 81.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.168 -0.924 . . . . 3.35 111.654 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 68.9 Cg_endo -75.46 97.43 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.127 1.218 . . . . 1.36 111.393 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 111' ' ' ILE . 46.9 p90 -129.24 133.45 47.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.822 -0.626 . . . . 1.1 110.208 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.672 ' O ' HG22 ' A' ' 108' ' ' ILE . 7.3 t70 -72.73 -4.27 30.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.916 -0.584 . . . . 1.77 111.413 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.672 HG22 ' O ' ' A' ' 107' ' ' ASP . 3.6 tt 63.06 -54.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.559 1.144 . . . . 1.39 109.882 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.2 -34.98 79.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.576 -0.284 . . . . 1.16 110.516 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.5 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 11.5 pt-20 -65.15 -27.41 68.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.579 -0.449 . . . . 0.84 110.772 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 106' ' ' PHE . 19.3 mt -80.51 -44.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.108 -0.33 . . . . 0.74 110.108 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.482 ' HD2' ' C ' ' A' ' 112' ' ' ARG . 2.4 ppt_? -69.73 -35.47 75.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.776 0.798 . . . . 0.72 109.423 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.0 t70 -63.77 -42.63 97.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.695 -0.854 . . . . 0.78 108.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.973 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -60.29 -48.79 80.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.857 -1.065 . . . . 0.59 111.462 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 112' ' ' ARG . 35.5 m -61.3 -43.06 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.912 -0.715 . . . . 0.47 111.004 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 8.3 ttpt -58.06 -55.96 28.18 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 120.909 0.385 . . . . 1.16 111.151 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.973 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 46.1 pttt -65.68 -13.15 58.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.516 0.562 . . . . 1.48 112.516 -176.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -92.01 -41.2 10.67 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.583 -0.447 . . . . 2.21 111.443 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -146.6 95.96 4.51 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.331 -0.988 . . . . 2.09 108.331 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -96.4 123.74 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.815 2.344 . . . . 0.92 114.182 -171.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 4' ' ' GLU . 12.7 tp . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.356 0.598 . . . . 1.25 110.076 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.854 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 120.701 0.286 . . . . 2.3 110.848 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.632 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 4.0 tppt? -134.6 140.44 46.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.016 0.436 . . . . 0.8 112.06 -173.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.891 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.9 mt -137.0 155.84 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.276 -0.874 . . . . 0.2 112.061 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.863 ' HG ' HG21 ' A' ' 42' ' ' ILE . 3.4 tt -133.86 118.35 17.87 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 107.934 -1.136 . . . . 0.17 107.934 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -105.72 102.98 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.886 -0.725 . . . . 0.22 110.211 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 44.3 t -89.38 79.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 122.967 0.167 . . . . 0.28 110.68 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.827 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.3 t70 -129.97 140.84 50.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 1.82 110.817 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.812 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 26.9 t70 -94.81 -32.91 13.07 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.501 -0.318 . . . . 0.51 111.048 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 70.07 8.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.497 -1.297 . . . . 2.07 107.497 173.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.441 ' O ' HG12 ' A' ' 17' ' ' ILE . 41.1 p90 -47.94 -16.08 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 111.862 -2.426 . . . . 1.44 115.342 -166.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.49 -61.62 6.18 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.751 -1.339 . . . . 0.38 109.751 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 3.1 mt -54.92 -29.34 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.224 0.535 . . . . 0.8 111.136 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.869 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -77.58 -48.67 16.36 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.772 -0.649 . . . . 0.38 111.055 -168.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 41.5 pt -75.71 -25.06 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.247 -0.649 . . . . 0.56 109.247 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.2 tp -58.64 -66.28 0.52 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.251 -0.886 . . . . 0.58 109.699 170.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 80.3 mt -53.83 -43.71 69.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.075 -0.343 . . . . 1.23 110.075 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.1 t30 -50.31 -66.1 0.45 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.261 -0.881 . . . . 0.94 110.079 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.81 -39.84 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.888 0.742 . . . . 2.46 110.75 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -54.86 -60.1 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.52 -0.309 . . . . 0.37 111.423 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.655 ' HB2' HG21 ' A' ' 30' ' ' THR . 2.0 m-85 -70.95 -39.99 72.26 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.016 -0.735 . . . . 0.43 109.016 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.627 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.2 t-20 -52.26 -52.69 51.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.895 -1.048 . . . . 0.28 109.333 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 2.8 tmmm? -60.87 -43.13 98.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.722 -1.581 . . . . 3.25 111.93 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.516 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 10.9 pt-20 -81.92 13.15 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 1.45 111.193 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.02 3.03 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.369 -0.92 . . . . 0.44 113.427 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.854 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 7.8 m-85 -77.76 150.25 34.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.926 0.869 . . . . 1.07 112.511 -165.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.632 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -98.01 82.15 2.94 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.91 -1.041 . . . . 1.14 108.336 166.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.891 HG22 ' HB ' ' A' ' 6' ' ' ILE . 19.3 p -92.52 138.59 31.37 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.659 -0.7 . . . . 0.14 109.883 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 10.5 m-85 -128.55 107.55 9.8 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.869 1.319 . . . . 0.34 110.299 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.869 ' HB2' HH11 ' A' ' 16' ' ' ARG . 5.3 pt20 -59.53 121.11 10.72 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 112.035 -2.348 . . . . 0.22 112.516 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.721 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -124.94 129.7 50.88 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 108.89 -0.781 . . . . 0.23 108.89 174.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.731 ' HB2' HH21 ' A' ' 16' ' ' ARG . . . -90.4 -9.65 46.78 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.07 -0.652 . . . . 0.18 110.831 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 3.4 p-10 -148.39 164.48 33.98 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.038 -0.528 . . . . 0.29 111.736 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 65' ' ' ILE . . . -69.42 -22.14 76.3 Favored Glycine 0 CA--C 1.504 -0.597 0 CA-C-N 115.254 -0.885 . . . . 0.14 113.745 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.36 -41.57 21.79 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 122.216 1.008 . . . . 0.28 108.946 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.808 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.1 tp60 -60.53 -39.67 88.7 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.584 -2.006 . . . . 1.29 105.584 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.57 88.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.132 -1.395 . . . . 0.14 111.281 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.547 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -56.41 -47.87 78.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.38 -0.827 . . . . 0.97 109.728 176.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -63.83 -36.0 82.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.326 -1.306 . . . . 1.32 111.317 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.863 HG21 ' HG ' ' A' ' 7' ' ' LEU . 26.7 mm -65.47 -49.47 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.277 -0.268 . . . . 0.14 110.277 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.7 t -58.68 -43.14 86.97 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.265 1.031 . . . . 0.15 108.835 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -58.13 -30.9 66.69 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.361 -1.291 . . . . 0.39 111.702 177.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.546 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 5.7 tptt -90.57 -50.48 5.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.064 -0.517 . . . . 2.42 111.511 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.578 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 58.1 mm-40 -106.1 -35.95 7.07 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.583 0.586 . . . . 0.63 112.583 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 43.6 mtt180 62.93 65.02 1.44 Allowed Pre-proline 0 C--N 1.322 -0.589 0 O-C-N 123.673 0.608 . . . . 3.66 110.323 -170.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.76 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 66.4 Cg_exo -60.32 163.48 14.77 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.116 1.877 . . . . 0.21 111.635 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.781 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.8 m-20 -92.6 -44.48 8.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.973 -0.751 . . . . 0.98 108.973 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.762 HD23 HD11 ' A' ' 79' ' ' ILE . 7.6 mp -107.29 110.4 22.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.26 110.014 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 7' ' ' LEU . 62.6 t -110.16 107.35 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.453 . . . . 0.21 111.197 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 3.1 mp -78.51 95.93 5.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.432 0.634 . . . . 0.15 110.032 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.63 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -85.65 92.83 8.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.951 -1.022 . . . . 1.53 110.2 -176.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.673 ' OD1' ' HG2' ' A' ' 56' ' ' LYS . 34.6 t70 -68.59 108.82 3.49 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.75 0.786 . . . . 1.47 109.739 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.632 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 20.8 mtm -93.48 16.89 12.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.226 -0.897 . . . . 0.94 110.244 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.673 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 2.9 mmpp? -54.09 -53.43 53.27 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 120.075 -0.65 . . . . 2.24 110.445 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.932 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.5 tt -179.83 -19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.563 -1.208 . . . . 2.06 114.209 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.932 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -26.81 -54.43 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.465 2.777 . . . . 0.45 116.014 -175.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.48 -55.65 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.742 -1.218 . . . . 0.47 112.904 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.427 ' HB3' HD11 ' A' ' 65' ' ' ILE . 46.0 tpp -142.25 165.15 28.21 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.35 -0.611 . . . . 2.23 109.35 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.2 m-20 -60.39 140.22 57.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.67 110.785 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.585 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -64.65 -12.48 52.91 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.825 -1.079 . . . . 0.32 112.184 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.635 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 11.9 mt -76.51 -46.72 31.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 1.31 110.149 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -60.07 -43.0 95.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.658 -0.868 . . . . 0.47 108.658 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.626 HD12 ' HA3' ' A' ' 36' ' ' GLY . 16.5 mm -68.6 -43.18 83.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.475 -0.784 . . . . 0.69 111.452 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 96' ' ' LEU . 3.0 pp -62.5 -37.66 86.91 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.718 -0.393 . . . . 1.47 110.236 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.0 ptpt -76.03 -36.37 59.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.125 -0.63 . . . . 0.65 111.827 -176.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HG3' HD23 ' A' ' 40' ' ' LEU . 3.0 ptm180 -67.38 -34.39 77.18 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.819 -1.152 . . . . 2.18 111.004 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.681 ' HG3' HG21 ' A' ' 76' ' ' ILE . 11.8 ptp -78.85 -18.58 53.75 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.018 -0.673 . . . . 1.28 109.725 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.4 mptt -70.95 -40.59 71.91 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.554 -0.906 . . . . 1.3 108.554 169.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 67' ' ' LYS . 92.8 t -61.41 -38.21 79.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.423 -0.808 . . . . 1.03 110.531 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.68 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -83.86 -30.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.377 -0.529 . . . . 0.26 110.325 175.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -156.04 83.48 1.01 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.728 0.64 . . . . 1.08 112.728 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 32.4 mt-10 -69.99 2.56 3.41 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.293 -0.879 . . . . 1.78 111.272 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -28.44 65.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.737 1.256 . . . . 0.35 107.729 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.681 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.8 tt -75.52 158.12 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 112.587 -2.097 . . . . 0.21 111.208 -172.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.781 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -134.19 -178.28 4.97 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.11 -0.95 . . . . 1.08 108.496 175.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.648 HG23 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -143.09 148.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 120.133 -0.627 . . . . 0.79 111.019 -175.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.762 HD11 HD23 ' A' ' 50' ' ' LEU . 64.5 mt -117.87 71.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.725 -1.213 . . . . 0.6 107.725 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.632 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.81 141.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 119.045 -1.062 . . . . 0.14 111.181 -172.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.515 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 22.4 mtp -109.25 111.91 23.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.676 -1.147 . . . . 1.88 110.412 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.708 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 1.2 t -120.55 166.65 13.33 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 122.162 -0.336 . . . . 1.13 111.316 -175.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.37 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.782 -0.644 . . . . 0.54 111.375 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 13.5 t80 59.67 3.66 0.46 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.828 1.251 . . . . 4.3 112.39 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.96 93.18 1.87 Allowed Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.923 -0.656 . . . . 0.62 112.354 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 90' ' ' ILE . 30.9 mt-10 -74.8 11.85 0.97 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 1.33 111.002 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 85' ' ' GLY . 26.4 mt 64.81 -177.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.593 0.96 . . . . 1.73 113.593 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 62.17 -92.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.606 -1.179 . . . . 1.38 111.327 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.503 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 71.0 mtm -64.23 -22.91 67.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 120.925 0.393 . . . . 2.72 110.428 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.582 HG13 ' N ' ' A' ' 86' ' ' GLU . 42.8 mm -67.03 -39.95 84.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.181 0.515 . . . . 0.67 110.012 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.67 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 12.7 mm100 -67.24 -42.29 84.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.264 -0.88 . . . . 2.5 108.996 176.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.628 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 9.4 tt0 -63.16 -39.92 96.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.371 -1.286 . . . . 1.27 112.047 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.425 ' CB ' HG12 ' A' ' 63' ' ' ILE . 8.5 t -55.37 -62.96 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 1.28 110.414 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.958 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 50.3 pttt -56.93 -36.79 70.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.998 -0.546 . . . . 1.91 111.892 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -65.99 -22.97 66.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.081 -0.248 . . . . 1.84 111.545 -178.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.722 ' HB3' HD11 ' A' ' 66' ' ' LEU . 4.4 mp -88.63 -4.98 58.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 1.25 111.495 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.42 16.72 1.84 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.864 -1.16 . . . . 0.35 113.135 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.958 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -89.39 132.01 35.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.121 -0.696 . . . . 0.21 109.121 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.679 HD21 ' HD3' ' A' ' 77' ' ' ARG . 13.9 mt -73.63 -49.07 27.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.807 0.813 . . . . 0.18 109.506 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.668 ' OG1' HG23 ' A' ' 79' ' ' ILE . 70.0 p -141.51 142.8 33.57 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.081 -1.418 . . . . 0.19 111.519 -173.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.31 85.73 2.41 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.811 -1.086 . . . . 0.52 109.457 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 13.3 m-85 -75.1 157.46 34.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 3.86 109.893 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -98.71 -170.71 1.98 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.338 0.496 . . . . 0.76 112.338 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 44.6 tttp -73.19 -45.47 8.03 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.087 -0.708 . . . . 3.35 109.087 172.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 36.1 Cg_endo -68.29 97.89 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.438 1.425 . . . . 1.36 111.026 166.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -112.67 139.32 48.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.488 -0.778 . . . . 1.1 109.65 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -87.56 20.21 3.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 119.238 -0.41 . . . . 1.77 111.306 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 109' ' ' ASP . 2.4 tt 49.18 -66.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 1.39 112.781 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.478 ' H ' HG23 ' A' ' 108' ' ' ILE . 5.6 t70 -64.27 -25.78 68.2 Favored 'General case' 0 C--O 1.212 -0.884 0 O-C-N 122.397 -0.189 . . . . 1.16 110.807 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.59 -27.86 65.46 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 120.425 -0.51 . . . . 0.84 109.765 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -76.65 -47.5 28.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.224 -0.658 . . . . 0.74 109.224 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.38 -39.32 85.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.122 0.487 . . . . 0.72 109.922 179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 24.4 t70 -65.72 -43.34 89.35 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.304 -0.628 . . . . 0.78 109.304 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.943 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.96 -51.05 69.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.666 -0.697 . . . . 0.59 111.124 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 112' ' ' ARG . 27.0 m -59.02 -50.77 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.844 -0.742 . . . . 0.47 111.475 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -65.36 -29.34 70.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.345 0.498 . . . . 1.16 112.345 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.943 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 56.9 pttt -81.52 -11.74 59.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.49 -0.884 . . . . 1.48 111.507 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.6 -58.65 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.175 0.512 . . . . 2.21 110.176 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.512 ' HG ' ' OE1' ' A' ' 4' ' ' GLU . 57.1 tp -122.67 109.77 32.28 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.384 -0.969 . . . . 2.09 108.384 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 47.4 Cg_endo -101.44 148.13 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.773 2.315 . . . . 0.92 114.331 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.766 -0.828 . . . . 1.25 108.766 174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.744 ' CD ' ' HB3' ' A' ' 121' ' ' LEU . 17.5 pt-20 . . . . . 0 N--CA 1.448 -0.575 0 CA-C-O 120.98 0.419 . . . . 2.3 109.991 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.827 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -117.23 144.88 44.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.8 111.812 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.869 ' HB ' HG22 ' A' ' 30' ' ' THR . 3.4 mt -135.02 153.47 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 114.933 -1.031 . . . . 0.2 111.655 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.861 ' HG ' HG21 ' A' ' 42' ' ' ILE . 2.4 tt -129.51 124.95 35.22 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.562 -1.273 . . . . 0.17 107.562 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.745 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.5 mp -112.26 107.57 23.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.124 -0.63 . . . . 0.22 109.963 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.669 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 57.6 t -96.15 89.55 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.103 -0.332 . . . . 0.28 110.103 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.717 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 0.8 OUTLIER -135.42 136.04 41.07 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.118 -0.492 . . . . 1.82 110.215 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.748 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 20.9 t70 -88.91 -41.65 12.3 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.486 0.184 . . . . 0.51 110.768 -177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HG3' ' CD1' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -78.69 70.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.819 -1.178 . . . . 2.07 107.819 172.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.8 p90 -48.09 -13.72 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 111.856 -2.429 . . . . 1.44 115.588 -163.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.08 -57.38 6.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.249 -0.977 . . . . 0.38 110.937 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 2.4 mt -59.94 -25.85 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.477 0.656 . . . . 0.8 110.664 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 1.0 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.5 ttm180 -78.9 -49.24 13.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.38 110.529 -168.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 37.9 pt -75.07 -24.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.219 -0.66 . . . . 0.56 109.219 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.765 HD11 HD11 ' A' ' 108' ' ' ILE . 7.5 tp -58.09 -67.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.947 -1.024 . . . . 0.58 109.827 171.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.575 HD13 HD22 ' A' ' 52' ' ' LEU . 69.8 mt -54.18 -41.15 68.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.179 -0.464 . . . . 1.23 110.08 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.7 t30 -49.94 -70.09 0.1 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.263 -0.88 . . . . 0.94 110.473 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -57.24 -36.9 71.5 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.308 0.38 . . . . 2.46 111.683 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 18' ' ' LEU . 31.1 t -55.92 -55.66 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.592 0.219 . . . . 0.37 111.592 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.717 ' HB2' HG21 ' A' ' 30' ' ' THR . 7.7 m-85 -78.18 -36.73 47.07 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 120.659 -0.416 . . . . 0.43 109.922 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.818 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.8 t-20 -50.27 -45.53 54.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.176 0.989 . . . . 0.28 108.753 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -60.35 -38.44 83.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.09 -1.868 . . . . 3.25 111.9 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' OE2' ' HD3' ' A' ' 112' ' ' ARG . 4.2 mm-40 -55.9 -33.14 64.36 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.297 1.046 . . . . 1.45 109.586 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.79 1.45 3.01 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 113.071 -1.877 . . . . 0.44 109.417 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.818 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 45.4 m-85 -75.37 132.3 40.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.364 0.602 . . . . 1.07 110.666 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.827 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 12.0 mt-30 -86.52 81.38 8.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.79 -1.189 . . . . 1.14 107.79 171.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.869 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.9 p -90.25 132.75 35.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.799 -0.637 . . . . 0.14 110.214 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 20.1 m-85 -124.42 123.75 40.85 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 122.826 1.298 . . . . 0.34 110.13 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 1.0 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.2 pt20 -82.74 121.91 27.49 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.053 -2.339 . . . . 0.22 112.073 -171.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.83 137.42 54.66 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.166 0.987 . . . . 0.23 108.678 174.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.659 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -98.98 -3.81 34.1 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.137 -0.625 . . . . 0.18 110.402 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 5.3 p-10 -148.51 163.7 36.42 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.792 -0.64 . . . . 0.29 111.315 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.17 79.41 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.534 -0.757 . . . . 0.14 113.306 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HB2' HD22 ' A' ' 35' ' ' ASN . 2.9 mm? -80.42 -40.83 25.64 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 122.395 1.093 . . . . 0.28 108.2 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.829 ' O ' HG12 ' A' ' 42' ' ' ILE . 2.6 tp-100 -58.96 -40.42 84.67 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.521 -2.127 . . . . 1.29 105.404 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -65.2 -45.56 84.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.794 -1.548 . . . . 0.14 111.544 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 68' ' ' ARG . 11.7 mt -55.53 -39.31 70.4 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.703 0.763 . . . . 0.97 109.556 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 21.3 t70 -72.3 -38.01 68.83 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.54 -1.209 . . . . 1.32 110.374 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.861 HG21 ' HG ' ' A' ' 7' ' ' LEU . 18.0 mm -58.86 -48.59 85.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 120.685 0.279 . . . . 0.14 110.674 176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 39' ' ' ALA . 24.0 t -61.43 -41.47 90.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.968 0.89 . . . . 0.15 109.723 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -63.23 -28.51 70.09 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.604 -1.18 . . . . 0.39 111.204 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -94.99 -48.53 5.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 2.42 111.766 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 66.7 mm-40 -104.63 -37.05 7.26 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.69 0.256 . . . . 0.63 111.69 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 62.88 67.83 1.05 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.787 -0.642 . . . . 3.66 110.02 -169.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.776 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 45.9 Cg_exo -65.03 154.89 71.18 Favored 'Trans proline' 0 CA--C 1.503 -1.035 0 C-N-CA 121.858 1.705 . . . . 0.21 111.424 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.805 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 8.3 m-20 -89.65 -41.69 11.8 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.723 -0.791 . . . . 0.98 109.013 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.538 HD23 HD11 ' A' ' 79' ' ' ILE . 6.7 mp -108.02 110.05 21.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.211 -0.45 . . . . 0.26 110.166 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.816 ' HB ' HG12 ' A' ' 78' ' ' VAL . 57.9 t -109.95 109.32 27.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.081 0.467 . . . . 0.21 111.584 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -80.5 91.15 5.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.393 0.616 . . . . 0.15 109.772 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.818 HD12 HG11 ' A' ' 78' ' ' VAL . 18.5 mt -89.13 103.13 15.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.298 -0.864 . . . . 1.53 111.079 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.625 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 12.4 t70 -67.06 116.83 8.31 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.128 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.643 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 13.0 mtm -98.14 12.19 35.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.793 -0.64 . . . . 0.94 110.696 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 13.0 mmmm -64.25 -49.32 72.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.662 -0.245 . . . . 2.24 111.368 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.892 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 17.3 tt 174.81 -28.6 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.718 1.377 . . . . 2.06 114.718 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.892 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -18.31 -59.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 124.546 3.497 . . . . 0.45 116.625 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.95 -63.86 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.072 -1.061 . . . . 0.47 112.225 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.5 tpt -148.72 167.02 26.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.577 -0.897 . . . . 2.23 108.577 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.46 135.67 57.74 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.67 0.748 . . . . 0.67 110.563 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -58.44 -18.79 38.14 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 114.239 -1.346 . . . . 0.32 111.751 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.657 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 4.0 mt -66.97 -49.6 72.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.01 0.433 . . . . 1.31 110.571 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.58 -34.65 77.46 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.635 0.731 . . . . 0.47 109.072 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.548 HG22 ' HE3' ' A' ' 69' ' ' MET . 17.0 mt -73.37 -38.57 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.189 -0.914 . . . . 0.69 111.025 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 4.3 pp -67.02 -35.09 79.13 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 121.074 -0.25 . . . . 1.47 110.412 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.2 ptpt -76.23 -33.41 59.2 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.406 -0.517 . . . . 0.65 111.12 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.2 ptp180 -70.49 -29.84 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 118.752 -1.179 . . . . 2.18 111.579 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.837 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.5 ptp -83.98 -13.36 53.52 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.455 -0.898 . . . . 1.28 109.579 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -78.68 -32.87 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.598 -0.728 . . . . 1.3 109.855 172.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -74.34 -36.27 42.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.781 -0.822 . . . . 1.03 108.781 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.837 HG12 ' HA ' ' A' ' 69' ' ' MET . 20.6 pt -80.62 -21.84 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.092 -0.958 . . . . 0.26 110.325 172.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.734 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 29.7 t0 -164.89 95.32 0.7 Allowed 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 112.887 0.699 . . . . 1.08 112.887 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.631 ' OE1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -77.81 6.09 8.22 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.979 -1.076 . . . . 1.78 110.126 174.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.734 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -78.53 -34.0 47.52 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.339 -1.356 . . . . 0.35 107.339 171.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.71 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.0 tt -60.18 159.38 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.185 -1.825 . . . . 0.21 111.685 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.805 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 2.8 ptp180 -142.76 173.83 11.19 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.989 -1.115 . . . . 1.08 107.989 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.818 HG11 HD12 ' A' ' 53' ' ' LEU . 2.3 m -141.79 147.98 21.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.477 -0.889 . . . . 0.79 112.066 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.672 HG23 ' OG1' ' A' ' 100' ' ' THR . 67.1 mt -116.4 72.85 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.57 -1.27 . . . . 0.6 107.57 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.643 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.66 142.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.615 -0.834 . . . . 0.14 112.069 -171.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 10.2 mtt -99.33 124.69 44.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.489 -0.778 . . . . 1.88 110.04 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.58 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t -133.15 160.3 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.998 0.74 . . . . 1.13 112.998 -173.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 63.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.649 -1.16 . . . . 0.54 110.664 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 67.41 5.12 4.09 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.571 0.748 . . . . 4.3 112.418 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.0 88.18 0.75 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.861 -0.685 . . . . 0.62 111.801 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.528 ' N ' HG13 ' A' ' 90' ' ' ILE . 39.7 mt-10 -65.61 -89.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.483 -0.358 . . . . 1.33 111.244 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HG ' ' H ' ' A' ' 88' ' ' ASP . 9.5 tp -177.53 -167.76 0.16 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.69 0.281 . . . . 1.73 111.716 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.722 ' H ' ' HG ' ' A' ' 87' ' ' LEU . 9.3 m-20 43.99 -89.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.857 1.263 . . . . 1.38 113.009 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.641 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 62.7 mtt -56.94 -35.51 69.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.106 -0.497 . . . . 2.72 110.461 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.528 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.6 mm -59.89 -44.76 95.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.81 -0.632 . . . . 0.67 110.278 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.63 -53.53 57.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.559 -0.746 . . . . 2.5 109.385 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 15.8 tt0 -58.9 -34.84 72.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.945 -1.025 . . . . 1.27 112.314 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.4 t -55.34 -69.51 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 1.28 110.89 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 16.6 pttp -55.9 -36.54 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.383 0.611 . . . . 1.91 111.069 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 10.9 tp10 -56.59 -45.37 81.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.864 -1.062 . . . . 1.84 111.99 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.8 mt -70.47 -39.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.38 -0.373 . . . . 1.25 111.16 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.54 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 170.19 15.15 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.818 -1.182 . . . . 0.35 113.52 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.946 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -83.9 128.75 34.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.538 -0.541 . . . . 0.21 109.538 173.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.529 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.6 mt -73.07 -49.44 28.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.891 0.853 . . . . 0.18 109.777 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 79' ' ' ILE . 49.8 p -141.92 158.8 43.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.079 -1.419 . . . . 0.19 111.642 -170.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -110.17 93.47 4.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.816 -1.084 . . . . 0.52 110.28 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HD2' HD12 ' A' ' 111' ' ' ILE . 29.6 t80 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.653 -0.703 . . . . 3.86 109.373 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.26 -178.66 4.05 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.76 111.492 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 65.1 tttp -47.97 -53.85 29.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.345 -0.843 . . . . 3.35 112.769 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 70.3 Cg_endo -77.09 98.28 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.279 1.319 . . . . 1.36 111.706 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 111' ' ' ILE . 33.2 p90 -127.9 129.15 46.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 1.1 110.665 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.646 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 7.0 t70 -67.9 -11.7 59.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.909 -0.587 . . . . 1.77 111.582 -177.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.765 HD11 HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER 71.34 -54.67 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-N 115.718 -0.674 . . . . 1.39 109.259 -164.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 15.9 t70 -66.9 -38.63 86.62 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 109.649 -0.5 . . . . 1.16 109.649 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.646 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 13.2 pt-20 -66.13 -18.94 65.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.84 110.807 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.577 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 7.4 mm -83.1 -45.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.466 -0.568 . . . . 0.74 109.466 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.52 ' HA ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.72 -31.06 67.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.876 0.846 . . . . 0.72 109.161 174.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.8 t70 -67.88 -41.18 83.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.998 -1.001 . . . . 0.78 109.324 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.639 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.28 -48.26 71.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.309 -0.859 . . . . 0.59 111.222 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 112' ' ' ARG . 29.4 m -58.95 -47.77 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.791 -0.764 . . . . 0.47 110.422 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 10.5 ttpt -60.94 -51.99 66.91 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.902 -0.59 . . . . 1.16 111.697 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.639 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -55.32 -26.86 43.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.721 -0.392 . . . . 1.48 111.866 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.535 ' HB3' HD22 ' A' ' 119' ' ' LEU . 35.1 m-85 -81.63 -71.72 0.46 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.75 -0.38 . . . . 2.21 111.193 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 118' ' ' TYR . 3.3 mm? -119.65 92.28 46.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.0 -0.37 . . . . 2.09 110.0 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -93.42 121.76 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.801 2.334 . . . . 0.92 113.895 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.744 ' HB3' ' CD ' ' A' ' 4' ' ' GLU . 11.7 tp . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.458 0.647 . . . . 1.25 109.364 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.765 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 104.449 -2.426 . . . . 2.3 104.449 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.989 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -163.56 141.46 7.6 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.542 -1.263 . . . . 0.8 110.499 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.904 ' HB ' HG22 ' A' ' 30' ' ' THR . 5.1 mt -136.62 153.08 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.313 -0.858 . . . . 0.2 111.659 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.811 HD11 ' HB ' ' A' ' 42' ' ' ILE . 3.3 tt -137.24 117.38 13.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.236 -1.394 . . . . 0.17 107.236 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.639 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.3 mp -106.32 107.99 24.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 119.716 -0.794 . . . . 0.22 110.235 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 47.6 t -93.95 76.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.036 0.21 . . . . 0.28 110.483 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.647 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.2 m-20 -123.45 133.03 54.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.421 . . . . 1.82 110.754 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 1.025 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 22.9 t70 -78.42 -39.04 39.98 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.146 -1.057 . . . . 0.51 108.146 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.837 ' HB2' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -64.23 78.38 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.658 -1.156 . . . . 2.07 108.283 164.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 19.9 p90 -55.84 -16.11 4.13 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.21 -0.905 . . . . 1.44 111.682 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.23 -60.21 9.17 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.875 -0.89 . . . . 0.38 110.875 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.837 HG12 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -58.35 -25.44 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 121.403 0.621 . . . . 0.8 109.972 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.957 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -79.4 -46.69 17.08 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.092 -0.958 . . . . 0.38 111.148 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 13' ' ' TYR . 38.7 pt -77.4 -27.12 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.441 -0.577 . . . . 0.56 109.441 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.1 tp -56.71 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.58 109.261 170.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.662 ' HG ' ' CZ ' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -53.52 -43.27 68.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.186 -0.915 . . . . 1.23 111.086 175.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.3 t30 -50.97 -70.02 0.1 Allowed 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.671 0.607 . . . . 0.94 109.425 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -55.08 -39.32 69.15 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.416 0.447 . . . . 2.46 112.175 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 112' ' ' ARG . 41.6 t -57.87 -53.64 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.114 0.413 . . . . 0.37 112.114 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.78 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -77.39 -40.26 44.35 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.264 -0.643 . . . . 0.43 109.264 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.779 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.4 t-20 -51.11 -44.45 61.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.371 -0.831 . . . . 0.28 108.793 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.22 -1.809 . . . . 3.25 111.613 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -56.19 -34.48 66.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.679 1.228 . . . . 1.45 109.273 177.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . 148.27 -17.53 1.33 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 112.828 -1.987 . . . . 0.44 110.012 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 59.7 m-85 -63.89 134.87 55.95 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 112.755 0.65 . . . . 1.07 112.755 -163.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.936 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 27.9 mt-30 -84.16 77.47 9.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.897 -0.779 . . . . 1.14 108.897 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.904 HG22 ' HB ' ' A' ' 6' ' ' ILE . 11.9 p -90.59 136.19 33.22 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.389 -0.823 . . . . 0.14 110.392 -176.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.4 m-85 -128.78 130.32 46.86 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 122.68 1.229 . . . . 0.34 109.888 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.957 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 3.8 pt20 -86.41 121.23 28.67 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 112.697 -2.047 . . . . 0.22 112.077 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.693 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -121.88 137.9 54.6 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.575 -0.738 . . . . 0.23 109.248 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -95.03 -12.44 26.6 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.118 -0.633 . . . . 0.18 110.133 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 2.0 p-10 -148.72 166.32 28.76 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.828 -0.624 . . . . 0.29 111.6 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -69.02 -20.78 75.03 Favored Glycine 0 CA--C 1.505 -0.534 0 O-C-N 123.899 0.75 . . . . 0.14 113.435 -174.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.93 -43.67 19.41 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.218 1.008 . . . . 0.28 108.666 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.778 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.1 tt0 -63.21 -36.01 82.24 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 112.798 -2.001 . . . . 1.29 105.94 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.77 -46.55 81.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.393 -1.276 . . . . 0.14 111.14 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.77 -48.39 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.67 0.748 . . . . 0.97 109.139 175.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 44' ' ' THR . 7.2 t70 -57.47 -42.93 83.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.155 -1.384 . . . . 1.32 111.09 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.903 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 16.2 mm -63.29 -45.05 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 120.796 -0.361 . . . . 0.14 110.41 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -60.95 -41.67 89.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.707 0.765 . . . . 0.15 109.631 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.34 -24.0 62.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 0.39 111.166 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 1.6 ptmt -89.75 -46.91 8.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.159 -0.473 . . . . 2.42 111.195 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 53.0 mm-40 -108.43 -37.93 5.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.706 0.289 . . . . 0.63 111.319 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 78.0 mtp180 66.27 65.62 0.79 Allowed Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.597 -0.728 . . . . 3.66 109.714 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.989 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.4 Cg_exo -64.4 158.55 48.61 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 122.185 1.924 . . . . 0.21 112.029 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.763 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 4.7 m-20 -93.53 -38.47 11.37 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.138 -1.06 . . . . 0.98 108.138 174.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 119' ' ' LEU . 5.7 mp -114.51 111.64 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.26 110.272 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.789 HG13 ' HB3' ' A' ' 7' ' ' LEU . 61.2 t -112.44 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.281 -0.418 . . . . 0.21 111.22 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' A' ' 19' ' ' LEU . 2.7 mp -78.52 93.73 4.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.789 0.804 . . . . 0.15 109.616 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.658 HD12 ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -86.59 96.98 10.28 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.468 -1.242 . . . . 1.53 110.691 -174.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.595 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 9.4 t70 -63.88 116.03 5.42 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.978 -0.689 . . . . 1.47 109.844 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.883 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.7 mtp -94.03 7.53 44.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.666 -0.697 . . . . 0.94 110.992 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 24.9 mmmt -63.82 -66.38 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.173 0.435 . . . . 2.24 112.173 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.021 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 14.6 tt -169.88 -17.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.289 1.588 . . . . 2.06 115.289 -171.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.025 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -27.15 -51.95 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.52 2.813 . . . . 0.45 116.112 175.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.38 -54.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.431 -1.366 . . . . 0.47 113.648 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.517 ' HB3' HD11 ' A' ' 65' ' ' ILE . 19.4 ttt -148.69 166.76 27.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.552 -0.536 . . . . 2.23 109.552 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.16 135.07 57.61 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.188 0.518 . . . . 0.67 109.959 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -62.61 -10.46 30.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.055 -0.975 . . . . 0.32 112.797 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.0 mt -82.84 -47.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.03 0.443 . . . . 1.31 110.593 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.4 mm-40 -64.62 -35.85 82.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.146 -0.687 . . . . 0.47 109.146 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.843 ' O ' ' HG2' ' A' ' 69' ' ' MET . 55.2 mt -72.27 -38.59 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.69 110.122 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.714 HD12 ' CG2' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -53.0 -49.53 66.01 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.44 173.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 71' ' ' VAL . 15.0 ptpt -72.81 -35.61 67.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.65 111.865 -174.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' A' ' 65' ' ' ILE . 4.3 ptp180 -64.35 -33.91 76.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 118.689 -1.204 . . . . 2.18 111.605 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.843 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 10.0 ptp -83.25 -16.51 46.09 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 119.697 -0.801 . . . . 1.28 109.289 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 13.1 mptt -72.32 -38.81 68.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.798 -0.816 . . . . 1.3 108.798 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 67' ' ' LYS . 74.9 t -63.59 -38.52 82.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 1.03 110.616 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.701 HG12 ' HA ' ' A' ' 69' ' ' MET . 11.4 pt -83.73 -30.01 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.535 -0.466 . . . . 0.26 110.608 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 88.03 1.0 Allowed 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 112.277 0.473 . . . . 1.08 112.277 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 37.0 mt-10 -66.39 -2.26 4.34 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.421 -0.799 . . . . 1.78 111.288 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.49 -25.8 60.62 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.696 -1.224 . . . . 0.35 107.696 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 48' ' ' PRO . 2.7 tt -71.34 154.46 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.14 -1.845 . . . . 0.21 110.513 -174.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 5.5 ptp180 -138.72 175.66 9.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.263 -1.014 . . . . 1.08 108.263 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.714 ' CG2' HD12 ' A' ' 66' ' ' LEU . 4.1 m -141.58 145.64 24.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 119.86 -0.736 . . . . 0.79 111.02 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.671 HG23 ' OG1' ' A' ' 100' ' ' THR . 64.0 mt -110.74 75.75 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.668 -1.234 . . . . 0.6 107.668 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.883 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -66.89 139.68 20.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.722 -0.791 . . . . 0.14 112.367 -171.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.547 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 3.0 mtp -101.28 120.18 39.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.155 -0.93 . . . . 1.88 110.586 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.432 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.2 t -133.22 164.57 26.77 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.454 0.538 . . . . 1.13 112.454 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.2 56.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.202 -0.908 . . . . 0.54 111.435 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 74.6 t80 69.24 6.88 5.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.788 0.835 . . . . 4.3 111.016 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.77 93.49 1.85 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.705 -0.759 . . . . 0.62 111.9 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' N ' HG13 ' A' ' 90' ' ' ILE . 33.6 mt-10 -71.69 9.6 0.84 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.239 0.542 . . . . 1.33 110.93 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 85' ' ' GLY . 40.9 mt 58.91 -169.5 0.13 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 1.73 113.006 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 54.87 -93.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.011 -0.995 . . . . 1.38 111.349 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.533 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 91.3 mtp -65.15 -23.96 67.27 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.666 0.27 . . . . 2.72 110.344 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.641 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.5 mm -66.61 -41.08 87.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.67 110.386 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.566 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 14.2 mt-30 -67.26 -35.53 79.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.014 0.911 . . . . 2.5 108.83 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 33.2 tt0 -72.85 -31.98 65.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.0 -1.455 . . . . 1.27 111.448 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.422 ' CB ' HG12 ' A' ' 63' ' ' ILE . 14.6 t -59.04 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 1.28 109.713 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.834 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 46.8 pttt -54.91 -38.84 68.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.91 111.698 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.9 pt-20 -64.63 -25.93 68.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.859 0.3 . . . . 1.84 111.203 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.458 HD12 ' CG2' ' A' ' 63' ' ' ILE . 17.9 mt -86.18 -19.24 30.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.968 0.413 . . . . 1.25 111.528 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.93 19.7 0.23 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.087 -1.054 . . . . 0.35 113.041 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -91.47 140.85 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.994 -0.743 . . . . 0.21 108.994 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.533 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.7 mt -82.92 -49.18 9.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.846 0.831 . . . . 0.18 109.842 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.671 ' OG1' HG23 ' A' ' 79' ' ' ILE . 51.3 p -143.39 150.61 39.33 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.022 -1.445 . . . . 0.19 111.685 -171.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -112.19 97.32 6.56 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.52 109.322 173.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -90.49 150.32 21.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.257 -0.428 . . . . 3.86 110.767 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -121.89 -171.53 2.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.321 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 40.0 ttmt -56.81 -47.21 99.43 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 3.35 111.804 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 51.8 Cg_endo -73.29 96.65 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 120.644 0.896 . . . . 1.36 111.03 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -137.22 138.36 40.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 1.1 110.281 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 22.7 t70 -76.6 -1.69 28.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.649 . . . . 1.77 110.984 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.43 -49.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.933 1.293 . . . . 1.39 112.526 -170.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -70.19 -26.51 63.93 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.634 -0.506 . . . . 1.16 109.634 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 12.5 pt-20 -67.87 -24.85 65.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.74 -0.467 . . . . 0.84 109.74 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.477 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 26.3 mt -81.04 -40.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.962 -0.563 . . . . 0.74 110.537 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.616 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.727 -0.789 . . . . 0.72 109.182 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.49 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 26.7 t70 -68.38 -32.36 72.38 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.581 -0.896 . . . . 0.78 108.581 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.797 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -64.08 -44.15 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.59 111.007 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 112' ' ' ARG . 21.9 m -64.76 -39.54 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 119.003 -1.079 . . . . 0.47 110.805 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -78.37 -21.45 49.39 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.332 0.493 . . . . 1.16 112.332 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.797 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -79.44 -24.32 42.52 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.461 -0.775 . . . . 1.48 110.983 175.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 48.5 m-85 -92.15 -70.58 0.69 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.831 -0.348 . . . . 2.21 111.84 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 1.056 ' HB3' HD11 ' A' ' 50' ' ' LEU . 2.4 tm? -127.03 89.72 51.28 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.504 -0.924 . . . . 2.09 108.504 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.654 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 65.0 Cg_endo -88.09 155.0 7.02 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.899 2.399 . . . . 0.92 113.971 -172.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 4' ' ' GLU . 11.3 tp . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 106.804 -1.554 . . . . 1.25 106.804 167.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 1.067 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 11.2 tt0 . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 121.231 0.538 . . . . 2.3 111.03 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.77 ' HD3' ' HB3' ' A' ' 29' ' ' GLN . 3.8 tppt? -137.39 142.51 41.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.298 0.639 . . . . 0.8 110.871 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.925 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.1 mt -138.28 157.61 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.788 -0.642 . . . . 0.2 111.46 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.823 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.8 tt -133.66 117.76 17.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.138 -1.06 . . . . 0.17 108.138 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.8 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.3 mp -107.25 113.28 43.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 120.245 -0.582 . . . . 0.22 110.255 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 53' ' ' LEU . 49.5 t -103.58 82.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.629 0.252 . . . . 0.28 111.335 -176.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.757 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 3.8 m-20 -121.05 130.97 54.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 1.82 109.903 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.895 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 27.6 t70 -81.57 -31.98 32.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.545 -1.28 . . . . 0.51 107.545 166.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.481 ' CG ' HD13 ' A' ' 15' ' ' ILE . 16.1 pt20 -74.32 74.69 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.455 -1.248 . . . . 2.07 108.198 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 15.1 p90 -61.47 -15.45 37.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.838 -1.528 . . . . 1.44 113.431 -167.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.65 -65.35 3.49 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.876 -1.289 . . . . 0.38 109.876 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.814 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.9 mp -47.25 -30.07 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 123.276 0.63 . . . . 0.8 112.31 172.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 8.8 ttm180 -76.37 -50.19 14.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.291 -0.413 . . . . 0.38 111.142 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 46.9 pt -75.34 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.375 -0.602 . . . . 0.56 109.375 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.5 tp -59.94 -65.52 0.67 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.58 109.627 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 52' ' ' LEU . 71.8 mt -54.29 -40.38 67.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.472 -0.331 . . . . 1.23 110.69 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t30 -51.09 -67.52 0.24 Allowed 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.64 -0.709 . . . . 0.94 109.755 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.25 -40.09 76.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.81 0.694 . . . . 2.46 111.997 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 18' ' ' LEU . 36.3 t -54.3 -54.52 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 111.492 0.182 . . . . 0.37 111.492 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.711 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -81.01 -35.91 31.31 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.49 -0.484 . . . . 0.43 110.223 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.631 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 10.0 t-20 -50.38 -47.28 56.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.857 0.837 . . . . 0.28 108.758 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 25' ' ' LYS . 1.7 tmmt? -61.3 -36.22 79.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.462 -1.699 . . . . 3.25 112.774 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 8.3 mm-40 -55.11 -31.81 61.54 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.204 1.002 . . . . 1.45 109.455 175.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 138.71 -10.65 3.42 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 113.161 -1.836 . . . . 0.44 109.132 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 1.067 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 2.1 m-85 -68.45 156.74 37.32 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 122.605 1.193 . . . . 1.07 111.089 -169.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.77 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 4.4 mt-30 -109.69 69.8 0.71 Allowed 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 113.293 -1.776 . . . . 1.14 108.042 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.925 HG22 ' HB ' ' A' ' 6' ' ' ILE . 16.0 p -90.01 132.01 35.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.687 -1.142 . . . . 0.14 110.486 -168.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 14.4 m-85 -125.37 124.5 41.66 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.563 1.173 . . . . 0.34 109.664 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.739 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.4 pt20 -80.8 122.05 26.7 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 112.764 -2.016 . . . . 0.22 112.118 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -120.86 142.08 49.99 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.999 -1.001 . . . . 0.23 108.561 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -98.64 -12.53 20.99 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.928 -0.709 . . . . 0.18 109.941 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.623 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 3.3 p-10 -148.09 165.25 31.38 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.729 -0.669 . . . . 0.29 111.703 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.16 73.39 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.552 -0.749 . . . . 0.14 113.45 -174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.444 ' HB2' HD22 ' A' ' 35' ' ' ASN . 3.2 mm? -81.94 -43.15 18.47 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.034 0.921 . . . . 0.28 109.14 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.764 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.2 tt0 -63.34 -34.83 78.56 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.103 -1.814 . . . . 1.29 106.103 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -66.52 -46.67 75.43 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.485 -1.234 . . . . 0.14 111.0 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.635 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -52.58 -46.92 67.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.641 0.734 . . . . 0.97 109.292 173.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.09 -41.3 92.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.293 -1.322 . . . . 1.32 111.203 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.823 ' HB ' HD11 ' A' ' 7' ' ' LEU . 17.2 mm -63.26 -48.32 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 110.121 -0.326 . . . . 0.14 110.121 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 38.7 t -60.19 -43.59 93.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-O 121.817 0.818 . . . . 0.15 109.283 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.54 -29.28 69.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.261 -0.881 . . . . 0.39 111.614 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -93.19 -45.08 8.03 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.949 0.352 . . . . 2.42 111.949 -176.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 57.2 mm-40 -107.78 -36.17 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 0.63 111.654 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 69.3 mtp180 62.74 62.01 2.0 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.368 -0.833 . . . . 3.66 109.547 -170.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.646 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 77.1 Cg_exo -58.66 156.94 29.68 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.046 1.83 . . . . 0.21 111.095 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.809 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -93.27 -34.7 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.901 -0.72 . . . . 0.98 109.585 175.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.684 HD23 HD11 ' A' ' 79' ' ' ILE . 7.1 mp -115.47 114.02 24.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.007 -0.542 . . . . 0.26 109.992 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG13 ' HB3' ' A' ' 7' ' ' LEU . 92.7 t -112.63 121.61 65.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 110.527 -0.175 . . . . 0.21 110.527 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 19' ' ' LEU . 2.4 mp -92.0 97.6 11.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.579 -0.526 . . . . 0.15 109.579 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 9' ' ' VAL . 44.0 mt -93.52 106.24 18.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.762 -0.654 . . . . 1.53 110.424 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 52.5 t0 -66.86 107.93 2.37 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.204 -0.598 . . . . 1.47 110.232 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.832 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 11.5 mtm -83.05 0.74 43.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.661 . . . . 0.94 110.797 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 25.5 mmmt -57.75 -58.5 8.08 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.408 0.522 . . . . 2.24 112.408 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.927 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 15.2 tt -175.57 -34.21 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.264 1.209 . . . . 2.06 114.264 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.927 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -20.23 -63.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.261 3.307 . . . . 0.45 116.482 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.93 -58.23 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.652 -1.261 . . . . 0.47 113.204 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.5 ' HB3' HD11 ' A' ' 65' ' ' ILE . 47.2 ttm -148.96 165.85 30.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.415 -0.587 . . . . 2.23 109.415 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 65' ' ' ILE . 38.3 m-20 -60.46 133.9 56.54 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.745 -0.465 . . . . 0.67 109.745 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 66' ' ' LEU . . . -67.55 1.65 6.99 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 120.892 -0.67 . . . . 0.32 112.364 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.3 mt -92.45 -45.7 14.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.842 0.353 . . . . 1.31 110.116 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.74 -36.08 81.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.47 109.701 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.674 ' HB ' HD13 ' A' ' 53' ' ' LEU . 15.6 mt -73.5 -34.19 41.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.929 -0.578 . . . . 0.69 109.483 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.665 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -54.77 -53.99 47.89 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.488 -0.778 . . . . 1.47 109.978 174.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.6 ptpt -71.47 -33.42 69.29 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.118 0.414 . . . . 0.65 112.118 -173.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.71 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.9 ptm180 -66.54 -34.6 78.27 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.465 -0.894 . . . . 2.18 110.95 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.661 ' HG3' HG21 ' A' ' 76' ' ' ILE . 10.1 ptp -82.75 -16.74 46.81 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 119.834 -0.746 . . . . 1.28 109.722 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.3 mptt -78.88 -30.25 44.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.723 0.773 . . . . 1.3 109.854 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 68' ' ' ARG . 2.7 p -78.59 -31.86 15.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.505 0.669 . . . . 1.03 109.261 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.644 HG12 ' HA ' ' A' ' 69' ' ' MET . 21.8 pt -86.52 -21.89 7.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.102 -0.954 . . . . 0.26 110.724 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -162.78 88.51 0.62 Allowed 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 112.559 0.577 . . . . 1.08 112.559 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 11.6 mt-10 -76.67 5.93 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 120.68 -1.263 . . . . 1.78 109.688 173.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -29.67 62.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.489 -1.232 . . . . 0.35 107.894 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.661 HG21 ' HG3' ' A' ' 69' ' ' MET . 5.2 tt -76.66 159.4 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 112.767 -2.015 . . . . 0.21 111.296 -170.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.817 ' HD3' HD21 ' A' ' 99' ' ' LEU . 4.2 ptp180 -134.84 177.21 7.97 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.335 -0.848 . . . . 1.08 109.392 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.65 HG11 HD12 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -132.58 159.65 43.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.505 0.669 . . . . 0.79 110.507 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.735 HG22 ' HD2' ' A' ' 102' ' ' PHE . 54.9 mt -131.01 66.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.071 -1.455 . . . . 0.6 107.071 170.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.832 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -63.5 140.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.745 0.783 . . . . 0.14 111.804 -170.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.773 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 mtp -95.84 124.1 39.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.764 -1.107 . . . . 1.88 110.371 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.465 HG21 ' HB1' ' A' ' 101' ' ' ALA . 12.1 p -130.84 159.13 38.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.1 -0.5 . . . . 1.13 112.173 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.494 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . . . -66.8 73.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.595 . . . . 0.54 109.863 165.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 26.5 p90 50.88 21.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.225 1.41 . . . . 4.3 113.714 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.65 92.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.828 -0.701 . . . . 0.62 112.688 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.674 ' N ' HG13 ' A' ' 90' ' ' ILE . 19.3 mt-10 -89.01 14.67 10.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.067 0.461 . . . . 1.33 110.855 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 65.65 -177.74 0.19 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.34 0.867 . . . . 1.73 113.34 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.0 t70 60.83 -100.24 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.738 -1.119 . . . . 1.38 112.042 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -58.97 -23.37 61.62 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.021 0.439 . . . . 2.72 110.613 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.674 HG13 ' N ' ' A' ' 86' ' ' GLU . 34.9 mm -65.83 -40.2 86.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.272 0.558 . . . . 0.67 110.088 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.502 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 22.8 mm-40 -72.76 -39.03 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.536 -0.756 . . . . 2.5 109.591 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.617 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 23.5 tt0 -67.95 -40.92 83.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.785 -1.098 . . . . 1.27 111.729 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.409 ' OG ' HG21 ' A' ' 80' ' ' ILE . 6.6 t -54.46 -61.01 2.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.144 0.497 . . . . 1.28 110.055 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.897 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -58.75 -39.45 80.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.91 111.422 176.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.0 pt-20 -62.17 -27.23 68.82 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.637 0.236 . . . . 1.84 111.637 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 11.8 mt -85.54 -8.23 58.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.256 0.465 . . . . 1.25 112.256 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.97 19.22 0.72 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.034 -1.079 . . . . 0.35 113.511 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.897 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -98.84 138.83 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.988 -0.745 . . . . 0.21 108.988 171.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.817 HD21 ' HD3' ' A' ' 77' ' ' ARG . 9.3 mt -77.41 -50.05 13.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.398 0.618 . . . . 0.18 110.397 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.59 ' OG1' HG23 ' A' ' 79' ' ' ILE . 62.6 p -139.65 148.72 42.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.224 -0.898 . . . . 0.19 111.664 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.95 84.35 2.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.962 -1.017 . . . . 0.52 108.973 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.773 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 1.1 p90 -86.73 144.4 27.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 3.86 110.568 -170.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 105' ' ' PRO . . . -95.98 166.31 11.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.76 110.743 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 18.0 pttp -70.36 -29.38 1.57 Allowed Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.724 0.639 . . . . 3.35 112.724 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 55.6 Cg_endo -76.14 95.45 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 120.501 1.215 . . . . 1.36 110.166 163.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.568 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 30.1 p90 -132.3 152.77 51.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.451 0.643 . . . . 1.1 111.318 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 109' ' ' ASP . 19.0 t70 -75.56 -3.9 36.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.117 -0.947 . . . . 1.77 111.653 -173.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.568 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 13.7 mt 65.35 -62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 1.39 110.114 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.507 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 29.8 t70 -63.06 -26.96 69.08 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.89 -0.596 . . . . 1.16 110.817 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.8 -34.31 76.52 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.039 0.447 . . . . 0.84 110.193 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 115' ' ' VAL . 28.3 mt -83.03 -40.22 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.987 -0.551 . . . . 0.74 110.108 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.58 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -66.59 -35.97 81.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.638 -0.875 . . . . 0.72 108.638 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.814 ' HA ' ' HE2' ' A' ' 116' ' ' LYS . 32.5 t70 -61.96 -53.03 61.31 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.999 -0.741 . . . . 0.78 108.999 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.923 ' HA ' ' HE3' ' A' ' 117' ' ' LYS . . . -52.09 -46.38 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.459 -0.792 . . . . 0.59 111.833 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 111' ' ' ILE . 32.3 m -68.24 -47.68 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.673 0.62 . . . . 0.47 112.673 -173.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.814 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 1.2 pptt? -85.24 -8.68 58.43 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.099 0.409 . . . . 1.16 111.665 -177.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.923 ' HE3' ' HA ' ' A' ' 114' ' ' ALA . 21.6 pttp -86.5 -21.52 26.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.715 -0.794 . . . . 1.48 109.749 167.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.843 ' HD1' ' HG ' ' A' ' 119' ' ' LEU . 14.8 t80 -80.56 -66.67 0.85 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.282 -0.417 . . . . 2.21 110.421 176.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.843 ' HG ' ' HD1' ' A' ' 118' ' ' TYR . 91.9 mt -122.36 86.23 48.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.414 -0.587 . . . . 2.09 109.414 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.653 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 93.1 Cg_endo -80.68 133.66 9.41 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.564 2.176 . . . . 0.92 113.434 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 4' ' ' GLU . 13.3 tp . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 121.6 0.714 . . . . 1.25 110.211 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.726 ' HB3' HD12 ' A' ' 121' ' ' LEU . 7.2 tp10 . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.198 0.523 . . . . 2.3 111.456 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.869 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -136.09 146.52 47.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.294 0.569 . . . . 0.8 111.368 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.901 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.9 mt -137.81 154.75 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.389 -0.823 . . . . 0.2 111.575 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.838 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -135.56 111.64 9.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.459 -1.246 . . . . 0.17 107.724 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.638 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.2 mp -99.42 104.62 16.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.175 -1.01 . . . . 0.22 110.219 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 47.9 t -85.67 93.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.777 -0.823 . . . . 0.28 108.777 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.608 ' OD2' ' HG3' ' A' ' 12' ' ' GLN . 25.8 t70 -152.6 104.81 2.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.643 -0.423 . . . . 1.82 111.138 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.79 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 19.7 t70 -54.14 -41.24 68.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.55 0.34 . . . . 0.51 111.46 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.608 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 3.6 pt20 -70.94 76.29 0.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 122.23 1.014 . . . . 2.07 109.217 173.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.451 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 31.0 p90 -53.67 -13.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.602 -1.635 . . . . 1.44 114.648 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.73 -67.49 1.27 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.366 -0.921 . . . . 0.38 111.547 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.782 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -70.48 -11.78 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 O-C-N 121.958 -0.731 . . . . 0.8 111.241 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.908 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.4 ttm180 -79.89 -42.12 24.81 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.612 -0.435 . . . . 0.38 110.229 -173.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.427 HG22 ' NE2' ' A' ' 32' ' ' GLN . 2.7 pp -83.64 -27.14 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.56 109.967 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.496 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 3.5 tp -61.78 -61.59 2.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.637 -0.711 . . . . 0.58 109.485 170.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.782 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 1.1 tp -52.51 -41.96 63.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.653 -0.703 . . . . 1.23 110.187 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.4 t30 -51.18 -70.9 0.07 Allowed 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.209 -0.905 . . . . 0.94 109.78 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.28 -39.12 69.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.355 0.41 . . . . 2.46 111.64 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' LEU . 35.6 t -55.76 -60.83 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.626 -0.261 . . . . 0.37 111.295 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.782 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 8.3 m-85 -72.37 -34.6 68.08 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.457 -0.571 . . . . 0.43 109.457 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.932 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 3.5 t-20 -52.06 -48.56 64.56 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.269 -0.878 . . . . 0.28 109.388 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.41 -31.72 73.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.626 -1.624 . . . . 3.25 112.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.686 ' HB2' ' CD1' ' A' ' 28' ' ' TYR . 6.1 mm-40 -63.67 -25.27 68.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.639 0.733 . . . . 1.45 110.313 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.653 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . 143.21 -16.47 2.32 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.491 -1.231 . . . . 0.44 110.648 -171.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.932 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 8.2 m-85 -81.64 124.06 29.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.308 0.575 . . . . 1.07 111.387 -162.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.869 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 20.7 mt-30 -79.39 82.61 5.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.46 -0.941 . . . . 1.14 108.46 172.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.901 HG22 ' HB ' ' A' ' 6' ' ' ILE . 20.8 p -90.19 135.85 33.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.645 -0.707 . . . . 0.14 109.921 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 15.4 m-85 -125.95 126.35 44.22 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.408 1.099 . . . . 0.34 109.265 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.908 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.5 pt20 -86.43 120.74 28.08 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.004 -1.907 . . . . 0.22 111.355 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.44 124.6 43.25 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.495 -0.558 . . . . 0.23 109.495 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 11' ' ' ASP . . . -74.71 -19.03 60.41 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.738 -0.385 . . . . 0.18 111.028 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.502 HD22 ' HB2' ' A' ' 37' ' ' LEU . 1.7 p-10 -148.23 168.57 22.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 0.29 111.567 -174.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -75.03 -14.32 81.91 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.834 -0.621 . . . . 0.14 113.33 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.502 ' HB2' HD22 ' A' ' 35' ' ' ASN . 3.2 mm? -79.9 -44.71 19.91 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 122.617 1.198 . . . . 0.28 108.279 175.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.803 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.3 tp-100 -60.94 -40.69 94.23 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 112.26 -2.245 . . . . 1.29 105.597 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -63.3 -44.36 95.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.722 -1.581 . . . . 0.14 111.258 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.7 -43.64 76.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.037 -0.727 . . . . 0.97 109.037 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 44' ' ' THR . 18.9 t70 -64.22 -41.95 96.79 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.492 -1.231 . . . . 1.32 110.616 177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.838 ' HB ' HD11 ' A' ' 7' ' ' LEU . 10.3 mm -60.69 -48.78 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 120.922 -0.311 . . . . 0.14 111.033 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 76' ' ' ILE . 46.8 t -57.97 -41.75 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.741 0.781 . . . . 0.15 109.947 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.38 -23.95 62.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.226 -0.897 . . . . 0.39 111.134 -178.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.742 ' HE3' ' HA ' ' A' ' 42' ' ' ILE . 9.7 ptpt -91.23 -42.34 10.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.695 0.283 . . . . 2.42 111.268 -177.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 62.5 mm-40 -111.61 -38.16 4.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 112.066 0.395 . . . . 0.63 112.066 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.2 mpt_? 64.78 64.28 1.11 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 123.857 0.723 . . . . 3.66 109.769 -169.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.761 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 51.7 Cg_exo -62.77 157.71 46.28 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 121.57 1.513 . . . . 0.21 111.473 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.927 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -85.03 -51.09 6.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.293 -1.373 . . . . 0.98 107.293 171.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.927 HD12 ' HB2' ' A' ' 49' ' ' ASP . 7.1 mp -105.11 111.59 24.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.716 -1.129 . . . . 0.26 110.75 -171.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.769 HG13 ' HB3' ' A' ' 7' ' ' LEU . 60.0 t -112.18 108.51 25.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.213 -0.449 . . . . 0.21 111.419 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.576 HD22 HD21 ' A' ' 19' ' ' LEU . 2.1 mp -75.68 89.12 2.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.795 0.807 . . . . 0.15 109.473 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -82.49 110.68 17.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.059 -1.428 . . . . 1.53 111.294 -172.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.12 127.19 18.5 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.697 0.76 . . . . 1.47 110.714 174.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.922 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 18.8 mtp -114.94 9.52 16.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.172 -0.922 . . . . 0.94 109.457 163.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -71.74 -67.55 0.52 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.63 . . . . 2.24 111.9 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.839 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -175.05 -36.03 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.036 0 CA-C-O 118.024 -0.989 . . . . 2.06 112.708 -172.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.839 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 4.7 Cg_exo -19.48 -62.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.726 3.617 . . . . 0.45 116.419 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.06 -73.23 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 119.764 -1.208 . . . . 0.47 113.394 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.3 tpt -148.9 168.55 22.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.574 -0.899 . . . . 2.23 108.574 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.17 129.18 40.79 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.172 0.51 . . . . 0.67 109.654 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.589 ' CA ' ' HG ' ' A' ' 53' ' ' LEU . . . -62.92 -7.19 15.07 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.08 -0.964 . . . . 0.32 112.718 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.724 HG13 ' HB3' ' A' ' 89' ' ' MET . 4.1 mm -78.22 -48.66 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.681 -0.488 . . . . 1.31 109.681 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.9 -33.46 75.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.876 -0.787 . . . . 0.47 108.876 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.739 ' O ' ' HG2' ' A' ' 69' ' ' MET . 59.9 mt -77.31 -38.79 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.292 -0.867 . . . . 0.69 111.371 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.64 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 3.7 pp -65.66 -36.85 84.86 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 120.291 -0.564 . . . . 1.47 110.285 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.678 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.8 ptpt -73.49 -35.41 65.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.332 -0.547 . . . . 0.65 111.182 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.6 ptm180 -65.28 -33.46 76.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 118.868 -1.133 . . . . 2.18 111.668 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.775 ' HA ' HG12 ' A' ' 72' ' ' ILE . 12.2 ptp -84.86 -11.99 54.47 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.046 -1.033 . . . . 1.28 109.405 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 12.5 mptt -76.84 -36.98 56.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.016 -0.735 . . . . 1.3 109.016 172.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 68' ' ' ARG . 4.0 p -72.07 -33.81 48.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.354 0.597 . . . . 1.03 109.648 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.775 HG12 ' HA ' ' A' ' 69' ' ' MET . 26.1 pt -84.27 -24.46 7.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.291 -0.868 . . . . 0.26 110.973 172.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -161.74 88.18 0.69 Allowed 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.043 0.386 . . . . 1.08 112.043 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 8.5 mt-10 -75.77 6.25 5.22 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.272 -0.892 . . . . 1.78 110.636 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -28.69 42.39 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.856 -1.535 . . . . 0.35 106.856 170.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.3 tt -67.61 153.8 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 113.556 -1.657 . . . . 0.21 110.686 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 6.3 ptp180 -135.45 177.9 7.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.792 -1.188 . . . . 1.08 107.792 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -144.17 144.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.52 0.676 . . . . 0.79 111.216 -174.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.709 HG23 ' OG1' ' A' ' 100' ' ' THR . 64.9 mt -114.79 74.75 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.304 -1.369 . . . . 0.6 107.304 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.922 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -62.55 140.11 19.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 119.544 -0.862 . . . . 0.14 112.735 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 7.4 mtp -100.81 102.68 13.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.734 -1.121 . . . . 1.88 110.159 -174.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.43 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.7 t -117.05 165.13 13.73 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.343 0.592 . . . . 1.13 112.284 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 56.09 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.954 -1.021 . . . . 0.54 110.26 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 t80 72.3 5.59 5.32 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.983 -1.008 . . . . 4.3 111.686 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.32 88.28 1.99 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.115 -0.564 . . . . 0.62 112.619 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.431 ' N ' HG13 ' A' ' 90' ' ' ILE . 24.2 mt-10 -81.38 9.36 7.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.924 0.393 . . . . 1.33 111.18 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.518 HD22 HE21 ' A' ' 91' ' ' GLN . 38.1 mt 65.8 -166.22 0.22 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.606 -0.725 . . . . 1.73 112.621 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.53 -99.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.297 -0.865 . . . . 1.38 111.531 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.724 ' HB3' HG13 ' A' ' 63' ' ' ILE . 2.0 mpt? -64.25 -18.0 64.14 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.421 -0.354 . . . . 2.72 110.291 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 87' ' ' LEU . 32.7 mm -69.49 -40.2 79.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.999 0.428 . . . . 0.67 110.265 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.518 HE21 HD22 ' A' ' 87' ' ' LEU . 73.1 mt-30 -67.02 -53.36 31.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.842 -0.799 . . . . 2.5 108.842 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 42.8 tt0 -56.72 -30.6 63.69 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 114.46 -1.245 . . . . 1.27 111.404 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 63' ' ' ILE . 27.6 t -54.59 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.754 0.788 . . . . 1.28 111.177 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 33.4 pttt -54.03 -38.02 64.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.629 -1.169 . . . . 1.91 110.714 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 8.2 tp10 -55.37 -43.42 75.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.739 -1.118 . . . . 1.84 111.874 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.75 -22.96 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.843 0.354 . . . . 1.25 111.165 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.88 21.97 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.004 -1.093 . . . . 0.35 113.935 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 78' ' ' VAL . . . -88.54 140.54 29.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.9 0.85 . . . . 0.21 109.277 169.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.514 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.3 mt -82.19 -48.95 10.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.718 0.771 . . . . 0.18 109.865 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.709 ' OG1' HG23 ' A' ' 79' ' ' ILE . 52.6 p -144.57 150.2 37.08 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.486 -1.234 . . . . 0.19 111.64 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -108.55 86.89 2.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.363 -0.835 . . . . 0.52 109.967 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 16.6 m-85 -84.33 143.02 29.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.985 0.421 . . . . 3.86 110.716 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB1' ' HD2' ' A' ' 105' ' ' PRO . . . -95.48 178.14 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.76 109.431 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' O ' ' HD1' ' A' ' 106' ' ' PHE . 20.5 mmtp -78.33 -29.75 0.66 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.639 0.607 . . . . 3.35 112.639 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' HB1' ' A' ' 103' ' ' ALA . 24.2 Cg_exo -65.62 96.99 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 120.368 1.167 . . . . 1.36 109.922 162.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.496 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 1.6 p90 -130.19 146.16 51.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.875 -0.602 . . . . 1.1 111.516 -172.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -86.15 18.4 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.598 . . . . 1.77 111.726 178.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.549 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.4 tt 48.3 -67.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 125.035 1.334 . . . . 1.39 113.003 -174.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.549 ' H ' HG23 ' A' ' 108' ' ' ILE . 18.5 t70 -58.22 -30.55 66.58 Favored 'General case' 0 C--O 1.212 -0.897 0 C-N-CA 122.55 0.34 . . . . 1.16 111.364 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.11 -28.15 67.92 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 119.997 -0.681 . . . . 0.84 110.143 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.54 HG22 ' HZ ' ' A' ' 23' ' ' PHE . 17.0 mt -80.76 -41.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.74 110.508 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HD2' ' C ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -68.68 -32.99 73.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.744 0.783 . . . . 0.72 109.215 175.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 19.1 t70 -70.91 -36.49 72.73 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.323 -0.853 . . . . 0.78 108.828 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.6 -45.29 79.66 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.079 -0.964 . . . . 0.59 111.459 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 112' ' ' ARG . 34.5 m -61.77 -42.59 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.598 -0.841 . . . . 0.47 110.184 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.524 ' HA ' ' OH ' ' A' ' 28' ' ' TYR . 7.1 ttpt -63.67 -49.65 72.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.795 -0.639 . . . . 1.16 111.418 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.739 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.5 OUTLIER -59.78 -30.67 69.04 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.664 -0.243 . . . . 1.48 111.399 -176.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.576 ' HB3' HD12 ' A' ' 119' ' ' LEU . 44.5 m-85 -81.91 -68.91 0.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.417 -0.513 . . . . 2.21 110.696 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 118' ' ' TYR . 6.7 mp -121.48 103.63 41.06 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.175 -0.676 . . . . 2.09 109.175 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -97.78 153.11 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.752 2.301 . . . . 0.92 114.493 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 1.25 108.396 172.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.853 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 8.3 tt0 . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 121.583 0.706 . . . . 2.3 110.916 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.688 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 3.6 tppt? -140.57 147.33 39.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.009 -0.541 . . . . 0.8 111.202 -172.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.899 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -141.23 153.99 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.439 -0.8 . . . . 0.2 111.696 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.796 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -131.82 123.47 27.64 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.61 -1.256 . . . . 0.17 107.61 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.701 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.4 mp -109.66 103.21 15.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.556 -0.858 . . . . 0.22 110.164 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.2 t -88.49 82.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.28 110.003 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.876 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.0 t70 -133.1 144.28 49.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.548 -0.296 . . . . 1.82 110.686 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.89 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 13.0 t70 -101.54 -35.94 8.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.896 -0.409 . . . . 0.51 109.896 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.658 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 4.4 pt20 -81.06 70.61 7.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.098 -1.445 . . . . 2.07 107.098 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.9 p90 -48.74 -13.92 0.06 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 112.334 -2.212 . . . . 1.44 115.181 -161.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' GLN . . . -46.68 -59.48 5.4 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.198 -1.001 . . . . 0.38 110.777 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 1.1 mm -54.51 -32.5 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.525 0.679 . . . . 0.8 110.245 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.876 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.6 ttm180 -77.12 -48.78 16.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.118 -0.946 . . . . 0.38 110.891 -165.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 42.4 pt -76.04 -25.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.312 -0.625 . . . . 0.56 109.312 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.4 tp -58.69 -68.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.58 109.416 171.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.798 HD13 HD22 ' A' ' 52' ' ' LEU . 39.0 mt -54.65 -40.91 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 1.23 110.563 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.632 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 7.6 t30 -50.48 -68.81 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.94 109.97 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.65 -40.04 82.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.265 0.353 . . . . 2.46 111.639 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -55.15 -55.43 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.052 0.22 . . . . 0.37 111.576 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB2' HG21 ' A' ' 30' ' ' THR . 11.8 m-85 -78.87 -36.66 41.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.61 -0.436 . . . . 0.43 110.038 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 9.3 t-20 -50.15 -50.54 48.55 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.176 0.988 . . . . 0.28 108.934 -176.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -54.77 -42.49 71.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 112.637 -2.074 . . . . 3.25 111.676 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 112' ' ' ARG . 4.5 mm-40 -52.22 -34.6 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 122.191 0.996 . . . . 1.45 109.733 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.612 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 138.08 -6.66 3.43 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 113.303 -1.771 . . . . 0.44 109.39 -171.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.856 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 5.5 m-85 -70.4 126.86 30.83 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.807 -0.757 . . . . 1.07 110.549 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.641 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 28.6 mt-30 -82.7 81.13 8.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.475 -0.935 . . . . 1.14 108.475 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.899 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -90.07 133.09 35.05 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.064 -0.971 . . . . 0.14 110.128 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.94 124.83 42.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.592 1.187 . . . . 0.34 109.732 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.71 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 1.5 pt20 -82.17 120.71 25.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 112.748 -2.024 . . . . 0.22 111.602 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.783 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -123.93 124.02 41.69 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.585 -0.734 . . . . 0.23 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -84.83 -8.19 58.89 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.223 -0.591 . . . . 0.18 111.293 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.496 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 1.7 p-10 -149.42 165.55 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.41 -0.359 . . . . 0.29 111.56 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.91 -19.92 77.32 Favored Glycine 0 CA--C 1.506 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.14 113.291 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' HD22 ' A' ' 35' ' ' ASN . 2.7 mm? -78.31 -42.97 29.16 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.458 1.123 . . . . 0.28 108.075 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.843 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -60.96 -41.66 96.75 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 112.6 -2.091 . . . . 1.29 105.805 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -60.9 -43.87 97.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.003 -1.453 . . . . 0.14 111.038 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.2 OUTLIER -57.44 -43.37 83.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.224 -0.658 . . . . 0.97 109.224 177.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 44' ' ' THR . 2.1 t70 -64.57 -44.58 90.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 114.951 -1.022 . . . . 1.32 110.213 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.843 HG12 ' O ' ' A' ' 38' ' ' GLN . 15.9 mm -60.19 -46.42 94.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.266 -0.879 . . . . 0.14 110.165 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 69' ' ' MET . 47.6 t -62.12 -41.25 90.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 121.727 0.775 . . . . 0.15 109.604 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -73.23 -20.71 60.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.606 -0.725 . . . . 0.39 111.155 -177.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.631 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -90.49 -45.99 8.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.604 -0.271 . . . . 2.42 111.246 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.631 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 8.3 mm-40 -110.63 -36.89 5.61 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.392 0.515 . . . . 0.63 112.392 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 14.1 mtm-85 65.36 65.43 0.92 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 O-C-N 123.639 0.587 . . . . 3.66 109.536 -170.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.751 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 71.3 Cg_exo -60.57 156.67 40.74 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 C-N-CA 121.689 1.592 . . . . 0.21 111.033 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.814 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 12.3 m-20 -89.51 -42.27 11.55 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.293 -0.963 . . . . 0.98 108.849 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.654 HD23 HD11 ' A' ' 79' ' ' ILE . 6.8 mp -110.42 111.97 23.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.737 -0.665 . . . . 0.26 109.864 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 7' ' ' LEU . 86.3 t -112.58 112.81 42.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.796 0.332 . . . . 0.21 110.669 -177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.798 HD22 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -83.64 93.01 7.8 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.411 0.624 . . . . 0.15 109.986 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.656 HD11 HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -84.63 104.7 14.84 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.826 -1.079 . . . . 1.53 111.155 -175.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.835 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 54.2 t0 -70.11 109.14 4.43 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.57 -0.852 . . . . 1.47 110.181 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.87 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.9 mtp -86.28 11.03 13.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.614 -0.721 . . . . 0.94 111.083 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -71.32 -60.16 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.029 0.752 . . . . 2.24 113.029 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.962 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.1 tp -173.08 -21.73 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.671 1.36 . . . . 2.06 114.671 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.962 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -27.62 -52.87 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 123.443 2.762 . . . . 0.45 116.105 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.02 -60.07 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.756 -1.211 . . . . 0.47 112.88 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 65' ' ' ILE . 20.6 ttt -149.53 170.18 19.21 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.403 -0.592 . . . . 2.23 109.403 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -57.66 135.38 56.72 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.977 0.417 . . . . 0.67 110.283 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.615 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -66.49 -2.07 13.71 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.408 -0.815 . . . . 0.32 112.885 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.528 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.2 mt -92.05 -42.03 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.157 0.503 . . . . 1.31 110.286 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.85 -38.9 80.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.571 0.701 . . . . 0.47 109.413 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.656 HD12 HD11 ' A' ' 53' ' ' LEU . 54.0 mt -71.57 -35.85 57.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.149 -0.932 . . . . 0.69 109.794 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.733 HD12 HG21 ' A' ' 78' ' ' VAL . 3.2 tt -53.34 -53.43 51.19 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.677 -0.692 . . . . 1.47 110.607 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.0 ptpp? -73.13 -30.16 63.41 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.233 -0.587 . . . . 0.65 112.083 -172.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.693 ' O ' HG12 ' A' ' 71' ' ' VAL . 15.0 ptp180 -68.97 -33.59 73.95 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 118.92 -1.112 . . . . 2.18 111.066 174.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.703 ' HE1' HG13 ' A' ' 78' ' ' VAL . 2.8 ptt? -80.63 -17.82 50.08 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 118.918 -1.113 . . . . 1.28 109.796 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.742 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -76.93 -30.24 55.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.636 . . . . 1.3 110.572 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.7 p -78.12 -34.95 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 109.531 -0.544 . . . . 1.03 109.531 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.567 HG12 ' HA ' ' A' ' 69' ' ' MET . 15.7 pt -81.42 -31.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.26 110.037 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.76 90.82 1.1 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.32 2.9 6.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.876 0.846 . . . . 1.78 109.796 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -26.11 64.35 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.55 -1.278 . . . . 0.35 107.55 171.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.0 tt -76.23 156.93 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 112.743 -2.026 . . . . 0.21 110.754 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.814 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -137.77 172.48 12.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.055 -0.975 . . . . 1.08 108.614 177.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -131.29 154.25 40.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 120.217 -0.593 . . . . 0.79 110.689 -171.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.654 HD11 HD23 ' A' ' 50' ' ' LEU . 61.5 mt -128.64 68.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.402 -1.333 . . . . 0.6 107.402 171.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.87 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -64.86 140.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.538 -0.756 . . . . 0.14 111.735 -172.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.638 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 11.0 mtt -93.15 131.1 38.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.071 -0.968 . . . . 1.88 110.019 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.638 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 4.6 t -132.85 156.85 46.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.329 0.585 . . . . 1.13 112.578 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . -72.36 63.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.761 -1.109 . . . . 0.54 109.804 170.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 40.3 t80 70.24 11.26 7.5 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.564 -1.198 . . . . 4.3 112.021 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.72 81.88 1.6 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.051 -0.595 . . . . 0.62 112.011 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' N ' HG13 ' A' ' 90' ' ' ILE . 5.6 mt-10 -72.6 8.12 1.59 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.678 0.791 . . . . 1.33 112.052 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.405 ' N ' HG13 ' A' ' 90' ' ' ILE . 25.6 mt 61.11 -177.55 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.569 1.322 . . . . 1.73 114.569 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 t70 57.7 -93.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.328 -1.306 . . . . 1.38 111.692 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.461 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 66.3 mtt -60.88 -26.77 67.65 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 120.838 0.351 . . . . 2.72 110.363 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 86' ' ' GLU . 15.7 mm -62.52 -43.25 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.057 0.456 . . . . 0.67 110.439 173.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.563 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 88.2 mt-30 -63.76 -48.31 77.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.473 -0.785 . . . . 2.5 109.493 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.783 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 22.7 tt0 -70.11 -20.52 63.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.539 -1.21 . . . . 1.27 112.102 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.8 t -66.68 -63.84 0.98 Allowed 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.876 -0.515 . . . . 1.28 110.062 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.919 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 17.0 ptpt -58.87 -31.14 68.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.694 0.759 . . . . 1.91 109.964 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.783 ' CB ' ' HA ' ' A' ' 92' ' ' GLU . 6.1 tt0 -47.38 -58.87 3.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.366 -1.288 . . . . 1.84 111.867 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.77 -28.57 65.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.764 -0.653 . . . . 1.25 112.36 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' HZ1' ' A' ' 70' ' ' LYS . . . 163.72 11.22 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.835 -1.174 . . . . 0.35 113.739 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.919 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -86.72 136.38 33.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.827 0.813 . . . . 0.21 109.66 173.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.415 HD11 ' HG3' ' A' ' 77' ' ' ARG . 7.8 mt -74.98 -49.24 20.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.708 0.766 . . . . 0.18 109.867 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.635 ' OG1' HG23 ' A' ' 79' ' ' ILE . 60.2 p -139.17 147.83 42.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.383 -1.281 . . . . 0.19 111.603 -172.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -107.59 88.7 2.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.862 -1.063 . . . . 0.52 108.431 170.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.603 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 0.3 OUTLIER -84.34 142.22 30.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.264 -0.425 . . . . 3.86 109.944 -172.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -108.42 177.07 4.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.76 111.424 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 10.2 mtpm? -59.37 -43.3 96.16 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.959 -0.564 . . . . 3.35 111.873 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 54.0 Cg_endo -74.37 96.2 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 120.633 0.889 . . . . 1.36 110.995 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.519 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 51.1 p90 -130.81 148.2 52.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.585 -0.734 . . . . 1.1 110.252 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 33.6 t70 -81.99 6.95 14.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.483 -0.78 . . . . 1.77 110.962 -174.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.519 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 6.0 tt 52.75 -60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.551 1.54 . . . . 1.39 112.162 -171.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 107' ' ' ASP . 29.0 t70 -62.05 -30.71 71.17 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 110.298 -0.26 . . . . 1.16 110.298 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 pt-20 -64.13 -29.71 70.82 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.536 -0.466 . . . . 0.84 110.185 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.512 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 34.2 mt -81.71 -42.47 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.245 -0.434 . . . . 0.74 110.459 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.446 ' C ' ' HD2' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -67.86 -34.96 77.71 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.818 0.818 . . . . 0.72 109.222 175.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.2 t70 -64.2 -49.44 72.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.986 -1.006 . . . . 0.78 108.664 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.859 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.94 -48.84 75.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.712 -1.131 . . . . 0.59 111.729 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 112' ' ' ARG . 35.7 m -60.8 -51.95 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.313 -0.555 . . . . 0.47 111.663 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.4 OUTLIER -71.21 -29.83 65.63 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.627 0.232 . . . . 1.16 111.627 -176.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.859 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 65.0 pttt -72.54 -26.09 61.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.64 -0.824 . . . . 1.48 111.184 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -77.89 -66.55 0.83 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.928 0.394 . . . . 2.21 110.283 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -121.23 97.71 47.4 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.538 -0.912 . . . . 2.09 108.538 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.554 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 77.1 Cg_endo -93.97 132.61 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.93 2.42 . . . . 0.92 113.952 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 4' ' ' GLU . 13.8 tp . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.299 0.571 . . . . 1.25 110.209 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.786 ' HB3' HD22 ' A' ' 121' ' ' LEU . 12.5 tt0 . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 121.952 0.882 . . . . 2.3 109.933 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.802 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -132.52 145.99 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.238 -0.892 . . . . 0.8 110.661 -173.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.886 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.8 mt -136.98 156.56 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.544 0.688 . . . . 0.2 111.774 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.917 HD11 ' HB ' ' A' ' 42' ' ' ILE . 1.9 tt -134.17 109.51 8.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.673 -1.149 . . . . 0.17 108.146 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.4 mp -97.37 108.07 21.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.324 -0.55 . . . . 0.22 109.763 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.739 HG21 HD23 ' A' ' 53' ' ' LEU . 59.9 t -97.04 88.53 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 110.005 -0.368 . . . . 0.28 110.005 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.8 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.1 t70 -134.77 140.79 46.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.517 -0.549 . . . . 1.82 109.517 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.893 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 35.8 t70 -88.81 -49.4 6.85 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.141 -0.349 . . . . 0.51 111.016 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HG3' HD12 ' A' ' 15' ' ' ILE . 9.2 pt20 -76.57 73.1 3.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.628 -0.879 . . . . 2.07 108.628 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.565 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 52.0 p90 -44.94 -12.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 112.206 -2.27 . . . . 1.44 115.986 -167.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.28 -58.87 4.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.978 -1.106 . . . . 0.38 110.789 170.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.634 HD12 ' HG3' ' A' ' 12' ' ' GLN . 2.3 mt -59.42 -27.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.608 0.718 . . . . 0.8 110.409 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.897 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.3 ttm180 -78.79 -43.83 24.58 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.879 -1.055 . . . . 0.38 110.513 -167.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.728 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 39.2 pt -80.46 -26.11 11.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.459 0.475 . . . . 0.56 109.901 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 19' ' ' LEU . 1.8 tp -59.05 -63.54 1.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.08 -0.711 . . . . 0.58 109.08 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.02 HD21 HD22 ' A' ' 52' ' ' LEU . 8.1 tp -57.93 -41.15 82.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.759 -1.109 . . . . 1.23 110.531 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.728 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.9 t-20 -51.14 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.406 -0.815 . . . . 0.94 110.566 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.55 -41.88 42.57 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.224 0.952 . . . . 2.46 112.244 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.8 t -55.1 -63.19 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.457 0.169 . . . . 0.37 111.457 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.797 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 16.1 m-85 -70.3 -37.31 74.76 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.379 -0.6 . . . . 0.43 109.379 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.832 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 12.0 t-20 -50.25 -49.01 54.4 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.93 -1.032 . . . . 0.28 109.024 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -60.52 -46.77 88.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.524 -1.671 . . . . 3.25 111.714 -176.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' OE2' ' HB2' ' A' ' 112' ' ' ARG . 9.6 pt-20 -80.71 11.87 3.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.451 -0.499 . . . . 1.45 112.235 -174.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.582 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 132.93 -16.53 4.72 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.523 -0.762 . . . . 0.44 112.963 171.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.832 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 12.3 m-85 -82.15 137.0 35.07 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.3 -0.96 . . . . 1.07 111.875 -166.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.802 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.9 mt-30 -89.05 83.62 6.57 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.413 -0.958 . . . . 1.14 108.413 168.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.886 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -91.33 132.54 36.1 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.898 -0.592 . . . . 0.14 110.193 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 9.9 m-85 -121.68 124.39 44.17 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 122.486 1.136 . . . . 0.34 109.254 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.897 ' HB2' HH11 ' A' ' 16' ' ' ARG . 4.5 pt20 -84.18 119.8 25.44 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 112.839 -1.982 . . . . 0.22 111.693 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.953 ' HB1' ' HB3' ' A' ' 38' ' ' GLN . . . -119.22 138.35 53.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.441 -0.948 . . . . 0.23 108.441 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.495 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -97.15 -7.54 32.29 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.596 -0.841 . . . . 0.18 110.3 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.599 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 5.5 p-10 -146.42 166.0 27.68 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 120.152 -0.619 . . . . 0.29 111.68 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.64 -22.68 78.03 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.605 -0.725 . . . . 0.14 112.543 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' HB2' HD22 ' A' ' 35' ' ' ASN . 3.3 mm? -78.84 -38.24 38.49 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.052 -0.722 . . . . 0.28 109.052 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.953 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -59.0 -46.19 88.79 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 104.618 -2.364 . . . . 1.29 104.618 175.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -59.19 -49.14 79.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.501 -1.681 . . . . 0.14 111.594 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.37 -42.13 66.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.674 0.749 . . . . 0.97 109.405 176.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.27 -30.22 60.37 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.708 -1.133 . . . . 1.32 111.47 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.917 ' HB ' HD11 ' A' ' 7' ' ' LEU . 8.8 mm -68.24 -46.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 O-C-N 121.714 -0.616 . . . . 0.14 110.003 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.2 t -58.07 -42.91 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.065 0.936 . . . . 0.15 108.771 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -34.66 70.15 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.037 -1.438 . . . . 0.39 111.388 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.741 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.92 -47.29 7.68 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.421 0.526 . . . . 2.42 112.421 -174.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 46.0 mm-40 -107.44 -32.7 7.62 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.19 0.441 . . . . 0.63 112.19 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 27.4 mtp85 63.69 61.17 1.74 Allowed Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 123.694 0.621 . . . . 3.66 110.247 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.788 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.2 Cg_exo -60.73 153.82 59.63 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 121.435 1.423 . . . . 0.21 111.635 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.745 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 5.2 m-20 -85.91 -42.01 14.45 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.303 -0.999 . . . . 0.98 108.303 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 49' ' ' ASP . 7.7 mp -111.56 111.61 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.422 -0.808 . . . . 0.26 110.585 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' HB3' ' A' ' 7' ' ' LEU . 91.7 t -109.99 113.54 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.075 0.464 . . . . 0.21 111.414 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.02 HD22 HD21 ' A' ' 19' ' ' LEU . 2.0 mp -87.47 87.34 7.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.53 0.681 . . . . 0.15 109.773 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 9' ' ' VAL . 37.8 mt -84.88 110.31 18.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.786 -1.097 . . . . 1.53 111.124 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.66 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 49.1 t0 -68.82 115.88 8.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.616 0.722 . . . . 1.47 111.1 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.489 ' SD ' HG12 ' A' ' 63' ' ' ILE . 9.2 mmm -84.33 -3.51 58.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.65 -1.159 . . . . 0.94 111.343 176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' NZ ' ' HB2' ' A' ' 83' ' ' ALA . 22.2 mmmt -61.75 -65.57 0.67 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.893 0.701 . . . . 2.24 112.893 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.969 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 10.1 tp -169.81 -30.69 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.594 1.331 . . . . 2.06 114.594 -171.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -23.72 -55.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 124.08 3.186 . . . . 0.45 116.204 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -144.6 -62.75 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.824 -1.179 . . . . 0.47 112.702 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.7 ttm -148.76 167.29 25.98 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.277 -0.638 . . . . 2.23 109.277 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 65' ' ' ILE . 7.3 m-20 -58.48 127.7 33.46 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.297 0.57 . . . . 0.67 109.485 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.36 -15.9 33.12 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.703 -1.135 . . . . 0.32 112.528 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 93' ' ' SER . 3.0 mm -77.75 -41.4 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 117.456 0.628 . . . . 1.31 110.379 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -68.48 -37.31 80.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.723 -0.671 . . . . 0.47 109.335 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.538 ' HB ' HD13 ' A' ' 53' ' ' LEU . 14.5 mt -72.72 -36.37 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.69 110.714 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.65 HD22 HG21 ' A' ' 78' ' ' VAL . 2.8 pp -67.32 -36.13 80.84 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.259 -0.576 . . . . 1.47 109.814 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.9 ptpp? -75.77 -32.62 60.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.619 -0.832 . . . . 0.65 111.354 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' CG ' ' HA ' ' A' ' 65' ' ' ILE . 10.9 ptp180 -67.71 -35.17 78.3 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 118.968 -1.093 . . . . 2.18 111.493 174.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.781 ' HA ' HG12 ' A' ' 72' ' ' ILE . 9.5 ptp -80.29 -17.31 52.48 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 120.164 -0.615 . . . . 1.28 109.641 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.4 mptp? -70.3 -40.83 74.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.363 -0.977 . . . . 1.3 108.363 167.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 67' ' ' LYS . 95.8 t -61.75 -39.16 82.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 1.03 110.605 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.781 HG12 ' HA ' ' A' ' 69' ' ' MET . 32.0 pt -85.19 -20.25 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.676 -0.41 . . . . 0.26 110.655 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.69 85.22 0.55 Allowed 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 112.555 0.576 . . . . 1.08 112.555 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.9 mt-10 -73.96 5.56 4.11 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.412 -0.805 . . . . 1.78 109.845 173.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.15 -28.52 62.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.562 1.172 . . . . 0.35 108.033 170.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.618 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.3 tt -76.06 161.63 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-N 112.843 -1.98 . . . . 0.21 111.403 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -138.47 176.76 8.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.737 -1.12 . . . . 1.08 108.179 173.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.68 HG11 HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -142.65 153.01 17.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 119.941 -0.704 . . . . 0.79 111.806 -173.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.712 HG23 ' OG1' ' A' ' 100' ' ' THR . 71.3 mt -124.71 73.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.328 -1.36 . . . . 0.6 107.328 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -65.41 138.23 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.216 -0.902 . . . . 0.14 111.829 -171.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.773 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 6.1 mtm -94.18 117.93 30.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.089 -0.96 . . . . 1.88 110.317 -174.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 11.0 p -125.82 157.4 37.65 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.667 -0.697 . . . . 1.13 112.163 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . . . -73.97 60.66 0.77 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.716 -0.675 . . . . 0.54 110.436 167.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 58.4 t80 60.43 54.61 3.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.334 0.587 . . . . 4.3 111.554 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.2 87.34 0.03 OUTLIER Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.891 -0.595 . . . . 0.62 113.475 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.657 ' N ' HG13 ' A' ' 90' ' ' ILE . 22.5 mt-10 -87.12 16.12 5.43 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.948 0.499 . . . . 1.33 111.582 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 87' ' ' LEU . 3.7 mm? 63.65 179.35 0.16 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.8 1.407 . . . . 1.73 114.8 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 89' ' ' MET . 1.7 t70 61.82 -93.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.268 -1.333 . . . . 1.38 111.658 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.824 ' HB3' HG13 ' A' ' 63' ' ' ILE . 1.1 mpt? -64.25 -14.34 55.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.066 0.46 . . . . 2.72 110.577 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.657 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.5 mm -77.34 -22.1 14.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.366 0.603 . . . . 0.67 110.605 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 13.4 mt-30 -81.15 -47.2 13.78 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.793 -1.188 . . . . 2.5 107.793 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.615 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 19.7 tt0 -65.33 -33.56 76.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.929 -1.487 . . . . 1.27 112.671 -177.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.833 ' HB3' HD12 ' A' ' 63' ' ' ILE . 7.9 p -52.45 -74.78 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.06 0.933 . . . . 1.28 111.611 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.6 pttt -53.78 -35.91 61.84 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.779 -1.555 . . . . 1.91 111.992 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -62.11 -34.3 76.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.886 -0.326 . . . . 1.84 111.161 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.3 mt -81.31 -24.66 37.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.896 0.379 . . . . 1.25 111.019 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.31 -1.79 0.25 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 119.877 -1.154 . . . . 0.35 113.706 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.649 ' CA ' HG23 ' A' ' 78' ' ' VAL . . . -70.74 132.15 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.954 0.877 . . . . 0.21 109.605 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.41 HD11 ' HG ' ' A' ' 50' ' ' LEU . 12.5 mt -75.29 -48.25 24.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.043 0.925 . . . . 0.18 109.392 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.712 ' OG1' HG23 ' A' ' 79' ' ' ILE . 71.1 p -141.72 156.74 45.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.889 -1.505 . . . . 0.19 111.914 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.62 98.62 8.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.354 -1.294 . . . . 0.52 109.47 171.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.773 ' HB3' ' HA ' ' A' ' 81' ' ' MET . 26.0 t80 -56.41 143.23 35.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.445 -0.798 . . . . 3.86 109.441 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -130.32 167.45 18.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.759 -0.46 . . . . 0.76 109.759 172.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 54.5 mtpt -68.15 -40.88 23.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.203 -0.453 . . . . 3.35 111.387 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 58.0 Cg_endo -76.6 96.36 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.767 0.952 . . . . 1.36 110.62 166.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.625 ' HB2' HD11 ' A' ' 111' ' ' ILE . 53.0 p90 -129.03 143.62 50.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.059 -0.519 . . . . 1.1 111.607 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.511 ' HB3' ' HG2' ' A' ' 110' ' ' GLU . 1.8 t70 -75.25 -3.68 34.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.888 -0.596 . . . . 1.77 110.712 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 107' ' ' ASP . 9.4 tp 52.2 -53.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.613 1.565 . . . . 1.39 112.206 -165.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.458 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 35.0 t70 -65.9 -26.99 67.87 Favored 'General case' 0 C--O 1.211 -0.924 0 O-C-N 122.384 -0.197 . . . . 1.16 110.94 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 11.3 pt-20 -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.203 -0.599 . . . . 0.84 109.864 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 106' ' ' PHE . 47.7 mt -83.23 -43.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.74 109.559 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.636 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -65.42 -39.58 92.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.809 -0.811 . . . . 0.72 108.809 175.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.8 t70 -67.95 -40.53 83.24 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.187 -0.671 . . . . 0.78 109.187 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.612 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.63 -48.71 74.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.324 -0.853 . . . . 0.59 110.927 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 112' ' ' ARG . 34.3 m -61.93 -48.23 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 120.082 -0.647 . . . . 0.47 111.173 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.631 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -70.91 -19.91 62.54 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.598 0.592 . . . . 1.16 112.598 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 7.4 pttm -86.61 -23.14 25.83 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.415 -0.914 . . . . 1.48 111.154 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.523 ' HD2' ' O ' ' A' ' 114' ' ' ALA . 28.4 m-85 -82.17 -67.19 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.024 -0.362 . . . . 2.21 110.024 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.0 95.05 49.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.26 -0.645 . . . . 2.09 109.26 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 84.1 Cg_endo -91.1 141.65 2.96 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.857 2.372 . . . . 0.92 113.942 -173.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.786 HD22 ' HB3' ' A' ' 4' ' ' GLU . 29.7 tp . . . . . 0 CA--C 1.51 -0.564 0 CA-C-O 121.725 0.774 . . . . 1.25 109.84 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.818 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 3.0 tp10 . . . . . 0 C--O 1.22 -0.49 0 N-CA-C 107.325 -1.361 . . . . 2.3 107.325 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.73 ' HD3' ' HB3' ' A' ' 46' ' ' GLU . 2.7 ttmt -150.31 139.73 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.188 1.181 . . . . 0.8 114.188 -167.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.938 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -139.39 154.82 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.233 -1.349 . . . . 0.2 111.49 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.01 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.4 tt -135.55 117.95 15.73 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.52 -1.289 . . . . 0.17 107.52 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.749 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -103.7 100.92 11.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.987 -0.685 . . . . 0.22 110.132 -177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.777 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 48.8 t -83.61 91.25 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.559 -0.534 . . . . 0.28 109.559 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.83 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.7 t70 -143.35 142.98 31.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.543 0.211 . . . . 1.82 110.607 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.883 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 15.2 t70 -102.46 -31.62 10.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.891 0.377 . . . . 0.51 110.27 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -79.12 70.91 5.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.507 -1.294 . . . . 2.07 107.507 172.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 17' ' ' ILE . 46.7 p90 -52.29 -15.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 112.88 -1.964 . . . . 1.44 115.099 -159.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.64 -60.9 5.54 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.906 -1.14 . . . . 0.38 110.334 169.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HA ' HD23 ' A' ' 18' ' ' LEU . 2.9 mt -55.17 -30.49 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.333 0.587 . . . . 0.8 111.056 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.83 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.1 ttm180 -76.29 -49.79 16.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.749 . . . . 0.38 110.596 -168.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.5 pt -76.19 -25.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.598 -0.519 . . . . 0.56 109.598 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 15' ' ' ILE . 2.8 tp -57.24 -65.26 0.65 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.348 -0.842 . . . . 0.58 109.457 171.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.827 HD13 HD22 ' A' ' 52' ' ' LEU . 57.8 mt -58.26 -44.15 88.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.23 109.939 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.609 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.5 t30 -50.5 -66.17 0.43 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.36 -0.837 . . . . 0.94 110.128 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.47 -39.21 82.95 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.662 0.601 . . . . 2.46 111.396 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.9 t -55.08 -58.17 5.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 111.787 0.291 . . . . 0.37 111.787 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.694 ' CD2' HD13 ' A' ' 6' ' ' ILE . 7.9 m-85 -73.56 -40.09 64.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.256 -0.646 . . . . 0.43 109.256 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.8 t-20 -50.78 -50.23 56.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.066 -0.97 . . . . 0.28 108.557 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -51.11 -46.75 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.275 -1.784 . . . . 3.25 112.58 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.625 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 6.5 pt-20 -88.21 16.16 6.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.116 -0.634 . . . . 1.45 111.544 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.79 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 126.98 -15.45 6.53 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.495 -0.859 . . . . 0.44 113.581 169.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.818 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 10.2 m-85 -73.83 160.22 31.77 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 118.899 -1.12 . . . . 1.07 112.407 -168.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.697 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 2.1 mp0 -106.83 76.32 1.1 Allowed 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.101 -1.409 . . . . 1.14 107.337 173.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.938 HG22 ' HB ' ' A' ' 6' ' ' ILE . 27.2 p -90.68 130.55 36.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.876 -1.056 . . . . 0.14 109.457 -173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.462 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.3 m-85 -126.9 108.96 11.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.632 1.206 . . . . 0.34 109.876 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.753 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.1 pt20 -61.29 120.72 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 112.483 -2.144 . . . . 0.22 112.577 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -124.33 125.94 45.17 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.957 0.903 . . . . 0.23 109.094 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -82.84 -11.03 58.55 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.042 -0.663 . . . . 0.18 111.058 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 1.7 p-10 -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.077 0.399 . . . . 0.29 112.077 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.5 -19.34 78.94 Favored Glycine 0 CA--C 1.506 -0.492 0 CA-C-N 115.794 -0.639 . . . . 0.14 113.051 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.62 -40.91 24.83 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.154 0.978 . . . . 0.28 108.949 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.827 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -61.17 -41.87 97.54 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.391 -2.077 . . . . 1.29 105.391 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -59.27 -46.74 87.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.157 -1.383 . . . . 0.14 111.17 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -53.76 -48.27 69.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.623 -0.717 . . . . 0.97 109.816 175.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.55 -39.1 92.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.42 -1.264 . . . . 1.32 111.064 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.86 ' HB ' HD11 ' A' ' 7' ' ' LEU . 20.0 mm -65.94 -48.68 81.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.234 -0.439 . . . . 0.14 110.083 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.494 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 59.4 t -58.46 -42.73 85.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.15 109.231 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.36 -29.74 70.09 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.117 -0.947 . . . . 0.39 111.425 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -88.94 -46.6 8.77 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.299 0.481 . . . . 2.42 112.299 -177.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.73 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 46.3 mm-40 -108.45 -35.05 6.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 111.975 0.361 . . . . 0.63 111.975 -176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 45.4 mtp180 63.69 60.39 1.8 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.294 -0.867 . . . . 3.66 109.889 -171.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 32.1 Cg_exo -62.65 146.62 95.31 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 121.376 1.384 . . . . 0.21 110.95 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 m-20 -85.96 -35.24 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.409 -0.916 . . . . 0.98 109.389 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 7.0 mp -113.13 111.11 21.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.26 109.638 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 7' ' ' LEU . 19.0 t -117.34 112.59 39.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.383 -0.372 . . . . 0.21 110.821 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.827 HD22 HD13 ' A' ' 19' ' ' LEU . 3.2 mp -83.59 104.67 13.9 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.957 -0.464 . . . . 0.15 110.496 -176.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.777 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 8.1 mp -99.04 102.52 14.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.516 -0.311 . . . . 1.53 111.824 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.658 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t70 -63.83 111.1 2.31 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.527 -0.469 . . . . 1.47 110.059 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.741 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 17.1 mtm -91.37 12.38 20.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.234 -0.439 . . . . 0.94 111.013 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.658 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 14.2 mmmm -70.61 -65.91 0.67 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.782 0.289 . . . . 2.24 111.782 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.995 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 2.3 pt -160.72 -39.5 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.908 1.077 . . . . 2.06 113.908 -169.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -21.2 -60.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 124.905 3.737 . . . . 0.45 116.928 -175.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.68 -66.64 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.651 -1.262 . . . . 0.47 113.0 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 49.5 ttm -139.69 164.14 30.73 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 2.23 109.414 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.463 ' O ' HG13 ' A' ' 65' ' ' ILE . 2.7 m-20 -61.06 134.67 57.31 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.75 -0.463 . . . . 0.67 109.75 174.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -62.01 -15.23 49.08 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 115.451 -0.795 . . . . 0.32 112.378 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.611 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 9.6 mt -78.3 -44.25 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.061 -0.67 . . . . 1.31 109.836 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.58 -33.56 74.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.351 0.596 . . . . 0.47 110.048 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 53' ' ' LEU . 31.9 mt -74.16 -39.38 49.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.69 110.453 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 2.9 pp -65.92 -36.8 84.37 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 120.187 -0.605 . . . . 1.47 109.951 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.1 ptpt -75.42 -36.08 60.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 120.491 -0.483 . . . . 0.65 111.391 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 11.2 ptm180 -64.87 -36.86 85.7 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 119.497 -0.881 . . . . 2.18 111.144 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.79 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.4 ptp -82.46 -14.12 55.6 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.102 -0.639 . . . . 1.28 109.618 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -70.45 -40.02 73.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.089 -1.078 . . . . 1.3 108.089 167.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 67' ' ' LYS . 94.0 t -62.54 -38.58 81.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.453 -0.794 . . . . 1.03 110.125 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.79 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.1 pt -86.47 -19.03 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.525 -0.47 . . . . 0.26 111.074 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.96 86.12 0.42 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.484 0.55 . . . . 1.08 112.484 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.586 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.1 mt-10 -70.53 1.34 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.046 -1.034 . . . . 1.78 110.646 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -30.43 64.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.596 1.189 . . . . 0.35 108.05 171.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.783 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.9 tt -69.24 161.54 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.636 -2.075 . . . . 0.21 111.482 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -141.56 174.72 10.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.849 -1.069 . . . . 1.08 108.649 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 98' ' ' ALA . 10.1 m -141.54 143.4 27.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.55 0.69 . . . . 0.79 111.273 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.625 HG23 ' OG1' ' A' ' 100' ' ' THR . 4.2 mp -108.79 75.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.581 -1.266 . . . . 0.6 107.581 174.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.741 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -69.51 141.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 119.363 -0.935 . . . . 0.14 112.016 -172.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.596 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 27.8 mtt -95.23 136.78 35.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.22 -0.9 . . . . 1.88 110.335 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.533 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.7 t -132.83 158.12 43.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.117 0.784 . . . . 1.13 113.117 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . . . -72.71 64.16 0.64 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.544 -1.207 . . . . 0.54 109.654 169.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 70.15 15.06 7.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.235 -0.893 . . . . 4.3 112.32 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.28 92.03 1.07 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.58 -0.819 . . . . 0.62 111.412 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.566 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.4 mt-10 -88.03 7.25 32.15 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 122.927 0.491 . . . . 1.33 111.644 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 59.9 -175.11 0.11 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.47 -0.786 . . . . 1.73 112.813 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.86 -93.34 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.083 -0.962 . . . . 1.38 112.324 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.533 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.8 ptt? -61.2 -24.11 66.09 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.137 0.494 . . . . 2.72 110.332 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.1 mm -66.01 -47.38 85.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 0.67 109.952 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 14.1 mm100 -61.64 -50.23 73.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.39 -0.823 . . . . 2.5 109.647 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 13.3 tt0 -63.59 -33.44 75.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.041 -0.981 . . . . 1.27 112.431 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -59.13 -63.7 1.21 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.662 0.268 . . . . 1.28 110.631 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.9 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 20.6 pttt -55.83 -40.18 72.45 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.433 0.635 . . . . 1.91 110.871 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 6.8 tp10 -54.52 -35.59 63.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 1.84 111.51 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.416 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 18.1 tp -90.19 -10.86 42.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.723 0.268 . . . . 1.25 111.723 -173.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.554 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 154.86 -12.13 0.45 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.76 -1.21 . . . . 0.35 113.644 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.9 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -73.99 145.59 44.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.292 0.546 . . . . 0.21 110.784 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 77' ' ' ARG . 16.7 mt -87.86 -50.37 6.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.501 0.667 . . . . 0.18 109.797 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.625 ' OG1' HG23 ' A' ' 79' ' ' ILE . 52.3 p -143.26 160.44 40.48 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.263 -1.335 . . . . 0.19 111.433 -170.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -109.98 98.22 7.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.846 -1.07 . . . . 0.52 110.081 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HD2' HD12 ' A' ' 111' ' ' ILE . 43.7 t80 -68.29 124.86 24.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.611 -0.722 . . . . 3.86 109.954 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.07 178.0 5.28 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.769 -0.372 . . . . 0.76 110.463 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 94.2 mttt -53.37 -47.16 97.15 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.501 0.556 . . . . 3.35 112.501 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 57.5 Cg_endo -73.27 97.49 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 120.86 1.04 . . . . 1.36 111.593 173.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.411 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 40.5 p90 -133.37 138.22 46.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.968 -0.56 . . . . 1.1 110.727 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.645 ' O ' HG22 ' A' ' 108' ' ' ILE . 8.0 t70 -72.82 -4.99 35.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.895 -0.593 . . . . 1.77 111.078 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 107' ' ' ASP . 6.3 tt 59.41 -56.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.856 1.262 . . . . 1.39 110.598 -165.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.96 -38.86 92.77 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 110.26 -0.274 . . . . 1.16 110.26 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.583 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 pt-20 -61.19 -27.92 68.77 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.695 -0.402 . . . . 0.84 110.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.611 HD12 ' HD2' ' A' ' 102' ' ' PHE . 4.7 mm -77.43 -50.91 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.354 -0.61 . . . . 0.74 109.354 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.625 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -66.87 -36.43 82.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.563 0.697 . . . . 0.72 109.697 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.526 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 35.0 t70 -69.56 -42.45 74.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.635 -0.711 . . . . 0.78 109.088 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.88 -40.74 98.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.525 -0.761 . . . . 0.59 110.978 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 112' ' ' ARG . 33.0 m -63.83 -53.38 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 119.15 -1.02 . . . . 0.47 110.952 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -69.68 -16.85 63.43 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.343 0.497 . . . . 1.16 112.343 -178.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 18.6 ptpt -83.64 -26.89 29.54 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.29 -0.881 . . . . 1.48 111.041 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -81.42 -59.39 2.64 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.996 0.427 . . . . 2.21 109.955 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 44.2 tp -120.55 107.83 38.24 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.368 -0.975 . . . . 2.09 108.368 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.54 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 91.2 Cg_endo -100.86 146.97 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.893 2.395 . . . . 0.92 114.683 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.79 HD23 ' HA3' ' A' ' 27' ' ' GLY . 16.4 tp . . . . . 0 N--CA 1.449 -0.518 0 CA-C-N 115.474 -0.785 . . . . 1.25 110.536 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.809 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 7.3 tt0 . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 122.096 0.95 . . . . 2.3 111.612 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.853 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -131.28 152.41 50.57 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.012 -0.994 . . . . 0.8 110.622 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.836 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.3 mt -142.36 154.25 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.614 0.721 . . . . 0.2 111.645 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.859 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.2 tt -132.11 122.04 24.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.418 -1.326 . . . . 0.17 107.418 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.6 mp -108.71 106.33 20.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.125 -0.63 . . . . 0.22 109.59 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 23.5 t -95.11 71.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 O-C-N 122.97 0.169 . . . . 0.28 110.683 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.836 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.1 m-20 -118.33 135.63 54.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.651 0.262 . . . . 1.82 111.208 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 1.05 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 29.7 t70 -86.69 -27.46 23.71 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.184 -1.043 . . . . 0.51 108.184 171.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.793 ' HB2' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -78.88 73.37 5.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.475 -1.306 . . . . 2.07 107.475 167.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 40.3 p90 -54.13 -17.49 2.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.829 -1.532 . . . . 1.44 113.178 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.5 -63.89 4.87 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.925 -1.27 . . . . 0.38 109.925 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 12' ' ' GLN . 3.0 mt -53.62 -25.28 11.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.869 0.366 . . . . 0.8 111.574 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.868 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 10.2 ttm180 -76.94 -50.24 13.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.308 -0.406 . . . . 0.38 111.081 -171.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.1 pt -74.74 -24.67 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.193 -0.669 . . . . 0.56 109.193 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.7 tp -57.27 -67.76 0.29 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.928 -1.033 . . . . 0.58 109.493 170.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 52' ' ' LEU . 60.5 mt -54.64 -40.88 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 1.23 110.451 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.8 t30 -50.68 -69.25 0.12 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.585 -0.734 . . . . 0.94 110.139 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.3 -39.41 75.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 2.46 111.568 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 18' ' ' LEU . 49.4 t -57.1 -55.69 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 111.999 0.37 . . . . 0.37 111.999 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.694 ' HB2' HG21 ' A' ' 30' ' ' THR . 6.7 m-85 -77.03 -37.73 54.27 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.782 -0.451 . . . . 0.43 109.782 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.823 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 17.1 t-20 -49.95 -50.3 47.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.033 0.921 . . . . 0.28 109.189 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.09 -33.68 71.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.343 -1.753 . . . . 3.25 113.06 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.672 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 4.2 mt-10 -68.08 -23.49 64.94 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.307 -0.627 . . . . 1.45 109.307 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.05 -13.32 2.6 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.66 -1.155 . . . . 0.44 110.569 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.823 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 6.7 m-85 -72.65 134.25 45.02 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.612 0.72 . . . . 1.07 111.557 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.853 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 19.2 mt-30 -88.61 80.95 7.19 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.212 -1.033 . . . . 1.14 108.212 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.836 HG22 ' HB ' ' A' ' 6' ' ' ILE . 17.2 p -90.25 137.32 32.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.808 -0.633 . . . . 0.14 110.026 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.584 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 38.1 m-85 -129.78 126.09 37.32 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.677 1.227 . . . . 0.34 110.272 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.868 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 4.6 pt20 -85.28 121.13 27.57 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.639 -2.073 . . . . 0.22 111.93 -171.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -121.47 137.12 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.89 . . . . 0.23 108.894 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 58' ' ' PRO . . . -93.06 -10.72 35.09 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.778 -0.369 . . . . 0.18 110.42 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.541 HD22 ' HB2' ' A' ' 37' ' ' LEU . 3.1 p-10 -149.0 165.8 30.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.29 111.444 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -71.94 -16.3 76.47 Favored Glycine 0 CA--C 1.504 -0.611 0 CA-C-N 115.747 -0.66 . . . . 0.14 113.467 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.541 ' HB2' HD22 ' A' ' 35' ' ' ASN . 2.8 mm? -81.31 -43.73 18.68 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.679 1.228 . . . . 0.28 108.038 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.8 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 tp-100 -60.33 -41.11 92.87 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.114 -2.312 . . . . 1.29 105.49 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.78 -44.23 90.66 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.699 -1.591 . . . . 0.14 111.079 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.581 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.3 OUTLIER -55.5 -42.63 74.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.401 -0.592 . . . . 0.97 109.401 175.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 14.7 m-20 -64.65 -41.79 95.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.108 -0.951 . . . . 1.32 110.906 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.859 ' HB ' HD11 ' A' ' 7' ' ' LEU . 9.9 mm -61.04 -50.11 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 121.015 -0.274 . . . . 0.14 110.748 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -59.04 -45.33 92.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-O 121.817 0.817 . . . . 0.15 109.45 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.581 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -59.87 -28.91 67.94 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.868 -1.06 . . . . 0.39 111.783 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -96.04 -46.66 6.41 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.966 -0.561 . . . . 2.42 111.848 -173.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 60.8 mm-40 -105.07 -36.52 7.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.733 0.271 . . . . 0.63 111.733 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 64.58 65.96 1.0 Allowed Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.776 0.672 . . . . 3.66 109.929 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.808 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 76.9 Cg_exo -58.97 161.42 15.75 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.803 1.669 . . . . 0.21 112.118 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.784 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.7 m-20 -94.63 -40.04 10.03 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.195 -1.039 . . . . 0.98 108.195 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mp -116.91 118.6 32.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.255 -0.884 . . . . 0.26 109.876 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 7' ' ' LEU . 96.7 t -118.06 112.02 36.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.122 0.487 . . . . 0.21 110.871 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -82.9 98.5 9.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.46 0.647 . . . . 0.15 109.544 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.677 HD12 ' HA2' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -88.18 99.71 12.41 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.972 -1.013 . . . . 1.53 111.007 -175.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 23.2 t0 -68.23 100.8 1.08 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.351 -0.611 . . . . 1.47 109.351 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.782 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 44.9 mtp -77.03 -5.9 50.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.041 -0.527 . . . . 0.94 110.95 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.2 mmmm -50.63 -54.64 21.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.267 0.84 . . . . 2.24 113.267 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.864 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 10.4 tp -177.48 -11.09 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 114.974 1.472 . . . . 2.06 114.974 -171.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.05 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -32.09 -51.04 0.33 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.991 2.461 . . . . 0.45 115.723 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.36 -43.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.913 -1.137 . . . . 0.47 112.739 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.8 tpt -147.81 167.23 25.27 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.816 -0.809 . . . . 2.23 108.816 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.23 139.1 57.29 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.247 0.546 . . . . 0.67 110.308 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.677 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -60.53 -15.06 38.04 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.984 -1.007 . . . . 0.32 112.49 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.829 HG13 ' HB3' ' A' ' 89' ' ' MET . 3.7 mm -79.85 -47.64 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.736 0.303 . . . . 1.31 110.311 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -61.43 -36.72 81.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.657 0.741 . . . . 0.47 109.216 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 68.1 mt -72.73 -36.93 54.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.137 -0.938 . . . . 0.69 111.225 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.624 ' CD2' ' HA ' ' A' ' 63' ' ' ILE . 2.2 pp -70.65 -37.44 73.73 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.289 -0.564 . . . . 1.47 110.715 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.663 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.1 ptpt -73.06 -34.57 66.36 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.526 -0.469 . . . . 0.65 110.964 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.702 ' O ' HG12 ' A' ' 71' ' ' VAL . 12.0 ptm180 -65.5 -34.68 78.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.436 -0.905 . . . . 2.18 111.29 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.685 ' HA ' HG12 ' A' ' 72' ' ' ILE . 4.7 ptt? -83.66 -12.33 56.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.894 -1.122 . . . . 1.28 109.864 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.6 mptp? -78.81 -35.05 44.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.635 -0.711 . . . . 1.3 110.058 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -73.79 -34.33 40.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.742 -0.663 . . . . 1.03 109.419 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.685 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.0 pt -80.85 -34.77 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.373 -0.83 . . . . 0.26 110.204 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -155.79 90.39 1.22 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.565 0.58 . . . . 1.08 112.565 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.04 4.72 3.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.525 0.679 . . . . 1.78 110.34 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -26.1 63.84 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.488 -1.301 . . . . 0.35 107.488 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.9 tt -77.32 160.43 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 112.706 -2.043 . . . . 0.21 110.919 -172.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.692 ' HE ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -137.63 -179.68 5.89 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.356 -0.838 . . . . 1.08 109.046 173.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.614 HG21 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -134.48 153.53 35.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.299 -0.561 . . . . 0.79 110.218 -172.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.635 HG23 ' OG1' ' A' ' 100' ' ' THR . 63.4 mt -130.73 71.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.411 -1.329 . . . . 0.6 107.411 170.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.782 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -68.31 139.61 20.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.257 -0.883 . . . . 0.14 111.849 -172.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 4.8 mtp -99.1 131.62 45.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.044 -0.98 . . . . 1.88 110.445 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 t -133.3 158.52 42.75 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.048 0.758 . . . . 1.13 113.048 -175.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.48 65.66 0.66 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.028 -0.987 . . . . 0.54 109.719 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.515 ' HE1' ' HE2' ' A' ' 104' ' ' LYS . 49.8 m-85 71.44 15.27 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 4.3 112.677 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 90' ' ' ILE . . . 85.51 79.87 1.14 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.332 -0.937 . . . . 0.62 111.522 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 90' ' ' ILE . 6.9 mt-10 -75.86 14.96 0.58 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.817 0.847 . . . . 1.33 111.693 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 27.6 mt 59.36 -170.48 0.13 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.62 0.97 . . . . 1.73 113.62 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 58.74 -94.6 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.801 -1.09 . . . . 1.38 110.885 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.829 ' HB3' HG13 ' A' ' 63' ' ' ILE . 3.1 mpp? -64.36 -19.66 65.62 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.943 0.402 . . . . 2.72 110.368 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 86' ' ' GLU . 41.6 mm -75.88 -23.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.601 0.715 . . . . 0.67 110.592 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 91' ' ' GLN . 10.6 mt-30 -82.37 -48.58 10.98 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.029 -1.1 . . . . 2.5 108.029 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 89' ' ' MET . 38.8 tt0 -63.48 -30.54 71.65 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 113.708 -1.587 . . . . 1.27 112.149 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.632 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 16.8 p -53.66 -77.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.094 0.95 . . . . 1.28 112.245 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 13.1 ptpt -51.0 -41.0 59.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.506 -1.679 . . . . 1.91 110.79 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 4.6 tp10 -54.58 -44.82 73.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.387 -0.824 . . . . 1.84 111.612 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.62 HD23 HD11 ' A' ' 66' ' ' LEU . 12.4 tp -82.68 -15.94 50.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 1.25 111.778 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.527 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 149.41 1.67 0.37 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.672 -1.251 . . . . 0.35 113.954 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 94' ' ' LYS . . . -80.64 137.54 36.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.992 0.896 . . . . 0.21 109.769 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.5 mt -76.3 -48.59 19.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.87 0.843 . . . . 0.18 109.411 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.635 ' OG1' HG23 ' A' ' 79' ' ' ILE . 41.1 p -139.29 150.77 45.82 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.368 -1.287 . . . . 0.19 111.955 -171.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -114.54 67.74 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.04 -0.982 . . . . 0.52 109.735 173.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 81' ' ' MET . 39.1 m-85 -62.18 130.31 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 3.86 110.543 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.16 -167.1 1.36 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.058 -0.519 . . . . 0.76 110.823 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HE2' ' HE1' ' A' ' 84' ' ' TYR . 46.1 mtmt -55.59 -43.08 98.98 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.226 -0.443 . . . . 3.35 112.064 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 44.1 Cg_endo -70.5 97.26 0.69 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 120.816 1.011 . . . . 1.36 111.218 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB2' HD11 ' A' ' 111' ' ' ILE . 45.1 p90 -131.7 136.71 47.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.732 -0.667 . . . . 1.1 110.049 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.7 t70 -84.73 14.38 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 1.77 111.04 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.2 tt 50.45 -64.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 125.095 1.497 . . . . 1.39 112.315 -171.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.8 OUTLIER -65.36 -23.87 67.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.815 -0.175 . . . . 1.16 110.66 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' OE2' ' HB2' ' A' ' 107' ' ' ASP . 8.9 pt-20 -68.5 -28.2 66.81 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.4 -0.52 . . . . 0.84 110.421 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' A' ' 106' ' ' PHE . 28.3 mt -81.21 -40.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.74 110.256 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.672 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.04 -37.1 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.843 0.83 . . . . 0.72 109.577 174.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.524 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 4.7 t70 -68.44 -37.02 79.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.379 -0.828 . . . . 0.78 109.359 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.506 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.98 -47.66 82.21 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.323 -0.853 . . . . 0.59 111.224 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.638 HG12 HD22 ' A' ' 50' ' ' LEU . 17.8 m -62.82 -48.77 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 119.209 -0.996 . . . . 0.47 110.377 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -53.98 -50.33 66.79 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.145 0.578 . . . . 1.16 112.237 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 19.1 ptpt -60.21 -35.54 75.66 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.778 -0.576 . . . . 1.48 111.462 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.497 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 24.6 m-85 -76.07 -56.4 4.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.993 0.425 . . . . 2.21 110.836 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.9 tp -127.47 97.53 30.8 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.925 -0.58 . . . . 2.09 109.686 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -98.58 117.29 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.83 2.354 . . . . 0.92 113.215 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.793 ' HB2' ' CD ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 122.138 0.97 . . . . 1.25 109.409 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 110.169 -0.308 . . . . 6.07 110.169 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 55.4 mtt -64.48 144.2 57.36 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.765 -0.457 . . . . 3.88 109.765 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -77.41 -5.58 50.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.085 -0.507 . . . . 2.35 111.398 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.828 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 13.8 tt0 69.57 101.92 0.06 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.545 0.688 . . . . 2.3 110.976 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.915 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.7 tppt? -134.74 145.15 48.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.108 0.48 . . . . 0.8 111.533 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.918 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.7 mt -136.7 156.41 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.305 -0.861 . . . . 0.2 111.454 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.862 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.1 tt -133.48 120.16 20.5 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.656 -1.239 . . . . 0.17 107.656 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.724 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.8 mp -107.48 103.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.474 -0.89 . . . . 0.22 110.385 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 28.9 t -88.7 82.62 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 110.051 -0.351 . . . . 0.28 110.051 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.859 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 51.8 t0 -133.5 138.92 46.36 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.115 -0.328 . . . . 1.82 110.115 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 1.013 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 37.0 t70 -85.82 -27.83 24.87 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.022 -0.732 . . . . 0.51 109.022 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' CB ' HD12 ' A' ' 15' ' ' ILE . 9.5 mm-40 -78.86 73.47 5.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.51 -1.293 . . . . 2.07 107.51 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 41.8 p90 -48.47 -19.67 0.34 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.511 -1.222 . . . . 1.44 113.271 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.03 -69.71 1.19 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.36 -1.096 . . . . 0.38 110.36 167.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.553 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 2.9 mp -51.03 -26.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 122.916 0.486 . . . . 0.8 111.863 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.94 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 9.0 ttm180 -76.96 -46.53 23.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.312 -0.404 . . . . 0.38 110.73 -172.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.49 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 36.3 pt -77.03 -25.45 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.283 -0.636 . . . . 0.56 109.283 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.5 tp -53.9 -66.19 0.44 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.135 -0.939 . . . . 0.58 109.157 169.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 64.5 mt -57.25 -39.95 76.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 1.23 110.57 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.72 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.5 t30 -51.53 -67.87 0.22 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.94 110.042 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -39.59 77.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.313 0.486 . . . . 2.46 112.313 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' LEU . 39.5 t -55.18 -58.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.787 0.292 . . . . 0.37 111.787 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.677 ' HB2' HG21 ' A' ' 30' ' ' THR . 8.2 m-85 -73.74 -35.13 65.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.287 -0.635 . . . . 0.43 109.287 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.932 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.3 t-20 -50.48 -47.93 56.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.06 -0.973 . . . . 0.28 108.668 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -57.68 -42.2 83.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.315 -1.766 . . . . 3.25 111.938 -178.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.079 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 3.2 mt-10 -58.62 -26.82 64.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.809 0.814 . . . . 1.45 109.719 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.682 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 139.09 -10.61 3.32 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 114.193 -1.367 . . . . 0.44 110.295 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.932 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 1.8 m-85 -71.62 124.03 23.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 120.119 -0.632 . . . . 1.07 110.838 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.915 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -79.12 82.99 5.23 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.26 -1.015 . . . . 1.14 108.26 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.918 HG22 ' HB ' ' A' ' 6' ' ' ILE . 20.6 p -91.04 134.02 34.84 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.973 -0.558 . . . . 0.14 110.493 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 12.9 m-85 -125.48 120.76 31.83 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.57 1.176 . . . . 0.34 109.419 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.94 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 5.2 pt20 -81.18 121.72 26.48 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 112.736 -2.029 . . . . 0.22 111.693 -173.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.919 ' HB1' ' HB3' ' A' ' 38' ' ' GLN . . . -122.14 131.3 53.89 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.696 0.799 . . . . 0.23 109.145 176.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.569 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -91.16 -7.17 52.25 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.983 -0.687 . . . . 0.18 110.897 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.557 HD22 ' HB2' ' A' ' 37' ' ' LEU . 2.4 p-10 -147.73 165.5 30.33 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.42 -0.512 . . . . 0.29 111.699 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -23.16 73.13 Favored Glycine 0 CA--C 1.507 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.14 113.118 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.557 ' HB2' HD22 ' A' ' 35' ' ' ASN . 2.9 mm? -76.54 -39.87 51.6 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.725 -0.843 . . . . 0.28 108.725 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.919 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -60.51 -44.88 95.55 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.091 -2.189 . . . . 1.29 105.091 177.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -61.14 -44.43 97.34 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.14 111.252 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.61 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -55.83 -44.82 78.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.461 0.648 . . . . 0.97 109.473 175.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -61.59 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.666 -1.152 . . . . 1.32 110.32 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.841 HG12 ' O ' ' A' ' 38' ' ' GLN . 8.5 mm -63.69 -47.35 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 120.551 0.215 . . . . 0.14 111.418 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 69' ' ' MET . 41.2 t -59.88 -42.43 89.16 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.678 0 CA-C-O 121.486 0.66 . . . . 0.15 109.506 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -72.31 -22.15 61.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.562 -0.745 . . . . 0.39 111.197 -177.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.83 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 2.1 ptmt -89.82 -44.89 9.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 2.42 111.225 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' HE3' ' A' ' 5' ' ' LYS . 60.6 mm-40 -111.14 -35.71 5.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 111.897 0.332 . . . . 0.63 111.897 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 43' ' ' VAL . 37.6 mmt180 69.01 59.83 0.62 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 123.936 0.772 . . . . 3.66 109.123 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' ILE . 52.4 Cg_exo -61.23 153.74 63.01 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 121.457 1.438 . . . . 0.21 111.222 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.3 m-20 -92.69 -34.1 14.09 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.713 -0.795 . . . . 0.98 109.415 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 79' ' ' ILE . 7.8 mp -118.57 113.33 21.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.013 -0.54 . . . . 0.26 110.214 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 7' ' ' LEU . 46.9 t -113.26 112.19 39.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.017 0.437 . . . . 0.21 111.665 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 2.9 mp -82.06 94.28 7.17 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.277 0.56 . . . . 0.15 110.389 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.682 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -83.04 98.8 9.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.18 -0.918 . . . . 1.53 111.635 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.63 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 35.6 t70 -70.98 103.91 2.82 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.426 -0.91 . . . . 1.47 109.156 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.624 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 19.9 mtm -80.29 -1.07 39.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.015 -0.539 . . . . 0.94 110.772 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.561 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 12.6 mmmm -56.9 -67.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.724 1.009 . . . . 2.24 113.724 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.859 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 4.6 pt -152.91 -22.87 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.638 1.347 . . . . 2.06 114.638 -167.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.013 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -33.62 -48.12 0.46 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.356 2.704 . . . . 0.45 115.564 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 -48.36 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.551 -1.309 . . . . 0.47 113.077 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.418 ' HG2' ' N ' ' A' ' 61' ' ' ASP . 58.1 ttm -143.35 163.35 33.28 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.113 -0.699 . . . . 2.23 109.113 -175.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 60' ' ' MET . 35.3 m-20 -61.15 136.57 58.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.094 0.473 . . . . 0.67 109.961 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 53' ' ' LEU . . . -63.65 -9.93 34.83 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.309 -0.948 . . . . 0.32 112.157 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.927 HD11 ' HB3' ' A' ' 89' ' ' MET . 4.7 mt -73.33 -52.64 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.123 0.487 . . . . 1.31 110.067 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.81 -33.21 75.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.749 0.785 . . . . 0.47 109.231 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 49.7 mt -74.82 -37.7 42.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.177 -0.92 . . . . 0.69 110.912 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 3.1 pp -66.96 -36.2 81.67 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.414 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.707 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.9 ptpt -75.84 -34.63 60.09 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.453 -0.499 . . . . 0.65 111.175 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.729 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.1 ptm180 -66.78 -33.49 75.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.559 -0.857 . . . . 2.18 111.054 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.761 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.8 ptp -82.8 -13.69 55.76 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.561 -0.856 . . . . 1.28 109.889 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.3 mptp? -79.12 -29.83 43.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.572 0.701 . . . . 1.3 109.877 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.4 p -78.47 -34.98 18.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.028 -0.73 . . . . 1.03 109.028 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.761 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -81.14 -28.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 0.26 109.98 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -157.94 88.93 0.98 Allowed 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 112.928 0.714 . . . . 1.08 112.928 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.0 1.73 10.28 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.047 -1.033 . . . . 1.78 109.831 175.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -27.29 63.86 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.796 1.284 . . . . 0.35 107.722 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.69 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.2 tt -74.25 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 112.492 -2.14 . . . . 0.21 110.938 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 3.4 ptp180 -139.21 174.32 10.64 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.981 -1.118 . . . . 1.08 107.981 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.696 HG23 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -138.97 148.32 24.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.618 0.723 . . . . 0.79 111.47 -173.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.694 HG23 ' OG1' ' A' ' 100' ' ' THR . 63.3 mt -119.72 72.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.961 -1.126 . . . . 0.6 107.961 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.642 HG22 ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -68.65 141.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.318 -0.856 . . . . 0.14 111.768 -172.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.555 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 4.0 mtm -102.05 135.22 44.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.012 -0.995 . . . . 1.88 110.595 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 t -133.4 161.59 34.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.493 0.663 . . . . 1.13 112.672 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . . . -74.1 52.74 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.99 -1.005 . . . . 0.54 110.593 169.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.406 ' HA ' ' CB ' ' A' ' 103' ' ' ALA . 22.4 t80 72.84 30.86 1.67 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.974 -1.012 . . . . 4.3 112.085 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.87 76.53 1.23 Allowed Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.885 -0.674 . . . . 0.62 112.892 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.446 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.5 mt-10 -81.06 12.04 3.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.444 -0.878 . . . . 1.33 111.799 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 87' ' ' LEU . 21.2 mt 54.38 -169.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.391 0.886 . . . . 1.73 113.391 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 58.08 -97.62 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.337 -0.847 . . . . 1.38 110.852 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.927 ' HB3' HD11 ' A' ' 63' ' ' ILE . 57.6 mtm -51.52 -37.01 47.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.834 0.854 . . . . 2.72 110.731 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 86' ' ' GLU . 33.0 mm -58.78 -47.67 88.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.67 111.109 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -60.69 -55.05 37.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.451 -0.795 . . . . 2.5 109.51 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HG2' HG21 ' A' ' 63' ' ' ILE . 7.0 tt0 -58.42 -33.57 69.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.853 -1.067 . . . . 1.27 112.085 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.47 ' OG ' HG12 ' A' ' 63' ' ' ILE . 4.9 m -54.08 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.63 0.729 . . . . 1.28 111.8 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.828 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 12.8 ptpt -52.33 -37.35 55.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.837 -1.074 . . . . 1.91 111.004 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 17.7 tp10 -55.98 -37.99 69.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.965 -1.016 . . . . 1.84 112.1 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.9 mt -85.77 -15.09 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.795 0.665 . . . . 1.25 112.795 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.48 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 147.54 4.18 0.39 Allowed Glycine 0 C--N 1.317 -0.519 0 C-N-CA 119.778 -1.201 . . . . 0.35 113.023 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.828 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -79.21 131.69 36.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.263 0.532 . . . . 0.21 109.936 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.513 HD11 ' HG3' ' A' ' 77' ' ' ARG . 11.2 mt -74.39 -49.32 23.06 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.856 0.836 . . . . 0.18 109.734 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.694 ' OG1' HG23 ' A' ' 79' ' ' ILE . 41.3 p -140.14 153.45 46.67 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.0 -1.455 . . . . 0.19 111.756 -170.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -116.96 85.7 2.37 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.871 -1.059 . . . . 0.52 109.215 172.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -76.43 145.66 39.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 3.86 110.579 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 84' ' ' TYR . . . -121.68 -168.43 1.69 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.109 -0.496 . . . . 0.76 112.001 -173.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 45.5 mtpt -52.92 -50.4 81.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.168 -0.924 . . . . 3.35 111.654 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 68.9 Cg_endo -75.46 97.43 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.127 1.218 . . . . 1.36 111.393 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 111' ' ' ILE . 46.9 p90 -129.24 133.45 47.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.822 -0.626 . . . . 1.1 110.208 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.672 ' O ' HG22 ' A' ' 108' ' ' ILE . 7.3 t70 -72.73 -4.27 30.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.916 -0.584 . . . . 1.77 111.413 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.672 HG22 ' O ' ' A' ' 107' ' ' ASP . 3.6 tt 63.06 -54.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.559 1.144 . . . . 1.39 109.882 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.2 -34.98 79.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.576 -0.284 . . . . 1.16 110.516 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.5 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 11.5 pt-20 -65.15 -27.41 68.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.579 -0.449 . . . . 0.84 110.772 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 106' ' ' PHE . 19.3 mt -80.51 -44.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.108 -0.33 . . . . 0.74 110.108 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.522 ' NH1' ' HA ' ' A' ' 124' ' ' ASN . 2.4 ppt_? -69.73 -35.47 75.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.776 0.798 . . . . 0.72 109.423 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.0 t70 -63.77 -42.63 97.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.695 -0.854 . . . . 0.78 108.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.973 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -60.29 -48.79 80.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.857 -1.065 . . . . 0.59 111.462 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 112' ' ' ARG . 35.5 m -61.3 -43.06 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.912 -0.715 . . . . 0.47 111.004 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 8.3 ttpt -58.06 -55.96 28.18 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 120.909 0.385 . . . . 1.16 111.151 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.973 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 46.1 pttt -65.68 -13.15 58.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.516 0.562 . . . . 1.48 112.516 -176.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -92.01 -41.2 10.67 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.583 -0.447 . . . . 2.21 111.443 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -146.6 95.96 4.51 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.331 -0.988 . . . . 2.09 108.331 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -96.4 123.74 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.815 2.344 . . . . 0.92 114.182 -171.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 4' ' ' GLU . 12.7 tp -105.44 -65.48 1.05 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.356 0.598 . . . . 1.25 110.076 176.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.727 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 48.5 mtmt -136.39 -57.97 0.74 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.171 -0.922 . . . . 2.78 109.21 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.079 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 89.8 p 60.26 171.12 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.021 1.119 . . . . 2.17 114.021 171.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.522 ' HA ' ' NH1' ' A' ' 112' ' ' ARG . 57.1 m-80 70.73 -108.42 0.06 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.452 -1.249 . . . . 5.26 111.509 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -179.78 -43.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.358 -0.979 . . . . 5.75 108.358 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.48 90.72 2.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.126 -0.943 . . . . 8.65 110.986 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.0 m80 60.15 -169.69 0.15 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.283 0.563 . . . . 9.73 111.125 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -109.32 95.88 5.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.786 -0.82 . . . . 12.67 108.786 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -121.19 -179.82 4.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.568 -0.287 . . . . 12.92 110.95 -174.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -67.02 -47.97 69.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 16.51 110.944 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -68.72 145.38 53.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.245 -0.434 . . . . 17.15 110.425 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.413 ' HB3' HH21 ' A' ' 112' ' ' ARG . 20.0 m170 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.82 -0.609 . . . . 19.6 110.255 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.027 -0.36 . . . . 6.07 110.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 53.2 mtm 66.16 164.8 0.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.944 0.778 . . . . 3.88 111.27 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.409 ' HB3' HE22 ' A' ' 29' ' ' GLN . 64.8 t30 -149.4 19.56 0.94 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.58 -0.526 . . . . 2.35 109.58 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.854 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER 69.83 102.37 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.411 -0.813 . . . . 2.3 110.848 177.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.632 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 4.0 tppt? -134.6 140.44 46.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.016 0.436 . . . . 0.8 112.06 -173.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.891 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.9 mt -137.0 155.84 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.276 -0.874 . . . . 0.2 112.061 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.863 ' HG ' HG21 ' A' ' 42' ' ' ILE . 3.4 tt -133.86 118.35 17.87 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 107.934 -1.136 . . . . 0.17 107.934 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -105.72 102.98 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.886 -0.725 . . . . 0.22 110.211 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 44.3 t -89.38 79.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 122.967 0.167 . . . . 0.28 110.68 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.827 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.3 t70 -129.97 140.84 50.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 1.82 110.817 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.812 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 26.9 t70 -94.81 -32.91 13.07 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.501 -0.318 . . . . 0.51 111.048 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 70.07 8.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.497 -1.297 . . . . 2.07 107.497 173.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.441 ' O ' HG12 ' A' ' 17' ' ' ILE . 41.1 p90 -47.94 -16.08 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 111.862 -2.426 . . . . 1.44 115.342 -166.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.49 -61.62 6.18 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.751 -1.339 . . . . 0.38 109.751 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 3.1 mt -54.92 -29.34 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.224 0.535 . . . . 0.8 111.136 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.869 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -77.58 -48.67 16.36 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.772 -0.649 . . . . 0.38 111.055 -168.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 41.5 pt -75.71 -25.06 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.247 -0.649 . . . . 0.56 109.247 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.2 tp -58.64 -66.28 0.52 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.251 -0.886 . . . . 0.58 109.699 170.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 80.3 mt -53.83 -43.71 69.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.075 -0.343 . . . . 1.23 110.075 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.1 t30 -50.31 -66.1 0.45 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.261 -0.881 . . . . 0.94 110.079 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.81 -39.84 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.888 0.742 . . . . 2.46 110.75 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -54.86 -60.1 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.52 -0.309 . . . . 0.37 111.423 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.655 ' HB2' HG21 ' A' ' 30' ' ' THR . 2.0 m-85 -70.95 -39.99 72.26 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.016 -0.735 . . . . 0.43 109.016 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.627 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.2 t-20 -52.26 -52.69 51.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.895 -1.048 . . . . 0.28 109.333 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 2.8 tmmm? -60.87 -43.13 98.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.722 -1.581 . . . . 3.25 111.93 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.879 ' HB2' ' HA ' ' A' ' 123' ' ' SER . 10.9 pt-20 -81.92 13.15 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 1.45 111.193 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.02 3.03 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.369 -0.92 . . . . 0.44 113.427 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.854 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 7.8 m-85 -77.76 150.25 34.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.926 0.869 . . . . 1.07 112.511 -165.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.632 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.3 mt-30 -98.01 82.15 2.94 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.91 -1.041 . . . . 1.14 108.336 166.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.891 HG22 ' HB ' ' A' ' 6' ' ' ILE . 19.3 p -92.52 138.59 31.37 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.659 -0.7 . . . . 0.14 109.883 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 10.5 m-85 -128.55 107.55 9.8 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.869 1.319 . . . . 0.34 110.299 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.869 ' HB2' HH11 ' A' ' 16' ' ' ARG . 5.3 pt20 -59.53 121.11 10.72 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 112.035 -2.348 . . . . 0.22 112.516 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.721 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -124.94 129.7 50.88 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 108.89 -0.781 . . . . 0.23 108.89 174.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.731 ' HB2' HH21 ' A' ' 16' ' ' ARG . . . -90.4 -9.65 46.78 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.07 -0.652 . . . . 0.18 110.831 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 3.4 p-10 -148.39 164.48 33.98 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.038 -0.528 . . . . 0.29 111.736 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 65' ' ' ILE . . . -69.42 -22.14 76.3 Favored Glycine 0 CA--C 1.504 -0.597 0 CA-C-N 115.254 -0.885 . . . . 0.14 113.745 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.36 -41.57 21.79 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 122.216 1.008 . . . . 0.28 108.946 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.808 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.1 tp60 -60.53 -39.67 88.7 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.584 -2.006 . . . . 1.29 105.584 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.57 88.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.132 -1.395 . . . . 0.14 111.281 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.547 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -56.41 -47.87 78.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.38 -0.827 . . . . 0.97 109.728 176.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -63.83 -36.0 82.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.326 -1.306 . . . . 1.32 111.317 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.863 HG21 ' HG ' ' A' ' 7' ' ' LEU . 26.7 mm -65.47 -49.47 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.277 -0.268 . . . . 0.14 110.277 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.7 t -58.68 -43.14 86.97 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.265 1.031 . . . . 0.15 108.835 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -58.13 -30.9 66.69 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.361 -1.291 . . . . 0.39 111.702 177.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.546 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 5.7 tptt -90.57 -50.48 5.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.064 -0.517 . . . . 2.42 111.511 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 58.1 mm-40 -106.1 -35.95 7.07 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.583 0.586 . . . . 0.63 112.583 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 43.6 mtt180 62.93 65.02 1.44 Allowed Pre-proline 0 C--N 1.322 -0.589 0 O-C-N 123.673 0.608 . . . . 3.66 110.323 -170.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.76 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 66.4 Cg_exo -60.32 163.48 14.77 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.116 1.877 . . . . 0.21 111.635 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.781 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.8 m-20 -92.6 -44.48 8.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.973 -0.751 . . . . 0.98 108.973 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.762 HD23 HD11 ' A' ' 79' ' ' ILE . 7.6 mp -107.29 110.4 22.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.26 110.014 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 7' ' ' LEU . 62.6 t -110.16 107.35 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.453 . . . . 0.21 111.197 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 3.1 mp -78.51 95.93 5.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.432 0.634 . . . . 0.15 110.032 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.63 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -85.65 92.83 8.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.951 -1.022 . . . . 1.53 110.2 -176.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.673 ' OD1' ' HG2' ' A' ' 56' ' ' LYS . 34.6 t70 -68.59 108.82 3.49 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.75 0.786 . . . . 1.47 109.739 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.632 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 20.8 mtm -93.48 16.89 12.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.226 -0.897 . . . . 0.94 110.244 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.673 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 2.9 mmpp? -54.09 -53.43 53.27 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 120.075 -0.65 . . . . 2.24 110.445 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.932 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.5 tt -179.83 -19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.563 -1.208 . . . . 2.06 114.209 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.932 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -26.81 -54.43 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.465 2.777 . . . . 0.45 116.014 -175.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.48 -55.65 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.742 -1.218 . . . . 0.47 112.904 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.427 ' HB3' HD11 ' A' ' 65' ' ' ILE . 46.0 tpp -142.25 165.15 28.21 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.35 -0.611 . . . . 2.23 109.35 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.2 m-20 -60.39 140.22 57.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.67 110.785 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.585 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -64.65 -12.48 52.91 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.825 -1.079 . . . . 0.32 112.184 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.635 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 11.9 mt -76.51 -46.72 31.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 1.31 110.149 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -60.07 -43.0 95.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.658 -0.868 . . . . 0.47 108.658 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.626 HD12 ' HA3' ' A' ' 36' ' ' GLY . 16.5 mm -68.6 -43.18 83.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.475 -0.784 . . . . 0.69 111.452 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 96' ' ' LEU . 3.0 pp -62.5 -37.66 86.91 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.718 -0.393 . . . . 1.47 110.236 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.0 ptpt -76.03 -36.37 59.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.125 -0.63 . . . . 0.65 111.827 -176.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HG3' HD23 ' A' ' 40' ' ' LEU . 3.0 ptm180 -67.38 -34.39 77.18 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.819 -1.152 . . . . 2.18 111.004 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.681 ' HG3' HG21 ' A' ' 76' ' ' ILE . 11.8 ptp -78.85 -18.58 53.75 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.018 -0.673 . . . . 1.28 109.725 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.4 mptt -70.95 -40.59 71.91 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.554 -0.906 . . . . 1.3 108.554 169.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 67' ' ' LYS . 92.8 t -61.41 -38.21 79.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.423 -0.808 . . . . 1.03 110.531 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.68 HG12 ' HA ' ' A' ' 69' ' ' MET . 19.1 pt -83.86 -30.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.377 -0.529 . . . . 0.26 110.325 175.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -156.04 83.48 1.01 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.728 0.64 . . . . 1.08 112.728 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 32.4 mt-10 -69.99 2.56 3.41 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.293 -0.879 . . . . 1.78 111.272 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -28.44 65.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.737 1.256 . . . . 0.35 107.729 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.681 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.8 tt -75.52 158.12 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 112.587 -2.097 . . . . 0.21 111.208 -172.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.781 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -134.19 -178.28 4.97 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.11 -0.95 . . . . 1.08 108.496 175.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.648 HG23 ' CA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -143.09 148.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 120.133 -0.627 . . . . 0.79 111.019 -175.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.762 HD11 HD23 ' A' ' 50' ' ' LEU . 64.5 mt -117.87 71.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.725 -1.213 . . . . 0.6 107.725 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.632 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.81 141.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 119.045 -1.062 . . . . 0.14 111.181 -172.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.515 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 22.4 mtp -109.25 111.91 23.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.676 -1.147 . . . . 1.88 110.412 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.708 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 1.2 t -120.55 166.65 13.33 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 122.162 -0.336 . . . . 1.13 111.316 -175.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.37 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.782 -0.644 . . . . 0.54 111.375 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 13.5 t80 59.67 3.66 0.46 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.828 1.251 . . . . 4.3 112.39 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.96 93.18 1.87 Allowed Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.923 -0.656 . . . . 0.62 112.354 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 90' ' ' ILE . 30.9 mt-10 -74.8 11.85 0.97 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 1.33 111.002 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 85' ' ' GLY . 26.4 mt 64.81 -177.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.593 0.96 . . . . 1.73 113.593 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 62.17 -92.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.606 -1.179 . . . . 1.38 111.327 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.503 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 71.0 mtm -64.23 -22.91 67.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 120.925 0.393 . . . . 2.72 110.428 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.582 HG13 ' N ' ' A' ' 86' ' ' GLU . 42.8 mm -67.03 -39.95 84.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.181 0.515 . . . . 0.67 110.012 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.67 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 12.7 mm100 -67.24 -42.29 84.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.264 -0.88 . . . . 2.5 108.996 176.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.628 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 9.4 tt0 -63.16 -39.92 96.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.371 -1.286 . . . . 1.27 112.047 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.425 ' CB ' HG12 ' A' ' 63' ' ' ILE . 8.5 t -55.37 -62.96 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 1.28 110.414 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.958 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 50.3 pttt -56.93 -36.79 70.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.998 -0.546 . . . . 1.91 111.892 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -65.99 -22.97 66.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.081 -0.248 . . . . 1.84 111.545 -178.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.722 ' HB3' HD11 ' A' ' 66' ' ' LEU . 4.4 mp -88.63 -4.98 58.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 1.25 111.495 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.42 16.72 1.84 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.864 -1.16 . . . . 0.35 113.135 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.958 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -89.39 132.01 35.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.121 -0.696 . . . . 0.21 109.121 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.679 HD21 ' HD3' ' A' ' 77' ' ' ARG . 13.9 mt -73.63 -49.07 27.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.807 0.813 . . . . 0.18 109.506 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.668 ' OG1' HG23 ' A' ' 79' ' ' ILE . 70.0 p -141.51 142.8 33.57 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.081 -1.418 . . . . 0.19 111.519 -173.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.31 85.73 2.41 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.811 -1.086 . . . . 0.52 109.457 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 13.3 m-85 -75.1 157.46 34.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 3.86 109.893 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -98.71 -170.71 1.98 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.338 0.496 . . . . 0.76 112.338 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 44.6 tttp -73.19 -45.47 8.03 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.087 -0.708 . . . . 3.35 109.087 172.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 36.1 Cg_endo -68.29 97.89 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.438 1.425 . . . . 1.36 111.026 166.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -112.67 139.32 48.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.488 -0.778 . . . . 1.1 109.65 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -87.56 20.21 3.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 119.238 -0.41 . . . . 1.77 111.306 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 109' ' ' ASP . 2.4 tt 49.18 -66.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 1.39 112.781 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.478 ' H ' HG23 ' A' ' 108' ' ' ILE . 5.6 t70 -64.27 -25.78 68.2 Favored 'General case' 0 C--O 1.212 -0.884 0 O-C-N 122.397 -0.189 . . . . 1.16 110.807 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.59 -27.86 65.46 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 120.425 -0.51 . . . . 0.84 109.765 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -76.65 -47.5 28.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.224 -0.658 . . . . 0.74 109.224 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.38 -39.32 85.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.122 0.487 . . . . 0.72 109.922 179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 24.4 t70 -65.72 -43.34 89.35 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.304 -0.628 . . . . 0.78 109.304 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.943 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.96 -51.05 69.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.666 -0.697 . . . . 0.59 111.124 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 112' ' ' ARG . 27.0 m -59.02 -50.77 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.844 -0.742 . . . . 0.47 111.475 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -65.36 -29.34 70.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.345 0.498 . . . . 1.16 112.345 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.943 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 56.9 pttt -81.52 -11.74 59.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.49 -0.884 . . . . 1.48 111.507 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.6 -58.65 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.175 0.512 . . . . 2.21 110.176 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.512 ' HG ' ' OE1' ' A' ' 4' ' ' GLU . 57.1 tp -122.67 109.77 32.28 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.384 -0.969 . . . . 2.09 108.384 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 47.4 Cg_endo -101.44 148.13 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.773 2.315 . . . . 0.92 114.331 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -125.67 -70.1 0.75 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.766 -0.828 . . . . 1.25 108.766 174.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.57 ' HE2' HD22 ' A' ' 121' ' ' LEU . 75.0 mmtt -133.79 -63.04 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.553 -1.203 . . . . 2.78 108.19 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.879 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 12.4 p 37.52 -89.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 125.04 1.462 . . . . 2.17 114.088 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -155.95 120.57 4.64 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.356 -0.609 . . . . 5.26 109.356 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 129' ' ' HIS . 89.7 mt -82.39 44.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.131 0.491 . . . . 5.75 110.059 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.474 ' H ' ' HG3' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -52.1 -56.98 10.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.725 -1.125 . . . . 8.65 113.308 -172.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -127.85 -67.45 0.82 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.031 0.443 . . . . 9.73 110.017 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -87.98 75.48 8.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.62 0.724 . . . . 12.67 111.112 -175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 125' ' ' LEU . 2.6 p-80 -95.81 103.65 15.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.51 -0.768 . . . . 12.92 109.874 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -104.58 133.13 49.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 16.51 110.549 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -86.57 107.49 18.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.2 -0.667 . . . . 17.15 109.2 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-N 115.135 -0.939 . . . . 19.6 110.197 -175.072 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.948 0.404 . . . . 6.07 110.727 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.587 ' O ' HD13 ' A' ' 121' ' ' LEU . 15.9 ptt? -109.82 174.93 5.64 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.361 -0.607 . . . . 3.88 109.361 173.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.532 ' HB3' ' NE2' ' A' ' 29' ' ' GLN . 83.5 m-20 -94.85 106.69 18.69 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.494 -1.299 . . . . 2.35 107.494 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.744 ' CD ' ' HB3' ' A' ' 121' ' ' LEU . 17.5 pt-20 -66.89 127.89 34.24 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.822 -0.626 . . . . 2.3 109.991 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.827 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -117.23 144.88 44.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.8 111.812 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.869 ' HB ' HG22 ' A' ' 30' ' ' THR . 3.4 mt -135.02 153.47 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 114.933 -1.031 . . . . 0.2 111.655 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.861 ' HG ' HG21 ' A' ' 42' ' ' ILE . 2.4 tt -129.51 124.95 35.22 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.562 -1.273 . . . . 0.17 107.562 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.745 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.5 mp -112.26 107.57 23.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.124 -0.63 . . . . 0.22 109.963 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.669 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 57.6 t -96.15 89.55 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.103 -0.332 . . . . 0.28 110.103 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.717 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 0.8 OUTLIER -135.42 136.04 41.07 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.118 -0.492 . . . . 1.82 110.215 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.748 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 20.9 t70 -88.91 -41.65 12.3 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.486 0.184 . . . . 0.51 110.768 -177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HG3' ' CD1' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -78.69 70.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.819 -1.178 . . . . 2.07 107.819 172.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.8 p90 -48.09 -13.72 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 111.856 -2.429 . . . . 1.44 115.588 -163.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.08 -57.38 6.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.249 -0.977 . . . . 0.38 110.937 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 2.4 mt -59.94 -25.85 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.477 0.656 . . . . 0.8 110.664 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 1.0 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.5 ttm180 -78.9 -49.24 13.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.38 110.529 -168.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 37.9 pt -75.07 -24.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.219 -0.66 . . . . 0.56 109.219 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.765 HD11 HD11 ' A' ' 108' ' ' ILE . 7.5 tp -58.09 -67.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.947 -1.024 . . . . 0.58 109.827 171.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.575 HD13 HD22 ' A' ' 52' ' ' LEU . 69.8 mt -54.18 -41.15 68.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.179 -0.464 . . . . 1.23 110.08 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 5.7 t30 -49.94 -70.09 0.1 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.263 -0.88 . . . . 0.94 110.473 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -57.24 -36.9 71.5 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.308 0.38 . . . . 2.46 111.683 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 18' ' ' LEU . 31.1 t -55.92 -55.66 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.592 0.219 . . . . 0.37 111.592 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.717 ' HB2' HG21 ' A' ' 30' ' ' THR . 7.7 m-85 -78.18 -36.73 47.07 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 120.659 -0.416 . . . . 0.43 109.922 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.818 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.8 t-20 -50.27 -45.53 54.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.176 0.989 . . . . 0.28 108.753 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -60.35 -38.44 83.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.09 -1.868 . . . . 3.25 111.9 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.68 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 4.2 mm-40 -55.9 -33.14 64.36 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.297 1.046 . . . . 1.45 109.586 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.79 1.45 3.01 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 113.071 -1.877 . . . . 0.44 109.417 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.818 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 45.4 m-85 -75.37 132.3 40.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.364 0.602 . . . . 1.07 110.666 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.827 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 12.0 mt-30 -86.52 81.38 8.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.79 -1.189 . . . . 1.14 107.79 171.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.869 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.9 p -90.25 132.75 35.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.799 -0.637 . . . . 0.14 110.214 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 20.1 m-85 -124.42 123.75 40.85 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 122.826 1.298 . . . . 0.34 110.13 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 1.0 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.2 pt20 -82.74 121.91 27.49 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.053 -2.339 . . . . 0.22 112.073 -171.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.83 137.42 54.66 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.166 0.987 . . . . 0.23 108.678 174.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.659 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -98.98 -3.81 34.1 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.137 -0.625 . . . . 0.18 110.402 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 5.3 p-10 -148.51 163.7 36.42 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.792 -0.64 . . . . 0.29 111.315 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.17 79.41 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.534 -0.757 . . . . 0.14 113.306 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HB2' HD22 ' A' ' 35' ' ' ASN . 2.9 mm? -80.42 -40.83 25.64 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 122.395 1.093 . . . . 0.28 108.2 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.829 ' O ' HG12 ' A' ' 42' ' ' ILE . 2.6 tp-100 -58.96 -40.42 84.67 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.521 -2.127 . . . . 1.29 105.404 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -65.2 -45.56 84.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.794 -1.548 . . . . 0.14 111.544 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 68' ' ' ARG . 11.7 mt -55.53 -39.31 70.4 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.703 0.763 . . . . 0.97 109.556 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 21.3 t70 -72.3 -38.01 68.83 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.54 -1.209 . . . . 1.32 110.374 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.861 HG21 ' HG ' ' A' ' 7' ' ' LEU . 18.0 mm -58.86 -48.59 85.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 120.685 0.279 . . . . 0.14 110.674 176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 39' ' ' ALA . 24.0 t -61.43 -41.47 90.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.968 0.89 . . . . 0.15 109.723 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -63.23 -28.51 70.09 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.604 -1.18 . . . . 0.39 111.204 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -94.99 -48.53 5.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 2.42 111.766 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 66.7 mm-40 -104.63 -37.05 7.26 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.69 0.256 . . . . 0.63 111.69 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 62.88 67.83 1.05 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.787 -0.642 . . . . 3.66 110.02 -169.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.776 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 45.9 Cg_exo -65.03 154.89 71.18 Favored 'Trans proline' 0 CA--C 1.503 -1.035 0 C-N-CA 121.858 1.705 . . . . 0.21 111.424 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.805 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 8.3 m-20 -89.65 -41.69 11.8 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.723 -0.791 . . . . 0.98 109.013 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.538 HD23 HD11 ' A' ' 79' ' ' ILE . 6.7 mp -108.02 110.05 21.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.211 -0.45 . . . . 0.26 110.166 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.816 ' HB ' HG12 ' A' ' 78' ' ' VAL . 57.9 t -109.95 109.32 27.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.081 0.467 . . . . 0.21 111.584 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -80.5 91.15 5.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.393 0.616 . . . . 0.15 109.772 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.818 HD12 HG11 ' A' ' 78' ' ' VAL . 18.5 mt -89.13 103.13 15.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.298 -0.864 . . . . 1.53 111.079 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.625 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 12.4 t70 -67.06 116.83 8.31 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.379 -0.528 . . . . 1.47 110.128 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.643 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 13.0 mtm -98.14 12.19 35.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.793 -0.64 . . . . 0.94 110.696 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 13.0 mmmm -64.25 -49.32 72.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.662 -0.245 . . . . 2.24 111.368 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.892 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 17.3 tt 174.81 -28.6 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.718 1.377 . . . . 2.06 114.718 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.892 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -18.31 -59.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 124.546 3.497 . . . . 0.45 116.625 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.95 -63.86 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.072 -1.061 . . . . 0.47 112.225 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.5 tpt -148.72 167.02 26.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.577 -0.897 . . . . 2.23 108.577 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.46 135.67 57.74 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.67 0.748 . . . . 0.67 110.563 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -58.44 -18.79 38.14 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 114.239 -1.346 . . . . 0.32 111.751 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.657 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 4.0 mt -66.97 -49.6 72.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.01 0.433 . . . . 1.31 110.571 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.58 -34.65 77.46 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.635 0.731 . . . . 0.47 109.072 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.548 HG22 ' HE3' ' A' ' 69' ' ' MET . 17.0 mt -73.37 -38.57 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.189 -0.914 . . . . 0.69 111.025 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 4.3 pp -67.02 -35.09 79.13 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 121.074 -0.25 . . . . 1.47 110.412 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.2 ptpt -76.23 -33.41 59.2 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.406 -0.517 . . . . 0.65 111.12 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.2 ptp180 -70.49 -29.84 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 118.752 -1.179 . . . . 2.18 111.579 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.837 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.5 ptp -83.98 -13.36 53.52 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.455 -0.898 . . . . 1.28 109.579 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -78.68 -32.87 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.598 -0.728 . . . . 1.3 109.855 172.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -74.34 -36.27 42.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.781 -0.822 . . . . 1.03 108.781 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.837 HG12 ' HA ' ' A' ' 69' ' ' MET . 20.6 pt -80.62 -21.84 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.092 -0.958 . . . . 0.26 110.325 172.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.734 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 29.7 t0 -164.89 95.32 0.7 Allowed 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 112.887 0.699 . . . . 1.08 112.887 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.631 ' OE1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -77.81 6.09 8.22 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.979 -1.076 . . . . 1.78 110.126 174.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.734 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -78.53 -34.0 47.52 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.339 -1.356 . . . . 0.35 107.339 171.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.71 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.0 tt -60.18 159.38 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.185 -1.825 . . . . 0.21 111.685 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.805 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 2.8 ptp180 -142.76 173.83 11.19 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.989 -1.115 . . . . 1.08 107.989 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.818 HG11 HD12 ' A' ' 53' ' ' LEU . 2.3 m -141.79 147.98 21.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.477 -0.889 . . . . 0.79 112.066 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.672 HG23 ' OG1' ' A' ' 100' ' ' THR . 67.1 mt -116.4 72.85 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.57 -1.27 . . . . 0.6 107.57 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.643 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -67.66 142.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.615 -0.834 . . . . 0.14 112.069 -171.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 10.2 mtt -99.33 124.69 44.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.489 -0.778 . . . . 1.88 110.04 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.58 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t -133.15 160.3 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.998 0.74 . . . . 1.13 112.998 -173.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 63.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.649 -1.16 . . . . 0.54 110.664 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 67.41 5.12 4.09 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.571 0.748 . . . . 4.3 112.418 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.0 88.18 0.75 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.861 -0.685 . . . . 0.62 111.801 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.528 ' N ' HG13 ' A' ' 90' ' ' ILE . 39.7 mt-10 -65.61 -89.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.483 -0.358 . . . . 1.33 111.244 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HG ' ' H ' ' A' ' 88' ' ' ASP . 9.5 tp -177.53 -167.76 0.16 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.69 0.281 . . . . 1.73 111.716 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.722 ' H ' ' HG ' ' A' ' 87' ' ' LEU . 9.3 m-20 43.99 -89.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.857 1.263 . . . . 1.38 113.009 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.641 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 62.7 mtt -56.94 -35.51 69.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.106 -0.497 . . . . 2.72 110.461 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.528 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.6 mm -59.89 -44.76 95.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.81 -0.632 . . . . 0.67 110.278 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.63 -53.53 57.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.559 -0.746 . . . . 2.5 109.385 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 15.8 tt0 -58.9 -34.84 72.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.945 -1.025 . . . . 1.27 112.314 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.4 t -55.34 -69.51 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 1.28 110.89 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 16.6 pttp -55.9 -36.54 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.383 0.611 . . . . 1.91 111.069 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 10.9 tp10 -56.59 -45.37 81.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.864 -1.062 . . . . 1.84 111.99 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.8 mt -70.47 -39.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.38 -0.373 . . . . 1.25 111.16 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.54 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 170.19 15.15 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.818 -1.182 . . . . 0.35 113.52 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.946 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -83.9 128.75 34.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.538 -0.541 . . . . 0.21 109.538 173.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.529 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.6 mt -73.07 -49.44 28.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.891 0.853 . . . . 0.18 109.777 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 79' ' ' ILE . 49.8 p -141.92 158.8 43.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.079 -1.419 . . . . 0.19 111.642 -170.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -110.17 93.47 4.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.816 -1.084 . . . . 0.52 110.28 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HD2' HD12 ' A' ' 111' ' ' ILE . 29.6 t80 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.653 -0.703 . . . . 3.86 109.373 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.26 -178.66 4.05 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.76 111.492 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 65.1 tttp -47.97 -53.85 29.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.345 -0.843 . . . . 3.35 112.769 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 70.3 Cg_endo -77.09 98.28 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.279 1.319 . . . . 1.36 111.706 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 111' ' ' ILE . 33.2 p90 -127.9 129.15 46.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 1.1 110.665 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.646 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 7.0 t70 -67.9 -11.7 59.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.909 -0.587 . . . . 1.77 111.582 -177.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.765 HD11 HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER 71.34 -54.67 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-N 115.718 -0.674 . . . . 1.39 109.259 -164.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 15.9 t70 -66.9 -38.63 86.62 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 109.649 -0.5 . . . . 1.16 109.649 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.646 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 13.2 pt-20 -66.13 -18.94 65.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.84 110.807 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.577 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 7.4 mm -83.1 -45.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.466 -0.568 . . . . 0.74 109.466 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.52 ' HA ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.72 -31.06 67.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.876 0.846 . . . . 0.72 109.161 174.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 21.8 t70 -67.88 -41.18 83.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.998 -1.001 . . . . 0.78 109.324 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.639 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.28 -48.26 71.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.309 -0.859 . . . . 0.59 111.222 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 112' ' ' ARG . 29.4 m -58.95 -47.77 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.791 -0.764 . . . . 0.47 110.422 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 10.5 ttpt -60.94 -51.99 66.91 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.902 -0.59 . . . . 1.16 111.697 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.639 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -55.32 -26.86 43.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.721 -0.392 . . . . 1.48 111.866 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.535 ' HB3' HD22 ' A' ' 119' ' ' LEU . 35.1 m-85 -81.63 -71.72 0.46 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.75 -0.38 . . . . 2.21 111.193 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 118' ' ' TYR . 3.3 mm? -119.65 92.28 46.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.0 -0.37 . . . . 2.09 110.0 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -93.42 121.76 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.801 2.334 . . . . 0.92 113.895 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.837 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 11.7 tp -97.35 -60.04 1.66 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.458 0.647 . . . . 1.25 109.364 172.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.837 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 88.3 mttt -142.63 -60.0 0.44 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.089 -0.959 . . . . 2.78 110.12 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 16.2 t 61.79 14.61 6.35 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.527 -0.761 . . . . 2.17 110.452 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 26' ' ' GLU . 52.1 m-80 61.75 30.3 18.33 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.455 -0.793 . . . . 5.26 111.268 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.82 21.88 0.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.769 -0.651 . . . . 5.75 110.431 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 126' ' ' GLU . 1.3 pm0 -71.12 168.67 16.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.307 -0.86 . . . . 8.65 111.815 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -57.24 -71.84 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.393 -0.821 . . . . 9.73 111.346 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -160.52 144.6 13.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.081 -0.711 . . . . 12.67 109.081 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -83.75 105.36 14.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.618 0.247 . . . . 12.92 110.594 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -83.42 134.68 34.87 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.989 -0.745 . . . . 16.51 108.989 173.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -97.52 143.95 27.71 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.943 0.402 . . . . 17.15 110.766 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.274 -0.869 . . . . 19.6 109.237 178.054 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.589 0.233 . . . . 6.07 111.102 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.403 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 24.3 mmt -78.52 -172.02 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.057 -0.349 . . . . 3.88 110.057 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -58.92 -59.58 5.22 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.032 -1.099 . . . . 2.35 108.032 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.765 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 0.6 OUTLIER 178.76 140.45 0.1 Allowed 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 104.449 -2.426 . . . . 2.3 104.449 167.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.989 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -163.56 141.46 7.6 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.542 -1.263 . . . . 0.8 110.499 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.904 ' HB ' HG22 ' A' ' 30' ' ' THR . 5.1 mt -136.62 153.08 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.313 -0.858 . . . . 0.2 111.659 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.811 HD11 ' HB ' ' A' ' 42' ' ' ILE . 3.3 tt -137.24 117.38 13.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.236 -1.394 . . . . 0.17 107.236 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.639 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.3 mp -106.32 107.99 24.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 119.716 -0.794 . . . . 0.22 110.235 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 47.6 t -93.95 76.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.036 0.21 . . . . 0.28 110.483 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.647 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.2 m-20 -123.45 133.03 54.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.421 . . . . 1.82 110.754 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 1.025 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 22.9 t70 -78.42 -39.04 39.98 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.146 -1.057 . . . . 0.51 108.146 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.837 ' HB2' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -64.23 78.38 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.658 -1.156 . . . . 2.07 108.283 164.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 19.9 p90 -55.84 -16.11 4.13 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.21 -0.905 . . . . 1.44 111.682 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.23 -60.21 9.17 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.875 -0.89 . . . . 0.38 110.875 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.837 HG12 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -58.35 -25.44 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 121.403 0.621 . . . . 0.8 109.972 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.957 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 8.5 ttm180 -79.4 -46.69 17.08 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.092 -0.958 . . . . 0.38 111.148 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 13' ' ' TYR . 38.7 pt -77.4 -27.12 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.441 -0.577 . . . . 0.56 109.441 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.1 tp -56.71 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.58 109.261 170.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.662 ' HG ' ' CZ ' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -53.52 -43.27 68.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.186 -0.915 . . . . 1.23 111.086 175.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.3 t30 -50.97 -70.02 0.1 Allowed 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.671 0.607 . . . . 0.94 109.425 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -55.08 -39.32 69.15 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.416 0.447 . . . . 2.46 112.175 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 112' ' ' ARG . 41.6 t -57.87 -53.64 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.114 0.413 . . . . 0.37 112.114 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.78 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -77.39 -40.26 44.35 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.264 -0.643 . . . . 0.43 109.264 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.779 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 6.4 t-20 -51.11 -44.45 61.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.371 -0.831 . . . . 0.28 108.793 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.22 -1.809 . . . . 3.25 111.613 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -56.19 -34.48 66.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.679 1.228 . . . . 1.45 109.273 177.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . 148.27 -17.53 1.33 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 112.828 -1.987 . . . . 0.44 110.012 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 59.7 m-85 -63.89 134.87 55.95 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 112.755 0.65 . . . . 1.07 112.755 -163.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.936 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 27.9 mt-30 -84.16 77.47 9.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.897 -0.779 . . . . 1.14 108.897 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.904 HG22 ' HB ' ' A' ' 6' ' ' ILE . 11.9 p -90.59 136.19 33.22 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.389 -0.823 . . . . 0.14 110.392 -176.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.4 m-85 -128.78 130.32 46.86 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 122.68 1.229 . . . . 0.34 109.888 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.957 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 3.8 pt20 -86.41 121.23 28.67 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 112.697 -2.047 . . . . 0.22 112.077 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.693 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -121.88 137.9 54.6 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.575 -0.738 . . . . 0.23 109.248 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -95.03 -12.44 26.6 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.118 -0.633 . . . . 0.18 110.133 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 2.0 p-10 -148.72 166.32 28.76 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.828 -0.624 . . . . 0.29 111.6 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -69.02 -20.78 75.03 Favored Glycine 0 CA--C 1.505 -0.534 0 O-C-N 123.899 0.75 . . . . 0.14 113.435 -174.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.93 -43.67 19.41 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.218 1.008 . . . . 0.28 108.666 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.778 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.1 tt0 -63.21 -36.01 82.24 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 112.798 -2.001 . . . . 1.29 105.94 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.77 -46.55 81.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.393 -1.276 . . . . 0.14 111.14 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.77 -48.39 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.67 0.748 . . . . 0.97 109.139 175.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 44' ' ' THR . 7.2 t70 -57.47 -42.93 83.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.155 -1.384 . . . . 1.32 111.09 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.903 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 16.2 mm -63.29 -45.05 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 120.796 -0.361 . . . . 0.14 110.41 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -60.95 -41.67 89.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.707 0.765 . . . . 0.15 109.631 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.34 -24.0 62.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 0.39 111.166 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 42' ' ' ILE . 1.6 ptmt -89.75 -46.91 8.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.159 -0.473 . . . . 2.42 111.195 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 53.0 mm-40 -108.43 -37.93 5.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.706 0.289 . . . . 0.63 111.319 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 78.0 mtp180 66.27 65.62 0.79 Allowed Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.597 -0.728 . . . . 3.66 109.714 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.989 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.4 Cg_exo -64.4 158.55 48.61 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 122.185 1.924 . . . . 0.21 112.029 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.763 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 4.7 m-20 -93.53 -38.47 11.37 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.138 -1.06 . . . . 0.98 108.138 174.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 119' ' ' LEU . 5.7 mp -114.51 111.64 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.26 110.272 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.789 HG13 ' HB3' ' A' ' 7' ' ' LEU . 61.2 t -112.44 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.281 -0.418 . . . . 0.21 111.22 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' A' ' 19' ' ' LEU . 2.7 mp -78.52 93.73 4.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.789 0.804 . . . . 0.15 109.616 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.658 HD12 ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -86.59 96.98 10.28 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.468 -1.242 . . . . 1.53 110.691 -174.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.595 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 9.4 t70 -63.88 116.03 5.42 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.978 -0.689 . . . . 1.47 109.844 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.883 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.7 mtp -94.03 7.53 44.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.666 -0.697 . . . . 0.94 110.992 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 24.9 mmmt -63.82 -66.38 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.173 0.435 . . . . 2.24 112.173 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.021 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 14.6 tt -169.88 -17.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.289 1.588 . . . . 2.06 115.289 -171.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.025 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -27.15 -51.95 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.52 2.813 . . . . 0.45 116.112 175.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.38 -54.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.431 -1.366 . . . . 0.47 113.648 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.517 ' HB3' HD11 ' A' ' 65' ' ' ILE . 19.4 ttt -148.69 166.76 27.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.552 -0.536 . . . . 2.23 109.552 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.16 135.07 57.61 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.188 0.518 . . . . 0.67 109.959 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -62.61 -10.46 30.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.055 -0.975 . . . . 0.32 112.797 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.0 mt -82.84 -47.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.03 0.443 . . . . 1.31 110.593 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.4 mm-40 -64.62 -35.85 82.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.146 -0.687 . . . . 0.47 109.146 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.843 ' O ' ' HG2' ' A' ' 69' ' ' MET . 55.2 mt -72.27 -38.59 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.69 110.122 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.714 HD12 ' CG2' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -53.0 -49.53 66.01 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.44 173.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 71' ' ' VAL . 15.0 ptpt -72.81 -35.61 67.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.65 111.865 -174.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' A' ' 65' ' ' ILE . 4.3 ptp180 -64.35 -33.91 76.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 118.689 -1.204 . . . . 2.18 111.605 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.843 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 10.0 ptp -83.25 -16.51 46.09 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 119.697 -0.801 . . . . 1.28 109.289 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 13.1 mptt -72.32 -38.81 68.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.798 -0.816 . . . . 1.3 108.798 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 67' ' ' LYS . 74.9 t -63.59 -38.52 82.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 1.03 110.616 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.701 HG12 ' HA ' ' A' ' 69' ' ' MET . 11.4 pt -83.73 -30.01 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.535 -0.466 . . . . 0.26 110.608 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 88.03 1.0 Allowed 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 112.277 0.473 . . . . 1.08 112.277 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 37.0 mt-10 -66.39 -2.26 4.34 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.421 -0.799 . . . . 1.78 111.288 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.49 -25.8 60.62 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.696 -1.224 . . . . 0.35 107.696 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 48' ' ' PRO . 2.7 tt -71.34 154.46 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.14 -1.845 . . . . 0.21 110.513 -174.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 5.5 ptp180 -138.72 175.66 9.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.263 -1.014 . . . . 1.08 108.263 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.714 ' CG2' HD12 ' A' ' 66' ' ' LEU . 4.1 m -141.58 145.64 24.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 119.86 -0.736 . . . . 0.79 111.02 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.671 HG23 ' OG1' ' A' ' 100' ' ' THR . 64.0 mt -110.74 75.75 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.668 -1.234 . . . . 0.6 107.668 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.883 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -66.89 139.68 20.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.722 -0.791 . . . . 0.14 112.367 -171.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.547 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 3.0 mtp -101.28 120.18 39.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.155 -0.93 . . . . 1.88 110.586 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.432 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.2 t -133.22 164.57 26.77 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.454 0.538 . . . . 1.13 112.454 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.2 56.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.202 -0.908 . . . . 0.54 111.435 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 74.6 t80 69.24 6.88 5.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.788 0.835 . . . . 4.3 111.016 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 87' ' ' LEU . . . 96.77 93.49 1.85 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.705 -0.759 . . . . 0.62 111.9 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' N ' HG13 ' A' ' 90' ' ' ILE . 33.6 mt-10 -71.69 9.6 0.84 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.239 0.542 . . . . 1.33 110.93 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 85' ' ' GLY . 40.9 mt 58.91 -169.5 0.13 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 1.73 113.006 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 54.87 -93.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.011 -0.995 . . . . 1.38 111.349 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.533 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 91.3 mtp -65.15 -23.96 67.27 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.666 0.27 . . . . 2.72 110.344 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.641 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.5 mm -66.61 -41.08 87.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.67 110.386 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.566 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 14.2 mt-30 -67.26 -35.53 79.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.014 0.911 . . . . 2.5 108.83 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 33.2 tt0 -72.85 -31.98 65.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.0 -1.455 . . . . 1.27 111.448 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.422 ' CB ' HG12 ' A' ' 63' ' ' ILE . 14.6 t -59.04 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 1.28 109.713 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.834 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 46.8 pttt -54.91 -38.84 68.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.91 111.698 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.9 pt-20 -64.63 -25.93 68.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.859 0.3 . . . . 1.84 111.203 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.458 HD12 ' CG2' ' A' ' 63' ' ' ILE . 17.9 mt -86.18 -19.24 30.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.968 0.413 . . . . 1.25 111.528 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.93 19.7 0.23 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.087 -1.054 . . . . 0.35 113.041 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -91.47 140.85 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.994 -0.743 . . . . 0.21 108.994 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.533 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.7 mt -82.92 -49.18 9.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.846 0.831 . . . . 0.18 109.842 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.671 ' OG1' HG23 ' A' ' 79' ' ' ILE . 51.3 p -143.39 150.61 39.33 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.022 -1.445 . . . . 0.19 111.685 -171.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -112.19 97.32 6.56 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.52 109.322 173.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -90.49 150.32 21.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.257 -0.428 . . . . 3.86 110.767 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -121.89 -171.53 2.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.321 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 40.0 ttmt -56.81 -47.21 99.43 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 3.35 111.804 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 51.8 Cg_endo -73.29 96.65 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 120.644 0.896 . . . . 1.36 111.03 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -137.22 138.36 40.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 1.1 110.281 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 22.7 t70 -76.6 -1.69 28.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.649 . . . . 1.77 110.984 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.43 -49.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.933 1.293 . . . . 1.39 112.526 -170.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -70.19 -26.51 63.93 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.634 -0.506 . . . . 1.16 109.634 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 12.5 pt-20 -67.87 -24.85 65.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.74 -0.467 . . . . 0.84 109.74 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.477 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 26.3 mt -81.04 -40.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.962 -0.563 . . . . 0.74 110.537 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.616 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.727 -0.789 . . . . 0.72 109.182 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.49 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 26.7 t70 -68.38 -32.36 72.38 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.581 -0.896 . . . . 0.78 108.581 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.797 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -64.08 -44.15 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.59 111.007 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 112' ' ' ARG . 21.9 m -64.76 -39.54 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 119.003 -1.079 . . . . 0.47 110.805 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -78.37 -21.45 49.39 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.332 0.493 . . . . 1.16 112.332 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.797 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -79.44 -24.32 42.52 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.461 -0.775 . . . . 1.48 110.983 175.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 48.5 m-85 -92.15 -70.58 0.69 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.831 -0.348 . . . . 2.21 111.84 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 1.056 ' HB3' HD11 ' A' ' 50' ' ' LEU . 2.4 tm? -127.03 89.72 51.28 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.504 -0.924 . . . . 2.09 108.504 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.654 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 65.0 Cg_endo -88.09 155.0 7.02 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.899 2.399 . . . . 0.92 113.971 -172.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.667 ' HG ' ' HG2' ' A' ' 122' ' ' LYS . 11.3 tp -88.7 -67.66 0.82 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.804 -1.554 . . . . 1.25 106.804 167.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.667 ' HG2' ' HG ' ' A' ' 121' ' ' LEU . 69.1 mmtt -148.99 -65.22 0.23 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.0 -1.454 . . . . 2.78 108.144 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t 66.52 -62.15 0.29 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.883 -1.053 . . . . 2.17 110.689 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 52.32 83.76 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.421 0.689 . . . . 5.26 112.247 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.1 mt -104.13 -55.07 2.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.128 -0.487 . . . . 5.75 109.895 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.3 153.75 49.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.845 -0.616 . . . . 8.65 110.517 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -89.18 157.3 18.32 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.536 -0.913 . . . . 9.73 108.536 173.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 130' ' ' HIS . 2.4 t60 -130.29 67.44 1.48 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.682 -0.807 . . . . 12.67 112.861 -165.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -108.87 -57.95 2.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.819 -1.178 . . . . 12.92 107.819 164.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 128' ' ' HIS . 59.5 m-70 58.68 -160.98 0.26 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.07 -0.968 . . . . 16.51 111.402 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -117.9 115.57 25.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.166 -0.47 . . . . 17.15 110.199 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.5 p80 . . . . . 0 C--O 1.246 0.908 0 N-CA-C 109.302 -0.629 . . . . 19.6 109.302 176.507 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.17 -0.307 . . . . 6.07 110.17 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.3 mpp? 62.41 -173.24 0.15 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.948 -0.569 . . . . 3.88 110.734 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.712 ' HB3' HE22 ' A' ' 29' ' ' GLN . 1.9 t-20 -116.75 11.82 14.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.048 -0.524 . . . . 2.35 109.639 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 1.067 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 11.2 tt0 71.68 101.61 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 124.0 0.813 . . . . 2.3 111.03 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.77 ' HD3' ' HB3' ' A' ' 29' ' ' GLN . 3.8 tppt? -137.39 142.51 41.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.298 0.639 . . . . 0.8 110.871 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.925 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.1 mt -138.28 157.61 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.788 -0.642 . . . . 0.2 111.46 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.823 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.8 tt -133.66 117.76 17.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.138 -1.06 . . . . 0.17 108.138 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.8 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.3 mp -107.25 113.28 43.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 120.245 -0.582 . . . . 0.22 110.255 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 53' ' ' LEU . 49.5 t -103.58 82.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.629 0.252 . . . . 0.28 111.335 -176.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.757 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 3.8 m-20 -121.05 130.97 54.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 1.82 109.903 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.895 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 27.6 t70 -81.57 -31.98 32.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.545 -1.28 . . . . 0.51 107.545 166.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.481 ' CG ' HD13 ' A' ' 15' ' ' ILE . 16.1 pt20 -74.32 74.69 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.455 -1.248 . . . . 2.07 108.198 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 15.1 p90 -61.47 -15.45 37.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.838 -1.528 . . . . 1.44 113.431 -167.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.65 -65.35 3.49 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.876 -1.289 . . . . 0.38 109.876 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.814 HD12 ' H ' ' A' ' 15' ' ' ILE . 4.9 mp -47.25 -30.07 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 123.276 0.63 . . . . 0.8 112.31 172.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 8.8 ttm180 -76.37 -50.19 14.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.291 -0.413 . . . . 0.38 111.142 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HA ' ' CB ' ' A' ' 20' ' ' ASN . 46.9 pt -75.34 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.375 -0.602 . . . . 0.56 109.375 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.5 tp -59.94 -65.52 0.67 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.58 109.627 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 52' ' ' LEU . 71.8 mt -54.29 -40.38 67.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.472 -0.331 . . . . 1.23 110.69 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t30 -51.09 -67.52 0.24 Allowed 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.64 -0.709 . . . . 0.94 109.755 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.25 -40.09 76.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.81 0.694 . . . . 2.46 111.997 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 18' ' ' LEU . 36.3 t -54.3 -54.52 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 111.492 0.182 . . . . 0.37 111.492 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.711 ' HB2' HG21 ' A' ' 30' ' ' THR . 4.9 m-85 -81.01 -35.91 31.31 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.49 -0.484 . . . . 0.43 110.223 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.631 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 10.0 t-20 -50.38 -47.28 56.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.857 0.837 . . . . 0.28 108.758 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 25' ' ' LYS . 1.7 tmmt? -61.3 -36.22 79.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.462 -1.699 . . . . 3.25 112.774 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 8.3 mm-40 -55.11 -31.81 61.54 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.204 1.002 . . . . 1.45 109.455 175.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 138.71 -10.65 3.42 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 113.161 -1.836 . . . . 0.44 109.132 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 1.067 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 2.1 m-85 -68.45 156.74 37.32 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 122.605 1.193 . . . . 1.07 111.089 -169.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.77 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 4.4 mt-30 -109.69 69.8 0.71 Allowed 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 113.293 -1.776 . . . . 1.14 108.042 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.925 HG22 ' HB ' ' A' ' 6' ' ' ILE . 16.0 p -90.01 132.01 35.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.687 -1.142 . . . . 0.14 110.486 -168.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 14.4 m-85 -125.37 124.5 41.66 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.563 1.173 . . . . 0.34 109.664 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.739 ' HB2' HH11 ' A' ' 16' ' ' ARG . 2.4 pt20 -80.8 122.05 26.7 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 112.764 -2.016 . . . . 0.22 112.118 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . . . -120.86 142.08 49.99 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.999 -1.001 . . . . 0.23 108.561 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -98.64 -12.53 20.99 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.928 -0.709 . . . . 0.18 109.941 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.623 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 3.3 p-10 -148.09 165.25 31.38 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.729 -0.669 . . . . 0.29 111.703 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.16 73.39 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.552 -0.749 . . . . 0.14 113.45 -174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.444 ' HB2' HD22 ' A' ' 35' ' ' ASN . 3.2 mm? -81.94 -43.15 18.47 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.034 0.921 . . . . 0.28 109.14 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.764 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.2 tt0 -63.34 -34.83 78.56 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.103 -1.814 . . . . 1.29 106.103 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -66.52 -46.67 75.43 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.485 -1.234 . . . . 0.14 111.0 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.635 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -52.58 -46.92 67.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.641 0.734 . . . . 0.97 109.292 173.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.09 -41.3 92.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.293 -1.322 . . . . 1.32 111.203 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.823 ' HB ' HD11 ' A' ' 7' ' ' LEU . 17.2 mm -63.26 -48.32 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 110.121 -0.326 . . . . 0.14 110.121 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 38.7 t -60.19 -43.59 93.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-O 121.817 0.818 . . . . 0.15 109.283 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.54 -29.28 69.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.261 -0.881 . . . . 0.39 111.614 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -93.19 -45.08 8.03 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.949 0.352 . . . . 2.42 111.949 -176.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 57.2 mm-40 -107.78 -36.17 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 0.63 111.654 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 69.3 mtp180 62.74 62.01 2.0 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.368 -0.833 . . . . 3.66 109.547 -170.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.646 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 77.1 Cg_exo -58.66 156.94 29.68 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.046 1.83 . . . . 0.21 111.095 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.809 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -93.27 -34.7 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.901 -0.72 . . . . 0.98 109.585 175.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.684 HD23 HD11 ' A' ' 79' ' ' ILE . 7.1 mp -115.47 114.02 24.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.007 -0.542 . . . . 0.26 109.992 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG13 ' HB3' ' A' ' 7' ' ' LEU . 92.7 t -112.63 121.61 65.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 110.527 -0.175 . . . . 0.21 110.527 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 19' ' ' LEU . 2.4 mp -92.0 97.6 11.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.579 -0.526 . . . . 0.15 109.579 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 9' ' ' VAL . 44.0 mt -93.52 106.24 18.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.762 -0.654 . . . . 1.53 110.424 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 52.5 t0 -66.86 107.93 2.37 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.204 -0.598 . . . . 1.47 110.232 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.832 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 11.5 mtm -83.05 0.74 43.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.661 . . . . 0.94 110.797 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 25.5 mmmt -57.75 -58.5 8.08 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.408 0.522 . . . . 2.24 112.408 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.927 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 15.2 tt -175.57 -34.21 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.264 1.209 . . . . 2.06 114.264 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.927 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -20.23 -63.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.261 3.307 . . . . 0.45 116.482 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.93 -58.23 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.652 -1.261 . . . . 0.47 113.204 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.5 ' HB3' HD11 ' A' ' 65' ' ' ILE . 47.2 ttm -148.96 165.85 30.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.415 -0.587 . . . . 2.23 109.415 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 65' ' ' ILE . 38.3 m-20 -60.46 133.9 56.54 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.745 -0.465 . . . . 0.67 109.745 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 66' ' ' LEU . . . -67.55 1.65 6.99 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 120.892 -0.67 . . . . 0.32 112.364 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.3 mt -92.45 -45.7 14.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.842 0.353 . . . . 1.31 110.116 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.74 -36.08 81.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.47 109.701 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.674 ' HB ' HD13 ' A' ' 53' ' ' LEU . 15.6 mt -73.5 -34.19 41.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.929 -0.578 . . . . 0.69 109.483 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.665 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -54.77 -53.99 47.89 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.488 -0.778 . . . . 1.47 109.978 174.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.6 ptpt -71.47 -33.42 69.29 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.118 0.414 . . . . 0.65 112.118 -173.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.71 ' O ' HG12 ' A' ' 71' ' ' VAL . 10.9 ptm180 -66.54 -34.6 78.27 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.465 -0.894 . . . . 2.18 110.95 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.661 ' HG3' HG21 ' A' ' 76' ' ' ILE . 10.1 ptp -82.75 -16.74 46.81 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 119.834 -0.746 . . . . 1.28 109.722 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 11.3 mptt -78.88 -30.25 44.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.723 0.773 . . . . 1.3 109.854 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 68' ' ' ARG . 2.7 p -78.59 -31.86 15.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.505 0.669 . . . . 1.03 109.261 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.644 HG12 ' HA ' ' A' ' 69' ' ' MET . 21.8 pt -86.52 -21.89 7.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.102 -0.954 . . . . 0.26 110.724 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -162.78 88.51 0.62 Allowed 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 112.559 0.577 . . . . 1.08 112.559 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 11.6 mt-10 -76.67 5.93 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 120.68 -1.263 . . . . 1.78 109.688 173.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -29.67 62.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.489 -1.232 . . . . 0.35 107.894 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.661 HG21 ' HG3' ' A' ' 69' ' ' MET . 5.2 tt -76.66 159.4 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 112.767 -2.015 . . . . 0.21 111.296 -170.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.817 ' HD3' HD21 ' A' ' 99' ' ' LEU . 4.2 ptp180 -134.84 177.21 7.97 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.335 -0.848 . . . . 1.08 109.392 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.65 HG11 HD12 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -132.58 159.65 43.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.505 0.669 . . . . 0.79 110.507 -175.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.735 HG22 ' HD2' ' A' ' 102' ' ' PHE . 54.9 mt -131.01 66.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.071 -1.455 . . . . 0.6 107.071 170.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.832 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -63.5 140.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.745 0.783 . . . . 0.14 111.804 -170.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.773 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 mtp -95.84 124.1 39.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.764 -1.107 . . . . 1.88 110.371 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.465 HG21 ' HB1' ' A' ' 101' ' ' ALA . 12.1 p -130.84 159.13 38.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.1 -0.5 . . . . 1.13 112.173 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.494 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . . . -66.8 73.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.595 . . . . 0.54 109.863 165.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 26.5 p90 50.88 21.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.225 1.41 . . . . 4.3 113.714 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.65 92.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.828 -0.701 . . . . 0.62 112.688 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.674 ' N ' HG13 ' A' ' 90' ' ' ILE . 19.3 mt-10 -89.01 14.67 10.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.067 0.461 . . . . 1.33 110.855 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 65.65 -177.74 0.19 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.34 0.867 . . . . 1.73 113.34 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.0 t70 60.83 -100.24 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.738 -1.119 . . . . 1.38 112.042 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -58.97 -23.37 61.62 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.021 0.439 . . . . 2.72 110.613 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.674 HG13 ' N ' ' A' ' 86' ' ' GLU . 34.9 mm -65.83 -40.2 86.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.272 0.558 . . . . 0.67 110.088 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.502 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 22.8 mm-40 -72.76 -39.03 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.536 -0.756 . . . . 2.5 109.591 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.617 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 23.5 tt0 -67.95 -40.92 83.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.785 -1.098 . . . . 1.27 111.729 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.409 ' OG ' HG21 ' A' ' 80' ' ' ILE . 6.6 t -54.46 -61.01 2.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.144 0.497 . . . . 1.28 110.055 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.897 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -58.75 -39.45 80.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.91 111.422 176.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 2.0 pt-20 -62.17 -27.23 68.82 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.637 0.236 . . . . 1.84 111.637 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 11.8 mt -85.54 -8.23 58.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.256 0.465 . . . . 1.25 112.256 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.97 19.22 0.72 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.034 -1.079 . . . . 0.35 113.511 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.897 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -98.84 138.83 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.988 -0.745 . . . . 0.21 108.988 171.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.817 HD21 ' HD3' ' A' ' 77' ' ' ARG . 9.3 mt -77.41 -50.05 13.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.398 0.618 . . . . 0.18 110.397 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.59 ' OG1' HG23 ' A' ' 79' ' ' ILE . 62.6 p -139.65 148.72 42.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.224 -0.898 . . . . 0.19 111.664 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -104.95 84.35 2.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.962 -1.017 . . . . 0.52 108.973 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.773 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 1.1 p90 -86.73 144.4 27.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 3.86 110.568 -170.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 105' ' ' PRO . . . -95.98 166.31 11.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.76 110.743 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 18.0 pttp -70.36 -29.38 1.57 Allowed Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.724 0.639 . . . . 3.35 112.724 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 55.6 Cg_endo -76.14 95.45 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 120.501 1.215 . . . . 1.36 110.166 163.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.568 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 30.1 p90 -132.3 152.77 51.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.451 0.643 . . . . 1.1 111.318 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 109' ' ' ASP . 19.0 t70 -75.56 -3.9 36.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.117 -0.947 . . . . 1.77 111.653 -173.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.568 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 13.7 mt 65.35 -62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 1.39 110.114 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.507 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 29.8 t70 -63.06 -26.96 69.08 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.89 -0.596 . . . . 1.16 110.817 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.8 -34.31 76.52 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.039 0.447 . . . . 0.84 110.193 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 115' ' ' VAL . 28.3 mt -83.03 -40.22 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.987 -0.551 . . . . 0.74 110.108 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.58 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -66.59 -35.97 81.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.638 -0.875 . . . . 0.72 108.638 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.814 ' HA ' ' HE2' ' A' ' 116' ' ' LYS . 32.5 t70 -61.96 -53.03 61.31 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.999 -0.741 . . . . 0.78 108.999 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.923 ' HA ' ' HE3' ' A' ' 117' ' ' LYS . . . -52.09 -46.38 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.459 -0.792 . . . . 0.59 111.833 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 111' ' ' ILE . 32.3 m -68.24 -47.68 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.673 0.62 . . . . 0.47 112.673 -173.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.814 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 1.2 pptt? -85.24 -8.68 58.43 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.099 0.409 . . . . 1.16 111.665 -177.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.923 ' HE3' ' HA ' ' A' ' 114' ' ' ALA . 21.6 pttp -86.5 -21.52 26.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.715 -0.794 . . . . 1.48 109.749 167.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.843 ' HD1' ' HG ' ' A' ' 119' ' ' LEU . 14.8 t80 -80.56 -66.67 0.85 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.282 -0.417 . . . . 2.21 110.421 176.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.843 ' HG ' ' HD1' ' A' ' 118' ' ' TYR . 91.9 mt -122.36 86.23 48.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.414 -0.587 . . . . 2.09 109.414 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.653 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 93.1 Cg_endo -80.68 133.66 9.41 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.564 2.176 . . . . 0.92 113.434 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.075 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 13.3 tp -113.07 -66.57 1.07 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.6 0.714 . . . . 1.25 110.211 176.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 1.075 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 63.6 mttm -127.65 -49.75 1.38 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.985 -1.007 . . . . 2.78 109.985 -175.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 79.7 p 54.34 39.1 30.63 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.157 -0.929 . . . . 2.17 109.908 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -71.78 94.69 1.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.992 -1.003 . . . . 5.26 111.13 -176.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.417 HD22 HH22 ' A' ' 112' ' ' ARG . 32.9 tp -91.46 -19.08 23.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.524 -0.762 . . . . 5.75 110.029 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.76 67.23 2.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.878 -0.601 . . . . 8.65 110.621 -172.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 55.81 -93.88 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.418 -0.81 . . . . 9.73 112.269 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -170.7 118.73 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.43 -0.582 . . . . 12.67 109.43 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -88.15 160.84 17.58 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.865 0.364 . . . . 12.92 110.959 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -124.04 128.58 49.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.764 -0.653 . . . . 16.51 109.49 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -71.61 131.05 42.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.761 0.315 . . . . 17.15 110.988 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.1 m80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.123 -0.941 . . . . 19.6 109.776 176.868 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.557 ' H1 ' ' HB3' ' A' ' 119' ' ' LEU . 78.4 mtp . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.276 -0.268 . . . . 6.07 110.276 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 1' ' ' MET . 86.4 mtp 70.45 -85.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.432 -0.581 . . . . 3.88 109.432 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.611 ' HB3' HE22 ' A' ' 29' ' ' GLN . 18.8 t-20 -121.86 4.16 9.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.639 -1.245 . . . . 2.35 107.639 171.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.726 ' HB3' HD12 ' A' ' 121' ' ' LEU . 7.2 tp10 66.4 110.84 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.018 -1.446 . . . . 2.3 111.456 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.869 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -136.09 146.52 47.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.294 0.569 . . . . 0.8 111.368 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.901 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.9 mt -137.81 154.75 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.389 -0.823 . . . . 0.2 111.575 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.838 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -135.56 111.64 9.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.459 -1.246 . . . . 0.17 107.724 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.638 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.2 mp -99.42 104.62 16.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.175 -1.01 . . . . 0.22 110.219 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 47.9 t -85.67 93.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.777 -0.823 . . . . 0.28 108.777 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.608 ' OD2' ' HG3' ' A' ' 12' ' ' GLN . 25.8 t70 -152.6 104.81 2.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.643 -0.423 . . . . 1.82 111.138 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.79 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 19.7 t70 -54.14 -41.24 68.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.55 0.34 . . . . 0.51 111.46 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.608 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 3.6 pt20 -70.94 76.29 0.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 122.23 1.014 . . . . 2.07 109.217 173.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.451 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 31.0 p90 -53.67 -13.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.602 -1.635 . . . . 1.44 114.648 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.73 -67.49 1.27 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.366 -0.921 . . . . 0.38 111.547 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.782 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -70.48 -11.78 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 O-C-N 121.958 -0.731 . . . . 0.8 111.241 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.908 HH11 ' HB2' ' A' ' 32' ' ' GLN . 7.4 ttm180 -79.89 -42.12 24.81 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.612 -0.435 . . . . 0.38 110.229 -173.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.427 HG22 ' NE2' ' A' ' 32' ' ' GLN . 2.7 pp -83.64 -27.14 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.56 109.967 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.496 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 3.5 tp -61.78 -61.59 2.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.637 -0.711 . . . . 0.58 109.485 170.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.782 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 1.1 tp -52.51 -41.96 63.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.653 -0.703 . . . . 1.23 110.187 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.4 t30 -51.18 -70.9 0.07 Allowed 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.209 -0.905 . . . . 0.94 109.78 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.28 -39.12 69.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.355 0.41 . . . . 2.46 111.64 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' LEU . 35.6 t -55.76 -60.83 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.626 -0.261 . . . . 0.37 111.295 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.782 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 8.3 m-85 -72.37 -34.6 68.08 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.457 -0.571 . . . . 0.43 109.457 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.932 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 3.5 t-20 -52.06 -48.56 64.56 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.269 -0.878 . . . . 0.28 109.388 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.41 -31.72 73.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.626 -1.624 . . . . 3.25 112.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.686 ' HB2' ' CD1' ' A' ' 28' ' ' TYR . 6.1 mm-40 -63.67 -25.27 68.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.639 0.733 . . . . 1.45 110.313 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.653 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . 143.21 -16.47 2.32 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.491 -1.231 . . . . 0.44 110.648 -171.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.932 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 8.2 m-85 -81.64 124.06 29.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.308 0.575 . . . . 1.07 111.387 -162.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.869 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 20.7 mt-30 -79.39 82.61 5.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.46 -0.941 . . . . 1.14 108.46 172.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.901 HG22 ' HB ' ' A' ' 6' ' ' ILE . 20.8 p -90.19 135.85 33.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.645 -0.707 . . . . 0.14 109.921 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 15.4 m-85 -125.95 126.35 44.22 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.408 1.099 . . . . 0.34 109.265 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.908 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.5 pt20 -86.43 120.74 28.08 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.004 -1.907 . . . . 0.22 111.355 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -123.44 124.6 43.25 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.495 -0.558 . . . . 0.23 109.495 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 11' ' ' ASP . . . -74.71 -19.03 60.41 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.738 -0.385 . . . . 0.18 111.028 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.502 HD22 ' HB2' ' A' ' 37' ' ' LEU . 1.7 p-10 -148.23 168.57 22.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 0.29 111.567 -174.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -75.03 -14.32 81.91 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.834 -0.621 . . . . 0.14 113.33 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.502 ' HB2' HD22 ' A' ' 35' ' ' ASN . 3.2 mm? -79.9 -44.71 19.91 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 122.617 1.198 . . . . 0.28 108.279 175.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.803 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.3 tp-100 -60.94 -40.69 94.23 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 112.26 -2.245 . . . . 1.29 105.597 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -63.3 -44.36 95.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.722 -1.581 . . . . 0.14 111.258 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.7 -43.64 76.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.037 -0.727 . . . . 0.97 109.037 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 44' ' ' THR . 18.9 t70 -64.22 -41.95 96.79 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.492 -1.231 . . . . 1.32 110.616 177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.838 ' HB ' HD11 ' A' ' 7' ' ' LEU . 10.3 mm -60.69 -48.78 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 120.922 -0.311 . . . . 0.14 111.033 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 76' ' ' ILE . 46.8 t -57.97 -41.75 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.741 0.781 . . . . 0.15 109.947 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -70.38 -23.95 62.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.226 -0.897 . . . . 0.39 111.134 -178.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.742 ' HE3' ' HA ' ' A' ' 42' ' ' ILE . 9.7 ptpt -91.23 -42.34 10.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.695 0.283 . . . . 2.42 111.268 -177.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 62.5 mm-40 -111.61 -38.16 4.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 112.066 0.395 . . . . 0.63 112.066 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.2 mpt_? 64.78 64.28 1.11 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 123.857 0.723 . . . . 3.66 109.769 -169.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.761 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 51.7 Cg_exo -62.77 157.71 46.28 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 121.57 1.513 . . . . 0.21 111.473 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.927 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -85.03 -51.09 6.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.293 -1.373 . . . . 0.98 107.293 171.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.927 HD12 ' HB2' ' A' ' 49' ' ' ASP . 7.1 mp -105.11 111.59 24.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.716 -1.129 . . . . 0.26 110.75 -171.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.769 HG13 ' HB3' ' A' ' 7' ' ' LEU . 60.0 t -112.18 108.51 25.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.213 -0.449 . . . . 0.21 111.419 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.576 HD22 HD21 ' A' ' 19' ' ' LEU . 2.1 mp -75.68 89.12 2.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.795 0.807 . . . . 0.15 109.473 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -82.49 110.68 17.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.059 -1.428 . . . . 1.53 111.294 -172.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.12 127.19 18.5 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.697 0.76 . . . . 1.47 110.714 174.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.922 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 18.8 mtp -114.94 9.52 16.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.172 -0.922 . . . . 0.94 109.457 163.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -71.74 -67.55 0.52 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.63 . . . . 2.24 111.9 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.839 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -175.05 -36.03 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.036 0 CA-C-O 118.024 -0.989 . . . . 2.06 112.708 -172.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.839 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 4.7 Cg_exo -19.48 -62.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.726 3.617 . . . . 0.45 116.419 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.06 -73.23 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 119.764 -1.208 . . . . 0.47 113.394 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.3 tpt -148.9 168.55 22.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.574 -0.899 . . . . 2.23 108.574 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.17 129.18 40.79 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.172 0.51 . . . . 0.67 109.654 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.589 ' CA ' ' HG ' ' A' ' 53' ' ' LEU . . . -62.92 -7.19 15.07 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.08 -0.964 . . . . 0.32 112.718 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.724 HG13 ' HB3' ' A' ' 89' ' ' MET . 4.1 mm -78.22 -48.66 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.681 -0.488 . . . . 1.31 109.681 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.9 -33.46 75.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.876 -0.787 . . . . 0.47 108.876 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.739 ' O ' ' HG2' ' A' ' 69' ' ' MET . 59.9 mt -77.31 -38.79 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.292 -0.867 . . . . 0.69 111.371 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.64 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 3.7 pp -65.66 -36.85 84.86 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 120.291 -0.564 . . . . 1.47 110.285 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.678 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 15.8 ptpt -73.49 -35.41 65.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.332 -0.547 . . . . 0.65 111.182 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.6 ptm180 -65.28 -33.46 76.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 118.868 -1.133 . . . . 2.18 111.668 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.775 ' HA ' HG12 ' A' ' 72' ' ' ILE . 12.2 ptp -84.86 -11.99 54.47 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.046 -1.033 . . . . 1.28 109.405 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 12.5 mptt -76.84 -36.98 56.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.016 -0.735 . . . . 1.3 109.016 172.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 68' ' ' ARG . 4.0 p -72.07 -33.81 48.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.354 0.597 . . . . 1.03 109.648 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.775 HG12 ' HA ' ' A' ' 69' ' ' MET . 26.1 pt -84.27 -24.46 7.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.291 -0.868 . . . . 0.26 110.973 172.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -161.74 88.18 0.69 Allowed 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.043 0.386 . . . . 1.08 112.043 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 8.5 mt-10 -75.77 6.25 5.22 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.272 -0.892 . . . . 1.78 110.636 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -28.69 42.39 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.856 -1.535 . . . . 0.35 106.856 170.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.3 tt -67.61 153.8 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 113.556 -1.657 . . . . 0.21 110.686 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 6.3 ptp180 -135.45 177.9 7.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.792 -1.188 . . . . 1.08 107.792 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -144.17 144.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.52 0.676 . . . . 0.79 111.216 -174.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.709 HG23 ' OG1' ' A' ' 100' ' ' THR . 64.9 mt -114.79 74.75 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.304 -1.369 . . . . 0.6 107.304 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.922 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -62.55 140.11 19.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 119.544 -0.862 . . . . 0.14 112.735 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 7.4 mtp -100.81 102.68 13.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.734 -1.121 . . . . 1.88 110.159 -174.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.43 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.7 t -117.05 165.13 13.73 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.343 0.592 . . . . 1.13 112.284 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 56.09 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.954 -1.021 . . . . 0.54 110.26 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 t80 72.3 5.59 5.32 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.983 -1.008 . . . . 4.3 111.686 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.32 88.28 1.99 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.115 -0.564 . . . . 0.62 112.619 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.431 ' N ' HG13 ' A' ' 90' ' ' ILE . 24.2 mt-10 -81.38 9.36 7.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.924 0.393 . . . . 1.33 111.18 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.518 HD22 HE21 ' A' ' 91' ' ' GLN . 38.1 mt 65.8 -166.22 0.22 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.606 -0.725 . . . . 1.73 112.621 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.53 -99.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.297 -0.865 . . . . 1.38 111.531 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.724 ' HB3' HG13 ' A' ' 63' ' ' ILE . 2.0 mpt? -64.25 -18.0 64.14 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.421 -0.354 . . . . 2.72 110.291 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 87' ' ' LEU . 32.7 mm -69.49 -40.2 79.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.999 0.428 . . . . 0.67 110.265 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.518 HE21 HD22 ' A' ' 87' ' ' LEU . 73.1 mt-30 -67.02 -53.36 31.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.842 -0.799 . . . . 2.5 108.842 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 42.8 tt0 -56.72 -30.6 63.69 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 114.46 -1.245 . . . . 1.27 111.404 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 63' ' ' ILE . 27.6 t -54.59 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.754 0.788 . . . . 1.28 111.177 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 33.4 pttt -54.03 -38.02 64.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.629 -1.169 . . . . 1.91 110.714 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 8.2 tp10 -55.37 -43.42 75.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.739 -1.118 . . . . 1.84 111.874 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.75 -22.96 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.843 0.354 . . . . 1.25 111.165 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.88 21.97 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.004 -1.093 . . . . 0.35 113.935 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 78' ' ' VAL . . . -88.54 140.54 29.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.9 0.85 . . . . 0.21 109.277 169.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.514 HD21 ' HD3' ' A' ' 77' ' ' ARG . 18.3 mt -82.19 -48.95 10.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.718 0.771 . . . . 0.18 109.865 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.709 ' OG1' HG23 ' A' ' 79' ' ' ILE . 52.6 p -144.57 150.2 37.08 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.486 -1.234 . . . . 0.19 111.64 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' CG2' ' A' ' 82' ' ' THR . . . -108.55 86.89 2.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.363 -0.835 . . . . 0.52 109.967 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 16.6 m-85 -84.33 143.02 29.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.985 0.421 . . . . 3.86 110.716 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB1' ' HD2' ' A' ' 105' ' ' PRO . . . -95.48 178.14 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.76 109.431 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' O ' ' HD1' ' A' ' 106' ' ' PHE . 20.5 mmtp -78.33 -29.75 0.66 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.639 0.607 . . . . 3.35 112.639 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' HB1' ' A' ' 103' ' ' ALA . 24.2 Cg_exo -65.62 96.99 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 120.368 1.167 . . . . 1.36 109.922 162.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.496 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 1.6 p90 -130.19 146.16 51.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.875 -0.602 . . . . 1.1 111.516 -172.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -86.15 18.4 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.598 . . . . 1.77 111.726 178.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.549 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.4 tt 48.3 -67.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 125.035 1.334 . . . . 1.39 113.003 -174.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.549 ' H ' HG23 ' A' ' 108' ' ' ILE . 18.5 t70 -58.22 -30.55 66.58 Favored 'General case' 0 C--O 1.212 -0.897 0 C-N-CA 122.55 0.34 . . . . 1.16 111.364 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.11 -28.15 67.92 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 119.997 -0.681 . . . . 0.84 110.143 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.54 HG22 ' HZ ' ' A' ' 23' ' ' PHE . 17.0 mt -80.76 -41.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.74 110.508 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HD2' ' C ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -68.68 -32.99 73.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.744 0.783 . . . . 0.72 109.215 175.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 19.1 t70 -70.91 -36.49 72.73 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.323 -0.853 . . . . 0.78 108.828 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -66.6 -45.29 79.66 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.079 -0.964 . . . . 0.59 111.459 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 112' ' ' ARG . 34.5 m -61.77 -42.59 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.598 -0.841 . . . . 0.47 110.184 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.524 ' HA ' ' OH ' ' A' ' 28' ' ' TYR . 7.1 ttpt -63.67 -49.65 72.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.795 -0.639 . . . . 1.16 111.418 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.739 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 0.5 OUTLIER -59.78 -30.67 69.04 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.664 -0.243 . . . . 1.48 111.399 -176.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.576 ' HB3' HD12 ' A' ' 119' ' ' LEU . 44.5 m-85 -81.91 -68.91 0.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.417 -0.513 . . . . 2.21 110.696 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 118' ' ' TYR . 6.7 mp -121.48 103.63 41.06 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.175 -0.676 . . . . 2.09 109.175 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -97.78 153.11 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.752 2.301 . . . . 0.92 114.493 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -127.35 -64.97 0.96 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 1.25 108.396 172.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.65 ' HG3' HD22 ' A' ' 121' ' ' LEU . 82.8 mttt -135.18 -50.3 0.75 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.169 -0.923 . . . . 2.78 110.234 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.609 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 56.0 p 54.99 87.97 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.408 1.068 . . . . 2.17 109.594 -171.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -115.48 147.41 40.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.024 -0.989 . . . . 5.26 111.701 -164.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.89 45.88 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.475 -0.33 . . . . 5.75 110.581 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 127' ' ' HIS . 9.1 pt-20 -59.41 -36.43 75.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.173 -0.467 . . . . 8.65 111.73 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.403 ' N ' ' HG3' ' A' ' 126' ' ' GLU . 36.3 m170 -72.77 160.26 32.47 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.358 0.599 . . . . 9.73 111.108 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -101.08 113.33 26.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.347 -0.842 . . . . 12.67 110.162 -171.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -65.78 -50.88 63.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.962 0.41 . . . . 12.92 110.547 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -97.55 129.67 44.67 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.041 -0.527 . . . . 16.51 110.058 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -102.04 143.62 31.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.142 -0.481 . . . . 17.15 109.791 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.4 p80 . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.227 -0.892 . . . . 19.6 110.332 179.416 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 109.897 -0.409 . . . . 6.07 109.897 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 56.0 mtp 61.07 -166.54 0.2 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.802 -0.635 . . . . 3.88 111.889 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.618 ' HB3' HE22 ' A' ' 29' ' ' GLN . 15.7 m120 -106.71 -18.86 13.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.216 -0.902 . . . . 2.35 110.391 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.853 ' HG2' ' HA ' ' A' ' 28' ' ' TYR . 8.3 tt0 68.02 105.69 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.583 0.706 . . . . 2.3 110.916 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.688 ' HB3' ' HA ' ' A' ' 48' ' ' PRO . 3.6 tppt? -140.57 147.33 39.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.009 -0.541 . . . . 0.8 111.202 -172.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.899 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -141.23 153.99 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.439 -0.8 . . . . 0.2 111.696 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.796 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.7 tt -131.82 123.47 27.64 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.61 -1.256 . . . . 0.17 107.61 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.701 ' HB ' ' HG2' ' A' ' 16' ' ' ARG . 1.4 mp -109.66 103.21 15.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.556 -0.858 . . . . 0.22 110.164 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.2 t -88.49 82.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.28 110.003 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.876 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.0 t70 -133.1 144.28 49.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.548 -0.296 . . . . 1.82 110.686 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.89 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 13.0 t70 -101.54 -35.94 8.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.896 -0.409 . . . . 0.51 109.896 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.658 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 4.4 pt20 -81.06 70.61 7.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.098 -1.445 . . . . 2.07 107.098 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.9 p90 -48.74 -13.92 0.06 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 112.334 -2.212 . . . . 1.44 115.181 -161.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' GLN . . . -46.68 -59.48 5.4 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.198 -1.001 . . . . 0.38 110.777 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 1.1 mm -54.51 -32.5 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.525 0.679 . . . . 0.8 110.245 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.876 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.6 ttm180 -77.12 -48.78 16.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.118 -0.946 . . . . 0.38 110.891 -165.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 42.4 pt -76.04 -25.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.312 -0.625 . . . . 0.56 109.312 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.4 tp -58.69 -68.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.58 109.416 171.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.798 HD13 HD22 ' A' ' 52' ' ' LEU . 39.0 mt -54.65 -40.91 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 1.23 110.563 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.632 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 7.6 t30 -50.48 -68.81 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.94 109.97 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.65 -40.04 82.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.265 0.353 . . . . 2.46 111.639 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.2 t -55.15 -55.43 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.052 0.22 . . . . 0.37 111.576 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB2' HG21 ' A' ' 30' ' ' THR . 11.8 m-85 -78.87 -36.66 41.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.61 -0.436 . . . . 0.43 110.038 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 9.3 t-20 -50.15 -50.54 48.55 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.176 0.988 . . . . 0.28 108.934 -176.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -54.77 -42.49 71.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 112.637 -2.074 . . . . 3.25 111.676 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.659 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 4.5 mm-40 -52.22 -34.6 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 122.191 0.996 . . . . 1.45 109.733 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.612 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 138.08 -6.66 3.43 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 113.303 -1.771 . . . . 0.44 109.39 -171.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.856 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 5.5 m-85 -70.4 126.86 30.83 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.807 -0.757 . . . . 1.07 110.549 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.641 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 28.6 mt-30 -82.7 81.13 8.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.475 -0.935 . . . . 1.14 108.475 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.899 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -90.07 133.09 35.05 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.064 -0.971 . . . . 0.14 110.128 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.94 124.83 42.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.592 1.187 . . . . 0.34 109.732 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.71 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 1.5 pt20 -82.17 120.71 25.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 112.748 -2.024 . . . . 0.22 111.602 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.783 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -123.93 124.02 41.69 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.585 -0.734 . . . . 0.23 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -84.83 -8.19 58.89 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.223 -0.591 . . . . 0.18 111.293 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.496 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 1.7 p-10 -149.42 165.55 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.41 -0.359 . . . . 0.29 111.56 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.91 -19.92 77.32 Favored Glycine 0 CA--C 1.506 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.14 113.291 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' HD22 ' A' ' 35' ' ' ASN . 2.7 mm? -78.31 -42.97 29.16 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.458 1.123 . . . . 0.28 108.075 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.843 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -60.96 -41.66 96.75 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 112.6 -2.091 . . . . 1.29 105.805 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -60.9 -43.87 97.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.003 -1.453 . . . . 0.14 111.038 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.2 OUTLIER -57.44 -43.37 83.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.224 -0.658 . . . . 0.97 109.224 177.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 44' ' ' THR . 2.1 t70 -64.57 -44.58 90.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 114.951 -1.022 . . . . 1.32 110.213 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.843 HG12 ' O ' ' A' ' 38' ' ' GLN . 15.9 mm -60.19 -46.42 94.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.266 -0.879 . . . . 0.14 110.165 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 69' ' ' MET . 47.6 t -62.12 -41.25 90.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 121.727 0.775 . . . . 0.15 109.604 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -73.23 -20.71 60.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.606 -0.725 . . . . 0.39 111.155 -177.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.631 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -90.49 -45.99 8.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.604 -0.271 . . . . 2.42 111.246 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.631 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 8.3 mm-40 -110.63 -36.89 5.61 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.392 0.515 . . . . 0.63 112.392 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 14.1 mtm-85 65.36 65.43 0.92 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 O-C-N 123.639 0.587 . . . . 3.66 109.536 -170.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.751 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 71.3 Cg_exo -60.57 156.67 40.74 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 C-N-CA 121.689 1.592 . . . . 0.21 111.033 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.814 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 12.3 m-20 -89.51 -42.27 11.55 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.293 -0.963 . . . . 0.98 108.849 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.654 HD23 HD11 ' A' ' 79' ' ' ILE . 6.8 mp -110.42 111.97 23.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.737 -0.665 . . . . 0.26 109.864 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 7' ' ' LEU . 86.3 t -112.58 112.81 42.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.796 0.332 . . . . 0.21 110.669 -177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.798 HD22 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -83.64 93.01 7.8 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.411 0.624 . . . . 0.15 109.986 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.656 HD11 HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -84.63 104.7 14.84 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.826 -1.079 . . . . 1.53 111.155 -175.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.835 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 54.2 t0 -70.11 109.14 4.43 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.57 -0.852 . . . . 1.47 110.181 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.87 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 29.9 mtp -86.28 11.03 13.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.614 -0.721 . . . . 0.94 111.083 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -71.32 -60.16 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.029 0.752 . . . . 2.24 113.029 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.962 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 11.1 tp -173.08 -21.73 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.671 1.36 . . . . 2.06 114.671 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.962 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -27.62 -52.87 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 123.443 2.762 . . . . 0.45 116.105 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.02 -60.07 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.756 -1.211 . . . . 0.47 112.88 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 65' ' ' ILE . 20.6 ttt -149.53 170.18 19.21 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.403 -0.592 . . . . 2.23 109.403 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -57.66 135.38 56.72 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.977 0.417 . . . . 0.67 110.283 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.615 ' HA2' ' CD1' ' A' ' 53' ' ' LEU . . . -66.49 -2.07 13.71 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.408 -0.815 . . . . 0.32 112.885 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.528 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 11.2 mt -92.05 -42.03 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.157 0.503 . . . . 1.31 110.286 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.85 -38.9 80.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.571 0.701 . . . . 0.47 109.413 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.656 HD12 HD11 ' A' ' 53' ' ' LEU . 54.0 mt -71.57 -35.85 57.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.149 -0.932 . . . . 0.69 109.794 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.733 HD12 HG21 ' A' ' 78' ' ' VAL . 3.2 tt -53.34 -53.43 51.19 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.677 -0.692 . . . . 1.47 110.607 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.0 ptpp? -73.13 -30.16 63.41 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.233 -0.587 . . . . 0.65 112.083 -172.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.693 ' O ' HG12 ' A' ' 71' ' ' VAL . 15.0 ptp180 -68.97 -33.59 73.95 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 118.92 -1.112 . . . . 2.18 111.066 174.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.703 ' HE1' HG13 ' A' ' 78' ' ' VAL . 2.8 ptt? -80.63 -17.82 50.08 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 118.918 -1.113 . . . . 1.28 109.796 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.742 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -76.93 -30.24 55.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.636 . . . . 1.3 110.572 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.7 p -78.12 -34.95 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 109.531 -0.544 . . . . 1.03 109.531 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.567 HG12 ' HA ' ' A' ' 69' ' ' MET . 15.7 pt -81.42 -31.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.26 110.037 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.76 90.82 1.1 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.32 2.9 6.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.876 0.846 . . . . 1.78 109.796 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -26.11 64.35 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.55 -1.278 . . . . 0.35 107.55 171.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 48' ' ' PRO . 3.0 tt -76.23 156.93 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 112.743 -2.026 . . . . 0.21 110.754 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.814 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -137.77 172.48 12.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.055 -0.975 . . . . 1.08 108.614 177.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -131.29 154.25 40.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 120.217 -0.593 . . . . 0.79 110.689 -171.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.654 HD11 HD23 ' A' ' 50' ' ' LEU . 61.5 mt -128.64 68.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.402 -1.333 . . . . 0.6 107.402 171.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.87 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -64.86 140.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.538 -0.756 . . . . 0.14 111.735 -172.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.638 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 11.0 mtt -93.15 131.1 38.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.071 -0.968 . . . . 1.88 110.019 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.638 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 4.6 t -132.85 156.85 46.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.329 0.585 . . . . 1.13 112.578 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . -72.36 63.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.761 -1.109 . . . . 0.54 109.804 170.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 103' ' ' ALA . 40.3 t80 70.24 11.26 7.5 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.564 -1.198 . . . . 4.3 112.021 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.72 81.88 1.6 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.051 -0.595 . . . . 0.62 112.011 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' N ' HG13 ' A' ' 90' ' ' ILE . 5.6 mt-10 -72.6 8.12 1.59 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.678 0.791 . . . . 1.33 112.052 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.405 ' N ' HG13 ' A' ' 90' ' ' ILE . 25.6 mt 61.11 -177.55 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.569 1.322 . . . . 1.73 114.569 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 t70 57.7 -93.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.328 -1.306 . . . . 1.38 111.692 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.461 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 66.3 mtt -60.88 -26.77 67.65 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 120.838 0.351 . . . . 2.72 110.363 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 86' ' ' GLU . 15.7 mm -62.52 -43.25 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.057 0.456 . . . . 0.67 110.439 173.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.563 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 88.2 mt-30 -63.76 -48.31 77.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.473 -0.785 . . . . 2.5 109.493 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.783 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 22.7 tt0 -70.11 -20.52 63.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.539 -1.21 . . . . 1.27 112.102 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.8 t -66.68 -63.84 0.98 Allowed 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.876 -0.515 . . . . 1.28 110.062 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.919 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 17.0 ptpt -58.87 -31.14 68.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.694 0.759 . . . . 1.91 109.964 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.783 ' CB ' ' HA ' ' A' ' 92' ' ' GLU . 6.1 tt0 -47.38 -58.87 3.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.366 -1.288 . . . . 1.84 111.867 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.77 -28.57 65.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.764 -0.653 . . . . 1.25 112.36 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' HZ1' ' A' ' 70' ' ' LYS . . . 163.72 11.22 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.835 -1.174 . . . . 0.35 113.739 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.919 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -86.72 136.38 33.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.827 0.813 . . . . 0.21 109.66 173.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.415 HD11 ' HG3' ' A' ' 77' ' ' ARG . 7.8 mt -74.98 -49.24 20.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.708 0.766 . . . . 0.18 109.867 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.635 ' OG1' HG23 ' A' ' 79' ' ' ILE . 60.2 p -139.17 147.83 42.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.383 -1.281 . . . . 0.19 111.603 -172.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -107.59 88.7 2.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.862 -1.063 . . . . 0.52 108.431 170.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.603 ' CE2' ' HG2' ' A' ' 81' ' ' MET . 0.3 OUTLIER -84.34 142.22 30.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.264 -0.425 . . . . 3.86 109.944 -172.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 84' ' ' TYR . . . -108.42 177.07 4.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.76 111.424 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 10.2 mtpm? -59.37 -43.3 96.16 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.959 -0.564 . . . . 3.35 111.873 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 54.0 Cg_endo -74.37 96.2 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 120.633 0.889 . . . . 1.36 110.995 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.519 ' HD1' ' H ' ' A' ' 108' ' ' ILE . 51.1 p90 -130.81 148.2 52.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.585 -0.734 . . . . 1.1 110.252 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 33.6 t70 -81.99 6.95 14.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.483 -0.78 . . . . 1.77 110.962 -174.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.519 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 6.0 tt 52.75 -60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.551 1.54 . . . . 1.39 112.162 -171.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 107' ' ' ASP . 29.0 t70 -62.05 -30.71 71.17 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 110.298 -0.26 . . . . 1.16 110.298 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 pt-20 -64.13 -29.71 70.82 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.536 -0.466 . . . . 0.84 110.185 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.512 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 34.2 mt -81.71 -42.47 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.245 -0.434 . . . . 0.74 110.459 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.446 ' C ' ' HD2' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -67.86 -34.96 77.71 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.818 0.818 . . . . 0.72 109.222 175.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.2 t70 -64.2 -49.44 72.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.986 -1.006 . . . . 0.78 108.664 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.859 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.94 -48.84 75.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.712 -1.131 . . . . 0.59 111.729 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 112' ' ' ARG . 35.7 m -60.8 -51.95 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.313 -0.555 . . . . 0.47 111.663 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.4 OUTLIER -71.21 -29.83 65.63 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.627 0.232 . . . . 1.16 111.627 -176.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.859 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 65.0 pttt -72.54 -26.09 61.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.64 -0.824 . . . . 1.48 111.184 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -77.89 -66.55 0.83 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.928 0.394 . . . . 2.21 110.283 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 119' ' ' LEU . 1.5 tm? -121.23 97.71 47.4 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.538 -0.912 . . . . 2.09 108.538 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.554 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 77.1 Cg_endo -93.97 132.61 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.93 2.42 . . . . 0.92 113.952 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.995 ' HG ' ' HG2' ' A' ' 122' ' ' LYS . 13.8 tp -114.34 -66.16 1.11 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.299 0.571 . . . . 1.25 110.209 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.995 ' HG2' ' HG ' ' A' ' 121' ' ' LEU . 32.9 mmtp -133.73 -63.07 0.75 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.232 -0.895 . . . . 2.78 109.256 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 36.6 p 51.44 -96.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.288 -0.869 . . . . 2.17 112.533 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -90.01 -9.4 48.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.19 0.519 . . . . 5.26 110.737 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.7 tp -92.99 83.63 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.785 -0.643 . . . . 5.75 109.685 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -141.01 128.26 20.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.698 -0.683 . . . . 8.65 110.638 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -120.48 -53.16 2.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.974 -0.75 . . . . 9.73 108.974 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -103.29 102.3 12.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.56 0.695 . . . . 12.67 109.809 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -109.51 133.33 53.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.457 -0.792 . . . . 12.92 108.888 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -85.74 112.38 21.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.083 0.468 . . . . 16.51 112.058 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -86.17 104.6 15.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.835 -0.802 . . . . 17.15 108.835 171.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 p80 . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.949 -1.024 . . . . 19.6 110.269 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.149 -0.686 . . . . 6.07 109.149 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.458 ' CE ' HH21 ' A' ' 47' ' ' ARG . 5.8 mmt -71.99 -19.13 61.92 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.01 -0.737 . . . . 3.88 109.01 175.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 89.4 m-20 74.42 35.94 0.67 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.016 -0.993 . . . . 2.35 111.023 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.786 ' HB3' HD22 ' A' ' 121' ' ' LEU . 12.5 tt0 68.41 94.54 0.07 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.952 0.882 . . . . 2.3 109.933 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.802 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -132.52 145.99 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.238 -0.892 . . . . 0.8 110.661 -173.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.886 ' HB ' HG22 ' A' ' 30' ' ' THR . 1.8 mt -136.98 156.56 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.544 0.688 . . . . 0.2 111.774 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.917 HD11 ' HB ' ' A' ' 42' ' ' ILE . 1.9 tt -134.17 109.51 8.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.673 -1.149 . . . . 0.17 108.146 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.4 mp -97.37 108.07 21.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.324 -0.55 . . . . 0.22 109.763 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.739 HG21 HD23 ' A' ' 53' ' ' LEU . 59.9 t -97.04 88.53 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 110.005 -0.368 . . . . 0.28 110.005 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.8 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 3.1 t70 -134.77 140.79 46.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.517 -0.549 . . . . 1.82 109.517 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.893 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 35.8 t70 -88.81 -49.4 6.85 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.141 -0.349 . . . . 0.51 111.016 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HG3' HD12 ' A' ' 15' ' ' ILE . 9.2 pt20 -76.57 73.1 3.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.628 -0.879 . . . . 2.07 108.628 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.565 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 52.0 p90 -44.94 -12.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 112.206 -2.27 . . . . 1.44 115.986 -167.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -45.28 -58.87 4.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.978 -1.106 . . . . 0.38 110.789 170.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.634 HD12 ' HG3' ' A' ' 12' ' ' GLN . 2.3 mt -59.42 -27.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.608 0.718 . . . . 0.8 110.409 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.897 HH11 ' HB2' ' A' ' 32' ' ' GLN . 8.3 ttm180 -78.79 -43.83 24.58 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.879 -1.055 . . . . 0.38 110.513 -167.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.728 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 39.2 pt -80.46 -26.11 11.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.459 0.475 . . . . 0.56 109.901 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 19' ' ' LEU . 1.8 tp -59.05 -63.54 1.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.08 -0.711 . . . . 0.58 109.08 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.02 HD21 HD22 ' A' ' 52' ' ' LEU . 8.1 tp -57.93 -41.15 82.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.759 -1.109 . . . . 1.23 110.531 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.728 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.9 t-20 -51.14 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.406 -0.815 . . . . 0.94 110.566 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.55 -41.88 42.57 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.224 0.952 . . . . 2.46 112.244 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.8 t -55.1 -63.19 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.457 0.169 . . . . 0.37 111.457 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.797 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 16.1 m-85 -70.3 -37.31 74.76 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.379 -0.6 . . . . 0.43 109.379 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.832 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 12.0 t-20 -50.25 -49.01 54.4 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.93 -1.032 . . . . 0.28 109.024 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -60.52 -46.77 88.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.524 -1.671 . . . . 3.25 111.714 -176.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 123' ' ' SER . 9.6 pt-20 -80.71 11.87 3.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.451 -0.499 . . . . 1.45 112.235 -174.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.582 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 132.93 -16.53 4.72 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.523 -0.762 . . . . 0.44 112.963 171.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.832 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 12.3 m-85 -82.15 137.0 35.07 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.3 -0.96 . . . . 1.07 111.875 -166.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.802 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 13.9 mt-30 -89.05 83.62 6.57 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.413 -0.958 . . . . 1.14 108.413 168.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.886 HG22 ' HB ' ' A' ' 6' ' ' ILE . 18.8 p -91.33 132.54 36.1 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.898 -0.592 . . . . 0.14 110.193 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 9.9 m-85 -121.68 124.39 44.17 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 122.486 1.136 . . . . 0.34 109.254 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.897 ' HB2' HH11 ' A' ' 16' ' ' ARG . 4.5 pt20 -84.18 119.8 25.44 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 112.839 -1.982 . . . . 0.22 111.693 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.953 ' HB1' ' HB3' ' A' ' 38' ' ' GLN . . . -119.22 138.35 53.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.441 -0.948 . . . . 0.23 108.441 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.495 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -97.15 -7.54 32.29 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.596 -0.841 . . . . 0.18 110.3 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.599 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 5.5 p-10 -146.42 166.0 27.68 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 120.152 -0.619 . . . . 0.29 111.68 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.64 -22.68 78.03 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.605 -0.725 . . . . 0.14 112.543 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' HB2' HD22 ' A' ' 35' ' ' ASN . 3.3 mm? -78.84 -38.24 38.49 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.052 -0.722 . . . . 0.28 109.052 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.953 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -59.0 -46.19 88.79 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 104.618 -2.364 . . . . 1.29 104.618 175.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -59.19 -49.14 79.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.501 -1.681 . . . . 0.14 111.594 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -53.37 -42.13 66.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.674 0.749 . . . . 0.97 109.405 176.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.27 -30.22 60.37 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.708 -1.133 . . . . 1.32 111.47 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.917 ' HB ' HD11 ' A' ' 7' ' ' LEU . 8.8 mm -68.24 -46.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 O-C-N 121.714 -0.616 . . . . 0.14 110.003 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 69' ' ' MET . 48.2 t -58.07 -42.91 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.065 0.936 . . . . 0.15 108.771 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -34.66 70.15 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.037 -1.438 . . . . 0.39 111.388 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.741 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.92 -47.29 7.68 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.421 0.526 . . . . 2.42 112.421 -174.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 46.0 mm-40 -107.44 -32.7 7.62 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.19 0.441 . . . . 0.63 112.19 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.458 HH21 ' CE ' ' A' ' 2' ' ' MET . 27.4 mtp85 63.69 61.17 1.74 Allowed Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 123.694 0.621 . . . . 3.66 110.247 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.788 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 53.2 Cg_exo -60.73 153.82 59.63 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 121.435 1.423 . . . . 0.21 111.635 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.745 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 5.2 m-20 -85.91 -42.01 14.45 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.303 -0.999 . . . . 0.98 108.303 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 49' ' ' ASP . 7.7 mp -111.56 111.61 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.422 -0.808 . . . . 0.26 110.585 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' HB3' ' A' ' 7' ' ' LEU . 91.7 t -109.99 113.54 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.075 0.464 . . . . 0.21 111.414 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.02 HD22 HD21 ' A' ' 19' ' ' LEU . 2.0 mp -87.47 87.34 7.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.53 0.681 . . . . 0.15 109.773 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 9' ' ' VAL . 37.8 mt -84.88 110.31 18.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.786 -1.097 . . . . 1.53 111.124 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.66 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 49.1 t0 -68.82 115.88 8.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.616 0.722 . . . . 1.47 111.1 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.489 ' SD ' HG12 ' A' ' 63' ' ' ILE . 9.2 mmm -84.33 -3.51 58.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.65 -1.159 . . . . 0.94 111.343 176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' NZ ' ' HB2' ' A' ' 83' ' ' ALA . 22.2 mmmt -61.75 -65.57 0.67 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.893 0.701 . . . . 2.24 112.893 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.969 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 10.1 tp -169.81 -30.69 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.594 1.331 . . . . 2.06 114.594 -171.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -23.72 -55.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 124.08 3.186 . . . . 0.45 116.204 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -144.6 -62.75 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.824 -1.179 . . . . 0.47 112.702 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.7 ttm -148.76 167.29 25.98 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.277 -0.638 . . . . 2.23 109.277 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 65' ' ' ILE . 7.3 m-20 -58.48 127.7 33.46 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.297 0.57 . . . . 0.67 109.485 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.36 -15.9 33.12 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.703 -1.135 . . . . 0.32 112.528 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 93' ' ' SER . 3.0 mm -77.75 -41.4 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 117.456 0.628 . . . . 1.31 110.379 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -68.48 -37.31 80.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.723 -0.671 . . . . 0.47 109.335 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.538 ' HB ' HD13 ' A' ' 53' ' ' LEU . 14.5 mt -72.72 -36.37 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.69 110.714 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.65 HD22 HG21 ' A' ' 78' ' ' VAL . 2.8 pp -67.32 -36.13 80.84 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.259 -0.576 . . . . 1.47 109.814 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 6.9 ptpp? -75.77 -32.62 60.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.619 -0.832 . . . . 0.65 111.354 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' CG ' ' HA ' ' A' ' 65' ' ' ILE . 10.9 ptp180 -67.71 -35.17 78.3 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 118.968 -1.093 . . . . 2.18 111.493 174.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.781 ' HA ' HG12 ' A' ' 72' ' ' ILE . 9.5 ptp -80.29 -17.31 52.48 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 120.164 -0.615 . . . . 1.28 109.641 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.4 mptp? -70.3 -40.83 74.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.363 -0.977 . . . . 1.3 108.363 167.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 67' ' ' LYS . 95.8 t -61.75 -39.16 82.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 1.03 110.605 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.781 HG12 ' HA ' ' A' ' 69' ' ' MET . 32.0 pt -85.19 -20.25 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.676 -0.41 . . . . 0.26 110.655 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.69 85.22 0.55 Allowed 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 112.555 0.576 . . . . 1.08 112.555 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.9 mt-10 -73.96 5.56 4.11 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.412 -0.805 . . . . 1.78 109.845 173.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.15 -28.52 62.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.562 1.172 . . . . 0.35 108.033 170.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.618 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.3 tt -76.06 161.63 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-N 112.843 -1.98 . . . . 0.21 111.403 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -138.47 176.76 8.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.737 -1.12 . . . . 1.08 108.179 173.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.68 HG11 HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -142.65 153.01 17.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 119.941 -0.704 . . . . 0.79 111.806 -173.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.712 HG23 ' OG1' ' A' ' 100' ' ' THR . 71.3 mt -124.71 73.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.328 -1.36 . . . . 0.6 107.328 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -65.41 138.23 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.216 -0.902 . . . . 0.14 111.829 -171.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.773 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 6.1 mtm -94.18 117.93 30.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.089 -0.96 . . . . 1.88 110.317 -174.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 11.0 p -125.82 157.4 37.65 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.667 -0.697 . . . . 1.13 112.163 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . . . -73.97 60.66 0.77 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.716 -0.675 . . . . 0.54 110.436 167.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 58.4 t80 60.43 54.61 3.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.334 0.587 . . . . 4.3 111.554 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.2 87.34 0.03 OUTLIER Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.891 -0.595 . . . . 0.62 113.475 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.657 ' N ' HG13 ' A' ' 90' ' ' ILE . 22.5 mt-10 -87.12 16.12 5.43 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.948 0.499 . . . . 1.33 111.582 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 87' ' ' LEU . 3.7 mm? 63.65 179.35 0.16 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.8 1.407 . . . . 1.73 114.8 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 89' ' ' MET . 1.7 t70 61.82 -93.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.268 -1.333 . . . . 1.38 111.658 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.824 ' HB3' HG13 ' A' ' 63' ' ' ILE . 1.1 mpt? -64.25 -14.34 55.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.066 0.46 . . . . 2.72 110.577 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.657 HG13 ' N ' ' A' ' 86' ' ' GLU . 40.5 mm -77.34 -22.1 14.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.366 0.603 . . . . 0.67 110.605 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 13.4 mt-30 -81.15 -47.2 13.78 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.793 -1.188 . . . . 2.5 107.793 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.615 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 19.7 tt0 -65.33 -33.56 76.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.929 -1.487 . . . . 1.27 112.671 -177.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.833 ' HB3' HD12 ' A' ' 63' ' ' ILE . 7.9 p -52.45 -74.78 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.06 0.933 . . . . 1.28 111.611 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.6 pttt -53.78 -35.91 61.84 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.779 -1.555 . . . . 1.91 111.992 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -62.11 -34.3 76.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.886 -0.326 . . . . 1.84 111.161 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.3 mt -81.31 -24.66 37.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.896 0.379 . . . . 1.25 111.019 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.31 -1.79 0.25 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 119.877 -1.154 . . . . 0.35 113.706 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.649 ' CA ' HG23 ' A' ' 78' ' ' VAL . . . -70.74 132.15 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.954 0.877 . . . . 0.21 109.605 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.41 HD11 ' HG ' ' A' ' 50' ' ' LEU . 12.5 mt -75.29 -48.25 24.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.043 0.925 . . . . 0.18 109.392 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.712 ' OG1' HG23 ' A' ' 79' ' ' ILE . 71.1 p -141.72 156.74 45.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.889 -1.505 . . . . 0.19 111.914 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.62 98.62 8.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.354 -1.294 . . . . 0.52 109.47 171.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.773 ' HB3' ' HA ' ' A' ' 81' ' ' MET . 26.0 t80 -56.41 143.23 35.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.445 -0.798 . . . . 3.86 109.441 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' THR . . . -130.32 167.45 18.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.759 -0.46 . . . . 0.76 109.759 172.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 54.5 mtpt -68.15 -40.88 23.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.203 -0.453 . . . . 3.35 111.387 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 58.0 Cg_endo -76.6 96.36 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.767 0.952 . . . . 1.36 110.62 166.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.625 ' HB2' HD11 ' A' ' 111' ' ' ILE . 53.0 p90 -129.03 143.62 50.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.059 -0.519 . . . . 1.1 111.607 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.511 ' HB3' ' HG2' ' A' ' 110' ' ' GLU . 1.8 t70 -75.25 -3.68 34.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.888 -0.596 . . . . 1.77 110.712 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 107' ' ' ASP . 9.4 tp 52.2 -53.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.613 1.565 . . . . 1.39 112.206 -165.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.458 ' HA ' ' HG3' ' A' ' 112' ' ' ARG . 35.0 t70 -65.9 -26.99 67.87 Favored 'General case' 0 C--O 1.211 -0.924 0 O-C-N 122.384 -0.197 . . . . 1.16 110.94 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 11.3 pt-20 -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.203 -0.599 . . . . 0.84 109.864 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 106' ' ' PHE . 47.7 mt -83.23 -43.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.74 109.559 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.636 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -65.42 -39.58 92.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.809 -0.811 . . . . 0.72 108.809 175.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 13.8 t70 -67.95 -40.53 83.24 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.187 -0.671 . . . . 0.78 109.187 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.612 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . . . -55.63 -48.71 74.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.324 -0.853 . . . . 0.59 110.927 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 112' ' ' ARG . 34.3 m -61.93 -48.23 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 120.082 -0.647 . . . . 0.47 111.173 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.631 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -70.91 -19.91 62.54 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.598 0.592 . . . . 1.16 112.598 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 114' ' ' ALA . 7.4 pttm -86.61 -23.14 25.83 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.415 -0.914 . . . . 1.48 111.154 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.523 ' HD2' ' O ' ' A' ' 114' ' ' ALA . 28.4 m-85 -82.17 -67.19 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.024 -0.362 . . . . 2.21 110.024 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.0 95.05 49.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.26 -0.645 . . . . 2.09 109.26 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 84.1 Cg_endo -91.1 141.65 2.96 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.857 2.372 . . . . 0.92 113.942 -173.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.02 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 29.7 tp -114.66 -66.28 1.1 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.725 0.774 . . . . 1.25 109.84 174.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 1.02 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 60.8 mttm -143.94 -51.51 0.32 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.645 -1.161 . . . . 2.78 109.87 -172.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.701 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 90.3 p 55.18 -108.75 0.45 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.012 -0.995 . . . . 2.17 111.252 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -174.94 -38.0 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 111.832 0.308 . . . . 5.26 111.832 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.8 tp -105.48 131.68 52.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.882 0.373 . . . . 5.75 111.583 -172.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -82.88 170.39 15.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.557 -0.747 . . . . 8.65 110.386 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 34.8 m80 62.85 -170.3 0.18 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.456 0.646 . . . . 9.73 111.628 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -146.15 91.34 2.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.587 -0.733 . . . . 12.67 109.332 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -79.43 -178.48 6.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.74 -0.664 . . . . 12.92 109.359 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 73.69 25.36 2.03 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.295 0.372 . . . . 16.51 110.198 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -73.58 96.43 2.44 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.362 -0.607 . . . . 17.15 109.362 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-N 114.846 -1.07 . . . . 19.6 111.094 -174.232 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.417 0.151 . . . . 6.07 110.929 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.8 tpt 176.99 -161.67 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.951 -1.129 . . . . 3.88 107.951 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.597 ' HB2' HE22 ' A' ' 29' ' ' GLN . 0.0 OUTLIER -91.39 -72.36 0.59 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.333 -0.988 . . . . 2.35 108.333 167.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.818 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 3.0 tp10 169.11 124.01 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.325 -1.361 . . . . 2.3 107.325 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.73 ' HD3' ' HB3' ' A' ' 46' ' ' GLU . 2.7 ttmt -150.31 139.73 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.188 1.181 . . . . 0.8 114.188 -167.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.938 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.6 mt -139.39 154.82 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.233 -1.349 . . . . 0.2 111.49 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.01 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.4 tt -135.55 117.95 15.73 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.52 -1.289 . . . . 0.17 107.52 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.749 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.1 mp -103.7 100.92 11.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.987 -0.685 . . . . 0.22 110.132 -177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.777 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 48.8 t -83.61 91.25 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.559 -0.534 . . . . 0.28 109.559 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.83 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 4.7 t70 -143.35 142.98 31.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.543 0.211 . . . . 1.82 110.607 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.883 ' H ' ' HG3' ' A' ' 58' ' ' PRO . 15.2 t70 -102.46 -31.62 10.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.891 0.377 . . . . 0.51 110.27 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -79.12 70.91 5.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.507 -1.294 . . . . 2.07 107.507 172.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 17' ' ' ILE . 46.7 p90 -52.29 -15.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 112.88 -1.964 . . . . 1.44 115.099 -159.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.64 -60.9 5.54 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.906 -1.14 . . . . 0.38 110.334 169.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HA ' HD23 ' A' ' 18' ' ' LEU . 2.9 mt -55.17 -30.49 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.333 0.587 . . . . 0.8 111.056 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.83 ' HG3' ' HB3' ' A' ' 10' ' ' ASP . 9.1 ttm180 -76.29 -49.79 16.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.749 . . . . 0.38 110.596 -168.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.5 pt -76.19 -25.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.598 -0.519 . . . . 0.56 109.598 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 15' ' ' ILE . 2.8 tp -57.24 -65.26 0.65 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.348 -0.842 . . . . 0.58 109.457 171.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.827 HD13 HD22 ' A' ' 52' ' ' LEU . 57.8 mt -58.26 -44.15 88.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.23 109.939 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.609 ' HB3' ' HA ' ' A' ' 17' ' ' ILE . 5.5 t30 -50.5 -66.17 0.43 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.36 -0.837 . . . . 0.94 110.128 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.47 -39.21 82.95 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.662 0.601 . . . . 2.46 111.396 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 18' ' ' LEU . 24.9 t -55.08 -58.17 5.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 111.787 0.291 . . . . 0.37 111.787 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.694 ' CD2' HD13 ' A' ' 6' ' ' ILE . 7.9 m-85 -73.56 -40.09 64.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.256 -0.646 . . . . 0.43 109.256 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 12.8 t-20 -50.78 -50.23 56.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.066 -0.97 . . . . 0.28 108.557 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -51.11 -46.75 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.275 -1.784 . . . . 3.25 112.58 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.625 ' OE1' ' HD3' ' A' ' 112' ' ' ARG . 6.5 pt-20 -88.21 16.16 6.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.116 -0.634 . . . . 1.45 111.544 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.79 ' HA3' HD23 ' A' ' 121' ' ' LEU . . . 126.98 -15.45 6.53 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.495 -0.859 . . . . 0.44 113.581 169.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.818 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 10.2 m-85 -73.83 160.22 31.77 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 118.899 -1.12 . . . . 1.07 112.407 -168.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.697 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 2.1 mp0 -106.83 76.32 1.1 Allowed 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.101 -1.409 . . . . 1.14 107.337 173.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.938 HG22 ' HB ' ' A' ' 6' ' ' ILE . 27.2 p -90.68 130.55 36.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.876 -1.056 . . . . 0.14 109.457 -173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.462 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 11.3 m-85 -126.9 108.96 11.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.632 1.206 . . . . 0.34 109.876 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.753 ' HB2' HH11 ' A' ' 16' ' ' ARG . 3.1 pt20 -61.29 120.72 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 112.483 -2.144 . . . . 0.22 112.577 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -124.33 125.94 45.17 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.957 0.903 . . . . 0.23 109.094 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 10' ' ' ASP . . . -82.84 -11.03 58.55 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.042 -0.663 . . . . 0.18 111.058 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 38' ' ' GLN . 1.7 p-10 -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.077 0.399 . . . . 0.29 112.077 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.5 -19.34 78.94 Favored Glycine 0 CA--C 1.506 -0.492 0 CA-C-N 115.794 -0.639 . . . . 0.14 113.051 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.62 -40.91 24.83 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.154 0.978 . . . . 0.28 108.949 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.827 ' O ' HG12 ' A' ' 42' ' ' ILE . 1.8 tp-100 -61.17 -41.87 97.54 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.391 -2.077 . . . . 1.29 105.391 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 9' ' ' VAL . . . -59.27 -46.74 87.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.157 -1.383 . . . . 0.14 111.17 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -53.76 -48.27 69.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.623 -0.717 . . . . 0.97 109.816 175.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.55 -39.1 92.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.42 -1.264 . . . . 1.32 111.064 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.86 ' HB ' HD11 ' A' ' 7' ' ' LEU . 20.0 mm -65.94 -48.68 81.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.234 -0.439 . . . . 0.14 110.083 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.494 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 59.4 t -58.46 -42.73 85.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.15 109.231 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.36 -29.74 70.09 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.117 -0.947 . . . . 0.39 111.425 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HE2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -88.94 -46.6 8.77 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.299 0.481 . . . . 2.42 112.299 -177.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.73 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 46.3 mm-40 -108.45 -35.05 6.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 111.975 0.361 . . . . 0.63 111.975 -176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 45.4 mtp180 63.69 60.39 1.8 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.294 -0.867 . . . . 3.66 109.889 -171.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 7' ' ' LEU . 32.1 Cg_exo -62.65 146.62 95.31 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 121.376 1.384 . . . . 0.21 110.95 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 m-20 -85.96 -35.24 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.409 -0.916 . . . . 0.98 109.389 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 7.0 mp -113.13 111.11 21.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.26 109.638 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 7' ' ' LEU . 19.0 t -117.34 112.59 39.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.383 -0.372 . . . . 0.21 110.821 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.827 HD22 HD13 ' A' ' 19' ' ' LEU . 3.2 mp -83.59 104.67 13.9 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.957 -0.464 . . . . 0.15 110.496 -176.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.777 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 8.1 mp -99.04 102.52 14.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.516 -0.311 . . . . 1.53 111.824 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.658 ' OD1' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t70 -63.83 111.1 2.31 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.527 -0.469 . . . . 1.47 110.059 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.741 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 17.1 mtm -91.37 12.38 20.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.234 -0.439 . . . . 0.94 111.013 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.658 ' HB2' ' OD1' ' A' ' 54' ' ' ASP . 14.2 mmmm -70.61 -65.91 0.67 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.782 0.289 . . . . 2.24 111.782 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.995 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 2.3 pt -160.72 -39.5 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.908 1.077 . . . . 2.06 113.908 -169.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -21.2 -60.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 124.905 3.737 . . . . 0.45 116.928 -175.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.68 -66.64 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.651 -1.262 . . . . 0.47 113.0 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 49.5 ttm -139.69 164.14 30.73 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 2.23 109.414 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.463 ' O ' HG13 ' A' ' 65' ' ' ILE . 2.7 m-20 -61.06 134.67 57.31 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.75 -0.463 . . . . 0.67 109.75 174.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 55' ' ' MET . . . -62.01 -15.23 49.08 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 115.451 -0.795 . . . . 0.32 112.378 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.611 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 9.6 mt -78.3 -44.25 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.061 -0.67 . . . . 1.31 109.836 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.58 -33.56 74.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.351 0.596 . . . . 0.47 110.048 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 53' ' ' LEU . 31.9 mt -74.16 -39.38 49.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.69 110.453 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 2.9 pp -65.92 -36.8 84.37 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 120.187 -0.605 . . . . 1.47 109.951 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 18.1 ptpt -75.42 -36.08 60.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 120.491 -0.483 . . . . 0.65 111.391 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 11.2 ptm180 -64.87 -36.86 85.7 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 119.497 -0.881 . . . . 2.18 111.144 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.79 ' HA ' HG12 ' A' ' 72' ' ' ILE . 11.4 ptp -82.46 -14.12 55.6 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.102 -0.639 . . . . 1.28 109.618 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.9 mptp? -70.45 -40.02 73.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.089 -1.078 . . . . 1.3 108.089 167.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 67' ' ' LYS . 94.0 t -62.54 -38.58 81.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.453 -0.794 . . . . 1.03 110.125 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.79 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.1 pt -86.47 -19.03 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.525 -0.47 . . . . 0.26 111.074 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.96 86.12 0.42 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.484 0.55 . . . . 1.08 112.484 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.586 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 32.1 mt-10 -70.53 1.34 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.046 -1.034 . . . . 1.78 110.646 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -30.43 64.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.596 1.189 . . . . 0.35 108.05 171.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.783 HG21 ' HG3' ' A' ' 69' ' ' MET . 3.9 tt -69.24 161.54 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.636 -2.075 . . . . 0.21 111.482 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -141.56 174.72 10.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.849 -1.069 . . . . 1.08 108.649 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 98' ' ' ALA . 10.1 m -141.54 143.4 27.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.55 0.69 . . . . 0.79 111.273 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.625 HG23 ' OG1' ' A' ' 100' ' ' THR . 4.2 mp -108.79 75.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.581 -1.266 . . . . 0.6 107.581 174.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.741 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -69.51 141.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 119.363 -0.935 . . . . 0.14 112.016 -172.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.596 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 27.8 mtt -95.23 136.78 35.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.22 -0.9 . . . . 1.88 110.335 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.533 ' CG2' ' HB1' ' A' ' 101' ' ' ALA . 4.7 t -132.83 158.12 43.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.117 0.784 . . . . 1.13 113.117 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . . . -72.71 64.16 0.64 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.544 -1.207 . . . . 0.54 109.654 169.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 70.15 15.06 7.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.235 -0.893 . . . . 4.3 112.32 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.28 92.03 1.07 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.58 -0.819 . . . . 0.62 111.412 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.566 ' N ' HG13 ' A' ' 90' ' ' ILE . 12.4 mt-10 -88.03 7.25 32.15 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 122.927 0.491 . . . . 1.33 111.644 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 59.9 -175.11 0.11 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.47 -0.786 . . . . 1.73 112.813 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.86 -93.34 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.083 -0.962 . . . . 1.38 112.324 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.533 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.8 ptt? -61.2 -24.11 66.09 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.137 0.494 . . . . 2.72 110.332 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 86' ' ' GLU . 26.1 mm -66.01 -47.38 85.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 0.67 109.952 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 14.1 mm100 -61.64 -50.23 73.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.39 -0.823 . . . . 2.5 109.647 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 13.3 tt0 -63.59 -33.44 75.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.041 -0.981 . . . . 1.27 112.431 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -59.13 -63.7 1.21 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.662 0.268 . . . . 1.28 110.631 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.9 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 20.6 pttt -55.83 -40.18 72.45 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.433 0.635 . . . . 1.91 110.871 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 6.8 tp10 -54.52 -35.59 63.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 1.84 111.51 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.416 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 18.1 tp -90.19 -10.86 42.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.723 0.268 . . . . 1.25 111.723 -173.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.554 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 154.86 -12.13 0.45 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.76 -1.21 . . . . 0.35 113.644 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.9 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -73.99 145.59 44.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.292 0.546 . . . . 0.21 110.784 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 77' ' ' ARG . 16.7 mt -87.86 -50.37 6.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.501 0.667 . . . . 0.18 109.797 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.625 ' OG1' HG23 ' A' ' 79' ' ' ILE . 52.3 p -143.26 160.44 40.48 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.263 -1.335 . . . . 0.19 111.433 -170.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -109.98 98.22 7.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.846 -1.07 . . . . 0.52 110.081 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HD2' HD12 ' A' ' 111' ' ' ILE . 43.7 t80 -68.29 124.86 24.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.611 -0.722 . . . . 3.86 109.954 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.07 178.0 5.28 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.769 -0.372 . . . . 0.76 110.463 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 94.2 mttt -53.37 -47.16 97.15 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.501 0.556 . . . . 3.35 112.501 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 57.5 Cg_endo -73.27 97.49 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 120.86 1.04 . . . . 1.36 111.593 173.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.411 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 40.5 p90 -133.37 138.22 46.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.968 -0.56 . . . . 1.1 110.727 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.645 ' O ' HG22 ' A' ' 108' ' ' ILE . 8.0 t70 -72.82 -4.99 35.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.895 -0.593 . . . . 1.77 111.078 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 107' ' ' ASP . 6.3 tt 59.41 -56.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.856 1.262 . . . . 1.39 110.598 -165.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.96 -38.86 92.77 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 110.26 -0.274 . . . . 1.16 110.26 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.583 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 pt-20 -61.19 -27.92 68.77 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.695 -0.402 . . . . 0.84 110.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.611 HD12 ' HD2' ' A' ' 102' ' ' PHE . 4.7 mm -77.43 -50.91 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.354 -0.61 . . . . 0.74 109.354 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.625 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -66.87 -36.43 82.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.563 0.697 . . . . 0.72 109.697 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.526 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 35.0 t70 -69.56 -42.45 74.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.635 -0.711 . . . . 0.78 109.088 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.88 -40.74 98.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.525 -0.761 . . . . 0.59 110.978 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 112' ' ' ARG . 33.0 m -63.83 -53.38 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 119.15 -1.02 . . . . 0.47 110.952 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -69.68 -16.85 63.43 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.343 0.497 . . . . 1.16 112.343 -178.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 18.6 ptpt -83.64 -26.89 29.54 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.29 -0.881 . . . . 1.48 111.041 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -81.42 -59.39 2.64 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.996 0.427 . . . . 2.21 109.955 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 44.2 tp -120.55 107.83 38.24 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.368 -0.975 . . . . 2.09 108.368 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.54 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 91.2 Cg_endo -100.86 146.97 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.893 2.395 . . . . 0.92 114.683 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.099 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 16.4 tp -116.08 -67.56 0.99 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.474 -0.785 . . . . 1.25 110.536 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 1.099 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 67.9 mttm -134.12 -42.05 0.81 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.888 -1.051 . . . . 2.78 111.211 -169.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 m -36.85 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.385 1.053 . . . . 2.17 110.311 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -105.71 141.3 37.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.334 -0.848 . . . . 5.26 112.524 -161.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.42 10.77 4.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.353 -0.839 . . . . 5.75 109.698 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -167.97 115.61 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.64 -0.709 . . . . 8.65 109.737 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -90.7 -52.91 4.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.118 0.485 . . . . 9.73 109.998 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -115.14 -77.12 0.57 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.589 -0.732 . . . . 12.67 109.203 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -135.66 156.44 48.84 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.52 -0.919 . . . . 12.92 108.52 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -75.02 123.77 25.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.209 -0.663 . . . . 16.51 109.209 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -79.44 98.28 6.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.767 0.794 . . . . 17.15 110.484 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.103 -0.953 . . . . 19.6 109.051 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.24 -0.281 . . . . 6.07 110.24 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.717 ' HB2' HD11 ' A' ' 119' ' ' LEU . 2.0 mpt? 52.43 -167.01 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.426 0.631 . . . . 3.88 112.06 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -112.36 -6.37 14.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.644 -0.707 . . . . 2.35 109.316 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.809 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 7.3 tt0 68.14 92.36 0.08 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.096 0.95 . . . . 2.3 111.612 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.853 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 3.6 tppt? -131.28 152.41 50.57 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.012 -0.994 . . . . 0.8 110.622 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.836 ' HB ' HG22 ' A' ' 30' ' ' THR . 2.3 mt -142.36 154.25 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.614 0.721 . . . . 0.2 111.645 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.859 HD11 ' HB ' ' A' ' 42' ' ' ILE . 2.2 tt -132.11 122.04 24.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.418 -1.326 . . . . 0.17 107.418 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 30' ' ' THR . 1.6 mp -108.71 106.33 20.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.125 -0.63 . . . . 0.22 109.59 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 53' ' ' LEU . 23.5 t -95.11 71.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 O-C-N 122.97 0.169 . . . . 0.28 110.683 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.836 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.1 m-20 -118.33 135.63 54.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.651 0.262 . . . . 1.82 111.208 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 1.05 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 29.7 t70 -86.69 -27.46 23.71 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.184 -1.043 . . . . 0.51 108.184 171.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.793 ' HB2' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -78.88 73.37 5.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.475 -1.306 . . . . 2.07 107.475 167.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 40.3 p90 -54.13 -17.49 2.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.829 -1.532 . . . . 1.44 113.178 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.5 -63.89 4.87 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.925 -1.27 . . . . 0.38 109.925 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 12' ' ' GLN . 3.0 mt -53.62 -25.28 11.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.869 0.366 . . . . 0.8 111.574 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.868 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 10.2 ttm180 -76.94 -50.24 13.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.308 -0.406 . . . . 0.38 111.081 -171.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 43.1 pt -74.74 -24.67 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.193 -0.669 . . . . 0.56 109.193 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.7 tp -57.27 -67.76 0.29 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.928 -1.033 . . . . 0.58 109.493 170.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 52' ' ' LEU . 60.5 mt -54.64 -40.88 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 1.23 110.451 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 6.8 t30 -50.68 -69.25 0.12 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.585 -0.734 . . . . 0.94 110.139 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.3 -39.41 75.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 2.46 111.568 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 18' ' ' LEU . 49.4 t -57.1 -55.69 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 111.999 0.37 . . . . 0.37 111.999 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.694 ' HB2' HG21 ' A' ' 30' ' ' THR . 6.7 m-85 -77.03 -37.73 54.27 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.782 -0.451 . . . . 0.43 109.782 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.823 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 17.1 t-20 -49.95 -50.3 47.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.033 0.921 . . . . 0.28 109.189 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.09 -33.68 71.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.343 -1.753 . . . . 3.25 113.06 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.872 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 4.2 mt-10 -68.08 -23.49 64.94 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.307 -0.627 . . . . 1.45 109.307 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.05 -13.32 2.6 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.66 -1.155 . . . . 0.44 110.569 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.823 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 6.7 m-85 -72.65 134.25 45.02 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.612 0.72 . . . . 1.07 111.557 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.853 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 19.2 mt-30 -88.61 80.95 7.19 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.212 -1.033 . . . . 1.14 108.212 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.836 HG22 ' HB ' ' A' ' 6' ' ' ILE . 17.2 p -90.25 137.32 32.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.808 -0.633 . . . . 0.14 110.026 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.584 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 38.1 m-85 -129.78 126.09 37.32 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.677 1.227 . . . . 0.34 110.272 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.868 ' HB2' ' HD2' ' A' ' 16' ' ' ARG . 4.6 pt20 -85.28 121.13 27.57 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.639 -2.073 . . . . 0.22 111.93 -171.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 42' ' ' ILE . . . -121.47 137.12 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.89 . . . . 0.23 108.894 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 58' ' ' PRO . . . -93.06 -10.72 35.09 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.778 -0.369 . . . . 0.18 110.42 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.541 HD22 ' HB2' ' A' ' 37' ' ' LEU . 3.1 p-10 -149.0 165.8 30.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.29 111.444 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 39' ' ' ALA . . . -71.94 -16.3 76.47 Favored Glycine 0 CA--C 1.504 -0.611 0 CA-C-N 115.747 -0.66 . . . . 0.14 113.467 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.541 ' HB2' HD22 ' A' ' 35' ' ' ASN . 2.8 mm? -81.31 -43.73 18.68 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 122.679 1.228 . . . . 0.28 108.038 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.8 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 tp-100 -60.33 -41.11 92.87 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.114 -2.312 . . . . 1.29 105.49 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.78 -44.23 90.66 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.699 -1.591 . . . . 0.14 111.079 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.581 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.3 OUTLIER -55.5 -42.63 74.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.401 -0.592 . . . . 0.97 109.401 175.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 14.7 m-20 -64.65 -41.79 95.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.108 -0.951 . . . . 1.32 110.906 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.859 ' HB ' HD11 ' A' ' 7' ' ' LEU . 9.9 mm -61.04 -50.11 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 121.015 -0.274 . . . . 0.14 110.748 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 41.2 t -59.04 -45.33 92.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-O 121.817 0.817 . . . . 0.15 109.45 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.581 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -59.87 -28.91 67.94 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.868 -1.06 . . . . 0.39 111.783 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -96.04 -46.66 6.41 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.966 -0.561 . . . . 2.42 111.848 -173.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' CD1' ' A' ' 31' ' ' PHE . 60.8 mm-40 -105.07 -36.52 7.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.733 0.271 . . . . 0.63 111.733 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 64.58 65.96 1.0 Allowed Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.776 0.672 . . . . 3.66 109.929 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.808 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 76.9 Cg_exo -58.97 161.42 15.75 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.803 1.669 . . . . 0.21 112.118 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.784 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.7 m-20 -94.63 -40.04 10.03 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.195 -1.039 . . . . 0.98 108.195 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mp -116.91 118.6 32.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.255 -0.884 . . . . 0.26 109.876 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 7' ' ' LEU . 96.7 t -118.06 112.02 36.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.122 0.487 . . . . 0.21 110.871 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 19' ' ' LEU . 2.6 mp -82.9 98.5 9.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.46 0.647 . . . . 0.15 109.544 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.677 HD12 ' HA2' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -88.18 99.71 12.41 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.972 -1.013 . . . . 1.53 111.007 -175.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HB3' ' HG2' ' A' ' 58' ' ' PRO . 23.2 t0 -68.23 100.8 1.08 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.351 -0.611 . . . . 1.47 109.351 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.782 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 44.9 mtp -77.03 -5.9 50.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.041 -0.527 . . . . 0.94 110.95 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.2 mmmm -50.63 -54.64 21.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.267 0.84 . . . . 2.24 113.267 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.864 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 10.4 tp -177.48 -11.09 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 114.974 1.472 . . . . 2.06 114.974 -171.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.05 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -32.09 -51.04 0.33 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.991 2.461 . . . . 0.45 115.723 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.36 -43.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.913 -1.137 . . . . 0.47 112.739 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.8 tpt -147.81 167.23 25.27 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.816 -0.809 . . . . 2.23 108.816 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.23 139.1 57.29 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.247 0.546 . . . . 0.67 110.308 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.677 ' HA2' HD12 ' A' ' 53' ' ' LEU . . . -60.53 -15.06 38.04 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.984 -1.007 . . . . 0.32 112.49 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.829 HG13 ' HB3' ' A' ' 89' ' ' MET . 3.7 mm -79.85 -47.64 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.736 0.303 . . . . 1.31 110.311 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -61.43 -36.72 81.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.657 0.741 . . . . 0.47 109.216 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 68.1 mt -72.73 -36.93 54.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.137 -0.938 . . . . 0.69 111.225 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.624 ' CD2' ' HA ' ' A' ' 63' ' ' ILE . 2.2 pp -70.65 -37.44 73.73 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.289 -0.564 . . . . 1.47 110.715 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.663 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 17.1 ptpt -73.06 -34.57 66.36 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.526 -0.469 . . . . 0.65 110.964 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.702 ' O ' HG12 ' A' ' 71' ' ' VAL . 12.0 ptm180 -65.5 -34.68 78.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.436 -0.905 . . . . 2.18 111.29 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.685 ' HA ' HG12 ' A' ' 72' ' ' ILE . 4.7 ptt? -83.66 -12.33 56.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.894 -1.122 . . . . 1.28 109.864 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 3.6 mptp? -78.81 -35.05 44.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.635 -0.711 . . . . 1.3 110.058 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 68' ' ' ARG . 3.9 p -73.79 -34.33 40.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.742 -0.663 . . . . 1.03 109.419 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.685 HG12 ' HA ' ' A' ' 69' ' ' MET . 22.0 pt -80.85 -34.77 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.373 -0.83 . . . . 0.26 110.204 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -155.79 90.39 1.22 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.565 0.58 . . . . 1.08 112.565 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -73.04 4.72 3.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.525 0.679 . . . . 1.78 110.34 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -26.1 63.84 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.488 -1.301 . . . . 0.35 107.488 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.9 tt -77.32 160.43 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 112.706 -2.043 . . . . 0.21 110.919 -172.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.692 ' HE ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -137.63 -179.68 5.89 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.356 -0.838 . . . . 1.08 109.046 173.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.614 HG21 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -134.48 153.53 35.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.299 -0.561 . . . . 0.79 110.218 -172.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.635 HG23 ' OG1' ' A' ' 100' ' ' THR . 63.4 mt -130.73 71.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.411 -1.329 . . . . 0.6 107.411 170.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.782 ' HB ' ' HG3' ' A' ' 55' ' ' MET . 0.2 OUTLIER -68.31 139.61 20.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.257 -0.883 . . . . 0.14 111.849 -172.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 4.8 mtp -99.1 131.62 45.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.044 -0.98 . . . . 1.88 110.445 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 t -133.3 158.52 42.75 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.048 0.758 . . . . 1.13 113.048 -175.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.48 65.66 0.66 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.028 -0.987 . . . . 0.54 109.719 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.515 ' HE1' ' HE2' ' A' ' 104' ' ' LYS . 49.8 m-85 71.44 15.27 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 4.3 112.677 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 90' ' ' ILE . . . 85.51 79.87 1.14 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.332 -0.937 . . . . 0.62 111.522 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 90' ' ' ILE . 6.9 mt-10 -75.86 14.96 0.58 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.817 0.847 . . . . 1.33 111.693 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 27.6 mt 59.36 -170.48 0.13 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.62 0.97 . . . . 1.73 113.62 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 58.74 -94.6 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.801 -1.09 . . . . 1.38 110.885 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.829 ' HB3' HG13 ' A' ' 63' ' ' ILE . 3.1 mpp? -64.36 -19.66 65.62 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.943 0.402 . . . . 2.72 110.368 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 86' ' ' GLU . 41.6 mm -75.88 -23.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.601 0.715 . . . . 0.67 110.592 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 91' ' ' GLN . 10.6 mt-30 -82.37 -48.58 10.98 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.029 -1.1 . . . . 2.5 108.029 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 89' ' ' MET . 38.8 tt0 -63.48 -30.54 71.65 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 113.708 -1.587 . . . . 1.27 112.149 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.632 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . 16.8 p -53.66 -77.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.094 0.95 . . . . 1.28 112.245 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 13.1 ptpt -51.0 -41.0 59.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.506 -1.679 . . . . 1.91 110.79 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 4.6 tp10 -54.58 -44.82 73.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.387 -0.824 . . . . 1.84 111.612 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.62 HD23 HD11 ' A' ' 66' ' ' LEU . 12.4 tp -82.68 -15.94 50.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 1.25 111.778 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.527 ' HA3' ' CE ' ' A' ' 70' ' ' LYS . . . 149.41 1.67 0.37 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.672 -1.251 . . . . 0.35 113.954 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 94' ' ' LYS . . . -80.64 137.54 36.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.992 0.896 . . . . 0.21 109.769 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 77' ' ' ARG . 9.5 mt -76.3 -48.59 19.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.87 0.843 . . . . 0.18 109.411 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.635 ' OG1' HG23 ' A' ' 79' ' ' ILE . 41.1 p -139.29 150.77 45.82 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.368 -1.287 . . . . 0.19 111.955 -171.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 80' ' ' ILE . . . -114.54 67.74 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.04 -0.982 . . . . 0.52 109.735 173.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 81' ' ' MET . 39.1 m-85 -62.18 130.31 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 3.86 110.543 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.16 -167.1 1.36 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.058 -0.519 . . . . 0.76 110.823 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HE2' ' HE1' ' A' ' 84' ' ' TYR . 46.1 mtmt -55.59 -43.08 98.98 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.226 -0.443 . . . . 3.35 112.064 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 44.1 Cg_endo -70.5 97.26 0.69 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 120.816 1.011 . . . . 1.36 111.218 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB2' HD11 ' A' ' 111' ' ' ILE . 45.1 p90 -131.7 136.71 47.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.732 -0.667 . . . . 1.1 110.049 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.7 t70 -84.73 14.38 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 1.77 111.04 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 109' ' ' ASP . 4.2 tt 50.45 -64.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 125.095 1.497 . . . . 1.39 112.315 -171.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 0.8 OUTLIER -65.36 -23.87 67.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.815 -0.175 . . . . 1.16 110.66 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' OE2' ' HB2' ' A' ' 107' ' ' ASP . 8.9 pt-20 -68.5 -28.2 66.81 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.4 -0.52 . . . . 0.84 110.421 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' A' ' 106' ' ' PHE . 28.3 mt -81.21 -40.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.74 110.256 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.672 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -67.04 -37.1 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.843 0.83 . . . . 0.72 109.577 174.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.524 ' N ' ' HD2' ' A' ' 112' ' ' ARG . 4.7 t70 -68.44 -37.02 79.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.379 -0.828 . . . . 0.78 109.359 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.506 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -62.98 -47.66 82.21 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.323 -0.853 . . . . 0.59 111.224 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.638 HG12 HD22 ' A' ' 50' ' ' LEU . 17.8 m -62.82 -48.77 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 119.209 -0.996 . . . . 0.47 110.377 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 3.6 ttpp -53.98 -50.33 66.79 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.145 0.578 . . . . 1.16 112.237 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 114' ' ' ALA . 19.1 ptpt -60.21 -35.54 75.66 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.778 -0.576 . . . . 1.48 111.462 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.497 ' HD1' ' O ' ' A' ' 114' ' ' ALA . 24.6 m-85 -76.07 -56.4 4.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.993 0.425 . . . . 2.21 110.836 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 2' ' ' MET . 55.9 tp -127.47 97.53 30.8 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.925 -0.58 . . . . 2.09 109.686 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -98.58 117.29 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.83 2.354 . . . . 0.92 113.215 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.895 HD22 ' HE3' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -90.36 -61.47 1.67 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.138 0.97 . . . . 1.25 109.409 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.895 ' HE3' HD22 ' A' ' 121' ' ' LEU . 32.3 mmtp -127.62 -41.98 1.65 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.465 -1.698 . . . . 2.78 109.923 -172.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.872 ' HB2' ' HB3' ' A' ' 26' ' ' GLU . 9.0 t -53.13 179.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.524 -1.216 . . . . 2.17 112.715 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.609 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 7.1 t30 90.54 -29.85 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.105 1.362 . . . . 5.26 109.683 -172.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.84 95.16 9.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.094 -0.706 . . . . 5.75 109.094 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -78.59 99.73 6.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.03 -0.532 . . . . 8.65 110.339 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.432 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 1.8 p80 -86.29 166.52 15.59 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.888 -0.596 . . . . 9.73 110.189 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -130.91 -75.77 0.53 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.894 -0.322 . . . . 12.67 110.615 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.0 m170 61.25 -89.19 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.56 0.538 . . . . 12.92 111.448 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -169.15 91.03 0.23 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.394 -0.965 . . . . 16.51 108.394 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -146.59 122.4 10.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.027 0.441 . . . . 17.15 111.141 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.2 m80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.008 -0.996 . . . . 19.6 109.742 175.86 . . . . . . . . 0 0 . 1 stop_ save_